{
  "doc_id": "aspen_pediatric_neonatal_nutrition_handbook_3rd_edition__cc7dd2",
  "original_filename": "ASPEN Pediatric Neonatal Nutrition Handbook 3rd Edition.pdf",
  "md_path": "data/parsed/ASPEN Pediatric Neonatal Nutrition Handbook 3rd Edition/ASPEN Pediatric Neonatal Nutrition Handbook 3rd Edition.md",
  "rmd_path": "data/parsed/ASPEN Pediatric Neonatal Nutrition Handbook 3rd Edition/ASPEN Pediatric Neonatal Nutrition Handbook 3rd Edition.rmd",
  "blocks": [
    {
      "type": "heading",
      "level": 1,
      "section": "ASPEN Pediatric and Neonatal Nutrition Support Handbook",
      "line": 0
    },
    {
      "type": "text",
      "section": "ASPEN Pediatric and Neonatal Nutrition Support Handbook",
      "line": 2,
      "preview": "THIRD EDITION"
    },
    {
      "type": "text",
      "section": "ASPEN Pediatric and Neonatal Nutrition Support Handbook",
      "line": 4,
      "preview": "EDITOR"
    },
    {
      "type": "text",
      "section": "ASPEN Pediatric and Neonatal Nutrition Support Handbook",
      "line": 5,
      "preview": "Catherine Larson-Nath, MD, CNSC"
    },
    {
      "type": "text",
      "section": "ASPEN Pediatric and Neonatal Nutrition Support Handbook",
      "line": 7,
      "preview": "--- page 1 ---"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "ASPEN <br> Pediatric and Neonatal Nutrition Support Handbook",
      "line": 9
    },
    {
      "type": "text",
      "section": "ASPEN <br> Pediatric and Neonatal Nutrition Support Handbook",
      "line": 11,
      "preview": "--- page 2 ---"
    },
    {
      "type": "text",
      "section": "ASPEN <br> Pediatric and Neonatal Nutrition Support Handbook",
      "line": 13,
      "preview": "."
    },
    {
      "type": "text",
      "section": "ASPEN <br> Pediatric and Neonatal Nutrition Support Handbook",
      "line": 15,
      "preview": "--- page 3 ---"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "ASPEN Pediatric and Neonatal Nutrition Support Handbook",
      "line": 17
    },
    {
      "type": "text",
      "section": "ASPEN Pediatric and Neonatal Nutrition Support Handbook",
      "line": 19,
      "preview": "THIRD EDITION"
    },
    {
      "type": "text",
      "section": "ASPEN Pediatric and Neonatal Nutrition Support Handbook",
      "line": 21,
      "preview": "EDITOR"
    },
    {
      "type": "text",
      "section": "ASPEN Pediatric and Neonatal Nutrition Support Handbook",
      "line": 22,
      "preview": "Catherine Larson-Nath, MD, CNSC"
    },
    {
      "type": "text",
      "section": "ASPEN Pediatric and Neonatal Nutrition Support Handbook",
      "line": 24,
      "preview": "--- page 4 ---"
    },
    {
      "type": "text",
      "section": "ASPEN Pediatric and Neonatal Nutrition Support Handbook",
      "line": 26,
      "preview": "."
    },
    {
      "type": "text",
      "section": "ASPEN Pediatric and Neonatal Nutrition Support Handbook",
      "line": 28,
      "preview": "--- page 5 ---"
    },
    {
      "type": "text",
      "section": "ASPEN Pediatric and Neonatal Nutrition Support Handbook",
      "line": 30,
      "preview": "Copyright (C) 2024 by the American Society for Parenteral and Enteral Nutrition (ASPEN). All rights "
    },
    {
      "type": "text",
      "section": "ASPEN Pediatric and Neonatal Nutrition Support Handbook",
      "line": 32,
      "preview": "Electronic edition published 2024."
    },
    {
      "type": "text",
      "section": "ASPEN Pediatric and Neonatal Nutrition Support Handbook",
      "line": 33,
      "preview": "ISBN: 978-1-8896-2255-2 (electronic edition)."
    },
    {
      "type": "text",
      "section": "ASPEN Pediatric and Neonatal Nutrition Support Handbook",
      "line": 34,
      "preview": "Published by ASPEN, 8401 Colesville Road, Suite 510, Silver Spring, MD 20910"
    },
    {
      "type": "text",
      "section": "ASPEN Pediatric and Neonatal Nutrition Support Handbook",
      "line": 35,
      "preview": "https://www.nutritioncare.org"
    },
    {
      "type": "text",
      "section": "ASPEN Pediatric and Neonatal Nutrition Support Handbook",
      "line": 36,
      "preview": "aspen@nutritioncare.org"
    },
    {
      "type": "text",
      "section": "ASPEN Pediatric and Neonatal Nutrition Support Handbook",
      "line": 37,
      "preview": "ASPEN is a scientific society whose members are dietitians, nurses, pharmacists, physicians, scienti"
    },
    {
      "type": "text",
      "section": "ASPEN Pediatric and Neonatal Nutrition Support Handbook",
      "line": 39,
      "preview": "NOTE: This publication is designed to provide accurate authoritative information regarding the subje"
    },
    {
      "type": "text",
      "section": "ASPEN Pediatric and Neonatal Nutrition Support Handbook",
      "line": 41,
      "preview": "This publication does not constitute medical or professional advice and should not be taken as such."
    },
    {
      "type": "text",
      "section": "ASPEN Pediatric and Neonatal Nutrition Support Handbook",
      "line": 43,
      "preview": "ISBN: 978-1-889622-54-5"
    },
    {
      "type": "text",
      "section": "ASPEN Pediatric and Neonatal Nutrition Support Handbook",
      "line": 44,
      "preview": "eISBN: 978-1-889622-55-2"
    },
    {
      "type": "text",
      "section": "ASPEN Pediatric and Neonatal Nutrition Support Handbook",
      "line": 46,
      "preview": "--- page 6 ---"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "Contents",
      "line": 48
    },
    {
      "type": "text",
      "section": "Contents",
      "line": 50,
      "preview": "List of Tables, Figures, Exhibits, and Appendices Contributors"
    },
    {
      "type": "text",
      "section": "Contents",
      "line": 51,
      "preview": "Preface"
    },
    {
      "type": "heading",
      "level": 2,
      "section": "PART I: Nutrition Status",
      "line": 53
    },
    {
      "type": "text",
      "section": "PART I: Nutrition Status",
      "line": 55,
      "preview": "1. Nutrition Screening and History"
    },
    {
      "type": "text",
      "section": "PART I: Nutrition Status",
      "line": 57,
      "preview": "Patricia J. Becker and Gina Rempel"
    },
    {
      "type": "text",
      "section": "PART I: Nutrition Status",
      "line": 58,
      "preview": "2. Malnutrition"
    },
    {
      "type": "text",
      "section": "PART I: Nutrition Status",
      "line": 60,
      "preview": "Patricia J. Becker and Gina Rempel"
    },
    {
      "type": "text",
      "section": "PART I: Nutrition Status",
      "line": 61,
      "preview": "3. Clinical Considerations"
    },
    {
      "type": "text",
      "section": "PART I: Nutrition Status",
      "line": 63,
      "preview": "Gina Rempel and Patricia J. Becker"
    },
    {
      "type": "heading",
      "level": 2,
      "section": "PART II: Nutrition Care Plan",
      "line": 65
    },
    {
      "type": "text",
      "section": "PART II: Nutrition Care Plan",
      "line": 67,
      "preview": "4. Infant to Adolescent"
    },
    {
      "type": "text",
      "section": "PART II: Nutrition Care Plan",
      "line": 69,
      "preview": "Mary Pat Turon-Findley"
    },
    {
      "type": "text",
      "section": "PART II: Nutrition Care Plan",
      "line": 70,
      "preview": "5. Enteral Nutrition"
    },
    {
      "type": "text",
      "section": "PART II: Nutrition Care Plan",
      "line": 72,
      "preview": "Laura Gearman"
    },
    {
      "type": "text",
      "section": "PART II: Nutrition Care Plan",
      "line": 73,
      "preview": "6. Parenteral Nutrition"
    },
    {
      "type": "text",
      "section": "PART II: Nutrition Care Plan",
      "line": 75,
      "preview": "Elaina Szeszycki and Francine Breckler"
    },
    {
      "type": "text",
      "section": "PART II: Nutrition Care Plan",
      "line": 76,
      "preview": "7. Neonatal Nutrition"
    },
    {
      "type": "text",
      "section": "PART II: Nutrition Care Plan",
      "line": 78,
      "preview": "Austin Michalski and Kathleen Gura"
    },
    {
      "type": "heading",
      "level": 2,
      "section": "PART III: Disease-Specific Nutrition",
      "line": 80
    },
    {
      "type": "text",
      "section": "PART III: Disease-Specific Nutrition",
      "line": 82,
      "preview": "--- page 7 ---"
    },
    {
      "type": "text",
      "section": "PART III: Disease-Specific Nutrition",
      "line": 84,
      "preview": "8. Allergy and Eosinophilic Esophagitis"
    },
    {
      "type": "text",
      "section": "PART III: Disease-Specific Nutrition",
      "line": 86,
      "preview": "Anam Bashir and Praveen S. Goday"
    },
    {
      "type": "text",
      "section": "PART III: Disease-Specific Nutrition",
      "line": 87,
      "preview": "9. Cardiac Disease"
    },
    {
      "type": "text",
      "section": "PART III: Disease-Specific Nutrition",
      "line": 89,
      "preview": "Erin Sullivan, Sharon Y. Irving, Vijay Srinivasan, and Chitra Ravishankar"
    },
    {
      "type": "text",
      "section": "PART III: Disease-Specific Nutrition",
      "line": 90,
      "preview": "10. Celiac Disease"
    },
    {
      "type": "text",
      "section": "PART III: Disease-Specific Nutrition",
      "line": 92,
      "preview": "Anam Bashir and Praveen S. Goday"
    },
    {
      "type": "text",
      "section": "PART III: Disease-Specific Nutrition",
      "line": 93,
      "preview": "11. Critical Illness"
    },
    {
      "type": "text",
      "section": "PART III: Disease-Specific Nutrition",
      "line": 95,
      "preview": "Sharon Y. Irving, Stephanie Seiple, and Vijay Srinivasan"
    },
    {
      "type": "text",
      "section": "PART III: Disease-Specific Nutrition",
      "line": 96,
      "preview": "12. Cystic Fibrosis"
    },
    {
      "type": "text",
      "section": "PART III: Disease-Specific Nutrition",
      "line": 98,
      "preview": "Anam Bashir and Praveen S. Goday"
    },
    {
      "type": "text",
      "section": "PART III: Disease-Specific Nutrition",
      "line": 99,
      "preview": "13. Neurological Impairment and Developmental Disabilities Gina Rempel"
    },
    {
      "type": "text",
      "section": "PART III: Disease-Specific Nutrition",
      "line": 100,
      "preview": "14. Diabetes Mellitus"
    },
    {
      "type": "text",
      "section": "PART III: Disease-Specific Nutrition",
      "line": 102,
      "preview": "Christina Wright Yee and Emely Reyes"
    },
    {
      "type": "text",
      "section": "PART III: Disease-Specific Nutrition",
      "line": 103,
      "preview": "15. Disordered Eating"
    },
    {
      "type": "text",
      "section": "PART III: Disease-Specific Nutrition",
      "line": 105,
      "preview": "Mary Pat Turon-Findley"
    },
    {
      "type": "text",
      "section": "PART III: Disease-Specific Nutrition",
      "line": 106,
      "preview": "16. Dyslipidemia"
    },
    {
      "type": "text",
      "section": "PART III: Disease-Specific Nutrition",
      "line": 108,
      "preview": "Kari Murdy"
    },
    {
      "type": "text",
      "section": "PART III: Disease-Specific Nutrition",
      "line": 109,
      "preview": "17. Inborn Errors of Metabolism"
    },
    {
      "type": "text",
      "section": "PART III: Disease-Specific Nutrition",
      "line": 111,
      "preview": "Mary Sowa, Laura Jaimes, and Sandy Van Calcar"
    },
    {
      "type": "text",
      "section": "PART III: Disease-Specific Nutrition",
      "line": 112,
      "preview": "18. Inflammatory Bowel Disease"
    },
    {
      "type": "text",
      "section": "PART III: Disease-Specific Nutrition",
      "line": 114,
      "preview": "Anam Bashir and Praveen S. Goday"
    },
    {
      "type": "text",
      "section": "PART III: Disease-Specific Nutrition",
      "line": 115,
      "preview": "19. Renal Disease"
    },
    {
      "type": "text",
      "section": "PART III: Disease-Specific Nutrition",
      "line": 117,
      "preview": "Paige Balgie"
    },
    {
      "type": "text",
      "section": "PART III: Disease-Specific Nutrition",
      "line": 118,
      "preview": "20. Liver Disease"
    },
    {
      "type": "text",
      "section": "PART III: Disease-Specific Nutrition",
      "line": 120,
      "preview": "Anam Bashir and Praveen S. Goday"
    },
    {
      "type": "text",
      "section": "PART III: Disease-Specific Nutrition",
      "line": 121,
      "preview": "21. Oncology and Hematopoietic Stem Cell Transplant"
    },
    {
      "type": "text",
      "section": "PART III: Disease-Specific Nutrition",
      "line": 123,
      "preview": "Temitope Pedro and Jocelyn Fry"
    },
    {
      "type": "text",
      "section": "PART III: Disease-Specific Nutrition",
      "line": 124,
      "preview": "22. Pancreatitis"
    },
    {
      "type": "text",
      "section": "PART III: Disease-Specific Nutrition",
      "line": 126,
      "preview": "Anam Bashir and Praveen S. Goday"
    },
    {
      "type": "text",
      "section": "PART III: Disease-Specific Nutrition",
      "line": 127,
      "preview": "23. Seizures and the Ketogenic Diet"
    },
    {
      "type": "text",
      "section": "PART III: Disease-Specific Nutrition",
      "line": 129,
      "preview": "Jessica Ernst and Meredith Johnson"
    },
    {
      "type": "text",
      "section": "PART III: Disease-Specific Nutrition",
      "line": 130,
      "preview": "24. Short Bowel Syndrome"
    },
    {
      "type": "text",
      "section": "PART III: Disease-Specific Nutrition",
      "line": 132,
      "preview": "Anam Bashir and Praveen S. Goday"
    },
    {
      "type": "text",
      "section": "PART III: Disease-Specific Nutrition",
      "line": 133,
      "preview": "25. Weight Management and Obesity"
    },
    {
      "type": "text",
      "section": "PART III: Disease-Specific Nutrition",
      "line": 135,
      "preview": "--- page 8 ---"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "Jessica Graumann",
      "line": 137
    },
    {
      "type": "text",
      "section": "Jessica Graumann",
      "line": 139,
      "preview": "Additional Resources: ASPEN Endorsed Pediatric Guidelines, Consensus Recommendations, and Other Docu"
    },
    {
      "type": "text",
      "section": "Jessica Graumann",
      "line": 141,
      "preview": "--- page 9 ---"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "List of Tables, Figures, Exhibits, and Appendices",
      "line": 143
    },
    {
      "type": "table",
      "section": "List of Tables, Figures, Exhibits, and Appendices",
      "line": 145,
      "preview": "| Tables |  |"
    },
    {
      "type": "table",
      "section": "List of Tables, Figures, Exhibits, and Appendices",
      "line": 146,
      "preview": "| :--: | :--: |"
    },
    {
      "type": "table",
      "section": "List of Tables, Figures, Exhibits, and Appendices",
      "line": 147,
      "preview": "| Table 1-1 | Parameters for Pediatric Malnutrition Risk Screening Tools |"
    },
    {
      "type": "table",
      "section": "List of Tables, Figures, Exhibits, and Appendices",
      "line": 148,
      "preview": "| Table 1-2 | Advantages/Disadvantages of Food Intake Collection Methods |"
    },
    {
      "type": "table",
      "section": "List of Tables, Figures, Exhibits, and Appendices",
      "line": 149,
      "preview": "| Table 1-3 | Assessing Intake for Breastfed Infants, Including Frequency of Intake, Output, and Wei"
    },
    {
      "type": "table",
      "section": "List of Tables, Figures, Exhibits, and Appendices",
      "line": 150,
      "preview": "| Table 1-4 | Measuring Anthropometrics in Children |"
    },
    {
      "type": "table",
      "section": "List of Tables, Figures, Exhibits, and Appendices",
      "line": 151,
      "preview": "| Table 1-5 | Segmental Measurement Techniques and Equations to Calculate Extrapolated Lengths |"
    },
    {
      "type": "table",
      "section": "List of Tables, Figures, Exhibits, and Appendices",
      "line": 152,
      "preview": "| Table 1-6 | Daily Weight Gain Velocity in Grams per Day for Infants and Children Under 24 Months |"
    },
    {
      "type": "table",
      "section": "List of Tables, Figures, Exhibits, and Appendices",
      "line": 153,
      "preview": "| Table 1-7 | Average Weight Gain and Growth Goals: Ages 310 Years |"
    },
    {
      "type": "table",
      "section": "List of Tables, Figures, Exhibits, and Appendices",
      "line": 154,
      "preview": "| Table 1-8 | Average Growth Goals: Males and Females Ages 11-20 Years |"
    },
    {
      "type": "table",
      "section": "List of Tables, Figures, Exhibits, and Appendices",
      "line": 155,
      "preview": "| Table 1-9 | WHO z Score Cutoff Points for Various Growth Concerns |"
    },
    {
      "type": "table",
      "section": "List of Tables, Figures, Exhibits, and Appendices",
      "line": 156,
      "preview": "| Table 1-10 | Gross Motor Function Classification Scale for Children With Cerebral Palsy |"
    },
    {
      "type": "table",
      "section": "List of Tables, Figures, Exhibits, and Appendices",
      "line": 157,
      "preview": "| Table 1-11 | Comparing WHO Percentiles From Set 1 of the WHO Growth Charts With Approximate Corres"
    },
    {
      "type": "text",
      "section": "List of Tables, Figures, Exhibits, and Appendices",
      "line": 159,
      "preview": "--- page 10 ---"
    },
    {
      "type": "table",
      "section": "List of Tables, Figures, Exhibits, and Appendices",
      "line": 161,
      "preview": "|  Table 1-12 | Nutrition-Focused Physical Examination Clinical Signs  |"
    },
    {
      "type": "table",
      "section": "List of Tables, Figures, Exhibits, and Appendices",
      "line": 162,
      "preview": "| --- | --- |"
    },
    {
      "type": "table",
      "section": "List of Tables, Figures, Exhibits, and Appendices",
      "line": 163,
      "preview": "|  Table 1-13 | Pediatric Nutrition-Focused Physical Examination Checklist  |"
    },
    {
      "type": "table",
      "section": "List of Tables, Figures, Exhibits, and Appendices",
      "line": 164,
      "preview": "|  Table 1-14 | Signs and Symptoms of Dehydration  |"
    },
    {
      "type": "table",
      "section": "List of Tables, Figures, Exhibits, and Appendices",
      "line": 165,
      "preview": "|  Table 1-15 | The Revised SGNA  |"
    },
    {
      "type": "table",
      "section": "List of Tables, Figures, Exhibits, and Appendices",
      "line": 166,
      "preview": "|  Table 2-1 | Pediatric Academy of Nutrition and Dietetics/ASPEN Consensus\u2013Derived \u201cIndicators of M"
    },
    {
      "type": "table",
      "section": "List of Tables, Figures, Exhibits, and Appendices",
      "line": 167,
      "preview": "|  Table 2-2 | Pediatric Academy of Nutrition and Dietetics/ASPEN Consensus\u2013Derived Indicators of Ma"
    },
    {
      "type": "table",
      "section": "List of Tables, Figures, Exhibits, and Appendices",
      "line": 168,
      "preview": "|  Table 2-3 | WHO-Based Weight Gain Velocity Assessment for Malnutrition: Girls 0\u201324 Months  |"
    },
    {
      "type": "table",
      "section": "List of Tables, Figures, Exhibits, and Appendices",
      "line": 169,
      "preview": "|  Table 2-4 | WHO-Based Weight Gain Velocity Assessment for Malnutrition: Boys 0\u201324 Months  |"
    },
    {
      "type": "table",
      "section": "List of Tables, Figures, Exhibits, and Appendices",
      "line": 170,
      "preview": "|  Table 2-5 | Biochemical Markers of Inflammation in Pediatric Patients  |"
    },
    {
      "type": "table",
      "section": "List of Tables, Figures, Exhibits, and Appendices",
      "line": 171,
      "preview": "|  Table 2-6 | Malnutrition Criteria for Preterm Infants and Neonates: Primary Indicators to Diagnos"
    },
    {
      "type": "table",
      "section": "List of Tables, Figures, Exhibits, and Appendices",
      "line": 172,
      "preview": "|  Table 3-1 | Developmental Feeding Stages and Appropriate Foods for Different Ages  |"
    },
    {
      "type": "table",
      "section": "List of Tables, Figures, Exhibits, and Appendices",
      "line": 173,
      "preview": "|  Table 3-2 | Potential Thickening Agents and Considerations  |"
    },
    {
      "type": "table",
      "section": "List of Tables, Figures, Exhibits, and Appendices",
      "line": 174,
      "preview": "|  Table 3-3 | Description of Enteral Access Devices and Their Advantages and Disadvantages  |"
    },
    {
      "type": "table",
      "section": "List of Tables, Figures, Exhibits, and Appendices",
      "line": 175,
      "preview": "|  Table 4-1 | Daily Energy Requirements for Pediatric Patients  |"
    },
    {
      "type": "table",
      "section": "List of Tables, Figures, Exhibits, and Appendices",
      "line": 176,
      "preview": "|  Table 4-2 | Daily Protein Requirements for Pediatric Patients  |"
    },
    {
      "type": "table",
      "section": "List of Tables, Figures, Exhibits, and Appendices",
      "line": 177,
      "preview": "|  Table 4-3 | Calculating Basal Metabolic Rate Using the Schofield Equation  |"
    },
    {
      "type": "table",
      "section": "List of Tables, Figures, Exhibits, and Appendices",
      "line": 178,
      "preview": "|  Table 4-4 | Calculating Resting Energy Expenditure Using the WHO Equation  |"
    },
    {
      "type": "table",
      "section": "List of Tables, Figures, Exhibits, and Appendices",
      "line": 179,
      "preview": "|  Table 4-5 | Calculating Estimated Fluid Requirements Using the Holliday-Segar Formula  |"
    },
    {
      "type": "text",
      "section": "List of Tables, Figures, Exhibits, and Appendices",
      "line": 181,
      "preview": "--- page 11 ---"
    },
    {
      "type": "table",
      "section": "List of Tables, Figures, Exhibits, and Appendices",
      "line": 183,
      "preview": "|  Table 4-6 | Dietary Reference Intake for Calcium, Phosphorus, and Magnesium  |"
    },
    {
      "type": "table",
      "section": "List of Tables, Figures, Exhibits, and Appendices",
      "line": 184,
      "preview": "| --- | --- |"
    },
    {
      "type": "table",
      "section": "List of Tables, Figures, Exhibits, and Appendices",
      "line": 185,
      "preview": "|  Table 4-7 | Dietary Reference Intake for Fat-Soluble Vitamins  |"
    },
    {
      "type": "table",
      "section": "List of Tables, Figures, Exhibits, and Appendices",
      "line": 186,
      "preview": "|  Table 4-8 | Content per Unit Dose of Fat-Soluble Multivitamin Preparations for Use With Parentera"
    },
    {
      "type": "table",
      "section": "List of Tables, Figures, Exhibits, and Appendices",
      "line": 187,
      "preview": "|  Table 4-9 | Dietary Reference Intake of Water-Soluble Essential Micronutrients in Pediatric Popul"
    },
    {
      "type": "table",
      "section": "List of Tables, Figures, Exhibits, and Appendices",
      "line": 188,
      "preview": "|  Table 4-10 | Daily Parenteral Water-Soluble Vitamin Recommendations for Pediatric Patients  |"
    },
    {
      "type": "table",
      "section": "List of Tables, Figures, Exhibits, and Appendices",
      "line": 189,
      "preview": "|  Table 4-11 | Suggested Parameters to Monitor for Infants and Children Receiving EN  |"
    },
    {
      "type": "table",
      "section": "List of Tables, Figures, Exhibits, and Appendices",
      "line": 190,
      "preview": "|  Table 5-1 | Short-Term Devices vs Long-Term Devices: Clinical Indications, Advantages, and Disadv"
    },
    {
      "type": "table",
      "section": "List of Tables, Figures, Exhibits, and Appendices",
      "line": 191,
      "preview": "|  Table 5-2 | Balloon Gastrostomy Tubes vs Nonballoon Tubes: Indications, Advantages, and Disadvant"
    },
    {
      "type": "table",
      "section": "List of Tables, Figures, Exhibits, and Appendices",
      "line": 192,
      "preview": "|  Table 5-3 | High-Profile Tubes vs Low-Profile Tubes: Indications, Advantages, and Disadvantages  "
    },
    {
      "type": "table",
      "section": "List of Tables, Figures, Exhibits, and Appendices",
      "line": 193,
      "preview": "|  Table 5-4 | Gastric Tubes vs Transpyloric Tubes: Indications, Advantages, and Disadvantages  |"
    },
    {
      "type": "table",
      "section": "List of Tables, Figures, Exhibits, and Appendices",
      "line": 194,
      "preview": "|  Table 5-5 | Action Plan of Tube Dislodgement Based on Type of EAD  |"
    },
    {
      "type": "table",
      "section": "List of Tables, Figures, Exhibits, and Appendices",
      "line": 195,
      "preview": "|  Table 5-6 | Infant Formula Powder Recipes  |"
    },
    {
      "type": "table",
      "section": "List of Tables, Figures, Exhibits, and Appendices",
      "line": 196,
      "preview": "|  Table 5-7 | Infant Formula Concentrate Recipes  |"
    },
    {
      "type": "table",
      "section": "List of Tables, Figures, Exhibits, and Appendices",
      "line": 197,
      "preview": "|  Table 5-8 | Initiation, Advancement, and Proposed Goal Volumes of Enteral Feedings  |"
    },
    {
      "type": "table",
      "section": "List of Tables, Figures, Exhibits, and Appendices",
      "line": 198,
      "preview": "|  Table 5-9 | Common Enteral Nutrition\u2013Related Complications and Interventions  |"
    },
    {
      "type": "table",
      "section": "List of Tables, Figures, Exhibits, and Appendices",
      "line": 199,
      "preview": "|  Table 5-10 | Liquid Medication Preparation  |"
    },
    {
      "type": "table",
      "section": "List of Tables, Figures, Exhibits, and Appendices",
      "line": 200,
      "preview": "|  Table 6-1 | Summary of miniMAGIC Guidelines  |"
    },
    {
      "type": "table",
      "section": "List of Tables, Figures, Exhibits, and Appendices",
      "line": 201,
      "preview": "|  Table 6-2 | Location, Advantages, and Disadvantages of Vascular Access Devices  |"
    },
    {
      "type": "table",
      "section": "List of Tables, Figures, Exhibits, and Appendices",
      "line": 202,
      "preview": "|  Table 6-3 | Dosing for Initiation and Advancement of PN Macronutrients  |"
    },
    {
      "type": "table",
      "section": "List of Tables, Figures, Exhibits, and Appendices",
      "line": 203,
      "preview": "|  Table 6-4 | Amino Acid Variations Between Pediatric Amino Acids and Adult or Standard Amino Acids"
    },
    {
      "type": "text",
      "section": "List of Tables, Figures, Exhibits, and Appendices",
      "line": 205,
      "preview": "--- page 12 ---"
    },
    {
      "type": "table",
      "section": "List of Tables, Figures, Exhibits, and Appendices",
      "line": 207,
      "preview": "|  Table 6-5 | Lipid Injectable Emulsion Products,Characteristics, Abbreviations, and Approval forUs"
    },
    {
      "type": "table",
      "section": "List of Tables, Figures, Exhibits, and Appendices",
      "line": 208,
      "preview": "| --- | --- |"
    },
    {
      "type": "table",
      "section": "List of Tables, Figures, Exhibits, and Appendices",
      "line": 209,
      "preview": "|  Table 6-6 | Composition and Properties of ILE Products  |"
    },
    {
      "type": "table",
      "section": "List of Tables, Figures, Exhibits, and Appendices",
      "line": 210,
      "preview": "|  Table 6-7 | Published Pediatric Dosage for ILE Products  |"
    },
    {
      "type": "table",
      "section": "List of Tables, Figures, Exhibits, and Appendices",
      "line": 211,
      "preview": "|  Table 6-8 | Electrolyte Composition of Body Fluids  |"
    },
    {
      "type": "table",
      "section": "List of Tables, Figures, Exhibits, and Appendices",
      "line": 212,
      "preview": "|  Table 6-9 | Drug-Induced Metabolic Disorders  |"
    },
    {
      "type": "table",
      "section": "List of Tables, Figures, Exhibits, and Appendices",
      "line": 213,
      "preview": "|  Table 6-10 | Daily Dose of Individual Electrolytes  |"
    },
    {
      "type": "table",
      "section": "List of Tables, Figures, Exhibits, and Appendices",
      "line": 214,
      "preview": "|  Table 6-11 | Frequency of Short-Term and Long-TermMetabolic Monitoring  |"
    },
    {
      "type": "table",
      "section": "List of Tables, Figures, Exhibits, and Appendices",
      "line": 215,
      "preview": "|  Table 6-12 | Comparison of Pediatric and Adult MultivitaminProducts  |"
    },
    {
      "type": "table",
      "section": "List of Tables, Figures, Exhibits, and Appendices",
      "line": 216,
      "preview": "|  Table 6-13 | Function of Trace Metals and Symptoms ofDeficiency  |"
    },
    {
      "type": "table",
      "section": "List of Tables, Figures, Exhibits, and Appendices",
      "line": 217,
      "preview": "|  Table 6-14 | Ingredients for Currently Available Trace ElementProducts in the United States  |"
    },
    {
      "type": "table",
      "section": "List of Tables, Figures, Exhibits, and Appendices",
      "line": 218,
      "preview": "|  Table 6-15 | Dosing of Trace Metals  |"
    },
    {
      "type": "table",
      "section": "List of Tables, Figures, Exhibits, and Appendices",
      "line": 219,
      "preview": "|  Table 6-16 | Composition of Frequently Used IV Iron Products  |"
    },
    {
      "type": "table",
      "section": "List of Tables, Figures, Exhibits, and Appendices",
      "line": 220,
      "preview": "|  Table 6-17 | Parameters to Evaluate Adequacy of PN Volume  |"
    },
    {
      "type": "table",
      "section": "List of Tables, Figures, Exhibits, and Appendices",
      "line": 221,
      "preview": "|  Table 6-18 | Frequency of Long-Term Nutrition-RelatedMonitoring  |"
    },
    {
      "type": "table",
      "section": "List of Tables, Figures, Exhibits, and Appendices",
      "line": 222,
      "preview": "|  Table 6-19 | ASPEN Consensus Criteria for IdentifyingPediatric Patients at Risk for Refeeding Syn"
    },
    {
      "type": "table",
      "section": "List of Tables, Figures, Exhibits, and Appendices",
      "line": 223,
      "preview": "|  Table 6-20 | ASPEN Consensus Recommendations forAvoidance and Management of RS in At-RiskPediatri"
    },
    {
      "type": "table",
      "section": "List of Tables, Figures, Exhibits, and Appendices",
      "line": 224,
      "preview": "|  Table 7-1 | Gestational Age Categories  |"
    },
    {
      "type": "table",
      "section": "List of Tables, Figures, Exhibits, and Appendices",
      "line": 225,
      "preview": "|  Table 7-2 | Birth Weight Classifications  |"
    },
    {
      "type": "table",
      "section": "List of Tables, Figures, Exhibits, and Appendices",
      "line": 226,
      "preview": "|  Table 7-3 | Birth Size Assessment  |"
    },
    {
      "type": "table",
      "section": "List of Tables, Figures, Exhibits, and Appendices",
      "line": 227,
      "preview": "|  Table 7-4 | Indications for Nutrition Support  |"
    },
    {
      "type": "table",
      "section": "List of Tables, Figures, Exhibits, and Appendices",
      "line": 228,
      "preview": "|  Table 7-5 | Neonatal Growth Charts  |"
    },
    {
      "type": "table",
      "section": "List of Tables, Figures, Exhibits, and Appendices",
      "line": 229,
      "preview": "|  Table 7-6 | Growth Monitoring  |"
    },
    {
      "type": "table",
      "section": "List of Tables, Figures, Exhibits, and Appendices",
      "line": 230,
      "preview": "|  Table 7-7 | Term Infant Energy and Protein Needs: DailyRequirements  |"
    },
    {
      "type": "table",
      "section": "List of Tables, Figures, Exhibits, and Appendices",
      "line": 231,
      "preview": "|  Table 7-8 | Preterm Infant Energy and Protein Needs: DailyRequirements  |"
    },
    {
      "type": "text",
      "section": "List of Tables, Figures, Exhibits, and Appendices",
      "line": 233,
      "preview": "--- page 13 ---"
    },
    {
      "type": "table",
      "section": "List of Tables, Figures, Exhibits, and Appendices",
      "line": 235,
      "preview": "|  Table 7-9 | Osmolarity of Select PN Solutions  |"
    },
    {
      "type": "table",
      "section": "List of Tables, Figures, Exhibits, and Appendices",
      "line": 236,
      "preview": "| --- | --- |"
    },
    {
      "type": "table",
      "section": "List of Tables, Figures, Exhibits, and Appendices",
      "line": 237,
      "preview": "|  Table 7-10 | Conditions That Influence Neonatal Fluid Requirements  |"
    },
    {
      "type": "table",
      "section": "List of Tables, Figures, Exhibits, and Appendices",
      "line": 238,
      "preview": "|  Table 7-11 | Gastrointestinal Electrolyte Losses and Suggested Replacement Regimen  |"
    },
    {
      "type": "table",
      "section": "List of Tables, Figures, Exhibits, and Appendices",
      "line": 239,
      "preview": "|  Table 7-12 | Energy Density of PN Macronutrients  |"
    },
    {
      "type": "table",
      "section": "List of Tables, Figures, Exhibits, and Appendices",
      "line": 240,
      "preview": "|  Table 7-13 | ASPEN Recommendations for Initiation and Advancement of Parenteral Nutrition Macronu"
    },
    {
      "type": "table",
      "section": "List of Tables, Figures, Exhibits, and Appendices",
      "line": 241,
      "preview": "|  Table 7-14 | Brand-Specific Composition of Common Pediatric Parenteral Amino Acid Solutions Desig"
    },
    {
      "type": "table",
      "section": "List of Tables, Figures, Exhibits, and Appendices",
      "line": 242,
      "preview": "|  Table 7-15 | ASPEN Recommendations for Parenteral Nutrition Electrolyte and Mineral Daily Doses  "
    },
    {
      "type": "table",
      "section": "List of Tables, Figures, Exhibits, and Appendices",
      "line": 243,
      "preview": "|  Table 7-16 | Factors That Influence Calcium Phosphorus Precipitation  |"
    },
    {
      "type": "table",
      "section": "List of Tables, Figures, Exhibits, and Appendices",
      "line": 244,
      "preview": "|  Table 7-17 | ASPEN Recommendations for Parenteral Nutrition Trace Element Daily Dosing  |"
    },
    {
      "type": "table",
      "section": "List of Tables, Figures, Exhibits, and Appendices",
      "line": 245,
      "preview": "|  Table 7-18 | Trace Element Dosing Using Combination Product: Multrys (American Regent)  |"
    },
    {
      "type": "table",
      "section": "List of Tables, Figures, Exhibits, and Appendices",
      "line": 246,
      "preview": "|  Table 7-19 | ASPEN Recommended Parenteral Nutrition Daily Multiple Vitamin Product Dosing  |"
    },
    {
      "type": "table",
      "section": "List of Tables, Figures, Exhibits, and Appendices",
      "line": 247,
      "preview": "|  Table 7-20 | Recommended Levels of Intake for Intravenous Multivitamins for Term and Preterm Infa"
    },
    {
      "type": "table",
      "section": "List of Tables, Figures, Exhibits, and Appendices",
      "line": 248,
      "preview": "|  Table 7-21 | Suggested PN Monitoring Guidelines  |"
    },
    {
      "type": "table",
      "section": "List of Tables, Figures, Exhibits, and Appendices",
      "line": 249,
      "preview": "|  Table 7-22 | Metabolic Complications Associated With PN Use  |"
    },
    {
      "type": "table",
      "section": "List of Tables, Figures, Exhibits, and Appendices",
      "line": 250,
      "preview": "|  Table 7-23 | Multinutrient Human Milk Fortifiers  |"
    },
    {
      "type": "table",
      "section": "List of Tables, Figures, Exhibits, and Appendices",
      "line": 251,
      "preview": "|  Table 7-24 | Preterm Infant Formulas and Human Milk Fortifiers  |"
    },
    {
      "type": "table",
      "section": "List of Tables, Figures, Exhibits, and Appendices",
      "line": 252,
      "preview": "|  Table 7-25 | Preterm Infant Formula Composition  |"
    },
    {
      "type": "table",
      "section": "List of Tables, Figures, Exhibits, and Appendices",
      "line": 253,
      "preview": "|  Table 7-26 | Enteral Feeding Routes in Term and Preterm Infants  |"
    },
    {
      "type": "table",
      "section": "List of Tables, Figures, Exhibits, and Appendices",
      "line": 254,
      "preview": "|  Table 7-27 | Recommended Daily Enteral Intake of Electrolytes, Minerals, and Trace Elements  |"
    },
    {
      "type": "table",
      "section": "List of Tables, Figures, Exhibits, and Appendices",
      "line": 255,
      "preview": "|  Table 7-28 | Recommended Enteral Intake of Vitamins  |"
    },
    {
      "type": "table",
      "section": "List of Tables, Figures, Exhibits, and Appendices",
      "line": 256,
      "preview": "|  Table 8-1 | Different Categories of Food Allergies  |"
    },
    {
      "type": "text",
      "section": "List of Tables, Figures, Exhibits, and Appendices",
      "line": 258,
      "preview": "--- page 14 ---"
    },
    {
      "type": "table",
      "section": "List of Tables, Figures, Exhibits, and Appendices",
      "line": 260,
      "preview": "|  Table 9-1 | Nutrition Guidelines for Neonates Undergoing Surgery for CHD  |"
    },
    {
      "type": "table",
      "section": "List of Tables, Figures, Exhibits, and Appendices",
      "line": 261,
      "preview": "| --- | --- |"
    },
    {
      "type": "table",
      "section": "List of Tables, Figures, Exhibits, and Appendices",
      "line": 262,
      "preview": "|  Table 9-2 | High MCT and/or Low LCT Formulas  |"
    },
    {
      "type": "table",
      "section": "List of Tables, Figures, Exhibits, and Appendices",
      "line": 263,
      "preview": "|  Table 10-1 | List of Common Gluten-Containing and Gluten-Free Foods  |"
    },
    {
      "type": "table",
      "section": "List of Tables, Figures, Exhibits, and Appendices",
      "line": 264,
      "preview": "|  Table 11-1 | Operational Definitions of Malnutrition  |"
    },
    {
      "type": "table",
      "section": "List of Tables, Figures, Exhibits, and Appendices",
      "line": 265,
      "preview": "|  Table 11-2 | Approach to Feeding Intolerance  |"
    },
    {
      "type": "table",
      "section": "List of Tables, Figures, Exhibits, and Appendices",
      "line": 266,
      "preview": "|  Table 11-3 | Nutrition Considerations for Children With Burn Injuries  |"
    },
    {
      "type": "table",
      "section": "List of Tables, Figures, Exhibits, and Appendices",
      "line": 267,
      "preview": "|  Table 11-4 | Vitamin and Mineral Supplementation and Laboratory Monitoring Recommendations for Pe"
    },
    {
      "type": "table",
      "section": "List of Tables, Figures, Exhibits, and Appendices",
      "line": 268,
      "preview": "|  Table 12-1 | Vitamin Supplementation in Children With Cystic Fibrosis  |"
    },
    {
      "type": "table",
      "section": "List of Tables, Figures, Exhibits, and Appendices",
      "line": 269,
      "preview": "|  Table 12-2 | Dosing of Pancreatic Enzymes  |"
    },
    {
      "type": "table",
      "section": "List of Tables, Figures, Exhibits, and Appendices",
      "line": 270,
      "preview": "|  Table 13-1 | Factors Impacting Nutrition Status and Their Outcomes in Children With NI  |"
    },
    {
      "type": "table",
      "section": "List of Tables, Figures, Exhibits, and Appendices",
      "line": 271,
      "preview": "|  Table 13-2 | Cooccurring Conditions and Their Impact on Nutrition in Children With NI  |"
    },
    {
      "type": "table",
      "section": "List of Tables, Figures, Exhibits, and Appendices",
      "line": 272,
      "preview": "|  Table 13-3 | Feeding History Framework for Children With NI  |"
    },
    {
      "type": "table",
      "section": "List of Tables, Figures, Exhibits, and Appendices",
      "line": 273,
      "preview": "|  Table 13-4 | Tools, Measurements, and Nutrition Targets for Children With NI  |"
    },
    {
      "type": "table",
      "section": "List of Tables, Figures, Exhibits, and Appendices",
      "line": 274,
      "preview": "|  Table 13-5 | Red Flags for Undernutrition in Children With NI  |"
    },
    {
      "type": "table",
      "section": "List of Tables, Figures, Exhibits, and Appendices",
      "line": 275,
      "preview": "|  Table 13-6 | Designing Diet Plans for Children With NI  |"
    },
    {
      "type": "table",
      "section": "List of Tables, Figures, Exhibits, and Appendices",
      "line": 276,
      "preview": "|  Table 14-1 | HbA1c and Estimated Average Glucose  |"
    },
    {
      "type": "table",
      "section": "List of Tables, Figures, Exhibits, and Appendices",
      "line": 277,
      "preview": "|  Table 14-2 | Plasma Blood Glucose and HbA1c Target for Pediatric Age Groups With T1DM  |"
    },
    {
      "type": "table",
      "section": "List of Tables, Figures, Exhibits, and Appendices",
      "line": 278,
      "preview": "|  Table 14-3 | Education Approaches for Mealtime Management for Children With Diabetes  |"
    },
    {
      "type": "table",
      "section": "List of Tables, Figures, Exhibits, and Appendices",
      "line": 279,
      "preview": "|  Table 14-4 | Helpful Tools for Carbohydrate Counting  |"
    },
    {
      "type": "table",
      "section": "List of Tables, Figures, Exhibits, and Appendices",
      "line": 280,
      "preview": "|  Table 14-5 | Subcutaneous Insulin Injectables  |"
    },
    {
      "type": "table",
      "section": "List of Tables, Figures, Exhibits, and Appendices",
      "line": 281,
      "preview": "|  Table 14-6 | Approved Medications for Children Over Age 10 Years With T2DM  |"
    },
    {
      "type": "table",
      "section": "List of Tables, Figures, Exhibits, and Appendices",
      "line": 282,
      "preview": "|  Table 14-7 | Monitoring of Laboratory Studies in Pediatric T1DM and T2DM  |"
    },
    {
      "type": "text",
      "section": "List of Tables, Figures, Exhibits, and Appendices",
      "line": 284,
      "preview": "--- page 15 ---"
    },
    {
      "type": "table",
      "section": "List of Tables, Figures, Exhibits, and Appendices",
      "line": 286,
      "preview": "|  Table 15-1 | Eating Disorder and Feeding Disorder Summary (DSM-5)  |"
    },
    {
      "type": "table",
      "section": "List of Tables, Figures, Exhibits, and Appendices",
      "line": 287,
      "preview": "| --- | --- |"
    },
    {
      "type": "table",
      "section": "List of Tables, Figures, Exhibits, and Appendices",
      "line": 288,
      "preview": "|  Table 15-2 | History and Examination Considerations in Disordered Eating  |"
    },
    {
      "type": "table",
      "section": "List of Tables, Figures, Exhibits, and Appendices",
      "line": 289,
      "preview": "|  Table 15-3 | Initiation and Advancement of Nutrition Support in Patients With Disordered Eating  "
    },
    {
      "type": "table",
      "section": "List of Tables, Figures, Exhibits, and Appendices",
      "line": 290,
      "preview": "|  Table 16-1 | Types of Dyslipidemia  |"
    },
    {
      "type": "table",
      "section": "List of Tables, Figures, Exhibits, and Appendices",
      "line": 291,
      "preview": "|  Table 16-2 | Lipoprotein Reference Ranges for Children and Adolescents  |"
    },
    {
      "type": "table",
      "section": "List of Tables, Figures, Exhibits, and Appendices",
      "line": 292,
      "preview": "|  Table 16-3 | Management of Specific Lipoprotein Abnormal Findings  |"
    },
    {
      "type": "table",
      "section": "List of Tables, Figures, Exhibits, and Appendices",
      "line": 293,
      "preview": "|  Table 16-4 | Specific Nutrient Recommendations  |"
    },
    {
      "type": "table",
      "section": "List of Tables, Figures, Exhibits, and Appendices",
      "line": 294,
      "preview": "|  Table 17-1 | Amino Acid Disorders  |"
    },
    {
      "type": "table",
      "section": "List of Tables, Figures, Exhibits, and Appendices",
      "line": 295,
      "preview": "|  Table 17-2 | Urea Cycle Disorders  |"
    },
    {
      "type": "table",
      "section": "List of Tables, Figures, Exhibits, and Appendices",
      "line": 296,
      "preview": "|  Table 17-3 | Organic Acidemias  |"
    },
    {
      "type": "table",
      "section": "List of Tables, Figures, Exhibits, and Appendices",
      "line": 297,
      "preview": "|  Table 17-4 | Fatty Acid Oxidation Disorders  |"
    },
    {
      "type": "table",
      "section": "List of Tables, Figures, Exhibits, and Appendices",
      "line": 298,
      "preview": "|  Table 17-5 | Disorders of Carbohydrate Metabolism  |"
    },
    {
      "type": "table",
      "section": "List of Tables, Figures, Exhibits, and Appendices",
      "line": 299,
      "preview": "|  Table 18-1 | Monitoring of Vitamin and Micronutrient Deficiency in Children With IBD  |"
    },
    {
      "type": "table",
      "section": "List of Tables, Figures, Exhibits, and Appendices",
      "line": 300,
      "preview": "|  Table 18-2 | Different Dietary Therapies Used in Crohn\u2019s Disease  |"
    },
    {
      "type": "table",
      "section": "List of Tables, Figures, Exhibits, and Appendices",
      "line": 301,
      "preview": "|  Table 19-1 | Stages of CKD: Greater Than 2 Years of Age  |"
    },
    {
      "type": "table",
      "section": "List of Tables, Figures, Exhibits, and Appendices",
      "line": 302,
      "preview": "|  Table 19-2 | Nutrition for Kidney Stone Management  |"
    },
    {
      "type": "table",
      "section": "List of Tables, Figures, Exhibits, and Appendices",
      "line": 303,
      "preview": "|  Table 19-3 | Energy and Protein Needs  |"
    },
    {
      "type": "table",
      "section": "List of Tables, Figures, Exhibits, and Appendices",
      "line": 304,
      "preview": "|  Table 19-4 | Micronutrients  |"
    },
    {
      "type": "table",
      "section": "List of Tables, Figures, Exhibits, and Appendices",
      "line": 305,
      "preview": "|  Table 19-5 | Commonly Used Phosphate Binder Medications and Their Calcium Content  |"
    },
    {
      "type": "table",
      "section": "List of Tables, Figures, Exhibits, and Appendices",
      "line": 306,
      "preview": "|  Table 19-6 | Renal Formulas  |"
    },
    {
      "type": "table",
      "section": "List of Tables, Figures, Exhibits, and Appendices",
      "line": 307,
      "preview": "|  Table 19-7 | Modulars and Additives  |"
    },
    {
      "type": "table",
      "section": "List of Tables, Figures, Exhibits, and Appendices",
      "line": 308,
      "preview": "|  Table 20-1 | Vitamin Supplementation in Patients With Liver Disease  |"
    },
    {
      "type": "table",
      "section": "List of Tables, Figures, Exhibits, and Appendices",
      "line": 309,
      "preview": "|  Table 20-2 | Management of Complications of Acute Liver Disease  |"
    },
    {
      "type": "table",
      "section": "List of Tables, Figures, Exhibits, and Appendices",
      "line": 310,
      "preview": "|  Table 21-1 | Contributors to Malnutrition in Pediatric Cancer  |"
    },
    {
      "type": "table",
      "section": "List of Tables, Figures, Exhibits, and Appendices",
      "line": 311,
      "preview": "|  Table 21-2 | Calorie and Protein Requirements of Pediatric Oncology Patients  |"
    },
    {
      "type": "text",
      "section": "List of Tables, Figures, Exhibits, and Appendices",
      "line": 313,
      "preview": "--- page 16 ---"
    },
    {
      "type": "table",
      "section": "List of Tables, Figures, Exhibits, and Appendices",
      "line": 315,
      "preview": "|  Table 21-3 | Calorie and Protein Requirements of Pediatric Patients Undergoing HSCT  |"
    },
    {
      "type": "table",
      "section": "List of Tables, Figures, Exhibits, and Appendices",
      "line": 316,
      "preview": "| --- | --- |"
    },
    {
      "type": "table",
      "section": "List of Tables, Figures, Exhibits, and Appendices",
      "line": 317,
      "preview": "|  Table 21-4 | Nutrition Strategies for Symptom Management  |"
    },
    {
      "type": "table",
      "section": "List of Tables, Figures, Exhibits, and Appendices",
      "line": 318,
      "preview": "|  Table 22-1 | Pancreatitis Diagnostic Criteria  |"
    },
    {
      "type": "table",
      "section": "List of Tables, Figures, Exhibits, and Appendices",
      "line": 319,
      "preview": "|  Table 23-1 | Types of Ketogenic Diets  |"
    },
    {
      "type": "table",
      "section": "List of Tables, Figures, Exhibits, and Appendices",
      "line": 320,
      "preview": "|  Table 23-2 | Epilepsy Syndromes and Conditions  |"
    },
    {
      "type": "table",
      "section": "List of Tables, Figures, Exhibits, and Appendices",
      "line": 321,
      "preview": "|  Table 23-3 | Contraindications to the Use of KDT  |"
    },
    {
      "type": "table",
      "section": "List of Tables, Figures, Exhibits, and Appendices",
      "line": 322,
      "preview": "|  Table 23-4 | Possible Adverse Effects of KDT  |"
    },
    {
      "type": "table",
      "section": "List of Tables, Figures, Exhibits, and Appendices",
      "line": 323,
      "preview": "|  Table 23-5 | Estimating Nutrient Needs  |"
    },
    {
      "type": "table",
      "section": "List of Tables, Figures, Exhibits, and Appendices",
      "line": 324,
      "preview": "|  Table 23-6 | Macronutrient Composition of Each Diet in Percentage of Total Calories  |"
    },
    {
      "type": "table",
      "section": "List of Tables, Figures, Exhibits, and Appendices",
      "line": 325,
      "preview": "|  Table 23-7 | Initiation Location  |"
    },
    {
      "type": "table",
      "section": "List of Tables, Figures, Exhibits, and Appendices",
      "line": 326,
      "preview": "|  Table 23-8 | Classic KDT Initiation Methods  |"
    },
    {
      "type": "table",
      "section": "List of Tables, Figures, Exhibits, and Appendices",
      "line": 327,
      "preview": "|  Table 23-9 | Laboratory Monitoring  |"
    },
    {
      "type": "table",
      "section": "List of Tables, Figures, Exhibits, and Appendices",
      "line": 328,
      "preview": "|  Table 23-10 | Ketone Measurements  |"
    },
    {
      "type": "table",
      "section": "List of Tables, Figures, Exhibits, and Appendices",
      "line": 329,
      "preview": "|  Table 23-11 | Sample KDT Weaning Plan  |"
    },
    {
      "type": "table",
      "section": "List of Tables, Figures, Exhibits, and Appendices",
      "line": 330,
      "preview": "|  Table 24-1 | Laboratory Monitoring in Patients With Short Bowel Syndrome  |"
    },
    {
      "type": "table",
      "section": "List of Tables, Figures, Exhibits, and Appendices",
      "line": 331,
      "preview": "|  Table 24-2 | Simple and Complex Carbohydrates  |"
    },
    {
      "type": "table",
      "section": "List of Tables, Figures, Exhibits, and Appendices",
      "line": 332,
      "preview": "|  Table 25-1 | Laboratory Assessment for Childhood and Adolescent Obesity  |"
    },
    {
      "type": "table",
      "section": "List of Tables, Figures, Exhibits, and Appendices",
      "line": 333,
      "preview": "|  Table 25-2 | Staged Approach to Weight Management in Children and Adolescents  |"
    },
    {
      "type": "table",
      "section": "List of Tables, Figures, Exhibits, and Appendices",
      "line": 334,
      "preview": "|  Table 25-3 | Weight Recommendations According to Age and BMI Percentile  |"
    },
    {
      "type": "table",
      "section": "List of Tables, Figures, Exhibits, and Appendices",
      "line": 335,
      "preview": "|  Table 25-4 | Estimated Daily Amounts of Food Groups Based on Calorie Range  |"
    },
    {
      "type": "table",
      "section": "List of Tables, Figures, Exhibits, and Appendices",
      "line": 336,
      "preview": "|  Table 25-5 | Traffic Light Diet Guidelines  |"
    },
    {
      "type": "table",
      "section": "List of Tables, Figures, Exhibits, and Appendices",
      "line": 337,
      "preview": "|  Table 25-6 | Postoperative Diet by Stages  |"
    },
    {
      "type": "table",
      "section": "List of Tables, Figures, Exhibits, and Appendices",
      "line": 338,
      "preview": "|  Figures |   |"
    },
    {
      "type": "table",
      "section": "List of Tables, Figures, Exhibits, and Appendices",
      "line": 339,
      "preview": "|  Figure 1-1 | Measuring Recumbent Length by Using an Infantometer  |"
    },
    {
      "type": "table",
      "section": "List of Tables, Figures, Exhibits, and Appendices",
      "line": 340,
      "preview": "|  Figure 1-2 | Measuring Standing Height by Using a Stadiometer  |"
    },
    {
      "type": "text",
      "section": "List of Tables, Figures, Exhibits, and Appendices",
      "line": 342,
      "preview": "--- page 17 ---"
    },
    {
      "type": "table",
      "section": "List of Tables, Figures, Exhibits, and Appendices",
      "line": 344,
      "preview": "|  Figure 1-3 | Technique for Measuring Mid\u2013Upper Arm Circumference  |"
    },
    {
      "type": "table",
      "section": "List of Tables, Figures, Exhibits, and Appendices",
      "line": 345,
      "preview": "| --- | --- |"
    },
    {
      "type": "table",
      "section": "List of Tables, Figures, Exhibits, and Appendices",
      "line": 346,
      "preview": "|  Figure 1-4 | Obtaining a Triceps Skinfold Measurement by Using a SkinfoldCaliper  |"
    },
    {
      "type": "table",
      "section": "List of Tables, Figures, Exhibits, and Appendices",
      "line": 347,
      "preview": "|  Figure 1-5 | Technique for Using a Handgrip Dynamometer  |"
    },
    {
      "type": "table",
      "section": "List of Tables, Figures, Exhibits, and Appendices",
      "line": 348,
      "preview": "|  Figure 3-1 | The IDDSI Categorization of Food and Liquid Viscosities and Consistencies  |"
    },
    {
      "type": "table",
      "section": "List of Tables, Figures, Exhibits, and Appendices",
      "line": 349,
      "preview": "|  Figure 3-2 | The IDDSI Syringe Test for Measuring Liquid Viscosity  |"
    },
    {
      "type": "table",
      "section": "List of Tables, Figures, Exhibits, and Appendices",
      "line": 350,
      "preview": "|  Figure 4-1 | ASPEN Pediatric Nutrition Care Pathway  |"
    },
    {
      "type": "table",
      "section": "List of Tables, Figures, Exhibits, and Appendices",
      "line": 351,
      "preview": "|  Figure 6-1 | Access Types and Locations of Select Central Venous Access Devices in Children  |"
    },
    {
      "type": "table",
      "section": "List of Tables, Figures, Exhibits, and Appendices",
      "line": 352,
      "preview": "|  Figure 9-1 | Pathway for Nutrition of Neonates Undergoing Surgery for Congenital Heart Disease  |"
    },
    {
      "type": "table",
      "section": "List of Tables, Figures, Exhibits, and Appendices",
      "line": 353,
      "preview": "|  Figure 9-2 | Clinical Management Algorithm for Postoperative Chylothorax  |"
    },
    {
      "type": "table",
      "section": "List of Tables, Figures, Exhibits, and Appendices",
      "line": 354,
      "preview": "|  Figure 20-1 | Effects of Liver Disease on Macronutrients  |"
    },
    {
      "type": "table",
      "section": "List of Tables, Figures, Exhibits, and Appendices",
      "line": 355,
      "preview": "|  Exhibits |   |"
    },
    {
      "type": "table",
      "section": "List of Tables, Figures, Exhibits, and Appendices",
      "line": 356,
      "preview": "|  Exhibit 1-1 | Pediatric Nutrition Screening Tool Questions  |"
    },
    {
      "type": "table",
      "section": "List of Tables, Figures, Exhibits, and Appendices",
      "line": 357,
      "preview": "|  Exhibit 1-2 | Screening for Nutrition Status in Children With Eating and Drinking Difficulties  |"
    },
    {
      "type": "table",
      "section": "List of Tables, Figures, Exhibits, and Appendices",
      "line": 358,
      "preview": "|  Exhibit 1-3 | Comparison of WHO and CDC Growth Charts  |"
    },
    {
      "type": "table",
      "section": "List of Tables, Figures, Exhibits, and Appendices",
      "line": 359,
      "preview": "|  Exhibit 6-1 | Considerations for Peripheral Parenteral Nutrition  |"
    },
    {
      "type": "table",
      "section": "List of Tables, Figures, Exhibits, and Appendices",
      "line": 360,
      "preview": "|  Exhibit 6-2 | Considerations When Reviewing Medication Compatibility With PN  |"
    },
    {
      "type": "table",
      "section": "List of Tables, Figures, Exhibits, and Appendices",
      "line": 361,
      "preview": "|  Exhibit 6-3 | Parameters to Evaluate Adequacy of PN Order  |"
    },
    {
      "type": "table",
      "section": "List of Tables, Figures, Exhibits, and Appendices",
      "line": 362,
      "preview": "|  Exhibit 10-1 | Common Sources of Contamination  |"
    },
    {
      "type": "table",
      "section": "List of Tables, Figures, Exhibits, and Appendices",
      "line": 363,
      "preview": "|  Exhibit 15-1 | Nutrition Support Order Set for Patient With Disordered Eating  |"
    },
    {
      "type": "table",
      "section": "List of Tables, Figures, Exhibits, and Appendices",
      "line": 364,
      "preview": "|  Exhibit 19-1 | Pretreatment of Liquids to Reduce Potassium Content  |"
    },
    {
      "type": "table",
      "section": "List of Tables, Figures, Exhibits, and Appendices",
      "line": 365,
      "preview": "|  Exhibit 19-2 | Nondietary Causes of Hyper- or Hypokalemia  |"
    },
    {
      "type": "table",
      "section": "List of Tables, Figures, Exhibits, and Appendices",
      "line": 366,
      "preview": "|  Exhibit 19-3 | Nutrition Considerations of Renal Replacement Therapy  |"
    },
    {
      "type": "text",
      "section": "List of Tables, Figures, Exhibits, and Appendices",
      "line": 368,
      "preview": "--- page 18 ---"
    },
    {
      "type": "table",
      "section": "List of Tables, Figures, Exhibits, and Appendices",
      "line": 370,
      "preview": "|  Exhibit 21-1 | Food Safety Practices for Immunocompromised Patients  |"
    },
    {
      "type": "table",
      "section": "List of Tables, Figures, Exhibits, and Appendices",
      "line": 371,
      "preview": "| --- | --- |"
    },
    {
      "type": "table",
      "section": "List of Tables, Figures, Exhibits, and Appendices",
      "line": 372,
      "preview": "|  Exhibit 25-1 | History Assessment  |"
    },
    {
      "type": "table",
      "section": "List of Tables, Figures, Exhibits, and Appendices",
      "line": 373,
      "preview": "|  Exhibit 25-2 | Physical Examination for Childhood Obesity  |"
    },
    {
      "type": "table",
      "section": "List of Tables, Figures, Exhibits, and Appendices",
      "line": 374,
      "preview": "|  Exhibit 25-3 | Indications and Contradictions for Adolescent Weight Loss Surgery  |"
    },
    {
      "type": "table",
      "section": "List of Tables, Figures, Exhibits, and Appendices",
      "line": 375,
      "preview": "|  Appendices |   |"
    },
    {
      "type": "table",
      "section": "List of Tables, Figures, Exhibits, and Appendices",
      "line": 376,
      "preview": "|  Appendix 5-1 | Sample Enteral Nutrition Plan for Pediatric and Infant Patients  |"
    },
    {
      "type": "table",
      "section": "List of Tables, Figures, Exhibits, and Appendices",
      "line": 377,
      "preview": "|  Appendix 5-2 | Standard Infant Formulas  |"
    },
    {
      "type": "table",
      "section": "List of Tables, Figures, Exhibits, and Appendices",
      "line": 378,
      "preview": "|  Appendix 5-3 | Reduced-Lactose Infant Formulas  |"
    },
    {
      "type": "table",
      "section": "List of Tables, Figures, Exhibits, and Appendices",
      "line": 379,
      "preview": "|  Appendix 5-4 | Soy Infant Formulas  |"
    },
    {
      "type": "table",
      "section": "List of Tables, Figures, Exhibits, and Appendices",
      "line": 380,
      "preview": "|  Appendix 5-5 | Extensively Hydrolyzed Protein Infant Formulas  |"
    },
    {
      "type": "table",
      "section": "List of Tables, Figures, Exhibits, and Appendices",
      "line": 381,
      "preview": "|  Appendix 5-6 | Elemental Infant Formulas  |"
    },
    {
      "type": "table",
      "section": "List of Tables, Figures, Exhibits, and Appendices",
      "line": 382,
      "preview": "|  Appendix 5-7 | Added Rice Starch Infant Formulas  |"
    },
    {
      "type": "table",
      "section": "List of Tables, Figures, Exhibits, and Appendices",
      "line": 383,
      "preview": "|  Appendix 5-8 | Other Specialized Infant Formulas  |"
    },
    {
      "type": "table",
      "section": "List of Tables, Figures, Exhibits, and Appendices",
      "line": 384,
      "preview": "|  Appendix 5-9 | Pediatric Elemental Formula  |"
    },
    {
      "type": "table",
      "section": "List of Tables, Figures, Exhibits, and Appendices",
      "line": 385,
      "preview": "|  Appendix 5-10 | Pediatric Semi-Elemental Formula  |"
    },
    {
      "type": "table",
      "section": "List of Tables, Figures, Exhibits, and Appendices",
      "line": 386,
      "preview": "|  Appendix 5-11 | Pediatric Standard Formula  |"
    },
    {
      "type": "table",
      "section": "List of Tables, Figures, Exhibits, and Appendices",
      "line": 387,
      "preview": "|  Appendix 5-12 | Pediatric Real Food\u2013Based Formula  |"
    },
    {
      "type": "table",
      "section": "List of Tables, Figures, Exhibits, and Appendices",
      "line": 388,
      "preview": "|  Appendix 5-13 | Standard Adult Formulas  |"
    },
    {
      "type": "table",
      "section": "List of Tables, Figures, Exhibits, and Appendices",
      "line": 389,
      "preview": "|  Appendix 5-14 | Adult Semi-Elemental Formulas  |"
    },
    {
      "type": "table",
      "section": "List of Tables, Figures, Exhibits, and Appendices",
      "line": 390,
      "preview": "|  Appendix 5-15 | Other Adult Formulas  |"
    },
    {
      "type": "table",
      "section": "List of Tables, Figures, Exhibits, and Appendices",
      "line": 391,
      "preview": "|  Appendix 5-16 | Product Manufacturer Websites  |"
    },
    {
      "type": "table",
      "section": "List of Tables, Figures, Exhibits, and Appendices",
      "line": 392,
      "preview": "|  Appendix 6-1 | Sample Parenteral Nutrition Plan  |"
    },
    {
      "type": "text",
      "section": "List of Tables, Figures, Exhibits, and Appendices",
      "line": 394,
      "preview": "--- page 19 ---"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "Contributors",
      "line": 396
    },
    {
      "type": "text",
      "section": "Contributors",
      "line": 398,
      "preview": "Paige Balgie, RDN, LD"
    },
    {
      "type": "text",
      "section": "Contributors",
      "line": 399,
      "preview": "M Health Fairview University of Minnesota Masonic Children's Hospital, Minneapolis"
    },
    {
      "type": "heading",
      "level": 2,
      "section": "Anam Bashir, MD",
      "line": 401
    },
    {
      "type": "text",
      "section": "Anam Bashir, MD",
      "line": 403,
      "preview": "Division of Pediatric Gastroenterology, Hepatology \\& Nutrition, Medical College of Wisconsin/Childr"
    },
    {
      "type": "text",
      "section": "Anam Bashir, MD",
      "line": 405,
      "preview": "Patricia J. Becker, MS, RDN, CSP, FAND"
    },
    {
      "type": "text",
      "section": "Anam Bashir, MD",
      "line": 406,
      "preview": "Pediatric Nutrition Specialist, KidsRD.com, Cincinnati, OH"
    },
    {
      "type": "heading",
      "level": 2,
      "section": "Francine Breckler, PharmD, BCPPS",
      "line": 408
    },
    {
      "type": "text",
      "section": "Francine Breckler, PharmD, BCPPS",
      "line": 410,
      "preview": "Clinical Pharmacist, Pediatric General Surgery, Riley Hospital for Children, Department of Pharmacy,"
    },
    {
      "type": "text",
      "section": "Francine Breckler, PharmD, BCPPS",
      "line": 412,
      "preview": "Jessica Ernst, MS, RDN, CSP, LD"
    },
    {
      "type": "text",
      "section": "Francine Breckler, PharmD, BCPPS",
      "line": 413,
      "preview": "Registered Dietitian Nutritionist, The Keto RD, LLC, Cincinnati, OH"
    },
    {
      "type": "text",
      "section": "Francine Breckler, PharmD, BCPPS",
      "line": 414,
      "preview": "Jocelyn Fry, RD, CSP"
    },
    {
      "type": "text",
      "section": "Francine Breckler, PharmD, BCPPS",
      "line": 415,
      "preview": "Clinical Dietitian III, Stanford Medicine, Children's Health, Palo Alto, CA"
    },
    {
      "type": "text",
      "section": "Francine Breckler, PharmD, BCPPS",
      "line": 417,
      "preview": "Laura Gearman, MS, RD, LD, CNSC"
    },
    {
      "type": "text",
      "section": "Francine Breckler, PharmD, BCPPS",
      "line": 418,
      "preview": "Clinical Nutrition Manager, M Health Fairview University of Minnesota Masonic Children's Hospital, M"
    },
    {
      "type": "text",
      "section": "Francine Breckler, PharmD, BCPPS",
      "line": 420,
      "preview": "--- page 20 ---"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "Praveen S. Goday, MBBS",
      "line": 422
    },
    {
      "type": "text",
      "section": "Praveen S. Goday, MBBS",
      "line": 424,
      "preview": "Director of Nutrition and Feeding Programs, Nationwide Children's Hospital, Professor of Clinical Pe"
    },
    {
      "type": "heading",
      "level": 2,
      "section": "Jessica Graumann, MS, RDN, LD",
      "line": 426
    },
    {
      "type": "text",
      "section": "Jessica Graumann, MS, RDN, LD",
      "line": 428,
      "preview": "Pediatric Clinical Dietitian, MHealth Fairview Masonic Children's Hospital, Minneapolis, MN"
    },
    {
      "type": "text",
      "section": "Jessica Graumann, MS, RDN, LD",
      "line": 430,
      "preview": "Kathleen Gura, PharmD, BCNSP, FASHP, FPPA, FASPEN, FMSHP Manager, Clinical Research, Department of P"
    },
    {
      "type": "heading",
      "level": 2,
      "section": "Sharon Y. Irving, PhD, CRNP",
      "line": 432
    },
    {
      "type": "text",
      "section": "Sharon Y. Irving, PhD, CRNP",
      "line": 434,
      "preview": "Department of Nursing and Clinical Care Services, Critical Care, The Children's Hospital of Philadel"
    },
    {
      "type": "heading",
      "level": 2,
      "section": "Laura Jaimes, MS, RD, CNSC",
      "line": 436
    },
    {
      "type": "text",
      "section": "Laura Jaimes, MS, RD, CNSC",
      "line": 438,
      "preview": "Clinical Dietitian, Metabolic Genetics, Oregon Health \\& Science University, Portland"
    },
    {
      "type": "text",
      "section": "Laura Jaimes, MS, RD, CNSC",
      "line": 440,
      "preview": "Meredith Johnson, MS, RDN, CSP, LD"
    },
    {
      "type": "text",
      "section": "Laura Jaimes, MS, RD, CNSC",
      "line": 441,
      "preview": "Nutritionist 3, Ketogenic Diet \\& Metabolics, Children's Healthcare of Atlanta, Atlanta, GA"
    },
    {
      "type": "heading",
      "level": 2,
      "section": "Austin Michalski, RDN, CNSC",
      "line": 443
    },
    {
      "type": "text",
      "section": "Austin Michalski, RDN, CNSC",
      "line": 445,
      "preview": "Registered Dietitian Nutritionist, CS Mott Children's Hospital, University of Michigan Health, Michi"
    },
    {
      "type": "heading",
      "level": 2,
      "section": "Kari Murdy, RD, LD",
      "line": 447
    },
    {
      "type": "text",
      "section": "Kari Murdy, RD, LD",
      "line": 449,
      "preview": "University of Minnesota Physicians, Minneapolis"
    },
    {
      "type": "heading",
      "level": 2,
      "section": "Temitope Pedro, MPH, RD, CSP",
      "line": 451
    },
    {
      "type": "text",
      "section": "Temitope Pedro, MPH, RD, CSP",
      "line": 453,
      "preview": "Clinical Dietitian III, Stanford Medicine, Children's Health, Palo Alto, CA"
    },
    {
      "type": "text",
      "section": "Temitope Pedro, MPH, RD, CSP",
      "line": 455,
      "preview": "--- page 21 ---"
    },
    {
      "type": "text",
      "section": "Temitope Pedro, MPH, RD, CSP",
      "line": 457,
      "preview": "Chitra Ravishankar, MBBS, MRCP (UK)"
    },
    {
      "type": "text",
      "section": "Temitope Pedro, MPH, RD, CSP",
      "line": 458,
      "preview": "Division of Cardiology, Department of Pediatrics, The Children's Hospital of Philadelphia, Universit"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "Gina Rempel, MD, FRCPC, FASPEN",
      "line": 460
    },
    {
      "type": "text",
      "section": "Gina Rempel, MD, FRCPC, FASPEN",
      "line": 462,
      "preview": "Health Sciences Center Winnipeg, Winnipeg, Manitoba"
    },
    {
      "type": "heading",
      "level": 2,
      "section": "Emely Reyes, RDN, CDCES",
      "line": 464
    },
    {
      "type": "text",
      "section": "Emely Reyes, RDN, CDCES",
      "line": 466,
      "preview": "Clinical Dietitian, Certified Diabetes Care and Education Specialist, Clinical Nutrition and Lactati"
    },
    {
      "type": "heading",
      "level": 2,
      "section": "Stephanie Seiple, RD, LDN, CNSC",
      "line": 468
    },
    {
      "type": "text",
      "section": "Stephanie Seiple, RD, LDN, CNSC",
      "line": 470,
      "preview": "Department of Clinical Nutrition, The Children's Hospital of Philadelphia, Philadelphia, PA"
    },
    {
      "type": "heading",
      "level": 2,
      "section": "Vijay Srinivasan, MBBS, MD",
      "line": 472
    },
    {
      "type": "text",
      "section": "Vijay Srinivasan, MBBS, MD",
      "line": 474,
      "preview": "Department of Anesthesiology, Critical Care, and Pediatrics, The Children's Hospital of Philadelphia"
    },
    {
      "type": "heading",
      "level": 2,
      "section": "Mary Sowa, MS, RD",
      "line": 476
    },
    {
      "type": "text",
      "section": "Mary Sowa, MS, RD",
      "line": 478,
      "preview": "Clinical Dietitian IV/Metabolic Dietitian, Children's Hospital of Orange County, Orange County, CA"
    },
    {
      "type": "heading",
      "level": 2,
      "section": "Erin Sullivan, RD, LDN, CSPCC",
      "line": 480
    },
    {
      "type": "text",
      "section": "Erin Sullivan, RD, LDN, CSPCC",
      "line": 482,
      "preview": "Department of Clinical Nutrition, The Children's Hospital of Philadelphia, Philadelphia, PA"
    },
    {
      "type": "heading",
      "level": 2,
      "section": "Elaina Szeszycki, PharmD, BCNSP",
      "line": 484
    },
    {
      "type": "text",
      "section": "Elaina Szeszycki, PharmD, BCNSP",
      "line": 486,
      "preview": "Clinical Pharmacist, Nutrition Support and Pediatric Gastroenterology, Department of Pharmacy Servic"
    },
    {
      "type": "text",
      "section": "Elaina Szeszycki, PharmD, BCNSP",
      "line": 488,
      "preview": "Mary Pat Turon-Findley, Med, RD, CMHIMP, LD"
    },
    {
      "type": "text",
      "section": "Elaina Szeszycki, PharmD, BCNSP",
      "line": 489,
      "preview": "Registered Dietitian, Cincinnati Children's Hospital, Cincinnati, OH"
    },
    {
      "type": "text",
      "section": "Elaina Szeszycki, PharmD, BCNSP",
      "line": 491,
      "preview": "--- page 22 ---"
    },
    {
      "type": "text",
      "section": "Elaina Szeszycki, PharmD, BCNSP",
      "line": 493,
      "preview": "Sandy Van Calcar, PhD, RD"
    },
    {
      "type": "text",
      "section": "Elaina Szeszycki, PharmD, BCNSP",
      "line": 494,
      "preview": "Associate Professor, Department of Molecular and Medical Genetics, Graduate Programs in Human Nutrit"
    },
    {
      "type": "text",
      "section": "Elaina Szeszycki, PharmD, BCNSP",
      "line": 496,
      "preview": "Christina Wright Yee, MPH, RD, CSP"
    },
    {
      "type": "text",
      "section": "Elaina Szeszycki, PharmD, BCNSP",
      "line": 497,
      "preview": "Clinical Dietitian III, Clinical Nutrition and Lactation Services, Children's Hospital of Orange Cou"
    },
    {
      "type": "text",
      "section": "Elaina Szeszycki, PharmD, BCNSP",
      "line": 499,
      "preview": "--- page 23 ---"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "Preface",
      "line": 501
    },
    {
      "type": "text",
      "section": "Preface",
      "line": 503,
      "preview": "The period from infancy through adolescence is a time of rapid growth and development filled with ma"
    },
    {
      "type": "text",
      "section": "Preface",
      "line": 505,
      "preview": "To provide the best care for children, practitioners must know how to recognize malnutrition and ide"
    },
    {
      "type": "text",
      "section": "Preface",
      "line": 507,
      "preview": "This handbook is divided into three sections to guide clinicians as they provide nutrition support-r"
    },
    {
      "type": "text",
      "section": "Preface",
      "line": 509,
      "preview": "--- page 24 ---"
    },
    {
      "type": "text",
      "section": "Preface",
      "line": 511,
      "preview": "The handbook is meant to supplement the ASPEN Pediatric Nutrition Support Core Curriculum, ASPEN gui"
    },
    {
      "type": "text",
      "section": "Preface",
      "line": 513,
      "preview": "--- page 25 ---"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "PART",
      "line": 515
    },
    {
      "type": "text",
      "section": "PART",
      "line": 517,
      "preview": "I"
    },
    {
      "type": "heading",
      "level": 2,
      "section": "Nutrition Status",
      "line": 519
    },
    {
      "type": "text",
      "section": "Nutrition Status",
      "line": 521,
      "preview": "--- page 26 ---"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "Nutrition Screening and History",
      "line": 523
    },
    {
      "type": "text",
      "section": "Nutrition Screening and History",
      "line": 525,
      "preview": "Patricia J. Becker, MS, RDN, CSP, FAND<br>Gina Rempel, MD, FRCPC, FASPEN"
    },
    {
      "type": "heading",
      "level": 2,
      "section": "Overview",
      "line": 527
    },
    {
      "type": "text",
      "section": "Overview",
      "line": 529,
      "preview": "Nutrition assessment lies at the heart of the nutrition care process, which involves developing a nu"
    },
    {
      "type": "text",
      "section": "Overview",
      "line": 531,
      "preview": "This chapter focuses on the nutrition assessment of infants and children, including ancillary condit"
    },
    {
      "type": "heading",
      "level": 2,
      "section": "Nutrition Screening",
      "line": 533
    },
    {
      "type": "text",
      "section": "Nutrition Screening",
      "line": 535,
      "preview": "Nutrition \"screening\" and \"assessment\" are different processes. The former indicates risk factors fo"
    },
    {
      "type": "text",
      "section": "Nutrition Screening",
      "line": 537,
      "preview": "--- page 27 ---"
    },
    {
      "type": "text",
      "section": "Nutrition Screening",
      "line": 539,
      "preview": "Early identification of nutrition risk facilitates timely nutrition intervention, potentially limiti"
    },
    {
      "type": "text",
      "section": "Nutrition Screening",
      "line": 541,
      "preview": "Nutrition screening tools are used to identify the risk of malnutrition or change in the risk of mal"
    },
    {
      "type": "text",
      "section": "Nutrition Screening",
      "line": 543,
      "preview": "- Appetite or dietary intake"
    },
    {
      "type": "text",
      "section": "Nutrition Screening",
      "line": 544,
      "preview": "- Clinical information, such as the presence of a medical condition that impacts nutrition status or"
    },
    {
      "type": "text",
      "section": "Nutrition Screening",
      "line": 545,
      "preview": "- One or more anthropometric measures and/or concerns about weight or growth ${ }^{4}$"
    },
    {
      "type": "text",
      "section": "Nutrition Screening",
      "line": 547,
      "preview": "Nutrition screening tools that have demonstrated moderate to high validity, reliability, and agreeme"
    },
    {
      "type": "text",
      "section": "Nutrition Screening",
      "line": 549,
      "preview": "Tools used to identify malnutrition risk should be valid and reliable for the population and setting"
    },
    {
      "type": "text",
      "section": "Nutrition Screening",
      "line": 551,
      "preview": "EXHIBIT 1-1. Pediatric Nutrition Screening Tool Questions"
    },
    {
      "type": "table",
      "section": "Nutrition Screening",
      "line": 553,
      "preview": "| Questions | Yes | No |"
    },
    {
      "type": "table",
      "section": "Nutrition Screening",
      "line": 554,
      "preview": "| :-- | :-- | :-- |"
    },
    {
      "type": "table",
      "section": "Nutrition Screening",
      "line": 555,
      "preview": "| Has the child lost weight unintentionally lately? |  |  |"
    },
    {
      "type": "table",
      "section": "Nutrition Screening",
      "line": 556,
      "preview": "| Has the child had poor weight gain over the past few months? |  |  |"
    },
    {
      "type": "table",
      "section": "Nutrition Screening",
      "line": 557,
      "preview": "| Has the child been eating/feeding less over the past few weeks? |  |  |"
    },
    {
      "type": "table",
      "section": "Nutrition Screening",
      "line": 558,
      "preview": "| Is the child obviously underweight? |  |  |"
    },
    {
      "type": "table",
      "section": "Nutrition Screening",
      "line": 559,
      "preview": "| Scoring: If yes to 2 or more of the above, refer the child for <br> - further nutrition assessment"
    },
    {
      "type": "text",
      "section": "Nutrition Screening",
      "line": 561,
      "preview": "--- page 28 ---"
    },
    {
      "type": "text",
      "section": "Nutrition Screening",
      "line": 563,
      "preview": "Adapted with permission from the American Society for Parenteral and Enteral Nutrition from White M,"
    },
    {
      "type": "text",
      "section": "Nutrition Screening",
      "line": 565,
      "preview": "There are several other tools besides the PNST that have moderate-to-high validation in the pediatri"
    },
    {
      "type": "text",
      "section": "Nutrition Screening",
      "line": 567,
      "preview": "- Screening Tool for Assessment of Malnutrition in Pediatrics"
    },
    {
      "type": "text",
      "section": "Nutrition Screening",
      "line": 568,
      "preview": "- Screening Tool for Risk of Nutrition Status and Growth"
    },
    {
      "type": "text",
      "section": "Nutrition Screening",
      "line": 569,
      "preview": "- Pediatric Yorkhill Malnutrition Screen"
    },
    {
      "type": "text",
      "section": "Nutrition Screening",
      "line": 570,
      "preview": "- Pediatric Nutrition Risk Screen"
    },
    {
      "type": "text",
      "section": "Nutrition Screening",
      "line": 572,
      "preview": "Table 1-1 outlines and compares parameters of these validated Pediatric Malnutrition Risk Scoring to"
    },
    {
      "type": "text",
      "section": "Nutrition Screening",
      "line": 574,
      "preview": "TABLE 1-1. Parameters for Pediatric Malnutrition Risk Screening Tools ${ }^{a}$"
    },
    {
      "type": "table",
      "section": "Nutrition Screening",
      "line": 576,
      "preview": "| Parameter | PNST | STAMP | STRONG $_{\\text {kids }}$ | PYMS | PNRS |"
    },
    {
      "type": "table",
      "section": "Nutrition Screening",
      "line": 577,
      "preview": "| :-- | :-- | :-- | :-- | :-- | :-- |"
    },
    {
      "type": "table",
      "section": "Nutrition Screening",
      "line": 578,
      "preview": "| Weight loss in the recent past | X |  | X | X | X |"
    },
    {
      "type": "table",
      "section": "Nutrition Screening",
      "line": 579,
      "preview": "| Poor growth in the recent past <br> (poor weight gain) | X |  | X |  |  |"
    },
    {
      "type": "table",
      "section": "Nutrition Screening",
      "line": 580,
      "preview": "| Poor dietary intake | X | X | X | X | X |"
    },
    {
      "type": "table",
      "section": "Nutrition Screening",
      "line": 581,
      "preview": "| Medical condition(s) that impact <br> nutritional status |  | X | X | X | X |"
    },
    {
      "type": "table",
      "section": "Nutrition Screening",
      "line": 582,
      "preview": "| Child appears thin or underweight <br> (observation) | X |  |  |  |  |"
    },
    {
      "type": "table",
      "section": "Nutrition Screening",
      "line": 583,
      "preview": "| BMI or weight for length decline <br> (anthropometric measurement) |  | X |  | X |  |"
    },
    {
      "type": "table",
      "section": "Nutrition Screening",
      "line": 584,
      "preview": "| Setting for use | IP or OP | IP or OP | IP or OP | IP | IP or OP |"
    },
    {
      "type": "table",
      "section": "Nutrition Screening",
      "line": 585,
      "preview": "| Other |  |  | X (appearance of <br> loss of fat/muscle <br> mass) |  | X (pain) |"
    },
    {
      "type": "text",
      "section": "Nutrition Screening",
      "line": 587,
      "preview": "Abbreviations: BMI, body mass index; IP, inpatient; OP, outpatient; PNRS, Pediatric Nutrition Risk S"
    },
    {
      "type": "text",
      "section": "Nutrition Screening",
      "line": 588,
      "preview": "${ }^{a}$ Data from Nutrition Screening Pediatrics: NSP tool component and descriptions (2018)."
    },
    {
      "type": "text",
      "section": "Nutrition Screening",
      "line": 589,
      "preview": "Academy of Nutrition and Dietetics. 2018. Accessed June 30, 2022."
    },
    {
      "type": "text",
      "section": "Nutrition Screening",
      "line": 590,
      "preview": "https://www.andeal.org/topic.cfm?menu=5767\\&cat=5922"
    },
    {
      "type": "text",
      "section": "Nutrition Screening",
      "line": 592,
      "preview": "--- page 29 ---"
    },
    {
      "type": "text",
      "section": "Nutrition Screening",
      "line": 594,
      "preview": "EXHIBIT 1-2. Screening for Nutrition Status in Children With Eating and Drinking Difficulties"
    },
    {
      "type": "table",
      "section": "Nutrition Screening",
      "line": 596,
      "preview": "| Score | An answer of \"yes\" scores 1 point. |"
    },
    {
      "type": "table",
      "section": "Nutrition Screening",
      "line": 597,
      "preview": "| :-- | :-- |"
    },
    {
      "type": "table",
      "section": "Nutrition Screening",
      "line": 598,
      "preview": "|  | Do you think your child is underweight? |"
    },
    {
      "type": "table",
      "section": "Nutrition Screening",
      "line": 599,
      "preview": "|  | Does your child have problems gaining weight? |"
    },
    {
      "type": "table",
      "section": "Nutrition Screening",
      "line": 600,
      "preview": "| Score | An answer of $>7$ scores 1 point. |"
    },
    {
      "type": "table",
      "section": "Nutrition Screening",
      "line": 601,
      "preview": "|  | Rate from 1 to 10 whether you think your child has any problem eating compared with <br> other "
    },
    {
      "type": "table",
      "section": "Nutrition Screening",
      "line": 602,
      "preview": "|  | Rate from 1 to 10 whether you think your child has any problem drinking compared with <br> othe"
    },
    {
      "type": "table",
      "section": "Nutrition Screening",
      "line": 603,
      "preview": "| Total: | A score $>3$ suggests a referral for assessment of nutrition status and eating and drinki"
    },
    {
      "type": "text",
      "section": "Nutrition Screening",
      "line": 605,
      "preview": "Adapted with permission from Bell KL, Benfer KA, Ware RS, et al. Development and validation of a scr"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "Nutrition Assessment and Interpretation",
      "line": 607
    },
    {
      "type": "text",
      "section": "Nutrition Assessment and Interpretation",
      "line": 609,
      "preview": "Upon completion of the nutrition risk screen, children who are deemed to be at nutrition risk should"
    },
    {
      "type": "text",
      "section": "Nutrition Assessment and Interpretation",
      "line": 611,
      "preview": "- The child's health and wellbeing"
    },
    {
      "type": "text",
      "section": "Nutrition Assessment and Interpretation",
      "line": 612,
      "preview": "- The child's intake"
    },
    {
      "type": "text",
      "section": "Nutrition Assessment and Interpretation",
      "line": 613,
      "preview": "- Anthropometric measures"
    },
    {
      "type": "text",
      "section": "Nutrition Assessment and Interpretation",
      "line": 614,
      "preview": "- Weight gain and growth velocity and appropriate growth charts"
    },
    {
      "type": "text",
      "section": "Nutrition Assessment and Interpretation",
      "line": 615,
      "preview": "- A nutrition-focused physical examination"
    },
    {
      "type": "text",
      "section": "Nutrition Assessment and Interpretation",
      "line": 616,
      "preview": "- Laboratory evaluation"
    },
    {
      "type": "heading",
      "level": 2,
      "section": "Data for the Nutrition Assessment",
      "line": 619
    },
    {
      "type": "text",
      "section": "Data for the Nutrition Assessment",
      "line": 621,
      "preview": "The nutrition providers who complete the nutrition assessment should ensure that all available infor"
    },
    {
      "type": "text",
      "section": "Data for the Nutrition Assessment",
      "line": 623,
      "preview": "- The health record"
    },
    {
      "type": "text",
      "section": "Data for the Nutrition Assessment",
      "line": 624,
      "preview": "- Biochemical data"
    },
    {
      "type": "text",
      "section": "Data for the Nutrition Assessment",
      "line": 625,
      "preview": "- Medical/surgical history"
    },
    {
      "type": "text",
      "section": "Data for the Nutrition Assessment",
      "line": 626,
      "preview": "- Vital signs"
    },
    {
      "type": "text",
      "section": "Data for the Nutrition Assessment",
      "line": 627,
      "preview": "- Medical procedures/consultations"
    },
    {
      "type": "text",
      "section": "Data for the Nutrition Assessment",
      "line": 628,
      "preview": "- Medication"
    },
    {
      "type": "text",
      "section": "Data for the Nutrition Assessment",
      "line": 629,
      "preview": "- Route of delivery"
    },
    {
      "type": "text",
      "section": "Data for the Nutrition Assessment",
      "line": 630,
      "preview": "- Recorded anthropometric measurements/growth history"
    },
    {
      "type": "text",
      "section": "Data for the Nutrition Assessment",
      "line": 632,
      "preview": "--- page 30 ---"
    },
    {
      "type": "text",
      "section": "Data for the Nutrition Assessment",
      "line": 634,
      "preview": "- Data created during the assessment"
    },
    {
      "type": "text",
      "section": "Data for the Nutrition Assessment",
      "line": 635,
      "preview": "- Client interview"
    },
    {
      "type": "text",
      "section": "Data for the Nutrition Assessment",
      "line": 636,
      "preview": "- Nutrient intake data"
    },
    {
      "type": "text",
      "section": "Data for the Nutrition Assessment",
      "line": 637,
      "preview": "- Mode of delivery"
    },
    {
      "type": "text",
      "section": "Data for the Nutrition Assessment",
      "line": 638,
      "preview": "- Obtained anthropometric measurements"
    },
    {
      "type": "text",
      "section": "Data for the Nutrition Assessment",
      "line": 639,
      "preview": "- Physical assessment"
    },
    {
      "type": "text",
      "section": "Data for the Nutrition Assessment",
      "line": 640,
      "preview": "- Biochemical Data"
    },
    {
      "type": "text",
      "section": "Data for the Nutrition Assessment",
      "line": 641,
      "preview": "- Other"
    },
    {
      "type": "text",
      "section": "Data for the Nutrition Assessment",
      "line": 642,
      "preview": "- Birth history"
    },
    {
      "type": "text",
      "section": "Data for the Nutrition Assessment",
      "line": 643,
      "preview": "- Feeding history"
    },
    {
      "type": "text",
      "section": "Data for the Nutrition Assessment",
      "line": 644,
      "preview": "- Developmental history"
    },
    {
      "type": "text",
      "section": "Data for the Nutrition Assessment",
      "line": 645,
      "preview": "- Achievement of developmental milestones"
    },
    {
      "type": "text",
      "section": "Data for the Nutrition Assessment",
      "line": 646,
      "preview": "- Social and family environment ${ }^{9}$"
    },
    {
      "type": "text",
      "section": "Data for the Nutrition Assessment",
      "line": 648,
      "preview": "Assessing nutrition status enables health professionals from a variety of disciplines to identify wh"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "Diet Assessment Methods",
      "line": 650
    },
    {
      "type": "text",
      "section": "Diet Assessment Methods",
      "line": 652,
      "preview": "Assessing the adequacy and appropriateness of a child's nutrient intake is essential to nutrition as"
    },
    {
      "type": "heading",
      "level": 2,
      "section": "Key Elements of a Pediatric Diet History",
      "line": 654
    },
    {
      "type": "text",
      "section": "Key Elements of a Pediatric Diet History",
      "line": 656,
      "preview": "The key elements of a pediatric diet history include the following:"
    },
    {
      "type": "text",
      "section": "Key Elements of a Pediatric Diet History",
      "line": 658,
      "preview": "- Type and amount of food, beverages, formula, and human milk consumed and route of intake"
    },
    {
      "type": "text",
      "section": "Key Elements of a Pediatric Diet History",
      "line": 659,
      "preview": "- Methods of food or formula preparation"
    },
    {
      "type": "text",
      "section": "Key Elements of a Pediatric Diet History",
      "line": 660,
      "preview": "- Feeding history/introduction of solids"
    },
    {
      "type": "text",
      "section": "Key Elements of a Pediatric Diet History",
      "line": 661,
      "preview": "- Meal/snack frequency/duration"
    },
    {
      "type": "text",
      "section": "Key Elements of a Pediatric Diet History",
      "line": 662,
      "preview": "- Use of/skill with eating utensils/cups"
    },
    {
      "type": "text",
      "section": "Key Elements of a Pediatric Diet History",
      "line": 663,
      "preview": "- Gastrointestinal function/gastroesophageal reflux, constipation"
    },
    {
      "type": "text",
      "section": "Key Elements of a Pediatric Diet History",
      "line": 664,
      "preview": "- Urinary output, quality/quantity"
    },
    {
      "type": "text",
      "section": "Key Elements of a Pediatric Diet History",
      "line": 665,
      "preview": "- Sleep schedule"
    },
    {
      "type": "text",
      "section": "Key Elements of a Pediatric Diet History",
      "line": 666,
      "preview": "- Caregiver/child interaction at meals/meal location/setting"
    },
    {
      "type": "heading",
      "level": 2,
      "section": "Approaches to Quantify Nutrient Intake",
      "line": 669
    },
    {
      "type": "text",
      "section": "Approaches to Quantify Nutrient Intake",
      "line": 671,
      "preview": "There are several approaches to quantify nutrient intake data:"
    },
    {
      "type": "text",
      "section": "Approaches to Quantify Nutrient Intake",
      "line": 673,
      "preview": "- Diet history is designed to determine the pattern of usual food intake. This type of history queri"
    },
    {
      "type": "text",
      "section": "Approaches to Quantify Nutrient Intake",
      "line": 675,
      "preview": "--- page 31 ---"
    },
    {
      "type": "text",
      "section": "Approaches to Quantify Nutrient Intake",
      "line": 677,
      "preview": "- 24-hour recall provides an estimate of nutrient intake based on the child's or their caregiver's r"
    },
    {
      "type": "text",
      "section": "Approaches to Quantify Nutrient Intake",
      "line": 678,
      "preview": "- 3-7 day food records provide prospective food intake data. These are recorded by the parent, child"
    },
    {
      "type": "text",
      "section": "Approaches to Quantify Nutrient Intake",
      "line": 679,
      "preview": "- Nutrient intake analysis (calorie count) is frequently ordered in inpatient facilities to assess a"
    },
    {
      "type": "text",
      "section": "Approaches to Quantify Nutrient Intake",
      "line": 680,
      "preview": "- Food frequencies estimate the frequency and amounts of specific foods eaten. These often consist o"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "TABLE 1-2. Advantages/Disadvantages of Food Intake Collection Methods ${ }^{\\mathbf{a}, \\mathbf{b}}$",
      "line": 683
    },
    {
      "type": "table",
      "section": "TABLE 1-2. Advantages/Disadvantages of Food Intake Collection Methods ${ }^{\\mathbf{a}, \\mathbf{b}}$",
      "line": 685,
      "preview": "| Data Collection <br> Method | Advantages | Disadvantages |"
    },
    {
      "type": "table",
      "section": "TABLE 1-2. Advantages/Disadvantages of Food Intake Collection Methods ${ }^{\\mathbf{a}, \\mathbf{b}}$",
      "line": 686,
      "preview": "| :--: | :--: | :--: |"
    },
    {
      "type": "table",
      "section": "TABLE 1-2. Advantages/Disadvantages of Food Intake Collection Methods ${ }^{\\mathbf{a}, \\mathbf{b}}$",
      "line": 687,
      "preview": "| Diet record | - Intake quantified <br> - Does not require recall <br> - Provides typical food inta"
    },
    {
      "type": "table",
      "section": "TABLE 1-2. Advantages/Disadvantages of Food Intake Collection Methods ${ }^{\\mathbf{a}, \\mathbf{b}}$",
      "line": 688,
      "preview": "| 24-h recall | - Intake is quantified <br> - Does not influence eating behavior <br> - Low patient "
    },
    {
      "type": "table",
      "section": "TABLE 1-2. Advantages/Disadvantages of Food Intake Collection Methods ${ }^{\\mathbf{a}, \\mathbf{b}}$",
      "line": 689,
      "preview": "| Food frequency <br> questionnaire | - Low patient burden <br> - Does not alter eating behavior <br"
    },
    {
      "type": "text",
      "section": "TABLE 1-2. Advantages/Disadvantages of Food Intake Collection Methods ${ }^{\\mathbf{a}, \\mathbf{b}}$",
      "line": 691,
      "preview": "[^0]"
    },
    {
      "type": "text",
      "section": "TABLE 1-2. Advantages/Disadvantages of Food Intake Collection Methods ${ }^{\\mathbf{a}, \\mathbf{b}}$",
      "line": 692,
      "preview": "[^0]:    ${ }^{a}$ Data from Thompson FE, Byers T. Dietary Assessment Resource Manual. J Nutr. 1994;"
    },
    {
      "type": "text",
      "section": "TABLE 1-2. Advantages/Disadvantages of Food Intake Collection Methods ${ }^{\\mathbf{a}, \\mathbf{b}}$",
      "line": 693,
      "preview": "${ }^{\\text {b }}$ Data from Diet Assessment Primer. National Cancer Institute. Accessed June 6, 202"
    },
    {
      "type": "text",
      "section": "TABLE 1-2. Advantages/Disadvantages of Food Intake Collection Methods ${ }^{\\mathbf{a}, \\mathbf{b}}$",
      "line": 695,
      "preview": "--- page 32 ---"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "Nutrition Analysis Programs",
      "line": 697
    },
    {
      "type": "text",
      "section": "Nutrition Analysis Programs",
      "line": 699,
      "preview": "After a food or nutrition intake history is obtained, there are several options for performing a nut"
    },
    {
      "type": "text",
      "section": "Nutrition Analysis Programs",
      "line": 701,
      "preview": "- The USDA food and nutrient database (FoodData Central: https://fdc.nal.usda.gov)"
    },
    {
      "type": "text",
      "section": "Nutrition Analysis Programs",
      "line": 702,
      "preview": "- Food Processor (https://esha.com/products/food-processor)"
    },
    {
      "type": "text",
      "section": "Nutrition Analysis Programs",
      "line": 703,
      "preview": "- Nutritionist Pro (https://nutritionistpro.com)"
    },
    {
      "type": "text",
      "section": "Nutrition Analysis Programs",
      "line": 704,
      "preview": "- Nutrihand (https://www.nutrihand.com/Static/index.html)"
    },
    {
      "type": "text",
      "section": "Nutrition Analysis Programs",
      "line": 705,
      "preview": "- Information for families and caregivers regarding food and nutrition:"
    },
    {
      "type": "text",
      "section": "Nutrition Analysis Programs",
      "line": 706,
      "preview": "- \"Nutrition Resources for Parents, Caregivers, and Teachers\""
    },
    {
      "type": "text",
      "section": "Nutrition Analysis Programs",
      "line": 707,
      "preview": "(https://www.nutrition.gov/topics/nutrition-age/teens/parents-caregivers-and-teachers)"
    },
    {
      "type": "text",
      "section": "Nutrition Analysis Programs",
      "line": 708,
      "preview": "- USDA MyPlate (https://www.myplate.gov)"
    },
    {
      "type": "text",
      "section": "Nutrition Analysis Programs",
      "line": 709,
      "preview": "- American Academy of Pediatrics (https://www.healthychildren.org/english/healthyliving/nutrition/pa"
    },
    {
      "type": "text",
      "section": "Nutrition Analysis Programs",
      "line": 710,
      "preview": "- CalorieKing (for calories in common \"fast foods\" (https://www.calorieking.com)"
    },
    {
      "type": "heading",
      "level": 2,
      "section": "Assessing Intake in Infants",
      "line": 713
    },
    {
      "type": "text",
      "section": "Assessing Intake in Infants",
      "line": 715,
      "preview": "For infants who are exclusively breastfed, adequacy of intake is based on the duration of feeding, h"
    },
    {
      "type": "text",
      "section": "Assessing Intake in Infants",
      "line": 717,
      "preview": "--- page 33 ---"
    },
    {
      "type": "text",
      "section": "Assessing Intake in Infants",
      "line": 719,
      "preview": "TABLE 1-3. Assessing Intake for Breastfed Infants, Including Frequency of Intake, Output, and Weight"
    },
    {
      "type": "table",
      "section": "Assessing Intake in Infants",
      "line": 721,
      "preview": "| Age <br> (mo) | Number of <br> Breastfeedings <br> per Day | Approximate <br> Volume/Feeding <br> "
    },
    {
      "type": "table",
      "section": "Assessing Intake in Infants",
      "line": 722,
      "preview": "| :-- | :--: | :--: | :--: | :-- | :--: | :--: | :--: |"
    },
    {
      "type": "table",
      "section": "Assessing Intake in Infants",
      "line": 723,
      "preview": "| $0-1$ | $8-12$ | $1-3$ | $10-30$ | None | $8+$ | $6+$ | $30 \\mathrm{~g} / \\mathrm{d}$ |"
    },
    {
      "type": "table",
      "section": "Assessing Intake in Infants",
      "line": 724,
      "preview": "| $1-2$ | $8+$ | $4-5$ | $15-30$ | None | $6-8$ | $6+$ | $30-34 \\mathrm{~g} / \\mathrm{d}$ |"
    },
    {
      "type": "table",
      "section": "Assessing Intake in Infants",
      "line": 725,
      "preview": "| $2-3$ | $6-8$ | $5-6$ | $15-30$ | None | $6+$ | $4+$ | $180 \\mathrm{~g} / \\mathrm{wk}$ |"
    },
    {
      "type": "table",
      "section": "Assessing Intake in Infants",
      "line": 726,
      "preview": "| $3-4$ | 6 | $6+$ | $15-20$ | None | $6+$ | $3+$ | $125 \\mathrm{~g} / \\mathrm{wk}$ |"
    },
    {
      "type": "table",
      "section": "Assessing Intake in Infants",
      "line": 727,
      "preview": "| $4-6$ | $5-6$ | $6-8$ | $15+$ | Iron- <br> containing <br> first <br> foods | $4-6$ | $2+$ | $100 "
    },
    {
      "type": "table",
      "section": "Assessing Intake in Infants",
      "line": 728,
      "preview": "| $6-8$ | $5-6$ | $6-8$ | $15+$ | Iron- <br> containing <br> first <br> foods | $4+$ | $1+$ | $80 \\m"
    },
    {
      "type": "table",
      "section": "Assessing Intake in Infants",
      "line": 729,
      "preview": "| $8-10$ | $4-5$ | $6-8$ | $15+$ | Soft <br> mashed <br> table <br> foods | $4+$ | $1+$ | $60 \\mathr"
    },
    {
      "type": "table",
      "section": "Assessing Intake in Infants",
      "line": 730,
      "preview": "| $10-12$ | 4 | 8 | $15+$ | Table <br> foods are <br> offered <br> first. Milk <br> is taken <br> fr"
    },
    {
      "type": "text",
      "section": "Assessing Intake in Infants",
      "line": 732,
      "preview": "${ }^{a}$ Data from American Academy of Pediatrics Committee on Nutrition. Breastfeeding. In: Kleinm"
    },
    {
      "type": "text",
      "section": "Assessing Intake in Infants",
      "line": 733,
      "preview": "${ }^{\\text {b }}$ First foods are generally pureed or blended single foods. Iron-containing foods s"
    },
    {
      "type": "text",
      "section": "Assessing Intake in Infants",
      "line": 735,
      "preview": "When discussing nutrient intake with caregivers, it is important to determine how the food and formu"
    },
    {
      "type": "text",
      "section": "Assessing Intake in Infants",
      "line": 737,
      "preview": "- What is the name of the pediatric or infant formula the child is receiving?"
    },
    {
      "type": "text",
      "section": "Assessing Intake in Infants",
      "line": 738,
      "preview": "- Is the formula being used as a ready-to-serve product?"
    },
    {
      "type": "text",
      "section": "Assessing Intake in Infants",
      "line": 739,
      "preview": "- How and where is the formula prepared and stored?"
    },
    {
      "type": "text",
      "section": "Assessing Intake in Infants",
      "line": 740,
      "preview": "- Is there a special recipe for mixing the formula or is it made as per can instructions?"
    },
    {
      "type": "text",
      "section": "Assessing Intake in Infants",
      "line": 741,
      "preview": "- What is the exact recipe?"
    },
    {
      "type": "text",
      "section": "Assessing Intake in Infants",
      "line": 742,
      "preview": "- How much water is used?"
    },
    {
      "type": "text",
      "section": "Assessing Intake in Infants",
      "line": 743,
      "preview": "- How much powder or liquid concentrate is being used?"
    },
    {
      "type": "text",
      "section": "Assessing Intake in Infants",
      "line": 744,
      "preview": "- Is water or powder added first?"
    },
    {
      "type": "text",
      "section": "Assessing Intake in Infants",
      "line": 745,
      "preview": "- How much liquid concentrate is used and how much water is added?"
    },
    {
      "type": "text",
      "section": "Assessing Intake in Infants",
      "line": 747,
      "preview": "--- page 34 ---"
    },
    {
      "type": "text",
      "section": "Assessing Intake in Infants",
      "line": 749,
      "preview": "- Is anything else being added to the formula (eg, thickeners, medications, vitamins)?"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "Anthropometric Measurement",
      "line": 752
    },
    {
      "type": "text",
      "section": "Anthropometric Measurement",
      "line": 754,
      "preview": "Anthropometric measures followed longitudinally are integral to the nutrition assessment. All anthro"
    },
    {
      "type": "text",
      "section": "Anthropometric Measurement",
      "line": 756,
      "preview": "Weights, length, or height are standard measurements for all children. Head circumference should be "
    },
    {
      "type": "text",
      "section": "Anthropometric Measurement",
      "line": 758,
      "preview": "Mid-upper arm circumference (MUAC), triceps skinfold (TSF), and midarm muscle circumference are meas"
    },
    {
      "type": "text",
      "section": "Anthropometric Measurement",
      "line": 760,
      "preview": "In children who are acutely ill, fluid shifts and edema may make the weight unreliable. In this situ"
    },
    {
      "type": "heading",
      "level": 2,
      "section": "Measurement Techniques",
      "line": 762
    },
    {
      "type": "text",
      "section": "Measurement Techniques",
      "line": 764,
      "preview": "Obtaining accurate anthropometric measurements is crucial to the assessment of the nutrition status "
    },
    {
      "type": "text",
      "section": "Measurement Techniques",
      "line": 766,
      "preview": "--- page 35 ---"
    },
    {
      "type": "text",
      "section": "Measurement Techniques",
      "line": 768,
      "preview": "TABLE 1-4. Measuring Anthropometrics in Children"
    },
    {
      "type": "table",
      "section": "Measurement Techniques",
      "line": 770,
      "preview": "| Anthropometrics for Typically Growing Children ${ }^{a}$ |  |  | References, Norms, or Comparative"
    },
    {
      "type": "table",
      "section": "Measurement Techniques",
      "line": 771,
      "preview": "| :--: | :--: | :--: | :--: |"
    },
    {
      "type": "table",
      "section": "Measurement Techniques",
      "line": 772,
      "preview": "| Parameter | Age | Measurement | Charting |"
    },
    {
      "type": "table",
      "section": "Measurement Techniques",
      "line": 773,
      "preview": "| Weight | $\\begin{aligned} & 0- \\\\ & 24 \\mathrm{mo} \\end{aligned}$ | Weigh the infant naked or wear"
    },
    {
      "type": "table",
      "section": "Measurement Techniques",
      "line": 774,
      "preview": "|  | $\\begin{aligned} & >24 \\\\ & \\text { mo } \\end{aligned}$ | Obtain a measured weight. <br> - Weig"
    },
    {
      "type": "table",
      "section": "Measurement Techniques",
      "line": 775,
      "preview": "| Length | $\\begin{aligned} & 0-24 \\\\ & \\text { mo } \\end{aligned}$ | Measure the child without shoe"
    },
    {
      "type": "table",
      "section": "Measurement Techniques",
      "line": 776,
      "preview": "|  | $\\begin{aligned} & 24- \\\\ & 36 \\mathrm{mo} \\end{aligned}$ | Measure recumbent length or standin"
    },
    {
      "type": "table",
      "section": "Measurement Techniques",
      "line": 777,
      "preview": "|  | $\\begin{aligned} & >36 \\\\ & \\text { mo } \\end{aligned}$ | Measure standing height without shoes"
    },
    {
      "type": "table",
      "section": "Measurement Techniques",
      "line": 778,
      "preview": "| Head circumference | $\\begin{aligned} & 0-24 \\\\ & \\text { mo } \\end{aligned}$ | - Position the mea"
    },
    {
      "type": "table",
      "section": "Measurement Techniques",
      "line": 779,
      "preview": "| MUAC | $\\begin{aligned} & 3 \\text { mo } \\\\ & \\text { to } 19 \\\\ & y \\end{aligned}$ | - Bend the a"
    },
    {
      "type": "text",
      "section": "Measurement Techniques",
      "line": 781,
      "preview": "--- page 36 ---"
    },
    {
      "type": "table",
      "section": "Measurement Techniques",
      "line": 783,
      "preview": "| Anthropometrics for Typically Growing Children ${ }^{a}$ |  |  | References, <br> Norms, or <br> C"
    },
    {
      "type": "table",
      "section": "Measurement Techniques",
      "line": 784,
      "preview": "| :--: | :--: | :--: | :--: |"
    },
    {
      "type": "table",
      "section": "Measurement Techniques",
      "line": 785,
      "preview": "| Parameter | Age | Measurement | Charting |"
    },
    {
      "type": "table",
      "section": "Measurement Techniques",
      "line": 786,
      "preview": "| TSF | 3 mo <br> to 19 <br> y | - A skinfold caliper is required. <br> - Measure the midpoint of th"
    },
    {
      "type": "table",
      "section": "Measurement Techniques",
      "line": 787,
      "preview": "| MAMC | $\\begin{aligned} & 1-19 \\\\ & y \\end{aligned}$ | MAMC determines muscle stores and is calcul"
    },
    {
      "type": "text",
      "section": "Measurement Techniques",
      "line": 789,
      "preview": "Abbreviations: CDC, Centers for Disease Control and Prevention; MAMC, midarm muscle circumference; M"
    },
    {
      "type": "text",
      "section": "Measurement Techniques",
      "line": 790,
      "preview": "${ }^{a}$ Data from DeTallo C, ed. The Practitioner's Guide to Nutrition-Focused Physical Exam of In"
    },
    {
      "type": "text",
      "section": "Measurement Techniques",
      "line": 791,
      "preview": "${ }^{\\text {b }}$ Child Growth Standards. World Health Organization. Accessed July 5, 2022."
    },
    {
      "type": "text",
      "section": "Measurement Techniques",
      "line": 792,
      "preview": "https://www.who.int/tools/child-growth-standards/standards"
    },
    {
      "type": "text",
      "section": "Measurement Techniques",
      "line": 793,
      "preview": "${ }^{c}$ Clinical Growth Charts. Centers for Disease Control and Prevention. June 16, 2017. Accesse"
    },
    {
      "type": "text",
      "section": "Measurement Techniques",
      "line": 794,
      "preview": "${ }^{d}$ Arm Circumference-for-age. World Health Organization. Accessed June 28, 2022."
    },
    {
      "type": "text",
      "section": "Measurement Techniques",
      "line": 795,
      "preview": "https://www.who.int/tools/child-growth-standards/standards/arm-circumference-for-age"
    },
    {
      "type": "text",
      "section": "Measurement Techniques",
      "line": 796,
      "preview": "${ }^{\\text {e }}$ Triceps Skinfold-for-age. World Health Organization. Accessed June 28, 2022."
    },
    {
      "type": "text",
      "section": "Measurement Techniques",
      "line": 797,
      "preview": "https://www.who.int/tools/child-growth-standards/standards/triceps-skinfold-for-age"
    },
    {
      "type": "text",
      "section": "Measurement Techniques",
      "line": 798,
      "preview": "${ }^{\\dagger}$ Frisancho AR. New norms of upper limb fat and muscle areas for assessment of nutriti"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "Illustrations of Measurement Techniques",
      "line": 800
    },
    {
      "type": "text",
      "section": "Illustrations of Measurement Techniques",
      "line": 802,
      "preview": "Figures 1-1 through 1-4 supplement the narrative descriptions for specific anthropometric measuremen"
    },
    {
      "type": "text",
      "section": "Illustrations of Measurement Techniques",
      "line": 804,
      "preview": "--- page 37 ---"
    },
    {
      "type": "image",
      "section": "Illustrations of Measurement Techniques",
      "line": 806,
      "content": "![img-0.jpeg](images/37eeb497adc74299.png)"
    },
    {
      "type": "text",
      "section": "Illustrations of Measurement Techniques",
      "line": 808,
      "preview": "FIGURE 1-1. Measuring recumbent length by using an infantometer. Reproduced with permission from the"
    },
    {
      "type": "text",
      "section": "Illustrations of Measurement Techniques",
      "line": 810,
      "preview": "--- page 38 ---"
    },
    {
      "type": "image",
      "section": "Illustrations of Measurement Techniques",
      "line": 812,
      "content": "![img-1.jpeg](images/97a7a5524c7b4785.png)"
    },
    {
      "type": "text",
      "section": "Illustrations of Measurement Techniques",
      "line": 814,
      "preview": "FIGURE 1-2. Measuring standing height by using a stadiometer. Reproduced with permission from the Am"
    },
    {
      "type": "text",
      "section": "Illustrations of Measurement Techniques",
      "line": 816,
      "preview": "--- page 39 ---"
    },
    {
      "type": "image",
      "section": "Illustrations of Measurement Techniques",
      "line": 818,
      "content": "![img-2.jpeg](images/31cb07498dae0b63.png)"
    },
    {
      "type": "text",
      "section": "Illustrations of Measurement Techniques",
      "line": 820,
      "preview": "FIGURE 1-3. Technique for measuring mid-upper arm circumference. Reproduced with permission from the"
    },
    {
      "type": "text",
      "section": "Illustrations of Measurement Techniques",
      "line": 822,
      "preview": "--- page 40 ---"
    },
    {
      "type": "image",
      "section": "Illustrations of Measurement Techniques",
      "line": 824,
      "content": "![img-3.jpeg](images/598a13bc1afd8de9.png)"
    },
    {
      "type": "text",
      "section": "Illustrations of Measurement Techniques",
      "line": 826,
      "preview": "FIGURE 1-4. Obtaining a triceps skinfold measurement by using a skinfold caliper. Reproduced with pe"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "Segmental Measurements of Height in Children",
      "line": 828
    },
    {
      "type": "text",
      "section": "Segmental Measurements of Height in Children",
      "line": 830,
      "preview": "For children who are unable to stand or who have skeletal deformities because of underlying NI, segm"
    },
    {
      "type": "text",
      "section": "Segmental Measurements of Height in Children",
      "line": 832,
      "preview": "--- page 41 ---"
    },
    {
      "type": "text",
      "section": "Segmental Measurements of Height in Children",
      "line": 834,
      "preview": "TABLE 1-5. Segmental Measurement Techniques and Equations to Calculate Extrapolated Lengths"
    },
    {
      "type": "table",
      "section": "Segmental Measurements of Height in Children",
      "line": 836,
      "preview": "| Measurement | Age | Equipment | Technique ${ }^{a}$ | Calculation |"
    },
    {
      "type": "table",
      "section": "Segmental Measurements of Height in Children",
      "line": 837,
      "preview": "| :--: | :--: | :--: | :--: | :--: |"
    },
    {
      "type": "table",
      "section": "Segmental Measurements of Height in Children",
      "line": 838,
      "preview": "| Knee height $(\\mathrm{KH})$ | All ages | KH calipers | With the child sitting, place the bottom bl"
    },
    {
      "type": "table",
      "section": "Segmental Measurements of Height in Children",
      "line": 839,
      "preview": "| Tibial length (TL) | $2-12 y$ | Tape measure | The tibia is measured on the inside of the leg (med"
    },
    {
      "type": "text",
      "section": "Segmental Measurements of Height in Children",
      "line": 841,
      "preview": "--- page 42 ---"
    },
    {
      "type": "table",
      "section": "Segmental Measurements of Height in Children",
      "line": 843,
      "preview": "| Measurement | Age | Equipment | Technique ${ }^{a}$ | Calculation |"
    },
    {
      "type": "table",
      "section": "Segmental Measurements of Height in Children",
      "line": 844,
      "preview": "| :--: | :--: | :--: | :--: | :--: |"
    },
    {
      "type": "table",
      "section": "Segmental Measurements of Height in Children",
      "line": 845,
      "preview": "| Arm span | All ages | Tape measure | - With the child recumbent lying on paper with horizontal lin"
    },
    {
      "type": "table",
      "section": "Segmental Measurements of Height in Children",
      "line": 846,
      "preview": "| Upper arm length | All ages | Anthropometer | The child should be sitting up with their arm relaxe"
    },
    {
      "type": "text",
      "section": "Segmental Measurements of Height in Children",
      "line": 848,
      "preview": "Abbreviation: NI, neurological impairment."
    },
    {
      "type": "text",
      "section": "Segmental Measurements of Height in Children",
      "line": 849,
      "preview": "${ }^{a}$ In children with motor impairment related to neurodevelopmental disabilities, measure the "
    },
    {
      "type": "text",
      "section": "Segmental Measurements of Height in Children",
      "line": 850,
      "preview": "${ }^{\\text {b }}$ Stevenson RD. Use of segmental measures to estimate stature in children with cere"
    },
    {
      "type": "text",
      "section": "Segmental Measurements of Height in Children",
      "line": 851,
      "preview": "https://doi.org/10.1001/archpedi.1995.02170190068012"
    },
    {
      "type": "text",
      "section": "Segmental Measurements of Height in Children",
      "line": 852,
      "preview": "${ }^{c}$ Chumlea WC, Guo SS, Steinbaugh ML. Prediction of stature from knee height for Black and Wh"
    },
    {
      "type": "text",
      "section": "Segmental Measurements of Height in Children",
      "line": 853,
      "preview": "${ }^{d}$ Tsuji M, Ayabe T, Tanaka R, et al. Comparative study on three different methods for arm-sp"
    },
    {
      "type": "text",
      "section": "Segmental Measurements of Height in Children",
      "line": 854,
      "preview": "${ }^{\\text {e }}$ Forman MR, Zhu Y, Hernandez LM, et al. Arm span and ulnar length are reliable and"
    },
    {
      "type": "text",
      "section": "Segmental Measurements of Height in Children",
      "line": 856,
      "preview": "--- page 43 ---"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "Interpreting Anthropometric Measurements",
      "line": 858
    },
    {
      "type": "text",
      "section": "Interpreting Anthropometric Measurements",
      "line": 860,
      "preview": "Anthropometric measures are an integral part of the nutrition assessment. They allow comparison with"
    },
    {
      "type": "heading",
      "level": 2,
      "section": "Interpreting Weight",
      "line": 862
    },
    {
      "type": "text",
      "section": "Interpreting Weight",
      "line": 864,
      "preview": "Like any anthropometric measure, a weight cannot be interpreted without understanding how it compare"
    },
    {
      "type": "text",
      "section": "Interpreting Weight",
      "line": 866,
      "preview": "Table 1-6 demonstrates weight gain velocity at different percentiles and their approximate $z$ score"
    },
    {
      "type": "text",
      "section": "Interpreting Weight",
      "line": 868,
      "preview": "--- page 44 ---"
    },
    {
      "type": "text",
      "section": "Interpreting Weight",
      "line": 870,
      "preview": "TABLE 1-6. Daily Weight Gain Velocity in Grams per Day for Infants and Children Under 24 Months ${ }"
    },
    {
      "type": "table",
      "section": "Interpreting Weight",
      "line": 872,
      "preview": "|  Interval <br> (mo) | Males (g/d) |  | Females (g/d) |   |"
    },
    {
      "type": "table",
      "section": "Interpreting Weight",
      "line": 873,
      "preview": "| --- | --- | --- | --- | --- |"
    },
    {
      "type": "table",
      "section": "Interpreting Weight",
      "line": 874,
      "preview": "|   | Daily Weight Velocity Range (15th to 85th Percentile; z Score From -1 to +1 ) | Daily Weight V"
    },
    {
      "type": "table",
      "section": "Interpreting Weight",
      "line": 875,
      "preview": "|  $0-1$ | $24-48$ | 37 | $22-42$ | 31  |"
    },
    {
      "type": "table",
      "section": "Interpreting Weight",
      "line": 876,
      "preview": "|  $1-2$ | $30-51$ | 40 | $24-43$ | 34  |"
    },
    {
      "type": "table",
      "section": "Interpreting Weight",
      "line": 877,
      "preview": "|  $2-3$ | $19-36$ | 27 | $16-23$ | 24  |"
    },
    {
      "type": "table",
      "section": "Interpreting Weight",
      "line": 878,
      "preview": "|  $3-6$ | $13-23$ | 18 | $12-21$ | 16  |"
    },
    {
      "type": "table",
      "section": "Interpreting Weight",
      "line": 879,
      "preview": "|  $6-9$ | $7-15$ | 11 | $6-15$ | 10  |"
    },
    {
      "type": "table",
      "section": "Interpreting Weight",
      "line": 880,
      "preview": "|  $9-12$ | $4-12$ | 8 | $4-12$ | 8  |"
    },
    {
      "type": "table",
      "section": "Interpreting Weight",
      "line": 881,
      "preview": "|  $12-18$ | $4-10$ | 7 | $4-10$ | 7  |"
    },
    {
      "type": "table",
      "section": "Interpreting Weight",
      "line": 882,
      "preview": "|  $18-24$ | $4-9$ | 6 | $4-10$ | 7  |"
    },
    {
      "type": "text",
      "section": "Interpreting Weight",
      "line": 884,
      "preview": "${ }^{a}$ Data from Weight Velocity. World Health Organization. Accessed June 30, 2022. https://www."
    },
    {
      "type": "text",
      "section": "Interpreting Weight",
      "line": 886,
      "preview": "TABLE 1-7. Average Weight Gain and Growth Goals: Ages 310 Years ${ }^{\\mathrm{a}, \\mathrm{b}}$"
    },
    {
      "type": "table",
      "section": "Interpreting Weight",
      "line": 888,
      "preview": "|  Age (y) | Weight (g/d) | Height (cm/mo)  |"
    },
    {
      "type": "table",
      "section": "Interpreting Weight",
      "line": 889,
      "preview": "| --- | --- | --- |"
    },
    {
      "type": "table",
      "section": "Interpreting Weight",
      "line": 890,
      "preview": "|  $2-<4$ | $3.5-5$ | $0.5-0.7$  |"
    },
    {
      "type": "table",
      "section": "Interpreting Weight",
      "line": 891,
      "preview": "|  $4-7$ | $4.5-6.5$ | 0.5  |"
    },
    {
      "type": "table",
      "section": "Interpreting Weight",
      "line": 892,
      "preview": "|  $7-<9$ | $5-8.5$ | $0.4-0.5$  |"
    },
    {
      "type": "table",
      "section": "Interpreting Weight",
      "line": 893,
      "preview": "|  $9-<10$ | $6-10$ | $0.3-0.4$  |"
    },
    {
      "type": "table",
      "section": "Interpreting Weight",
      "line": 894,
      "preview": "|  $10-<11$ | $7-11$ | $0.3-0.5$  |"
    },
    {
      "type": "text",
      "section": "Interpreting Weight",
      "line": 896,
      "preview": "${ }^{a}$ Growth velocity based on the median $z$ score for age from the Centers for Disease Control"
    },
    {
      "type": "text",
      "section": "Interpreting Weight",
      "line": 898,
      "preview": "--- page 45 ---"
    },
    {
      "type": "text",
      "section": "Interpreting Weight",
      "line": 900,
      "preview": "TABLE 1-8. Average Growth Goals: Males and Females Ages 11-20 Years $^{\\mathrm{a}, \\mathrm{b}}$"
    },
    {
      "type": "table",
      "section": "Interpreting Weight",
      "line": 902,
      "preview": "| Age (y) | Weight Gain <br> Velocity (kg/y) | Height Gain <br> Velocity (cm/y) | Weight Gain <br> V"
    },
    {
      "type": "table",
      "section": "Interpreting Weight",
      "line": 903,
      "preview": "| :-- | :--: | :--: | :--: | :--: |"
    },
    {
      "type": "table",
      "section": "Interpreting Weight",
      "line": 904,
      "preview": "|  | Males |  | Females |  |"
    },
    {
      "type": "table",
      "section": "Interpreting Weight",
      "line": 905,
      "preview": "| $11-12$ | 4.7 | 5 | $4-5$ | $5-8$ |"
    },
    {
      "type": "table",
      "section": "Interpreting Weight",
      "line": 906,
      "preview": "| $12-15$ | $5.2-5.4$ | $6-8$ | $2-3.5$ | $2-3$ |"
    },
    {
      "type": "table",
      "section": "Interpreting Weight",
      "line": 907,
      "preview": "| $15-17$ | $3.6-4.6$ | $4-6$ | $1-2$ | $0.5-1$ |"
    },
    {
      "type": "table",
      "section": "Interpreting Weight",
      "line": 908,
      "preview": "| $17-18$ | 2.6 | $2-4$ | NA | NA |"
    },
    {
      "type": "table",
      "section": "Interpreting Weight",
      "line": 909,
      "preview": "| $18-20$ | 1.9 | 2 | NA | NA |"
    },
    {
      "type": "text",
      "section": "Interpreting Weight",
      "line": 911,
      "preview": "Abbreviation: NA, not applicable."
    },
    {
      "type": "text",
      "section": "Interpreting Weight",
      "line": 912,
      "preview": "${ }^{a}$ Growth velocity is based on the median $z$ score for age from the Centers for Disease Cont"
    },
    {
      "type": "text",
      "section": "Interpreting Weight",
      "line": 913,
      "preview": "${ }^{\\text {b }}$ Data from Clinical Growth Charts. Centers for Disease Control and Prevention. Acc"
    },
    {
      "type": "text",
      "section": "Interpreting Weight",
      "line": 915,
      "preview": "Recovery Growth. Recovery or \"catch-up\" growth can be seen when an acceleration in weight gain veloc"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "Interpreting Length and Height",
      "line": 917
    },
    {
      "type": "text",
      "section": "Interpreting Length and Height",
      "line": 919,
      "preview": "Well-nourished children who meet their nutrient needs should follow a stable growth trajectory on a "
    },
    {
      "type": "text",
      "section": "Interpreting Length and Height",
      "line": 921,
      "preview": "Although downward trends of height percentiles on growth charts can be indicators of poor nutrition "
    },
    {
      "type": "text",
      "section": "Interpreting Length and Height",
      "line": 923,
      "preview": "A child's height percentile before pubertal growth should fall within 2 SDs or 8.5 cm of midparental"
    },
    {
      "type": "text",
      "section": "Interpreting Length and Height",
      "line": 925,
      "preview": "--- page 46 ---"
    },
    {
      "type": "text",
      "section": "Interpreting Length and Height",
      "line": 927,
      "preview": "Males: [(father's height in centimeters + mother's height"
    },
    {
      "type": "text",
      "section": "Interpreting Length and Height",
      "line": 928,
      "preview": "in centimeters) +13 ]/2"
    },
    {
      "type": "text",
      "section": "Interpreting Length and Height",
      "line": 929,
      "preview": "Females: [(father's height in centimeters + mother's height"
    },
    {
      "type": "text",
      "section": "Interpreting Length and Height",
      "line": 930,
      "preview": "in centimeters) -13 ]/2"
    },
    {
      "type": "text",
      "section": "Interpreting Length and Height",
      "line": 932,
      "preview": "Health and wellness, nutrition intake, and pubertal status all impact growth. A detailed chart of th"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "Interpreting Body Mass Index",
      "line": 934
    },
    {
      "type": "text",
      "section": "Interpreting Body Mass Index",
      "line": 936,
      "preview": "Body mass index (BMI) correlates with body fat, and a high BMI has been linked to future obesity. Ag"
    },
    {
      "type": "text",
      "section": "Interpreting Body Mass Index",
      "line": 938,
      "preview": "Weight in kilograms/height in meter squared"
    },
    {
      "type": "text",
      "section": "Interpreting Body Mass Index",
      "line": 939,
      "preview": "(Weight in kilograms/height in meters)/height in meters"
    },
    {
      "type": "text",
      "section": "Interpreting Body Mass Index",
      "line": 941,
      "preview": "BMI can be difficult to interpret in children who have skeletal deformities or are unable to stand b"
    },
    {
      "type": "text",
      "section": "Interpreting Body Mass Index",
      "line": 943,
      "preview": "Comparing the weight and height by using weight for length or BMI plays an important role in assessi"
    },
    {
      "type": "text",
      "section": "Interpreting Body Mass Index",
      "line": 945,
      "preview": "--- page 47 ---"
    },
    {
      "type": "text",
      "section": "Interpreting Body Mass Index",
      "line": 947,
      "preview": "TABLE 1-9. WHO z Score ${ }^{a}$ Cutoff Points for Various Growth Concerns"
    },
    {
      "type": "table",
      "section": "Interpreting Body Mass Index",
      "line": 949,
      "preview": "| Growth Concern | Birth to 2 y: Weight for <br> Length | 2-5 y: BMI for <br> Age | 5-19 y: BMI for "
    },
    {
      "type": "table",
      "section": "Interpreting Body Mass Index",
      "line": 950,
      "preview": "| :-- | :--: | :--: | :--: |"
    },
    {
      "type": "table",
      "section": "Interpreting Body Mass Index",
      "line": 951,
      "preview": "| Severely wasted | -3 | -3 | -3 |"
    },
    {
      "type": "table",
      "section": "Interpreting Body Mass Index",
      "line": 952,
      "preview": "| Wasted | -2 | -2 | -2 |"
    },
    {
      "type": "table",
      "section": "Interpreting Body Mass Index",
      "line": 953,
      "preview": "| Risk of <br> overweight | +1 | +1 | NA |"
    },
    {
      "type": "table",
      "section": "Interpreting Body Mass Index",
      "line": 954,
      "preview": "| Overweight | +2 | +2 | +1 |"
    },
    {
      "type": "table",
      "section": "Interpreting Body Mass Index",
      "line": 955,
      "preview": "| Obese | +3 | +3 | +2 |"
    },
    {
      "type": "table",
      "section": "Interpreting Body Mass Index",
      "line": 956,
      "preview": "| Severely obese | NA | NA | +3 |"
    },
    {
      "type": "text",
      "section": "Interpreting Body Mass Index",
      "line": 958,
      "preview": "Abbreviations: BMI, body mass index; NA, not applicable; WHO, World Health Organization. Adapted wit"
    },
    {
      "type": "text",
      "section": "Interpreting Body Mass Index",
      "line": 959,
      "preview": "https://www.dietitians.ca/DietitiansOfCanada/media/Documents/WHO\\ Growth\\ Charts/2014 -A-Health-Prof"
    },
    {
      "type": "text",
      "section": "Interpreting Body Mass Index",
      "line": 960,
      "preview": "${ }^{a}$ For more information on interpreting $z$ scores, see \"Interpreting Patterns of Growth\" sec"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "Growth Charts",
      "line": 962
    },
    {
      "type": "text",
      "section": "Growth Charts",
      "line": 964,
      "preview": "Growth Charts for All Children. All anthropometric measures should be compared with appropriate refe"
    },
    {
      "type": "text",
      "section": "Growth Charts",
      "line": 966,
      "preview": "EXHIBIT 1-3. Comparison of WHO and CDC Growth Charts"
    },
    {
      "type": "text",
      "section": "Growth Charts",
      "line": 967,
      "preview": "2006 WHO Child Growth Standards From Birth to 5 Years ${ }^{a}$"
    },
    {
      "type": "text",
      "section": "Growth Charts",
      "line": 969,
      "preview": "--- page 48 ---"
    },
    {
      "type": "text",
      "section": "Growth Charts",
      "line": 971,
      "preview": "- A growth standard defines a recommended \"model\" pattern of growth associated with specified health"
    },
    {
      "type": "text",
      "section": "Growth Charts",
      "line": 972,
      "preview": "- These prescriptive standards are based on term, singleton babies receiving optimal health care, wi"
    },
    {
      "type": "text",
      "section": "Growth Charts",
      "line": 973,
      "preview": "- In addition, they are based on international sample population in 6 different countries (Brazil, G"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "2007 WHO Growth Reference Charts From 5 to 19 Years ${ }^{b}$",
      "line": 976
    },
    {
      "type": "text",
      "section": "2007 WHO Growth Reference Charts From 5 to 19 Years ${ }^{b}$",
      "line": 978,
      "preview": "- A growth reference describes the growth pattern of a defined population without making claims abou"
    },
    {
      "type": "text",
      "section": "2007 WHO Growth Reference Charts From 5 to 19 Years ${ }^{b}$",
      "line": 979,
      "preview": "- They are updated to address the obesity epidemic and are therefore closer to being considered grow"
    },
    {
      "type": "text",
      "section": "2007 WHO Growth Reference Charts From 5 to 19 Years ${ }^{b}$",
      "line": 980,
      "preview": "- Data fitted to an almost perfect match of measurements at 5 years of age between the growth standa"
    },
    {
      "type": "text",
      "section": "2007 WHO Growth Reference Charts From 5 to 19 Years ${ }^{b}$",
      "line": 981,
      "preview": "- Set 1 of the WHO child growth standards and growth references includes the third, 15th, 50th, 85th"
    },
    {
      "type": "text",
      "section": "2007 WHO Growth Reference Charts From 5 to 19 Years ${ }^{b}$",
      "line": 982,
      "preview": "- Set 2 of the WHO Child Growth Standards include the third, 10th, 25th, 50th, 75th, 90th and 97 th "
    },
    {
      "type": "heading",
      "level": 2,
      "section": "2000 CDC Growth Charts ${ }^{c}$",
      "line": 985
    },
    {
      "type": "text",
      "section": "2000 CDC Growth Charts ${ }^{c}$",
      "line": 987,
      "preview": "- The CDC growth charts represent the standard growth reference for American children describing how"
    },
    {
      "type": "text",
      "section": "2000 CDC Growth Charts ${ }^{c}$",
      "line": 988,
      "preview": "- The clinical charts for infants and older children were published in 2 sets:"
    },
    {
      "type": "text",
      "section": "2000 CDC Growth Charts ${ }^{c}$",
      "line": 989,
      "preview": "- Set 1 contains 10 charts ( 5 for boys and 5 for girls), which include the fifth, 10th, 25th, 50th,"
    },
    {
      "type": "text",
      "section": "2000 CDC Growth Charts ${ }^{c}$",
      "line": 990,
      "preview": "- Set 2 contains 10 charts ( 5 for boys and 5 for girls), which include the third, 10th, 25th, 50th,"
    },
    {
      "type": "text",
      "section": "2000 CDC Growth Charts ${ }^{c}$",
      "line": 992,
      "preview": "Abbreviations: BMI, body mass index; CDC, Centers for Disease Control and Prevention; WHO, World Hea"
    },
    {
      "type": "text",
      "section": "2000 CDC Growth Charts ${ }^{c}$",
      "line": 993,
      "preview": "${ }^{a}$ Child Growth Standards. World Health Organization. Accessed July 5, 2022."
    },
    {
      "type": "text",
      "section": "2000 CDC Growth Charts ${ }^{c}$",
      "line": 994,
      "preview": "https://www.who.int/tools/child-growth-standards/standards"
    },
    {
      "type": "text",
      "section": "2000 CDC Growth Charts ${ }^{c}$",
      "line": 995,
      "preview": "${ }^{\\text {b }}$ A Health Professional's Guide for Using the WHO Growth Charts for Canada. Dietiti"
    },
    {
      "type": "text",
      "section": "2000 CDC Growth Charts ${ }^{c}$",
      "line": 996,
      "preview": "https://www.dietitians.ca/Downloadable-Content/Public/Growth_Charts_backgrounder_eng.aspx"
    },
    {
      "type": "text",
      "section": "2000 CDC Growth Charts ${ }^{c}$",
      "line": 997,
      "preview": "${ }^{c}$ Clinical Growth Charts. Centers for Disease Control and Prevention. June 16, 2017. Accesse"
    },
    {
      "type": "text",
      "section": "2000 CDC Growth Charts ${ }^{c}$",
      "line": 999,
      "preview": "--- page 49 ---"
    },
    {
      "type": "text",
      "section": "2000 CDC Growth Charts ${ }^{c}$",
      "line": 1001,
      "preview": "Specialized Growth Charts. Specialized growth charts are available for children with genetic or neur"
    },
    {
      "type": "text",
      "section": "2000 CDC Growth Charts ${ }^{c}$",
      "line": 1003,
      "preview": "When assessing specialized growth charts, check the following:"
    },
    {
      "type": "text",
      "section": "2000 CDC Growth Charts ${ }^{c}$",
      "line": 1005,
      "preview": "- What are the sources of the data, sample size, and age of participants?"
    },
    {
      "type": "text",
      "section": "2000 CDC Growth Charts ${ }^{c}$",
      "line": 1006,
      "preview": "- How was the data collected?"
    },
    {
      "type": "text",
      "section": "2000 CDC Growth Charts ${ }^{c}$",
      "line": 1007,
      "preview": "- What measurements were collected?"
    },
    {
      "type": "text",
      "section": "2000 CDC Growth Charts ${ }^{c}$",
      "line": 1008,
      "preview": "- Are the curves \"smoothed?\""
    },
    {
      "type": "text",
      "section": "2000 CDC Growth Charts ${ }^{c}$",
      "line": 1009,
      "preview": "- Are weights and heights collected appropriately?"
    },
    {
      "type": "text",
      "section": "2000 CDC Growth Charts ${ }^{c}$",
      "line": 1010,
      "preview": "- Was the information generated before treatment for the condition or nutrition support was availabl"
    },
    {
      "type": "text",
      "section": "2000 CDC Growth Charts ${ }^{c}$",
      "line": 1012,
      "preview": "Trisomy 21 is the most common chromosomal variation. Growth charts have been developed and should be"
    },
    {
      "type": "text",
      "section": "2000 CDC Growth Charts ${ }^{c}$",
      "line": 1014,
      "preview": "Cerebral palsy (CP) is a neuromuscular condition that affects motor function and tone. It is the mos"
    },
    {
      "type": "text",
      "section": "2000 CDC Growth Charts ${ }^{c}$",
      "line": 1016,
      "preview": "The CP-specific growth charts are stratified by sex, tube feeding, and functional severity by using "
    },
    {
      "type": "text",
      "section": "2000 CDC Growth Charts ${ }^{c}$",
      "line": 1018,
      "preview": "--- page 50 ---"
    },
    {
      "type": "text",
      "section": "2000 CDC Growth Charts ${ }^{c}$",
      "line": 1020,
      "preview": "TABLE 1-10. Gross Motor Function Classification Scale for Children With Cerebral Palsy"
    },
    {
      "type": "table",
      "section": "2000 CDC Growth Charts ${ }^{c}$",
      "line": 1022,
      "preview": "| Level | Description |"
    },
    {
      "type": "table",
      "section": "2000 CDC Growth Charts ${ }^{c}$",
      "line": 1023,
      "preview": "| :-- | :-- |"
    },
    {
      "type": "table",
      "section": "2000 CDC Growth Charts ${ }^{c}$",
      "line": 1024,
      "preview": "| 1 | Walks without limitations |"
    },
    {
      "type": "table",
      "section": "2000 CDC Growth Charts ${ }^{c}$",
      "line": 1025,
      "preview": "| 2 | Walks with limitations |"
    },
    {
      "type": "table",
      "section": "2000 CDC Growth Charts ${ }^{c}$",
      "line": 1026,
      "preview": "| 3 | Walks with hand-held mobility device |"
    },
    {
      "type": "table",
      "section": "2000 CDC Growth Charts ${ }^{c}$",
      "line": 1027,
      "preview": "| 4 | Self-mobility with limitations; may use powered mobility |"
    },
    {
      "type": "table",
      "section": "2000 CDC Growth Charts ${ }^{c}$",
      "line": 1028,
      "preview": "| 5 | Transported in a manual wheelchair |"
    },
    {
      "type": "text",
      "section": "2000 CDC Growth Charts ${ }^{c}$",
      "line": 1030,
      "preview": "Data from Palisano R, Rosenbaum P, Bartlett D, Livingston M. Gross Motor Function Classification Sys"
    },
    {
      "type": "text",
      "section": "2000 CDC Growth Charts ${ }^{c}$",
      "line": 1031,
      "preview": "ER_English.pdf"
    },
    {
      "type": "text",
      "section": "2000 CDC Growth Charts ${ }^{c}$",
      "line": 1033,
      "preview": "Plotting under the 20th percentile for weight for age on the CP growth charts places children in the"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "Interpreting Patterns of Growth",
      "line": 1035
    },
    {
      "type": "text",
      "section": "Interpreting Patterns of Growth",
      "line": 1037,
      "preview": "The following scenarios trigger a deeper look into a child's nutrition and general health status:"
    },
    {
      "type": "text",
      "section": "Interpreting Patterns of Growth",
      "line": 1039,
      "preview": "- sharp inclines or declines in weight gain or growth,"
    },
    {
      "type": "text",
      "section": "Interpreting Patterns of Growth",
      "line": 1040,
      "preview": "- plateau of weight or growth percentiles or $z$ scores, and/or"
    },
    {
      "type": "text",
      "section": "Interpreting Patterns of Growth",
      "line": 1041,
      "preview": "- unexpected movement downward from a previously established growth pattern on weight or growth perc"
    },
    {
      "type": "text",
      "section": "Interpreting Patterns of Growth",
      "line": 1043,
      "preview": "Investigation of changes in weight and height should occur before a child has crossed 2 percentiles "
    },
    {
      "type": "heading",
      "level": 2,
      "section": "Use of z Scores (SDs vs Percentiles)",
      "line": 1045
    },
    {
      "type": "text",
      "section": "Use of z Scores (SDs vs Percentiles)",
      "line": 1047,
      "preview": "--- page 51 ---"
    },
    {
      "type": "text",
      "section": "Use of z Scores (SDs vs Percentiles)",
      "line": 1049,
      "preview": "Percentiles are commonly used and indicate the child's position within the context of the reference "
    },
    {
      "type": "text",
      "section": "Use of z Scores (SDs vs Percentiles)",
      "line": 1051,
      "preview": "Values expressed as $z$ scores describe how far, in SDs or SD units, the child's measurement is from"
    },
    {
      "type": "text",
      "section": "Use of z Scores (SDs vs Percentiles)",
      "line": 1053,
      "preview": "The use of $z$ scores is beneficial when the child plots far from the expected growth percentiles on"
    },
    {
      "type": "text",
      "section": "Use of z Scores (SDs vs Percentiles)",
      "line": 1055,
      "preview": "Table 1-11 shows percentiles from set 1 of the WHO child growth standards and the corresponding $z$ "
    },
    {
      "type": "text",
      "section": "Use of z Scores (SDs vs Percentiles)",
      "line": 1057,
      "preview": "TABLE 1-11. Comparing WHO Percentiles From Set 1 of the WHO Growth Charts With Approximate Correspon"
    },
    {
      "type": "table",
      "section": "Use of z Scores (SDs vs Percentiles)",
      "line": 1059,
      "preview": "| Rounded Percentile | Corresponding $\\boldsymbol{z}$ Score |"
    },
    {
      "type": "table",
      "section": "Use of z Scores (SDs vs Percentiles)",
      "line": 1060,
      "preview": "| :-- | :--: |"
    },
    {
      "type": "table",
      "section": "Use of z Scores (SDs vs Percentiles)",
      "line": 1061,
      "preview": "| 0.1 st | -3 |"
    },
    {
      "type": "table",
      "section": "Use of z Scores (SDs vs Percentiles)",
      "line": 1062,
      "preview": "| 3rd | -2 |"
    },
    {
      "type": "table",
      "section": "Use of z Scores (SDs vs Percentiles)",
      "line": 1063,
      "preview": "| 15th | -1 |"
    },
    {
      "type": "table",
      "section": "Use of z Scores (SDs vs Percentiles)",
      "line": 1064,
      "preview": "| 50th | 0 |"
    },
    {
      "type": "table",
      "section": "Use of z Scores (SDs vs Percentiles)",
      "line": 1065,
      "preview": "| 85th | +1 |"
    },
    {
      "type": "table",
      "section": "Use of z Scores (SDs vs Percentiles)",
      "line": 1066,
      "preview": "| 97th | +2 |"
    },
    {
      "type": "table",
      "section": "Use of z Scores (SDs vs Percentiles)",
      "line": 1067,
      "preview": "| 99.9 th | +3 |"
    },
    {
      "type": "text",
      "section": "Use of z Scores (SDs vs Percentiles)",
      "line": 1069,
      "preview": "Abbreviation: WHO, World Health Organization."
    },
    {
      "type": "text",
      "section": "Use of z Scores (SDs vs Percentiles)",
      "line": 1070,
      "preview": "${ }^{a}$ Data from Child Growth Standards, Set 1 WHO Growth Charts. World Health Organization. Acce"
    },
    {
      "type": "text",
      "section": "Use of z Scores (SDs vs Percentiles)",
      "line": 1071,
      "preview": "${ }^{\\text {b }}$ Data from A Health Professional's Guide for Using the WHO Growth Charts for Canad"
    },
    {
      "type": "text",
      "section": "Use of z Scores (SDs vs Percentiles)",
      "line": 1072,
      "preview": "https://www.dietitians.ca/Downloadable-Content/Public/Growth_Charts_backgrounder_eng.aspx"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "Mobile Device and Online Applications to Assist With Nutrition Assessments",
      "line": 1074
    },
    {
      "type": "text",
      "section": "Mobile Device and Online Applications to Assist With Nutrition Assessments",
      "line": 1076,
      "preview": "--- page 52 ---"
    },
    {
      "type": "text",
      "section": "Mobile Device and Online Applications to Assist With Nutrition Assessments",
      "line": 1078,
      "preview": "There are several mobile device and online applications that can be used to assist with nutrition as"
    },
    {
      "type": "text",
      "section": "Mobile Device and Online Applications to Assist With Nutrition Assessments",
      "line": 1080,
      "preview": "- PediTools Home (https://www.peditools.org and mobile app)"
    },
    {
      "type": "text",
      "section": "Mobile Device and Online Applications to Assist With Nutrition Assessments",
      "line": 1081,
      "preview": "- WHO growth charts including weight, length/height, weight for height and BMI, head circumference, "
    },
    {
      "type": "text",
      "section": "Mobile Device and Online Applications to Assist With Nutrition Assessments",
      "line": 1082,
      "preview": "- CDC growth charts (https://www.cdc.gov/growthcharts/cdc_charts.htm)"
    },
    {
      "type": "text",
      "section": "Mobile Device and Online Applications to Assist With Nutrition Assessments",
      "line": 1083,
      "preview": "- Fenton growth charts for preterm infants (https://peditools.org/fenton2013)"
    },
    {
      "type": "text",
      "section": "Mobile Device and Online Applications to Assist With Nutrition Assessments",
      "line": 1084,
      "preview": "- Olsen growth charts for preterm infants (https://www.peditools.org/olsen2010)"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "Nutrition-Focused Physical Examination",
      "line": 1087
    },
    {
      "type": "text",
      "section": "Nutrition-Focused Physical Examination",
      "line": 1089,
      "preview": "The nutrition-focused physical examination (NFPE) is an important part of the overall nutrition asse"
    },
    {
      "type": "text",
      "section": "Nutrition-Focused Physical Examination",
      "line": 1091,
      "preview": "The clinical signs of malnutrition due to potential nutrient deficiency and the clinical data that s"
    },
    {
      "type": "text",
      "section": "Nutrition-Focused Physical Examination",
      "line": 1093,
      "preview": "--- page 53 ---"
    },
    {
      "type": "text",
      "section": "Nutrition-Focused Physical Examination",
      "line": 1095,
      "preview": "TABLE 1-12. Nutrition-Focused Physical Examination Clinical Signs ${ }^{\\text {a,b }}$"
    },
    {
      "type": "table",
      "section": "Nutrition-Focused Physical Examination",
      "line": 1097,
      "preview": "| Physical Findings | Potential <br> Nutrient <br> Deficiency | Potential Clinical Support Data |"
    },
    {
      "type": "table",
      "section": "Nutrition-Focused Physical Examination",
      "line": 1098,
      "preview": "| :--: | :--: | :--: |"
    },
    {
      "type": "table",
      "section": "Nutrition-Focused Physical Examination",
      "line": 1099,
      "preview": "| Skin |  |  |"
    },
    {
      "type": "table",
      "section": "Nutrition-Focused Physical Examination",
      "line": 1100,
      "preview": "| Lanugo hair (fine, unpigmented, downy) | Protein/calorie | $\\downarrow$ Serum urea nitrogen $\\down"
    },
    {
      "type": "table",
      "section": "Nutrition-Focused Physical Examination",
      "line": 1101,
      "preview": "| Xerosis, dry, scaling | Essential fatty acid | Elevated triene/tetraene ratio |"
    },
    {
      "type": "table",
      "section": "Nutrition-Focused Physical Examination",
      "line": 1102,
      "preview": "| Hyperkeratosis, plaques around hair follicles | Vitamins A and K | $\\downarrow$ Plasma retinol <br"
    },
    {
      "type": "table",
      "section": "Nutrition-Focused Physical Examination",
      "line": 1103,
      "preview": "| Ecchymoses, petechiae | Vitamin C | $\\downarrow$ Serum ascorbic acid |"
    },
    {
      "type": "table",
      "section": "Nutrition-Focused Physical Examination",
      "line": 1104,
      "preview": "| Hyperpigmentation | Vitamin $B_{12}$ <br> Niacin | $\\begin{aligned} & \\downarrow \\text { Serum } B"
    },
    {
      "type": "table",
      "section": "Nutrition-Focused Physical Examination",
      "line": 1105,
      "preview": "| Hair |  |  |"
    },
    {
      "type": "table",
      "section": "Nutrition-Focused Physical Examination",
      "line": 1106,
      "preview": "| Easily plucked, dyspigmented, lackluster | Protein | $\\downarrow$ Serum protein <br> $\\downarrow$ "
    },
    {
      "type": "table",
      "section": "Nutrition-Focused Physical Examination",
      "line": 1107,
      "preview": "| Nails |  |  |"
    },
    {
      "type": "table",
      "section": "Nutrition-Focused Physical Examination",
      "line": 1108,
      "preview": "| Thin, spoon-shaped | Iron | $\\begin{aligned} & \\downarrow \\text { Ferritin } \\\\ & \\downarrow \\text"
    },
    {
      "type": "table",
      "section": "Nutrition-Focused Physical Examination",
      "line": 1109,
      "preview": "| Eyes, nose, mouth |  |  |"
    },
    {
      "type": "table",
      "section": "Nutrition-Focused Physical Examination",
      "line": 1110,
      "preview": "| Pale conjunctiva | Iron <br> Folic acid <br> Vitamin $B_{12}$ <br> Copper | $\\begin{aligned} & \\do"
    },
    {
      "type": "table",
      "section": "Nutrition-Focused Physical Examination",
      "line": 1111,
      "preview": "| Bitot spots (foamy spots on the whites of the eye [conjunctiva]) | Vitamin A | $\\downarrow$ Plasma"
    },
    {
      "type": "table",
      "section": "Nutrition-Focused Physical Examination",
      "line": 1112,
      "preview": "| Conjunctival or corneal xerosis, keratomalacia (softening of part or all of cornea) | Vitamin A | "
    },
    {
      "type": "table",
      "section": "Nutrition-Focused Physical Examination",
      "line": 1113,
      "preview": "| Cracks at nasal angles | Niacin | $\\downarrow$ Urinary $N$-methyl nicotinamide <br> $\\downarrow$ P"
    },
    {
      "type": "table",
      "section": "Nutrition-Focused Physical Examination",
      "line": 1114,
      "preview": "| Angular fissures, redness, edema at corners of mouth | Riboflavin <br> Pyridoxine | $\\begin{aligne"
    },
    {
      "type": "table",
      "section": "Nutrition-Focused Physical Examination",
      "line": 1115,
      "preview": "| Magenta tongue | Riboflavin | $\\downarrow$ RBC glutathione reductase |"
    },
    {
      "type": "text",
      "section": "Nutrition-Focused Physical Examination",
      "line": 1117,
      "preview": "--- page 54 ---"
    },
    {
      "type": "table",
      "section": "Nutrition-Focused Physical Examination",
      "line": 1119,
      "preview": "| Physical Findings | Potential <br> Nutrient <br> Deficiency | Potential Clinical Support Data |"
    },
    {
      "type": "table",
      "section": "Nutrition-Focused Physical Examination",
      "line": 1120,
      "preview": "| :--: | :--: | :--: |"
    },
    {
      "type": "table",
      "section": "Nutrition-Focused Physical Examination",
      "line": 1121,
      "preview": "| Beefy red tongue, edema | Vitamin $B_{12}$ <br> Niacin | $\\downarrow$ Serum $B_{12}$ <br> Macrocyt"
    },
    {
      "type": "table",
      "section": "Nutrition-Focused Physical Examination",
      "line": 1122,
      "preview": "| Pale gums/lips | Iron, folic acid Vitamin $B_{12}$ Copper | $\\begin{aligned} & \\downarrow \\text { "
    },
    {
      "type": "table",
      "section": "Nutrition-Focused Physical Examination",
      "line": 1123,
      "preview": "| Bleeding spongy gums | Vitamin C | $\\downarrow$ Serum ascorbic acid |"
    },
    {
      "type": "table",
      "section": "Nutrition-Focused Physical Examination",
      "line": 1124,
      "preview": "| General |  |  |"
    },
    {
      "type": "table",
      "section": "Nutrition-Focused Physical Examination",
      "line": 1125,
      "preview": "| Edema <br> Pallor | Protein <br> Vitamin E (in preterm infants) Iron <br> Folic acid <br> Vitamin "
    },
    {
      "type": "table",
      "section": "Nutrition-Focused Physical Examination",
      "line": 1126,
      "preview": "| Muscle wasting, prominence of body skeleton, poor muscle tone | Protein/calorie | $\\begin{aligned}"
    },
    {
      "type": "table",
      "section": "Nutrition-Focused Physical Examination",
      "line": 1127,
      "preview": "| Poor weight bearing or sudden inability to walk | Vitamin C | $\\begin{aligned} & \\downarrow \\text "
    },
    {
      "type": "text",
      "section": "Nutrition-Focused Physical Examination",
      "line": 1129,
      "preview": "Note: The traditional signs of mucous membrane ecchymosis may be less common in children. Abbreviati"
    },
    {
      "type": "text",
      "section": "Nutrition-Focused Physical Examination",
      "line": 1130,
      "preview": "${ }^{a}$ Data from Gerasimidis K, Bronsky J, Catchpole A, et al; ESPGHAN Committee on Nutrition. As"
    },
    {
      "type": "text",
      "section": "Nutrition-Focused Physical Examination",
      "line": 1131,
      "preview": "https://doi.org/10.1097/MPG.0000000000002688"
    },
    {
      "type": "text",
      "section": "Nutrition-Focused Physical Examination",
      "line": 1132,
      "preview": "${ }^{\\text {b }}$ Data from DeTallo C, ed. The Practitioner's Guide to Nutrition-Focused Physical E"
    },
    {
      "type": "text",
      "section": "Nutrition-Focused Physical Examination",
      "line": 1134,
      "preview": "--- page 55 ---"
    },
    {
      "type": "text",
      "section": "Nutrition-Focused Physical Examination",
      "line": 1136,
      "preview": "Using a checklist format (as shown in Table 1-13) when performing a NFPE allows the practitioner to "
    },
    {
      "type": "text",
      "section": "Nutrition-Focused Physical Examination",
      "line": 1138,
      "preview": "TABLE 1-13. Pediatric Nutrition-Focused Physical Examination Checklist ${ }^{\\mathrm{a}, \\mathrm{b}}"
    },
    {
      "type": "table",
      "section": "Nutrition-Focused Physical Examination",
      "line": 1140,
      "preview": "| Head | Characteristic |  |  |  |  |  |  |"
    },
    {
      "type": "table",
      "section": "Nutrition-Focused Physical Examination",
      "line": 1141,
      "preview": "| :--: | :--: | :--: | :--: | :--: | :--: | :--: | :--: |"
    },
    {
      "type": "table",
      "section": "Nutrition-Focused Physical Examination",
      "line": 1142,
      "preview": "| Hair | Dry | Pluckable | Pale | Dull | Thin | Striped | Normal |"
    },
    {
      "type": "table",
      "section": "Nutrition-Focused Physical Examination",
      "line": 1143,
      "preview": "| Skull | Sunken temples (temporal wasting) |  | Sunken fontanelle in infants |  | Buccal fat pad wa"
    },
    {
      "type": "table",
      "section": "Nutrition-Focused Physical Examination",
      "line": 1144,
      "preview": "| Eye | Dark circles | Pale conjunctiva | Dry | Sunken | Dull | Spots on cornea | Normal |"
    },
    {
      "type": "table",
      "section": "Nutrition-Focused Physical Examination",
      "line": 1145,
      "preview": "| Nose | Red | Cracked | Fissures | Scaling | Dry | Crusted | Normal |"
    },
    {
      "type": "table",
      "section": "Nutrition-Focused Physical Examination",
      "line": 1146,
      "preview": "| Mouth | Cracks at corners | Gums: spongy/bleeding |  | Lesions | Thrush | Receding | Normal |"
    },
    {
      "type": "table",
      "section": "Nutrition-Focused Physical Examination",
      "line": 1147,
      "preview": "| Tongue | White patches | Atrophy <br> papillae | Edema | Red | Dry | Swollen | Normal |"
    },
    {
      "type": "table",
      "section": "Nutrition-Focused Physical Examination",
      "line": 1148,
      "preview": "| Teeth | Decay | Missing | Mottled | Malocclusion | Horizontal lines | Bleeding gums | Normal |"
    },
    {
      "type": "table",
      "section": "Nutrition-Focused Physical Examination",
      "line": 1149,
      "preview": "| Lips | Cracked, dry | Lesions | Angular fissures | Red | Swollen | Ulcers | Normal |"
    },
    {
      "type": "text",
      "section": "Nutrition-Focused Physical Examination",
      "line": 1151,
      "preview": "${ }^{a}$ Data from DeTallo C, ed. The Practitioner's Guide to Nutrition-Focused Physical Exam of In"
    },
    {
      "type": "text",
      "section": "Nutrition-Focused Physical Examination",
      "line": 1152,
      "preview": "${ }^{\\text {b }}$ Data from Green Corkins K. Nutrition-focused physical examination in pediatric pa"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "Assessments of Muscle Wasting and Strength",
      "line": 1154
    },
    {
      "type": "text",
      "section": "Assessments of Muscle Wasting and Strength",
      "line": 1156,
      "preview": "Malnourished children can have muscle wasting, fatigue, and decreased muscle strength. ${ }^{44-46}$"
    },
    {
      "type": "text",
      "section": "Assessments of Muscle Wasting and Strength",
      "line": 1158,
      "preview": "--- page 56 ---"
    },
    {
      "type": "image",
      "section": "Assessments of Muscle Wasting and Strength",
      "line": 1160,
      "content": "![img-4.jpeg](images/1efd974d1d479d0a.png)"
    },
    {
      "type": "text",
      "section": "Assessments of Muscle Wasting and Strength",
      "line": 1162,
      "preview": "FIGURE 1-5. Technique for using a handgrip dynamometer. Reproduced with permission from the American"
    },
    {
      "type": "text",
      "section": "Assessments of Muscle Wasting and Strength",
      "line": 1164,
      "preview": "A 6-minute walk test measures how far an individual can walk in 6 minutes. It has broad applications"
    },
    {
      "type": "text",
      "section": "Assessments of Muscle Wasting and Strength",
      "line": 1166,
      "preview": "If children are undergoing regular 6 -minute walk tests for other reasons, the results could be used"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "Assessments of Fluid Status",
      "line": 1168
    },
    {
      "type": "text",
      "section": "Assessments of Fluid Status",
      "line": 1170,
      "preview": "Fluid status and hydration in children should be assessed as part of the overall nutrition assessmen"
    },
    {
      "type": "text",
      "section": "Assessments of Fluid Status",
      "line": 1172,
      "preview": "--- page 57 ---"
    },
    {
      "type": "text",
      "section": "Assessments of Fluid Status",
      "line": 1174,
      "preview": "TABLE 1-14. Signs and Symptoms of Dehydration"
    },
    {
      "type": "table",
      "section": "Assessments of Fluid Status",
      "line": 1176,
      "preview": "| Parameter | Mild <br> Dehydration | Moderate <br> Dehydration | Severe <br> Dehydration |"
    },
    {
      "type": "table",
      "section": "Assessments of Fluid Status",
      "line": 1177,
      "preview": "| :-- | :-- | :-- | :-- |"
    },
    {
      "type": "table",
      "section": "Assessments of Fluid Status",
      "line": 1178,
      "preview": "| Recent weight loss from usual body <br> weight | Up to 3\\% | $4 \\%-7 \\%$ | $>7 \\%$ |"
    },
    {
      "type": "table",
      "section": "Assessments of Fluid Status",
      "line": 1179,
      "preview": "| Mental status | Normal | Listless, irritable | Altered |"
    },
    {
      "type": "table",
      "section": "Assessments of Fluid Status",
      "line": 1180,
      "preview": "| Heart rate | Normal | Increased | Increased |"
    },
    {
      "type": "table",
      "section": "Assessments of Fluid Status",
      "line": 1181,
      "preview": "| Capillary refill | Normal | Prolonged | Prolonged |"
    },
    {
      "type": "table",
      "section": "Assessments of Fluid Status",
      "line": 1182,
      "preview": "| Urine output/tears | Normal | Decreased | Absent |"
    },
    {
      "type": "table",
      "section": "Assessments of Fluid Status",
      "line": 1183,
      "preview": "| Urine color | Light yellow | Dark yellow to <br> brown | Absent |"
    },
    {
      "type": "table",
      "section": "Assessments of Fluid Status",
      "line": 1184,
      "preview": "| Blood pressure | Normal | Normal | Decreased |"
    },
    {
      "type": "table",
      "section": "Assessments of Fluid Status",
      "line": 1185,
      "preview": "| Mucous membranes | Normal | Dry | Dry |"
    },
    {
      "type": "text",
      "section": "Assessments of Fluid Status",
      "line": 1187,
      "preview": "Adapted with permission from StatPearls Publishing from Vega RM, Avva U. Pediatric dehydration. In: "
    },
    {
      "type": "heading",
      "level": 1,
      "section": "Subjective Global Nutrition Assessment",
      "line": 1189
    },
    {
      "type": "text",
      "section": "Subjective Global Nutrition Assessment",
      "line": 1191,
      "preview": "The Subjective Global Nutrition Assessment (SGNA) is an assessment tool that has been validated for "
    },
    {
      "type": "text",
      "section": "Subjective Global Nutrition Assessment",
      "line": 1193,
      "preview": "--- page 58 ---"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "TABLE 1-15. The Revised SGNA",
      "line": 1195
    },
    {
      "type": "table",
      "section": "TABLE 1-15. The Revised SGNA",
      "line": 1197,
      "preview": "| Nutrition-Focused History | Normal | Moderate | Severe |"
    },
    {
      "type": "table",
      "section": "TABLE 1-15. The Revised SGNA",
      "line": 1198,
      "preview": "| :--: | :--: | :--: | :--: |"
    },
    {
      "type": "table",
      "section": "TABLE 1-15. The Revised SGNA",
      "line": 1199,
      "preview": "| 1. Appropriateness of height for age |  |  |  |"
    },
    {
      "type": "table",
      "section": "TABLE 1-15. The Revised SGNA",
      "line": 1200,
      "preview": "| a. HAZ | $>-2 z$ score | -2 to -3 z score | $<-3 z$ score |"
    },
    {
      "type": "table",
      "section": "TABLE 1-15. The Revised SGNA",
      "line": 1201,
      "preview": "| b. Serial growth | HAZ remains stable or trends upward on growth curve | HAZ shows a gradual downw"
    },
    {
      "type": "table",
      "section": "TABLE 1-15. The Revised SGNA",
      "line": 1202,
      "preview": "| c. Appropriate considering midparental height ${ }^{a}$ | Within 8.5 cm or 2 SDs of calculated mid"
    },
    {
      "type": "table",
      "section": "TABLE 1-15. The Revised SGNA",
      "line": 1203,
      "preview": "| 2. Appropriateness of current weight for length or height BMI for age | $>-2 z$ score | -2 to -3 z"
    },
    {
      "type": "table",
      "section": "TABLE 1-15. The Revised SGNA",
      "line": 1204,
      "preview": "| 3. Unintentional change in body weight |  |  |  |"
    },
    {
      "type": "table",
      "section": "TABLE 1-15. The Revised SGNA",
      "line": 1205,
      "preview": "| a. Change in weight for age $z$ score | Remains stable on growth curve | Declined, but recovering "
    },
    {
      "type": "table",
      "section": "TABLE 1-15. The Revised SGNA",
      "line": 1206,
      "preview": "| b. Weight loss | $<5 \\%$ UBW | $5 \\%-10 \\%$ UBW | $>10 \\%$ UBW |"
    },
    {
      "type": "table",
      "section": "TABLE 1-15. The Revised SGNA",
      "line": 1207,
      "preview": "| c. Changes in past 2 wk | No change | Increased weight loss | Decreased weight loss |"
    },
    {
      "type": "table",
      "section": "TABLE 1-15. The Revised SGNA",
      "line": 1208,
      "preview": "| 4. Adequacy of diet intake |  |  |  |"
    },
    {
      "type": "table",
      "section": "TABLE 1-15. The Revised SGNA",
      "line": 1209,
      "preview": "| a. Current vs usual | Adequate intake | $50 \\%-75 \\%$ of need | $<50 \\%$ of need |"
    },
    {
      "type": "table",
      "section": "TABLE 1-15. The Revised SGNA",
      "line": 1210,
      "preview": "| b. Duration of change | Short | Moderate | Prolonged |"
    },
    {
      "type": "table",
      "section": "TABLE 1-15. The Revised SGNA",
      "line": 1211,
      "preview": "| 5. GI symptoms |  |  |  |"
    },
    {
      "type": "table",
      "section": "TABLE 1-15. The Revised SGNA",
      "line": 1212,
      "preview": "| a. Presence of GI symptoms | No symptoms | 1 or more but not daily | Multiple/daily symptoms |"
    },
    {
      "type": "table",
      "section": "TABLE 1-15. The Revised SGNA",
      "line": 1213,
      "preview": "| b. Duration of symptoms | Short | Moderate | Prolonged |"
    },
    {
      "type": "table",
      "section": "TABLE 1-15. The Revised SGNA",
      "line": 1214,
      "preview": "| 6. Functional capacity |  |  |  |"
    },
    {
      "type": "table",
      "section": "TABLE 1-15. The Revised SGNA",
      "line": 1215,
      "preview": "| a. Overall | Can perform ageappropriate activity, play | Increased fatigue, reduced play, light ac"
    },
    {
      "type": "table",
      "section": "TABLE 1-15. The Revised SGNA",
      "line": 1216,
      "preview": "| b. Function in past 2 wk | Improved | Unchanged | Worsened |"
    },
    {
      "type": "table",
      "section": "TABLE 1-15. The Revised SGNA",
      "line": 1217,
      "preview": "| c. Metabolic stress of disease | None | Moderate | Severe |"
    },
    {
      "type": "table",
      "section": "TABLE 1-15. The Revised SGNA",
      "line": 1218,
      "preview": "| 7. Nutrition-focused physical exam |  |  |  |"
    },
    {
      "type": "table",
      "section": "TABLE 1-15. The Revised SGNA",
      "line": 1219,
      "preview": "| a. Loss of subcutaneous fat | None | Some loss | Severe loss |"
    },
    {
      "type": "table",
      "section": "TABLE 1-15. The Revised SGNA",
      "line": 1220,
      "preview": "| b. Muscle wasting | None | Some wasting | Severe wasting |"
    },
    {
      "type": "table",
      "section": "TABLE 1-15. The Revised SGNA",
      "line": 1221,
      "preview": "| c. Edema | None | Moderate | Severe |"
    },
    {
      "type": "table",
      "section": "TABLE 1-15. The Revised SGNA",
      "line": 1222,
      "preview": "| Overall SGNA Score |  |  |  |"
    },
    {
      "type": "text",
      "section": "TABLE 1-15. The Revised SGNA",
      "line": 1224,
      "preview": "Abbreviations: BMI, body mass index; GI, gastrointestinal; HAZ, height-for-age z score; SGNA, Subjec"
    },
    {
      "type": "text",
      "section": "TABLE 1-15. The Revised SGNA",
      "line": 1226,
      "preview": "--- page 59 ---"
    },
    {
      "type": "text",
      "section": "TABLE 1-15. The Revised SGNA",
      "line": 1228,
      "preview": "Adapted with permission from the American Society for Parenteral and Enteral Nutrition from Carter L"
    },
    {
      "type": "text",
      "section": "TABLE 1-15. The Revised SGNA",
      "line": 1229,
      "preview": "https://doi.org/10.1002/ncp. 10859"
    },
    {
      "type": "text",
      "section": "TABLE 1-15. The Revised SGNA",
      "line": 1230,
      "preview": "${ }^{a}$ Boys: father's height (cm) + 13 cm + mother's height (cm) divided by 2"
    },
    {
      "type": "text",
      "section": "TABLE 1-15. The Revised SGNA",
      "line": 1231,
      "preview": "Girls: father's height (cm) - 13 cm + mother's height (cm) divided by 2"
    },
    {
      "type": "text",
      "section": "TABLE 1-15. The Revised SGNA",
      "line": 1232,
      "preview": "Note: This is expected height at age 18 years."
    },
    {
      "type": "heading",
      "level": 1,
      "section": "Laboratory Evaluation",
      "line": 1234
    },
    {
      "type": "text",
      "section": "Laboratory Evaluation",
      "line": 1236,
      "preview": "Laboratory evaluation of nutrition-related factors depends on the child's cooccurring medical condit"
    },
    {
      "type": "text",
      "section": "Laboratory Evaluation",
      "line": 1238,
      "preview": "The same applies for all children with limited dietary repertoires. Deficiencies in iron (especially"
    },
    {
      "type": "heading",
      "level": 2,
      "section": "Summary of Nutrition Assessment",
      "line": 1240
    },
    {
      "type": "text",
      "section": "Summary of Nutrition Assessment",
      "line": 1242,
      "preview": "All children should be screened for nutrition risk in all settings, including inpatient (acute care)"
    },
    {
      "type": "text",
      "section": "Summary of Nutrition Assessment",
      "line": 1244,
      "preview": "The assessment of nutrition status that includes all the information from the dietary and medical hi"
    },
    {
      "type": "text",
      "section": "Summary of Nutrition Assessment",
      "line": 1246,
      "preview": "--- page 60 ---"
    },
    {
      "type": "text",
      "section": "Summary of Nutrition Assessment",
      "line": 1248,
      "preview": "the child. This information should be documented and communicated to the medical team to ensure that"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "References",
      "line": 1250
    },
    {
      "type": "text",
      "section": "References",
      "line": 1252,
      "preview": "1. Swan WI, Vivanti A, Hakel-Smith NA, et al. Nutrition care process and model update: toward realiz"
    },
    {
      "type": "text",
      "section": "References",
      "line": 1253,
      "preview": "2. Model and process for nutrition and dietetic practice. British Dietetics Association. 2021. Acces"
    },
    {
      "type": "text",
      "section": "References",
      "line": 1254,
      "preview": "3. Correia MITD. Nutrition screening vs nutrition assessment: what's the difference? Nutr Clin Pract"
    },
    {
      "type": "text",
      "section": "References",
      "line": 1255,
      "preview": "4. Becker PJ, Gunnell Bellini S, Wong Vega M, et al. Validity and reliability of pediatric nutrition"
    },
    {
      "type": "text",
      "section": "References",
      "line": 1256,
      "preview": "5. White M, Lawson K, Ramsey R, et al. Simple nutrition screening tool for pediatric inpatients. JPE"
    },
    {
      "type": "text",
      "section": "References",
      "line": 1257,
      "preview": "6. Nutrition Screening Pediatrics: NSP tool component and descriptions (2018). Academy of Nutrition "
    },
    {
      "type": "text",
      "section": "References",
      "line": 1258,
      "preview": "7. Bell KL, Benfer KA, Ware RS, et al. Development and validation of a screening tool for feeding/sw"
    },
    {
      "type": "text",
      "section": "References",
      "line": 1259,
      "preview": "8. Allen J, Molloy E, McDonald D. Severe neurological impairment: a review of the definition. Dev Me"
    },
    {
      "type": "text",
      "section": "References",
      "line": 1260,
      "preview": "9. American Academy of Pediatrics Committee on Nutrition. Assessment of nutritional status. In: Klei"
    },
    {
      "type": "text",
      "section": "References",
      "line": 1261,
      "preview": "10. Sharman SJ, Skouteris H, Powell MB, Watson B. Factors related to the accuracy of self-reported d"
    },
    {
      "type": "text",
      "section": "References",
      "line": 1262,
      "preview": "11. Mauch C, Magarey A, Byrne R, Daniels L. Serve sizes and frequency of food consumption in Austral"
    },
    {
      "type": "text",
      "section": "References",
      "line": 1263,
      "preview": "12. Zheng M, Campbell K, Scanlan E, McNaughton. Development and evaluation of a food frequency quest"
    },
    {
      "type": "text",
      "section": "References",
      "line": 1264,
      "preview": "13. Vioque J, Gimenez-Monzo D, Navarrete-Mu\u00f1oz EM, et al; INMA-Valencia Cohort Study. Reproducibilit"
    },
    {
      "type": "text",
      "section": "References",
      "line": 1265,
      "preview": "14. Thompson FE, Byers T. Dietary assessment resource manual. J Nutr. 1994;124(11) (suppl):2245S-231"
    },
    {
      "type": "text",
      "section": "References",
      "line": 1267,
      "preview": "--- page 61 ---"
    },
    {
      "type": "text",
      "section": "References",
      "line": 1269,
      "preview": "15. Haytowitz DB, Ahuja JKC, Wu X, et al. USDA National Nutrient Database for Standard Reference, le"
    },
    {
      "type": "text",
      "section": "References",
      "line": 1270,
      "preview": "16. American Academy of Pediatrics Committee on Nutrition. Breastfeeding. In: Kleinman RE, Greer FR,"
    },
    {
      "type": "text",
      "section": "References",
      "line": 1271,
      "preview": "17. Beer SS, Juarez MD, Vega MW, Canada NL. Pediatric malnutrition: putting the new definition and s"
    },
    {
      "type": "text",
      "section": "References",
      "line": 1272,
      "preview": "18. Child growth standards. World Health Organization. Accessed July 5, 2022. https://www.who.int/to"
    },
    {
      "type": "text",
      "section": "References",
      "line": 1273,
      "preview": "19. Clinical growth charts. Centers for Disease Control and Prevention. June 16, 2017. Accessed July"
    },
    {
      "type": "text",
      "section": "References",
      "line": 1274,
      "preview": "20. Arm circumference-for-age. World Health Organization. Accessed June 28, 2022. https://www.who.in"
    },
    {
      "type": "text",
      "section": "References",
      "line": 1275,
      "preview": "21. Triceps skinfold-for-age. World Health Organization. Accessed June 28, 2022. https://www.who.int"
    },
    {
      "type": "text",
      "section": "References",
      "line": 1276,
      "preview": "22. Frisancho AR. New norms of upper limb fat and muscle areas for assessment of nutritional status."
    },
    {
      "type": "text",
      "section": "References",
      "line": 1277,
      "preview": "23. Nutrition assessment. In: DeTallo C, ed. The Practitioner's Guide to Nutrition-Focused Physical "
    },
    {
      "type": "text",
      "section": "References",
      "line": 1278,
      "preview": "24. Stevenson RD. Use of segmental measures to estimate stature in children with cerebral palsy. Arc"
    },
    {
      "type": "text",
      "section": "References",
      "line": 1279,
      "preview": "25. Tsuji M, Ayabe T, Tanaka R, et al. Comparative study on three different methods for arm-span mea"
    },
    {
      "type": "text",
      "section": "References",
      "line": 1280,
      "preview": "26. Chumlea WC, Guo SS, Steinbaugh ML. Prediction of stature from knee height for Black and White ad"
    },
    {
      "type": "text",
      "section": "References",
      "line": 1281,
      "preview": "27. Forman MR, Zhu Y, Hernandez LM, et al. Arm span and ulnar length are reliable and accurate estim"
    },
    {
      "type": "text",
      "section": "References",
      "line": 1282,
      "preview": "28. Wright CM, Parkinson KN. Postnatal weight loss in term infants: what is normal and do growth cha"
    },
    {
      "type": "text",
      "section": "References",
      "line": 1283,
      "preview": "29. Danner E, Joeckel R, Michalak S, Phillips S, Goday PS. Weight velocity in infants and children. "
    },
    {
      "type": "text",
      "section": "References",
      "line": 1284,
      "preview": "30. Wagner E, Sentongo T. Assessment of nutrition status by age and determining nutrient needs. In: "
    },
    {
      "type": "text",
      "section": "References",
      "line": 1285,
      "preview": "31. Tanner JM, Goldstein H, Whitehouse RH. Standards for children's height at ages 2-9 years allowin"
    },
    {
      "type": "text",
      "section": "References",
      "line": 1286,
      "preview": "32. Koopman-Verhoeff ME, Gredvig-Ardito C, Barker DH, Saletin JM, Carskadon MA. Classifying pubertal"
    },
    {
      "type": "text",
      "section": "References",
      "line": 1287,
      "preview": "33. Tanner JM, Whitehouse RH. Clinical longitudinal standards for height, weight, height velocity, w"
    },
    {
      "type": "text",
      "section": "References",
      "line": 1288,
      "preview": "34. A health professional's guide for using the WHO growth charts for Canada. Dietitians of Canada a"
    },
    {
      "type": "text",
      "section": "References",
      "line": 1290,
      "preview": "--- page 62 ---"
    },
    {
      "type": "text",
      "section": "References",
      "line": 1292,
      "preview": "https://www.dietitians.ca/DietitiansOfCanada/media/Documents/WHO\\%20Growth\\%20Charts/2014-A-Health-P"
    },
    {
      "type": "text",
      "section": "References",
      "line": 1293,
      "preview": "35. Growth charts for children with down syndrome. Centers for Disease Control and Prevention. Decem"
    },
    {
      "type": "text",
      "section": "References",
      "line": 1294,
      "preview": "36. Zemel BS, Pipan M, Stallings VA, et al. Growth charts for children with Down syndrome in the Uni"
    },
    {
      "type": "text",
      "section": "References",
      "line": 1295,
      "preview": "37. Palisano R, Rosenbaum P, Bartlett D, Livingston M. Gross Motor Function Classification SystemExp"
    },
    {
      "type": "text",
      "section": "References",
      "line": 1296,
      "preview": "ER_English.pdf"
    },
    {
      "type": "text",
      "section": "References",
      "line": 1297,
      "preview": "38. Stevenson RD, Conaway MR. Weight \\& mortality rates: \"G\u00f3mez classification\" for children with ce"
    },
    {
      "type": "text",
      "section": "References",
      "line": 1298,
      "preview": "39. Mei Z, Grummer-Strawn LM, Thompson D, Dietz WH. Shifts in percentiles of growth during early chi"
    },
    {
      "type": "text",
      "section": "References",
      "line": 1299,
      "preview": "40. Kothari P, Tate A, Adewumi A, Kinlin LM, Ritwik P. The risk for scurvy in children with neurodev"
    },
    {
      "type": "text",
      "section": "References",
      "line": 1300,
      "preview": "41. Yule S, Wanik J, Holm EM, et al. Nutritional deficiency disease secondary to ARFID symptoms asso"
    },
    {
      "type": "text",
      "section": "References",
      "line": 1301,
      "preview": "42. Overview of physical exam techniques. In: DeTallo C, ed. The Practitioner's Guide to NutritionFo"
    },
    {
      "type": "text",
      "section": "References",
      "line": 1302,
      "preview": "43. Physical exam of subcutaneous fat loss and muscle wasting. In: DeTallo C, ed. The Practitioner's"
    },
    {
      "type": "text",
      "section": "References",
      "line": 1303,
      "preview": "44. Green Corkins K. Nutrition-focused physical examination in pediatric patients. Nutr Clin Pract. "
    },
    {
      "type": "text",
      "section": "References",
      "line": 1304,
      "preview": "45. Briend A, Khara T, Dolan C. Wasting and stunting-similarities and differences: policy and progra"
    },
    {
      "type": "text",
      "section": "References",
      "line": 1305,
      "preview": "46. Mehta NM, Corkins MR, Lyman B, et al; American Society for Parenteral and Enteral Nutrition Boar"
    },
    {
      "type": "text",
      "section": "References",
      "line": 1306,
      "preview": "47. Assessing functional status. In: DeTallo C, ed. The Practitioner's Guide to Nutrition-Focused Ph"
    },
    {
      "type": "text",
      "section": "References",
      "line": 1307,
      "preview": "48. Mylius CF, Paap D, Takken T. Reference value for the 6-minute walk test in children and adolesce"
    },
    {
      "type": "text",
      "section": "References",
      "line": 1308,
      "preview": "49. Vega RM, Avva U. Pediatric dehydration. In: StatPearls. StatPearls Publishing; 2022. Updated Aug"
    },
    {
      "type": "text",
      "section": "References",
      "line": 1309,
      "preview": "50. Secker DJ, Jeejeebhoy KN. Subjective Global Nutritional Assessment for children. Am J Clin Nutr."
    },
    {
      "type": "text",
      "section": "References",
      "line": 1310,
      "preview": "51. Secker DJ, Jeejeebhoy KN. How to perform Subjective Global Nutritional Assessment in children. $"
    },
    {
      "type": "text",
      "section": "References",
      "line": 1311,
      "preview": "52. Carter L, Hulst JM, Afzal N, Jeejeebhoy K, Brunet-Wood K. Update to the pediatric Subjective Glo"
    },
    {
      "type": "text",
      "section": "References",
      "line": 1313,
      "preview": "--- page 63 ---"
    },
    {
      "type": "text",
      "section": "References",
      "line": 1315,
      "preview": "53. Evans DC, Corkins MR, Malone A, et al; ASPEN Malnutrition Committee. The use of visceral protein"
    },
    {
      "type": "text",
      "section": "References",
      "line": 1316,
      "preview": "54. Romano C, van Wynckel M, Hulst J, et al. European Society for Paediatric Gastroenterology, Hepat"
    },
    {
      "type": "text",
      "section": "References",
      "line": 1318,
      "preview": "--- page 64 ---"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "2",
      "line": 1320
    },
    {
      "type": "heading",
      "level": 2,
      "section": "Malnutrition",
      "line": 1322
    },
    {
      "type": "text",
      "section": "Malnutrition",
      "line": 1324,
      "preview": "Patricia J. Becker, MS, RDN, CSP, FAND<br>Gina Rempel, MD, FRCPC, FASPEN"
    },
    {
      "type": "heading",
      "level": 2,
      "section": "Malnutrition in Children",
      "line": 1326
    },
    {
      "type": "text",
      "section": "Malnutrition in Children",
      "line": 1328,
      "preview": "In the assessment for malnutrition in children, it is beneficial to use established standards to ide"
    },
    {
      "type": "text",
      "section": "Malnutrition in Children",
      "line": 1330,
      "preview": "--- page 65 ---"
    },
    {
      "type": "text",
      "section": "Malnutrition in Children",
      "line": 1332,
      "preview": "TABLE 2-1. Pediatric Academy of Nutrition and Dietetics/ASPEN Consensus-Derived \"Indicators of Malnu"
    },
    {
      "type": "table",
      "section": "Malnutrition in Children",
      "line": 1334,
      "preview": "| Indicators | Severe <br> Malnutrition | Moderate <br> Malnutrition | Mild Malnutrition |"
    },
    {
      "type": "table",
      "section": "Malnutrition in Children",
      "line": 1335,
      "preview": "| :--: | :--: | :--: | :--: |"
    },
    {
      "type": "table",
      "section": "Malnutrition in Children",
      "line": 1336,
      "preview": "| Billing codes ${ }^{\\text {a,b }}$ | ICD-10/E43 | ICD-10/E44.0 | ICD-10/E44.1 |"
    },
    {
      "type": "table",
      "section": "Malnutrition in Children",
      "line": 1337,
      "preview": "| Weight-for-length $z$ score | $\\geq-3 z$ score | $\\begin{aligned} & -2.0 \\text { to }-2.99 z \\\\ & "
    },
    {
      "type": "table",
      "section": "Malnutrition in Children",
      "line": 1338,
      "preview": "| BMI-for-age $z$ score | $\\geq-3 z$ score | -2.0 to 2.99 z score | $\\begin{aligned} & -1.0 \\text { "
    },
    {
      "type": "table",
      "section": "Malnutrition in Children",
      "line": 1339,
      "preview": "| Length/height $z$ score | $\\geq-3 z$ score | No data available | No data available |"
    },
    {
      "type": "table",
      "section": "Malnutrition in Children",
      "line": 1340,
      "preview": "| Mid-upper arm circumference | $\\geq-3 z$ score | $\\begin{aligned} & -2.0 \\text { to }-2.99 z \\\\ & "
    },
    {
      "type": "table",
      "section": "Malnutrition in Children",
      "line": 1341,
      "preview": "| Weight gain velocity ${ }^{c}(\\leq 2$ y of age) | $\\leq 25 \\%$ of norm | $26 \\%-50 \\%$ of norm | $"
    },
    {
      "type": "table",
      "section": "Malnutrition in Children",
      "line": 1342,
      "preview": "| Weight loss 2-20 y | 10\\% of UBW | 7.5\\% of UBW | 5\\% of UBW |"
    },
    {
      "type": "table",
      "section": "Malnutrition in Children",
      "line": 1343,
      "preview": "| Deceleration in weight for length/height or BMI for age | Deceleration across $3 z$ score lines (d"
    },
    {
      "type": "table",
      "section": "Malnutrition in Children",
      "line": 1344,
      "preview": "| Inadequate nutrient intake | $\\leq 25 \\%$ of estimated energy/protein need | $26 \\%-50 \\%$ of esti"
    },
    {
      "type": "text",
      "section": "Malnutrition in Children",
      "line": 1346,
      "preview": "Abbreviations: BMI, body mass index; ICD-10, International Classification of Diseases, Tenth Revisio"
    },
    {
      "type": "text",
      "section": "Malnutrition in Children",
      "line": 1347,
      "preview": "Adapted with permission from the American Society for Parenteral and Enteral Nutrition from Becker P"
    },
    {
      "type": "text",
      "section": "Malnutrition in Children",
      "line": 1348,
      "preview": "https://doi.org/10.1177/0884533614557642"
    },
    {
      "type": "text",
      "section": "Malnutrition in Children",
      "line": 1349,
      "preview": "${ }^{a}$ International Statistical Classification of Diseases and Related Health Problems, Tenth Re"
    },
    {
      "type": "text",
      "section": "Malnutrition in Children",
      "line": 1350,
      "preview": "https://www.cdc.gov/nchs/icd/icd10.htm"
    },
    {
      "type": "text",
      "section": "Malnutrition in Children",
      "line": 1352,
      "preview": "--- page 66 ---"
    },
    {
      "type": "text",
      "section": "Malnutrition in Children",
      "line": 1354,
      "preview": "${ }^{\\text {b }}$ ICD-10 codes are used for medical claim reporting in all health care settings, IC"
    },
    {
      "type": "text",
      "section": "Malnutrition in Children",
      "line": 1355,
      "preview": "${ }^{\\text {c }}$ Weight gain increments at the median of the WHO growth velocity standards for the"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "TABLE 2-2. Pediatric Academy of Nutrition and Dietetics/ASPEN Consensus-Derived Indicators of Malnutrition Factors to Include When Assessing for Pediatric Malnutrition",
      "line": 1357
    },
    {
      "type": "table",
      "section": "TABLE 2-2. Pediatric Academy of Nutrition and Dietetics/ASPEN Consensus-Derived Indicators of Malnutrition Factors to Include When Assessing for Pediatric Malnutrition",
      "line": 1359,
      "preview": "| Children 1-24 mo | Children 2-18 y |"
    },
    {
      "type": "table",
      "section": "TABLE 2-2. Pediatric Academy of Nutrition and Dietetics/ASPEN Consensus-Derived Indicators of Malnutrition Factors to Include When Assessing for Pediatric Malnutrition",
      "line": 1360,
      "preview": "| :-- | :-- |"
    },
    {
      "type": "table",
      "section": "TABLE 2-2. Pediatric Academy of Nutrition and Dietetics/ASPEN Consensus-Derived Indicators of Malnutrition Factors to Include When Assessing for Pediatric Malnutrition",
      "line": 1361,
      "preview": "| WHZ | BAZ |"
    },
    {
      "type": "table",
      "section": "TABLE 2-2. Pediatric Academy of Nutrition and Dietetics/ASPEN Consensus-Derived Indicators of Malnutrition Factors to Include When Assessing for Pediatric Malnutrition",
      "line": 1362,
      "preview": "| Length-for-age z score | HAZ |"
    },
    {
      "type": "table",
      "section": "TABLE 2-2. Pediatric Academy of Nutrition and Dietetics/ASPEN Consensus-Derived Indicators of Malnutrition Factors to Include When Assessing for Pediatric Malnutrition",
      "line": 1363,
      "preview": "| MUAC | MUAC |"
    },
    {
      "type": "table",
      "section": "TABLE 2-2. Pediatric Academy of Nutrition and Dietetics/ASPEN Consensus-Derived Indicators of Malnutrition Factors to Include When Assessing for Pediatric Malnutrition",
      "line": 1364,
      "preview": "| Weight gain velocity | Weight loss as percentage of UBW |"
    },
    {
      "type": "table",
      "section": "TABLE 2-2. Pediatric Academy of Nutrition and Dietetics/ASPEN Consensus-Derived Indicators of Malnutrition Factors to Include When Assessing for Pediatric Malnutrition",
      "line": 1365,
      "preview": "| Decline in WHZ | Decline in BAZ |"
    },
    {
      "type": "table",
      "section": "TABLE 2-2. Pediatric Academy of Nutrition and Dietetics/ASPEN Consensus-Derived Indicators of Malnutrition Factors to Include When Assessing for Pediatric Malnutrition",
      "line": 1366,
      "preview": "| Inadequate nutrient intake compared <br> with estimated need | Inadequate nutrient intake compared"
    },
    {
      "type": "text",
      "section": "TABLE 2-2. Pediatric Academy of Nutrition and Dietetics/ASPEN Consensus-Derived Indicators of Malnutrition Factors to Include When Assessing for Pediatric Malnutrition",
      "line": 1368,
      "preview": "Abbreviations: BAZ, BMI-for-age z score; HAZ, height-for-age z score; mo, months; MUAC, mid-upper ar"
    },
    {
      "type": "text",
      "section": "TABLE 2-2. Pediatric Academy of Nutrition and Dietetics/ASPEN Consensus-Derived Indicators of Malnutrition Factors to Include When Assessing for Pediatric Malnutrition",
      "line": 1369,
      "preview": "Data from Becker P, Carney LN, Corkins MR, et al; Academy of Nutrition and Dietetics; American Socie"
    },
    {
      "type": "text",
      "section": "TABLE 2-2. Pediatric Academy of Nutrition and Dietetics/ASPEN Consensus-Derived Indicators of Malnutrition Factors to Include When Assessing for Pediatric Malnutrition",
      "line": 1370,
      "preview": "https://doi.org/10.1177/0884533614557642"
    },
    {
      "type": "text",
      "section": "TABLE 2-2. Pediatric Academy of Nutrition and Dietetics/ASPEN Consensus-Derived Indicators of Malnutrition Factors to Include When Assessing for Pediatric Malnutrition",
      "line": 1372,
      "preview": "Weight gain velocity assessment for malnutrition is based on an average daily or monthly weight gain"
    },
    {
      "type": "text",
      "section": "TABLE 2-2. Pediatric Academy of Nutrition and Dietetics/ASPEN Consensus-Derived Indicators of Malnutrition Factors to Include When Assessing for Pediatric Malnutrition",
      "line": 1374,
      "preview": "--- page 67 ---"
    },
    {
      "type": "text",
      "section": "TABLE 2-2. Pediatric Academy of Nutrition and Dietetics/ASPEN Consensus-Derived Indicators of Malnutrition Factors to Include When Assessing for Pediatric Malnutrition",
      "line": 1376,
      "preview": "table from birth to 12 months, and as 2- to 6-month increment tables from birth to 24 months. The ca"
    },
    {
      "type": "text",
      "section": "TABLE 2-2. Pediatric Academy of Nutrition and Dietetics/ASPEN Consensus-Derived Indicators of Malnutrition Factors to Include When Assessing for Pediatric Malnutrition",
      "line": 1378,
      "preview": "- Weight-for-height/length $z$ score (WHZ) of less than -3 of the WHO 2006 standard"
    },
    {
      "type": "text",
      "section": "TABLE 2-2. Pediatric Academy of Nutrition and Dietetics/ASPEN Consensus-Derived Indicators of Malnutrition Factors to Include When Assessing for Pediatric Malnutrition",
      "line": 1379,
      "preview": "- Mid-upper arm circumference (MUAC) of less than 115 mm"
    },
    {
      "type": "text",
      "section": "TABLE 2-2. Pediatric Academy of Nutrition and Dietetics/ASPEN Consensus-Derived Indicators of Malnutrition Factors to Include When Assessing for Pediatric Malnutrition",
      "line": 1380,
      "preview": "- Edema related to nutrition status"
    },
    {
      "type": "text",
      "section": "TABLE 2-2. Pediatric Academy of Nutrition and Dietetics/ASPEN Consensus-Derived Indicators of Malnutrition Factors to Include When Assessing for Pediatric Malnutrition",
      "line": 1382,
      "preview": "TABLE 2-3. WHO-Based Weight Gain Velocity Assessment for Malnutrition: Girls 0-24 Months"
    },
    {
      "type": "table",
      "section": "TABLE 2-2. Pediatric Academy of Nutrition and Dietetics/ASPEN Consensus-Derived Indicators of Malnutrition Factors to Include When Assessing for Pediatric Malnutrition",
      "line": 1384,
      "preview": "| Age | Median <br> Weight <br> Gain |  | Mild <br> Malnutrition, <br> $<75 \\%$ Expected |  | Modera"
    },
    {
      "type": "table",
      "section": "TABLE 2-2. Pediatric Academy of Nutrition and Dietetics/ASPEN Consensus-Derived Indicators of Malnutrition Factors to Include When Assessing for Pediatric Malnutrition",
      "line": 1385,
      "preview": "| :--: | :--: | :--: | :--: | :--: | :--: | :--: | :--: | :--: |"
    },
    {
      "type": "table",
      "section": "TABLE 2-2. Pediatric Academy of Nutrition and Dietetics/ASPEN Consensus-Derived Indicators of Malnutrition Factors to Include When Assessing for Pediatric Malnutrition",
      "line": 1386,
      "preview": "|  | g/d | g/mo | g/d | g/mo | g/d | g/mo | g/d | g/mo |"
    },
    {
      "type": "table",
      "section": "TABLE 2-2. Pediatric Academy of Nutrition and Dietetics/ASPEN Consensus-Derived Indicators of Malnutrition Factors to Include When Assessing for Pediatric Malnutrition",
      "line": 1387,
      "preview": "| $0-30$ <br> d | 30 | 880 | 22 | 660 | 15 | 440 | 7.5 | 220 |"
    },
    {
      "type": "table",
      "section": "TABLE 2-2. Pediatric Academy of Nutrition and Dietetics/ASPEN Consensus-Derived Indicators of Malnutrition Factors to Include When Assessing for Pediatric Malnutrition",
      "line": 1388,
      "preview": "| $30-60$ <br> d | 34 | 1012 | 25 | 760 | 17 | 506 | 8.5 | 253 |"
    },
    {
      "type": "table",
      "section": "TABLE 2-2. Pediatric Academy of Nutrition and Dietetics/ASPEN Consensus-Derived Indicators of Malnutrition Factors to Include When Assessing for Pediatric Malnutrition",
      "line": 1389,
      "preview": "| $2-4$ <br> mo | 24 | 720 | 18 | 540 | 12 | 360 | 6 | 180 |"
    },
    {
      "type": "table",
      "section": "TABLE 2-2. Pediatric Academy of Nutrition and Dietetics/ASPEN Consensus-Derived Indicators of Malnutrition Factors to Include When Assessing for Pediatric Malnutrition",
      "line": 1390,
      "preview": "| $4-6$ <br> mo | 15 | 445 | 11 | 334 | 7.5 | 223 | 4 | 111 |"
    },
    {
      "type": "table",
      "section": "TABLE 2-2. Pediatric Academy of Nutrition and Dietetics/ASPEN Consensus-Derived Indicators of Malnutrition Factors to Include When Assessing for Pediatric Malnutrition",
      "line": 1391,
      "preview": "| $6-9$ <br> mo | 10 | 310 | 8 | 232 | 6 | 173 | 3 | 86 |"
    },
    {
      "type": "table",
      "section": "TABLE 2-2. Pediatric Academy of Nutrition and Dietetics/ASPEN Consensus-Derived Indicators of Malnutrition Factors to Include When Assessing for Pediatric Malnutrition",
      "line": 1392,
      "preview": "| $9-12$ <br> mo | 8 | 240 | 6 | 180 | 4 | 120 | 2 | 60 |"
    },
    {
      "type": "table",
      "section": "TABLE 2-2. Pediatric Academy of Nutrition and Dietetics/ASPEN Consensus-Derived Indicators of Malnutrition Factors to Include When Assessing for Pediatric Malnutrition",
      "line": 1393,
      "preview": "| $12-$ <br> 18 mo | 7 | 200 | 5 | 150 | 3.5 | 100 | 2 | 50 |"
    },
    {
      "type": "text",
      "section": "TABLE 2-2. Pediatric Academy of Nutrition and Dietetics/ASPEN Consensus-Derived Indicators of Malnutrition Factors to Include When Assessing for Pediatric Malnutrition",
      "line": 1395,
      "preview": "Abbreviation: WHO, World Health Organization."
    },
    {
      "type": "text",
      "section": "TABLE 2-2. Pediatric Academy of Nutrition and Dietetics/ASPEN Consensus-Derived Indicators of Malnutrition Factors to Include When Assessing for Pediatric Malnutrition",
      "line": 1396,
      "preview": "Data from Child Growth Standards: Weight Velocity. World Health Organization."
    },
    {
      "type": "text",
      "section": "TABLE 2-2. Pediatric Academy of Nutrition and Dietetics/ASPEN Consensus-Derived Indicators of Malnutrition Factors to Include When Assessing for Pediatric Malnutrition",
      "line": 1397,
      "preview": "Accessed May 31, 2022. https://www.who.int/tools/child-growth-"
    },
    {
      "type": "text",
      "section": "TABLE 2-2. Pediatric Academy of Nutrition and Dietetics/ASPEN Consensus-Derived Indicators of Malnutrition Factors to Include When Assessing for Pediatric Malnutrition",
      "line": 1398,
      "preview": "standards/standards/weight-velocity"
    },
    {
      "type": "text",
      "section": "TABLE 2-2. Pediatric Academy of Nutrition and Dietetics/ASPEN Consensus-Derived Indicators of Malnutrition Factors to Include When Assessing for Pediatric Malnutrition",
      "line": 1400,
      "preview": "--- page 68 ---"
    },
    {
      "type": "text",
      "section": "TABLE 2-2. Pediatric Academy of Nutrition and Dietetics/ASPEN Consensus-Derived Indicators of Malnutrition Factors to Include When Assessing for Pediatric Malnutrition",
      "line": 1402,
      "preview": "TABLE 2-4. WHO-Based Weight Gain Velocity Assessment for Malnutrition: Boys 0-24 Months"
    },
    {
      "type": "table",
      "section": "TABLE 2-2. Pediatric Academy of Nutrition and Dietetics/ASPEN Consensus-Derived Indicators of Malnutrition Factors to Include When Assessing for Pediatric Malnutrition",
      "line": 1404,
      "preview": "|  | Median <br> Weight <br> Gain |  | Mild <br> Malnutrition, <75\\% Expected |  | Moderate <br> Mal"
    },
    {
      "type": "table",
      "section": "TABLE 2-2. Pediatric Academy of Nutrition and Dietetics/ASPEN Consensus-Derived Indicators of Malnutrition Factors to Include When Assessing for Pediatric Malnutrition",
      "line": 1405,
      "preview": "| :--: | :--: | :--: | :--: | :--: | :--: | :--: | :--: | :--: |"
    },
    {
      "type": "table",
      "section": "TABLE 2-2. Pediatric Academy of Nutrition and Dietetics/ASPEN Consensus-Derived Indicators of Malnutrition Factors to Include When Assessing for Pediatric Malnutrition",
      "line": 1406,
      "preview": "| Age | g/d | g/mo | g/d | g/mo | g/d | g/mo | g/d | g/mo |"
    },
    {
      "type": "table",
      "section": "TABLE 2-2. Pediatric Academy of Nutrition and Dietetics/ASPEN Consensus-Derived Indicators of Malnutrition Factors to Include When Assessing for Pediatric Malnutrition",
      "line": 1407,
      "preview": "| $\\begin{aligned} & 0-30 \\\\ & d \\end{aligned}$ | 35 | 1025 | 26 | 770 | 17 | 513 | 9 | 256 |"
    },
    {
      "type": "table",
      "section": "TABLE 2-2. Pediatric Academy of Nutrition and Dietetics/ASPEN Consensus-Derived Indicators of Malnutrition Factors to Include When Assessing for Pediatric Malnutrition",
      "line": 1408,
      "preview": "| $\\begin{aligned} & 30-60 \\\\ & d \\end{aligned}$ | 40 | 1200 | 30 | 900 | 20 | 600 | 10 | 300 |"
    },
    {
      "type": "table",
      "section": "TABLE 2-2. Pediatric Academy of Nutrition and Dietetics/ASPEN Consensus-Derived Indicators of Malnutrition Factors to Include When Assessing for Pediatric Malnutrition",
      "line": 1409,
      "preview": "| $\\begin{aligned} & 2-4 \\\\ & \\text { mo } \\end{aligned}$ | 25 | 815 | 20 | 611 | 13.5 | 407 | 7 | 2"
    },
    {
      "type": "table",
      "section": "TABLE 2-2. Pediatric Academy of Nutrition and Dietetics/ASPEN Consensus-Derived Indicators of Malnutrition Factors to Include When Assessing for Pediatric Malnutrition",
      "line": 1410,
      "preview": "| $\\begin{aligned} & 4-6 \\\\ & \\text { mo } \\end{aligned}$ | 16 | 475 | 12 | 356 | 8 | 238 | 4 | 120 "
    },
    {
      "type": "table",
      "section": "TABLE 2-2. Pediatric Academy of Nutrition and Dietetics/ASPEN Consensus-Derived Indicators of Malnutrition Factors to Include When Assessing for Pediatric Malnutrition",
      "line": 1411,
      "preview": "| $\\begin{aligned} & 6-9 \\\\ & \\text { mo } \\end{aligned}$ | 11 | 330 | 8 | 250 | 6 | 165 | 3 | 83 |"
    },
    {
      "type": "table",
      "section": "TABLE 2-2. Pediatric Academy of Nutrition and Dietetics/ASPEN Consensus-Derived Indicators of Malnutrition Factors to Include When Assessing for Pediatric Malnutrition",
      "line": 1412,
      "preview": "| $\\begin{aligned} & 9-12 \\\\ & \\text { mo } \\end{aligned}$ | 9 | 254 | 7 | 191 | 4.5 | 127 | 2 | 64 "
    },
    {
      "type": "table",
      "section": "TABLE 2-2. Pediatric Academy of Nutrition and Dietetics/ASPEN Consensus-Derived Indicators of Malnutrition Factors to Include When Assessing for Pediatric Malnutrition",
      "line": 1413,
      "preview": "| $\\begin{aligned} & 12-18 \\\\ & \\text { mo } \\end{aligned}$ | 7 | 200 | 5 | 150 | 3.5 | 100 | 2 | 50"
    },
    {
      "type": "table",
      "section": "TABLE 2-2. Pediatric Academy of Nutrition and Dietetics/ASPEN Consensus-Derived Indicators of Malnutrition Factors to Include When Assessing for Pediatric Malnutrition",
      "line": 1414,
      "preview": "| $\\begin{aligned} & 18- \\\\ & 24 \\mathrm{mo} \\end{aligned}$ | 7 | 195 | 5 | 147 | 3.5 | 98 | 2 | 49 "
    },
    {
      "type": "text",
      "section": "TABLE 2-2. Pediatric Academy of Nutrition and Dietetics/ASPEN Consensus-Derived Indicators of Malnutrition Factors to Include When Assessing for Pediatric Malnutrition",
      "line": 1416,
      "preview": "Abbreviation: WHO, World Health Organization."
    },
    {
      "type": "text",
      "section": "TABLE 2-2. Pediatric Academy of Nutrition and Dietetics/ASPEN Consensus-Derived Indicators of Malnutrition Factors to Include When Assessing for Pediatric Malnutrition",
      "line": 1417,
      "preview": "Data from Child Growth Standards: Weight Velocity. World Health Organization."
    },
    {
      "type": "text",
      "section": "TABLE 2-2. Pediatric Academy of Nutrition and Dietetics/ASPEN Consensus-Derived Indicators of Malnutrition Factors to Include When Assessing for Pediatric Malnutrition",
      "line": 1418,
      "preview": "Accessed May 31, 2022. https://www.who.int/tools/child-growth-"
    },
    {
      "type": "text",
      "section": "TABLE 2-2. Pediatric Academy of Nutrition and Dietetics/ASPEN Consensus-Derived Indicators of Malnutrition Factors to Include When Assessing for Pediatric Malnutrition",
      "line": 1419,
      "preview": "standards/standards/weight-velocity"
    },
    {
      "type": "text",
      "section": "TABLE 2-2. Pediatric Academy of Nutrition and Dietetics/ASPEN Consensus-Derived Indicators of Malnutrition Factors to Include When Assessing for Pediatric Malnutrition",
      "line": 1421,
      "preview": "Children identified with severe acute malnutrition by a low MUAC $(<115 \\mathrm{~mm})$ and those ide"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "Coding and Billing for Malnutrition",
      "line": 1423
    },
    {
      "type": "text",
      "section": "Coding and Billing for Malnutrition",
      "line": 1425,
      "preview": "--- page 69 ---"
    },
    {
      "type": "text",
      "section": "Coding and Billing for Malnutrition",
      "line": 1427,
      "preview": "The use of terms such as \"failure to thrive\" (FTT) to diagnose growth failure are less beneficial in"
    },
    {
      "type": "text",
      "section": "Coding and Billing for Malnutrition",
      "line": 1428,
      "preview": "\"Malnutrition Matters: A Call to Action for Providers Caring for Pediatric Patients\" provides inform"
    },
    {
      "type": "text",
      "section": "Coding and Billing for Malnutrition",
      "line": 1430,
      "preview": "Inflammation related to malnutrition leads to adverse outcomes through poor appetite and decreased f"
    },
    {
      "type": "text",
      "section": "Coding and Billing for Malnutrition",
      "line": 1432,
      "preview": "--- page 70 ---"
    },
    {
      "type": "text",
      "section": "Coding and Billing for Malnutrition",
      "line": 1434,
      "preview": "TABLE 2-5. Biochemical Markers of Inflammation in Pediatric Patients ${ }^{a}$"
    },
    {
      "type": "table",
      "section": "Coding and Billing for Malnutrition",
      "line": 1436,
      "preview": "| Marker | Value (Units) | Increase in | Decrease in | Comments |"
    },
    {
      "type": "table",
      "section": "Coding and Billing for Malnutrition",
      "line": 1437,
      "preview": "| :--: | :--: | :--: | :--: | :--: |"
    },
    {
      "type": "table",
      "section": "Coding and Billing for Malnutrition",
      "line": 1438,
      "preview": "| WBCs | $\\begin{aligned} & 5-11.5 \\\\ & \\left(\\times 10^{3} / \\mathrm{mm}^{3} / \\mathrm{L}\\right)^{\\"
    },
    {
      "type": "table",
      "section": "Coding and Billing for Malnutrition",
      "line": 1439,
      "preview": "| CRP | $\\begin{aligned} & <0.35 \\\\ & (<1.0 \\mathrm{mg} / \\mathrm{L}) \\end{aligned}$ | Infection Inf"
    },
    {
      "type": "table",
      "section": "Coding and Billing for Malnutrition",
      "line": 1440,
      "preview": "| Hematocrit/ hemoglobin | $\\begin{aligned} & 35 \\%- \\\\ & 45 \\% / 11.5-15 \\\\ & \\mathrm{~g} / \\mathrm"
    },
    {
      "type": "table",
      "section": "Coding and Billing for Malnutrition",
      "line": 1441,
      "preview": "| Albumin | $3.5-5 \\mathrm{~g} / \\mathrm{dL}^{\\mathrm{b}}$ | Dehydration | Inflammation Overhydratio"
    },
    {
      "type": "table",
      "section": "Coding and Billing for Malnutrition",
      "line": 1442,
      "preview": "| Prealbumin | $14-30 \\mathrm{mg} / \\mathrm{dL}^{\\mathrm{b}}$ | Dehydration | Inflammation Overhydra"
    },
    {
      "type": "table",
      "section": "Coding and Billing for Malnutrition",
      "line": 1443,
      "preview": "| Temperature | $36.5-37.2^{\\circ} \\mathrm{C}$ (oral) | Infection Dehydration Stress | Malnutrition "
    },
    {
      "type": "table",
      "section": "Coding and Billing for Malnutrition",
      "line": 1444,
      "preview": "| Zinc | $65-144 \\mu \\mathrm{~g} / \\mathrm{dL}$ | Over supplementation | Malnutrition Starvation | D"
    },
    {
      "type": "text",
      "section": "Coding and Billing for Malnutrition",
      "line": 1446,
      "preview": "Abbreviations: CRP, C-reactive protein; IGF-1, insulin-like growth factor-1; NA, not applicable; Tma"
    },
    {
      "type": "text",
      "section": "Coding and Billing for Malnutrition",
      "line": 1447,
      "preview": "${ }^{a}$ Data from Evans DC, Corkins MR, Malone A et al; ASPEN Malnutrition Committee. The use of v"
    },
    {
      "type": "text",
      "section": "Coding and Billing for Malnutrition",
      "line": 1448,
      "preview": "${ }^{\\text {b }}$ Range varies with age. A reference app called Caliper (Canadian Laboratory Initia"
    },
    {
      "type": "text",
      "section": "Coding and Billing for Malnutrition",
      "line": 1450,
      "preview": "--- page 71 ---"
    },
    {
      "type": "text",
      "section": "Coding and Billing for Malnutrition",
      "line": 1452,
      "preview": "for laboratory tests at different ages and with different units. It is available free of charge wher"
    },
    {
      "type": "text",
      "section": "Coding and Billing for Malnutrition",
      "line": 1453,
      "preview": "${ }^{c}$ DeBoer MD, Scharf RJ, Leite AM, et al. Systemic inflammation, growth factors, and linear g"
    },
    {
      "type": "text",
      "section": "Coding and Billing for Malnutrition",
      "line": 1454,
      "preview": "${ }^{d}$ Jensen GL. Malnutrition and inflammation-\"burning down the house\": inflammation as an adap"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "Malnutrition in Preterm Infants and Neonates",
      "line": 1456
    },
    {
      "type": "text",
      "section": "Malnutrition in Preterm Infants and Neonates",
      "line": 1458,
      "preview": "Malnutrition in the preterm infant and neonate can have a lifelong negative impact. The data used to"
    },
    {
      "type": "text",
      "section": "Malnutrition in Preterm Infants and Neonates",
      "line": 1460,
      "preview": "Growth assessment begins at birth by identifying whether an infant is small for gestational age (SGA"
    },
    {
      "type": "text",
      "section": "Malnutrition in Preterm Infants and Neonates",
      "line": 1462,
      "preview": "Criteria for the diagnosis of preterm and neonatal infant malnutrition were suggested in an article "
    },
    {
      "type": "text",
      "section": "Malnutrition in Preterm Infants and Neonates",
      "line": 1464,
      "preview": "1. Those that require only a single indicator for diagnoses:"
    },
    {
      "type": "text",
      "section": "Malnutrition in Preterm Infants and Neonates",
      "line": 1466,
      "preview": "--- page 72 ---"
    },
    {
      "type": "text",
      "section": "Malnutrition in Preterm Infants and Neonates",
      "line": 1468,
      "preview": "a. \"Adequacy of nutrient intake\": preferred indicator for diagnosing malnutrition in the first 2 wee"
    },
    {
      "type": "text",
      "section": "Malnutrition in Preterm Infants and Neonates",
      "line": 1469,
      "preview": "b. Decline in weight-for-age $z$ score and weight gain velocity lower than expected"
    },
    {
      "type": "text",
      "section": "Malnutrition in Preterm Infants and Neonates",
      "line": 1470,
      "preview": "2. Those that require 2 indicators for diagnosis of malnutrition in preterm infants and neonates:"
    },
    {
      "type": "text",
      "section": "Malnutrition in Preterm Infants and Neonates",
      "line": 1471,
      "preview": "a. Number of days to regain birth weight"
    },
    {
      "type": "text",
      "section": "Malnutrition in Preterm Infants and Neonates",
      "line": 1472,
      "preview": "b. Length gain velocity"
    },
    {
      "type": "text",
      "section": "Malnutrition in Preterm Infants and Neonates",
      "line": 1473,
      "preview": "c. Decline in length-for-age $z$ score."
    },
    {
      "type": "text",
      "section": "Malnutrition in Preterm Infants and Neonates",
      "line": 1475,
      "preview": "In general, these indicators are used in combination with inadequate nutrient (energy and/or protein"
    },
    {
      "type": "text",
      "section": "Malnutrition in Preterm Infants and Neonates",
      "line": 1477,
      "preview": "--- page 73 ---"
    },
    {
      "type": "text",
      "section": "Malnutrition in Preterm Infants and Neonates",
      "line": 1479,
      "preview": "TABLE 2-6. Malnutrition Criteria for Preterm Infants and Neonates: Primary Indicators to Diagnose Ma"
    },
    {
      "type": "table",
      "section": "Malnutrition in Preterm Infants and Neonates",
      "line": 1481,
      "preview": "| Primary <br> Indicator | Mild Malnutrition | Moderate <br> Malnutrition | Severe <br> Malnutrition"
    },
    {
      "type": "table",
      "section": "Malnutrition in Preterm Infants and Neonates",
      "line": 1482,
      "preview": "| :-- | :-- | :-- | :-- | :-- |"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "Criteria requiring a single indicator to diagnose malnutrition",
      "line": 1484
    },
    {
      "type": "table",
      "section": "Criteria requiring a single indicator to diagnose malnutrition",
      "line": 1486,
      "preview": "| Decline in weight-for-age $z$ score $^{a}$ | Decline of 0.8-1.2 <br> SD | Decline of $>1.2-2$ <br>"
    },
    {
      "type": "table",
      "section": "Criteria requiring a single indicator to diagnose malnutrition",
      "line": 1487,
      "preview": "| :--: | :--: | :--: | :--: | :--: |"
    },
    {
      "type": "table",
      "section": "Criteria requiring a single indicator to diagnose malnutrition",
      "line": 1488,
      "preview": "| Weight gain velocity | $<75 \\%$ of expected rate of weight gain to maintain growth rate | $<50 \\%$"
    },
    {
      "type": "table",
      "section": "Criteria requiring a single indicator to diagnose malnutrition",
      "line": 1489,
      "preview": "| Nutrient intake | $\\geq 3-5$ consecutive days of protein or energy intake $\\leq 75 \\%$ of estimate"
    },
    {
      "type": "table",
      "section": "Criteria requiring a single indicator to diagnose malnutrition",
      "line": 1490,
      "preview": "| Criteria requiring 2 indicators to diagnose malnutrition |  |  |  |  |"
    },
    {
      "type": "table",
      "section": "Criteria requiring a single indicator to diagnose malnutrition",
      "line": 1491,
      "preview": "| Days to regain birth weight | $15-18$ | $19-21$ | $>21$ | Use information with nutrient intake |"
    },
    {
      "type": "table",
      "section": "Criteria requiring a single indicator to diagnose malnutrition",
      "line": 1492,
      "preview": "| Linear growth velocity $^{a}$ | $<75 \\%$ of expected rate of linear gain to maintain expected grow"
    },
    {
      "type": "table",
      "section": "Criteria requiring a single indicator to diagnose malnutrition",
      "line": 1493,
      "preview": "| Decline in length-for-age $z$ score $^{a}$ | $<75 \\%$ of expected rate of linear gain to maintain "
    },
    {
      "type": "text",
      "section": "Criteria requiring a single indicator to diagnose malnutrition",
      "line": 1495,
      "preview": "Adapted with permission from the Academy of Nutrition and Dietetics from Goldberg DL, Becker PJ, Bri"
    },
    {
      "type": "text",
      "section": "Criteria requiring a single indicator to diagnose malnutrition",
      "line": 1496,
      "preview": "${ }^{a}$ Expected weight growth velocity and $z$ scores can be determined using the online calculat"
    },
    {
      "type": "text",
      "section": "Criteria requiring a single indicator to diagnose malnutrition",
      "line": 1498,
      "preview": "--- page 74 ---"
    },
    {
      "type": "text",
      "section": "Criteria requiring a single indicator to diagnose malnutrition",
      "line": 1500,
      "preview": "${ }^{\\text {b }}$ Use with a second indicator and an accurate length measurement."
    },
    {
      "type": "heading",
      "level": 1,
      "section": "Regain of Birth Weight",
      "line": 1502
    },
    {
      "type": "text",
      "section": "Regain of Birth Weight",
      "line": 1504,
      "preview": "Most infants, both term and preterm, demonstrate an initial postnatal weight loss. This usually resu"
    },
    {
      "type": "heading",
      "level": 2,
      "section": "Weight Gain Velocity",
      "line": 1506
    },
    {
      "type": "text",
      "section": "Weight Gain Velocity",
      "line": 1508,
      "preview": "The growth goal for the infant to maintain a weight gain velocity that will allow them to improve or"
    },
    {
      "type": "heading",
      "level": 2,
      "section": "Change in Weight-for-Age z Score",
      "line": 1510
    },
    {
      "type": "text",
      "section": "Change in Weight-for-Age z Score",
      "line": 1512,
      "preview": "Faltering growth as indicated by a decline in weight-for-age $z$ score is one of the recommended ind"
    },
    {
      "type": "text",
      "section": "Change in Weight-for-Age z Score",
      "line": 1514,
      "preview": "--- page 75 ---"
    },
    {
      "type": "text",
      "section": "Change in Weight-for-Age z Score",
      "line": 1516,
      "preview": "neonates. ${ }^{22}$ Rates of weight gain vary depending on the infant and need to be calculated bas"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "Length",
      "line": 1518
    },
    {
      "type": "text",
      "section": "Length",
      "line": 1520,
      "preview": "The indicators related to length include less-than-expected linear growth velocity and decline in le"
    },
    {
      "type": "text",
      "section": "Length",
      "line": 1522,
      "preview": "The publication \"Applying the Recommended Indicators for the Diagnosis of Preterm and Neonatal Malnu"
    },
    {
      "type": "text",
      "section": "Length",
      "line": 1524,
      "preview": "1. Determine which set of criteria to use to diagnose the infant."
    },
    {
      "type": "text",
      "section": "Length",
      "line": 1525,
      "preview": "a. Is the infant preterm-is the infant term and less than 30 days old?"
    },
    {
      "type": "text",
      "section": "Length",
      "line": 1527,
      "preview": "- Use the preterm/neonatal indicators."
    },
    {
      "type": "text",
      "section": "Length",
      "line": 1528,
      "preview": "b. Is the infant a term baby and/or are they 1 month of age or older?"
    },
    {
      "type": "text",
      "section": "Length",
      "line": 1529,
      "preview": "- Use the pediatric criteria."
    },
    {
      "type": "text",
      "section": "Length",
      "line": 1531,
      "preview": "2. Assess all criteria for which data are available."
    },
    {
      "type": "text",
      "section": "Length",
      "line": 1532,
      "preview": "a. Preterm-neonatal criteria"
    },
    {
      "type": "text",
      "section": "Length",
      "line": 1533,
      "preview": "b. Pediatric criteria for $1-24$ months of age"
    },
    {
      "type": "text",
      "section": "Length",
      "line": 1534,
      "preview": "3. Select the criteria with the highest acuity/severity on which to base the diagnosis."
    },
    {
      "type": "text",
      "section": "Length",
      "line": 1535,
      "preview": "a. Mild vs moderate vs severe malnutrition"
    },
    {
      "type": "text",
      "section": "Length",
      "line": 1536,
      "preview": "4. Document the diagnosis and the assessment on which the diagnosis is based."
    },
    {
      "type": "text",
      "section": "Length",
      "line": 1537,
      "preview": "a. State the diagnosis, the criteria, and the severity"
    },
    {
      "type": "text",
      "section": "Length",
      "line": 1538,
      "preview": "5. Communicate the diagnosis and treatment to the medical provider responsible for the care of the c"
    },
    {
      "type": "heading",
      "level": 2,
      "section": "References",
      "line": 1540
    },
    {
      "type": "text",
      "section": "References",
      "line": 1542,
      "preview": "1. Becker P, Carney LN, Corkins MR, et al; Academy of Nutrition and Dietetics; American Society for "
    },
    {
      "type": "text",
      "section": "References",
      "line": 1544,
      "preview": "--- page 76 ---"
    },
    {
      "type": "text",
      "section": "References",
      "line": 1546,
      "preview": "nutrition). Nutr Clin Pract. 2015;30(1):147-161. https://doi.org/10.1177/0884533614557642"
    },
    {
      "type": "text",
      "section": "References",
      "line": 1547,
      "preview": "2. International Statistical Classification of Diseases and Related Health Problems, Tenth Revision."
    },
    {
      "type": "text",
      "section": "References",
      "line": 1548,
      "preview": "3. Child growth standards: weight velocity. World Health Organization. Accessed May 31, 2022. https:"
    },
    {
      "type": "text",
      "section": "References",
      "line": 1549,
      "preview": "4. Grellety E, Golden MH. Severely malnourished children with a low weight-for-height have a higher "
    },
    {
      "type": "text",
      "section": "References",
      "line": 1550,
      "preview": "5. Grellety E, Golden MH. Severely malnourished children with a low weight-for-height have a higher "
    },
    {
      "type": "text",
      "section": "References",
      "line": 1551,
      "preview": "6. ASPEN Malnutrition Committee 2018. Malnutrition Matters for Pediatric Patients [Video]. YouTube. "
    },
    {
      "type": "text",
      "section": "References",
      "line": 1552,
      "preview": "7. Beser OF, Cokugras FC, Erkan T, et al; TUHAMAR Study Group. Evaluation of malnutrition developmen"
    },
    {
      "type": "text",
      "section": "References",
      "line": 1553,
      "preview": "8. Diamanti A, Cereda E, Capriati T, et al. Prevalence and outcome of malnutrition in pediatric pati"
    },
    {
      "type": "text",
      "section": "References",
      "line": 1554,
      "preview": "9. Gerasimidis K, Milani S, Tester A, et al. A multicentre development and evaluation of a dietetic "
    },
    {
      "type": "text",
      "section": "References",
      "line": 1555,
      "preview": "10. Ladd MR, Garcia AV, Leeds IL, et al. Malnutrition increases the risk of 30-day complications aft"
    },
    {
      "type": "text",
      "section": "References",
      "line": 1556,
      "preview": "11. Jensen GL. Malnutrition and inflammation-\"burning down the house\": inflammation as an adaptive p"
    },
    {
      "type": "text",
      "section": "References",
      "line": 1557,
      "preview": "12. DeBoer MD, Scharf RJ, Leite AM, et al. Systemic inflammation, growth factors, and linear growth "
    },
    {
      "type": "text",
      "section": "References",
      "line": 1558,
      "preview": "13. Secker DJ, Jeejeebhoy KN. How to perform Subjective Global Nutritional assessment in children. J"
    },
    {
      "type": "text",
      "section": "References",
      "line": 1559,
      "preview": "14. Fenton TR, Kim JH. A systematic review and meta-analysis to revise the Fenton growth chart for p"
    },
    {
      "type": "text",
      "section": "References",
      "line": 1560,
      "preview": "15. Olsen IE, Groveman SA, Lawson ML, Clark RH, Zemel BS. New intrauterine growth curves based on Un"
    },
    {
      "type": "text",
      "section": "References",
      "line": 1562,
      "preview": "--- page 77 ---"
    },
    {
      "type": "text",
      "section": "References",
      "line": 1564,
      "preview": "16. Goldberg DL, Becker PJ, Brigham K, et al. Identifying malnutrition in preterm and neonatal popul"
    },
    {
      "type": "text",
      "section": "References",
      "line": 1565,
      "preview": "17. Clark RH, Olsen IE, Spitzer AR. Assessment of neonatal growth in prematurely born infants. Clin "
    },
    {
      "type": "text",
      "section": "References",
      "line": 1566,
      "preview": "18. Fenton TR, Elmrayed S, Alshaikh B. Nutrition, growth and long-term outcomes. World Rev Nutr Diet"
    },
    {
      "type": "text",
      "section": "References",
      "line": 1567,
      "preview": "19. Wright CM, Parkinson KN. Postnatal weight loss in term infants: what is normal and do growth cha"
    },
    {
      "type": "text",
      "section": "References",
      "line": 1568,
      "preview": "20. Fenton TR, Anderson D, Groh-Wargo S, Hoyos A, Ehrenkranz RA, Senterre T. An attempt to standardi"
    },
    {
      "type": "text",
      "section": "References",
      "line": 1569,
      "preview": "21. Rochow N, Fusch G, M\u00fchlinghaus A, et al. A nutritional program to improve outcome of very low bi"
    },
    {
      "type": "text",
      "section": "References",
      "line": 1570,
      "preview": "22. Rochow N, Raja P, Liu K, et al. Physiological adjustment to postnatal growth trajectories in hea"
    },
    {
      "type": "text",
      "section": "References",
      "line": 1571,
      "preview": "23. Power VA, Spittle AJ, Lee KJ, et al. Nutrition, growth, brain volume, and neurodevelopment in ve"
    },
    {
      "type": "text",
      "section": "References",
      "line": 1572,
      "preview": "24. Goldberg DL, Becker PJ. Applying the recommended indicators for the diagnosis of preterm and neo"
    },
    {
      "type": "text",
      "section": "References",
      "line": 1574,
      "preview": "--- page 78 ---"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "3",
      "line": 1576
    },
    {
      "type": "heading",
      "level": 2,
      "section": "Clinical Considerations",
      "line": 1578
    },
    {
      "type": "text",
      "section": "Clinical Considerations",
      "line": 1580,
      "preview": "Gina Rempel, MD, FRCPC, FAND<br>Patricia J. Becker, MS, RDN, CSP, SNSC"
    },
    {
      "type": "heading",
      "level": 2,
      "section": "Developmental Feeding Stages",
      "line": 1582
    },
    {
      "type": "text",
      "section": "Developmental Feeding Stages",
      "line": 1584,
      "preview": "As part of the nutrition assessment, noting the child's achievement of their developmental milestone"
    },
    {
      "type": "text",
      "section": "Developmental Feeding Stages",
      "line": 1586,
      "preview": "--- page 79 ---"
    },
    {
      "type": "text",
      "section": "Developmental Feeding Stages",
      "line": 1588,
      "preview": "TABLE 3-1. Developmental Feeding Stages and Appropriate Foods for Different Ages ${ }^{\\text {a,b }}"
    },
    {
      "type": "table",
      "section": "Developmental Feeding Stages",
      "line": 1590,
      "preview": "| Age | Major Motor Developmental Milestones | Developmental Feeding Stage | Appropriate Foods | Fee"
    },
    {
      "type": "table",
      "section": "Developmental Feeding Stages",
      "line": 1591,
      "preview": "| :--: | :--: | :--: | :--: | :--: | :--: |"
    },
    {
      "type": "table",
      "section": "Developmental Feeding Stages",
      "line": 1592,
      "preview": "| Newborn and infant, $0-4 \\mathrm{mo}$ | Head control developing | - Reflexive suckle dominates <br"
    },
    {
      "type": "table",
      "section": "Developmental Feeding Stages",
      "line": 1593,
      "preview": "| 4-6 mo | - Steady head control <br> - Can reach for spoon <br> - Supported sitting | - Transition "
    },
    {
      "type": "table",
      "section": "Developmental Feeding Stages",
      "line": 1594,
      "preview": "| 6-9 mo | - Good head control <br> - Hand-tomouth play around 6 mo <br> - Transfers objects from on"
    },
    {
      "type": "text",
      "section": "Developmental Feeding Stages",
      "line": 1596,
      "preview": "--- page 80 ---"
    },
    {
      "type": "table",
      "section": "Developmental Feeding Stages",
      "line": 1598,
      "preview": "| Age | Major Motor Developmental Milestones | Developmental <br> Feeding Stage | Appropriate Foods "
    },
    {
      "type": "table",
      "section": "Developmental Feeding Stages",
      "line": 1599,
      "preview": "| :--: | :--: | :--: | :--: | :--: | :--: |"
    },
    {
      "type": "table",
      "section": "Developmental Feeding Stages",
      "line": 1600,
      "preview": "| 9-11 mo | - Sitting for prolonged periods <br> - Crawling <br> - Pulling to stand | - Tongue is le"
    },
    {
      "type": "table",
      "section": "Developmental Feeding Stages",
      "line": 1601,
      "preview": "| 11-12 mo | - Cruising furniture <br> - Walking with support <br> - Pincer grasp facilitates pickin"
    },
    {
      "type": "table",
      "section": "Developmental Feeding Stages",
      "line": 1602,
      "preview": "| 12-18 mo | Independent walker | - Can eat chopped meats <br> - Can eat sandwiches <br> - Can use u"
    },
    {
      "type": "table",
      "section": "Developmental Feeding Stages",
      "line": 1603,
      "preview": "| 19-24 mo | Can walk, run, and climb | - Can sit at a table in a chair <br> - Can drink from an ope"
    },
    {
      "type": "text",
      "section": "Developmental Feeding Stages",
      "line": 1605,
      "preview": "--- page 81 ---"
    },
    {
      "type": "table",
      "section": "Developmental Feeding Stages",
      "line": 1607,
      "preview": "| Age | Major Motor <br> Developmental <br> Milestones | Developmental <br> Feeding Stage | Appropri"
    },
    {
      "type": "table",
      "section": "Developmental Feeding Stages",
      "line": 1608,
      "preview": "| :-- | :-- | :-- | :-- | :-- | :-- |"
    },
    {
      "type": "table",
      "section": "Developmental Feeding Stages",
      "line": 1609,
      "preview": "| Preschooler, <br> $2-4 \\mathrm{y}$ | - Strong <br> independent <br> mobility skills <br> - Able to"
    },
    {
      "type": "table",
      "section": "Developmental Feeding Stages",
      "line": 1610,
      "preview": "| Young <br> schoolers, <br> $5-6 \\mathrm{y}$ | - Strong <br> independent <br> mobility skills <br> "
    },
    {
      "type": "text",
      "section": "Developmental Feeding Stages",
      "line": 1612,
      "preview": "Abbreviation: AAP, American Academy of Pediatrics."
    },
    {
      "type": "text",
      "section": "Developmental Feeding Stages",
      "line": 1613,
      "preview": "${ }^{a}$ Data from Nutrition. American Academy of Pediatrics. Accessed February 14, 2023. https://w"
    },
    {
      "type": "text",
      "section": "Developmental Feeding Stages",
      "line": 1614,
      "preview": "${ }^{b}$ Data from Corkins MR, McKown CG, Gosa MM. Mechanics of nutrient intake. In: Corkins MR, ed"
    },
    {
      "type": "text",
      "section": "Developmental Feeding Stages",
      "line": 1615,
      "preview": "${ }^{c}$ Spoon feeding is generally not started until head control is achieved."
    },
    {
      "type": "text",
      "section": "Developmental Feeding Stages",
      "line": 1616,
      "preview": "${ }^{d}$ Avoid foods with a high risk of choking, which include but are not limited to hard fruits "
    },
    {
      "type": "text",
      "section": "Developmental Feeding Stages",
      "line": 1617,
      "preview": "${ }^{e}$ Muth ND. Recommended Drinks for Children Age 5 \\& Younger. American Academy of Pediatrics."
    },
    {
      "type": "text",
      "section": "Developmental Feeding Stages",
      "line": 1618,
      "preview": "${ }^{h}$ Childhood Nutrition Facts. Centers for Disease Control and Prevention. August 5, 2022. htt"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "Feeding, Eating, and Drinking Difficulties, Including Swallowing Problems (Dysphagia)",
      "line": 1620
    },
    {
      "type": "text",
      "section": "Feeding, Eating, and Drinking Difficulties, Including Swallowing Problems (Dysphagia)",
      "line": 1622,
      "preview": "--- page 82 ---"
    },
    {
      "type": "text",
      "section": "Feeding, Eating, and Drinking Difficulties, Including Swallowing Problems (Dysphagia)",
      "line": 1624,
      "preview": "Feeding oneself or feeding someone else involves more than just swallowing. Food is imbued with a ta"
    },
    {
      "type": "text",
      "section": "Feeding, Eating, and Drinking Difficulties, Including Swallowing Problems (Dysphagia)",
      "line": 1626,
      "preview": "The same holds true for children with feeding, eating, and drinking difficulties. They and their fam"
    },
    {
      "type": "text",
      "section": "Feeding, Eating, and Drinking Difficulties, Including Swallowing Problems (Dysphagia)",
      "line": 1628,
      "preview": "Dysphagia is difficulty swallowing. It has different connotations for different people; hence, we wi"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "Three Phases of Swallowing",
      "line": 1630
    },
    {
      "type": "text",
      "section": "Three Phases of Swallowing",
      "line": 1632,
      "preview": "The process of swallowing is usually divided into three phases: oral, pharyngeal, and esophageal pha"
    },
    {
      "type": "text",
      "section": "Three Phases of Swallowing",
      "line": 1634,
      "preview": "Once triggered, the pharyngeal phase is involuntary. It involves the following:"
    },
    {
      "type": "text",
      "section": "Three Phases of Swallowing",
      "line": 1636,
      "preview": "- Moving food or liquid through the pharynx"
    },
    {
      "type": "text",
      "section": "Three Phases of Swallowing",
      "line": 1637,
      "preview": "- Automatic closures of the"
    },
    {
      "type": "text",
      "section": "Three Phases of Swallowing",
      "line": 1638,
      "preview": "- Nasopharynx with the uvula and soft palate rising"
    },
    {
      "type": "text",
      "section": "Three Phases of Swallowing",
      "line": 1639,
      "preview": "- Larynx and the epiglottis retroflexing over the airway"
    },
    {
      "type": "text",
      "section": "Three Phases of Swallowing",
      "line": 1640,
      "preview": "- Brief cessation of breathing followed by an exhalation"
    },
    {
      "type": "text",
      "section": "Three Phases of Swallowing",
      "line": 1642,
      "preview": "--- page 83 ---"
    },
    {
      "type": "text",
      "section": "Three Phases of Swallowing",
      "line": 1644,
      "preview": "The esophageal phase is also involuntary. The upper esophageal sphincter opens, and food is propelle"
    },
    {
      "type": "text",
      "section": "Three Phases of Swallowing",
      "line": 1646,
      "preview": "Feeding, eating, and swallowing difficulties include ${ }^{6}$ food processing issues occurring in t"
    },
    {
      "type": "text",
      "section": "Three Phases of Swallowing",
      "line": 1648,
      "preview": "Oral-sensory problems occur most often in children with autism spectrum disorder (ASD), although the"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "Conditions Causing Feeding, Eating, and Swallowing Difficulties",
      "line": 1650
    },
    {
      "type": "text",
      "section": "Conditions Causing Feeding, Eating, and Swallowing Difficulties",
      "line": 1652,
      "preview": "Feeding, eating, and swallowing difficulties may occur in children with any of the following conditi"
    },
    {
      "type": "heading",
      "level": 2,
      "section": "Craniofacial Anomalies",
      "line": 1654
    },
    {
      "type": "text",
      "section": "Craniofacial Anomalies",
      "line": 1656,
      "preview": "- Choanal atresia may cause difficulties because infants are obligate nasal breathers."
    },
    {
      "type": "text",
      "section": "Craniofacial Anomalies",
      "line": 1657,
      "preview": "- A cleft lip may also cause difficulties, so consider using a nipple with a broad base or alternati"
    },
    {
      "type": "text",
      "section": "Craniofacial Anomalies",
      "line": 1659,
      "preview": "--- page 84 ---"
    },
    {
      "type": "text",
      "section": "Craniofacial Anomalies",
      "line": 1661,
      "preview": "- A cleft palate can impact food/liquid intake, processing, and swallowing, so special bottle system"
    },
    {
      "type": "text",
      "section": "Craniofacial Anomalies",
      "line": 1662,
      "preview": "- Chiari malformations may impact swallowing function because of brain stem effects."
    },
    {
      "type": "heading",
      "level": 1,
      "section": "Aerodigestive Tract Anomalies",
      "line": 1665
    },
    {
      "type": "text",
      "section": "Aerodigestive Tract Anomalies",
      "line": 1667,
      "preview": "- Laryngomalacia: It is important to pay close attention to infants' respiratory effort expended for"
    },
    {
      "type": "text",
      "section": "Aerodigestive Tract Anomalies",
      "line": 1668,
      "preview": "- Vocal cord dysfunction: Can occur congenitally or after cardiothoracic surgery and can impair airw"
    },
    {
      "type": "text",
      "section": "Aerodigestive Tract Anomalies",
      "line": 1669,
      "preview": "- liquid modification,"
    },
    {
      "type": "text",
      "section": "Aerodigestive Tract Anomalies",
      "line": 1670,
      "preview": "- adjusting liquid flow, and"
    },
    {
      "type": "text",
      "section": "Aerodigestive Tract Anomalies",
      "line": 1671,
      "preview": "- alternative positions for breastfeeding may help."
    },
    {
      "type": "text",
      "section": "Aerodigestive Tract Anomalies",
      "line": 1672,
      "preview": "- Tracheolaryngeal clefts: Success of feeding depends on the depth of the cleft. Some require surgic"
    },
    {
      "type": "text",
      "section": "Aerodigestive Tract Anomalies",
      "line": 1673,
      "preview": "- Tracheoesophageal fistula with or without esophageal atresia: Requires surgical intervention and t"
    },
    {
      "type": "text",
      "section": "Aerodigestive Tract Anomalies",
      "line": 1674,
      "preview": "- Vascular rings"
    },
    {
      "type": "text",
      "section": "Aerodigestive Tract Anomalies",
      "line": 1675,
      "preview": "- Tumors/growths"
    },
    {
      "type": "heading",
      "level": 2,
      "section": "Neurological Conditions, Developmental Variation, and Genetic Conditions",
      "line": 1678
    },
    {
      "type": "text",
      "section": "Neurological Conditions, Developmental Variation, and Genetic Conditions",
      "line": 1680,
      "preview": "Any condition impacting the nerves or muscles can affect the complex choreography between swallowing"
    },
    {
      "type": "heading",
      "level": 2,
      "section": "Chronic Lung Disease and Cardiovascular Disease",
      "line": 1682
    },
    {
      "type": "text",
      "section": "Chronic Lung Disease and Cardiovascular Disease",
      "line": 1684,
      "preview": "Chronic lung disease can impact the respiratory rate and effort during eating or feeding, which can "
    },
    {
      "type": "text",
      "section": "Chronic Lung Disease and Cardiovascular Disease",
      "line": 1686,
      "preview": "--- page 85 ---"
    },
    {
      "type": "text",
      "section": "Chronic Lung Disease and Cardiovascular Disease",
      "line": 1688,
      "preview": "with heart disease. This can result in the energy cost of drinking/eating exceeding their caloric in"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "GI Tract Disturbance",
      "line": 1690
    },
    {
      "type": "text",
      "section": "GI Tract Disturbance",
      "line": 1692,
      "preview": "GER disease can impact swallowing function by affecting the esophageal phase of swallowing. It can a"
    },
    {
      "type": "heading",
      "level": 2,
      "section": "Preterm Birth",
      "line": 1694
    },
    {
      "type": "text",
      "section": "Preterm Birth",
      "line": 1696,
      "preview": "Preterm birth can affect the feeding process because preterm infants often have chronic lung disease"
    },
    {
      "type": "text",
      "section": "Preterm Birth",
      "line": 1698,
      "preview": "- oromotor work,"
    },
    {
      "type": "text",
      "section": "Preterm Birth",
      "line": 1699,
      "preview": "- positioning, and"
    },
    {
      "type": "text",
      "section": "Preterm Birth",
      "line": 1700,
      "preview": "- flow control from the nipple."
    },
    {
      "type": "text",
      "section": "Preterm Birth",
      "line": 1702,
      "preview": "A lot of patience with very cautious increases in intake can facilitate safe feeding."
    },
    {
      "type": "heading",
      "level": 2,
      "section": "An Approach to Feeding, Eating, and Drinking Difficulties",
      "line": 1704
    },
    {
      "type": "text",
      "section": "An Approach to Feeding, Eating, and Drinking Difficulties",
      "line": 1706,
      "preview": "The International Classification of Function, Disease and Disability ${ }^{7}$ can be used to map fe"
    },
    {
      "type": "text",
      "section": "An Approach to Feeding, Eating, and Drinking Difficulties",
      "line": 1708,
      "preview": "The following are considerations for approaching feeding, eating, and drinking difficulties. All the"
    },
    {
      "type": "text",
      "section": "An Approach to Feeding, Eating, and Drinking Difficulties",
      "line": 1710,
      "preview": "1. Fitness to eat"
    },
    {
      "type": "text",
      "section": "An Approach to Feeding, Eating, and Drinking Difficulties",
      "line": 1711,
      "preview": "a. Cognition, awareness, and sensing hunger and thirst"
    },
    {
      "type": "text",
      "section": "An Approach to Feeding, Eating, and Drinking Difficulties",
      "line": 1713,
      "preview": "--- page 86 ---"
    },
    {
      "type": "text",
      "section": "An Approach to Feeding, Eating, and Drinking Difficulties",
      "line": 1715,
      "preview": "b. Strength, control, and endurance"
    },
    {
      "type": "text",
      "section": "An Approach to Feeding, Eating, and Drinking Difficulties",
      "line": 1716,
      "preview": "c. Impact of illness and hospitalization on intake"
    },
    {
      "type": "text",
      "section": "An Approach to Feeding, Eating, and Drinking Difficulties",
      "line": 1717,
      "preview": "2. Health"
    },
    {
      "type": "text",
      "section": "An Approach to Feeding, Eating, and Drinking Difficulties",
      "line": 1718,
      "preview": "a. Nutrition and hydration"
    },
    {
      "type": "text",
      "section": "An Approach to Feeding, Eating, and Drinking Difficulties",
      "line": 1719,
      "preview": "b. Secretion management"
    },
    {
      "type": "text",
      "section": "An Approach to Feeding, Eating, and Drinking Difficulties",
      "line": 1720,
      "preview": "c. Aspiration"
    },
    {
      "type": "text",
      "section": "An Approach to Feeding, Eating, and Drinking Difficulties",
      "line": 1721,
      "preview": "d. Respiratory illness"
    },
    {
      "type": "text",
      "section": "An Approach to Feeding, Eating, and Drinking Difficulties",
      "line": 1723,
      "preview": "- Chronic lung disease"
    },
    {
      "type": "text",
      "section": "An Approach to Feeding, Eating, and Drinking Difficulties",
      "line": 1724,
      "preview": "- Obstructive sleep apnea"
    },
    {
      "type": "text",
      "section": "An Approach to Feeding, Eating, and Drinking Difficulties",
      "line": 1725,
      "preview": "e. Cardiovascular disease"
    },
    {
      "type": "text",
      "section": "An Approach to Feeding, Eating, and Drinking Difficulties",
      "line": 1726,
      "preview": "f. GI disturbances"
    },
    {
      "type": "text",
      "section": "An Approach to Feeding, Eating, and Drinking Difficulties",
      "line": 1727,
      "preview": "- Food protein-induced syndromes"
    },
    {
      "type": "text",
      "section": "An Approach to Feeding, Eating, and Drinking Difficulties",
      "line": 1728,
      "preview": "- GER"
    },
    {
      "type": "text",
      "section": "An Approach to Feeding, Eating, and Drinking Difficulties",
      "line": 1729,
      "preview": "- Constipation"
    },
    {
      "type": "text",
      "section": "An Approach to Feeding, Eating, and Drinking Difficulties",
      "line": 1730,
      "preview": "g. Pubertal status affecting weight gain and growth rates ${ }^{8}$"
    },
    {
      "type": "text",
      "section": "An Approach to Feeding, Eating, and Drinking Difficulties",
      "line": 1732,
      "preview": "3. Functional motor ability to consume food"
    },
    {
      "type": "text",
      "section": "An Approach to Feeding, Eating, and Drinking Difficulties",
      "line": 1733,
      "preview": "a. Sensory factors affecting intake"
    },
    {
      "type": "text",
      "section": "An Approach to Feeding, Eating, and Drinking Difficulties",
      "line": 1734,
      "preview": "b. Positioning challenges for children with skeletal deformities"
    },
    {
      "type": "text",
      "section": "An Approach to Feeding, Eating, and Drinking Difficulties",
      "line": 1735,
      "preview": "c. Oromotor skills"
    },
    {
      "type": "text",
      "section": "An Approach to Feeding, Eating, and Drinking Difficulties",
      "line": 1736,
      "preview": "d. Swallowing competence"
    },
    {
      "type": "text",
      "section": "An Approach to Feeding, Eating, and Drinking Difficulties",
      "line": 1737,
      "preview": "4. Adaptation of the environment to foster participation in eating"
    },
    {
      "type": "text",
      "section": "An Approach to Feeding, Eating, and Drinking Difficulties",
      "line": 1738,
      "preview": "a. Safety of eating across all environments"
    },
    {
      "type": "text",
      "section": "An Approach to Feeding, Eating, and Drinking Difficulties",
      "line": 1739,
      "preview": "b. Training all caregivers"
    },
    {
      "type": "text",
      "section": "An Approach to Feeding, Eating, and Drinking Difficulties",
      "line": 1740,
      "preview": "c. Participation in the \"activity of eating,\" when possible, with family, at school, and in communit"
    },
    {
      "type": "text",
      "section": "An Approach to Feeding, Eating, and Drinking Difficulties",
      "line": 1741,
      "preview": "5. Environmental factors"
    },
    {
      "type": "text",
      "section": "An Approach to Feeding, Eating, and Drinking Difficulties",
      "line": 1742,
      "preview": "a. Family values around food"
    },
    {
      "type": "text",
      "section": "An Approach to Feeding, Eating, and Drinking Difficulties",
      "line": 1743,
      "preview": "b. Adequate time to eat"
    },
    {
      "type": "text",
      "section": "An Approach to Feeding, Eating, and Drinking Difficulties",
      "line": 1744,
      "preview": "c. Appropriate utensils"
    },
    {
      "type": "text",
      "section": "An Approach to Feeding, Eating, and Drinking Difficulties",
      "line": 1745,
      "preview": "d. Access to appropriate, affordable food"
    },
    {
      "type": "text",
      "section": "An Approach to Feeding, Eating, and Drinking Difficulties",
      "line": 1746,
      "preview": "e. Food preparation for appropriate texture and viscosity"
    },
    {
      "type": "text",
      "section": "An Approach to Feeding, Eating, and Drinking Difficulties",
      "line": 1747,
      "preview": "f. Air quality affecting lung health and thereby affecting oral intake and swallowing competence"
    },
    {
      "type": "text",
      "section": "An Approach to Feeding, Eating, and Drinking Difficulties",
      "line": 1748,
      "preview": "6. Personal factors"
    },
    {
      "type": "text",
      "section": "An Approach to Feeding, Eating, and Drinking Difficulties",
      "line": 1749,
      "preview": "a. Behavioral issues interfering with intake"
    },
    {
      "type": "text",
      "section": "An Approach to Feeding, Eating, and Drinking Difficulties",
      "line": 1750,
      "preview": "b. Food preferences"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "Medical Tests in the Assessment of Eating and Drinking Difficulties",
      "line": 1752
    },
    {
      "type": "text",
      "section": "Medical Tests in the Assessment of Eating and Drinking Difficulties",
      "line": 1754,
      "preview": "A good history, physical examination, and feeding observation lie at the heart of a complete feeding"
    },
    {
      "type": "text",
      "section": "Medical Tests in the Assessment of Eating and Drinking Difficulties",
      "line": 1756,
      "preview": "--- page 87 ---"
    },
    {
      "type": "text",
      "section": "Medical Tests in the Assessment of Eating and Drinking Difficulties",
      "line": 1758,
      "preview": "fiberoptic endoscopic evaluation of swallowing (FEES) are extensions of the clinical information obt"
    },
    {
      "type": "text",
      "section": "Medical Tests in the Assessment of Eating and Drinking Difficulties",
      "line": 1760,
      "preview": "Other common tests for children with eating and drinking difficulties include the following:"
    },
    {
      "type": "text",
      "section": "Medical Tests in the Assessment of Eating and Drinking Difficulties",
      "line": 1762,
      "preview": "- Chest x-ray to assess chronic signs of aspiration."
    },
    {
      "type": "text",
      "section": "Medical Tests in the Assessment of Eating and Drinking Difficulties",
      "line": 1763,
      "preview": "- VFSS, also known as a \"modified barium swallow,\" can be used to assess all phases of swallowing an"
    },
    {
      "type": "text",
      "section": "Medical Tests in the Assessment of Eating and Drinking Difficulties",
      "line": 1764,
      "preview": "- Food and liquids of different skill level-appropriate consistencies, viscosities, and textures are"
    },
    {
      "type": "text",
      "section": "Medical Tests in the Assessment of Eating and Drinking Difficulties",
      "line": 1765,
      "preview": "- The VFSS is not the same as an upper GI series, which is also sometimes called a \"barium swallow.\""
    },
    {
      "type": "text",
      "section": "Medical Tests in the Assessment of Eating and Drinking Difficulties",
      "line": 1766,
      "preview": "- FEES, an evaluation in which a laryngoscope is placed above the larynx while feeding is observed. "
    },
    {
      "type": "text",
      "section": "Medical Tests in the Assessment of Eating and Drinking Difficulties",
      "line": 1767,
      "preview": "- A salivagram is a nuclear medicine test showing the transit of saliva from the mouth to the stomac"
    },
    {
      "type": "text",
      "section": "Medical Tests in the Assessment of Eating and Drinking Difficulties",
      "line": 1768,
      "preview": "- In an upper GI series, an x-ray contrast study is often done when reflux is suspected and one want"
    },
    {
      "type": "text",
      "section": "Medical Tests in the Assessment of Eating and Drinking Difficulties",
      "line": 1769,
      "preview": "- Endoscopy of the otorhinological system, respiratory system, and the GI tract may be required to f"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "Interventions for Swallowing Dysfunction",
      "line": 1772
    },
    {
      "type": "text",
      "section": "Interventions for Swallowing Dysfunction",
      "line": 1774,
      "preview": "Swallowing safety is impacted by a host of factors, which have been mentioned in previous sections. "
    },
    {
      "type": "text",
      "section": "Interventions for Swallowing Dysfunction",
      "line": 1776,
      "preview": "--- page 88 ---"
    },
    {
      "type": "text",
      "section": "Interventions for Swallowing Dysfunction",
      "line": 1778,
      "preview": "required to ensure that the bolus is homogeneous because of poor oral processing skills or because a"
    },
    {
      "type": "text",
      "section": "Interventions for Swallowing Dysfunction",
      "line": 1780,
      "preview": "Improving swallowing safety may involve thickening the liquids, which changes the swallowing mechani"
    },
    {
      "type": "text",
      "section": "Interventions for Swallowing Dysfunction",
      "line": 1782,
      "preview": "- The effect of thickening may lie in the inherent properties of a thickened liquid being more cohes"
    },
    {
      "type": "text",
      "section": "Interventions for Swallowing Dysfunction",
      "line": 1783,
      "preview": "- Thickening may, however, result in more residual food in the pharynx that a child is unable to cle"
    },
    {
      "type": "text",
      "section": "Interventions for Swallowing Dysfunction",
      "line": 1784,
      "preview": "- Thickening may also decrease liquid palatability and increase the risk of dehydration. ${ }^{10}$ "
    },
    {
      "type": "heading",
      "level": 1,
      "section": "The International Dysphagia Diet Standardisation Initiative",
      "line": 1787
    },
    {
      "type": "text",
      "section": "The International Dysphagia Diet Standardisation Initiative",
      "line": 1789,
      "preview": "The International Dysphagia Diet Standardisation Initiative (IDDSI) ${ }^{11}$ was founded with the "
    },
    {
      "type": "text",
      "section": "The International Dysphagia Diet Standardisation Initiative",
      "line": 1791,
      "preview": "--- page 89 ---"
    },
    {
      "type": "image",
      "section": "The International Dysphagia Diet Standardisation Initiative",
      "line": 1793,
      "content": "![img-5.jpeg](images/af0f796d36132aa6.png)"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "**FOODS**",
      "line": 1795
    },
    {
      "type": "heading",
      "level": 2,
      "section": "**REGULAR EASY TO CHEW**",
      "line": 1797
    },
    {
      "type": "heading",
      "level": 3,
      "section": "**SOFT & BITE-SIZED**",
      "line": 1799
    },
    {
      "type": "text",
      "section": "**SOFT & BITE-SIZED**",
      "line": 1801,
      "preview": "- **MINCED & MOIST**"
    },
    {
      "type": "text",
      "section": "**SOFT & BITE-SIZED**",
      "line": 1802,
      "preview": "- **PUREED**"
    },
    {
      "type": "text",
      "section": "**SOFT & BITE-SIZED**",
      "line": 1803,
      "preview": "- **4 EXTREMELY THICK**"
    },
    {
      "type": "text",
      "section": "**SOFT & BITE-SIZED**",
      "line": 1804,
      "preview": "- **LIQUIDISED**"
    },
    {
      "type": "text",
      "section": "**SOFT & BITE-SIZED**",
      "line": 1805,
      "preview": "- **3 MODERATELY THICK**"
    },
    {
      "type": "text",
      "section": "**SOFT & BITE-SIZED**",
      "line": 1806,
      "preview": "- **1**"
    },
    {
      "type": "text",
      "section": "**SOFT & BITE-SIZED**",
      "line": 1807,
      "preview": "- **2 MILDLY THICK**"
    },
    {
      "type": "text",
      "section": "**SOFT & BITE-SIZED**",
      "line": 1808,
      "preview": "- **SLIGHTLY THICK**"
    },
    {
      "type": "text",
      "section": "**SOFT & BITE-SIZED**",
      "line": 1809,
      "preview": "- **THIN**"
    },
    {
      "type": "heading",
      "level": 2,
      "section": "**DRINKS**",
      "line": 1811
    },
    {
      "type": "table",
      "section": "**DRINKS**",
      "line": 1813,
      "preview": "Complete IDDSI Framework Detailed definitions 2.0 | 2019"
    },
    {
      "type": "text",
      "section": "**DRINKS**",
      "line": 1815,
      "preview": "--- page 90 ---"
    },
    {
      "type": "text",
      "section": "**DRINKS**",
      "line": 1817,
      "preview": "FIGURE 3-1. The IDDSI categorization of food and liquid viscosities and consistencies. Abbreviation:"
    },
    {
      "type": "text",
      "section": "**DRINKS**",
      "line": 1819,
      "preview": "The IDDSI group also developed the \"syringe flow test\" to measure the consistency, thickness, and fl"
    },
    {
      "type": "text",
      "section": "**DRINKS**",
      "line": 1821,
      "preview": "However, the IDDSI syringe flow test does not always match the viscosities as measured by a viscomet"
    },
    {
      "type": "text",
      "section": "**DRINKS**",
      "line": 1823,
      "preview": "--- page 91 ---"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "THE IDDSI Flow Test is used to classify liquid thickness",
      "line": 1825
    },
    {
      "type": "text",
      "section": "THE IDDSI Flow Test is used to classify liquid thickness",
      "line": 1827,
      "preview": "IDDSI uses an objective measurement tool for liquid thickness, 10 mL syringe. In the near future fun"
    },
    {
      "type": "image",
      "section": "THE IDDSI Flow Test is used to classify liquid thickness",
      "line": 1828,
      "content": "![img-6.jpeg](images/1293d58c6dff208b.png)"
    },
    {
      "type": "text",
      "section": "THE IDDSI Flow Test is used to classify liquid thickness",
      "line": 1830,
      "preview": "FIGURE 3-2. The IDDSI syringe test for measuring liquid viscosity. Abbreviation: IDDSI, Internationa"
    },
    {
      "type": "text",
      "section": "THE IDDSI Flow Test is used to classify liquid thickness",
      "line": 1832,
      "preview": "Sometimes, viscosity, consistency, or texture changes achieved by using blenderized tube feeding is "
    },
    {
      "type": "heading",
      "level": 2,
      "section": "Thickening Agents",
      "line": 1834
    },
    {
      "type": "text",
      "section": "Thickening Agents",
      "line": 1836,
      "preview": "--- page 92 ---"
    },
    {
      "type": "text",
      "section": "Thickening Agents",
      "line": 1838,
      "preview": "Commercial thickeners need to be used with caution in preterm infants, especially before they reach "
    },
    {
      "type": "text",
      "section": "Thickening Agents",
      "line": 1840,
      "preview": "--- page 93 ---"
    },
    {
      "type": "text",
      "section": "Thickening Agents",
      "line": 1842,
      "preview": "TABLE 3-2. Potential Thickening Agents and Considerations"
    },
    {
      "type": "table",
      "section": "Thickening Agents",
      "line": 1844,
      "preview": "| Thickener | Approved Age of Use | Special Considerations |"
    },
    {
      "type": "table",
      "section": "Thickening Agents",
      "line": 1845,
      "preview": "| :--: | :--: | :--: |"
    },
    {
      "type": "table",
      "section": "Thickening Agents",
      "line": 1846,
      "preview": "| Infant cereal | - Preterm infants must be $>44$ wk of corrected age. <br> - Term infants should be"
    },
    {
      "type": "table",
      "section": "Thickening Agents",
      "line": 1847,
      "preview": "| Commercial thickened infant formula (rice starchadded infant formula) | - Preterm infants must be "
    },
    {
      "type": "table",
      "section": "Thickening Agents",
      "line": 1848,
      "preview": "| Gum-based thickeners | - Carob bean gum thickener is used in preterm infants $>42 \\mathrm{wk}$ of "
    },
    {
      "type": "table",
      "section": "Thickening Agents",
      "line": 1849,
      "preview": "|  | - Xanthan gum thickeners <br> - Gels and powders are not recommended for infants $<1 \\mathrm{y}"
    },
    {
      "type": "table",
      "section": "Thickening Agents",
      "line": 1850,
      "preview": "|  | - Tara gum thickener for children $>1 \\mathrm{y}$ |  |"
    },
    {
      "type": "text",
      "section": "Thickening Agents",
      "line": 1852,
      "preview": "--- page 94 ---"
    },
    {
      "type": "table",
      "section": "Thickening Agents",
      "line": 1854,
      "preview": "| Thickener | Approved Age of Use | Special Considerations |"
    },
    {
      "type": "table",
      "section": "Thickening Agents",
      "line": 1855,
      "preview": "| :-- | :-- | :-- |"
    },
    {
      "type": "text",
      "section": "Thickening Agents",
      "line": 1857,
      "preview": "Abbreviation: IDDSI, International Dysphagia Diet Standardisation Initiative."
    },
    {
      "type": "text",
      "section": "Thickening Agents",
      "line": 1858,
      "preview": "${ }^{a}$ Beal J, Silverman B, Bellant J, Young TE, Klontz K. Late onset necrotizing enterocolitis i"
    },
    {
      "type": "text",
      "section": "Thickening Agents",
      "line": 1859,
      "preview": "${ }^{\\text {b }}$ Not all thickeners can be used to thicken breast milk because the enzymes in the "
    },
    {
      "type": "text",
      "section": "Thickening Agents",
      "line": 1860,
      "preview": "${ }^{c}$ Different jurisdictions have different rules and requirements for the safety of thickener "
    },
    {
      "type": "text",
      "section": "Thickening Agents",
      "line": 1861,
      "preview": "${ }^{d}$ Brooks L, Liao J, Ford J, Harmon S, Breedveld V. Thickened liquids using pureed foods for "
    },
    {
      "type": "heading",
      "level": 1,
      "section": "Options for Route of Intake",
      "line": 1863
    },
    {
      "type": "text",
      "section": "Options for Route of Intake",
      "line": 1865,
      "preview": "When oral feeding is unsafe or insufficient to meet the nutrition requirements, enteral feeding may "
    },
    {
      "type": "text",
      "section": "Options for Route of Intake",
      "line": 1867,
      "preview": "--- page 95 ---"
    },
    {
      "type": "text",
      "section": "Options for Route of Intake",
      "line": 1869,
      "preview": "communication skills, where we learn about celebrations and family traditions."
    },
    {
      "type": "text",
      "section": "Options for Route of Intake",
      "line": 1871,
      "preview": "When introducing the concept of enteral feeding, it is important for team members to explore the fam"
    },
    {
      "type": "text",
      "section": "Options for Route of Intake",
      "line": 1873,
      "preview": "It is important for team members evaluating oral feeding to appreciate that skills do change over ti"
    },
    {
      "type": "text",
      "section": "Options for Route of Intake",
      "line": 1875,
      "preview": "--- page 96 ---"
    },
    {
      "type": "text",
      "section": "Options for Route of Intake",
      "line": 1877,
      "preview": "TABLE 3-3. Description of Enteral Access Devices and Their Advantages and Disadvantages"
    },
    {
      "type": "table",
      "section": "Options for Route of Intake",
      "line": 1879,
      "preview": "| Enteral <br> Access <br> Devices | Usage | Advantages | Disadvantages |"
    },
    {
      "type": "table",
      "section": "Options for Route of Intake",
      "line": 1880,
      "preview": "| :--: | :--: | :--: | :--: |"
    },
    {
      "type": "table",
      "section": "Options for Route of Intake",
      "line": 1881,
      "preview": "| OG tube | When NG tube is difficult to place (choanal atresia) or infant is unable to breathe easi"
    },
    {
      "type": "table",
      "section": "Options for Route of Intake",
      "line": 1882,
      "preview": "| NG tube | - Generally thought of as \"short-term usage\" (<12 wk) but can be used for longer periods"
    },
    {
      "type": "table",
      "section": "Options for Route of Intake",
      "line": 1883,
      "preview": "| NJ tube | Short-term usage for children with intractable emesis (eg, those undergoing chemotherapy"
    },
    {
      "type": "table",
      "section": "Options for Route of Intake",
      "line": 1884,
      "preview": "| GT | - Tubes are placed directly into the stomach by endoscopic, laparoscopic, or open procedure <"
    },
    {
      "type": "text",
      "section": "Options for Route of Intake",
      "line": 1886,
      "preview": "--- page 97 ---"
    },
    {
      "type": "table",
      "section": "Options for Route of Intake",
      "line": 1888,
      "preview": "| Enteral <br> Access <br> Devices | Usage | Advantages | Disadvantages |"
    },
    {
      "type": "table",
      "section": "Options for Route of Intake",
      "line": 1889,
      "preview": "| :--: | :--: | :--: | :--: |"
    },
    {
      "type": "table",
      "section": "Options for Route of Intake",
      "line": 1890,
      "preview": "| Jejunal tubes ${ }^{c}$ | - Usually placed in situations of intractable regurgitation but indicati"
    },
    {
      "type": "text",
      "section": "Options for Route of Intake",
      "line": 1892,
      "preview": "Abbreviations: GJ, gastrojejunal; GT, gastrostomy tube; NG, nasogastric; NJ, nasojejunal; OG, orogas"
    },
    {
      "type": "text",
      "section": "Options for Route of Intake",
      "line": 1893,
      "preview": "Note: Entanglement risk needs to be discussed, especially when using enteral tubes at home when the "
    },
    {
      "type": "text",
      "section": "Options for Route of Intake",
      "line": 1894,
      "preview": "${ }^{a}$ Irving SY, Rempel G, Lyman B, Sevilla WMA, Northington L, Guenter P; American Society for "
    },
    {
      "type": "text",
      "section": "Options for Route of Intake",
      "line": 1896,
      "preview": "--- page 98 ---"
    },
    {
      "type": "text",
      "section": "Options for Route of Intake",
      "line": 1898,
      "preview": "and Verification: Best Practice Recommendations from the NOVEL Project. Nutr Clin Pract. 2018;33(6):"
    },
    {
      "type": "text",
      "section": "Options for Route of Intake",
      "line": 1899,
      "preview": "${ }^{\\text {b }}$ McSweeney ME, Kerr J, Amirault J, Mitchell PD, Larson K, Rosen R. Oral feeding re"
    },
    {
      "type": "text",
      "section": "Options for Route of Intake",
      "line": 1900,
      "preview": "${ }^{\\text {c }}$ Broekaert, I, Falconer J, Bronsky, et al. The use of jejunal tube feeding in chil"
    },
    {
      "type": "text",
      "section": "Options for Route of Intake",
      "line": 1901,
      "preview": "https://doi.org/10.1097/MPG. 0000000000002379"
    },
    {
      "type": "text",
      "section": "Options for Route of Intake",
      "line": 1902,
      "preview": "${ }^{d}$ Campwala I, Perrone E, Yanni G, Shah M, Gollin G. Complications of gastrojejunal feeding t"
    },
    {
      "type": "text",
      "section": "Options for Route of Intake",
      "line": 1903,
      "preview": "https://doi.org/10.1016/j.jss.2015.06.058"
    },
    {
      "type": "text",
      "section": "Options for Route of Intake",
      "line": 1904,
      "preview": "${ }^{\\text {e }}$ Watson J, McGuire W. Transpyloric versus gastric tube feeding for preterm infants"
    },
    {
      "type": "text",
      "section": "Options for Route of Intake",
      "line": 1905,
      "preview": "https://doi.org/10.1002/14651858.CD003487.pub3"
    },
    {
      "type": "text",
      "section": "Options for Route of Intake",
      "line": 1906,
      "preview": "${ }^{\\text {f }}$ Demehri FR, Simha S, Herrman E, Jarboe MD, Geiger JD, Teitelbaum DH, Gadepalli SK"
    },
    {
      "type": "text",
      "section": "Options for Route of Intake",
      "line": 1907,
      "preview": "https://doi.org/10.1016/j.jpedsurg.2016.02.072"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "References",
      "line": 1909
    },
    {
      "type": "text",
      "section": "References",
      "line": 1911,
      "preview": "1. Nutrition. American Academy of Pediatrics. Accessed February 14, 2023. https://www.healthychildre"
    },
    {
      "type": "text",
      "section": "References",
      "line": 1912,
      "preview": "2. Corkins MR, McKown CG, Gosa MM. Mechanics of nutrient intake. In: Corkins MR, ed. Bobo E, Christe"
    },
    {
      "type": "text",
      "section": "References",
      "line": 1913,
      "preview": "3. Muth ND. Recommended drinks for children age $5 \\&$ younger. American Academy of Pediatrics. May "
    },
    {
      "type": "text",
      "section": "References",
      "line": 1914,
      "preview": "4. Child feeding ages and stages. Ellyn Satter Institute. Accessed April 1, 2023. https://www.ellyns"
    },
    {
      "type": "text",
      "section": "References",
      "line": 1915,
      "preview": "5. Meek JY, Noble L; Section on Breastfeeding. Policy statement: breastfeeding and the use of human "
    },
    {
      "type": "text",
      "section": "References",
      "line": 1916,
      "preview": "6. Tutor JD, Gosa MM. Dysphagia and aspiration in children.Pediatr Pulmonol. 2012;47(4):321-337. htt"
    },
    {
      "type": "text",
      "section": "References",
      "line": 1917,
      "preview": "7. International classification of functioning, disability and health (ICF). World Health Organizati"
    },
    {
      "type": "text",
      "section": "References",
      "line": 1919,
      "preview": "--- page 99 ---"
    },
    {
      "type": "text",
      "section": "References",
      "line": 1921,
      "preview": "https://www.who.int/standards/classifications/international-classification-of-functioning-disability"
    },
    {
      "type": "text",
      "section": "References",
      "line": 1922,
      "preview": "8. Wagner E, Sentongo T. Assessment of nutrition status by age and determining nutrient needs. In: C"
    },
    {
      "type": "text",
      "section": "References",
      "line": 1923,
      "preview": "9. Duncan DR, Larson K, Rosen RL. Clinical aspects of thickeners for pediatric gastroesophageal refl"
    },
    {
      "type": "text",
      "section": "References",
      "line": 1924,
      "preview": "10. Newman R, Vilardell N, Clav\u00e9 P, Speyer R. Effect of bolus viscosity on the safety and efficacy o"
    },
    {
      "type": "text",
      "section": "References",
      "line": 1925,
      "preview": "11. The IDDSI framework. International Dysphagia Diet Standardization Initiative. 2019. Accessed Jun"
    },
    {
      "type": "text",
      "section": "References",
      "line": 1926,
      "preview": "12. Hron B, Rosen R. Viscosity of commercial food-based formulas and home-prepared blenderized feeds"
    },
    {
      "type": "text",
      "section": "References",
      "line": 1927,
      "preview": "13. Weston S, Clarke T. Determining viscosity of blenderized formula: a novel approach using the Int"
    },
    {
      "type": "text",
      "section": "References",
      "line": 1928,
      "preview": "14. Beal J, Silverman B, Bellant J, Young TE, Klontz K. Late onset necrotizing enterocolitis in infa"
    },
    {
      "type": "text",
      "section": "References",
      "line": 1929,
      "preview": "15. Brooks L, Liao J, Ford J, Harmon S, Breedveld V. Thickened liquids using pureed foods for childr"
    },
    {
      "type": "text",
      "section": "References",
      "line": 1930,
      "preview": "16. Irving SY, Rempel G, Lyman B, Sevilla WMA, Northington L, Guenter P; American Society for Parent"
    },
    {
      "type": "text",
      "section": "References",
      "line": 1931,
      "preview": "17. McSweeney ME, Kerr J, Amirault J, Mitchell PD, Larson K, Rosen R. Oral feeding reduces hospitali"
    },
    {
      "type": "text",
      "section": "References",
      "line": 1932,
      "preview": "18. Broekaert IJ, Falconer J, Bronsky J, et al. The use of jejunal tube feeding in children: a posit"
    },
    {
      "type": "text",
      "section": "References",
      "line": 1933,
      "preview": "19. Campwala I, Perrone E, Yanni G, Shah M, Gollin G. Complications of gastrojejunal feeding tubes i"
    },
    {
      "type": "text",
      "section": "References",
      "line": 1934,
      "preview": "20. Demehri FR, Simha S, Herrman E, et al. Analysis of risk factors contributing to morbidity from g"
    },
    {
      "type": "text",
      "section": "References",
      "line": 1936,
      "preview": "--- page 100 ---"
    },
    {
      "type": "text",
      "section": "References",
      "line": 1938,
      "preview": "21. Watson J, McGuire W. Transpyloric versus gastric tube feeding for preterm infants. Cochrane Data"
    },
    {
      "type": "text",
      "section": "References",
      "line": 1940,
      "preview": "--- page 101 ---"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "PART II",
      "line": 1942
    },
    {
      "type": "heading",
      "level": 2,
      "section": "Nutrition Care Plan",
      "line": 1944
    },
    {
      "type": "text",
      "section": "Nutrition Care Plan",
      "line": 1946,
      "preview": "--- page 102 ---"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "Infant to Adolescent",
      "line": 1948
    },
    {
      "type": "text",
      "section": "Infant to Adolescent",
      "line": 1950,
      "preview": "Mary Pat Turon-Findley, Med, RD, CMHIMP, LD"
    },
    {
      "type": "heading",
      "level": 2,
      "section": "Introduction",
      "line": 1952
    },
    {
      "type": "text",
      "section": "Introduction",
      "line": 1954,
      "preview": "Health status and a fundamental nutrition base start at the level of conception, with the support of"
    },
    {
      "type": "heading",
      "level": 2,
      "section": "Determining Nutrient Needs",
      "line": 1956
    },
    {
      "type": "text",
      "section": "Determining Nutrient Needs",
      "line": 1958,
      "preview": "Determining nutrient and fluid needs is a critical step in developing an enteral nutrition (EN) plan"
    },
    {
      "type": "text",
      "section": "Determining Nutrient Needs",
      "line": 1960,
      "preview": "--- page 103 ---"
    },
    {
      "type": "text",
      "section": "Determining Nutrient Needs",
      "line": 1962,
      "preview": "TABLE 4-1. Daily Energy Requirements for Pediatric Patients"
    },
    {
      "type": "table",
      "section": "Determining Nutrient Needs",
      "line": 1964,
      "preview": "| Age Group | Energy Requirements $(\\mathbf{k c a l} / \\mathbf{k g} / \\mathbf{d})^{\\mathbf{a}}$ |"
    },
    {
      "type": "table",
      "section": "Determining Nutrient Needs",
      "line": 1965,
      "preview": "| :-- | :--: |"
    },
    {
      "type": "table",
      "section": "Determining Nutrient Needs",
      "line": 1966,
      "preview": "| Preterm neonates | $90-120$ |"
    },
    {
      "type": "table",
      "section": "Determining Nutrient Needs",
      "line": 1967,
      "preview": "| $<6$ mo | $85-105$ |"
    },
    {
      "type": "table",
      "section": "Determining Nutrient Needs",
      "line": 1968,
      "preview": "| 6-12 mo | $80-100$ |"
    },
    {
      "type": "table",
      "section": "Determining Nutrient Needs",
      "line": 1969,
      "preview": "| $1-7$ y | $75-90$ |"
    },
    {
      "type": "table",
      "section": "Determining Nutrient Needs",
      "line": 1970,
      "preview": "| $7-12$ y | $60-75$ |"
    },
    {
      "type": "table",
      "section": "Determining Nutrient Needs",
      "line": 1971,
      "preview": "| $12-18$ y | $30-50$ |"
    },
    {
      "type": "text",
      "section": "Determining Nutrient Needs",
      "line": 1973,
      "preview": "Adapted with permission from the American Society for Parenteral and Enteral Nutrition from Malone A"
    },
    {
      "type": "text",
      "section": "Determining Nutrient Needs",
      "line": 1974,
      "preview": "${ }^{a}$ Assumes normal age-related organ function and normal losses."
    },
    {
      "type": "text",
      "section": "Determining Nutrient Needs",
      "line": 1976,
      "preview": "TABLE 4-2. Daily Protein Requirements for Pediatric Patients"
    },
    {
      "type": "table",
      "section": "Determining Nutrient Needs",
      "line": 1978,
      "preview": "| Age or Weight Group | Protein Requirements $(\\mathbf{g} / \\mathbf{k g} / \\mathbf{d})^{\\mathbf{a}}$"
    },
    {
      "type": "table",
      "section": "Determining Nutrient Needs",
      "line": 1979,
      "preview": "| :-- | :--: |"
    },
    {
      "type": "table",
      "section": "Determining Nutrient Needs",
      "line": 1980,
      "preview": "| Preterm neonates | $3-4$ |"
    },
    {
      "type": "table",
      "section": "Determining Nutrient Needs",
      "line": 1981,
      "preview": "| Birth to age 1 y | $2-3$ |"
    },
    {
      "type": "table",
      "section": "Determining Nutrient Needs",
      "line": 1982,
      "preview": "| Weight $>10 \\mathrm{~kg}$ or ages $1-10 \\mathrm{y}$ | $1-2$ |"
    },
    {
      "type": "table",
      "section": "Determining Nutrient Needs",
      "line": 1983,
      "preview": "| Ages $11-17 \\mathrm{y}$ | $0.8-1.5$ |"
    },
    {
      "type": "text",
      "section": "Determining Nutrient Needs",
      "line": 1985,
      "preview": "Adapted with permission from the American Society for Parenteral and Enteral Nutrition from Malone A"
    },
    {
      "type": "text",
      "section": "Determining Nutrient Needs",
      "line": 1986,
      "preview": "${ }^{a}$ Assumes normal age-related organ function and normal losses."
    },
    {
      "type": "heading",
      "level": 1,
      "section": "Energy Needs",
      "line": 1988
    },
    {
      "type": "text",
      "section": "Energy Needs",
      "line": 1990,
      "preview": "Indirect calorimetry (IC) is the gold standard for estimating resting energy expenditure (REE). ${ }"
    },
    {
      "type": "text",
      "section": "Energy Needs",
      "line": 1992,
      "preview": "--- page 104 ---"
    },
    {
      "type": "text",
      "section": "Energy Needs",
      "line": 1994,
      "preview": "handheld unit. ${ }^{2}$ See chapter 11, \"Critical Care,\" for further discussion of IC."
    },
    {
      "type": "text",
      "section": "Energy Needs",
      "line": 1996,
      "preview": "To estimate energy needs for children without IC available, calculate basal metabolic rate (BMR), as"
    },
    {
      "type": "text",
      "section": "Energy Needs",
      "line": 1998,
      "preview": "- Starvation: $0.7-0.85$"
    },
    {
      "type": "text",
      "section": "Energy Needs",
      "line": 1999,
      "preview": "- Surgery: $1.05-1.5$"
    },
    {
      "type": "text",
      "section": "Energy Needs",
      "line": 2000,
      "preview": "- Sepsis: $1.2-1.6$"
    },
    {
      "type": "text",
      "section": "Energy Needs",
      "line": 2001,
      "preview": "- Closed head injury: 1.3"
    },
    {
      "type": "text",
      "section": "Energy Needs",
      "line": 2002,
      "preview": "- Trauma: $1.1-1.8$"
    },
    {
      "type": "text",
      "section": "Energy Needs",
      "line": 2003,
      "preview": "- Growth Failure: $1.5-2$"
    },
    {
      "type": "text",
      "section": "Energy Needs",
      "line": 2004,
      "preview": "- Burn: $1.5-2.5^{3}$"
    },
    {
      "type": "text",
      "section": "Energy Needs",
      "line": 2006,
      "preview": "--- page 105 ---"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "TABLE 4-3. Calculating Basal Metabolic Rate Using the Schofield Equation",
      "line": 2008
    },
    {
      "type": "table",
      "section": "TABLE 4-3. Calculating Basal Metabolic Rate Using the Schofield Equation",
      "line": 2010,
      "preview": "|  | Calculations |  |"
    },
    {
      "type": "table",
      "section": "TABLE 4-3. Calculating Basal Metabolic Rate Using the Schofield Equation",
      "line": 2011,
      "preview": "| :-- | :-- | :-- |"
    },
    {
      "type": "table",
      "section": "TABLE 4-3. Calculating Basal Metabolic Rate Using the Schofield Equation",
      "line": 2012,
      "preview": "| Age (y) | Males | Females |"
    },
    {
      "type": "table",
      "section": "TABLE 4-3. Calculating Basal Metabolic Rate Using the Schofield Equation",
      "line": 2013,
      "preview": "| $0-3$ | $(0.167 \\times \\mathrm{wt}[\\mathrm{kg}])+$ | $(16.252 \\times \\mathrm{wt}[\\mathrm{kg}])+$ |"
    },
    {
      "type": "table",
      "section": "TABLE 4-3. Calculating Basal Metabolic Rate Using the Schofield Equation",
      "line": 2014,
      "preview": "|  | $(15.174 \\times \\mathrm{ht}[\\mathrm{cm}])-617.6$ | $(10.232 \\times \\mathrm{ht}[\\mathrm{cm}])-41"
    },
    {
      "type": "table",
      "section": "TABLE 4-3. Calculating Basal Metabolic Rate Using the Schofield Equation",
      "line": 2015,
      "preview": "| $3-10$ | $(19.59 \\times \\mathrm{wt}[\\mathrm{kg}])+$ | $(16.969 \\times \\mathrm{wt}[\\mathrm{kg}])+$ "
    },
    {
      "type": "table",
      "section": "TABLE 4-3. Calculating Basal Metabolic Rate Using the Schofield Equation",
      "line": 2016,
      "preview": "|  | $(1.303 \\times \\mathrm{ht}[\\mathrm{cm}])+414.9$ | $(1.618 \\times \\mathrm{ht}[\\mathrm{cm}])+371."
    },
    {
      "type": "table",
      "section": "TABLE 4-3. Calculating Basal Metabolic Rate Using the Schofield Equation",
      "line": 2017,
      "preview": "| $10-18$ | $(16.25 \\times \\mathrm{wt}[\\mathrm{kg}])+$ | $(8.365 \\times \\mathrm{wt}[\\mathrm{kg}])+$ "
    },
    {
      "type": "table",
      "section": "TABLE 4-3. Calculating Basal Metabolic Rate Using the Schofield Equation",
      "line": 2018,
      "preview": "|  | $(1.372 \\times \\mathrm{ht}[\\mathrm{cm}])+515.5$ | $(4.65 \\times \\mathrm{ht}[\\mathrm{cm}])+200$ "
    },
    {
      "type": "table",
      "section": "TABLE 4-3. Calculating Basal Metabolic Rate Using the Schofield Equation",
      "line": 2019,
      "preview": "| $>18$ | $(15.057 \\times \\mathrm{wt}[\\mathrm{kg}])+$ | $(13.623 \\times \\mathrm{wt}[\\mathrm{kg}])+$ "
    },
    {
      "type": "table",
      "section": "TABLE 4-3. Calculating Basal Metabolic Rate Using the Schofield Equation",
      "line": 2020,
      "preview": "|  | $(1.0004 \\times \\mathrm{ht}[\\mathrm{cm}])+705.8$ | $(23.8 \\times \\mathrm{ht}[\\mathrm{cm}])+98.2"
    },
    {
      "type": "text",
      "section": "TABLE 4-3. Calculating Basal Metabolic Rate Using the Schofield Equation",
      "line": 2022,
      "preview": "Abbreviations: ht, height; wt, weight."
    },
    {
      "type": "text",
      "section": "TABLE 4-3. Calculating Basal Metabolic Rate Using the Schofield Equation",
      "line": 2023,
      "preview": "Data from Wagner E, Sentongo T. Assessment of nutrition status by age and determining nutrient needs"
    },
    {
      "type": "heading",
      "level": 2,
      "section": "TABLE 4-4. Calculating Resting Energy Expenditure Using the WHO Equation",
      "line": 2025
    },
    {
      "type": "table",
      "section": "TABLE 4-4. Calculating Resting Energy Expenditure Using the WHO Equation",
      "line": 2027,
      "preview": "|  | Calculations |  |"
    },
    {
      "type": "table",
      "section": "TABLE 4-4. Calculating Resting Energy Expenditure Using the WHO Equation",
      "line": 2028,
      "preview": "| :-- | :-- | :-- |"
    },
    {
      "type": "table",
      "section": "TABLE 4-4. Calculating Resting Energy Expenditure Using the WHO Equation",
      "line": 2029,
      "preview": "| Age (y) | Males | Females |"
    },
    {
      "type": "table",
      "section": "TABLE 4-4. Calculating Resting Energy Expenditure Using the WHO Equation",
      "line": 2030,
      "preview": "| $0-3$ | $(60.9 \\times \\mathrm{wt}[\\mathrm{kg}])-54$ | $(61 \\times \\mathrm{wt}[\\mathrm{kg}])-51$ |"
    },
    {
      "type": "table",
      "section": "TABLE 4-4. Calculating Resting Energy Expenditure Using the WHO Equation",
      "line": 2031,
      "preview": "| $3-10$ | $(22.7 \\times \\mathrm{wt}[\\mathrm{kg}])+495$ | $(22.5 \\times \\mathrm{wt}[\\mathrm{kg}])+49"
    },
    {
      "type": "table",
      "section": "TABLE 4-4. Calculating Resting Energy Expenditure Using the WHO Equation",
      "line": 2032,
      "preview": "| $10-18$ | $(17.5 \\times \\mathrm{wt}[\\mathrm{kg}])+651$ | $(12.2 \\times \\mathrm{wt}[\\mathrm{kg}])+7"
    },
    {
      "type": "text",
      "section": "TABLE 4-4. Calculating Resting Energy Expenditure Using the WHO Equation",
      "line": 2034,
      "preview": "Abbreviations: WHO, World Health Organization; wt, weight."
    },
    {
      "type": "text",
      "section": "TABLE 4-4. Calculating Resting Energy Expenditure Using the WHO Equation",
      "line": 2035,
      "preview": "Data from Wagner E, Sentongo T. Assessment of nutrition status by age and determining nutrient needs"
    },
    {
      "type": "text",
      "section": "TABLE 4-4. Calculating Resting Energy Expenditure Using the WHO Equation",
      "line": 2037,
      "preview": "Catch-up growth for children who are medically stable may additionally be calculated as follows:"
    },
    {
      "type": "text",
      "section": "TABLE 4-4. Calculating Resting Energy Expenditure Using the WHO Equation",
      "line": 2039,
      "preview": "--- page 106 ---"
    },
    {
      "type": "text",
      "section": "TABLE 4-4. Calculating Resting Energy Expenditure Using the WHO Equation",
      "line": 2041,
      "preview": "(Recommended dietary allowance [RDA] for age and weight in kcal/kg $\\times$ ideal body weight for he"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "Fluids",
      "line": 2043
    },
    {
      "type": "text",
      "section": "Fluids",
      "line": 2045,
      "preview": "Adequate hydration is essential for maintenance of health. The HolidaySegar method allows for calcul"
    },
    {
      "type": "heading",
      "level": 2,
      "section": "TABLE 4-5. Calculating Estimated Fluid Requirements Using the Holliday-Segar Formula",
      "line": 2047
    },
    {
      "type": "table",
      "section": "TABLE 4-5. Calculating Estimated Fluid Requirements Using the Holliday-Segar Formula",
      "line": 2049,
      "preview": "| Body Weight | Daily Fluid Requirement (Holliday-Segar) | Fluid Requirements (4:2:1 Shortcut) |"
    },
    {
      "type": "table",
      "section": "TABLE 4-5. Calculating Estimated Fluid Requirements Using the Holliday-Segar Formula",
      "line": 2050,
      "preview": "| :--: | :--: | :--: |"
    },
    {
      "type": "table",
      "section": "TABLE 4-5. Calculating Estimated Fluid Requirements Using the Holliday-Segar Formula",
      "line": 2051,
      "preview": "| $\\leq 10 \\mathrm{~kg}$ | $100 \\mathrm{~mL} / \\mathrm{kg}$ | $4 \\mathrm{~mL} / \\mathrm{kg} / \\mathr"
    },
    {
      "type": "table",
      "section": "TABLE 4-5. Calculating Estimated Fluid Requirements Using the Holliday-Segar Formula",
      "line": 2052,
      "preview": "| $>10 \\mathrm{~kg}$ to $\\leq 20 \\mathrm{~kg}$ | $\\begin{aligned} & 1000 \\mathrm{~mL}+50 \\mathrm{~mL"
    },
    {
      "type": "table",
      "section": "TABLE 4-5. Calculating Estimated Fluid Requirements Using the Holliday-Segar Formula",
      "line": 2053,
      "preview": "| $>20 \\mathrm{~kg}$ | $\\begin{aligned} & 1500 \\mathrm{~mL}+20 \\mathrm{~mL} / \\mathrm{kg} \\text { fo"
    },
    {
      "type": "text",
      "section": "TABLE 4-5. Calculating Estimated Fluid Requirements Using the Holliday-Segar Formula",
      "line": 2055,
      "preview": "Abbreviation: wt, weight."
    },
    {
      "type": "text",
      "section": "TABLE 4-5. Calculating Estimated Fluid Requirements Using the Holliday-Segar Formula",
      "line": 2056,
      "preview": "Reproduced with permission from the American Society for Parenteral and Enteral Nutrition from Schmi"
    },
    {
      "type": "text",
      "section": "TABLE 4-5. Calculating Estimated Fluid Requirements Using the Holliday-Segar Formula",
      "line": 2057,
      "preview": "${ }^{a}$ This may underestimate fluid requirements by about $5 \\%$ in young children; 5 $\\mathrm{mL"
    },
    {
      "type": "heading",
      "level": 2,
      "section": "Acid-Base Status",
      "line": 2059
    },
    {
      "type": "text",
      "section": "Acid-Base Status",
      "line": 2061,
      "preview": "Acid-base balance is maintained by the lungs, kidneys, and endogenous buffers. Acid-base disorders i"
    },
    {
      "type": "text",
      "section": "Acid-Base Status",
      "line": 2063,
      "preview": "--- page 107 ---"
    },
    {
      "type": "text",
      "section": "Acid-Base Status",
      "line": 2065,
      "preview": "metabolic or respiratory origin. Many of these imbalances may be attributed to chronic health issues"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "Vitamins and Minerals",
      "line": 2067
    },
    {
      "type": "text",
      "section": "Vitamins and Minerals",
      "line": 2069,
      "preview": "Vitamins and minerals are essential for growth and development in infants and children. Ensuring ade"
    },
    {
      "type": "text",
      "section": "Vitamins and Minerals",
      "line": 2071,
      "preview": "- Estimated average requirements (EAR): The intake value that is estimated to meet the requirement d"
    },
    {
      "type": "text",
      "section": "Vitamins and Minerals",
      "line": 2072,
      "preview": "- Recommended dietary allowance (RDA): The intake level that is sufficient to meet the nutrient requ"
    },
    {
      "type": "text",
      "section": "Vitamins and Minerals",
      "line": 2073,
      "preview": "- Adequate intake (AI): The recommended daily average intake from observed estimates that is assumed"
    },
    {
      "type": "text",
      "section": "Vitamins and Minerals",
      "line": 2074,
      "preview": "- Upper intake limit (UL): The maximum level of daily nutrient intake that is unlikely to pose risk "
    },
    {
      "type": "text",
      "section": "Vitamins and Minerals",
      "line": 2075,
      "preview": "- Daily dietary reference intake (DRI): Intake amounts based on contemporary studies that not only a"
    },
    {
      "type": "text",
      "section": "Vitamins and Minerals",
      "line": 2077,
      "preview": "See Tables 4-6 through 4-10 for vitamin and mineral references."
    },
    {
      "type": "text",
      "section": "Vitamins and Minerals",
      "line": 2079,
      "preview": "--- page 108 ---"
    },
    {
      "type": "text",
      "section": "Vitamins and Minerals",
      "line": 2081,
      "preview": "TABLE 4-6. Dietary Reference Intake for Calcium, Phosphorus, and Magnesium ${ }^{a}$"
    },
    {
      "type": "table",
      "section": "Vitamins and Minerals",
      "line": 2083,
      "preview": "| Life Stage | Calcium (mg/d) ${ }^{\\text {b }}$ | Phosphorus $(\\mathrm{mg} / \\mathrm{d})^{\\text {b "
    },
    {
      "type": "table",
      "section": "Vitamins and Minerals",
      "line": 2084,
      "preview": "| :--: | :--: | :--: | :--: |"
    },
    {
      "type": "table",
      "section": "Vitamins and Minerals",
      "line": 2085,
      "preview": "| 0-6 mo | 200 (1000) | 100 | 30 |"
    },
    {
      "type": "table",
      "section": "Vitamins and Minerals",
      "line": 2086,
      "preview": "| 7-12 mo | 260 (1000) | 275 | 75 |"
    },
    {
      "type": "table",
      "section": "Vitamins and Minerals",
      "line": 2087,
      "preview": "| 1-3 y | 700 (2500) | 460 (3000) | 80 (65) |"
    },
    {
      "type": "table",
      "section": "Vitamins and Minerals",
      "line": 2088,
      "preview": "| 4-8 y | 1000 (2500) | 500 (3000) | 130 (110) |"
    },
    {
      "type": "table",
      "section": "Vitamins and Minerals",
      "line": 2089,
      "preview": "| Males |  |  |  |"
    },
    {
      "type": "table",
      "section": "Vitamins and Minerals",
      "line": 2090,
      "preview": "| 9-13 y | 1300 (3000) | 1250 (4000) | 240 (350) |"
    },
    {
      "type": "table",
      "section": "Vitamins and Minerals",
      "line": 2091,
      "preview": "| 14-18 y | 1300 (3000) | 1250 (4000) | 410 (350) |"
    },
    {
      "type": "table",
      "section": "Vitamins and Minerals",
      "line": 2092,
      "preview": "| Females |  |  |  |"
    },
    {
      "type": "table",
      "section": "Vitamins and Minerals",
      "line": 2093,
      "preview": "| 9-13 y | 1300 (3000) | 1250 (4000) | 240 (350) |"
    },
    {
      "type": "table",
      "section": "Vitamins and Minerals",
      "line": 2094,
      "preview": "| 14-18 y | 1300 (3000) | 1250 (4000) | 360 (350) |"
    },
    {
      "type": "table",
      "section": "Vitamins and Minerals",
      "line": 2095,
      "preview": "| Pregnancy |  |  |  |"
    },
    {
      "type": "table",
      "section": "Vitamins and Minerals",
      "line": 2096,
      "preview": "| 14-18 y | 1300 (3000) | 1250 (3500) | 400 (350) |"
    },
    {
      "type": "table",
      "section": "Vitamins and Minerals",
      "line": 2097,
      "preview": "| Lactation |  |  |  |"
    },
    {
      "type": "table",
      "section": "Vitamins and Minerals",
      "line": 2098,
      "preview": "| 14-18 y | 1300 (3000) | 1250 (4000) | 360 (350) |"
    },
    {
      "type": "text",
      "section": "Vitamins and Minerals",
      "line": 2100,
      "preview": "${ }^{a}$ Adapted with permission from the American Society for Parenteral and Enteral Nutrition fro"
    },
    {
      "type": "text",
      "section": "Vitamins and Minerals",
      "line": 2101,
      "preview": "${ }^{\\text {b }}$ Tolerable upper intake level for each life stage is indicated in parenthesis. Mag"
    },
    {
      "type": "text",
      "section": "Vitamins and Minerals",
      "line": 2103,
      "preview": "--- page 109 ---"
    },
    {
      "type": "text",
      "section": "Vitamins and Minerals",
      "line": 2105,
      "preview": "TABLE 4-7. Dietary Reference Intake for Fat-Soluble Vitamins ${ }^{a}$"
    },
    {
      "type": "table",
      "section": "Vitamins and Minerals",
      "line": 2107,
      "preview": "| Life <br> Stage | Vitamin A, mg RAE (1 mg 5 $3.3 \\mathrm{IU})^{\\mathrm{b}}$ | Vitamin D, IU (1 mg "
    },
    {
      "type": "table",
      "section": "Vitamins and Minerals",
      "line": 2108,
      "preview": "| :--: | :--: | :--: | :--: | :--: |"
    },
    {
      "type": "table",
      "section": "Vitamins and Minerals",
      "line": 2109,
      "preview": "| $0-6$ mo | 400 (600) | 400 (1000) | 4 | 2.0 |"
    },
    {
      "type": "table",
      "section": "Vitamins and Minerals",
      "line": 2110,
      "preview": "| 7-12 mo | 500 (600) | 400 (1500) | 5 | 2.5 |"
    },
    {
      "type": "table",
      "section": "Vitamins and Minerals",
      "line": 2111,
      "preview": "| $1-3 y$ | 300 (600) | 600 (2500) | 6 (200) | 30 |"
    },
    {
      "type": "table",
      "section": "Vitamins and Minerals",
      "line": 2112,
      "preview": "| $4-8 y$ | 400 (900) | 600 (3000) | 7 (300) | 55 |"
    },
    {
      "type": "table",
      "section": "Vitamins and Minerals",
      "line": 2113,
      "preview": "| 9-13 y | 600 (1700) | 600 (4000) | 11 (600) | 60 |"
    },
    {
      "type": "table",
      "section": "Vitamins and Minerals",
      "line": 2114,
      "preview": "| Males |  |  |  |  |"
    },
    {
      "type": "table",
      "section": "Vitamins and Minerals",
      "line": 2115,
      "preview": "| 14-18 y | 900 (2800) | 600 (4000) | 15 (800) | 75 |"
    },
    {
      "type": "table",
      "section": "Vitamins and Minerals",
      "line": 2116,
      "preview": "| Females |  |  |  |  |"
    },
    {
      "type": "table",
      "section": "Vitamins and Minerals",
      "line": 2117,
      "preview": "| 14-18 y | 700 (2800) | 600 (4000) | 15 (800) | 75 |"
    },
    {
      "type": "table",
      "section": "Vitamins and Minerals",
      "line": 2118,
      "preview": "| Pregnancy |  |  |  |  |"
    },
    {
      "type": "table",
      "section": "Vitamins and Minerals",
      "line": 2119,
      "preview": "| 14-18 y | 750 (2800) | 600 (4000) | 15 (800) | 75 |"
    },
    {
      "type": "table",
      "section": "Vitamins and Minerals",
      "line": 2120,
      "preview": "| Lactation |  |  |  |  |"
    },
    {
      "type": "table",
      "section": "Vitamins and Minerals",
      "line": 2121,
      "preview": "| 14-18 y | 1200 (2800) | 600 (4000) | 19 (800) | 75 |"
    },
    {
      "type": "text",
      "section": "Vitamins and Minerals",
      "line": 2123,
      "preview": "Abbreviation: RAE, retinol activity equivalent."
    },
    {
      "type": "text",
      "section": "Vitamins and Minerals",
      "line": 2124,
      "preview": "${ }^{a}$ Adapted with permission from the American Society for Parenteral and Enteral Nutrition fro"
    },
    {
      "type": "text",
      "section": "Vitamins and Minerals",
      "line": 2125,
      "preview": "${ }^{\\text {b }}$ Upper limit for each life stage is indicated in parenthesis."
    },
    {
      "type": "text",
      "section": "Vitamins and Minerals",
      "line": 2127,
      "preview": "--- page 110 ---"
    },
    {
      "type": "text",
      "section": "Vitamins and Minerals",
      "line": 2129,
      "preview": "TABLE 4-8. Content per Unit Dose of Fat-Soluble Multivitamin Preparations for Use With Parenteral Nu"
    },
    {
      "type": "table",
      "section": "Vitamins and Minerals",
      "line": 2131,
      "preview": "| Ingredient | M.V.I. <br> Pediatric | Infuvite <br> Pediatric | M.V.I. Adult for Ages $\\geq 11$ y |"
    },
    {
      "type": "table",
      "section": "Vitamins and Minerals",
      "line": 2132,
      "preview": "| :--: | :--: | :--: | :--: | :--: | :--: |"
    },
    {
      "type": "table",
      "section": "Vitamins and Minerals",
      "line": 2133,
      "preview": "| Unit dose volume (mL) | 5 | 5 | 10 | 10 | 10 |"
    },
    {
      "type": "table",
      "section": "Vitamins and Minerals",
      "line": 2134,
      "preview": "| Fat-Soluble Vitamins |  |  |  |  |  |"
    },
    {
      "type": "table",
      "section": "Vitamins and Minerals",
      "line": 2135,
      "preview": "| Vitamin A (retinol; mg) | 0.7 | 0.7 | 1 | 1 | 1 |"
    },
    {
      "type": "table",
      "section": "Vitamins and Minerals",
      "line": 2136,
      "preview": "| Vitamin D (ergocalciferol, cholecalciferol; $\\mu \\mathrm{g}$ ) | 10 | 10 | 5 | 5 | 5 |"
    },
    {
      "type": "table",
      "section": "Vitamins and Minerals",
      "line": 2137,
      "preview": "| Vitamin E (DL- $\\alpha$ tocopherol acetate; mg) | 7 | 7 | 10 | 10 | 10 |"
    },
    {
      "type": "table",
      "section": "Vitamins and Minerals",
      "line": 2138,
      "preview": "| Vitamin K (phytonadione; $\\mu \\mathrm{g}$ ) | 200 | 200 | 150 | None | 150 |"
    },
    {
      "type": "table",
      "section": "Vitamins and Minerals",
      "line": 2139,
      "preview": "| Other |  |  |  |  |  |"
    },
    {
      "type": "table",
      "section": "Vitamins and Minerals",
      "line": 2140,
      "preview": "| Aluminum ( $\\mu \\mathrm{g} / \\mathrm{L}$ ) | 42 | 30 | 43-183 | 43-78 | 70 |"
    },
    {
      "type": "table",
      "section": "Vitamins and Minerals",
      "line": 2141,
      "preview": "| Polysorbate 80 (mg) | 50 | 50 | 160 | 160 | 140 |"
    },
    {
      "type": "table",
      "section": "Vitamins and Minerals",
      "line": 2142,
      "preview": "| Polysorbate 20 (mg) | 0.8 | - | 2.8 | 2.8 | - |"
    },
    {
      "type": "table",
      "section": "Vitamins and Minerals",
      "line": 2143,
      "preview": "| Propylene glycol (g) | - | - | 3 | 3 | 3 |"
    },
    {
      "type": "text",
      "section": "Vitamins and Minerals",
      "line": 2145,
      "preview": "Adapted with permission from the American Society for Parenteral and Enteral Nutrition from Koo W, S"
    },
    {
      "type": "text",
      "section": "Vitamins and Minerals",
      "line": 2147,
      "preview": "--- page 111 ---"
    },
    {
      "type": "text",
      "section": "Vitamins and Minerals",
      "line": 2149,
      "preview": "TABLE 4-9. Dietary Reference Intake of Water-Soluble Essential Micronutrients in Pediatric Populatio"
    },
    {
      "type": "table",
      "section": "Vitamins and Minerals",
      "line": 2151,
      "preview": "| Life <br> Stage | Thiamin $\\left(B_{1}\\right), \\mathrm{mg}$ | Riboflavin $\\left(B_{2}\\right), \\mat"
    },
    {
      "type": "table",
      "section": "Vitamins and Minerals",
      "line": 2152,
      "preview": "| :--: | :--: | :--: | :--: | :--: | :--: | :--: | :--: | :--: | :--: | :--: |"
    },
    {
      "type": "table",
      "section": "Vitamins and Minerals",
      "line": 2153,
      "preview": "| $0-6 m$ | 0.2 | 0.3 | 2 | 0.1 | 65 | 0.4 | 40 | 1.7 | 5 | 125 |"
    },
    {
      "type": "table",
      "section": "Vitamins and Minerals",
      "line": 2154,
      "preview": "| 7-12 m | 0.3 | 0.4 | 4 | 0.3 | 80 | 0.5 | 50 | 1.8 | 6 | 150 |"
    },
    {
      "type": "table",
      "section": "Vitamins and Minerals",
      "line": 2155,
      "preview": "| $1-3 y$ | 0.5 | 0.5 | 6 (15) | 0.5 (30) | $\\begin{aligned} & 150 \\\\ & (300) \\end{aligned}$ | 0.9 |"
    },
    {
      "type": "table",
      "section": "Vitamins and Minerals",
      "line": 2156,
      "preview": "| $4-8 y$ | 0.6 | 0.6 | 8 (20) | 0.6 (40) | $\\begin{aligned} & 200 \\\\ & (400) \\end{aligned}$ | 1.2 |"
    },
    {
      "type": "table",
      "section": "Vitamins and Minerals",
      "line": 2157,
      "preview": "| Males |  |  |  |  |  |  |  |  |  |  |"
    },
    {
      "type": "table",
      "section": "Vitamins and Minerals",
      "line": 2158,
      "preview": "| 9-13 y | 0.9 | 0.9 | 12 (20) | 1.0 (60) | $\\begin{aligned} & 300 \\\\ & (600) \\end{aligned}$ | 1.8 |"
    },
    {
      "type": "table",
      "section": "Vitamins and Minerals",
      "line": 2159,
      "preview": "| $\\begin{aligned} & 14- \\\\ & 18 \\text { y } \\end{aligned}$ | 1.2 | 1.3 | 16 (30) | 1.3 (80) | $\\beg"
    },
    {
      "type": "table",
      "section": "Vitamins and Minerals",
      "line": 2160,
      "preview": "| Females |  |  |  |  |  |  |  |  |  |  |"
    },
    {
      "type": "table",
      "section": "Vitamins and Minerals",
      "line": 2161,
      "preview": "| 9-13 y | 0.9 | 0.9 | 12 (20) | 1.0 (60) | $\\begin{aligned} & 300 \\\\ & (600) \\end{aligned}$ | 1.8 |"
    },
    {
      "type": "table",
      "section": "Vitamins and Minerals",
      "line": 2162,
      "preview": "| $\\begin{aligned} & 14-18 \\\\ & y \\end{aligned}$ | 1.0 | 1.0 | 14 (30) | 1.2 (80) | $\\begin{aligned}"
    },
    {
      "type": "table",
      "section": "Vitamins and Minerals",
      "line": 2163,
      "preview": "| Pregnancy |  |  |  |  |  |  |  |  |  |  |"
    },
    {
      "type": "table",
      "section": "Vitamins and Minerals",
      "line": 2164,
      "preview": "| $\\begin{aligned} & 14-18 \\\\ & y \\end{aligned}$ | 1.4 | 1.4 | 18 (30) | 1.9 (80) | $\\begin{aligned}"
    },
    {
      "type": "table",
      "section": "Vitamins and Minerals",
      "line": 2165,
      "preview": "| Lactation |  |  |  |  |  |  |  |  |  |  |"
    },
    {
      "type": "table",
      "section": "Vitamins and Minerals",
      "line": 2166,
      "preview": "| $\\begin{aligned} & 14-18 \\\\ & y \\end{aligned}$ | 1.4 | 1.6 | 17 (30) | 2.0 (80) | $\\begin{aligned}"
    },
    {
      "type": "table",
      "section": "Vitamins and Minerals",
      "line": 2167,
      "preview": "| $\\begin{aligned} & \\text { Highest } \\\\ & \\text { intake } \\end{aligned}$ | $\\begin{aligned} & 11 "
    },
    {
      "type": "text",
      "section": "Vitamins and Minerals",
      "line": 2169,
      "preview": "Abbreviation: NA, not available."
    },
    {
      "type": "text",
      "section": "Vitamins and Minerals",
      "line": 2170,
      "preview": "${ }^{a}$ Adapted with permission from the American Society for Parenteral and Enteral Nutrition fro"
    },
    {
      "type": "text",
      "section": "Vitamins and Minerals",
      "line": 2171,
      "preview": "${ }^{\\text {b }}$ Upper limit for each life stage is indicated in parenthesis."
    },
    {
      "type": "text",
      "section": "Vitamins and Minerals",
      "line": 2173,
      "preview": "--- page 112 ---"
    },
    {
      "type": "text",
      "section": "Vitamins and Minerals",
      "line": 2175,
      "preview": "TABLE 4-10. Daily Parenteral Water-Soluble Vitamin Recommendations for Pediatric Patients"
    },
    {
      "type": "table",
      "section": "Vitamins and Minerals",
      "line": 2177,
      "preview": "|  | Neonates <br> Preterm | Neonates <br> Term | Infants | Children |"
    },
    {
      "type": "table",
      "section": "Vitamins and Minerals",
      "line": 2178,
      "preview": "| :-- | :-- | :-- | :-- | :-- |"
    },
    {
      "type": "table",
      "section": "Vitamins and Minerals",
      "line": 2179,
      "preview": "| Thiamin <br> (vitamin $\\mathrm{B}_{1}$ ) | $200-350 \\mathrm{mcg} / \\mathrm{kg} / \\mathrm{d}$ | $1."
    },
    {
      "type": "table",
      "section": "Vitamins and Minerals",
      "line": 2180,
      "preview": "| Riboflavin <br> (vitamin $\\mathrm{B}_{2}$ ) | $150-200 \\mathrm{mcg} / \\mathrm{kg} / \\mathrm{d}$ | "
    },
    {
      "type": "table",
      "section": "Vitamins and Minerals",
      "line": 2181,
      "preview": "| Niacin <br> (vitamin $\\mathrm{B}_{3}$ ) | $4-6.8 \\mathrm{mg} / \\mathrm{kg} / \\mathrm{d}$ | $17 \\ma"
    },
    {
      "type": "table",
      "section": "Vitamins and Minerals",
      "line": 2182,
      "preview": "| Vitamin B6 | $150-200 \\mathrm{mcg} / \\mathrm{kg} / \\mathrm{d}$ | $1000 \\mathrm{mcg} / \\mathrm{d}$ "
    },
    {
      "type": "table",
      "section": "Vitamins and Minerals",
      "line": 2183,
      "preview": "| Folate <br> (vitamin B9) | $56 \\mathrm{mcg} / \\mathrm{kg} / \\mathrm{d}$ | $140 \\mathrm{mcg} / \\mat"
    },
    {
      "type": "table",
      "section": "Vitamins and Minerals",
      "line": 2184,
      "preview": "| Vitamin B12 | $0.3 \\mathrm{mcg} / \\mathrm{kg} / \\mathrm{d}$ | $1 \\mathrm{mcg} / \\mathrm{d}$ | $0.3"
    },
    {
      "type": "table",
      "section": "Vitamins and Minerals",
      "line": 2185,
      "preview": "| Vitamin C | $15-25 \\mathrm{mg} / \\mathrm{kg} / \\mathrm{d}$ | $80 \\mathrm{mg} / \\mathrm{d}$ | $15-2"
    },
    {
      "type": "table",
      "section": "Vitamins and Minerals",
      "line": 2186,
      "preview": "| Pantothenic <br> acid <br> (vitamin B5) | $1-2 \\mathrm{mg} / \\mathrm{kg} / \\mathrm{d}$ | $5 \\mathr"
    },
    {
      "type": "table",
      "section": "Vitamins and Minerals",
      "line": 2187,
      "preview": "| Biotin <br> (vitamin B7) | $5-8 \\mathrm{mcg} / \\mathrm{kg} / \\mathrm{d}$ | $20 \\mathrm{mcg} / \\mat"
    },
    {
      "type": "text",
      "section": "Vitamins and Minerals",
      "line": 2189,
      "preview": "No parenteral choline preparation."
    },
    {
      "type": "text",
      "section": "Vitamins and Minerals",
      "line": 2190,
      "preview": "Reproduced with permission from the American Society for Parenteral and Enteral Nutrition from Koo W"
    },
    {
      "type": "text",
      "section": "Vitamins and Minerals",
      "line": 2192,
      "preview": "2nd ed. American Society for Parenteral and Enteral Nutrition; 2015:72."
    },
    {
      "type": "heading",
      "level": 1,
      "section": "Nutrition Diagnosis",
      "line": 2194
    },
    {
      "type": "text",
      "section": "Nutrition Diagnosis",
      "line": 2196,
      "preview": "Ascertainment of information is critical to support an accurate and descriptive nutrition diagnosis."
    },
    {
      "type": "text",
      "section": "Nutrition Diagnosis",
      "line": 2198,
      "preview": "--- page 113 ---"
    },
    {
      "type": "text",
      "section": "Nutrition Diagnosis",
      "line": 2200,
      "preview": "gastrointestinal (GI) issues/concerns, physical activity/interests, sleep patterns, signs and sympto"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "Terminology",
      "line": 2202
    },
    {
      "type": "text",
      "section": "Terminology",
      "line": 2204,
      "preview": "In the nutrition care plan, it is important to document the presence of malnutrition, chronicity, an"
    },
    {
      "type": "text",
      "section": "Terminology",
      "line": 2206,
      "preview": "- Acute malnutrition: Present $<3$ months"
    },
    {
      "type": "text",
      "section": "Terminology",
      "line": 2207,
      "preview": "- Chronic malnutrition: Present $>3$ months"
    },
    {
      "type": "text",
      "section": "Terminology",
      "line": 2208,
      "preview": "- Illness-related malnutrition: Occurs as the result of a disease process leading to increased nutri"
    },
    {
      "type": "text",
      "section": "Terminology",
      "line": 2209,
      "preview": "- Non-illness-related malnutrition: Occurs as the result of environmental or behavioral factors that"
    },
    {
      "type": "text",
      "section": "Terminology",
      "line": 2211,
      "preview": "Chapter 1, \"Nutrition Screening and History,\" and chapter 2, \"Malnutrition,\" further discuss malnutr"
    },
    {
      "type": "heading",
      "level": 2,
      "section": "Billing and Coding",
      "line": 2213
    },
    {
      "type": "text",
      "section": "Billing and Coding",
      "line": 2215,
      "preview": "The nutrition diagnosis should reflect specific criteria to align with the billable diagnosis. ${ }^"
    },
    {
      "type": "text",
      "section": "Billing and Coding",
      "line": 2217,
      "preview": "- E44.1: Mild protein-calorie malnutrition"
    },
    {
      "type": "text",
      "section": "Billing and Coding",
      "line": 2218,
      "preview": "- E44.0: Moderate protein-calorie malnutrition"
    },
    {
      "type": "text",
      "section": "Billing and Coding",
      "line": 2219,
      "preview": "- E43: Severe protein-calorie malnutrition"
    },
    {
      "type": "heading",
      "level": 2,
      "section": "Nutrition Interventions",
      "line": 2222
    },
    {
      "type": "text",
      "section": "Nutrition Interventions",
      "line": 2224,
      "preview": "Nutrition interventions should be patient- and disease-specific with a nutrition care plan that addr"
    },
    {
      "type": "text",
      "section": "Nutrition Interventions",
      "line": 2226,
      "preview": "--- page 114 ---"
    },
    {
      "type": "text",
      "section": "Nutrition Interventions",
      "line": 2228,
      "preview": "clinical nutrition professional and team. ${ }^{1,2,6,9}$"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "Nutrition Care Plan",
      "line": 2230
    },
    {
      "type": "text",
      "section": "Nutrition Care Plan",
      "line": 2232,
      "preview": "The basic nutrition care plan for nutrition support should include the following:"
    },
    {
      "type": "text",
      "section": "Nutrition Care Plan",
      "line": 2234,
      "preview": "- Route of administration"
    },
    {
      "type": "text",
      "section": "Nutrition Care Plan",
      "line": 2235,
      "preview": "- Type of diet or formula"
    },
    {
      "type": "text",
      "section": "Nutrition Care Plan",
      "line": 2236,
      "preview": "- Schedule of administration"
    },
    {
      "type": "text",
      "section": "Nutrition Care Plan",
      "line": 2237,
      "preview": "- Starting rate, advancement plan, and target rate"
    },
    {
      "type": "text",
      "section": "Nutrition Care Plan",
      "line": 2238,
      "preview": "- Monitoring frequency"
    },
    {
      "type": "text",
      "section": "Nutrition Care Plan",
      "line": 2239,
      "preview": "- Details of nutrient goals (energy, protein, carbohydrates, fat, fluid, vitamin, and minerals as ap"
    },
    {
      "type": "text",
      "section": "Nutrition Care Plan",
      "line": 2240,
      "preview": "- Weight gain and growth targets"
    },
    {
      "type": "text",
      "section": "Nutrition Care Plan",
      "line": 2242,
      "preview": "The ASPEN Pediatric Nutrition Care Pathway guides the nutrition care professional through all steps "
    },
    {
      "type": "text",
      "section": "Nutrition Care Plan",
      "line": 2244,
      "preview": "--- page 115 ---"
    },
    {
      "type": "image",
      "section": "Nutrition Care Plan",
      "line": 2246,
      "content": "![img-7.jpeg](images/9f2f7438aacc3b5b.png)"
    },
    {
      "type": "text",
      "section": "Nutrition Care Plan",
      "line": 2248,
      "preview": "FIGURE 4-1. ASPEN Pediatric Nutrition Care Pathway (ages 1 month to 18 years). Reproduced with permi"
    },
    {
      "type": "text",
      "section": "Nutrition Care Plan",
      "line": 2250,
      "preview": "--- page 116 ---"
    },
    {
      "type": "text",
      "section": "Nutrition Care Plan",
      "line": 2252,
      "preview": "https://www.nutritioncare.org/uploadedFiles/Documents/Malnutrition/Pediatric-Nutrition-Pathway_9.14."
    },
    {
      "type": "text",
      "section": "Nutrition Care Plan",
      "line": 2254,
      "preview": "--- page 117 ---"
    },
    {
      "type": "text",
      "section": "Nutrition Care Plan",
      "line": 2256,
      "preview": "."
    },
    {
      "type": "text",
      "section": "Nutrition Care Plan",
      "line": 2258,
      "preview": "--- page 118 ---"
    },
    {
      "type": "image",
      "section": "Nutrition Care Plan",
      "line": 2260,
      "content": "![img-8.jpeg](images/5459020903f860ef.png)"
    },
    {
      "type": "text",
      "section": "Nutrition Care Plan",
      "line": 2262,
      "preview": "FIGURE 4-1. (Continued)"
    },
    {
      "type": "text",
      "section": "Nutrition Care Plan",
      "line": 2264,
      "preview": "--- page 119 ---"
    },
    {
      "type": "text",
      "section": "Nutrition Care Plan",
      "line": 2266,
      "preview": "Frequency of monitoring the nutrition care plan depends on the age and severity of malnutrition pres"
    },
    {
      "type": "text",
      "section": "Nutrition Care Plan",
      "line": 2268,
      "preview": "--- page 120 ---"
    },
    {
      "type": "text",
      "section": "Nutrition Care Plan",
      "line": 2270,
      "preview": "TABLE 4-11. Suggested Parameters to Monitor for Infants and Children Receiving EN"
    },
    {
      "type": "table",
      "section": "Nutrition Care Plan",
      "line": 2272,
      "preview": "| Parameter | Initial <br> Week | During Hospitalization | Outpatient EN Only Patient | Outpatient E"
    },
    {
      "type": "table",
      "section": "Nutrition Care Plan",
      "line": 2273,
      "preview": "| :--: | :--: | :--: | :--: | :--: |"
    },
    {
      "type": "table",
      "section": "Nutrition Care Plan",
      "line": 2274,
      "preview": "| Growth parameters |  |  |  |  |"
    },
    {
      "type": "table",
      "section": "Nutrition Care Plan",
      "line": 2275,
      "preview": "| Weight |  |  |  |  |"
    },
    {
      "type": "table",
      "section": "Nutrition Care Plan",
      "line": 2276,
      "preview": "| NICU | Daily | Daily | Weekly to monthly | Weekly |"
    },
    {
      "type": "table",
      "section": "Nutrition Care Plan",
      "line": 2277,
      "preview": "| Infants | Daily | Daily | Weekly to monthly | Weekly |"
    },
    {
      "type": "table",
      "section": "Nutrition Care Plan",
      "line": 2278,
      "preview": "| Children | Daily | Daily to twice weekly | Weekly or at clinic | Weekly |"
    },
    {
      "type": "table",
      "section": "Nutrition Care Plan",
      "line": 2279,
      "preview": "| Length |  |  |  |  |"
    },
    {
      "type": "table",
      "section": "Nutrition Care Plan",
      "line": 2280,
      "preview": "| NICU | Baseline | Weekly | Monthly or at clinic | Monthly or at clinic |"
    },
    {
      "type": "table",
      "section": "Nutrition Care Plan",
      "line": 2281,
      "preview": "| Infants | Baseline | Monthly | \u2014 | \u2014 |"
    },
    {
      "type": "table",
      "section": "Nutrition Care Plan",
      "line": 2282,
      "preview": "| Children | Baseline | Monthly | \u2014 | \u2014 |"
    },
    {
      "type": "table",
      "section": "Nutrition Care Plan",
      "line": 2283,
      "preview": "| Height (>24 mo) | Baseline | Monthly | \u2014 | \u2014 |"
    },
    {
      "type": "table",
      "section": "Nutrition Care Plan",
      "line": 2284,
      "preview": "| Head circumference (<24 mo) | Baseline | Weekly to monthly | Monthly or at clinic | Monthly or at "
    },
    {
      "type": "table",
      "section": "Nutrition Care Plan",
      "line": 2285,
      "preview": "| Weight gain | Daily to weekly | Daily to weekly | Weekly to monthly | Weekly |"
    },
    {
      "type": "table",
      "section": "Nutrition Care Plan",
      "line": 2286,
      "preview": "| Linear/OFC gain |  |  |  |  |"
    },
    {
      "type": "table",
      "section": "Nutrition Care Plan",
      "line": 2287,
      "preview": "| NICU | Weekly | Weekly | \u2014 | \u2014 |"
    },
    {
      "type": "table",
      "section": "Nutrition Care Plan",
      "line": 2288,
      "preview": "| Infants | Weekly | Weekly to monthly | Monthly | Monthly |"
    },
    {
      "type": "table",
      "section": "Nutrition Care Plan",
      "line": 2289,
      "preview": "| Intake parameters |  |  |  |  |"
    },
    {
      "type": "table",
      "section": "Nutrition Care Plan",
      "line": 2290,
      "preview": "| Intake | Daily | Weekly | Monthly | Weekly |"
    },
    {
      "type": "table",
      "section": "Nutrition Care Plan",
      "line": 2291,
      "preview": "| Calories |  |  |  |  |"
    },
    {
      "type": "table",
      "section": "Nutrition Care Plan",
      "line": 2292,
      "preview": "| Protein |  |  |  |  |"
    },
    {
      "type": "table",
      "section": "Nutrition Care Plan",
      "line": 2293,
      "preview": "| Vitamins |  |  |  |  |"
    },
    {
      "type": "table",
      "section": "Nutrition Care Plan",
      "line": 2294,
      "preview": "| Minerals |  |  |  |  |"
    },
    {
      "type": "table",
      "section": "Nutrition Care Plan",
      "line": 2295,
      "preview": "| Fluid balance |  |  |  |  |"
    },
    {
      "type": "text",
      "section": "Nutrition Care Plan",
      "line": 2297,
      "preview": "--- page 121 ---"
    },
    {
      "type": "table",
      "section": "Nutrition Care Plan",
      "line": 2299,
      "preview": "| Parameter | Initial <br> Week | During Hospitalization | Outpatient EN Only Patient | Outpatient E"
    },
    {
      "type": "table",
      "section": "Nutrition Care Plan",
      "line": 2300,
      "preview": "| :--: | :--: | :--: | :--: | :--: |"
    },
    {
      "type": "table",
      "section": "Nutrition Care Plan",
      "line": 2301,
      "preview": "| GI tolerance |  |  |  |  |"
    },
    {
      "type": "table",
      "section": "Nutrition Care Plan",
      "line": 2302,
      "preview": "| Abdominal girth | As indicated | As indicated | As indicated | As indicated |"
    },
    {
      "type": "table",
      "section": "Nutrition Care Plan",
      "line": 2303,
      "preview": "| Emesis | As reported | As reported | As reported | As reported |"
    },
    {
      "type": "table",
      "section": "Nutrition Care Plan",
      "line": 2304,
      "preview": "| Stool (volume, frequency, consistency, color) | Daily as reported | Daily as reported | Report cha"
    },
    {
      "type": "table",
      "section": "Nutrition Care Plan",
      "line": 2305,
      "preview": "| Ostomy (volume, consistency) |  |  |  |  |"
    },
    {
      "type": "table",
      "section": "Nutrition Care Plan",
      "line": 2306,
      "preview": "| Physical |  |  |  |  |"
    },
    {
      "type": "table",
      "section": "Nutrition Care Plan",
      "line": 2307,
      "preview": "| Temperature | Per nursing policy | Per nursing policy | Report when $>101^{\\circ} \\mathrm{F}\\left("
    },
    {
      "type": "table",
      "section": "Nutrition Care Plan",
      "line": 2308,
      "preview": "| Tube placement | Prior to each feeding | Before each feeding | Before each feeding | Prior to each"
    },
    {
      "type": "table",
      "section": "Nutrition Care Plan",
      "line": 2309,
      "preview": "| Tube site care | Daily | Daily | Daily | Daily |"
    },
    {
      "type": "text",
      "section": "Nutrition Care Plan",
      "line": 2311,
      "preview": "Abbreviations: EN, enteral nutrition; GI, gastrointestinal; NICU, neonatal intensive care unit; OFC,"
    },
    {
      "type": "text",
      "section": "Nutrition Care Plan",
      "line": 2312,
      "preview": "Adapted with permission from the American Society for Parenteral and Enteral Nutrition from Szeszyck"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "Route of Administration",
      "line": 2314
    },
    {
      "type": "text",
      "section": "Route of Administration",
      "line": 2316,
      "preview": "Whenever possible, the GI tract should be used. If a patient is able to take any or all oral feeds s"
    },
    {
      "type": "text",
      "section": "Route of Administration",
      "line": 2318,
      "preview": "--- page 122 ---"
    },
    {
      "type": "text",
      "section": "Route of Administration",
      "line": 2320,
      "preview": "tolerance, refeeding syndrome if applicable, changes in malnutrition status, and medical stability."
    },
    {
      "type": "text",
      "section": "Route of Administration",
      "line": 2322,
      "preview": "For cases in which oral and enteral tube feeding are not available or tolerated, parenteral feeding "
    },
    {
      "type": "heading",
      "level": 1,
      "section": "Feeding Advancement",
      "line": 2324
    },
    {
      "type": "text",
      "section": "Feeding Advancement",
      "line": 2326,
      "preview": "Initiate feeds and advance to the anticipated goal taking into consideration medical status, toleran"
    },
    {
      "type": "heading",
      "level": 2,
      "section": "Transitions",
      "line": 2328
    },
    {
      "type": "text",
      "section": "Transitions",
      "line": 2330,
      "preview": "Managing transitional feedings is the process of transitioning nutrition support from one modality t"
    },
    {
      "type": "text",
      "section": "Transitions",
      "line": 2332,
      "preview": "Parenteral Nutrition to Tube Feedings. When transitioning from PN to tube feeding, begin tapering PN"
    },
    {
      "type": "text",
      "section": "Transitions",
      "line": 2334,
      "preview": "--- page 123 ---"
    },
    {
      "type": "text",
      "section": "Transitions",
      "line": 2336,
      "preview": "Tube Feeding to Oral Intake. As oral intake increases, supplement EN to meet needs at a reduced rate"
    },
    {
      "type": "text",
      "section": "Transitions",
      "line": 2338,
      "preview": "Ways to help increase oral intake include the following:"
    },
    {
      "type": "text",
      "section": "Transitions",
      "line": 2340,
      "preview": "- Offer meals in an age-appropriate seat."
    },
    {
      "type": "text",
      "section": "Transitions",
      "line": 2341,
      "preview": "- Schedule meals and snacks to prevent grazing."
    },
    {
      "type": "text",
      "section": "Transitions",
      "line": 2342,
      "preview": "- Ensure that there are no distractions during mealtime., 1,2,6,7"
    },
    {
      "type": "text",
      "section": "Transitions",
      "line": 2343,
      "preview": "- Offer oral foods before tube feeds."
    },
    {
      "type": "text",
      "section": "Transitions",
      "line": 2344,
      "preview": "- Give tube feeds while offering oral foods."
    },
    {
      "type": "heading",
      "level": 1,
      "section": "Communication With the Patient and Family",
      "line": 2347
    },
    {
      "type": "text",
      "section": "Communication With the Patient and Family",
      "line": 2349,
      "preview": "Communication is key to improved assessment, treatment, intervention, outcomes, and continuity of ca"
    },
    {
      "type": "text",
      "section": "Communication With the Patient and Family",
      "line": 2351,
      "preview": "It is important to address barriers to communication, including the following:"
    },
    {
      "type": "text",
      "section": "Communication With the Patient and Family",
      "line": 2353,
      "preview": "- Cultural differences and beliefs"
    },
    {
      "type": "text",
      "section": "Communication With the Patient and Family",
      "line": 2354,
      "preview": "- Language"
    },
    {
      "type": "text",
      "section": "Communication With the Patient and Family",
      "line": 2355,
      "preview": "- Educational levels, including understanding of health and medical terms"
    },
    {
      "type": "text",
      "section": "Communication With the Patient and Family",
      "line": 2356,
      "preview": "- Cognitive issues, including past trauma, substance use, and neurological losses"
    },
    {
      "type": "text",
      "section": "Communication With the Patient and Family",
      "line": 2357,
      "preview": "- Religious beliefs"
    },
    {
      "type": "text",
      "section": "Communication With the Patient and Family",
      "line": 2358,
      "preview": "- Economic or family stressors"
    },
    {
      "type": "text",
      "section": "Communication With the Patient and Family",
      "line": 2359,
      "preview": "- Geography and location"
    },
    {
      "type": "text",
      "section": "Communication With the Patient and Family",
      "line": 2360,
      "preview": "- Grief"
    },
    {
      "type": "text",
      "section": "Communication With the Patient and Family",
      "line": 2361,
      "preview": "- Surrogate decision makers"
    },
    {
      "type": "text",
      "section": "Communication With the Patient and Family",
      "line": 2362,
      "preview": "- Shortages in staffing and/or supplies"
    },
    {
      "type": "text",
      "section": "Communication With the Patient and Family",
      "line": 2363,
      "preview": "- Insurance"
    },
    {
      "type": "text",
      "section": "Communication With the Patient and Family",
      "line": 2364,
      "preview": "- Any additional barriers to care. ${ }^{1,2,9}$"
    },
    {
      "type": "text",
      "section": "Communication With the Patient and Family",
      "line": 2366,
      "preview": "Taking time to address the individualized communication needs of patients and their families will ai"
    },
    {
      "type": "text",
      "section": "Communication With the Patient and Family",
      "line": 2368,
      "preview": "--- page 124 ---"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "References",
      "line": 2370
    },
    {
      "type": "text",
      "section": "References",
      "line": 2372,
      "preview": "1. Corkins MR, ed. Bobo E, Christensen ML, Larson-Nath C, Nuse Tome R, Plogsted S, associate eds.ASP"
    },
    {
      "type": "text",
      "section": "References",
      "line": 2373,
      "preview": "2. Konek S, Becker P.Pediatric Nutrition in Clinical Care. 5th ed. Jones and Barrett Learning; 2020."
    },
    {
      "type": "text",
      "section": "References",
      "line": 2374,
      "preview": "3. Table 8.10. In: Leonberg B.ADA Pocket Guide to Pediatric Nutrition Assessment. American Dietetic "
    },
    {
      "type": "text",
      "section": "References",
      "line": 2375,
      "preview": "4. Peterson KE, Washington J, Rathbun JM. Team management of failure to thrive.J Am Diet Assoc. 1984"
    },
    {
      "type": "text",
      "section": "References",
      "line": 2376,
      "preview": "5. Malone A, Carney LN, Carrera AL, Mays A, eds.ASPEN Enteral Nutrition Handbook. 2nd ed. American S"
    },
    {
      "type": "text",
      "section": "References",
      "line": 2377,
      "preview": "6. Pediatric Nutrition Dietetic Practice Group, Academy of Nutrition and Dietetics.Pediatric Nutriti"
    },
    {
      "type": "text",
      "section": "References",
      "line": 2378,
      "preview": "7. Division of Nutrition Therapy.Pediatric Nutrition Handbook. 4th ed. Cincinnati Children's Hospita"
    },
    {
      "type": "text",
      "section": "References",
      "line": 2379,
      "preview": "8. What isICD (International Classification of Diseases)? ICD codes. October 1, 2015. Accessed Febru"
    },
    {
      "type": "text",
      "section": "References",
      "line": 2380,
      "preview": "9. Kleinman RE, Greer FR, eds.Pediatric Nutrition. 8th ed. American Academy of Pediatrics; 2020."
    },
    {
      "type": "text",
      "section": "References",
      "line": 2382,
      "preview": "--- page 125 ---"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "5",
      "line": 2384
    },
    {
      "type": "heading",
      "level": 2,
      "section": "Enteral Nutrition",
      "line": 2386
    },
    {
      "type": "text",
      "section": "Enteral Nutrition",
      "line": 2388,
      "preview": "Laura Gearman, MS, RD, LD, CNSC"
    },
    {
      "type": "heading",
      "level": 2,
      "section": "Enteral Nutrition Access",
      "line": 2390
    },
    {
      "type": "text",
      "section": "Enteral Nutrition Access",
      "line": 2392,
      "preview": "Enteral nutrition (EN) support is a nutrition intervention that can provide full or partial nutritio"
    },
    {
      "type": "text",
      "section": "Enteral Nutrition Access",
      "line": 2394,
      "preview": "- Not safe or unable to feed by mouth"
    },
    {
      "type": "text",
      "section": "Enteral Nutrition Access",
      "line": 2395,
      "preview": "- Not able to eat enough by mouth"
    },
    {
      "type": "text",
      "section": "Enteral Nutrition Access",
      "line": 2396,
      "preview": "- Unable to consume special medical diet by mouth"
    },
    {
      "type": "text",
      "section": "Enteral Nutrition Access",
      "line": 2397,
      "preview": "- Adequate support for management of a short-term device not available"
    },
    {
      "type": "text",
      "section": "Enteral Nutrition Access",
      "line": 2398,
      "preview": "- Require gastric decompression ${ }^{2}$"
    },
    {
      "type": "text",
      "section": "Enteral Nutrition Access",
      "line": 2400,
      "preview": "Tables 5-1 through 5-5 further discuss EADs."
    },
    {
      "type": "text",
      "section": "Enteral Nutrition Access",
      "line": 2402,
      "preview": "--- page 126 ---"
    },
    {
      "type": "text",
      "section": "Enteral Nutrition Access",
      "line": 2404,
      "preview": "TABLE 5-1. Short-Term Devices vs Long-Term Devices: Clinical Indications, Advantages, and Disadvanta"
    },
    {
      "type": "table",
      "section": "Enteral Nutrition Access",
      "line": 2406,
      "preview": "| Enteral <br> Nutrition <br> Access <br> Device | Indications | Advantages | Disadvantages |"
    },
    {
      "type": "table",
      "section": "Enteral Nutrition Access",
      "line": 2407,
      "preview": "| :--: | :--: | :--: | :--: |"
    },
    {
      "type": "table",
      "section": "Enteral Nutrition Access",
      "line": 2408,
      "preview": "| Short-term EAD (NG, OG, NJ) | - Short duration (<12 wk) <br> - Temporary | - Can be placed at the "
    },
    {
      "type": "table",
      "section": "Enteral Nutrition Access",
      "line": 2409,
      "preview": "| Long-term EAD (gastric, GJ, jejunal) | Duration anticipated to be long term ( $>4-12 \\mathrm{wk}$ "
    },
    {
      "type": "text",
      "section": "Enteral Nutrition Access",
      "line": 2411,
      "preview": "Abbreviations: EAD, enteral access device; GJ, gastrojejunal; NG, nasogastric; NJ, nasojejunal; OG, "
    },
    {
      "type": "text",
      "section": "Enteral Nutrition Access",
      "line": 2412,
      "preview": "Adapted with permission from Ruba Abdelhadi. Copyright 2022."
    },
    {
      "type": "text",
      "section": "Enteral Nutrition Access",
      "line": 2414,
      "preview": "--- page 127 ---"
    },
    {
      "type": "text",
      "section": "Enteral Nutrition Access",
      "line": 2416,
      "preview": "TABLE 5-2. Balloon Gastrostomy Tubes vs Nonballoon Tubes: Indications, Advantages, and Disadvantages"
    },
    {
      "type": "table",
      "section": "Enteral Nutrition Access",
      "line": 2418,
      "preview": "| Enteral <br> Nutrition <br> Access <br> Device | Indications | Advantages | Disadvantages |"
    },
    {
      "type": "table",
      "section": "Enteral Nutrition Access",
      "line": 2419,
      "preview": "| :--: | :--: | :--: | :--: |"
    },
    {
      "type": "table",
      "section": "Enteral Nutrition Access",
      "line": 2420,
      "preview": "| Balloon <br> gastrostomy <br> tube | Any age | - Balloon <br> facilitates <br> bedside <br> replac"
    },
    {
      "type": "table",
      "section": "Enteral Nutrition Access",
      "line": 2421,
      "preview": "| Nonballoon <br> gastrostomy <br> tube | - Children whom the <br> balloon was noted <br> to obstruc"
    },
    {
      "type": "text",
      "section": "Enteral Nutrition Access",
      "line": 2423,
      "preview": "Adapted with permission from Ruba Abdelhadi. Copyright 2022."
    },
    {
      "type": "text",
      "section": "Enteral Nutrition Access",
      "line": 2425,
      "preview": "--- page 128 ---"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "TABLE 5-3. High-Profile Tubes vs Low-Profile Tubes: Indications, Advantages, and Disadvantages",
      "line": 2427
    },
    {
      "type": "table",
      "section": "TABLE 5-3. High-Profile Tubes vs Low-Profile Tubes: Indications, Advantages, and Disadvantages",
      "line": 2429,
      "preview": "| Enteral <br> Nutrition <br> Access <br> Device | Indications | Advantages | Disadvantages |"
    },
    {
      "type": "table",
      "section": "TABLE 5-3. High-Profile Tubes vs Low-Profile Tubes: Indications, Advantages, and Disadvantages",
      "line": 2430,
      "preview": "| :--: | :--: | :--: | :--: |"
    },
    {
      "type": "table",
      "section": "TABLE 5-3. High-Profile Tubes vs Low-Profile Tubes: Indications, Advantages, and Disadvantages",
      "line": 2431,
      "preview": "| Highprofile tube | - Anterior abdominal wall thickness $>5 \\mathrm{~cm}$ <br> - Intermittent abdom"
    },
    {
      "type": "table",
      "section": "TABLE 5-3. High-Profile Tubes vs Low-Profile Tubes: Indications, Advantages, and Disadvantages",
      "line": 2432,
      "preview": "| Lowprofile tube | - Anterior abdominal wall thickness $<5 \\mathrm{~cm}$ <br> - Any age | - Less vi"
    },
    {
      "type": "text",
      "section": "TABLE 5-3. High-Profile Tubes vs Low-Profile Tubes: Indications, Advantages, and Disadvantages",
      "line": 2434,
      "preview": "Adapted with permission from Ruba Abdelhadi. Copyright 2022."
    },
    {
      "type": "text",
      "section": "TABLE 5-3. High-Profile Tubes vs Low-Profile Tubes: Indications, Advantages, and Disadvantages",
      "line": 2436,
      "preview": "--- page 129 ---"
    },
    {
      "type": "text",
      "section": "TABLE 5-3. High-Profile Tubes vs Low-Profile Tubes: Indications, Advantages, and Disadvantages",
      "line": 2438,
      "preview": "TABLE 5-4. Gastric Tubes vs Transpyloric Tubes: Indications, Advantages, and Disadvantages"
    },
    {
      "type": "table",
      "section": "TABLE 5-3. High-Profile Tubes vs Low-Profile Tubes: Indications, Advantages, and Disadvantages",
      "line": 2440,
      "preview": "| Enteral <br> Nutrition <br> Access <br> Device | Indications | Advantages | Disadvantages |"
    },
    {
      "type": "table",
      "section": "TABLE 5-3. High-Profile Tubes vs Low-Profile Tubes: Indications, Advantages, and Disadvantages",
      "line": 2441,
      "preview": "| :--: | :--: | :--: | :--: |"
    },
    {
      "type": "table",
      "section": "TABLE 5-3. High-Profile Tubes vs Low-Profile Tubes: Indications, Advantages, and Disadvantages",
      "line": 2442,
      "preview": "| Gastric tube | Any age | Most tubes can be inserted at bedside as well as by trained caregivers | "
    },
    {
      "type": "table",
      "section": "TABLE 5-3. High-Profile Tubes vs Low-Profile Tubes: Indications, Advantages, and Disadvantages",
      "line": 2443,
      "preview": "| Transpyloric tube | - Recurrent aspiration <br> - Chronic or worsening lung disease <br> - Duodena"
    },
    {
      "type": "text",
      "section": "TABLE 5-3. High-Profile Tubes vs Low-Profile Tubes: Indications, Advantages, and Disadvantages",
      "line": 2445,
      "preview": "Adapted with permission from Ruba Abdelhadi. Copyright 2022."
    },
    {
      "type": "text",
      "section": "TABLE 5-3. High-Profile Tubes vs Low-Profile Tubes: Indications, Advantages, and Disadvantages",
      "line": 2447,
      "preview": "--- page 130 ---"
    },
    {
      "type": "text",
      "section": "TABLE 5-3. High-Profile Tubes vs Low-Profile Tubes: Indications, Advantages, and Disadvantages",
      "line": 2449,
      "preview": "TABLE 5-5. Action Plan of Tube Dislodgement Based on Type of EAD"
    },
    {
      "type": "table",
      "section": "TABLE 5-3. High-Profile Tubes vs Low-Profile Tubes: Indications, Advantages, and Disadvantages",
      "line": 2451,
      "preview": "| Dislodged <br> Tube | Intervention |"
    },
    {
      "type": "table",
      "section": "TABLE 5-3. High-Profile Tubes vs Low-Profile Tubes: Indications, Advantages, and Disadvantages",
      "line": 2452,
      "preview": "| :-- | :-- |"
    },
    {
      "type": "table",
      "section": "TABLE 5-3. High-Profile Tubes vs Low-Profile Tubes: Indications, Advantages, and Disadvantages",
      "line": 2453,
      "preview": "| Nasogastric <br> tube | Caregiver is trained to reinsert nasogastric tubes and verify placement |"
    },
    {
      "type": "table",
      "section": "TABLE 5-3. High-Profile Tubes vs Low-Profile Tubes: Indications, Advantages, and Disadvantages",
      "line": 2454,
      "preview": "| Low-profile <br> balloon <br> tube | Caregiver can reinsert the tube, but if the reinsertion faces"
    },
    {
      "type": "table",
      "section": "TABLE 5-3. High-Profile Tubes vs Low-Profile Tubes: Indications, Advantages, and Disadvantages",
      "line": 2455,
      "preview": "| Low-profile <br> nonballoon <br> tube | Caregiver should have the child seen at the hospital so th"
    },
    {
      "type": "table",
      "section": "TABLE 5-3. High-Profile Tubes vs Low-Profile Tubes: Indications, Advantages, and Disadvantages",
      "line": 2456,
      "preview": "| High-profile <br> balloon <br> tube |  |"
    },
    {
      "type": "table",
      "section": "TABLE 5-3. High-Profile Tubes vs Low-Profile Tubes: Indications, Advantages, and Disadvantages",
      "line": 2457,
      "preview": "| All <br> transpyloric <br> tubes |  |"
    },
    {
      "type": "text",
      "section": "TABLE 5-3. High-Profile Tubes vs Low-Profile Tubes: Indications, Advantages, and Disadvantages",
      "line": 2459,
      "preview": "Abbreviation: EAD, enteral access device."
    },
    {
      "type": "text",
      "section": "TABLE 5-3. High-Profile Tubes vs Low-Profile Tubes: Indications, Advantages, and Disadvantages",
      "line": 2460,
      "preview": "Adapted with permission from Ruba Abdelhadi. Copyright 2022."
    },
    {
      "type": "heading",
      "level": 1,
      "section": "Enteral Nutrition Complications",
      "line": 2462
    },
    {
      "type": "heading",
      "level": 2,
      "section": "Clogged Tubes",
      "line": 2464
    },
    {
      "type": "text",
      "section": "Clogged Tubes",
      "line": 2466,
      "preview": "Any feeding tube may become clogged; however, smaller-bore and longer EADs are most implicated. Feed"
    },
    {
      "type": "text",
      "section": "Clogged Tubes",
      "line": 2468,
      "preview": "- Provide adequate flushing with sterile water before and after administering medications."
    },
    {
      "type": "text",
      "section": "Clogged Tubes",
      "line": 2469,
      "preview": "- Avoid providing crushed medications."
    },
    {
      "type": "text",
      "section": "Clogged Tubes",
      "line": 2470,
      "preview": "- Provide scheduled flushing of jejunal tubes. ${ }^{2}$"
    },
    {
      "type": "text",
      "section": "Clogged Tubes",
      "line": 2472,
      "preview": "If a tube does become clogged, a pancreatic enzyme activated with a $650-\\mathrm{mg}$ tablet of sodi"
    },
    {
      "type": "text",
      "section": "Clogged Tubes",
      "line": 2474,
      "preview": "--- page 131 ---"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "Skin Complications",
      "line": 2476
    },
    {
      "type": "text",
      "section": "Skin Complications",
      "line": 2478,
      "preview": "Caring for the skin around an EAD is essential to maintaining skin integrity. Skin breakdown around "
    },
    {
      "type": "heading",
      "level": 2,
      "section": "Formula Selection",
      "line": 2480
    },
    {
      "type": "heading",
      "level": 2,
      "section": "Human Milk",
      "line": 2482
    },
    {
      "type": "text",
      "section": "Human Milk",
      "line": 2484,
      "preview": "Human milk is the optimal feeding choice for most infants. Mother's milk or donor human milk may be "
    },
    {
      "type": "heading",
      "level": 2,
      "section": "Human Milk Fortification",
      "line": 2486
    },
    {
      "type": "text",
      "section": "Human Milk Fortification",
      "line": 2488,
      "preview": "Human milk can be fortified for both preterm and term infants. Liquid human milk fortifiers, powdere"
    },
    {
      "type": "heading",
      "level": 2,
      "section": "Infant Formulas",
      "line": 2490
    },
    {
      "type": "text",
      "section": "Infant Formulas",
      "line": 2492,
      "preview": "Infant formulas are regulated by the US Food and Drug Administration (FDA) with specifications regar"
    },
    {
      "type": "text",
      "section": "Infant Formulas",
      "line": 2494,
      "preview": "--- page 132 ---"
    },
    {
      "type": "text",
      "section": "Infant Formulas",
      "line": 2496,
      "preview": "levels are present in the product. There are established minimal levels for 29 nutrients and maximum"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "Standard Infant Formulas",
      "line": 2498
    },
    {
      "type": "text",
      "section": "Standard Infant Formulas",
      "line": 2500,
      "preview": "Standard infant formulas have the following characteristics (see Appendix 5-2):"
    },
    {
      "type": "text",
      "section": "Standard Infant Formulas",
      "line": 2502,
      "preview": "- They are made from cow's milk and suitable for most term infants."
    },
    {
      "type": "text",
      "section": "Standard Infant Formulas",
      "line": 2503,
      "preview": "- Composition of macronutrients and micronutrients varies among manufacturers."
    },
    {
      "type": "text",
      "section": "Standard Infant Formulas",
      "line": 2504,
      "preview": "- Higher in protein and some essential nutrients than breast milk, in which these nutrients are more"
    },
    {
      "type": "text",
      "section": "Standard Infant Formulas",
      "line": 2505,
      "preview": "- Varieties include organic formulas, formulas targeted for breast milk supplementation, and formula"
    },
    {
      "type": "heading",
      "level": 2,
      "section": "Reduced-Lactose/Lactose-Free Formulas",
      "line": 2508
    },
    {
      "type": "text",
      "section": "Reduced-Lactose/Lactose-Free Formulas",
      "line": 2510,
      "preview": "Reduced-lactose and lactose-free formulas are similar to standard milkbased formulas in both macronu"
    },
    {
      "type": "heading",
      "level": 2,
      "section": "Soy-Based Formulas",
      "line": 2512
    },
    {
      "type": "text",
      "section": "Soy-Based Formulas",
      "line": 2514,
      "preview": "Soy-based formulas are fortified with iron and are lactose free. They contain higher calcium and pho"
    },
    {
      "type": "heading",
      "level": 2,
      "section": "Extensively Hydrolyzed Protein Formulas",
      "line": 2516
    },
    {
      "type": "text",
      "section": "Extensively Hydrolyzed Protein Formulas",
      "line": 2518,
      "preview": "Extensively hydrolyzed protein formulas are considered hypoallergenic and can be used for infants wi"
    },
    {
      "type": "text",
      "section": "Extensively Hydrolyzed Protein Formulas",
      "line": 2520,
      "preview": "--- page 133 ---"
    },
    {
      "type": "text",
      "section": "Extensively Hydrolyzed Protein Formulas",
      "line": 2522,
      "preview": "because of the protein content of free amino acids and small peptides. These formulas have similar m"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "Amino Acid-Based Formulas",
      "line": 2524
    },
    {
      "type": "text",
      "section": "Amino Acid-Based Formulas",
      "line": 2526,
      "preview": "Amino acid-based formulas contain free amino acids as the protein source with varying carbohydrate a"
    },
    {
      "type": "heading",
      "level": 2,
      "section": "Added Rice Starch Formulas",
      "line": 2528
    },
    {
      "type": "text",
      "section": "Added Rice Starch Formulas",
      "line": 2530,
      "preview": "Formulas with added rice starch are designed to thicken in the acidic environment of the stomach to "
    },
    {
      "type": "heading",
      "level": 2,
      "section": "Preterm Formulas",
      "line": 2532
    },
    {
      "type": "text",
      "section": "Preterm Formulas",
      "line": 2534,
      "preview": "Preterm or low birth weight formulas as well as preterm discharge formulas are discussed in chapter "
    },
    {
      "type": "heading",
      "level": 2,
      "section": "Other Infant Formulas",
      "line": 2536
    },
    {
      "type": "text",
      "section": "Other Infant Formulas",
      "line": 2538,
      "preview": "Other types of infant formulas include the following (see Appendix 5-8):"
    },
    {
      "type": "text",
      "section": "Other Infant Formulas",
      "line": 2540,
      "preview": "- Carbohydrate free: Designed for infants with carbohydrate metabolism disorders or carbohydrate mal"
    },
    {
      "type": "text",
      "section": "Other Infant Formulas",
      "line": 2541,
      "preview": "- Modified fat: Used in conditions of fat malabsorption, lymphatic disorders, chylothorax, or long-c"
    },
    {
      "type": "text",
      "section": "Other Infant Formulas",
      "line": 2542,
      "preview": "- Reduced mineral: Designed to mimic mineral content of human milk to support infants with calcium d"
    },
    {
      "type": "text",
      "section": "Other Infant Formulas",
      "line": 2544,
      "preview": "--- page 134 ---"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "European Formulas",
      "line": 2546
    },
    {
      "type": "text",
      "section": "European Formulas",
      "line": 2548,
      "preview": "European formulas for infants have several differences compared with formulas produced in the United"
    },
    {
      "type": "heading",
      "level": 2,
      "section": "Concentration",
      "line": 2550
    },
    {
      "type": "text",
      "section": "Concentration",
      "line": 2552,
      "preview": "Infants may require concentrated infant formula if their fluid volume is limited and/or energy needs"
    },
    {
      "type": "text",
      "section": "Concentration",
      "line": 2554,
      "preview": "--- page 135 ---"
    },
    {
      "type": "text",
      "section": "Concentration",
      "line": 2556,
      "preview": "TABLE 5-6. Infant Formula Powder Recipes ${ }^{a}$"
    },
    {
      "type": "table",
      "section": "Concentration",
      "line": 2558,
      "preview": "| Concentration | Powder | Water | Final Volume |"
    },
    {
      "type": "table",
      "section": "Concentration",
      "line": 2559,
      "preview": "| :-- | :--: | :--: | :--: |"
    },
    {
      "type": "table",
      "section": "Concentration",
      "line": 2560,
      "preview": "| $22 \\mathrm{cal} / \\mathrm{oz}$ | 3 scoops | 5.5 oz | 6 oz |"
    },
    {
      "type": "table",
      "section": "Concentration",
      "line": 2561,
      "preview": "| $24 \\mathrm{cal} / \\mathrm{oz}$ | 3 scoops | 5 oz | 3.5 oz |"
    },
    {
      "type": "table",
      "section": "Concentration",
      "line": 2562,
      "preview": "| $26 \\mathrm{cal} / \\mathrm{oz}$ | 2 scoops | 3 oz | 5 oz |"
    },
    {
      "type": "table",
      "section": "Concentration",
      "line": 2563,
      "preview": "| $27 \\mathrm{cal} / \\mathrm{oz}$ | 4 scoops | 6 oz | 6.5 oz |"
    },
    {
      "type": "table",
      "section": "Concentration",
      "line": 2564,
      "preview": "| $28 \\mathrm{cal} / \\mathrm{oz}$ | 3 scoops | 4 oz | 4.5 oz |"
    },
    {
      "type": "table",
      "section": "Concentration",
      "line": 2565,
      "preview": "| $30 \\mathrm{cal} / \\mathrm{oz}$ | 4 scoops | 5 oz | 5.5 oz |"
    },
    {
      "type": "text",
      "section": "Concentration",
      "line": 2567,
      "preview": "${ }^{a}$ Confirm mixing instructions for the individual formula."
    },
    {
      "type": "text",
      "section": "Concentration",
      "line": 2569,
      "preview": "TABLE 5-7. Infant Formula Concentrate Recipes ${ }^{a}$"
    },
    {
      "type": "table",
      "section": "Concentration",
      "line": 2571,
      "preview": "| Concentration | Concentrate | Water | Final Volume |"
    },
    {
      "type": "table",
      "section": "Concentration",
      "line": 2572,
      "preview": "| :-- | :--: | :--: | :--: |"
    },
    {
      "type": "table",
      "section": "Concentration",
      "line": 2573,
      "preview": "| $22 \\mathrm{cal} / \\mathrm{oz}$ | 13 oz | 11 oz | 24 oz |"
    },
    {
      "type": "table",
      "section": "Concentration",
      "line": 2574,
      "preview": "| $24 \\mathrm{cal} / \\mathrm{oz}$ | 13 oz | 9 oz | 22 oz |"
    },
    {
      "type": "table",
      "section": "Concentration",
      "line": 2575,
      "preview": "| $26 \\mathrm{cal} / \\mathrm{oz}$ | 13 oz | 7 oz | 20 oz |"
    },
    {
      "type": "table",
      "section": "Concentration",
      "line": 2576,
      "preview": "| $27 \\mathrm{cal} / \\mathrm{oz}$ | 13 oz | 6 oz | 19 oz |"
    },
    {
      "type": "table",
      "section": "Concentration",
      "line": 2577,
      "preview": "| $28 \\mathrm{cal} / \\mathrm{oz}$ | 13 oz | 5 oz | 18 oz |"
    },
    {
      "type": "table",
      "section": "Concentration",
      "line": 2578,
      "preview": "| $30 \\mathrm{cal} / \\mathrm{oz}$ | 13 oz | 4 oz | 17 oz |"
    },
    {
      "type": "text",
      "section": "Concentration",
      "line": 2580,
      "preview": "${ }^{a}$ Confirm mixing instructions for the individual formula."
    },
    {
      "type": "heading",
      "level": 1,
      "section": "Functional Ingredients",
      "line": 2582
    },
    {
      "type": "heading",
      "level": 2,
      "section": "Docosahexaenoic Acid/Arachidonic Acid",
      "line": 2584
    },
    {
      "type": "text",
      "section": "Docosahexaenoic Acid/Arachidonic Acid",
      "line": 2586,
      "preview": "DHA and ARA are long-chain polyunsaturated fatty acids that are synthesized from the dietary EFAs $\\"
    },
    {
      "type": "heading",
      "level": 2,
      "section": "Prebiotics",
      "line": 2588
    },
    {
      "type": "text",
      "section": "Prebiotics",
      "line": 2590,
      "preview": "Prebiotics are fermentable carbohydrates that are not fully digested in the small intestine and prom"
    },
    {
      "type": "text",
      "section": "Prebiotics",
      "line": 2592,
      "preview": "--- page 136 ---"
    },
    {
      "type": "text",
      "section": "Prebiotics",
      "line": 2594,
      "preview": "pathogenic bacteria. Fermentation produces short-chain fatty acids that can be used for energy by co"
    },
    {
      "type": "text",
      "section": "Prebiotics",
      "line": 2596,
      "preview": "Human milk oligosaccharides are prebiotics that may be added to infant formulas. ${ }^{8}$"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "Probiotics",
      "line": 2598
    },
    {
      "type": "text",
      "section": "Probiotics",
      "line": 2600,
      "preview": "Probiotics consist of nonpathogenic bacteria that change microflora in the intestine and may promote"
    },
    {
      "type": "heading",
      "level": 2,
      "section": "Synbiotics",
      "line": 2602
    },
    {
      "type": "text",
      "section": "Synbiotics",
      "line": 2604,
      "preview": "Synbiotics are a combination of both probiotics and prebiotics. They may be beneficial, but more stu"
    },
    {
      "type": "heading",
      "level": 2,
      "section": "Postbiotics",
      "line": 2606
    },
    {
      "type": "text",
      "section": "Postbiotics",
      "line": 2608,
      "preview": "Postbiotics consist of inactivated microbial cells with demonstrated health benefits. They are more "
    },
    {
      "type": "text",
      "section": "Postbiotics",
      "line": 2610,
      "preview": "Formulas fermented withBifidobacterium breve C50 andStreptococcus thermophilus are available in some"
    },
    {
      "type": "heading",
      "level": 2,
      "section": "Human Milk Oligosaccharides",
      "line": 2612
    },
    {
      "type": "text",
      "section": "Human Milk Oligosaccharides",
      "line": 2614,
      "preview": "More than 100 human milk oligosaccharides (HMOs) have been identified in human milk. They are the th"
    },
    {
      "type": "text",
      "section": "Human Milk Oligosaccharides",
      "line": 2616,
      "preview": "--- page 137 ---"
    },
    {
      "type": "text",
      "section": "Human Milk Oligosaccharides",
      "line": 2618,
      "preview": "is the most abundant HMO in most human milk analyzed. The HMO 2'FL is thought to act as a prebiotic "
    },
    {
      "type": "text",
      "section": "Human Milk Oligosaccharides",
      "line": 2620,
      "preview": "Lacto- N -neotetraose is a tetra-saccharide also added to infant formulas. ${ }^{8}$"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "Pediatric Formulas",
      "line": 2622
    },
    {
      "type": "text",
      "section": "Pediatric Formulas",
      "line": 2624,
      "preview": "Pediatric enteral product options continue to increase as alternative formulas for specific disease "
    },
    {
      "type": "heading",
      "level": 2,
      "section": "Oral Supplements",
      "line": 2626
    },
    {
      "type": "text",
      "section": "Oral Supplements",
      "line": 2628,
      "preview": "Oral supplements are intended to supplement insufficient oral diets and may not be appropriate for s"
    },
    {
      "type": "heading",
      "level": 2,
      "section": "Pediatric Elemental Enteral Formulas",
      "line": 2630
    },
    {
      "type": "text",
      "section": "Pediatric Elemental Enteral Formulas",
      "line": 2632,
      "preview": "Pediatric elemental enteral formulas are the sole-source nutrition indicated for malabsorption or mu"
    },
    {
      "type": "heading",
      "level": 2,
      "section": "Pediatric Semi-Elemental/Hydrolysate Enteral Formulas",
      "line": 2634
    },
    {
      "type": "text",
      "section": "Pediatric Semi-Elemental/Hydrolysate Enteral Formulas",
      "line": 2636,
      "preview": "Pediatric semi-elemental/hydrolysate enteral formulas are the sole-source nutrition designed for mal"
    },
    {
      "type": "text",
      "section": "Pediatric Semi-Elemental/Hydrolysate Enteral Formulas",
      "line": 2638,
      "preview": "- Protein content of peptides derived from hydrolyzed whey or soy protein"
    },
    {
      "type": "text",
      "section": "Pediatric Semi-Elemental/Hydrolysate Enteral Formulas",
      "line": 2640,
      "preview": "--- page 138 ---"
    },
    {
      "type": "text",
      "section": "Pediatric Semi-Elemental/Hydrolysate Enteral Formulas",
      "line": 2642,
      "preview": "- Higher amount of fat from medium-chain triglycerides (MCTs) than polymeric formula"
    },
    {
      "type": "text",
      "section": "Pediatric Semi-Elemental/Hydrolysate Enteral Formulas",
      "line": 2643,
      "preview": "- Available in $1 \\mathrm{kcal} / \\mathrm{mL}$ and $1.5 \\mathrm{kcal} / \\mathrm{mL}$"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "Pediatric Polymeric Complete Enteral Formulas",
      "line": 2646
    },
    {
      "type": "text",
      "section": "Pediatric Polymeric Complete Enteral Formulas",
      "line": 2648,
      "preview": "Pediatric polymeric complete enteral formulas are sole-source nutrition indicated for tube feeding f"
    },
    {
      "type": "text",
      "section": "Pediatric Polymeric Complete Enteral Formulas",
      "line": 2650,
      "preview": "- May be flavored or unflavored"
    },
    {
      "type": "text",
      "section": "Pediatric Polymeric Complete Enteral Formulas",
      "line": 2651,
      "preview": "- Milk-based, lactose-free, soy, and pea protein option"
    },
    {
      "type": "text",
      "section": "Pediatric Polymeric Complete Enteral Formulas",
      "line": 2652,
      "preview": "- Available with and without fiber"
    },
    {
      "type": "text",
      "section": "Pediatric Polymeric Complete Enteral Formulas",
      "line": 2653,
      "preview": "- Caloric densities: $0.67 \\mathrm{kcal} / \\mathrm{mL}, 1 \\mathrm{kcal} / \\mathrm{mL}, 1.5 \\mathrm{k"
    },
    {
      "type": "heading",
      "level": 2,
      "section": "Pediatric Whole Food-Based Enteral Formulas",
      "line": 2656
    },
    {
      "type": "text",
      "section": "Pediatric Whole Food-Based Enteral Formulas",
      "line": 2658,
      "preview": "Some pediatric whole food-based enteral formula varieties are tailored to sole-source nutrition, whe"
    },
    {
      "type": "text",
      "section": "Pediatric Whole Food-Based Enteral Formulas",
      "line": 2660,
      "preview": "- The protein source may be plant or meat based."
    },
    {
      "type": "text",
      "section": "Pediatric Whole Food-Based Enteral Formulas",
      "line": 2661,
      "preview": "- They differ in caloric densities: 1.1 to $1.4 \\mathrm{kcal} / \\mathrm{mL}$"
    },
    {
      "type": "text",
      "section": "Pediatric Whole Food-Based Enteral Formulas",
      "line": 2662,
      "preview": "- They may need to be diluted to be thin enough to be safely and effectively administered."
    },
    {
      "type": "heading",
      "level": 2,
      "section": "Other Specialized Pediatric Enteral Formulas",
      "line": 2665
    },
    {
      "type": "text",
      "section": "Other Specialized Pediatric Enteral Formulas",
      "line": 2667,
      "preview": "For other specialized pediatric enteral formulas, consider the following:"
    },
    {
      "type": "text",
      "section": "Other Specialized Pediatric Enteral Formulas",
      "line": 2669,
      "preview": "- Ketogenic: Ratios of 3:1 and 4:1 available in standard protein or semi-elemental varieties (see ch"
    },
    {
      "type": "text",
      "section": "Other Specialized Pediatric Enteral Formulas",
      "line": 2670,
      "preview": "- Altered fat content: Increased MCTs and low long-chain triglycerides (LCTs)"
    },
    {
      "type": "text",
      "section": "Other Specialized Pediatric Enteral Formulas",
      "line": 2671,
      "preview": "- Renal disease: Liquid and powdered formulas available (see chapter 19, \"Renal Disease\")"
    },
    {
      "type": "text",
      "section": "Other Specialized Pediatric Enteral Formulas",
      "line": 2672,
      "preview": "- Metabolic diseases: Modified amino acid content, altered fat content, and protein-free formulas (s"
    },
    {
      "type": "heading",
      "level": 2,
      "section": "Adult Formula",
      "line": 2675
    },
    {
      "type": "text",
      "section": "Adult Formula",
      "line": 2677,
      "preview": "Adult formulas may be indicated for use in pediatric patients with increased protein needs because o"
    },
    {
      "type": "text",
      "section": "Adult Formula",
      "line": 2679,
      "preview": "--- page 139 ---"
    },
    {
      "type": "text",
      "section": "Adult Formula",
      "line": 2681,
      "preview": "micronutrient content. When adult formulas are used in pediatric patients, total micronutrient intak"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "Modular Macronutrients",
      "line": 2683
    },
    {
      "type": "text",
      "section": "Modular Macronutrients",
      "line": 2685,
      "preview": "Modulars can be used to increase the calorie, protein, and/or fat content of formula."
    },
    {
      "type": "text",
      "section": "Modular Macronutrients",
      "line": 2687,
      "preview": "- Protein:"
    },
    {
      "type": "text",
      "section": "Modular Macronutrients",
      "line": 2688,
      "preview": "- Liquid or powder"
    },
    {
      "type": "text",
      "section": "Modular Macronutrients",
      "line": 2689,
      "preview": "- Intact or extensively hydrolyzed"
    },
    {
      "type": "text",
      "section": "Modular Macronutrients",
      "line": 2690,
      "preview": "- Pureed baby food meats"
    },
    {
      "type": "text",
      "section": "Modular Macronutrients",
      "line": 2691,
      "preview": "- May alter osmolarity of formula significantly"
    },
    {
      "type": "text",
      "section": "Modular Macronutrients",
      "line": 2692,
      "preview": "- Carbohydrate:"
    },
    {
      "type": "text",
      "section": "Modular Macronutrients",
      "line": 2693,
      "preview": "- Liquid or powder"
    },
    {
      "type": "text",
      "section": "Modular Macronutrients",
      "line": 2694,
      "preview": "- Table sugar, juice, corn starch"
    },
    {
      "type": "text",
      "section": "Modular Macronutrients",
      "line": 2695,
      "preview": "- May significantly alter osmolarity of formula"
    },
    {
      "type": "text",
      "section": "Modular Macronutrients",
      "line": 2696,
      "preview": "- Fat:"
    },
    {
      "type": "text",
      "section": "Modular Macronutrients",
      "line": 2697,
      "preview": "- MCTs or LCTs"
    },
    {
      "type": "text",
      "section": "Modular Macronutrients",
      "line": 2699,
      "preview": "Combination products with varying contents of carbohydrate, protein, or fat available"
    },
    {
      "type": "heading",
      "level": 2,
      "section": "Formula Safety",
      "line": 2701
    },
    {
      "type": "text",
      "section": "Formula Safety",
      "line": 2703,
      "preview": "Enteral formulas are shelf stable. Once the container is opened, it can be covered and stored for 24"
    },
    {
      "type": "heading",
      "level": 2,
      "section": "Recommended Hang Time",
      "line": 2705
    },
    {
      "type": "text",
      "section": "Recommended Hang Time",
      "line": 2707,
      "preview": "Recommended hang times for enteral formulas are as follows:"
    },
    {
      "type": "text",
      "section": "Recommended Hang Time",
      "line": 2709,
      "preview": "- Formula from powder, formula with additives, and human milk: 4 hours"
    },
    {
      "type": "text",
      "section": "Recommended Hang Time",
      "line": 2710,
      "preview": "- Sterile, ready-to-feed formula: 8 hours"
    },
    {
      "type": "text",
      "section": "Recommended Hang Time",
      "line": 2711,
      "preview": "- Closed system: 24 hours"
    },
    {
      "type": "text",
      "section": "Recommended Hang Time",
      "line": 2712,
      "preview": "- Home blended: 2 hours ${ }^{11}$"
    },
    {
      "type": "text",
      "section": "Recommended Hang Time",
      "line": 2714,
      "preview": "--- page 140 ---"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "Administration",
      "line": 2716
    },
    {
      "type": "heading",
      "level": 2,
      "section": "Bolus Feeds",
      "line": 2718
    },
    {
      "type": "text",
      "section": "Bolus Feeds",
      "line": 2720,
      "preview": "Bolus feeds can only be administered into the stomach via a nasogastric (NG) tube or gastrostomy tub"
    },
    {
      "type": "heading",
      "level": 2,
      "section": "Gravity Feeds",
      "line": 2722
    },
    {
      "type": "text",
      "section": "Gravity Feeds",
      "line": 2724,
      "preview": "In gravity feeds formula is placed into a feeding syringe and allowed to flow into the tube."
    },
    {
      "type": "text",
      "section": "Gravity Feeds",
      "line": 2726,
      "preview": "- Minimal equipment is required."
    },
    {
      "type": "text",
      "section": "Gravity Feeds",
      "line": 2727,
      "preview": "- The rate of administration can be changed by how far the feeding is from the patient. Holding the "
    },
    {
      "type": "heading",
      "level": 2,
      "section": "Syringe Feeds",
      "line": 2730
    },
    {
      "type": "text",
      "section": "Syringe Feeds",
      "line": 2732,
      "preview": "In syringe feeds, formula is put into the feeding syringe, and a plunger is used to administer the f"
    },
    {
      "type": "text",
      "section": "Syringe Feeds",
      "line": 2734,
      "preview": "- The rate of administration can be controlled."
    },
    {
      "type": "text",
      "section": "Syringe Feeds",
      "line": 2735,
      "preview": "- Syringe feeds may be required for the administration of blended tube feeds because of the viscosit"
    },
    {
      "type": "heading",
      "level": 2,
      "section": "Pump-Assisted Feeds",
      "line": 2738
    },
    {
      "type": "text",
      "section": "Pump-Assisted Feeds",
      "line": 2740,
      "preview": "Pump-assisted feeds require a pump, pole, and necessary supplies."
    },
    {
      "type": "text",
      "section": "Pump-Assisted Feeds",
      "line": 2742,
      "preview": "- Required for jejunal feedings"
    },
    {
      "type": "text",
      "section": "Pump-Assisted Feeds",
      "line": 2743,
      "preview": "- More options for feeding rate and duration"
    },
    {
      "type": "heading",
      "level": 2,
      "section": "Continuous Feeds",
      "line": 2746
    },
    {
      "type": "text",
      "section": "Continuous Feeds",
      "line": 2748,
      "preview": "Continuous feeds require a feeding pump and can be administered in the stomach or small intestine. I"
    },
    {
      "type": "text",
      "section": "Continuous Feeds",
      "line": 2750,
      "preview": "--- page 141 ---"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "Initiation of Formula",
      "line": 2752
    },
    {
      "type": "text",
      "section": "Initiation of Formula",
      "line": 2754,
      "preview": "EN schedules and delivery methods are patient dependent and should be adjusted based on tolerance of"
    },
    {
      "type": "heading",
      "level": 2,
      "section": "TABLE 5-8. Initiation, Advancement, and Proposed Goal Volumes of Enteral Feedings",
      "line": 2756
    },
    {
      "type": "table",
      "section": "TABLE 5-8. Initiation, Advancement, and Proposed Goal Volumes of Enteral Feedings",
      "line": 2758,
      "preview": "| Age | Continuous Feeds |  |  | Bolus Feeds |  |  |"
    },
    {
      "type": "table",
      "section": "TABLE 5-8. Initiation, Advancement, and Proposed Goal Volumes of Enteral Feedings",
      "line": 2759,
      "preview": "| :--: | :--: | :--: | :--: | :--: | :--: | :--: |"
    },
    {
      "type": "table",
      "section": "TABLE 5-8. Initiation, Advancement, and Proposed Goal Volumes of Enteral Feedings",
      "line": 2760,
      "preview": "|  | Initiation | Advancement | Goal Volume | Initiation | Advancement | Goal Volume |"
    },
    {
      "type": "table",
      "section": "TABLE 5-8. Initiation, Advancement, and Proposed Goal Volumes of Enteral Feedings",
      "line": 2761,
      "preview": "| $\\begin{aligned} & 0- \\\\ & 12 \\\\ & \\text { mo } \\end{aligned}$ | $\\begin{aligned} & 1-2 \\\\ & \\math"
    },
    {
      "type": "table",
      "section": "TABLE 5-8. Initiation, Advancement, and Proposed Goal Volumes of Enteral Feedings",
      "line": 2762,
      "preview": "| $\\begin{aligned} & 1-6 \\\\ & y \\end{aligned}$ | $\\begin{aligned} & 1 \\\\ & \\mathrm{~mL} / \\mathrm{kg"
    },
    {
      "type": "table",
      "section": "TABLE 5-8. Initiation, Advancement, and Proposed Goal Volumes of Enteral Feedings",
      "line": 2763,
      "preview": "| $>7$ y | $25 \\mathrm{~mL} / \\mathrm{h}$ | $\\begin{aligned} & 25 \\mathrm{~mL} \\text { every } \\\\ & "
    },
    {
      "type": "text",
      "section": "TABLE 5-8. Initiation, Advancement, and Proposed Goal Volumes of Enteral Feedings",
      "line": 2765,
      "preview": "Data from Yi DY. Enteral nutrition in pediatric patients. Pediatr Gastroenterol Hepatol Nutr. 2018;2"
    },
    {
      "type": "heading",
      "level": 2,
      "section": "Tolerance of Formula",
      "line": 2767
    },
    {
      "type": "text",
      "section": "Tolerance of Formula",
      "line": 2769,
      "preview": "Diarrhea, constipation, delayed gastric emptying, and vomiting may all be signs of formula intoleran"
    },
    {
      "type": "text",
      "section": "Tolerance of Formula",
      "line": 2771,
      "preview": "--- page 142 ---"
    },
    {
      "type": "text",
      "section": "Tolerance of Formula",
      "line": 2773,
      "preview": "causes and interventions to improve the symptoms. See Table 5-9 for common interventions for symptom"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "TABLE 5-9. Common Enteral Nutrition-Related Complications and Interventions",
      "line": 2775
    },
    {
      "type": "table",
      "section": "TABLE 5-9. Common Enteral Nutrition-Related Complications and Interventions",
      "line": 2777,
      "preview": "| Problem | Potential Interventions |"
    },
    {
      "type": "table",
      "section": "TABLE 5-9. Common Enteral Nutrition-Related Complications and Interventions",
      "line": 2778,
      "preview": "| :--: | :--: |"
    },
    {
      "type": "table",
      "section": "TABLE 5-9. Common Enteral Nutrition-Related Complications and Interventions",
      "line": 2779,
      "preview": "| Constipation | - Evaluate fluid intake to ensure meeting goals <br> - Change to formula with fiber"
    },
    {
      "type": "table",
      "section": "TABLE 5-9. Common Enteral Nutrition-Related Complications and Interventions",
      "line": 2780,
      "preview": "| Delayed gastric emptying | - Position patient upright <br> - Change to lower fat formula <br> - De"
    },
    {
      "type": "table",
      "section": "TABLE 5-9. Common Enteral Nutrition-Related Complications and Interventions",
      "line": 2781,
      "preview": "| Diarrhea | - Look at medications that may be causing diarrhea (especially liquid medications that "
    },
    {
      "type": "table",
      "section": "TABLE 5-9. Common Enteral Nutrition-Related Complications and Interventions",
      "line": 2782,
      "preview": "| Nausea/vomiting | - Position patient upright or elevate head of bed <br> - Provide room-temperatur"
    },
    {
      "type": "text",
      "section": "TABLE 5-9. Common Enteral Nutrition-Related Complications and Interventions",
      "line": 2784,
      "preview": "Data from Singhal S, Baker SS, Bojczuk GA, Baker RD. Tube feeding in children. Pediatr Rev. 2017;38("
    },
    {
      "type": "text",
      "section": "TABLE 5-9. Common Enteral Nutrition-Related Complications and Interventions",
      "line": 2786,
      "preview": "Changes in tolerance of formula may also indicate acute illness or changes in chronic illness manage"
    },
    {
      "type": "text",
      "section": "TABLE 5-9. Common Enteral Nutrition-Related Complications and Interventions",
      "line": 2788,
      "preview": "--- page 143 ---"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "Nutrition-Focused Physical Examination Related to Enteral Nutrition",
      "line": 2790
    },
    {
      "type": "text",
      "section": "Nutrition-Focused Physical Examination Related to Enteral Nutrition",
      "line": 2792,
      "preview": "Nutrition-focused physical examination (NFPE) is an important tool for clinicians' evaluation of pat"
    },
    {
      "type": "text",
      "section": "Nutrition-Focused Physical Examination Related to Enteral Nutrition",
      "line": 2794,
      "preview": "For infants and children without known malabsorption issues who are receiving adequate volumes of fo"
    },
    {
      "type": "text",
      "section": "Nutrition-Focused Physical Examination Related to Enteral Nutrition",
      "line": 2796,
      "preview": "- Volume of feeds not adequate to meet minimum micronutrient requirements for age without additional"
    },
    {
      "type": "text",
      "section": "Nutrition-Focused Physical Examination Related to Enteral Nutrition",
      "line": 2797,
      "preview": "- Use of home-blended tube feeds, formulas that are not FDA regulated, or formulas that do not have "
    },
    {
      "type": "text",
      "section": "Nutrition-Focused Physical Examination Related to Enteral Nutrition",
      "line": 2798,
      "preview": "- Enteral regimens with low provisions of any macronutrients (low fat, low carbohydrate, low protein"
    },
    {
      "type": "text",
      "section": "Nutrition-Focused Physical Examination Related to Enteral Nutrition",
      "line": 2799,
      "preview": "- Known malabsorptive condition or chronic GI losses"
    },
    {
      "type": "text",
      "section": "Nutrition-Focused Physical Examination Related to Enteral Nutrition",
      "line": 2800,
      "preview": "- Receiving micronutrient supplementation or other dietary supplements"
    },
    {
      "type": "text",
      "section": "Nutrition-Focused Physical Examination Related to Enteral Nutrition",
      "line": 2801,
      "preview": "- Patients with unknown or inconsistent total intakes of enteral formula"
    },
    {
      "type": "text",
      "section": "Nutrition-Focused Physical Examination Related to Enteral Nutrition",
      "line": 2802,
      "preview": "- Partial enteral feeds with oral or parenteral nutrition intakes"
    },
    {
      "type": "text",
      "section": "Nutrition-Focused Physical Examination Related to Enteral Nutrition",
      "line": 2804,
      "preview": "See chapter 1, \"Nutrition Screening and History,\" Table 1-12 for physical examination findings assoc"
    },
    {
      "type": "heading",
      "level": 2,
      "section": "Medication Administration",
      "line": 2806
    },
    {
      "type": "text",
      "section": "Medication Administration",
      "line": 2808,
      "preview": "Consider the following for medication administration in patients receiving EN:"
    },
    {
      "type": "text",
      "section": "Medication Administration",
      "line": 2810,
      "preview": "--- page 144 ---"
    },
    {
      "type": "text",
      "section": "Medication Administration",
      "line": 2812,
      "preview": "- Site, size, and type of feeding tube"
    },
    {
      "type": "text",
      "section": "Medication Administration",
      "line": 2813,
      "preview": "- Formulation of medication"
    },
    {
      "type": "text",
      "section": "Medication Administration",
      "line": 2814,
      "preview": "- Drug-nutrient interactions"
    },
    {
      "type": "text",
      "section": "Medication Administration",
      "line": 2815,
      "preview": "- Safety"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "Feeding Tube Sites",
      "line": 2818
    },
    {
      "type": "heading",
      "level": 2,
      "section": "Gastric Access",
      "line": 2820
    },
    {
      "type": "text",
      "section": "Gastric Access",
      "line": 2822,
      "preview": "Gastric access is the preferred administration site if a patient is unable to take medication orally"
    },
    {
      "type": "text",
      "section": "Gastric Access",
      "line": 2824,
      "preview": "- The stomach is more tolerant of hypertonic medications than the jejunum."
    },
    {
      "type": "text",
      "section": "Gastric Access",
      "line": 2825,
      "preview": "- A bolus feeding schedule may be used, allowing medication and feeds to be separated for fewer conc"
    },
    {
      "type": "text",
      "section": "Gastric Access",
      "line": 2826,
      "preview": "- EN should be held 30 minutes before and after administration of ketoconazole, penicillin, and tetr"
    },
    {
      "type": "heading",
      "level": 2,
      "section": "Jejunal Access",
      "line": 2829
    },
    {
      "type": "text",
      "section": "Jejunal Access",
      "line": 2831,
      "preview": "The following are considerations for jejunal access:"
    },
    {
      "type": "text",
      "section": "Jejunal Access",
      "line": 2833,
      "preview": "- Hypertonic medications should be diluted with $10-30 \\mathrm{~mL}$ of sterile water before adminis"
    },
    {
      "type": "text",
      "section": "Jejunal Access",
      "line": 2834,
      "preview": "- Medications with minimal effects if not administered into the stomach include calcium carbonate, s"
    },
    {
      "type": "text",
      "section": "Jejunal Access",
      "line": 2835,
      "preview": "- There is decreased bioavailability if ketoconazole and itraconazole are not administered into the "
    },
    {
      "type": "text",
      "section": "Jejunal Access",
      "line": 2836,
      "preview": "- Some medications may have increased absorption and greater systemic effects when administered into"
    },
    {
      "type": "text",
      "section": "Jejunal Access",
      "line": 2837,
      "preview": "- There is decreased bioavailability of iron, warfarin, and tacrolimus if administered into the jeju"
    },
    {
      "type": "heading",
      "level": 2,
      "section": "Medication Formulation",
      "line": 2840
    },
    {
      "type": "heading",
      "level": 2,
      "section": "Liquid Preparations",
      "line": 2842
    },
    {
      "type": "text",
      "section": "Liquid Preparations",
      "line": 2844,
      "preview": "The preferred method of administering medications via enteral tubes in most scenarios is by using a "
    },
    {
      "type": "text",
      "section": "Liquid Preparations",
      "line": 2846,
      "preview": "--- page 145 ---"
    },
    {
      "type": "text",
      "section": "Liquid Preparations",
      "line": 2848,
      "preview": "TABLE 5-10. Liquid Medication Preparation"
    },
    {
      "type": "table",
      "section": "Liquid Preparations",
      "line": 2850,
      "preview": "| Advantages | Disadvantages |"
    },
    {
      "type": "table",
      "section": "Liquid Preparations",
      "line": 2851,
      "preview": "| :-- | :-- |"
    },
    {
      "type": "table",
      "section": "Liquid Preparations",
      "line": 2852,
      "preview": "| Less likely to cause to <br> cause tube occlusions | Syrups may cause clumping when exposed to for"
    },
    {
      "type": "table",
      "section": "Liquid Preparations",
      "line": 2853,
      "preview": "| Readily absorbed | Large volumes may be needed for older children or adult <br> patients, especial"
    },
    {
      "type": "table",
      "section": "Liquid Preparations",
      "line": 2854,
      "preview": "| Less preparation <br> required. <br> a | May be hyperosmolar or contain sorbitol leading to GI <br"
    },
    {
      "type": "text",
      "section": "Liquid Preparations",
      "line": 2856,
      "preview": "Abbreviation: GI, gastrointestinal."
    },
    {
      "type": "text",
      "section": "Liquid Preparations",
      "line": 2857,
      "preview": "${ }^{a}$ Williams NT. Medication administration through enteral feeding tubes. Am J Health Syst Pha"
    },
    {
      "type": "text",
      "section": "Liquid Preparations",
      "line": 2858,
      "preview": "${ }^{\\text {b }}$ Bayraktar Ekincioglu A, Demirkan K. Clinical nutrition and drug interactions. Ulu"
    },
    {
      "type": "text",
      "section": "Liquid Preparations",
      "line": 2859,
      "preview": "${ }^{c}$ Bankhead R, Boullata J, Brantley S, et al; A.S.P.E.N. Board of Directors. A.S.P.E.N. enter"
    },
    {
      "type": "text",
      "section": "Liquid Preparations",
      "line": 2861,
      "preview": "If a liquid preparation is not available or inappropriate with enteral feedings, certain solid-dose "
    },
    {
      "type": "heading",
      "level": 1,
      "section": "Tablets",
      "line": 2863
    },
    {
      "type": "text",
      "section": "Tablets",
      "line": 2865,
      "preview": "Medications that are immediate release and sugar or film coated may be crushed with minimal pharmaco"
    },
    {
      "type": "heading",
      "level": 2,
      "section": "Capsules",
      "line": 2867
    },
    {
      "type": "text",
      "section": "Capsules",
      "line": 2869,
      "preview": "Hard gelatin capsules may be opened and the contents diluted in 10-15 mL of water to make a slurry f"
    },
    {
      "type": "text",
      "section": "Capsules",
      "line": 2871,
      "preview": "--- page 146 ---"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "Dose Forms Not Appropriate for Enteral Administration",
      "line": 2873
    },
    {
      "type": "text",
      "section": "Dose Forms Not Appropriate for Enteral Administration",
      "line": 2875,
      "preview": "Dose forms not appropriate for enteral administration include the following:"
    },
    {
      "type": "text",
      "section": "Dose Forms Not Appropriate for Enteral Administration",
      "line": 2877,
      "preview": "- Enteric-coated products should not be crushed because it may cause adverse effects in the stomach,"
    },
    {
      "type": "text",
      "section": "Dose Forms Not Appropriate for Enteral Administration",
      "line": 2878,
      "preview": "- Buccal or sublingual preparations should not be administered via EADs because they are not designe"
    },
    {
      "type": "text",
      "section": "Dose Forms Not Appropriate for Enteral Administration",
      "line": 2879,
      "preview": "- Medications with carcinogenic, teratogenic, or cytotoxic properties should not be crushed because "
    },
    {
      "type": "text",
      "section": "Dose Forms Not Appropriate for Enteral Administration",
      "line": 2880,
      "preview": "- Extended-release capsules may be opened and the contents administered via an EAD if appropriate; h"
    },
    {
      "type": "heading",
      "level": 2,
      "section": "Safety",
      "line": 2883
    },
    {
      "type": "text",
      "section": "Safety",
      "line": 2885,
      "preview": "Medications should only be drawn up and dispensed in oral syringes to avoid accidental parenteral ad"
    },
    {
      "type": "heading",
      "level": 2,
      "section": "Drug-Formula Incompatibilities",
      "line": 2887
    },
    {
      "type": "text",
      "section": "Drug-Formula Incompatibilities",
      "line": 2889,
      "preview": "Medications (other than liquid electrolytes) should not be added to enteral formula because of the f"
    },
    {
      "type": "text",
      "section": "Drug-Formula Incompatibilities",
      "line": 2891,
      "preview": "- Physical incompatibilities with acidic syrup and elixirs denaturing the protein in formula (seen m"
    },
    {
      "type": "text",
      "section": "Drug-Formula Incompatibilities",
      "line": 2892,
      "preview": "- Decreased drug absorption"
    },
    {
      "type": "text",
      "section": "Drug-Formula Incompatibilities",
      "line": 2893,
      "preview": "- Increased risk of tube occlusions"
    },
    {
      "type": "text",
      "section": "Drug-Formula Incompatibilities",
      "line": 2894,
      "preview": "- Potential microbial contamination"
    },
    {
      "type": "text",
      "section": "Drug-Formula Incompatibilities",
      "line": 2895,
      "preview": "- Suboptimal drug dosing if tube feeding is interrupted ${ }^{13}$"
    },
    {
      "type": "heading",
      "level": 2,
      "section": "Administration of Medication",
      "line": 2898
    },
    {
      "type": "text",
      "section": "Administration of Medication",
      "line": 2900,
      "preview": "Medications should be given as a bolus and separated from EN when possible, using the following proc"
    },
    {
      "type": "text",
      "section": "Administration of Medication",
      "line": 2902,
      "preview": "--- page 147 ---"
    },
    {
      "type": "text",
      "section": "Administration of Medication",
      "line": 2904,
      "preview": "1. Flush feeding tube with $15-30 \\mathrm{~mL}$ water."
    },
    {
      "type": "text",
      "section": "Administration of Medication",
      "line": 2905,
      "preview": "2. Administer medication after diluting with water if appropriate."
    },
    {
      "type": "text",
      "section": "Administration of Medication",
      "line": 2906,
      "preview": "3. If multiple medications are being provided, flush with $5-10 \\mathrm{~mL}$ water between each med"
    },
    {
      "type": "text",
      "section": "Administration of Medication",
      "line": 2907,
      "preview": "4. Flush feeding tube with $15-30 \\mathrm{~mL}$ water."
    },
    {
      "type": "text",
      "section": "Administration of Medication",
      "line": 2909,
      "preview": "Adequate flushing of an EAD maintains patency of the tube, reduces risk of occlusion, and ensures dr"
    },
    {
      "type": "text",
      "section": "Administration of Medication",
      "line": 2911,
      "preview": "When administering medication with continuous feeding, EN may need to be interrupted multiple times "
    },
    {
      "type": "heading",
      "level": 1,
      "section": "Drug-Nutrient Interactions",
      "line": 2913
    },
    {
      "type": "text",
      "section": "Drug-Nutrient Interactions",
      "line": 2915,
      "preview": "ASPEN recommends stopping feeds for 30 minutes before and after administration of drugs whose absorp"
    },
    {
      "type": "text",
      "section": "Drug-Nutrient Interactions",
      "line": 2917,
      "preview": "- Ciprofloxacin"
    },
    {
      "type": "text",
      "section": "Drug-Nutrient Interactions",
      "line": 2918,
      "preview": "- Doxycycline"
    },
    {
      "type": "text",
      "section": "Drug-Nutrient Interactions",
      "line": 2919,
      "preview": "- Isoniazid"
    },
    {
      "type": "text",
      "section": "Drug-Nutrient Interactions",
      "line": 2920,
      "preview": "- Levofloxacin"
    },
    {
      "type": "text",
      "section": "Drug-Nutrient Interactions",
      "line": 2921,
      "preview": "- Ofloxacin"
    },
    {
      "type": "text",
      "section": "Drug-Nutrient Interactions",
      "line": 2922,
      "preview": "- Penicillin"
    },
    {
      "type": "text",
      "section": "Drug-Nutrient Interactions",
      "line": 2923,
      "preview": "- Rifampicin"
    },
    {
      "type": "text",
      "section": "Drug-Nutrient Interactions",
      "line": 2924,
      "preview": "- Phenytoin"
    },
    {
      "type": "text",
      "section": "Drug-Nutrient Interactions",
      "line": 2925,
      "preview": "- Carbamazepine"
    },
    {
      "type": "text",
      "section": "Drug-Nutrient Interactions",
      "line": 2926,
      "preview": "- Theophylline"
    },
    {
      "type": "text",
      "section": "Drug-Nutrient Interactions",
      "line": 2927,
      "preview": "- Strontium"
    },
    {
      "type": "text",
      "section": "Drug-Nutrient Interactions",
      "line": 2928,
      "preview": "- Aluminum"
    },
    {
      "type": "text",
      "section": "Drug-Nutrient Interactions",
      "line": 2929,
      "preview": "- Magnesium"
    },
    {
      "type": "text",
      "section": "Drug-Nutrient Interactions",
      "line": 2930,
      "preview": "- Calcium-containing preparations ${ }^{14}$"
    },
    {
      "type": "text",
      "section": "Drug-Nutrient Interactions",
      "line": 2932,
      "preview": "--- page 148 ---"
    },
    {
      "type": "text",
      "section": "Drug-Nutrient Interactions",
      "line": 2934,
      "preview": "Other studies suggest a longer duration of feeding interruptions of 12 hours before and after admini"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "References",
      "line": 2936
    },
    {
      "type": "text",
      "section": "References",
      "line": 2938,
      "preview": "1. Corkins MR, ed. Bobo E, Christensen ML, Larson-Nath C, Nuse Tome R, Plogsted S, associate eds.ASP"
    },
    {
      "type": "text",
      "section": "References",
      "line": 2939,
      "preview": "2. Abdelhadi RA, Rahe K, Lyman B. Pediatric enteral access device management.Nutr Clin Pract. 2016;3"
    },
    {
      "type": "text",
      "section": "References",
      "line": 2940,
      "preview": "3. Dandeles LM, Lodolce AE. Efficacy of agents to prevent and treat enteral feeding tube clogs.Ann P"
    },
    {
      "type": "text",
      "section": "References",
      "line": 2941,
      "preview": "4. Feeding Tube Awareness Foundation. Accessed June 26, 2022. https://www.feedingtubeawareness.org/"
    },
    {
      "type": "text",
      "section": "References",
      "line": 2942,
      "preview": "5. Federal Food, Drug, and Cosmetic Act, 412. 21 CFR \u00a7106.1, \u00a7107."
    },
    {
      "type": "text",
      "section": "References",
      "line": 2943,
      "preview": "6. Food for Infants and Young Children. Accessed June 26, 2022. https://ec.europa.eu/food/safety/lab"
    },
    {
      "type": "text",
      "section": "References",
      "line": 2944,
      "preview": "7. DiMaggio DM, Du N, Scherer C, Brodlie S, Shabanova V, Belamarich P, Porto AF. Comparison of impor"
    },
    {
      "type": "text",
      "section": "References",
      "line": 2945,
      "preview": "8. Salminen S, Stahl B, Vinderola G, Szajewska H. Infant formula supplemented with biotics: current "
    },
    {
      "type": "text",
      "section": "References",
      "line": 2946,
      "preview": "9. Szajewska H, Ko\u0142odziej M, Sk\u00f3rka A, Pie\u015bcik-Lech M. Infant formulas with postbiotics: an updated "
    },
    {
      "type": "text",
      "section": "References",
      "line": 2947,
      "preview": "10. Reverri EJ, Devitt AA, Kajzer JA, Baggs GE, Borschel MW. Review of the clinical experiences of f"
    },
    {
      "type": "text",
      "section": "References",
      "line": 2948,
      "preview": "11. Steele C, Collins E, eds. Infant and Pediatric Feedings: Guidelines for Preparation of Human Mil"
    },
    {
      "type": "text",
      "section": "References",
      "line": 2949,
      "preview": "12. Green Corkins K. Nutrition-focused physical examination in pediatric patients.Nutr Clin Pract. 2"
    },
    {
      "type": "text",
      "section": "References",
      "line": 2950,
      "preview": "13. Williams NT. Medication administration through enteral feeding tubes.Am J Health Syst Pharm. 200"
    },
    {
      "type": "text",
      "section": "References",
      "line": 2952,
      "preview": "--- page 149 ---"
    },
    {
      "type": "text",
      "section": "References",
      "line": 2954,
      "preview": "14. Bayraktar Ekincioglu A, Demirkan K. Clinical nutrition and drug interactions. Ulus Cerrahi Derg."
    },
    {
      "type": "text",
      "section": "References",
      "line": 2955,
      "preview": "15. Bankhead R, Boullata J, Brantley S, et al; A.S.P.E.N. Board of Directors. A.S.P.E.N. enteral nut"
    },
    {
      "type": "text",
      "section": "References",
      "line": 2956,
      "preview": "16. Magnuson BL, Clifford TM, Hoskins LA, Bernard AC. Enteral nutrition and drug administration, int"
    },
    {
      "type": "text",
      "section": "References",
      "line": 2958,
      "preview": "--- page 150 ---"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "APPENDIX 5-1. Sample Enteral Nutrition Plan for Pediatric and Infant Patients",
      "line": 2960
    },
    {
      "type": "heading",
      "level": 2,
      "section": "Pediatric Patient",
      "line": 2962
    },
    {
      "type": "text",
      "section": "Pediatric Patient",
      "line": 2964,
      "preview": "Patient: 8-year-old female with a history of complex congenital heart disease. She has a gastrostomy"
    },
    {
      "type": "text",
      "section": "Pediatric Patient",
      "line": 2966,
      "preview": "- Height: $129 \\mathrm{~cm}, 29$ th percentile, $-0.57 z$ score"
    },
    {
      "type": "text",
      "section": "Pediatric Patient",
      "line": 2967,
      "preview": "- Weight: $28 \\mathrm{~kg}, 45$ th percentile, $-0.13 z$ score"
    },
    {
      "type": "text",
      "section": "Pediatric Patient",
      "line": 2968,
      "preview": "- Body mass index: $16.83 \\mathrm{~kg} / \\mathrm{m}^{2}, 60$ th percentile, $0.27 z$ score"
    },
    {
      "type": "heading",
      "level": 2,
      "section": "Assessed Nutrition Needs",
      "line": 2971
    },
    {
      "type": "text",
      "section": "Assessed Nutrition Needs",
      "line": 2973,
      "preview": "- Basal metabolic rate (BMR) (Schofield): 1063 kcal (38 kcal/kg)"
    },
    {
      "type": "text",
      "section": "Assessed Nutrition Needs",
      "line": 2974,
      "preview": "- Estimated energy needs: $38-46 \\mathrm{kcal} / \\mathrm{kg}$ [BMR - (BMR \u00d7 1.2)] with critical illn"
    },
    {
      "type": "text",
      "section": "Assessed Nutrition Needs",
      "line": 2975,
      "preview": "- Estimated protein needs: $1.5-2 \\mathrm{~g} / \\mathrm{kg}$ with critical illness"
    },
    {
      "type": "text",
      "section": "Assessed Nutrition Needs",
      "line": 2976,
      "preview": "- Estimated fluid needs: per team"
    },
    {
      "type": "text",
      "section": "Assessed Nutrition Needs",
      "line": 2977,
      "preview": "- Micronutrient needs: recommended dietary allowance (RDA) for age"
    },
    {
      "type": "text",
      "section": "Assessed Nutrition Needs",
      "line": 2979,
      "preview": "Trophic feeds initiated postoperative day 5 with standard non-fiber-containing formula at 15 mL ever"
    },
    {
      "type": "text",
      "section": "Assessed Nutrition Needs",
      "line": 2981,
      "preview": "After 6 days on NJ feeds, patient was noted to have improved bowel sounds and motility, with decreas"
    },
    {
      "type": "text",
      "section": "Assessed Nutrition Needs",
      "line": 2983,
      "preview": "--- page 151 ---"
    },
    {
      "type": "text",
      "section": "Assessed Nutrition Needs",
      "line": 2985,
      "preview": "medications still providing additional fluid as well as clinical status not appropriate for addition"
    },
    {
      "type": "text",
      "section": "Assessed Nutrition Needs",
      "line": 2987,
      "preview": "Patient proceeded to have tracheostomy placed. Postoperatively, feeds were transitioned from continu"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "Infant Patient",
      "line": 2989
    },
    {
      "type": "text",
      "section": "Infant Patient",
      "line": 2991,
      "preview": "Patient: 5-month-old female admitted with respiratory distress due to respiratory syncytial virus re"
    },
    {
      "type": "text",
      "section": "Infant Patient",
      "line": 2993,
      "preview": "- Length: $60 \\mathrm{~cm}, 5$ th percentile, -1.68 z score"
    },
    {
      "type": "text",
      "section": "Infant Patient",
      "line": 2994,
      "preview": "- Weight: $6 \\mathrm{~kg}, 15$ th percentile, -1.04 z score"
    },
    {
      "type": "text",
      "section": "Infant Patient",
      "line": 2995,
      "preview": "- Head circumference: $40 \\mathrm{~cm}, 15$ th percentile, -1.02 z score"
    },
    {
      "type": "text",
      "section": "Infant Patient",
      "line": 2996,
      "preview": "- Weight for length: 59th percentile, 0.23 z score"
    },
    {
      "type": "text",
      "section": "Infant Patient",
      "line": 2998,
      "preview": "Review of the growth chart reveals age-appropriate weight gain and linear growth for age."
    },
    {
      "type": "heading",
      "level": 2,
      "section": "Assessed Nutrition Needs",
      "line": 3000
    },
    {
      "type": "text",
      "section": "Assessed Nutrition Needs",
      "line": 3002,
      "preview": "- RDA for age: $108 \\mathrm{kcal} / \\mathrm{kg}, 2.2 \\mathrm{~g} / \\mathrm{kg}$ protein, home intake"
    },
    {
      "type": "text",
      "section": "Assessed Nutrition Needs",
      "line": 3003,
      "preview": "- Estimated energy needs: $90-100 \\mathrm{kcal} / \\mathrm{kg} / \\mathrm{d}$ (while intubated)"
    },
    {
      "type": "text",
      "section": "Assessed Nutrition Needs",
      "line": 3004,
      "preview": "- Estimated protein needs: $2.2-3 \\mathrm{~g} / \\mathrm{kg} / \\mathrm{d}$"
    },
    {
      "type": "text",
      "section": "Assessed Nutrition Needs",
      "line": 3005,
      "preview": "- Estimated fluid needs: $100 \\mathrm{~mL} / \\mathrm{kg} / \\mathrm{d}$ minimum"
    },
    {
      "type": "text",
      "section": "Assessed Nutrition Needs",
      "line": 3007,
      "preview": "Nasogastric (NG) bolus feeds begin the day of intubation with home infant formula of standard diluti"
    },
    {
      "type": "text",
      "section": "Assessed Nutrition Needs",
      "line": 3009,
      "preview": "Patient is extubated after 3 days and is cleared by speech language pathologist to start taking form"
    },
    {
      "type": "text",
      "section": "Assessed Nutrition Needs",
      "line": 3011,
      "preview": "--- page 152 ---"
    },
    {
      "type": "text",
      "section": "Assessed Nutrition Needs",
      "line": 3013,
      "preview": "mouth/NG bolus schedule, and feedings are increased to home intakes of 180 mL per feeding. She is ab"
    },
    {
      "type": "text",
      "section": "Assessed Nutrition Needs",
      "line": 3015,
      "preview": "APPENDIX 5-2. Standard Infant Formulas"
    },
    {
      "type": "table",
      "section": "Assessed Nutrition Needs",
      "line": 3017,
      "preview": "| Formula | Protein Type | Whey/Casein | Carbohydrate Source | Prebiotics |"
    },
    {
      "type": "table",
      "section": "Assessed Nutrition Needs",
      "line": 3018,
      "preview": "| :--: | :--: | :--: | :--: | :--: |"
    },
    {
      "type": "table",
      "section": "Assessed Nutrition Needs",
      "line": 3019,
      "preview": "| Enfamil Enspire (Mead Johnson) | Nonfat milk, whey protein concentrate | 60:40 | Lactose | Galacto"
    },
    {
      "type": "table",
      "section": "Assessed Nutrition Needs",
      "line": 3020,
      "preview": "| Enfamil <br> NeuroPro <br> Infant (Mead <br> Johnson) | Nonfat milk, whey protein concentrate | 60"
    },
    {
      "type": "table",
      "section": "Assessed Nutrition Needs",
      "line": 3021,
      "preview": "| Enfamil Simply Organic (Mead Johnson) | Nonfat milk, whey protein concentrate | 60:40 | Organic la"
    },
    {
      "type": "table",
      "section": "Assessed Nutrition Needs",
      "line": 3022,
      "preview": "| Gerber Good Start GentlePro (Gerber) | Hydrolyzed whey protein | 100\\% whey | Lactose, maltodextri"
    },
    {
      "type": "table",
      "section": "Assessed Nutrition Needs",
      "line": 3023,
      "preview": "| Similac 360 <br> Total Care (Abbott Nutrition) | Nonfat milk, whey protein concentrate | 48:52 | L"
    },
    {
      "type": "table",
      "section": "Assessed Nutrition Needs",
      "line": 3024,
      "preview": "| Similac Organic (Abbott Nutrition) | Organic nonfat milk | 18:82 | Organic lactose | Short-chain f"
    },
    {
      "type": "text",
      "section": "Assessed Nutrition Needs",
      "line": 3026,
      "preview": "Abbreviations: 2'-FL, 2'-fucosyllactose; HMO, human milk oligosaccharide."
    },
    {
      "type": "text",
      "section": "Assessed Nutrition Needs",
      "line": 3027,
      "preview": "Note: All values accurate at the time of publication. Always check with manufacturer for the most up"
    },
    {
      "type": "text",
      "section": "Assessed Nutrition Needs",
      "line": 3029,
      "preview": "--- page 153 ---"
    },
    {
      "type": "text",
      "section": "Assessed Nutrition Needs",
      "line": 3031,
      "preview": "APPENDIX 5-3. Reduced-Lactose Infant Formulas"
    },
    {
      "type": "table",
      "section": "Assessed Nutrition Needs",
      "line": 3033,
      "preview": "| Formula | Protein Type | Whey/Casein | Carbohydrate Source | Prebiotic |"
    },
    {
      "type": "table",
      "section": "Assessed Nutrition Needs",
      "line": 3034,
      "preview": "| :--: | :--: | :--: | :--: | :--: |"
    },
    {
      "type": "table",
      "section": "Assessed Nutrition Needs",
      "line": 3035,
      "preview": "| Enfamil <br> NeuroPro <br> Gentlease <br> (Mead <br> Johnson) | Partially hydrolyzed nonfat milk a"
    },
    {
      "type": "table",
      "section": "Assessed Nutrition Needs",
      "line": 3036,
      "preview": "| Enfamil <br> Reguline <br> (Mead <br> Johnson) | Partially hydrolyzed nonfat milk and whey protein"
    },
    {
      "type": "table",
      "section": "Assessed Nutrition Needs",
      "line": 3037,
      "preview": "| Gerber <br> Good Start <br> Soothe <br> (Gerber) | Partially hydrolyzed whey protein | $100 \\%$ wh"
    },
    {
      "type": "table",
      "section": "Assessed Nutrition Needs",
      "line": 3038,
      "preview": "| Similac 360 <br> Total Care <br> Sensitive <br> (Abbott <br> Nutrition) | Milk protein isolate | 1"
    },
    {
      "type": "table",
      "section": "Assessed Nutrition Needs",
      "line": 3039,
      "preview": "| Similac Pro- <br> Total <br> Comfort <br> (Abbott <br> Nutrition) | Whey protein hydrolysate | $10"
    },
    {
      "type": "text",
      "section": "Assessed Nutrition Needs",
      "line": 3041,
      "preview": "Note: All values accurate at the time of publication. Always check with manufacturer for the most up"
    },
    {
      "type": "text",
      "section": "Assessed Nutrition Needs",
      "line": 3043,
      "preview": "APPENDIX 5-4. Soy Infant Formulas"
    },
    {
      "type": "table",
      "section": "Assessed Nutrition Needs",
      "line": 3045,
      "preview": "|  | Protein Type | Carbohydrate <br> Source |"
    },
    {
      "type": "table",
      "section": "Assessed Nutrition Needs",
      "line": 3046,
      "preview": "| :-- | :-- | :-- | :-- |"
    },
    {
      "type": "text",
      "section": "Assessed Nutrition Needs",
      "line": 3048,
      "preview": "--- page 154 ---"
    },
    {
      "type": "table",
      "section": "Assessed Nutrition Needs",
      "line": 3050,
      "preview": "| Formula | Protein Type | Carbohydrate <br> Source |"
    },
    {
      "type": "table",
      "section": "Assessed Nutrition Needs",
      "line": 3051,
      "preview": "| :-- | :-- | :-- |"
    },
    {
      "type": "table",
      "section": "Assessed Nutrition Needs",
      "line": 3052,
      "preview": "| Earth's Best Non-GMO Plant Based <br> (Earth's Best) | Soy protein | Corn syrup solids |"
    },
    {
      "type": "table",
      "section": "Assessed Nutrition Needs",
      "line": 3053,
      "preview": "| Enfamil ProSobee Simply Plant-Based <br> (Mead Johnson) | Soy protein isolate | Corn syrup solids "
    },
    {
      "type": "table",
      "section": "Assessed Nutrition Needs",
      "line": 3054,
      "preview": "| Gerber Good Start Gentle Soy (Gerber) | Hydrolyzed soy <br> protein isolate | Maltodextrin (corn),"
    },
    {
      "type": "table",
      "section": "Assessed Nutrition Needs",
      "line": 3055,
      "preview": "| Similac Soy Isomil (Abbott Nutrition) | Soy protein isolate | Corn syrup solids, <br> sugar |"
    },
    {
      "type": "text",
      "section": "Assessed Nutrition Needs",
      "line": 3057,
      "preview": "Abbreviation: GMO, genetically modified organism."
    },
    {
      "type": "text",
      "section": "Assessed Nutrition Needs",
      "line": 3058,
      "preview": "Note: All values accurate at the time of publication. Always check with manufacturer for the most up"
    },
    {
      "type": "text",
      "section": "Assessed Nutrition Needs",
      "line": 3060,
      "preview": "APPENDIX 5-5. Extensively Hydrolyzed Protein Infant Formulas"
    },
    {
      "type": "table",
      "section": "Assessed Nutrition Needs",
      "line": 3062,
      "preview": "| Formula | Protein <br> Type | Whey/Casein | Carbohydrate <br> Source | MCT <br> Percentage | Probi"
    },
    {
      "type": "table",
      "section": "Assessed Nutrition Needs",
      "line": 3063,
      "preview": "| :-- | :-- | :-- | :-- | :--: | :-- |"
    },
    {
      "type": "table",
      "section": "Assessed Nutrition Needs",
      "line": 3064,
      "preview": "| Gerber <br> Extensive <br> HA <br> (Gerber) | Whey <br> protein <br> hydrolysate | $100 \\%$ whey |"
    },
    {
      "type": "table",
      "section": "Assessed Nutrition Needs",
      "line": 3065,
      "preview": "| Nutramigen <br> with <br> Probiotic <br> LGG <br> (Mead <br> Johnson) | Casein <br> hydrolysate | "
    },
    {
      "type": "table",
      "section": "Assessed Nutrition Needs",
      "line": 3066,
      "preview": "| Pregestimil <br> (Mead <br> Johnson) | Casein <br> hydrolysate | $100 \\%$ casein | Corn syrup <br>"
    },
    {
      "type": "table",
      "section": "Assessed Nutrition Needs",
      "line": 3067,
      "preview": "| Similac <br> Alimentum <br> (Abbott <br> Nutrition) | Casein <br> hydrolysate | $100 \\%$ casein, <"
    },
    {
      "type": "text",
      "section": "Assessed Nutrition Needs",
      "line": 3069,
      "preview": "Abbreviations: HA, hypoallergenic; LGG, Lactobacillus rhamnosus GG; MCT, mediumchain triglyceride."
    },
    {
      "type": "text",
      "section": "Assessed Nutrition Needs",
      "line": 3070,
      "preview": "Note: All values accurate at the time of publication. Always check with manufacturer for the most up"
    },
    {
      "type": "text",
      "section": "Assessed Nutrition Needs",
      "line": 3072,
      "preview": "--- page 155 ---"
    },
    {
      "type": "text",
      "section": "Assessed Nutrition Needs",
      "line": 3074,
      "preview": "APPENDIX 5-6. Elemental Infant Formulas"
    },
    {
      "type": "table",
      "section": "Assessed Nutrition Needs",
      "line": 3076,
      "preview": "| Formula | Protein <br> Type | Carbohydrate <br> Source | MCT <br> Percentage | Other Information |"
    },
    {
      "type": "table",
      "section": "Assessed Nutrition Needs",
      "line": 3077,
      "preview": "| :-- | :-- | :-- | :--: | :-- |"
    },
    {
      "type": "table",
      "section": "Assessed Nutrition Needs",
      "line": 3078,
      "preview": "| Alfamino Infant <br> (Nestl\u00e9) | Amino <br> acids | Corn syrup <br> solids, potato <br> starch | 43"
    },
    {
      "type": "table",
      "section": "Assessed Nutrition Needs",
      "line": 3079,
      "preview": "| EleCare Infant <br> (Abbott <br> Nutrition) | Amino <br> acids | Corn syrup solids | 33 | - |"
    },
    {
      "type": "table",
      "section": "Assessed Nutrition Needs",
      "line": 3080,
      "preview": "| Neocate Infant <br> DHA/ARA <br> (Nutricia) | Amino <br> acids | Corn syrup solids | 33 | - |"
    },
    {
      "type": "table",
      "section": "Assessed Nutrition Needs",
      "line": 3081,
      "preview": "| Neocate Syneo <br> Infant (Nutricia) | Amino <br> acids | Corn syrup solids | 33 | Prebiotics: fru"
    },
    {
      "type": "table",
      "section": "Assessed Nutrition Needs",
      "line": 3082,
      "preview": "| PurAmino <br> (Mead <br> Johnson) | Amino <br> acids | Corn syrup <br> solids, modified <br> tapio"
    },
    {
      "type": "text",
      "section": "Assessed Nutrition Needs",
      "line": 3084,
      "preview": "Abbreviation: MCT, medium-chain triglyceride."
    },
    {
      "type": "text",
      "section": "Assessed Nutrition Needs",
      "line": 3085,
      "preview": "Note: All values accurate at the time of publication. Always check with manufacturer for the most up"
    },
    {
      "type": "text",
      "section": "Assessed Nutrition Needs",
      "line": 3087,
      "preview": "APPENDIX 5-7. Added Rice Starch Infant Formulas"
    },
    {
      "type": "table",
      "section": "Assessed Nutrition Needs",
      "line": 3089,
      "preview": "| Product | Protein Type | Whey/Casein | Carbohydrate <br> Source | Prebiotic |"
    },
    {
      "type": "table",
      "section": "Assessed Nutrition Needs",
      "line": 3090,
      "preview": "| :-- | :-- | :-- | :-- | :-- |"
    },
    {
      "type": "table",
      "section": "Assessed Nutrition Needs",
      "line": 3091,
      "preview": "| Enfamil A.R. <br> (Mead <br> Johnson) | Nonfat milk, <br> whey protein <br> concentrate | $20: 80$"
    },
    {
      "type": "table",
      "section": "Assessed Nutrition Needs",
      "line": 3092,
      "preview": "| Similac for Spit <br> Up (Abbott <br> Nutrition) | Milk protein <br> isolate | $18: 82$ | Corn syr"
    },
    {
      "type": "text",
      "section": "Assessed Nutrition Needs",
      "line": 3094,
      "preview": "Note: All values accurate at the time of publication. Always check with manufacturer for the most up"
    },
    {
      "type": "text",
      "section": "Assessed Nutrition Needs",
      "line": 3096,
      "preview": "APPENDIX 5-8. Other Specialized Infant Formulas"
    },
    {
      "type": "text",
      "section": "Assessed Nutrition Needs",
      "line": 3098,
      "preview": "--- page 156 ---"
    },
    {
      "type": "table",
      "section": "Assessed Nutrition Needs",
      "line": 3100,
      "preview": "| Formula | Protein Type | Whey/Casein <br> Ratio | Carbohydrate <br> Source | Notes |"
    },
    {
      "type": "table",
      "section": "Assessed Nutrition Needs",
      "line": 3101,
      "preview": "| :-- | :-- | :-- | :-- | :-- |"
    },
    {
      "type": "table",
      "section": "Assessed Nutrition Needs",
      "line": 3102,
      "preview": "| Enfaport <br> (Mead <br> Johnson) | Nonfat milk, <br> whey protein <br> concentrate | $60: 40$ | C"
    },
    {
      "type": "table",
      "section": "Assessed Nutrition Needs",
      "line": 3103,
      "preview": "| LIPIstart <br> (Vitaflo) | Whey protein <br> concentrate | - | Corn syrup | $75 \\%$ of fat as MCT "
    },
    {
      "type": "table",
      "section": "Assessed Nutrition Needs",
      "line": 3104,
      "preview": "| Monogen <br> (Nutricia) | Skim milk <br> powder, whey <br> protein <br> concentrate, <br> caseinat"
    },
    {
      "type": "table",
      "section": "Assessed Nutrition Needs",
      "line": 3105,
      "preview": "| Similac PM <br> 60/40 <br> (Abbott <br> Nutrition) | Whey protein <br> concentrate, <br> sodium ca"
    },
    {
      "type": "text",
      "section": "Assessed Nutrition Needs",
      "line": 3107,
      "preview": "Abbreviation: MCT, medium-chain triglyceride."
    },
    {
      "type": "text",
      "section": "Assessed Nutrition Needs",
      "line": 3108,
      "preview": "Note: All values accurate at the time of publication. Always check with manufacturer for the most up"
    },
    {
      "type": "text",
      "section": "Assessed Nutrition Needs",
      "line": 3109,
      "preview": "${ }^{a}$ Suited for $>1$ year of age per manufacturer."
    },
    {
      "type": "text",
      "section": "Assessed Nutrition Needs",
      "line": 3111,
      "preview": "APPENDIX 5-9. Pediatric Elemental Formula"
    },
    {
      "type": "table",
      "section": "Assessed Nutrition Needs",
      "line": 3113,
      "preview": "| Product | Protein <br> Type | Carbohydrate <br> Source | Percentage <br> of Fat as <br> MCTs | Not"
    },
    {
      "type": "table",
      "section": "Assessed Nutrition Needs",
      "line": 3114,
      "preview": "| :-- | :-- | :-- | :--: | :-- |"
    },
    {
      "type": "table",
      "section": "Assessed Nutrition Needs",
      "line": 3115,
      "preview": "| Alfamino Junior <br> (Nestl\u00e9) | Amino <br> acids | Corn syrup <br> solids, potato <br> starch | 65"
    },
    {
      "type": "table",
      "section": "Assessed Nutrition Needs",
      "line": 3116,
      "preview": "| EleCare Junior <br> (Abbott <br> Nutrition) | Amino <br> acids | Corn syrup <br> solids | 33 | Add"
    },
    {
      "type": "text",
      "section": "Assessed Nutrition Needs",
      "line": 3118,
      "preview": "--- page 157 ---"
    },
    {
      "type": "table",
      "section": "Assessed Nutrition Needs",
      "line": 3120,
      "preview": "| Product | Protein <br> Type | Carbohydrate <br> Source | Percentage <br> of Fat as <br> MCTs | Not"
    },
    {
      "type": "table",
      "section": "Assessed Nutrition Needs",
      "line": 3121,
      "preview": "| :-- | :-- | :-- | :--: | :-- |"
    },
    {
      "type": "table",
      "section": "Assessed Nutrition Needs",
      "line": 3122,
      "preview": "| Neocate Junior <br> (Nutricia) | Amino <br> acids | Corn syrup <br> solids | 35 | Additional flavo"
    },
    {
      "type": "table",
      "section": "Assessed Nutrition Needs",
      "line": 3123,
      "preview": "| Neocate Junior <br> with Prebiotics <br> (Nutricia) | Amino <br> acids | Corn syrup <br> solids | "
    },
    {
      "type": "table",
      "section": "Assessed Nutrition Needs",
      "line": 3124,
      "preview": "| Neocate Splash <br> (Nutricia) | Amino <br> acids | Maltodextrin, <br> sugar | 35 | Additional fla"
    },
    {
      "type": "table",
      "section": "Assessed Nutrition Needs",
      "line": 3125,
      "preview": "| PurAmino <br> Junior (Mead <br> Johnson) | Amino <br> acids | Corn syrup <br> solids, modified <br"
    },
    {
      "type": "table",
      "section": "Assessed Nutrition Needs",
      "line": 3126,
      "preview": "| Vivonex <br> Pediatric <br> (Nestl\u00e9) | Amino <br> acids | Maltodextrin, <br> modified corn <br> st"
    },
    {
      "type": "text",
      "section": "Assessed Nutrition Needs",
      "line": 3128,
      "preview": "Abbreviation: MCT, medium-chain triglyceride."
    },
    {
      "type": "text",
      "section": "Assessed Nutrition Needs",
      "line": 3129,
      "preview": "Note: All values accurate at the time of publication. Always check with manufacturer for the most up"
    },
    {
      "type": "text",
      "section": "Assessed Nutrition Needs",
      "line": 3131,
      "preview": "APPENDIX 5-10. Pediatric Semi-Elemental Formula"
    },
    {
      "type": "table",
      "section": "Assessed Nutrition Needs",
      "line": 3133,
      "preview": "| Product | Protein Type | Carbohydrate <br> Source | Percentage <br> of Fat as <br> MCTs | Notes |"
    },
    {
      "type": "table",
      "section": "Assessed Nutrition Needs",
      "line": 3134,
      "preview": "| :-- | :-- | :-- | :--: | :-- |"
    },
    {
      "type": "table",
      "section": "Assessed Nutrition Needs",
      "line": 3135,
      "preview": "| Kate Farms <br> Pediatric <br> Peptide 1.0 <br> Vanilla (Kate <br> Farms) | Organic <br> hydrolyze"
    },
    {
      "type": "table",
      "section": "Assessed Nutrition Needs",
      "line": 3136,
      "preview": "| Kate Farms <br> Pediatric <br> Peptide 1.5 <br> (Kate Farms) | Organic <br> hydrolyzed <br> pea pr"
    },
    {
      "type": "text",
      "section": "Assessed Nutrition Needs",
      "line": 3138,
      "preview": "--- page 158 ---"
    },
    {
      "type": "table",
      "section": "Assessed Nutrition Needs",
      "line": 3140,
      "preview": "| Product | Protein Type | Carbohydrate Source | Percentage of Fat as MCTs | Notes |"
    },
    {
      "type": "table",
      "section": "Assessed Nutrition Needs",
      "line": 3141,
      "preview": "| :--: | :--: | :--: | :--: | :--: |"
    },
    {
      "type": "table",
      "section": "Assessed Nutrition Needs",
      "line": 3142,
      "preview": "| PediaSure <br> Peptide <br> (Abbott <br> Nutrition) | Whey protein hydrolysate, hydrolyzed sodium "
    },
    {
      "type": "table",
      "section": "Assessed Nutrition Needs",
      "line": 3143,
      "preview": "| PediaSure <br> Peptide 1.5 <br> Vanilla <br> (Abbott <br> Nutrition) | Whey protein hydrolysate, h"
    },
    {
      "type": "table",
      "section": "Assessed Nutrition Needs",
      "line": 3144,
      "preview": "| Peptamen Jr (Nestl\u00e9) | Hydrolyzed whey protein | Maltodextrin, corn starch | 60 | Additional flavo"
    },
    {
      "type": "table",
      "section": "Assessed Nutrition Needs",
      "line": 3145,
      "preview": "| Peptamen Jr High Protein (Nestl\u00e9) | Hydrolyzed whey protein ( $16 \\%$ of calories from protein) | "
    },
    {
      "type": "table",
      "section": "Assessed Nutrition Needs",
      "line": 3146,
      "preview": "| Peptamen Jr PHGG (Nestl\u00e9) | Hydrolyzed whey protein | Maltodextrin, sugar, corn starch | 60 | $12 "
    },
    {
      "type": "table",
      "section": "Assessed Nutrition Needs",
      "line": 3147,
      "preview": "| Peptamen Jr 1.5 (Nestl\u00e9) | Hydrolyzed whey protein | Maltodextrin, corn starch | 60 | $6 \\mathrm{~"
    },
    {
      "type": "table",
      "section": "Assessed Nutrition Needs",
      "line": 3148,
      "preview": "| Peptamen Jr with Fiber (Nestl\u00e9) | Hydrolyzed whey protein | Maltodextrin, sugar, corn starch | 60 "
    },
    {
      "type": "table",
      "section": "Assessed Nutrition Needs",
      "line": 3149,
      "preview": "| Vital Peptide <br> 1.5 Vanilla <br> (Abbott <br> Nutrition) | Whey protein hydrolysate, hydrolyzed"
    },
    {
      "type": "text",
      "section": "Assessed Nutrition Needs",
      "line": 3151,
      "preview": "Abbreviation: MCT, medium-chain triglyceride."
    },
    {
      "type": "text",
      "section": "Assessed Nutrition Needs",
      "line": 3152,
      "preview": "Note: All values accurate at the time of publication. Always check with manufacturer for the most up"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "APPENDIX 5-11. Pediatric Standard Formula",
      "line": 3154
    },
    {
      "type": "text",
      "section": "APPENDIX 5-11. Pediatric Standard Formula",
      "line": 3156,
      "preview": "--- page 159 ---"
    },
    {
      "type": "table",
      "section": "APPENDIX 5-11. Pediatric Standard Formula",
      "line": 3158,
      "preview": "| Product | Protein Type | Carbohydrate Source | Percentage of Fat as MCTs | Notes |"
    },
    {
      "type": "table",
      "section": "APPENDIX 5-11. Pediatric Standard Formula",
      "line": 3159,
      "preview": "| :--: | :--: | :--: | :--: | :--: |"
    },
    {
      "type": "table",
      "section": "APPENDIX 5-11. Pediatric Standard Formula",
      "line": 3160,
      "preview": "| Boost Kid Essentials 1.0 (Nestl\u00e9) | Milk protein concentrate | Brown rice syrup, sugar | 0 | Flavo"
    },
    {
      "type": "table",
      "section": "APPENDIX 5-11. Pediatric Standard Formula",
      "line": 3161,
      "preview": "| Boost Kid Essentials 1.5 (Nestl\u00e9) | Milk protein concentrate | Brown rice syrup, sugar | 10 | Flav"
    },
    {
      "type": "table",
      "section": "APPENDIX 5-11. Pediatric Standard Formula",
      "line": 3162,
      "preview": "| Boost Kid Essentials 1.5 with Fiber (Nestl\u00e9) | Milk protein concentrate | Brown rice syrup, sugar "
    },
    {
      "type": "table",
      "section": "APPENDIX 5-11. Pediatric Standard Formula",
      "line": 3163,
      "preview": "| Kate Farms <br> Pediatric <br> Standard 1.2 <br> Vanilla (Kate <br> Farms) | Organic pea protein |"
    },
    {
      "type": "table",
      "section": "APPENDIX 5-11. Pediatric Standard Formula",
      "line": 3164,
      "preview": "| Nutren Jr (Nestl\u00e9) | Milk protein concentrate, whey protein concentrate (50\\%) | Maltodextrin, sug"
    },
    {
      "type": "table",
      "section": "APPENDIX 5-11. Pediatric Standard Formula",
      "line": 3165,
      "preview": "| Nutren Jr with Fiber (Nestl\u00e9) | Milk protein concentrate, whey protein concentrate (50\\%) | Maltod"
    },
    {
      "type": "table",
      "section": "APPENDIX 5-11. Pediatric Standard Formula",
      "line": 3166,
      "preview": "| PediaSure <br> Enteral (Abbott <br> Nutrition) | Milk protein concentrate, soy protein isolate | C"
    },
    {
      "type": "table",
      "section": "APPENDIX 5-11. Pediatric Standard Formula",
      "line": 3167,
      "preview": "| PediaSure <br> Enteral with <br> Fiber (Abbott <br> Nutrition) | Milk protein concentrate, soy pro"
    },
    {
      "type": "text",
      "section": "APPENDIX 5-11. Pediatric Standard Formula",
      "line": 3169,
      "preview": "--- page 160 ---"
    },
    {
      "type": "table",
      "section": "APPENDIX 5-11. Pediatric Standard Formula",
      "line": 3171,
      "preview": "| Product | Protein Type | Carbohydrate <br> Source | Percentage <br> of Fat as <br> MCTs | Notes |"
    },
    {
      "type": "table",
      "section": "APPENDIX 5-11. Pediatric Standard Formula",
      "line": 3172,
      "preview": "| :-- | :-- | :-- | :--: | :-- |"
    },
    {
      "type": "table",
      "section": "APPENDIX 5-11. Pediatric Standard Formula",
      "line": 3173,
      "preview": "| PediaSure <br> Enteral 1.5 <br> (Abbott <br> Nutrition) | Milk protein <br> concentrate, <br> soy "
    },
    {
      "type": "table",
      "section": "APPENDIX 5-11. Pediatric Standard Formula",
      "line": 3174,
      "preview": "| PediaSure <br> Enteral 1.5 with <br> Fiber (Abbott <br> Nutrition) | Milk protein <br> concentrate"
    },
    {
      "type": "text",
      "section": "APPENDIX 5-11. Pediatric Standard Formula",
      "line": 3176,
      "preview": "Abbreviation: MCT, medium-chain triglyceride."
    },
    {
      "type": "text",
      "section": "APPENDIX 5-11. Pediatric Standard Formula",
      "line": 3177,
      "preview": "Note: All values accurate at the time of publication. Always check with manufacturer for the most up"
    },
    {
      "type": "text",
      "section": "APPENDIX 5-11. Pediatric Standard Formula",
      "line": 3179,
      "preview": "APPENDIX 5-12. Pediatric Real Food-Based Formula"
    },
    {
      "type": "table",
      "section": "APPENDIX 5-11. Pediatric Standard Formula",
      "line": 3181,
      "preview": "| Product | Protein Type | Carbohydrate <br> Source | MCT <br> Percentage | Fiber |"
    },
    {
      "type": "table",
      "section": "APPENDIX 5-11. Pediatric Standard Formula",
      "line": 3182,
      "preview": "| :-- | :-- | :-- | :--: | :-- |"
    },
    {
      "type": "table",
      "section": "APPENDIX 5-11. Pediatric Standard Formula",
      "line": 3183,
      "preview": "| Compleat <br> Pediatric <br> (Nestl\u00e9) | Dehydrated <br> chicken <br> powder, milk <br> protein <br"
    },
    {
      "type": "table",
      "section": "APPENDIX 5-11. Pediatric Standard Formula",
      "line": 3184,
      "preview": "| Compleat <br> Pediatric <br> Reduced <br> Calorie (0.6 <br> kcal/mL) <br> (Nestl\u00e9) | Dehydrated <b"
    },
    {
      "type": "table",
      "section": "APPENDIX 5-11. Pediatric Standard Formula",
      "line": 3185,
      "preview": "| Compleat <br> Pediatric <br> Peptide 1.5 <br> (Nestl\u00e9) | Hydrolyzed pea <br> protein isolate, <br>"
    },
    {
      "type": "table",
      "section": "APPENDIX 5-11. Pediatric Standard Formula",
      "line": 3186,
      "preview": "| Compleat <br> Pediatric <br> Standard <br> 1.0 (Nestl\u00e9) | Pea protein <br> isolate, I- <br> cystin"
    },
    {
      "type": "text",
      "section": "APPENDIX 5-11. Pediatric Standard Formula",
      "line": 3188,
      "preview": "--- page 161 ---"
    },
    {
      "type": "table",
      "section": "APPENDIX 5-11. Pediatric Standard Formula",
      "line": 3190,
      "preview": "| Product | Protein Type | Carbohydrate Source | MCT <br> Percentage | Fiber |"
    },
    {
      "type": "table",
      "section": "APPENDIX 5-11. Pediatric Standard Formula",
      "line": 3191,
      "preview": "| :--: | :--: | :--: | :--: | :--: |"
    },
    {
      "type": "table",
      "section": "APPENDIX 5-11. Pediatric Standard Formula",
      "line": 3192,
      "preview": "| Compleat <br> Pediatric <br> Standard <br> Plant Based <br> 1.4 (Nestl\u00e9) | Pea protein isolate, Ic"
    },
    {
      "type": "table",
      "section": "APPENDIX 5-11. Pediatric Standard Formula",
      "line": 3193,
      "preview": "| Compleat <br> Pediatric <br> Organic <br> Blends <br> Chicken- <br> Garden <br> Blend (1.2 <br> kc"
    },
    {
      "type": "table",
      "section": "APPENDIX 5-11. Pediatric Standard Formula",
      "line": 3194,
      "preview": "| Compleat <br> Pediatric <br> Organic <br> Blends Plant <br> Based Blend <br> (1.2 <br> kcal/mL) <b"
    },
    {
      "type": "table",
      "section": "APPENDIX 5-11. Pediatric Standard Formula",
      "line": 3195,
      "preview": "| Nourish <br> (Functional <br> Formularies) | Organic pea protein, organic whole grain brown rice, "
    },
    {
      "type": "table",
      "section": "APPENDIX 5-11. Pediatric Standard Formula",
      "line": 3196,
      "preview": "| PediaSure <br> Harvest <br> (Abbott <br> Nutrition) | Organic brown rice, soy protein isolate, org"
    },
    {
      "type": "text",
      "section": "APPENDIX 5-11. Pediatric Standard Formula",
      "line": 3198,
      "preview": "--- page 162 ---"
    },
    {
      "type": "table",
      "section": "APPENDIX 5-11. Pediatric Standard Formula",
      "line": 3200,
      "preview": "| Product | Protein Type | Carbohydrate <br> Source | MCT <br> Percentage | Fiber |"
    },
    {
      "type": "table",
      "section": "APPENDIX 5-11. Pediatric Standard Formula",
      "line": 3201,
      "preview": "| :-- | :-- | :-- | :-- | :-- |"
    },
    {
      "type": "table",
      "section": "APPENDIX 5-11. Pediatric Standard Formula",
      "line": 3202,
      "preview": "| Real Food <br> Blends $^{\\mathrm{a}}$ <br> (Real Food <br> Blends) | Varies: turkey, <br> chicken,"
    },
    {
      "type": "text",
      "section": "APPENDIX 5-11. Pediatric Standard Formula",
      "line": 3204,
      "preview": "Abbreviation: MCT, medium-chain triglyceride."
    },
    {
      "type": "text",
      "section": "APPENDIX 5-11. Pediatric Standard Formula",
      "line": 3205,
      "preview": "Note: All values accurate at the time of publication. Always check with manufacturer for the most up"
    },
    {
      "type": "text",
      "section": "APPENDIX 5-11. Pediatric Standard Formula",
      "line": 3206,
      "preview": "${ }^{a}$ Not nutritionally complete."
    },
    {
      "type": "text",
      "section": "APPENDIX 5-11. Pediatric Standard Formula",
      "line": 3208,
      "preview": "APPENDIX 5-13. Standard Adult Formulas"
    },
    {
      "type": "table",
      "section": "APPENDIX 5-11. Pediatric Standard Formula",
      "line": 3210,
      "preview": "| Product | Protein <br> Type | Carbohydrate <br> Source | Fiber | Notes |"
    },
    {
      "type": "table",
      "section": "APPENDIX 5-11. Pediatric Standard Formula",
      "line": 3211,
      "preview": "| :-- | :-- | :-- | :-- | :-- |"
    },
    {
      "type": "table",
      "section": "APPENDIX 5-11. Pediatric Standard Formula",
      "line": 3212,
      "preview": "| Fibersource HN <br> (Nestl\u00e9) | Milk <br> (casein), <br> soy | Glucose syrup, <br> maltodextrin | $"
    },
    {
      "type": "table",
      "section": "APPENDIX 5-11. Pediatric Standard Formula",
      "line": 3213,
      "preview": "| Isosource HN <br> (Nestl\u00e9) | Milk <br> (casein), <br> Soy | Corn syrup, <br> maltodextrin | None |"
    },
    {
      "type": "table",
      "section": "APPENDIX 5-11. Pediatric Standard Formula",
      "line": 3214,
      "preview": "| Isosource 1.5 <br> (Nestl\u00e9) | Milk <br> (casein), <br> soy | Glucose syrup, <br> maltodextrin | $1"
    },
    {
      "type": "table",
      "section": "APPENDIX 5-11. Pediatric Standard Formula",
      "line": 3215,
      "preview": "| Jevity 1.0 <br> (Abbott <br> Nutrition) | Milk <br> (casein), <br> soy | Corn <br> maltodextrin, c"
    },
    {
      "type": "table",
      "section": "APPENDIX 5-11. Pediatric Standard Formula",
      "line": 3216,
      "preview": "| Jevity 1.2 <br> (Abbott <br> Nutrition) | Milk <br> (casein), <br> soy | Corn maltodextrin, corn s"
    },
    {
      "type": "table",
      "section": "APPENDIX 5-11. Pediatric Standard Formula",
      "line": 3217,
      "preview": "| Jevity 1.5 <br> (Abbott <br> Nutrition) | Milk <br> (casein), <br> Soy | Corn <br> maltodextrin, c"
    },
    {
      "type": "table",
      "section": "APPENDIX 5-11. Pediatric Standard Formula",
      "line": 3218,
      "preview": "| Nutren 1.0 <br> (Nestl\u00e9) | Milk <br> (casein), <br> soy | Corn syrup, <br> maltodextrin | None | -"
    },
    {
      "type": "text",
      "section": "APPENDIX 5-11. Pediatric Standard Formula",
      "line": 3220,
      "preview": "--- page 163 ---"
    },
    {
      "type": "table",
      "section": "APPENDIX 5-11. Pediatric Standard Formula",
      "line": 3222,
      "preview": "| Product | Protein <br> Type | Carbohydrate Source | Fiber | Notes |"
    },
    {
      "type": "table",
      "section": "APPENDIX 5-11. Pediatric Standard Formula",
      "line": 3223,
      "preview": "| :--: | :--: | :--: | :--: | :--: |"
    },
    {
      "type": "table",
      "section": "APPENDIX 5-11. Pediatric Standard Formula",
      "line": 3224,
      "preview": "| Nutren 1.0 Fiber (Nestl\u00e9) | Milk (casein), soy | Corn syrup, maltodextrin | $12 \\mathrm{~g} / \\mat"
    },
    {
      "type": "table",
      "section": "APPENDIX 5-11. Pediatric Standard Formula",
      "line": 3225,
      "preview": "| Nutren 1.5 (Nestl\u00e9) | Milk (casein), soy | Corn syrup, maltodextrin | None | \u2014 |"
    },
    {
      "type": "table",
      "section": "APPENDIX 5-11. Pediatric Standard Formula",
      "line": 3226,
      "preview": "| Nutren 2.0 (Nestl\u00e9) | Milk (casein), soy | Corn syrup, maltodextrin | None | \u2014 |"
    },
    {
      "type": "table",
      "section": "APPENDIX 5-11. Pediatric Standard Formula",
      "line": 3227,
      "preview": "| Osmolite 1.0 <br> (Abbott <br> Nutrition) | Milk (casein), soy | Corn maltodextrin, corn syrup sol"
    },
    {
      "type": "table",
      "section": "APPENDIX 5-11. Pediatric Standard Formula",
      "line": 3228,
      "preview": "| Osmolite 1.2 <br> (Abbott <br> Nutrition) | Milk (casein) | Corn maltodextrin | None | \u2014 |"
    },
    {
      "type": "table",
      "section": "APPENDIX 5-11. Pediatric Standard Formula",
      "line": 3229,
      "preview": "| Osmolite 1.5 <br> (Abbott <br> Nutrition) | Milk (casein), soy | Corn maltodextrin, corn syrup sol"
    },
    {
      "type": "table",
      "section": "APPENDIX 5-11. Pediatric Standard Formula",
      "line": 3230,
      "preview": "| Promote (Abbott Nutrition) | Milk (casein), soy | Corn maltodextrin, sugar | None | Available in v"
    },
    {
      "type": "table",
      "section": "APPENDIX 5-11. Pediatric Standard Formula",
      "line": 3231,
      "preview": "| Promote with Fiber (Abbott Nutrition) | Milk (casein), soy | Corn maltodextrin, sugar | $14.4 \\mat"
    },
    {
      "type": "table",
      "section": "APPENDIX 5-11. Pediatric Standard Formula",
      "line": 3232,
      "preview": "| Replete (Nestl\u00e9) | Milk (casein) | Corn syrup, maltodextrin | None | \u2014 |"
    },
    {
      "type": "table",
      "section": "APPENDIX 5-11. Pediatric Standard Formula",
      "line": 3233,
      "preview": "| Replete with Fiber (Nestl\u00e9) | Milk (casein), soy | Corn syrup, maltodextrin | $12 \\mathrm{~g} / \\m"
    },
    {
      "type": "table",
      "section": "APPENDIX 5-11. Pediatric Standard Formula",
      "line": 3234,
      "preview": "| TwoCal HN (Abbott Nutrition) | Milk (casein) | Corn syrup solids, corn maltodextrin, sugar | None "
    },
    {
      "type": "text",
      "section": "APPENDIX 5-11. Pediatric Standard Formula",
      "line": 3236,
      "preview": "Note: All values accurate at the time of publication. Always check with manufacturer for the most up"
    },
    {
      "type": "text",
      "section": "APPENDIX 5-11. Pediatric Standard Formula",
      "line": 3238,
      "preview": "--- page 164 ---"
    },
    {
      "type": "text",
      "section": "APPENDIX 5-11. Pediatric Standard Formula",
      "line": 3240,
      "preview": "APPENDIX 5-14. Adult Semi-Elemental Formulas"
    },
    {
      "type": "table",
      "section": "APPENDIX 5-11. Pediatric Standard Formula",
      "line": 3242,
      "preview": "| Product | Protein Type | Carbohydrate Source | Fiber | Notes |"
    },
    {
      "type": "table",
      "section": "APPENDIX 5-11. Pediatric Standard Formula",
      "line": 3243,
      "preview": "| :--: | :--: | :--: | :--: | :--: |"
    },
    {
      "type": "table",
      "section": "APPENDIX 5-11. Pediatric Standard Formula",
      "line": 3244,
      "preview": "| Impact Peptide 1.5 (Nestl\u00e9) | Hydrolyzed whey (milk) | Maltodextrin, cornstarch | None | \u2014 |"
    },
    {
      "type": "table",
      "section": "APPENDIX 5-11. Pediatric Standard Formula",
      "line": 3245,
      "preview": "| Peptamen (Nestl\u00e9) | Hydrolyzed whey (milk) | Maltodextrin, corn starch | None | \u2014 |"
    },
    {
      "type": "table",
      "section": "APPENDIX 5-11. Pediatric Standard Formula",
      "line": 3246,
      "preview": "| Peptamen AF (Nestl\u00e9) | Hydrolyzed whey (milk) | Maltodextrin, corn starch | $6 \\mathrm{~g} / \\math"
    },
    {
      "type": "table",
      "section": "APPENDIX 5-11. Pediatric Standard Formula",
      "line": 3247,
      "preview": "| Peptamen with Prebio (Nestl\u00e9) | Hydrolyzed whey (milk) | Maltodextrin, corn starch | $12 \\mathrm{~"
    },
    {
      "type": "table",
      "section": "APPENDIX 5-11. Pediatric Standard Formula",
      "line": 3248,
      "preview": "| Peptamen 1.5 (Nestl\u00e9) | Hydrolyzed whey (milk) | Maltodextrin, corn starch | None | \u2014 |"
    },
    {
      "type": "table",
      "section": "APPENDIX 5-11. Pediatric Standard Formula",
      "line": 3249,
      "preview": "| Peptamen 1.5 with Prebio (Nestl\u00e9) | Hydrolyzed whey (milk) | Maltodextrin, sugar, corn starch | $6"
    },
    {
      "type": "table",
      "section": "APPENDIX 5-11. Pediatric Standard Formula",
      "line": 3250,
      "preview": "| Peptamen Intense VHP (Nestl\u00e9) | Hydrolyzed whey (milk) | Maltodextrin, corn starch | $4 \\mathrm{~g"
    },
    {
      "type": "table",
      "section": "APPENDIX 5-11. Pediatric Standard Formula",
      "line": 3251,
      "preview": "| Perative (Abbott Nutrition) | Hydrolyzed whey and casein (milk) | Maltodextrin (corn) | $6.4 \\math"
    },
    {
      "type": "table",
      "section": "APPENDIX 5-11. Pediatric Standard Formula",
      "line": 3252,
      "preview": "| Pivot 1.5 (Abbott Nutrition) | Hydrolyzed whey and casein (milk) | Corn syrup solids | $7.2 \\mathr"
    },
    {
      "type": "table",
      "section": "APPENDIX 5-11. Pediatric Standard Formula",
      "line": 3253,
      "preview": "| Vital (Abbott Nutrition) | Hydrolyzed whey and casein (milk) | Corn maltodextrin, sugar | $4 \\math"
    },
    {
      "type": "table",
      "section": "APPENDIX 5-11. Pediatric Standard Formula",
      "line": 3254,
      "preview": "| Vital 1.5 (Abbott Nutrition) | Hydrolyzed whey and casein (milk) | Corn maltodextrin, sugar | $5.6"
    },
    {
      "type": "table",
      "section": "APPENDIX 5-11. Pediatric Standard Formula",
      "line": 3255,
      "preview": "| Vital AF 1.2 (Abbott Nutrition) | Hydrolyzed whey and casein (milk) | Corn maltodextrin | $5.1 \\ma"
    },
    {
      "type": "table",
      "section": "APPENDIX 5-11. Pediatric Standard Formula",
      "line": 3256,
      "preview": "| Vital High <br> Protein (Abbott Nutrition) | Hydrolyzed whey and casein (milk) | Corn maltodextrin"
    },
    {
      "type": "text",
      "section": "APPENDIX 5-11. Pediatric Standard Formula",
      "line": 3258,
      "preview": "--- page 165 ---"
    },
    {
      "type": "text",
      "section": "APPENDIX 5-11. Pediatric Standard Formula",
      "line": 3260,
      "preview": "Note: All values accurate at the time of publication. Always check with manufacturer for the most up"
    },
    {
      "type": "text",
      "section": "APPENDIX 5-11. Pediatric Standard Formula",
      "line": 3262,
      "preview": "APPENDIX 5-15. Other Adult Formulas"
    },
    {
      "type": "table",
      "section": "APPENDIX 5-11. Pediatric Standard Formula",
      "line": 3264,
      "preview": "| Product | Protein <br> Type | Carbohydrate <br> Source | Fiber | Notes |"
    },
    {
      "type": "table",
      "section": "APPENDIX 5-11. Pediatric Standard Formula",
      "line": 3265,
      "preview": "| :-- | :-- | :-- | :-- | :-- |"
    },
    {
      "type": "table",
      "section": "APPENDIX 5-11. Pediatric Standard Formula",
      "line": 3266,
      "preview": "| Nepro <br> Vanilla <br> (Abbott <br> Nutrition) | Milk protein <br> isolate, <br> caseinates | Cor"
    },
    {
      "type": "table",
      "section": "APPENDIX 5-11. Pediatric Standard Formula",
      "line": 3267,
      "preview": "| Novasource <br> Renal Vanilla <br> (Nestl\u00e9) | Milk <br> (casein), <br> soy | Corn syrup, <br> suga"
    },
    {
      "type": "table",
      "section": "APPENDIX 5-11. Pediatric Standard Formula",
      "line": 3268,
      "preview": "| Nutren <br> Pulmonary <br> (Nestl\u00e9) | Milk <br> (casein) | Sugar, <br> maltodextrin | None | $1.5 "
    },
    {
      "type": "table",
      "section": "APPENDIX 5-11. Pediatric Standard Formula",
      "line": 3269,
      "preview": "| Pulmocare <br> (Abbott <br> Nutrition) | Milk <br> (casein) | Sugar, corn <br> maltodextrin | None"
    },
    {
      "type": "table",
      "section": "APPENDIX 5-11. Pediatric Standard Formula",
      "line": 3270,
      "preview": "| Suplena <br> Vanilla <br> (Abbott <br> Nutrition) | Milk <br> (casein) | Corn <br> maltodextrin, <"
    },
    {
      "type": "table",
      "section": "APPENDIX 5-11. Pediatric Standard Formula",
      "line": 3271,
      "preview": "| Tolerex <br> (Nestl\u00e9) | Free amino <br> acids | Maltodextrin, <br> modified <br> cornstarch | None"
    },
    {
      "type": "table",
      "section": "APPENDIX 5-11. Pediatric Standard Formula",
      "line": 3272,
      "preview": "| Vivonex Plus <br> (Nestl\u00e9) | Free amino <br> acids | Maltodextrin, <br> modified <br> cornstarch |"
    },
    {
      "type": "table",
      "section": "APPENDIX 5-11. Pediatric Standard Formula",
      "line": 3273,
      "preview": "| Vivonex RTF <br> (Nestl\u00e9) | Free amino <br> acids | Maltodextrin, <br> modified <br> cornstarch | "
    },
    {
      "type": "table",
      "section": "APPENDIX 5-11. Pediatric Standard Formula",
      "line": 3274,
      "preview": "| Vivonex <br> T.E.N. <br> (Nestl\u00e9) | Free amino <br> acids | Maltodextrin, <br> modified <br> corns"
    },
    {
      "type": "text",
      "section": "APPENDIX 5-11. Pediatric Standard Formula",
      "line": 3276,
      "preview": "Abbreviation: MCT, medium-chain triglyceride."
    },
    {
      "type": "text",
      "section": "APPENDIX 5-11. Pediatric Standard Formula",
      "line": 3277,
      "preview": "Note: All values accurate at the time of publication. Always check with manufacturer for the most up"
    },
    {
      "type": "text",
      "section": "APPENDIX 5-11. Pediatric Standard Formula",
      "line": 3279,
      "preview": "--- page 166 ---"
    },
    {
      "type": "text",
      "section": "APPENDIX 5-11. Pediatric Standard Formula",
      "line": 3281,
      "preview": "APPENDIX 5-16. Product Manufacturer Websites ${ }^{a}$"
    },
    {
      "type": "table",
      "section": "APPENDIX 5-11. Pediatric Standard Formula",
      "line": 3283,
      "preview": "| Company | Website |"
    },
    {
      "type": "table",
      "section": "APPENDIX 5-11. Pediatric Standard Formula",
      "line": 3284,
      "preview": "| :-- | :-- |"
    },
    {
      "type": "table",
      "section": "APPENDIX 5-11. Pediatric Standard Formula",
      "line": 3285,
      "preview": "| Abbott Nutrition | https://abbottnutrition.com/ |"
    },
    {
      "type": "table",
      "section": "APPENDIX 5-11. Pediatric Standard Formula",
      "line": 3286,
      "preview": "| Earth's Best | https://www.earthsbest.com/ |"
    },
    {
      "type": "table",
      "section": "APPENDIX 5-11. Pediatric Standard Formula",
      "line": 3287,
      "preview": "| Functional Formularies | https://www.functionalformularies.com/ |"
    },
    {
      "type": "table",
      "section": "APPENDIX 5-11. Pediatric Standard Formula",
      "line": 3288,
      "preview": "| Gerber | https://www.gerber.com/gerber-good-start |"
    },
    {
      "type": "table",
      "section": "APPENDIX 5-11. Pediatric Standard Formula",
      "line": 3289,
      "preview": "| Kate Farms | https://www.katefarms.com/ |"
    },
    {
      "type": "table",
      "section": "APPENDIX 5-11. Pediatric Standard Formula",
      "line": 3290,
      "preview": "| Mead Johnson | https://www.meadjohnson.com/ |"
    },
    {
      "type": "table",
      "section": "APPENDIX 5-11. Pediatric Standard Formula",
      "line": 3291,
      "preview": "| Nestl\u00e9 | https://www.nestlehealthscience.com/ |"
    },
    {
      "type": "table",
      "section": "APPENDIX 5-11. Pediatric Standard Formula",
      "line": 3292,
      "preview": "| Nutricia | https://nutricia-na.com/ |"
    },
    {
      "type": "table",
      "section": "APPENDIX 5-11. Pediatric Standard Formula",
      "line": 3293,
      "preview": "| Real Food Blends | https://www.realfoodblends.com/ |"
    },
    {
      "type": "table",
      "section": "APPENDIX 5-11. Pediatric Standard Formula",
      "line": 3294,
      "preview": "| Vitaflo | https://www.vitaflousa.com/ |"
    },
    {
      "type": "text",
      "section": "APPENDIX 5-11. Pediatric Standard Formula",
      "line": 3296,
      "preview": "Note: All values accurate at the time of publication. Always check manufacturer information for the "
    },
    {
      "type": "text",
      "section": "APPENDIX 5-11. Pediatric Standard Formula",
      "line": 3297,
      "preview": "${ }^{a}$ All values accurate at time of creation. Always check with manufacturer for the most up-to"
    },
    {
      "type": "text",
      "section": "APPENDIX 5-11. Pediatric Standard Formula",
      "line": 3299,
      "preview": "--- page 167 ---"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "6",
      "line": 3301
    },
    {
      "type": "heading",
      "level": 2,
      "section": "Parenteral Nutrition",
      "line": 3303
    },
    {
      "type": "text",
      "section": "Parenteral Nutrition",
      "line": 3305,
      "preview": "Elaina Szeszycki, PharmD"
    },
    {
      "type": "text",
      "section": "Parenteral Nutrition",
      "line": 3306,
      "preview": "Francine Breckler, PharmD, BCPPS"
    },
    {
      "type": "heading",
      "level": 2,
      "section": "Indications for Parenteral Nutrition",
      "line": 3308
    },
    {
      "type": "text",
      "section": "Indications for Parenteral Nutrition",
      "line": 3310,
      "preview": "Parenteral nutrition (PN) is a therapeutic option for patients who are unable to tolerate an enteral"
    },
    {
      "type": "text",
      "section": "Indications for Parenteral Nutrition",
      "line": 3312,
      "preview": "- Identify clinical indicators for PN such as impaired gastrointestinal (GI) absorption, mechanical "
    },
    {
      "type": "text",
      "section": "Indications for Parenteral Nutrition",
      "line": 3313,
      "preview": "- Identify clinical scenarios in which PN may not be indicated."
    },
    {
      "type": "text",
      "section": "Indications for Parenteral Nutrition",
      "line": 3314,
      "preview": "- Ensure appropriate selection of vascular access devices."
    },
    {
      "type": "text",
      "section": "Indications for Parenteral Nutrition",
      "line": 3315,
      "preview": "- Take measures to ensure safe use of PN and decrease adverse effects."
    },
    {
      "type": "text",
      "section": "Indications for Parenteral Nutrition",
      "line": 3316,
      "preview": "- Ensure continual PN evaluation, including ongoing need."
    },
    {
      "type": "text",
      "section": "Indications for Parenteral Nutrition",
      "line": 3317,
      "preview": "- Transition to oral nutrition or enteral nutrition (EN) when feasible."
    },
    {
      "type": "text",
      "section": "Indications for Parenteral Nutrition",
      "line": 3318,
      "preview": "- Collaborate with multiple disciplines to ensure appropriate therapy decisions and outcomes."
    },
    {
      "type": "text",
      "section": "Indications for Parenteral Nutrition",
      "line": 3320,
      "preview": "The focus of this chapter is to provide a concise review of PN therapy including vascular access sel"
    },
    {
      "type": "heading",
      "level": 2,
      "section": "Vascular Access for PN",
      "line": 3322
    },
    {
      "type": "text",
      "section": "Vascular Access for PN",
      "line": 3324,
      "preview": "--- page 168 ---"
    },
    {
      "type": "text",
      "section": "Vascular Access for PN",
      "line": 3326,
      "preview": "Selection of a vascular access device for PN requires careful consideration that should account for "
    },
    {
      "type": "text",
      "section": "Vascular Access for PN",
      "line": 3328,
      "preview": "TABLE 6-1. Summary of miniMAGIC Guidelines"
    },
    {
      "type": "table",
      "section": "Vascular Access for PN",
      "line": 3330,
      "preview": "| Age | Duration of <br> Catheter Need <br> (Days) | Peripherally <br> Compatible IV <br> Solution |"
    },
    {
      "type": "table",
      "section": "Vascular Access for PN",
      "line": 3331,
      "preview": "| :-- | :-- | :-- | :-- |"
    },
    {
      "type": "table",
      "section": "Vascular Access for PN",
      "line": 3332,
      "preview": "| Hospitalized <br> infant $\\leq 1$ y | $\\leq 14 \\mathrm{~d}$ | PIV <br> PICC <br> Tunneled CVC, PIC"
    },
    {
      "type": "table",
      "section": "Vascular Access for PN",
      "line": 3333,
      "preview": "| Hospitalized <br> child $>1$ y | $\\leq 14 \\mathrm{~d}$ | PIV, midline | PICC, nontunneled CVC <br>"
    },
    {
      "type": "table",
      "section": "Vascular Access for PN",
      "line": 3334,
      "preview": "|  | $15-30 \\mathrm{~d}$ | PICC <br> PICC, tunneled CVC, <br> implantable CVC (port) |  |"
    },
    {
      "type": "text",
      "section": "Vascular Access for PN",
      "line": 3336,
      "preview": "Abbreviations: CVC, central venous catheter; IV, intravenous; miniMAGIC, Michigan Appropriateness Gu"
    },
    {
      "type": "text",
      "section": "Vascular Access for PN",
      "line": 3338,
      "preview": "--- page 169 ---"
    },
    {
      "type": "text",
      "section": "Vascular Access for PN",
      "line": 3340,
      "preview": "TABLE 6-2. Location, Advantages, and Disadvantages of Vascular Access Devices"
    },
    {
      "type": "table",
      "section": "Vascular Access for PN",
      "line": 3342,
      "preview": "| Vascular <br> Access <br> Device | Location of <br> Access | Advantages | Disadvantages |"
    },
    {
      "type": "table",
      "section": "Vascular Access for PN",
      "line": 3343,
      "preview": "| :--: | :--: | :--: | :--: |"
    },
    {
      "type": "table",
      "section": "Vascular Access for PN",
      "line": 3344,
      "preview": "| Peripheral <br> IV catheter | Hand, antecubital, <br> scalp veins | - Lower cost of placement <br>"
    },
    {
      "type": "table",
      "section": "Vascular Access for PN",
      "line": 3345,
      "preview": "| Midline catheter | Proximal basilic or cephalic veins | - May retain in place longer than peripher"
    },
    {
      "type": "table",
      "section": "Vascular Access for PN",
      "line": 3346,
      "preview": "| PICC | Basilic, brachial or cephalic vein | - Decreased risk of pneumothorax <br> - May be used fo"
    },
    {
      "type": "table",
      "section": "Vascular Access for PN",
      "line": 3347,
      "preview": "| Nontunneled CVC | Internal jugular vein, subclavian vein, and femoral vein | - Can infuse hyperosm"
    },
    {
      "type": "table",
      "section": "Vascular Access for PN",
      "line": 3348,
      "preview": "| Tunneled CVC | Subclavian or internal jugular vein | - Can be used long term <br> - Useful for hom"
    },
    {
      "type": "text",
      "section": "Vascular Access for PN",
      "line": 3350,
      "preview": "--- page 170 ---"
    },
    {
      "type": "table",
      "section": "Vascular Access for PN",
      "line": 3352,
      "preview": "| Vascular <br> Access <br> Device | Location of <br> Access | Advantages | Disadvantages |"
    },
    {
      "type": "table",
      "section": "Vascular Access for PN",
      "line": 3353,
      "preview": "| :-- | :-- | :-- | :-- |"
    },
    {
      "type": "table",
      "section": "Vascular Access for PN",
      "line": 3354,
      "preview": "| Implantable <br> CVC (port) | Subclavian or <br> internal jugular vein | - Longest <br> duration o"
    },
    {
      "type": "text",
      "section": "Vascular Access for PN",
      "line": 3356,
      "preview": "Abbreviations: CVC, central venous catheter; IV, intravenous; PICC, peripherally inserted central ca"
    },
    {
      "type": "image",
      "section": "Vascular Access for PN",
      "line": 3357,
      "content": "![img-9.jpeg](images/71b18c5337391a90.png)"
    },
    {
      "type": "text",
      "section": "Vascular Access for PN",
      "line": 3359,
      "preview": "FIGURE 6-1. Access types and locations of select central venous access devices in children. PICC, pe"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "PN Ordering and Safety Considerations",
      "line": 3361
    },
    {
      "type": "text",
      "section": "PN Ordering and Safety Considerations",
      "line": 3363,
      "preview": "PN is a complex IV solution that requires specialized expertise to ensure that the order is both saf"
    },
    {
      "type": "text",
      "section": "PN Ordering and Safety Considerations",
      "line": 3365,
      "preview": "--- page 171 ---"
    },
    {
      "type": "text",
      "section": "PN Ordering and Safety Considerations",
      "line": 3367,
      "preview": "nutrition status, EN is still preferred over PN because of decreased complications and cost. ${ }^{6"
    },
    {
      "type": "text",
      "section": "PN Ordering and Safety Considerations",
      "line": 3369,
      "preview": "1. Assessment"
    },
    {
      "type": "text",
      "section": "PN Ordering and Safety Considerations",
      "line": 3371,
      "preview": "- Evaluation of patient history"
    },
    {
      "type": "text",
      "section": "PN Ordering and Safety Considerations",
      "line": 3372,
      "preview": "- Physical and caloric requirements"
    },
    {
      "type": "text",
      "section": "PN Ordering and Safety Considerations",
      "line": 3373,
      "preview": "- Access options"
    },
    {
      "type": "text",
      "section": "PN Ordering and Safety Considerations",
      "line": 3375,
      "preview": "2. Prescription"
    },
    {
      "type": "text",
      "section": "PN Ordering and Safety Considerations",
      "line": 3377,
      "preview": "- Indication for PN"
    },
    {
      "type": "text",
      "section": "PN Ordering and Safety Considerations",
      "line": 3378,
      "preview": "- Patient weight"
    },
    {
      "type": "text",
      "section": "PN Ordering and Safety Considerations",
      "line": 3379,
      "preview": "- Macronutrients ordered as $\\mathrm{g} / \\mathrm{kg} / \\mathrm{d}$ or $\\mathrm{g} / \\mathrm{d}$"
    },
    {
      "type": "text",
      "section": "PN Ordering and Safety Considerations",
      "line": 3380,
      "preview": "- Order based on access (peripheral or central)"
    },
    {
      "type": "text",
      "section": "PN Ordering and Safety Considerations",
      "line": 3381,
      "preview": "- Desired PN volume"
    },
    {
      "type": "text",
      "section": "PN Ordering and Safety Considerations",
      "line": 3382,
      "preview": "- Nutrition goals for macronutrients"
    },
    {
      "type": "text",
      "section": "PN Ordering and Safety Considerations",
      "line": 3383,
      "preview": "- Choice of electrolytes including decision for selection of cations and anions as determined by the"
    },
    {
      "type": "text",
      "section": "PN Ordering and Safety Considerations",
      "line": 3384,
      "preview": "- Micronutrients (use of a commercially available trace metal package vs prescribing each individual"
    },
    {
      "type": "text",
      "section": "PN Ordering and Safety Considerations",
      "line": 3385,
      "preview": "- Multivitamins"
    },
    {
      "type": "text",
      "section": "PN Ordering and Safety Considerations",
      "line": 3386,
      "preview": "- Additives (Carnitine, heparin, etc)"
    },
    {
      "type": "text",
      "section": "PN Ordering and Safety Considerations",
      "line": 3388,
      "preview": "3. Review"
    },
    {
      "type": "text",
      "section": "PN Ordering and Safety Considerations",
      "line": 3390,
      "preview": "- Appropriate route of administration"
    },
    {
      "type": "text",
      "section": "PN Ordering and Safety Considerations",
      "line": 3391,
      "preview": "- Appropriate weight"
    },
    {
      "type": "text",
      "section": "PN Ordering and Safety Considerations",
      "line": 3392,
      "preview": "- Current date and time"
    },
    {
      "type": "text",
      "section": "PN Ordering and Safety Considerations",
      "line": 3393,
      "preview": "- Correct PN prescription form for weight and age"
    },
    {
      "type": "text",
      "section": "PN Ordering and Safety Considerations",
      "line": 3394,
      "preview": "- Infusion rate within usual limits for weight and age ( $\\mathrm{mL} / \\mathrm{kg} / \\mathrm{d}$ or"
    },
    {
      "type": "text",
      "section": "PN Ordering and Safety Considerations",
      "line": 3395,
      "preview": "- Macronutrients, micronutrient, medication additives within usual dosing limits"
    },
    {
      "type": "text",
      "section": "PN Ordering and Safety Considerations",
      "line": 3396,
      "preview": "- Multivitamin ordered based on weight and age"
    },
    {
      "type": "text",
      "section": "PN Ordering and Safety Considerations",
      "line": 3397,
      "preview": "- Trace minerals ordered based on weight and age"
    },
    {
      "type": "text",
      "section": "PN Ordering and Safety Considerations",
      "line": 3398,
      "preview": "- Appropriate ordering units (grams, milligrams, micrograms, millimoles, etc)"
    },
    {
      "type": "text",
      "section": "PN Ordering and Safety Considerations",
      "line": 3399,
      "preview": "- Calcium and phosphorus solubility within limits"
    },
    {
      "type": "text",
      "section": "PN Ordering and Safety Considerations",
      "line": 3400,
      "preview": "- Formulation within all stability limits"
    },
    {
      "type": "text",
      "section": "PN Ordering and Safety Considerations",
      "line": 3401,
      "preview": "- Osmolarity not exceeded if peripheral PN ordered"
    },
    {
      "type": "text",
      "section": "PN Ordering and Safety Considerations",
      "line": 3403,
      "preview": "All disciplines should be involved in assessing, prescribing, ordering, administering, evaluating, a"
    },
    {
      "type": "text",
      "section": "PN Ordering and Safety Considerations",
      "line": 3405,
      "preview": "--- page 172 ---"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "Access Considerations",
      "line": 3407
    },
    {
      "type": "text",
      "section": "Access Considerations",
      "line": 3409,
      "preview": "The type of access will determine whether a peripheral or central PN can be ordered. Central access "
    },
    {
      "type": "heading",
      "level": 2,
      "section": "EXHIBIT 6-1. Considerations for Peripheral Parenteral Nutrition",
      "line": 3411
    },
    {
      "type": "text",
      "section": "EXHIBIT 6-1. Considerations for Peripheral Parenteral Nutrition",
      "line": 3413,
      "preview": "- Limited by osmolarity ( $60-900 \\mathrm{mOsm} / \\mathrm{L}$ [institution specific])"
    },
    {
      "type": "text",
      "section": "EXHIBIT 6-1. Considerations for Peripheral Parenteral Nutrition",
      "line": 3414,
      "preview": "- Generally, will not meet $100 \\%$ of estimated calories and protein"
    },
    {
      "type": "text",
      "section": "EXHIBIT 6-1. Considerations for Peripheral Parenteral Nutrition",
      "line": 3415,
      "preview": "- Used for short-term nutrition support (3-7 d) until transitioned to CPN or EN"
    },
    {
      "type": "text",
      "section": "EXHIBIT 6-1. Considerations for Peripheral Parenteral Nutrition",
      "line": 3416,
      "preview": "- Maximum dextrose concentration $12.5 \\%$"
    },
    {
      "type": "text",
      "section": "EXHIBIT 6-1. Considerations for Peripheral Parenteral Nutrition",
      "line": 3417,
      "preview": "- Osmolarity driven by amino acids, dextrose, sodium, potassium, and calcium"
    },
    {
      "type": "text",
      "section": "EXHIBIT 6-1. Considerations for Peripheral Parenteral Nutrition",
      "line": 3418,
      "preview": "- Monitor closely for phlebitis or infiltration of intravenous line"
    },
    {
      "type": "text",
      "section": "EXHIBIT 6-1. Considerations for Peripheral Parenteral Nutrition",
      "line": 3420,
      "preview": "Abbreviations: CPN, central parenteral nutrition; EN, enteral nutrition."
    },
    {
      "type": "heading",
      "level": 2,
      "section": "Use of 2-in-1 vs 3-in-1 PN",
      "line": 3422
    },
    {
      "type": "text",
      "section": "Use of 2-in-1 vs 3-in-1 PN",
      "line": 3424,
      "preview": "The PN can be ordered as amino acid/dextrose solution with the lipids co-infused (2-in-1) or all 3 m"
    },
    {
      "type": "text",
      "section": "Use of 2-in-1 vs 3-in-1 PN",
      "line": 3426,
      "preview": "--- page 173 ---"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "Use of Filters and Photoprotection",
      "line": 3428
    },
    {
      "type": "heading",
      "level": 2,
      "section": "Filters",
      "line": 3430
    },
    {
      "type": "text",
      "section": "Filters",
      "line": 3432,
      "preview": "Filters are available in a variety of sizes and are essential for trapping particulate matter, micro"
    },
    {
      "type": "text",
      "section": "Filters",
      "line": 3434,
      "preview": "- Ensure pharmacist review of the stability and compatibility of the PN solution."
    },
    {
      "type": "text",
      "section": "Filters",
      "line": 3435,
      "preview": "- Perform a visual inspection of the PN."
    },
    {
      "type": "text",
      "section": "Filters",
      "line": 3436,
      "preview": "- If a 2-in-1 PN solution is ordered, the amino acids and dextrose should be set up first, and the i"
    },
    {
      "type": "text",
      "section": "Filters",
      "line": 3437,
      "preview": "- Avoid co-administration of medications if possible."
    },
    {
      "type": "text",
      "section": "Filters",
      "line": 3438,
      "preview": "- Ensure use of appropriate flushing techniques before and after medication administration."
    },
    {
      "type": "text",
      "section": "Filters",
      "line": 3439,
      "preview": "- If a medication must be co-administered with the PN, the medication tubing should be attached at a"
    },
    {
      "type": "text",
      "section": "Filters",
      "line": 3440,
      "preview": "- Medications that cannot be filtered should not be given with PN."
    },
    {
      "type": "text",
      "section": "Filters",
      "line": 3441,
      "preview": "- Use a $1.2-\\mu \\mathrm{m}$ filter for all PN admixtures."
    },
    {
      "type": "heading",
      "level": 2,
      "section": "Photoprotection",
      "line": 3444
    },
    {
      "type": "text",
      "section": "Photoprotection",
      "line": 3446,
      "preview": "Components of the PN including lipid injectable emulsions (ILEs) can undergo oxidation when exposed "
    },
    {
      "type": "heading",
      "level": 2,
      "section": "Calculating PN Fluid Requirements",
      "line": 3448
    },
    {
      "type": "text",
      "section": "Calculating PN Fluid Requirements",
      "line": 3450,
      "preview": "The PN fluid volume is usually based on the patient's maintenance requirements. Other clinical facto"
    },
    {
      "type": "text",
      "section": "Calculating PN Fluid Requirements",
      "line": 3452,
      "preview": "--- page 174 ---"
    },
    {
      "type": "text",
      "section": "Calculating PN Fluid Requirements",
      "line": 3454,
      "preview": "for patients who have an increased amount of ostomy output or diarrhea. A volume less than maintenan"
    },
    {
      "type": "text",
      "section": "Calculating PN Fluid Requirements",
      "line": 3456,
      "preview": "Individualized patient assessment, especially in the critically ill child, is necessary to determine"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "Macronutrient Requirements",
      "line": 3458
    },
    {
      "type": "heading",
      "level": 2,
      "section": "General",
      "line": 3460
    },
    {
      "type": "text",
      "section": "General",
      "line": 3462,
      "preview": "The amounts of amino acids, dextrose, and ILEs are based on individual requirements. Table 6-3 provi"
    },
    {
      "type": "text",
      "section": "General",
      "line": 3464,
      "preview": "--- page 175 ---"
    },
    {
      "type": "text",
      "section": "General",
      "line": 3466,
      "preview": "TABLE 6-3. Dosing for Initiation and Advancement of PN Macronutrients ${ }^{\\mathrm{a}, \\mathrm{b}}$"
    },
    {
      "type": "table",
      "section": "General",
      "line": 3468,
      "preview": "|  | Initiation | Advance By | Goal |"
    },
    {
      "type": "table",
      "section": "General",
      "line": 3469,
      "preview": "| :-- | :--: | :--: | :--: |"
    },
    {
      "type": "table",
      "section": "General",
      "line": 3470,
      "preview": "| Children (1-10 y) |  |  |  |"
    },
    {
      "type": "table",
      "section": "General",
      "line": 3471,
      "preview": "| Protein $(\\mathrm{g} / \\mathrm{kg} / \\mathrm{d})$ | $1.5-2.5$ | - | $1.5-2.5$ |"
    },
    {
      "type": "table",
      "section": "General",
      "line": 3472,
      "preview": "| Dextrose $(\\mathrm{mg} / \\mathrm{kg} / \\mathrm{min})$ | $3-6$ | $1-2$ | $8-10$ |"
    },
    {
      "type": "table",
      "section": "General",
      "line": 3473,
      "preview": "| SO-ILE | $1-2$ | $0.5-1$ | $2-2.5$ |"
    },
    {
      "type": "table",
      "section": "General",
      "line": 3474,
      "preview": "| Adolescents |  |  |  |"
    },
    {
      "type": "table",
      "section": "General",
      "line": 3475,
      "preview": "| Protein $(\\mathrm{g} / \\mathrm{kg} / \\mathrm{d})$ | $0.8-2$ | - | $0.8-2$ |"
    },
    {
      "type": "table",
      "section": "General",
      "line": 3476,
      "preview": "| Dextrose $(\\mathrm{mg} / \\mathrm{kg} / \\mathrm{min})$ | $2.5-3$ | $1-2$ | $5-6$ |"
    },
    {
      "type": "table",
      "section": "General",
      "line": 3477,
      "preview": "| SO-ILE | 1 | 1 | $1-2$ |"
    },
    {
      "type": "text",
      "section": "General",
      "line": 3479,
      "preview": "Abbreviations: GIR, glucose infusion rate; PN, parenteral nutrition; SO-ILE, soybean oil-based lipid"
    },
    {
      "type": "text",
      "section": "General",
      "line": 3480,
      "preview": "${ }^{a}$ Adapted with permission from the American Society for Parenteral and Enteral Nutrition fro"
    },
    {
      "type": "text",
      "section": "General",
      "line": 3481,
      "preview": "${ }^{\\text {b }}$ GIR calculation in $\\mathrm{mg} / \\mathrm{kg} / \\mathrm{min}=[$ dextrose $(\\mathr"
    },
    {
      "type": "text",
      "section": "General",
      "line": 3483,
      "preview": "Macronutrients are generally ordered in weight-based units such as $\\mathrm{g} / \\mathrm{kg} / \\math"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "Amino Acids",
      "line": 3485
    },
    {
      "type": "text",
      "section": "Amino Acids",
      "line": 3487,
      "preview": "Pediatric amino acid products are usually reserved for neonatal patients based on the original resea"
    },
    {
      "type": "text",
      "section": "Amino Acids",
      "line": 3489,
      "preview": "--- page 176 ---"
    },
    {
      "type": "text",
      "section": "Amino Acids",
      "line": 3491,
      "preview": "immature and damaged livers. Standard amino acids are routinely used in the remainder of our pediatr"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "TABLE 6-4. Amino Acid Variations Between Pediatric Amino Acids and Adult or Standard Amino Acids",
      "line": 3493
    },
    {
      "type": "table",
      "section": "TABLE 6-4. Amino Acid Variations Between Pediatric Amino Acids and Adult or Standard Amino Acids",
      "line": 3495,
      "preview": "| Amino Acid Type | Pediatric Amino Acid | Standard Amino Acid |"
    },
    {
      "type": "table",
      "section": "TABLE 6-4. Amino Acid Variations Between Pediatric Amino Acids and Adult or Standard Amino Acids",
      "line": 3496,
      "preview": "| :--: | :--: | :--: |"
    },
    {
      "type": "table",
      "section": "TABLE 6-4. Amino Acid Variations Between Pediatric Amino Acids and Adult or Standard Amino Acids",
      "line": 3497,
      "preview": "| Essential amino acids |  |  |"
    },
    {
      "type": "table",
      "section": "TABLE 6-4. Amino Acid Variations Between Pediatric Amino Acids and Adult or Standard Amino Acids",
      "line": 3498,
      "preview": "| Leucine (branched chain) | Higher | Lower |"
    },
    {
      "type": "table",
      "section": "TABLE 6-4. Amino Acid Variations Between Pediatric Amino Acids and Adult or Standard Amino Acids",
      "line": 3499,
      "preview": "| Isoleucine (branched chain) | Higher | Lower |"
    },
    {
      "type": "table",
      "section": "TABLE 6-4. Amino Acid Variations Between Pediatric Amino Acids and Adult or Standard Amino Acids",
      "line": 3500,
      "preview": "| Valine (branched chain) | Slightly higher | Slightly lower |"
    },
    {
      "type": "table",
      "section": "TABLE 6-4. Amino Acid Variations Between Pediatric Amino Acids and Adult or Standard Amino Acids",
      "line": 3501,
      "preview": "| Lysine | Similar | Similar |"
    },
    {
      "type": "table",
      "section": "TABLE 6-4. Amino Acid Variations Between Pediatric Amino Acids and Adult or Standard Amino Acids",
      "line": 3502,
      "preview": "| Histidine | Slightly lower | Slightly higher |"
    },
    {
      "type": "table",
      "section": "TABLE 6-4. Amino Acid Variations Between Pediatric Amino Acids and Adult or Standard Amino Acids",
      "line": 3503,
      "preview": "| Phenylalanine (aromatic) | Slightly lower | Slightly higher |"
    },
    {
      "type": "table",
      "section": "TABLE 6-4. Amino Acid Variations Between Pediatric Amino Acids and Adult or Standard Amino Acids",
      "line": 3504,
      "preview": "| Threonine | Similar | Similar |"
    },
    {
      "type": "table",
      "section": "TABLE 6-4. Amino Acid Variations Between Pediatric Amino Acids and Adult or Standard Amino Acids",
      "line": 3505,
      "preview": "| Methionine (sulfur containing) | Lower | Higher |"
    },
    {
      "type": "table",
      "section": "TABLE 6-4. Amino Acid Variations Between Pediatric Amino Acids and Adult or Standard Amino Acids",
      "line": 3506,
      "preview": "| Tyrosine (aromatic) | Higher | Lower |"
    },
    {
      "type": "table",
      "section": "TABLE 6-4. Amino Acid Variations Between Pediatric Amino Acids and Adult or Standard Amino Acids",
      "line": 3507,
      "preview": "| Tryptophan (aromatic) | Slightly higher | Slightly lower |"
    },
    {
      "type": "table",
      "section": "TABLE 6-4. Amino Acid Variations Between Pediatric Amino Acids and Adult or Standard Amino Acids",
      "line": 3508,
      "preview": "| Cysteine (sulfur containing) | Small amount | None |"
    },
    {
      "type": "table",
      "section": "TABLE 6-4. Amino Acid Variations Between Pediatric Amino Acids and Adult or Standard Amino Acids",
      "line": 3509,
      "preview": "| Nonessential amino acids |  |  |"
    },
    {
      "type": "table",
      "section": "TABLE 6-4. Amino Acid Variations Between Pediatric Amino Acids and Adult or Standard Amino Acids",
      "line": 3510,
      "preview": "| Arginine | Higher | Lower |"
    },
    {
      "type": "table",
      "section": "TABLE 6-4. Amino Acid Variations Between Pediatric Amino Acids and Adult or Standard Amino Acids",
      "line": 3511,
      "preview": "| Proline | Slightly higher | Slightly lower |"
    },
    {
      "type": "table",
      "section": "TABLE 6-4. Amino Acid Variations Between Pediatric Amino Acids and Adult or Standard Amino Acids",
      "line": 3512,
      "preview": "| Alanine | Lower | Higher |"
    },
    {
      "type": "table",
      "section": "TABLE 6-4. Amino Acid Variations Between Pediatric Amino Acids and Adult or Standard Amino Acids",
      "line": 3513,
      "preview": "| Glutamic acid | Similar | Similar |"
    },
    {
      "type": "table",
      "section": "TABLE 6-4. Amino Acid Variations Between Pediatric Amino Acids and Adult or Standard Amino Acids",
      "line": 3514,
      "preview": "| Serine | Similar | Similar |"
    },
    {
      "type": "table",
      "section": "TABLE 6-4. Amino Acid Variations Between Pediatric Amino Acids and Adult or Standard Amino Acids",
      "line": 3515,
      "preview": "| Glycine | Lower | Higher |"
    },
    {
      "type": "table",
      "section": "TABLE 6-4. Amino Acid Variations Between Pediatric Amino Acids and Adult or Standard Amino Acids",
      "line": 3516,
      "preview": "| Aspartic acid | Slightly higher | Slightly lower |"
    },
    {
      "type": "table",
      "section": "TABLE 6-4. Amino Acid Variations Between Pediatric Amino Acids and Adult or Standard Amino Acids",
      "line": 3517,
      "preview": "| Taurine (sulfur containing) | Small amount | None |"
    },
    {
      "type": "heading",
      "level": 2,
      "section": "Dextrose",
      "line": 3519
    },
    {
      "type": "text",
      "section": "Dextrose",
      "line": 3521,
      "preview": "--- page 177 ---"
    },
    {
      "type": "text",
      "section": "Dextrose",
      "line": 3523,
      "preview": "Carbohydrate calories are ordered as dextrose, which provides energy or $3.4 \\mathrm{kcal} / \\mathrm"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "Lipid Injectable Emulsions",
      "line": 3525
    },
    {
      "type": "text",
      "section": "Lipid Injectable Emulsions",
      "line": 3527,
      "preview": "Lipid injectable emulsions (ILEs) provide a concentrated source of calories and essential fatty acid"
    },
    {
      "type": "text",
      "section": "Lipid Injectable Emulsions",
      "line": 3529,
      "preview": "--- page 178 ---"
    },
    {
      "type": "text",
      "section": "Lipid Injectable Emulsions",
      "line": 3531,
      "preview": "lipid emulsions. Table 6-7 provides dosing recommendations for the ILE products."
    },
    {
      "type": "text",
      "section": "Lipid Injectable Emulsions",
      "line": 3533,
      "preview": "--- page 179 ---"
    },
    {
      "type": "text",
      "section": "Lipid Injectable Emulsions",
      "line": 3535,
      "preview": "TABLE 6-5. Lipid Injectable Emulsion Products, Characteristics, Abbreviations, and Approval for Use "
    },
    {
      "type": "table",
      "section": "Lipid Injectable Emulsions",
      "line": 3537,
      "preview": "| Lipid <br> Injectable <br> Emulsion | Characteristic | Abbreviation | FDA-Approved Neonatal and <b"
    },
    {
      "type": "table",
      "section": "Lipid Injectable Emulsions",
      "line": 3538,
      "preview": "| :-- | :-- | :-- | :-- |"
    },
    {
      "type": "table",
      "section": "Lipid Injectable Emulsions",
      "line": 3539,
      "preview": "| - | Lipid injectable <br> emulsion | ILE | - |"
    },
    {
      "type": "table",
      "section": "Lipid Injectable Emulsions",
      "line": 3540,
      "preview": "| Intralipid <br> (Baxter <br> Healthcare <br> Corporation) | Soybean oil- <br> based ILE | SO-ILE |"
    },
    {
      "type": "table",
      "section": "Lipid Injectable Emulsions",
      "line": 3541,
      "preview": "| Nutrilipid (B. <br> Braun <br> Medical, <br> Inc) | Soybean oil- <br> based ILE | SO-ILE | A sourc"
    },
    {
      "type": "table",
      "section": "Lipid Injectable Emulsions",
      "line": 3542,
      "preview": "| SMOFlipid <br> (Fresenius <br> Kabi) | Soybean, <br> MCTs, olive, <br> fish oil-based <br> ILE | S"
    },
    {
      "type": "table",
      "section": "Lipid Injectable Emulsions",
      "line": 3543,
      "preview": "| Omegaven <br> (Fresenius <br> Kabi) | Fish oil-based <br> ILE | FO-ILE | A source of calories and "
    },
    {
      "type": "table",
      "section": "Lipid Injectable Emulsions",
      "line": 3544,
      "preview": "| Clinolipid <br> (Baxter <br> Healthcare <br> Corporation) | Olive, soybean <br> oil-based ILE | OO"
    },
    {
      "type": "text",
      "section": "Lipid Injectable Emulsions",
      "line": 3546,
      "preview": "Abbreviations: EFA, essential fatty acid; EFAD, EFA deficiency; EN, enteral nutrition; FA, fatty aci"
    },
    {
      "type": "text",
      "section": "Lipid Injectable Emulsions",
      "line": 3547,
      "preview": "Adapted with permission from the American Society for Parenteral and Enteral Nutrition from Cober MP"
    },
    {
      "type": "text",
      "section": "Lipid Injectable Emulsions",
      "line": 3548,
      "preview": "${ }^{a}$ Intralipid 20\\%. Package insert. Fresenius Kabi; 2016."
    },
    {
      "type": "text",
      "section": "Lipid Injectable Emulsions",
      "line": 3549,
      "preview": "${ }^{\\text {b }}$ Nutrilipid. Package insert. B. Braun Medical Inc; 2020."
    },
    {
      "type": "text",
      "section": "Lipid Injectable Emulsions",
      "line": 3550,
      "preview": "${ }^{\\text {c }}$ SMOFlipid. Package insert. Fresenius Kabi; 2022."
    },
    {
      "type": "text",
      "section": "Lipid Injectable Emulsions",
      "line": 3552,
      "preview": "--- page 180 ---"
    },
    {
      "type": "text",
      "section": "Lipid Injectable Emulsions",
      "line": 3554,
      "preview": "${ }^{d}$ Omegaven. Package insert. Fresenius Kabi; 2018."
    },
    {
      "type": "text",
      "section": "Lipid Injectable Emulsions",
      "line": 3555,
      "preview": "${ }^{e}$ Clinolipid. Package insert. Baxter Healthcare Corporation, 2016."
    },
    {
      "type": "text",
      "section": "Lipid Injectable Emulsions",
      "line": 3557,
      "preview": "--- page 181 ---"
    },
    {
      "type": "text",
      "section": "Lipid Injectable Emulsions",
      "line": 3559,
      "preview": "TABLE 6-6. Composition and Properties of ILE Products"
    },
    {
      "type": "table",
      "section": "Lipid Injectable Emulsions",
      "line": 3561,
      "preview": "| Category | Component $^{\\text {a }}$ | $\\begin{gathered} \\text { OO,SO- } \\\\ \\text { ILE }^{\\text "
    },
    {
      "type": "table",
      "section": "Lipid Injectable Emulsions",
      "line": 3562,
      "preview": "| :--: | :--: | :--: | :--: | :--: | :--: | :--: |"
    },
    {
      "type": "table",
      "section": "Lipid Injectable Emulsions",
      "line": 3563,
      "preview": "| Source oil | SO, \\% | 20 | 100 | 100 | 0 | 30 |"
    },
    {
      "type": "table",
      "section": "Lipid Injectable Emulsions",
      "line": 3564,
      "preview": "|  | FO, \\% | 0 | 0 | 0 | 100 | 15 |"
    },
    {
      "type": "table",
      "section": "Lipid Injectable Emulsions",
      "line": 3565,
      "preview": "|  | MCT, \\% | 0 | 0 | 0 | 0 | 30 |"
    },
    {
      "type": "table",
      "section": "Lipid Injectable Emulsions",
      "line": 3566,
      "preview": "|  | OO, \\% | 80 | 0 | 0 | 0 | 25 |"
    },
    {
      "type": "table",
      "section": "Lipid Injectable Emulsions",
      "line": 3567,
      "preview": "| Additives | Egg phospholipid, $\\mathrm{g} / 100 \\mathrm{~mL}$ | 1.2 | 1.2 | 1.2 | 1.2 | 1.2 |"
    },
    {
      "type": "table",
      "section": "Lipid Injectable Emulsions",
      "line": 3568,
      "preview": "|  | Glycerin, g/100 mL | 2.25 | 2.25 | 2.5 | 2.5 | 2.5 |"
    },
    {
      "type": "table",
      "section": "Lipid Injectable Emulsions",
      "line": 3569,
      "preview": "|  | $\\alpha$-Tocopherol, $\\mathrm{mg} / 100 \\mathrm{~mL}$ | 3.2 | 0 | 0 | $15-30$ | 16.3-22.5 |"
    },
    {
      "type": "table",
      "section": "Lipid Injectable Emulsions",
      "line": 3570,
      "preview": "|  | Sodium oleate, $\\mathrm{g} / 100 \\mathrm{~mL}$ | 0.03 | 0 | 0.03 | 0.03 | 0.03 |"
    },
    {
      "type": "table",
      "section": "Lipid Injectable Emulsions",
      "line": 3571,
      "preview": "| $\\omega-3$ | Linolenic acid, \\% | $0.5-4.2$ | $4-11$ | $4-11$ | $\\begin{gathered} 1.1 \\\\ \\text { ("
    },
    {
      "type": "table",
      "section": "Lipid Injectable Emulsions",
      "line": 3572,
      "preview": "|  | EPA, \\% | 0 | 0 | 0 | $13-26$ | $1-3.5$ |"
    },
    {
      "type": "table",
      "section": "Lipid Injectable Emulsions",
      "line": 3573,
      "preview": "|  | DHA, \\% | 0 | 0 | 0 | $14-27$ | $1-3.5$ |"
    },
    {
      "type": "table",
      "section": "Lipid Injectable Emulsions",
      "line": 3574,
      "preview": "| $\\omega-6$ | Linoleic acid, \\% | $13.8-22$ | $44-62$ | $\\begin{gathered} 48- \\\\ 58 \\end{gathered}$"
    },
    {
      "type": "table",
      "section": "Lipid Injectable Emulsions",
      "line": 3575,
      "preview": "|  | Arachidonic acid, \\% | 0 | 0 | 0 | $0.2-2$ | NR |"
    },
    {
      "type": "table",
      "section": "Lipid Injectable Emulsions",
      "line": 3576,
      "preview": "| $\\omega-7$ | Palmitoleic acid, \\% | 0 | 0 | 0 | $4-10$ | NR |"
    },
    {
      "type": "table",
      "section": "Lipid Injectable Emulsions",
      "line": 3577,
      "preview": "| $\\omega-9$ | Oleic acid, \\% | $\\begin{gathered} 44.3- \\\\ 79.5 \\end{gathered}$ | $19-30$ | $\\begin{"
    },
    {
      "type": "table",
      "section": "Lipid Injectable Emulsions",
      "line": 3578,
      "preview": "| Saturated fatty acids | Caprylic acid, \\% | 0 | 0 | 0 | 0 | $13-24$ |"
    },
    {
      "type": "table",
      "section": "Lipid Injectable Emulsions",
      "line": 3579,
      "preview": "|  | Capric acid, \\% | 0 | 0 | 0 | 0 | $5-15$ |"
    },
    {
      "type": "table",
      "section": "Lipid Injectable Emulsions",
      "line": 3580,
      "preview": "|  | Palmitic acid, \\% | $\\begin{gathered} 7.6- \\\\ 19.3 \\end{gathered}$ | $7-14$ | $9-13$ | $4-12$ |"
    },
    {
      "type": "table",
      "section": "Lipid Injectable Emulsions",
      "line": 3581,
      "preview": "|  | Stearic acid, \\% | $0.7-5$ | $1.4-5.5$ | $\\begin{gathered} 2.5- \\\\ 5 \\end{gathered}$ | 0 | $1.5"
    },
    {
      "type": "table",
      "section": "Lipid Injectable Emulsions",
      "line": 3582,
      "preview": "|  | Myristic acid, \\% | 0 | 0 | 0 | $2-7$ | NR |"
    },
    {
      "type": "table",
      "section": "Lipid Injectable Emulsions",
      "line": 3583,
      "preview": "|  | $\\omega-6 / \\omega-3$ ratio | 9:1 | 7:1 | 7:1 | 1:8 | 2.5:1 |"
    },
    {
      "type": "text",
      "section": "Lipid Injectable Emulsions",
      "line": 3585,
      "preview": "--- page 182 ---"
    },
    {
      "type": "table",
      "section": "Lipid Injectable Emulsions",
      "line": 3587,
      "preview": "| Category | Component $^{\\text {a }}$ | $\\begin{gathered} \\text { OO,SO- } \\\\ \\text { ILE }^{\\text "
    },
    {
      "type": "table",
      "section": "Lipid Injectable Emulsions",
      "line": 3588,
      "preview": "| :--: | :--: | :--: | :--: | :--: | :--: | :--: |"
    },
    {
      "type": "table",
      "section": "Lipid Injectable Emulsions",
      "line": 3589,
      "preview": "|  | Phytosterols, $\\mathrm{mg} / \\mathrm{L}^{\\mathrm{g}}$ | $\\begin{gathered} 208.8 \\pm \\\\ 39.4 \\en"
    },
    {
      "type": "table",
      "section": "Lipid Injectable Emulsions",
      "line": 3590,
      "preview": "| Energy, $\\mathrm{kcal} / \\mathrm{mL}$ | \u2014 | 2 | $2^{\\text {h }}$ | 2 | 1.12 | 2 |"
    },
    {
      "type": "text",
      "section": "Lipid Injectable Emulsions",
      "line": 3592,
      "preview": "Abbreviations: DHA, docosahexaenoic acid; EPA, eicosapentaenoic acid; FO, fish oil; FO-ILE, FO-based"
    },
    {
      "type": "text",
      "section": "Lipid Injectable Emulsions",
      "line": 3593,
      "preview": "Reproduced with permission from the American Society for Parenteral and Enteral Nutrition from Cober"
    },
    {
      "type": "text",
      "section": "Lipid Injectable Emulsions",
      "line": 3594,
      "preview": "${ }^{a}$ The \"\\%\" symbol in this column refers to the percent of total oil content of the product."
    },
    {
      "type": "text",
      "section": "Lipid Injectable Emulsions",
      "line": 3595,
      "preview": "${ }^{\\text {b }}$ Clinolipid. Package insert. Baxter Healthcare Corporation, 2016."
    },
    {
      "type": "text",
      "section": "Lipid Injectable Emulsions",
      "line": 3596,
      "preview": "${ }^{\\text {c }}$ Intralipid 20\\%. Package insert. Fresenius Kabi; 2016."
    },
    {
      "type": "text",
      "section": "Lipid Injectable Emulsions",
      "line": 3597,
      "preview": "${ }^{d}$ Nutrilipid. Package insert. B. Braun Medical Inc; 2020."
    },
    {
      "type": "text",
      "section": "Lipid Injectable Emulsions",
      "line": 3598,
      "preview": "${ }^{\\text {e }}$ Omegaven. Package insert. Fresenius Kabi; 2018."
    },
    {
      "type": "text",
      "section": "Lipid Injectable Emulsions",
      "line": 3599,
      "preview": "${ }^{f}$ SMOFlipid. Package insert. Fresenius Kabi; 2015."
    },
    {
      "type": "text",
      "section": "Lipid Injectable Emulsions",
      "line": 3600,
      "preview": "${ }^{9}$ Llop Talaver\u00f3n JM, Novak A, Su\u00f1\u00e9 Negre JM, Badia Tahull M, Leiva Badosa E, Tic\u00f3 Grau JR. P"
    },
    {
      "type": "text",
      "section": "Lipid Injectable Emulsions",
      "line": 3601,
      "preview": "${ }^{\\text {h }}$ This applies for the $20 \\%$ product, whereas there is also a $30 \\%$ product to "
    },
    {
      "type": "text",
      "section": "Lipid Injectable Emulsions",
      "line": 3603,
      "preview": "--- page 183 ---"
    },
    {
      "type": "text",
      "section": "Lipid Injectable Emulsions",
      "line": 3605,
      "preview": "TABLE 6-7. Published Pediatric Dosage for ILE Products"
    },
    {
      "type": "table",
      "section": "Lipid Injectable Emulsions",
      "line": 3607,
      "preview": "|  | $\\begin{gathered} \\text { OO,SO-ILE } \\\\ (\\mathrm{g} / \\mathrm{kg} / \\mathrm{d})^{\\mathrm{a}, \\"
    },
    {
      "type": "table",
      "section": "Lipid Injectable Emulsions",
      "line": 3608,
      "preview": "| :--: | :--: | :--: | :--: | :--: |"
    },
    {
      "type": "table",
      "section": "Lipid Injectable Emulsions",
      "line": 3609,
      "preview": "| Preterm neonate | $3^{9}$ | 3 | $1^{9}$ | $3^{9}$ |"
    },
    {
      "type": "table",
      "section": "Lipid Injectable Emulsions",
      "line": 3610,
      "preview": "| Term neonate, infant $(0-12 \\mathrm{mo})$ | $3^{9}$ | $2.5-3$ | $1^{9}$ | $3^{9}$ |"
    },
    {
      "type": "table",
      "section": "Lipid Injectable Emulsions",
      "line": 3611,
      "preview": "| Pediatric (1-10 y) | $3^{9}$ | 2.5 | $1^{9}$ | $2.5-3^{9}$ |"
    },
    {
      "type": "table",
      "section": "Lipid Injectable Emulsions",
      "line": 3612,
      "preview": "| Adolescent (11-17 y) | $2.5^{9}$ | $2-2.5$ | $1^{9}$ | $2-2.5^{9}$ |"
    },
    {
      "type": "text",
      "section": "Lipid Injectable Emulsions",
      "line": 3614,
      "preview": "Abbreviations: FO-ILE, fish oil-based ILE; ILE, lipid injectable emulsion; OO,SO-ILE, olive oil and "
    },
    {
      "type": "text",
      "section": "Lipid Injectable Emulsions",
      "line": 3615,
      "preview": "Reproduced with permission from the American Society for Parenteral and Enteral Nutrition from Cober"
    },
    {
      "type": "text",
      "section": "Lipid Injectable Emulsions",
      "line": 3616,
      "preview": "${ }^{a}$ Kerner JA Jr, Poole RL. The use of IV fat in neonates. Nutr Clin Prac. 2006;21(4):374-380."
    },
    {
      "type": "text",
      "section": "Lipid Injectable Emulsions",
      "line": 3617,
      "preview": "${ }^{\\text {b }}$ Gura KM, Calkins KL, Puder M. Use of fish oil lipid intravenous emulsions as mono"
    },
    {
      "type": "text",
      "section": "Lipid Injectable Emulsions",
      "line": 3618,
      "preview": "${ }^{\\text {c }}$ Intralipid 20\\%. Package insert. Fresenius Kabi; 2016."
    },
    {
      "type": "text",
      "section": "Lipid Injectable Emulsions",
      "line": 3619,
      "preview": "${ }^{d}$ Nutrilipid. Package insert. B. Braun Medical Inc; 2020."
    },
    {
      "type": "text",
      "section": "Lipid Injectable Emulsions",
      "line": 3620,
      "preview": "${ }^{\\text {e }}$ Omegaven. Package insert. Fresenius Kabi; 2018."
    },
    {
      "type": "text",
      "section": "Lipid Injectable Emulsions",
      "line": 3621,
      "preview": "${ }^{f}$ Diamond IR, Grant RC, Pencharz PB, et al. Preventing the progression of intestinal failure"
    },
    {
      "type": "text",
      "section": "Lipid Injectable Emulsions",
      "line": 3622,
      "preview": "${ }^{9} 1.5 \\mathrm{~g} / \\mathrm{kg} / \\mathrm{d}$ has been used off label for FO51 doses for OO, "
    },
    {
      "type": "text",
      "section": "Lipid Injectable Emulsions",
      "line": 3624,
      "preview": "The maximum lipid infusion rate is not clearly established for pediatric patients, but there are stu"
    },
    {
      "type": "text",
      "section": "Lipid Injectable Emulsions",
      "line": 3626,
      "preview": "--- page 184 ---"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "Micronutrients: Electrolytes",
      "line": 3628
    },
    {
      "type": "text",
      "section": "Micronutrients: Electrolytes",
      "line": 3630,
      "preview": "Electrolytes play a large role in many physiologic functions and are added to PN solutions to mainta"
    },
    {
      "type": "text",
      "section": "Micronutrients: Electrolytes",
      "line": 3632,
      "preview": "- Sodium is the main cation in the extracellular fluid and is responsible for maintaining intravascu"
    },
    {
      "type": "text",
      "section": "Micronutrients: Electrolytes",
      "line": 3633,
      "preview": "- Potassium is the major intracellular cation and is responsible for neuromuscular function and prot"
    },
    {
      "type": "text",
      "section": "Micronutrients: Electrolytes",
      "line": 3634,
      "preview": "- Chloride and acetate are the 2 main anions that are responsible for acid/base balance and osmotic "
    },
    {
      "type": "text",
      "section": "Micronutrients: Electrolytes",
      "line": 3635,
      "preview": "- Calcium and phosphorus are very important for bone mineralization and growth. ${ }^{8}$ In additio"
    },
    {
      "type": "text",
      "section": "Micronutrients: Electrolytes",
      "line": 3636,
      "preview": "- Magnesium is important for coenzyme activation and calcium and potassium homeostasis."
    },
    {
      "type": "text",
      "section": "Micronutrients: Electrolytes",
      "line": 3638,
      "preview": "Abnormal fluid losses as the result of diarrhea, vomiting, high nasogastric tube, or ostomy output c"
    },
    {
      "type": "text",
      "section": "Micronutrients: Electrolytes",
      "line": 3640,
      "preview": "--- page 185 ---"
    },
    {
      "type": "text",
      "section": "Micronutrients: Electrolytes",
      "line": 3642,
      "preview": "TABLE 6-8. Electrolyte Composition of Body Fluids"
    },
    {
      "type": "table",
      "section": "Micronutrients: Electrolytes",
      "line": 3644,
      "preview": "| Fluid <br> Type | Sodium <br> $(\\mathbf{m E q} / \\mathbf{L})$ | Potassium <br> $(\\mathbf{m E q} / "
    },
    {
      "type": "table",
      "section": "Micronutrients: Electrolytes",
      "line": 3645,
      "preview": "| :-- | :--: | :--: | :--: | :--: | :--: |"
    },
    {
      "type": "table",
      "section": "Micronutrients: Electrolytes",
      "line": 3646,
      "preview": "| Gastric | $20-80$ | $5-20$ | 0 | $8-154$ | $100-4000$ |"
    },
    {
      "type": "table",
      "section": "Micronutrients: Electrolytes",
      "line": 3647,
      "preview": "| Small <br> intestine | $100-140$ | $5-15$ | 40 | 80 | $100-2000$ |"
    },
    {
      "type": "table",
      "section": "Micronutrients: Electrolytes",
      "line": 3648,
      "preview": "| Diarrheal <br> stool | $10-90$ | $10-80$ | 40 | - | - |"
    },
    {
      "type": "table",
      "section": "Micronutrients: Electrolytes",
      "line": 3649,
      "preview": "| Ileostomy | $45-135$ | $3-15$ | 40 | $43-137$ | $100-9000$ |"
    },
    {
      "type": "table",
      "section": "Micronutrients: Electrolytes",
      "line": 3650,
      "preview": "| Colon | 60 | 30 | 0 | 40 | - |"
    },
    {
      "type": "table",
      "section": "Micronutrients: Electrolytes",
      "line": 3651,
      "preview": "| Bile | $131-164$ | $3-12$ | 35 | 100 | $50-800$ |"
    },
    {
      "type": "table",
      "section": "Micronutrients: Electrolytes",
      "line": 3652,
      "preview": "| Pancreas | $113-185$ | $3-7$ | 115 | $54-95$ | $100-800$ |"
    },
    {
      "type": "text",
      "section": "Micronutrients: Electrolytes",
      "line": 3654,
      "preview": "TABLE 6-9. Drug-Induced Metabolic Disorders"
    },
    {
      "type": "table",
      "section": "Micronutrients: Electrolytes",
      "line": 3656,
      "preview": "| Medication | Metabolic Disorder |"
    },
    {
      "type": "table",
      "section": "Micronutrients: Electrolytes",
      "line": 3657,
      "preview": "| :-- | :-- |"
    },
    {
      "type": "table",
      "section": "Micronutrients: Electrolytes",
      "line": 3658,
      "preview": "| Loop diuretics | Hyponatremia, hypokalemia, hypocalcemia, metabolic <br> alkalosis |"
    },
    {
      "type": "table",
      "section": "Micronutrients: Electrolytes",
      "line": 3659,
      "preview": "| Histamine 2 receptor <br> antagonists | Hyponatremia |"
    },
    {
      "type": "table",
      "section": "Micronutrients: Electrolytes",
      "line": 3660,
      "preview": "| Corticosteroids | Hypokalemia, hypocalcemia, hypophosphatemia, <br> metabolic alkalosis |"
    },
    {
      "type": "table",
      "section": "Micronutrients: Electrolytes",
      "line": 3661,
      "preview": "| Amphotericin B | Hypokalemia, hypomagnesemia, metabolic acidosis |"
    },
    {
      "type": "table",
      "section": "Micronutrients: Electrolytes",
      "line": 3662,
      "preview": "| Calcineurin inhibitors | Hypomagnesemia, hyperkalemia, hypertriglyceridemia |"
    },
    {
      "type": "table",
      "section": "Micronutrients: Electrolytes",
      "line": 3663,
      "preview": "| Aminoglycosides | Metabolic acidosis |"
    },
    {
      "type": "table",
      "section": "Micronutrients: Electrolytes",
      "line": 3664,
      "preview": "| Citrate | Hypocalcemia |"
    },
    {
      "type": "text",
      "section": "Micronutrients: Electrolytes",
      "line": 3666,
      "preview": "Monitoring of drug interactions with PN electrolytes and adjustment is an important role of the phar"
    },
    {
      "type": "text",
      "section": "Micronutrients: Electrolytes",
      "line": 3668,
      "preview": "--- page 186 ---"
    },
    {
      "type": "text",
      "section": "Micronutrients: Electrolytes",
      "line": 3670,
      "preview": "for new PN starts. Once the patient is on a stable formulation, weekly or twice weekly electrolyte m"
    },
    {
      "type": "text",
      "section": "Micronutrients: Electrolytes",
      "line": 3672,
      "preview": "TABLE 6-10. Daily Dose of Individual Electrolytes"
    },
    {
      "type": "table",
      "section": "Micronutrients: Electrolytes",
      "line": 3674,
      "preview": "| Electrolyte | Pediatric Dosing | Adolescents/Children <br> Weighing $>50 \\mathrm{~kg}$ |"
    },
    {
      "type": "table",
      "section": "Micronutrients: Electrolytes",
      "line": 3675,
      "preview": "| :-- | :-- | :-- |"
    },
    {
      "type": "table",
      "section": "Micronutrients: Electrolytes",
      "line": 3676,
      "preview": "| Sodium | $2-5 \\mathrm{mEq} / \\mathrm{kg}$ | $1-2 \\mathrm{mEq} / \\mathrm{kg}$ |"
    },
    {
      "type": "table",
      "section": "Micronutrients: Electrolytes",
      "line": 3677,
      "preview": "| Potassium | $2-4 \\mathrm{mEq} / \\mathrm{kg}$ | $1-2 \\mathrm{mEq} / \\mathrm{kg}$ |"
    },
    {
      "type": "table",
      "section": "Micronutrients: Electrolytes",
      "line": 3678,
      "preview": "| Chloride and <br> acetate | As needed to maintain <br> acid/base balance | As needed to maintain a"
    },
    {
      "type": "table",
      "section": "Micronutrients: Electrolytes",
      "line": 3679,
      "preview": "| Calcium | $0.5-4 \\mathrm{mEq} / \\mathrm{kg}$ | $10-20 \\mathrm{mEq}$ |"
    },
    {
      "type": "table",
      "section": "Micronutrients: Electrolytes",
      "line": 3680,
      "preview": "| Phosphorus | $0.5-2 \\mathrm{mmol} / \\mathrm{kg}$ | $10-40 \\mathrm{mmol}$ |"
    },
    {
      "type": "table",
      "section": "Micronutrients: Electrolytes",
      "line": 3681,
      "preview": "| Magnesium | $0.3-0.5 \\mathrm{mEq} / \\mathrm{kg} / \\mathrm{d}$ | $10-30 \\mathrm{mEq} / \\mathrm{d}$ "
    },
    {
      "type": "text",
      "section": "Micronutrients: Electrolytes",
      "line": 3683,
      "preview": "--- page 187 ---"
    },
    {
      "type": "text",
      "section": "Micronutrients: Electrolytes",
      "line": 3685,
      "preview": "TABLE 6-11. Frequency of Short-Term and Long-Term Metabolic Monitoring"
    },
    {
      "type": "table",
      "section": "Micronutrients: Electrolytes",
      "line": 3687,
      "preview": "| Parameter | Initial | Follow-Up |"
    },
    {
      "type": "table",
      "section": "Micronutrients: Electrolytes",
      "line": 3688,
      "preview": "| :-- | :-- | :-- |"
    },
    {
      "type": "table",
      "section": "Micronutrients: Electrolytes",
      "line": 3689,
      "preview": "| BMP | Daily | Included in <br> CMP |"
    },
    {
      "type": "table",
      "section": "Micronutrients: Electrolytes",
      "line": 3690,
      "preview": "| Magnesium | Daily to weekly | Every 1-4 wk |"
    },
    {
      "type": "table",
      "section": "Micronutrients: Electrolytes",
      "line": 3691,
      "preview": "| Phosphorus | Daily to weekly | Every 1-4 wk |"
    },
    {
      "type": "table",
      "section": "Micronutrients: Electrolytes",
      "line": 3692,
      "preview": "| CMP | Weekly | Every 1-4 wk |"
    },
    {
      "type": "table",
      "section": "Micronutrients: Electrolytes",
      "line": 3693,
      "preview": "| CBC with <br> differential/platelets | Weekly | Every 1-4 wk |"
    },
    {
      "type": "table",
      "section": "Micronutrients: Electrolytes",
      "line": 3694,
      "preview": "| Triglycerides | Baseline and then weekly or as <br> indicated | Monthly |"
    },
    {
      "type": "table",
      "section": "Micronutrients: Electrolytes",
      "line": 3695,
      "preview": "| GGTP | Baseline if indicated | Monthly |"
    },
    {
      "type": "table",
      "section": "Micronutrients: Electrolytes",
      "line": 3696,
      "preview": "| Direct or conjugated <br> bilirubin | Baseline if indicated | Every 1-4 wk |"
    },
    {
      "type": "table",
      "section": "Micronutrients: Electrolytes",
      "line": 3697,
      "preview": "| PT/INR | Baseline | Monthly |"
    },
    {
      "type": "text",
      "section": "Micronutrients: Electrolytes",
      "line": 3699,
      "preview": "Abbreviations: BMP, basic metabolic panel; CBC, complete blood cell count; CMP, comprehensive metabo"
    },
    {
      "type": "text",
      "section": "Micronutrients: Electrolytes",
      "line": 3700,
      "preview": "Adapted with permission from the American Society for Parenteral and Enteral Nutrition from Szeszyck"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "Micronutrients: Multivitamins",
      "line": 3702
    },
    {
      "type": "text",
      "section": "Micronutrients: Multivitamins",
      "line": 3704,
      "preview": "IV multivitamins provide the fat-soluble vitamins A, D, E, and K; watersoluble B vitamins; and ascor"
    },
    {
      "type": "text",
      "section": "Micronutrients: Multivitamins",
      "line": 3706,
      "preview": "--- page 188 ---"
    },
    {
      "type": "text",
      "section": "Micronutrients: Multivitamins",
      "line": 3708,
      "preview": "TABLE 6-12. Comparison of Pediatric and Adult Multivitamin Products"
    },
    {
      "type": "table",
      "section": "Micronutrients: Multivitamins",
      "line": 3710,
      "preview": "| Vitamin | Infuvite: Neonatal/Pediatric, 5 mL | Infuvite: 10 mL |"
    },
    {
      "type": "table",
      "section": "Micronutrients: Multivitamins",
      "line": 3711,
      "preview": "| :-- | :-- | :-- |"
    },
    {
      "type": "table",
      "section": "Micronutrients: Multivitamins",
      "line": 3712,
      "preview": "| Ascorbic acid | 80 mg | 200 mg |"
    },
    {
      "type": "table",
      "section": "Micronutrients: Multivitamins",
      "line": 3713,
      "preview": "| Vitamin A | 2300 IU | 3300 IU |"
    },
    {
      "type": "table",
      "section": "Micronutrients: Multivitamins",
      "line": 3714,
      "preview": "| Vitamin D | 400 IU | 200 IU |"
    },
    {
      "type": "table",
      "section": "Micronutrients: Multivitamins",
      "line": 3715,
      "preview": "| Thiamine | 1.2 mg | 6 mg |"
    },
    {
      "type": "table",
      "section": "Micronutrients: Multivitamins",
      "line": 3716,
      "preview": "| Riboflavin | 1.4 mg | 3.6 mg |"
    },
    {
      "type": "table",
      "section": "Micronutrients: Multivitamins",
      "line": 3717,
      "preview": "| Pyridoxine | 1 mg | 6 mg |"
    },
    {
      "type": "table",
      "section": "Micronutrients: Multivitamins",
      "line": 3718,
      "preview": "| Niacinamide | 17 mg | 40 mg |"
    },
    {
      "type": "table",
      "section": "Micronutrients: Multivitamins",
      "line": 3719,
      "preview": "| Dexpanthenol | 5 mg | 15 mg |"
    },
    {
      "type": "table",
      "section": "Micronutrients: Multivitamins",
      "line": 3720,
      "preview": "| Vitamin E | 7 IU | 10 IU |"
    },
    {
      "type": "table",
      "section": "Micronutrients: Multivitamins",
      "line": 3721,
      "preview": "| Biotin | 20 mcg | 60 mcg |"
    },
    {
      "type": "table",
      "section": "Micronutrients: Multivitamins",
      "line": 3722,
      "preview": "| Folic acid | 140 mcg | 600 mcg |"
    },
    {
      "type": "table",
      "section": "Micronutrients: Multivitamins",
      "line": 3723,
      "preview": "| Cyanocobalamin | 1 mcg | 5 mcg |"
    },
    {
      "type": "table",
      "section": "Micronutrients: Multivitamins",
      "line": 3724,
      "preview": "| Vitamin K | 200 mcg | 150 mcg |"
    },
    {
      "type": "text",
      "section": "Micronutrients: Multivitamins",
      "line": 3726,
      "preview": "Note: All values accurate at the time of publication."
    },
    {
      "type": "heading",
      "level": 1,
      "section": "Micronutrients: Trace Metals",
      "line": 3728
    },
    {
      "type": "text",
      "section": "Micronutrients: Trace Metals",
      "line": 3730,
      "preview": "Trace metals represent a very small component of normal dietary intake. ${ }^{29}$ These micronutrie"
    },
    {
      "type": "text",
      "section": "Micronutrients: Trace Metals",
      "line": 3732,
      "preview": "--- page 189 ---"
    },
    {
      "type": "text",
      "section": "Micronutrients: Trace Metals",
      "line": 3734,
      "preview": "based on weight, or institutions may develop a standardized protocol for ease of ordering. Manganese"
    },
    {
      "type": "text",
      "section": "Micronutrients: Trace Metals",
      "line": 3736,
      "preview": "--- page 190 ---"
    },
    {
      "type": "text",
      "section": "Micronutrients: Trace Metals",
      "line": 3738,
      "preview": "TABLE 6-13. Function of Trace Metals and Symptoms of Deficiency"
    },
    {
      "type": "table",
      "section": "Micronutrients: Trace Metals",
      "line": 3740,
      "preview": "| Trace <br> Metal | Role | Signs of <br> Deficiency |"
    },
    {
      "type": "table",
      "section": "Micronutrients: Trace Metals",
      "line": 3741,
      "preview": "| :-- | :-- | :-- |"
    },
    {
      "type": "table",
      "section": "Micronutrients: Trace Metals",
      "line": 3742,
      "preview": "| Zinc | - Growth <br> - Immune health <br> - Tissue repair | - Dermatitis <br> - Alopecia <br> - Gr"
    },
    {
      "type": "table",
      "section": "Micronutrients: Trace Metals",
      "line": 3743,
      "preview": "| Copper | - Hemoglobin synthesis <br> - Bone formation <br> - Neurotransmitter synthesis | - Neutro"
    },
    {
      "type": "table",
      "section": "Micronutrients: Trace Metals",
      "line": 3744,
      "preview": "| Selenium | - Protection against oxidative stress <br> - Thyroid metabolism <br> - Immune health | "
    },
    {
      "type": "table",
      "section": "Micronutrients: Trace Metals",
      "line": 3745,
      "preview": "| Chromium | - Glucose metabolism <br> - Coenzyme | - Hyperglycemia <br> - Weight loss <br> - Increa"
    },
    {
      "type": "table",
      "section": "Micronutrients: Trace Metals",
      "line": 3746,
      "preview": "| Manganese | Cofactor for enzymatic reactions including those <br> involved in immune health, repro"
    },
    {
      "type": "text",
      "section": "Micronutrients: Trace Metals",
      "line": 3748,
      "preview": "--- page 191 ---"
    },
    {
      "type": "text",
      "section": "Micronutrients: Trace Metals",
      "line": 3750,
      "preview": "TABLE 6-14. Ingredients for Currently Available Trace Element Products in the United States ${ }^{a}"
    },
    {
      "type": "table",
      "section": "Micronutrients: Trace Metals",
      "line": 3752,
      "preview": "| Per 1 mL | Tralement (Trace Element <br> Injection 4) | Multrys (Trace Element Injection <br> 4 Pe"
    },
    {
      "type": "table",
      "section": "Micronutrients: Trace Metals",
      "line": 3753,
      "preview": "| :-- | :-- | :-- |"
    },
    {
      "type": "table",
      "section": "Micronutrients: Trace Metals",
      "line": 3754,
      "preview": "| Zinc | 3 mg | 1 mg |"
    },
    {
      "type": "table",
      "section": "Micronutrients: Trace Metals",
      "line": 3755,
      "preview": "| Copper | 0.3 mg | 0.06 mg |"
    },
    {
      "type": "table",
      "section": "Micronutrients: Trace Metals",
      "line": 3756,
      "preview": "| Selenium | $60 \\mu \\mathrm{~g}$ | $6 \\mu \\mathrm{~g}$ |"
    },
    {
      "type": "table",
      "section": "Micronutrients: Trace Metals",
      "line": 3757,
      "preview": "| Chromium | - | - |"
    },
    {
      "type": "table",
      "section": "Micronutrients: Trace Metals",
      "line": 3758,
      "preview": "| Manganese | $55 \\mu \\mathrm{~g}$ | $3 \\mu \\mathrm{~g}$ |"
    },
    {
      "type": "text",
      "section": "Micronutrients: Trace Metals",
      "line": 3760,
      "preview": "${ }^{a}$ Accurate at the time of publication."
    },
    {
      "type": "text",
      "section": "Micronutrients: Trace Metals",
      "line": 3762,
      "preview": "TABLE 6-15. Dosing of Trace Metals"
    },
    {
      "type": "table",
      "section": "Micronutrients: Trace Metals",
      "line": 3764,
      "preview": "| Trace <br> Metal | Term Neonates/Infants, 3- <br> 10 kg (mcg/kg/d) | Children, 10- <br> 40 kg (mcg"
    },
    {
      "type": "table",
      "section": "Micronutrients: Trace Metals",
      "line": 3765,
      "preview": "| :-- | :-- | :-- | :-- |"
    },
    {
      "type": "table",
      "section": "Micronutrients: Trace Metals",
      "line": 3766,
      "preview": "| Zinc | $50-250$ | $50-125$ <br> (max 5000 mcg/d) | $2-5 \\mathrm{mg}$ |"
    },
    {
      "type": "table",
      "section": "Micronutrients: Trace Metals",
      "line": 3767,
      "preview": "| Copper | 20 | $20(\\max 500$ <br> $\\mathrm{mcg} / \\mathrm{d})$ | $200-500 \\mathrm{mcg}$ |"
    },
    {
      "type": "table",
      "section": "Micronutrients: Trace Metals",
      "line": 3768,
      "preview": "| Selenium | 2 | $2 \\mathrm{mcg} / \\mathrm{kg}$ <br> (max $100 \\mathrm{mcg} / \\mathrm{d})$ | $40-60 "
    },
    {
      "type": "table",
      "section": "Micronutrients: Trace Metals",
      "line": 3769,
      "preview": "| Chromium | 0.2 | $0.2 \\mathrm{mcg} / \\mathrm{kg}$ <br> (max $5 \\mathrm{mcg} / \\mathrm{d})$ | $5-15"
    },
    {
      "type": "table",
      "section": "Micronutrients: Trace Metals",
      "line": 3770,
      "preview": "| Manganese | 1 | $1 \\mathrm{mcg} / \\mathrm{kg}$ <br> (max $55 \\mathrm{mcg} / \\mathrm{d})$ | $40-100"
    },
    {
      "type": "text",
      "section": "Micronutrients: Trace Metals",
      "line": 3772,
      "preview": "Abbreviation: max, maximum."
    },
    {
      "type": "heading",
      "level": 1,
      "section": "Other Micronutrients and Additives: Heparin, Carnitine, and Iron",
      "line": 3774
    },
    {
      "type": "text",
      "section": "Other Micronutrients and Additives: Heparin, Carnitine, and Iron",
      "line": 3776,
      "preview": "Medication additives may be added to a PN solution based on patient need and compatibility with othe"
    },
    {
      "type": "text",
      "section": "Other Micronutrients and Additives: Heparin, Carnitine, and Iron",
      "line": 3778,
      "preview": "--- page 192 ---"
    },
    {
      "type": "text",
      "section": "Other Micronutrients and Additives: Heparin, Carnitine, and Iron",
      "line": 3780,
      "preview": "issues are common in neonatal and pediatric patients because of the small inner lumens of pediatric "
    },
    {
      "type": "text",
      "section": "Other Micronutrients and Additives: Heparin, Carnitine, and Iron",
      "line": 3782,
      "preview": "Carnitine is a quaternary ammonium compound that is synthesized from lysine and methionine and is re"
    },
    {
      "type": "text",
      "section": "Other Micronutrients and Additives: Heparin, Carnitine, and Iron",
      "line": 3784,
      "preview": "Patients dependent on PN routinely develop iron deficiency anemia (IDA) because of inadequate entera"
    },
    {
      "type": "text",
      "section": "Other Micronutrients and Additives: Heparin, Carnitine, and Iron",
      "line": 3786,
      "preview": "--- page 193 ---"
    },
    {
      "type": "text",
      "section": "Other Micronutrients and Additives: Heparin, Carnitine, and Iron",
      "line": 3788,
      "preview": "TABLE 6-16. Composition of Frequently Used IV Iron Products"
    },
    {
      "type": "table",
      "section": "Other Micronutrients and Additives: Heparin, Carnitine, and Iron",
      "line": 3790,
      "preview": "| Parameter | Ferric <br> Carboxymaltose (Injectafer) | Sodium Ferric Gluconate (Ferrlecit) | Iron S"
    },
    {
      "type": "table",
      "section": "Other Micronutrients and Additives: Heparin, Carnitine, and Iron",
      "line": 3791,
      "preview": "| :--: | :--: | :--: | :--: | :--: |"
    },
    {
      "type": "table",
      "section": "Other Micronutrients and Additives: Heparin, Carnitine, and Iron",
      "line": 3792,
      "preview": "| FDA <br> Indications | Iron deficiency anemia, with intolerance or inadequate response to oral iro"
    },
    {
      "type": "table",
      "section": "Other Micronutrients and Additives: Heparin, Carnitine, and Iron",
      "line": 3793,
      "preview": "| PN <br> compatibility | No | No | No | 2 in 1 only |"
    },
    {
      "type": "table",
      "section": "Other Micronutrients and Additives: Heparin, Carnitine, and Iron",
      "line": 3794,
      "preview": "| Total dose infusion possible | No | No | No | Yes |"
    },
    {
      "type": "table",
      "section": "Other Micronutrients and Additives: Heparin, Carnitine, and Iron",
      "line": 3795,
      "preview": "| Test dose | None | Not required | Not required | - Required prior to first therapeutic dose <br> -"
    },
    {
      "type": "text",
      "section": "Other Micronutrients and Additives: Heparin, Carnitine, and Iron",
      "line": 3797,
      "preview": "--- page 194 ---"
    },
    {
      "type": "table",
      "section": "Other Micronutrients and Additives: Heparin, Carnitine, and Iron",
      "line": 3799,
      "preview": "| Parameter | Ferric <br> Carboxymaltose (Injectafer) | Sodium Ferric Gluconate (Ferrlecit) | Iron S"
    },
    {
      "type": "table",
      "section": "Other Micronutrients and Additives: Heparin, Carnitine, and Iron",
      "line": 3800,
      "preview": "| :--: | :--: | :--: | :--: | :--: |"
    },
    {
      "type": "table",
      "section": "Other Micronutrients and Additives: Heparin, Carnitine, and Iron",
      "line": 3801,
      "preview": "| Pediatric dose | Total replacement dose: <br> - Weight $<50 \\mathrm{~kg}$ : <br> $15 \\mathrm{mg} /"
    },
    {
      "type": "text",
      "section": "Other Micronutrients and Additives: Heparin, Carnitine, and Iron",
      "line": 3803,
      "preview": "--- page 195 ---"
    },
    {
      "type": "table",
      "section": "Other Micronutrients and Additives: Heparin, Carnitine, and Iron",
      "line": 3805,
      "preview": "| Parameter | Ferric <br> Carboxymaltose (Injectafer) | Sodium Ferric Gluconate (Ferrlecit) | Iron S"
    },
    {
      "type": "table",
      "section": "Other Micronutrients and Additives: Heparin, Carnitine, and Iron",
      "line": 3806,
      "preview": "| :--: | :--: | :--: | :--: | :--: |"
    },
    {
      "type": "table",
      "section": "Other Micronutrients and Additives: Heparin, Carnitine, and Iron",
      "line": 3807,
      "preview": "|  | Maintenance dose: NA | Maintenance dose: <br> - Children $\\geq 6$ $y$ and adolescents $<17$ y: "
    },
    {
      "type": "table",
      "section": "Other Micronutrients and Additives: Heparin, Carnitine, and Iron",
      "line": 3808,
      "preview": "| Black box warning | None | None | None | Anaphylaxis |"
    },
    {
      "type": "table",
      "section": "Other Micronutrients and Additives: Heparin, Carnitine, and Iron",
      "line": 3809,
      "preview": "| Adverse events | See package insert | See package insert | See package insert | See package insert"
    },
    {
      "type": "text",
      "section": "Other Micronutrients and Additives: Heparin, Carnitine, and Iron",
      "line": 3811,
      "preview": "Abbreviations: CKD, chronic kidney disease; FDA, US Food and Drug Administration; Hb , hemoglobin; I"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "Medication Compatibility With PN",
      "line": 3813
    },
    {
      "type": "text",
      "section": "Medication Compatibility With PN",
      "line": 3815,
      "preview": "Compatibility questions are a frequent occurrence with PN to pediatric patients because of limited v"
    },
    {
      "type": "text",
      "section": "Medication Compatibility With PN",
      "line": 3817,
      "preview": "--- page 196 ---"
    },
    {
      "type": "text",
      "section": "Medication Compatibility With PN",
      "line": 3819,
      "preview": "discuss alternatives, which may include more access, brief PN pause, change to enteral, change to co"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "EXHIBIT 6-2. Considerations When Reviewing Medication Compatibility With PN",
      "line": 3821
    },
    {
      "type": "text",
      "section": "EXHIBIT 6-2. Considerations When Reviewing Medication Compatibility With PN",
      "line": 3823,
      "preview": "- Medication concentration tested as a Y-site, additive, or in a syringe"
    },
    {
      "type": "text",
      "section": "EXHIBIT 6-2. Considerations When Reviewing Medication Compatibility With PN",
      "line": 3824,
      "preview": "- Diluent of medication"
    },
    {
      "type": "text",
      "section": "EXHIBIT 6-2. Considerations When Reviewing Medication Compatibility With PN",
      "line": 3825,
      "preview": "- Concentration of amino acid and dextrose in PN"
    },
    {
      "type": "text",
      "section": "EXHIBIT 6-2. Considerations When Reviewing Medication Compatibility With PN",
      "line": 3826,
      "preview": "- Total nutrient admixture (3-in-1 or 2-in-1)"
    },
    {
      "type": "text",
      "section": "EXHIBIT 6-2. Considerations When Reviewing Medication Compatibility With PN",
      "line": 3827,
      "preview": "- Electrolyte, mineral, vitamin, trace mineral additives, and medications (ie, heparin) in PN"
    },
    {
      "type": "text",
      "section": "EXHIBIT 6-2. Considerations When Reviewing Medication Compatibility With PN",
      "line": 3828,
      "preview": "- Organic or inorganic salts in PN"
    },
    {
      "type": "text",
      "section": "EXHIBIT 6-2. Considerations When Reviewing Medication Compatibility With PN",
      "line": 3829,
      "preview": "- Type, pH , inactive ingredients, salts, in amino acid product"
    },
    {
      "type": "text",
      "section": "EXHIBIT 6-2. Considerations When Reviewing Medication Compatibility With PN",
      "line": 3830,
      "preview": "- Type, pH , globule size in lipid product"
    },
    {
      "type": "text",
      "section": "EXHIBIT 6-2. Considerations When Reviewing Medication Compatibility With PN",
      "line": 3831,
      "preview": "- Temperature of testing conditions"
    },
    {
      "type": "text",
      "section": "EXHIBIT 6-2. Considerations When Reviewing Medication Compatibility With PN",
      "line": 3832,
      "preview": "- Duration of testing conditions"
    },
    {
      "type": "text",
      "section": "EXHIBIT 6-2. Considerations When Reviewing Medication Compatibility With PN",
      "line": 3833,
      "preview": "- Container used for testing"
    },
    {
      "type": "text",
      "section": "EXHIBIT 6-2. Considerations When Reviewing Medication Compatibility With PN",
      "line": 3835,
      "preview": "Abbreviation: PN, parenteral nutrition."
    },
    {
      "type": "heading",
      "level": 2,
      "section": "Drug and Enteral Formula Shortages",
      "line": 3837
    },
    {
      "type": "text",
      "section": "Drug and Enteral Formula Shortages",
      "line": 3839,
      "preview": "Awareness of drug and enteral formula shortages are a part of the medical and nutrition support team"
    },
    {
      "type": "heading",
      "level": 2,
      "section": "Assessing Tolerance to PN",
      "line": 3841
    },
    {
      "type": "text",
      "section": "Assessing Tolerance to PN",
      "line": 3843,
      "preview": "--- page 197 ---"
    },
    {
      "type": "text",
      "section": "Assessing Tolerance to PN",
      "line": 3845,
      "preview": "Once the PN is at goal, constant monitoring and evaluation of PN adequacy begins. Exhibit 6-3 lists "
    },
    {
      "type": "heading",
      "level": 1,
      "section": "EXHIBIT 6-3. Parameters to Evaluate Adequacy of PN Order",
      "line": 3847
    },
    {
      "type": "text",
      "section": "EXHIBIT 6-3. Parameters to Evaluate Adequacy of PN Order",
      "line": 3849,
      "preview": "- Weight"
    },
    {
      "type": "text",
      "section": "EXHIBIT 6-3. Parameters to Evaluate Adequacy of PN Order",
      "line": 3850,
      "preview": "- Length or height"
    },
    {
      "type": "text",
      "section": "EXHIBIT 6-3. Parameters to Evaluate Adequacy of PN Order",
      "line": 3851,
      "preview": "- Head circumference"
    },
    {
      "type": "text",
      "section": "EXHIBIT 6-3. Parameters to Evaluate Adequacy of PN Order",
      "line": 3852,
      "preview": "- Weight gain"
    },
    {
      "type": "text",
      "section": "EXHIBIT 6-3. Parameters to Evaluate Adequacy of PN Order",
      "line": 3853,
      "preview": "- Linear/occipital frontal circumference gain"
    },
    {
      "type": "text",
      "section": "EXHIBIT 6-3. Parameters to Evaluate Adequacy of PN Order",
      "line": 3854,
      "preview": "- MUAC"
    },
    {
      "type": "text",
      "section": "EXHIBIT 6-3. Parameters to Evaluate Adequacy of PN Order",
      "line": 3855,
      "preview": "- Skin or wound healing"
    },
    {
      "type": "text",
      "section": "EXHIBIT 6-3. Parameters to Evaluate Adequacy of PN Order",
      "line": 3856,
      "preview": "- Functional capacity (energy and strength)"
    },
    {
      "type": "text",
      "section": "EXHIBIT 6-3. Parameters to Evaluate Adequacy of PN Order",
      "line": 3858,
      "preview": "Abbreviations: MUAC, mid-upper arm circumference; PN, parenteral nutrition."
    },
    {
      "type": "text",
      "section": "EXHIBIT 6-3. Parameters to Evaluate Adequacy of PN Order",
      "line": 3860,
      "preview": "--- page 198 ---"
    },
    {
      "type": "text",
      "section": "EXHIBIT 6-3. Parameters to Evaluate Adequacy of PN Order",
      "line": 3862,
      "preview": "TABLE 6-17. Parameters to Evaluate Adequacy of PN Volume"
    },
    {
      "type": "table",
      "section": "EXHIBIT 6-3. Parameters to Evaluate Adequacy of PN Order",
      "line": 3864,
      "preview": "| Parameter | Dehydration | Fluid Overload |"
    },
    {
      "type": "table",
      "section": "EXHIBIT 6-3. Parameters to Evaluate Adequacy of PN Order",
      "line": 3865,
      "preview": "| :-- | :-- | :-- |"
    },
    {
      "type": "table",
      "section": "EXHIBIT 6-3. Parameters to Evaluate Adequacy of PN Order",
      "line": 3866,
      "preview": "| Weight <br> change; <br> real vs fluid | Rapid $\\downarrow$ weight | Rapid $\\uparrow$ weight |"
    },
    {
      "type": "table",
      "section": "EXHIBIT 6-3. Parameters to Evaluate Adequacy of PN Order",
      "line": 3867,
      "preview": "| All recorded <br> intake | Total intake < total output | Total intake $>$ total output |"
    },
    {
      "type": "table",
      "section": "EXHIBIT 6-3. Parameters to Evaluate Adequacy of PN Order",
      "line": 3868,
      "preview": "| All recorded <br> output | Decreased urine output; dark <br> urine | Increased urine output in pat"
    },
    {
      "type": "table",
      "section": "EXHIBIT 6-3. Parameters to Evaluate Adequacy of PN Order",
      "line": 3869,
      "preview": "| Laboratory | $\\uparrow$ Serum urea nitrogen, <br> $\\uparrow$ sodium, $\\uparrow$ serum osmolality, "
    },
    {
      "type": "table",
      "section": "EXHIBIT 6-3. Parameters to Evaluate Adequacy of PN Order",
      "line": 3870,
      "preview": "| Vitals | $\\uparrow$ Heart rate, $\\uparrow$ insensible losses <br> with fever | $\\uparrow$ Respirat"
    },
    {
      "type": "table",
      "section": "EXHIBIT 6-3. Parameters to Evaluate Adequacy of PN Order",
      "line": 3871,
      "preview": "| Medications | Addition of diuretic or change in <br> frequency | Fluid retention with steroids or "
    },
    {
      "type": "table",
      "section": "EXHIBIT 6-3. Parameters to Evaluate Adequacy of PN Order",
      "line": 3872,
      "preview": "| Physical <br> assessment | Thirst, dry lips, dry mucous <br> membranes, dry skin, <br> headaches, "
    },
    {
      "type": "text",
      "section": "EXHIBIT 6-3. Parameters to Evaluate Adequacy of PN Order",
      "line": 3874,
      "preview": "Abbreviations: Hb , hemoglobin; PN, parenteral nutrition."
    },
    {
      "type": "text",
      "section": "EXHIBIT 6-3. Parameters to Evaluate Adequacy of PN Order",
      "line": 3875,
      "preview": "Adapted with permission from the American Society for Parenteral and Enteral Nutrition from Szeszyck"
    },
    {
      "type": "text",
      "section": "EXHIBIT 6-3. Parameters to Evaluate Adequacy of PN Order",
      "line": 3877,
      "preview": "As macronutrients are advanced, monitoring for hyperglycemia, hypertriglyceridemia, and azotemia wil"
    },
    {
      "type": "text",
      "section": "EXHIBIT 6-3. Parameters to Evaluate Adequacy of PN Order",
      "line": 3879,
      "preview": "--- page 199 ---"
    },
    {
      "type": "text",
      "section": "EXHIBIT 6-3. Parameters to Evaluate Adequacy of PN Order",
      "line": 3881,
      "preview": "vitamin K deficiency present prior to initiation of PN and any need for consistent monitoring of the"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "Refeeding Syndrome",
      "line": 3883
    },
    {
      "type": "text",
      "section": "Refeeding Syndrome",
      "line": 3885,
      "preview": "Refeeding syndrome (RS) occurs in patients who have had prolonged undernutrition, especially with co"
    },
    {
      "type": "text",
      "section": "Refeeding Syndrome",
      "line": 3887,
      "preview": "--- page 200 ---"
    },
    {
      "type": "text",
      "section": "Refeeding Syndrome",
      "line": 3889,
      "preview": "TABLE 6-19. ASPEN Consensus Criteria ${ }^{a}$ for Identifying Pediatric Patients at Risk for Refeed"
    },
    {
      "type": "table",
      "section": "Refeeding Syndrome",
      "line": 3891,
      "preview": "| Parameter | Mild Risk: 3 <br> Risk <br> Categories <br> Needed | Moderate Risk: 2 <br> Risk Criter"
    },
    {
      "type": "table",
      "section": "Refeeding Syndrome",
      "line": 3892,
      "preview": "| :--: | :--: | :--: | :--: |"
    },
    {
      "type": "table",
      "section": "Refeeding Syndrome",
      "line": 3893,
      "preview": "| Weight-for-length $z$ score (1-24 mo) or BMI-forage $z$ score (220 y) | -1 to $-1.9 z$ score that "
    },
    {
      "type": "table",
      "section": "Refeeding Syndrome",
      "line": 3894,
      "preview": "| Weight loss | $<75 \\%$ of norm for expected weight gain | $<50 \\%$ of norm for expected weight gai"
    },
    {
      "type": "table",
      "section": "Refeeding Syndrome",
      "line": 3895,
      "preview": "| Energy intake | 3-5 <br> consecutive d of protein or energy intake $<75 \\%$ of estimated need | 5-"
    },
    {
      "type": "table",
      "section": "Refeeding Syndrome",
      "line": 3896,
      "preview": "| Abnormal prefeeding serum potassium, phosphorus, or magnesium concentrations ${ }^{e}$ | Mildly ab"
    },
    {
      "type": "table",
      "section": "Refeeding Syndrome",
      "line": 3897,
      "preview": "| Higher-risk comorbidities | Mild disease | Moderate disease | Severe disease |"
    },
    {
      "type": "table",
      "section": "Refeeding Syndrome",
      "line": 3898,
      "preview": "| Loss of subcutaneous fat | Evidence of mild loss OR MUAC $z$ score of -1 to -1.9 z score | Evidenc"
    },
    {
      "type": "table",
      "section": "Refeeding Syndrome",
      "line": 3899,
      "preview": "| Loss of muscle mass | \u2014 | Evidence of mild or moderate loss OR <br> MUAC $z$ score of -2 to -2.9 |"
    },
    {
      "type": "text",
      "section": "Refeeding Syndrome",
      "line": 3901,
      "preview": "--- page 201 ---"
    },
    {
      "type": "text",
      "section": "Refeeding Syndrome",
      "line": 3903,
      "preview": "Abbreviations: BMI, body mass index; MUAC, mid-upper arm circumference."
    },
    {
      "type": "text",
      "section": "Refeeding Syndrome",
      "line": 3904,
      "preview": "Reproduced with permission from the American Society for Parenteral and Enteral Nutrition from da Si"
    },
    {
      "type": "text",
      "section": "Refeeding Syndrome",
      "line": 3905,
      "preview": "${ }^{a}$ Not intended for use in patients $\\leq 28 \\mathrm{~d}$ of life or $\\leq 44 \\mathrm{wk}$ of"
    },
    {
      "type": "text",
      "section": "Refeeding Syndrome",
      "line": 3906,
      "preview": "${ }^{\\text {b }}$ Data from Khan LU, Ahmed J, Khan S, Macfie J. Refeeding syndrome: a literature re"
    },
    {
      "type": "text",
      "section": "Refeeding Syndrome",
      "line": 3907,
      "preview": "https://doi.org/10.1155/2011/410971"
    },
    {
      "type": "text",
      "section": "Refeeding Syndrome",
      "line": 3908,
      "preview": "${ }^{\\text {c }}$ Data from Mehanna H, Nankivell PC, Moledina J, Travis J. Refeeding syndromeawaren"
    },
    {
      "type": "text",
      "section": "Refeeding Syndrome",
      "line": 3909,
      "preview": "https//doi.org/10.1186/1758-3284-1-4"
    },
    {
      "type": "text",
      "section": "Refeeding Syndrome",
      "line": 3910,
      "preview": "${ }^{d}$ Data from Becker P, Carney LN, Corkins MR, et al; Academy of Nutrition and Dietetics; Amer"
    },
    {
      "type": "text",
      "section": "Refeeding Syndrome",
      "line": 3911,
      "preview": "https://doi.org/10.1177/0884533614557642"
    },
    {
      "type": "text",
      "section": "Refeeding Syndrome",
      "line": 3912,
      "preview": "${ }^{\\text {e }}$ Please note that electrolytes may be normal despite total-body deficiency, which "
    },
    {
      "type": "text",
      "section": "Refeeding Syndrome",
      "line": 3914,
      "preview": "--- page 202 ---"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "TABLE 6-20. ASPEN Consensus Recommendations for Avoidance and Management of RS in At-Risk Pediatric Patients",
      "line": 3916
    },
    {
      "type": "table",
      "section": "TABLE 6-20. ASPEN Consensus Recommendations for Avoidance and Management of RS in At-Risk Pediatric Patients",
      "line": 3918,
      "preview": "| Aspect of <br> Care | Recommendations |"
    },
    {
      "type": "table",
      "section": "TABLE 6-20. ASPEN Consensus Recommendations for Avoidance and Management of RS in At-Risk Pediatric Patients",
      "line": 3919,
      "preview": "| :-- | :-- |"
    },
    {
      "type": "table",
      "section": "TABLE 6-20. ASPEN Consensus Recommendations for Avoidance and Management of RS in At-Risk Pediatric Patients",
      "line": 3920,
      "preview": "| Initiation of <br> nutrition | - Initiate nutrition at a maximum of 40\\%-50\\% goal, but usually <b"
    },
    {
      "type": "table",
      "section": "TABLE 6-20. ASPEN Consensus Recommendations for Avoidance and Management of RS in At-Risk Pediatric Patients",
      "line": 3921,
      "preview": "| Fluid <br> restriction | No recommendation |"
    },
    {
      "type": "table",
      "section": "TABLE 6-20. ASPEN Consensus Recommendations for Avoidance and Management of RS in At-Risk Pediatric Patients",
      "line": 3922,
      "preview": "| Sodium <br> restriction | No recommendation |"
    },
    {
      "type": "table",
      "section": "TABLE 6-20. ASPEN Consensus Recommendations for Avoidance and Management of RS in At-Risk Pediatric Patients",
      "line": 3923,
      "preview": "| Protein <br> restriction | No recommendation |"
    },
    {
      "type": "table",
      "section": "TABLE 6-20. ASPEN Consensus Recommendations for Avoidance and Management of RS in At-Risk Pediatric Patients",
      "line": 3924,
      "preview": "| Electrolytes | - Check serum potassium, magnesium, and phosphorus before <br> initiation of nutrit"
    },
    {
      "type": "text",
      "section": "TABLE 6-20. ASPEN Consensus Recommendations for Avoidance and Management of RS in At-Risk Pediatric Patients",
      "line": 3926,
      "preview": "--- page 203 ---"
    },
    {
      "type": "table",
      "section": "TABLE 6-20. ASPEN Consensus Recommendations for Avoidance and Management of RS in At-Risk Pediatric Patients",
      "line": 3928,
      "preview": "| Aspect of <br> Care | Recommendations |"
    },
    {
      "type": "table",
      "section": "TABLE 6-20. ASPEN Consensus Recommendations for Avoidance and Management of RS in At-Risk Pediatric Patients",
      "line": 3929,
      "preview": "| :-- | :-- |"
    },
    {
      "type": "table",
      "section": "TABLE 6-20. ASPEN Consensus Recommendations for Avoidance and Management of RS in At-Risk Pediatric Patients",
      "line": 3930,
      "preview": "| Thiamin and <br> multivitamins | - Thiamin $2 \\mathrm{mg} / \\mathrm{kg}$ to a max of $100-200 \\mat"
    },
    {
      "type": "table",
      "section": "TABLE 6-20. ASPEN Consensus Recommendations for Avoidance and Management of RS in At-Risk Pediatric Patients",
      "line": 3931,
      "preview": "| Monitoring <br> and long- <br> term care | - Recommend vital signs every 4 h for the first 24 h af"
    },
    {
      "type": "text",
      "section": "TABLE 6-20. ASPEN Consensus Recommendations for Avoidance and Management of RS in At-Risk Pediatric Patients",
      "line": 3933,
      "preview": "Abbreviations: IV, intravenous; MVI, multivitamin injectable; PN, parenteral nutrition; RS, refeedin"
    },
    {
      "type": "text",
      "section": "TABLE 6-20. ASPEN Consensus Recommendations for Avoidance and Management of RS in At-Risk Pediatric Patients",
      "line": 3934,
      "preview": "Reproduced with permission from the American Society for Parenteral and Enteral Nutrition from da Si"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "Managing Discontinuation of PN",
      "line": 3936
    },
    {
      "type": "text",
      "section": "Managing Discontinuation of PN",
      "line": 3938,
      "preview": "As EN intake improves, PN can be decreased in a stepwise fashion. The volume and rate, macronutrient"
    },
    {
      "type": "text",
      "section": "Managing Discontinuation of PN",
      "line": 3940,
      "preview": "--- page 204 ---"
    },
    {
      "type": "text",
      "section": "Managing Discontinuation of PN",
      "line": 3942,
      "preview": "discontinuation. Cyclic PN can be considered in patients who are able to eat but experience poor app"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "Nutrition-Focused Physical Examination for PN",
      "line": 3944
    },
    {
      "type": "text",
      "section": "Nutrition-Focused Physical Examination for PN",
      "line": 3946,
      "preview": "Nutrition-focused physical examination (NFPE) is an important piece of the nutrition evaluation of p"
    },
    {
      "type": "heading",
      "level": 2,
      "section": "Long-Term PN Management",
      "line": 3948
    },
    {
      "type": "text",
      "section": "Long-Term PN Management",
      "line": 3950,
      "preview": "If PN continues for weeks to months, then it is considered long-term PN, and metabolic monitoring fr"
    },
    {
      "type": "text",
      "section": "Long-Term PN Management",
      "line": 3952,
      "preview": "--- page 205 ---"
    },
    {
      "type": "text",
      "section": "Long-Term PN Management",
      "line": 3954,
      "preview": "the anemia associated with chronic disease and iron-deficient anemia. The need for nutrition-related"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "TABLE 6-18. Frequency of Long-Term Nutrition-Related Monitoring",
      "line": 3956
    },
    {
      "type": "table",
      "section": "TABLE 6-18. Frequency of Long-Term Nutrition-Related Monitoring",
      "line": 3958,
      "preview": "| Parameter | Initial | Follow-Up |"
    },
    {
      "type": "table",
      "section": "TABLE 6-18. Frequency of Long-Term Nutrition-Related Monitoring",
      "line": 3959,
      "preview": "| :-- | :-- | :-- |"
    },
    {
      "type": "table",
      "section": "TABLE 6-18. Frequency of Long-Term Nutrition-Related Monitoring",
      "line": 3960,
      "preview": "| Iron studies | 3 mo | Every 3-6 mo |"
    },
    {
      "type": "table",
      "section": "TABLE 6-18. Frequency of Long-Term Nutrition-Related Monitoring",
      "line": 3961,
      "preview": "| Zinc | $2-3$ mo | Every 3-6 mo |"
    },
    {
      "type": "table",
      "section": "TABLE 6-18. Frequency of Long-Term Nutrition-Related Monitoring",
      "line": 3962,
      "preview": "| Selenium | $2-3$ mo | Every 3-6 mo |"
    },
    {
      "type": "table",
      "section": "TABLE 6-18. Frequency of Long-Term Nutrition-Related Monitoring",
      "line": 3963,
      "preview": "| Copper | $2-3$ mo | Every 3-6 mo |"
    },
    {
      "type": "table",
      "section": "TABLE 6-18. Frequency of Long-Term Nutrition-Related Monitoring",
      "line": 3964,
      "preview": "| Manganese | $2-3$ mo | Every 6-12 mo if in PN |"
    },
    {
      "type": "table",
      "section": "TABLE 6-18. Frequency of Long-Term Nutrition-Related Monitoring",
      "line": 3965,
      "preview": "| Chromium | $2-3$ mo | Every 6-12 mo if in PN |"
    },
    {
      "type": "table",
      "section": "TABLE 6-18. Frequency of Long-Term Nutrition-Related Monitoring",
      "line": 3966,
      "preview": "| Vitamin D | $2-3$ mo | Every 3-6 mo |"
    },
    {
      "type": "table",
      "section": "TABLE 6-18. Frequency of Long-Term Nutrition-Related Monitoring",
      "line": 3967,
      "preview": "| Prothrombin/INR | Baseline if <br> indicated | Every 1-3 mo |"
    },
    {
      "type": "table",
      "section": "TABLE 6-18. Frequency of Long-Term Nutrition-Related Monitoring",
      "line": 3968,
      "preview": "| Essential fatty acid panel | $3-6$ mo | Every 6-12 mo |"
    },
    {
      "type": "table",
      "section": "TABLE 6-18. Frequency of Long-Term Nutrition-Related Monitoring",
      "line": 3969,
      "preview": "| Carnitine profile | 3 mo | Every 6-12 mo |"
    },
    {
      "type": "table",
      "section": "TABLE 6-18. Frequency of Long-Term Nutrition-Related Monitoring",
      "line": 3970,
      "preview": "| Thyroid function tests and urine <br> iodine | 3 mo | Every 3-6 mo |"
    },
    {
      "type": "text",
      "section": "TABLE 6-18. Frequency of Long-Term Nutrition-Related Monitoring",
      "line": 3972,
      "preview": "Abbreviations: INR, international normalized ratio; PN, parenteral nutrition. Adapted with permissio"
    },
    {
      "type": "text",
      "section": "TABLE 6-18. Frequency of Long-Term Nutrition-Related Monitoring",
      "line": 3974,
      "preview": "Patients on long-term PN generally receive no to minimal EN or are unable to adequately absorb enoug"
    },
    {
      "type": "text",
      "section": "TABLE 6-18. Frequency of Long-Term Nutrition-Related Monitoring",
      "line": 3976,
      "preview": "--- page 206 ---"
    },
    {
      "type": "text",
      "section": "TABLE 6-18. Frequency of Long-Term Nutrition-Related Monitoring",
      "line": 3978,
      "preview": "subsequent additive modification. If individual injectable vitamins, minerals, and other nutrient ad"
    },
    {
      "type": "text",
      "section": "TABLE 6-18. Frequency of Long-Term Nutrition-Related Monitoring",
      "line": 3980,
      "preview": "Growth and development are monitored routinely by a multidisciplinary team through clinic, virtual, "
    },
    {
      "type": "heading",
      "level": 1,
      "section": "References",
      "line": 3982
    },
    {
      "type": "text",
      "section": "References",
      "line": 3984,
      "preview": "1. Worthington P, Balint J, Bechtold M, et al. When is parenteral nutrition appropriate? JPEN J Pare"
    },
    {
      "type": "text",
      "section": "References",
      "line": 3985,
      "preview": "2. Ullman AJ, Bernstein SJ, Brown E, et al. The Michigan Appropriateness Guide for Intravenous Cathe"
    },
    {
      "type": "text",
      "section": "References",
      "line": 3986,
      "preview": "3. Naik VM, Mantha SSP, Rayani BK. Vascular access in children. Indian J Anaesth. 2019;63(9):737-745"
    },
    {
      "type": "text",
      "section": "References",
      "line": 3987,
      "preview": "4. Lappas BM, Patel D, Kumpf V, Adams DW, Seidner DL. Parenteral nutrition indications, access, and "
    },
    {
      "type": "text",
      "section": "References",
      "line": 3988,
      "preview": "5. Vanek VW. The ins and outs of venous access: part 1. Nutr Clin Pract. 2002;17(2):85-98. https://d"
    },
    {
      "type": "text",
      "section": "References",
      "line": 3989,
      "preview": "6. Cober MP, Gura KM. Enteral and parenteral nutrition considerations in pediatric patients. Am J He"
    },
    {
      "type": "text",
      "section": "References",
      "line": 3990,
      "preview": "7. Ayers P, Adams S, Boullata J, et al; American Society for Parenteral and Enteral Nutrition. A.S.P"
    },
    {
      "type": "text",
      "section": "References",
      "line": 3991,
      "preview": "8. Boullata JI, Gilbert K, Sacks G, et al. A.S.P.E.N. Clinical guidelines: parenteral nutrition orde"
    },
    {
      "type": "text",
      "section": "References",
      "line": 3993,
      "preview": "--- page 207 ---"
    },
    {
      "type": "text",
      "section": "References",
      "line": 3995,
      "preview": "Nutr. 2014;38(3):334-377. https://doi.org/10.1177/0148607114521833"
    },
    {
      "type": "text",
      "section": "References",
      "line": 3996,
      "preview": "9. Chhim RF, Crill CM. Premixed parenteral nutrition solution use in children. J Pediatr Pharmacol T"
    },
    {
      "type": "text",
      "section": "References",
      "line": 3997,
      "preview": "10. Boullata JI, Mirtallo JM, Sacks GS, et al; ASPEN Parenteral Nutrition Safety Committee. Parenter"
    },
    {
      "type": "text",
      "section": "References",
      "line": 3998,
      "preview": "11. Worthington P, Gura KM, Kraft MD, Nishikawa R, Guenter P, Sacks GS; ASPEN PN Safety Committee. U"
    },
    {
      "type": "text",
      "section": "References",
      "line": 3999,
      "preview": "12. Robinson DT, Ayers P, Fleming B, et al. Recommendations for photoprotection of parenteral nutrit"
    },
    {
      "type": "text",
      "section": "References",
      "line": 4000,
      "preview": "13. Holliday MA, Segar WE. The maintenance need for water in parenteral fluid therapy. Pediatrics. 1"
    },
    {
      "type": "text",
      "section": "References",
      "line": 4001,
      "preview": "14. Choong K, Bohn D. Maintenance parenteral fluids in the critically ill child. J Pediatr (Rio J). "
    },
    {
      "type": "text",
      "section": "References",
      "line": 4002,
      "preview": "15. Szeszycki E, Cruse W, McLaughlin C. Evaluation and monitoring of pediatric patients receiving sp"
    },
    {
      "type": "text",
      "section": "References",
      "line": 4003,
      "preview": "16. Hermanspann T, Scoberer M, Robel-Tillig E, et al. Incidence and severity of prescribing errors i"
    },
    {
      "type": "text",
      "section": "References",
      "line": 4004,
      "preview": "17. Storm MC, Helms RA. Normalizing plasma amino acid levels in pediatric patients requiring parente"
    },
    {
      "type": "text",
      "section": "References",
      "line": 4005,
      "preview": "18. Premasol. Package insert. Baxter Healthcare Corporation; 2014."
    },
    {
      "type": "text",
      "section": "References",
      "line": 4006,
      "preview": "19. Clinisol. Package insert. Baxter Healthcare Corporation; 2018."
    },
    {
      "type": "text",
      "section": "References",
      "line": 4007,
      "preview": "20. Mirtallo J, Canada T, Johnson D, et al; Task Force for the Revision of Safe Practices for Parent"
    },
    {
      "type": "text",
      "section": "References",
      "line": 4008,
      "preview": "21. Mehta NM, Skillman HE, Irving SY, et al. Guidelines for the provision and assessment of nutritio"
    },
    {
      "type": "text",
      "section": "References",
      "line": 4009,
      "preview": "22. Wales PW, Allen N, Worthington P, et al; American Society for Parenteral and Enteral Nutrition. "
    },
    {
      "type": "text",
      "section": "References",
      "line": 4010,
      "preview": "23. Cober MP, Gura, KM, Mirtallo JM, et al; ASPEN Parenteral Nutrition Safety Committee. ASPEN lipid"
    },
    {
      "type": "text",
      "section": "References",
      "line": 4011,
      "preview": "24. Rhoda KM, Porter MJ, Quintini C. Fluid and electrolyte management: putting a plan in motion. JPE"
    },
    {
      "type": "text",
      "section": "References",
      "line": 4013,
      "preview": "--- page 208 ---"
    },
    {
      "type": "text",
      "section": "References",
      "line": 4015,
      "preview": "25. Nyffeler MS, Frankel E, Hayes E, et al. Drug-nutrient interactions. In: Merritt R, Delegge MH, H"
    },
    {
      "type": "text",
      "section": "References",
      "line": 4016,
      "preview": "26. Alexander E, Weatherhead J, Creo A, et al. Fluid management in hospitalized pediatric patients. "
    },
    {
      "type": "text",
      "section": "References",
      "line": 4017,
      "preview": "27. Infuvite Pediatric/Adult. Package insert. Baxter Healthcare Corporation; 2003."
    },
    {
      "type": "text",
      "section": "References",
      "line": 4018,
      "preview": "28. Perks P, Huynh E, Kaluza K, Boullata JI. Advances in trace metal supplementation for parenteral "
    },
    {
      "type": "text",
      "section": "References",
      "line": 4019,
      "preview": "29. Wong T. Parenteral trace elements in children: clinical aspects and dosage recommendations. Curr"
    },
    {
      "type": "text",
      "section": "References",
      "line": 4020,
      "preview": "30. Hardy G, Wong T, Morrissey H, et al. Parenteral provision of micronutrients to pediatric patient"
    },
    {
      "type": "text",
      "section": "References",
      "line": 4021,
      "preview": "31. Tralement. Package insert, American Regent, Inc.; 2020."
    },
    {
      "type": "text",
      "section": "References",
      "line": 4022,
      "preview": "32. Multrys. Package insert. American Regent, Inc.; 2021."
    },
    {
      "type": "text",
      "section": "References",
      "line": 4023,
      "preview": "33. Szeszycki E, Cruse W, McLaughlin C. Evaluation and monitoring of pediatric patients receiving sp"
    },
    {
      "type": "text",
      "section": "References",
      "line": 4024,
      "preview": "34. Domell\u00f6f M, Szitanyi P, Simchowitz V, et al. ESPGHAN/ESPEN/ESPR/CSPEN guidelines on pediatric pa"
    },
    {
      "type": "text",
      "section": "References",
      "line": 4025,
      "preview": "35. Gervasio JM, McKinney M, Kalsekar I, Szeszycki E. A comparison of efficacy of heparin 0.5 unit $"
    },
    {
      "type": "text",
      "section": "References",
      "line": 4026,
      "preview": "36. Vanek, VW, Borum P, Buchman A, et al; Novel Nutrient Task Force, Parenteral MultiVitamin and Mul"
    },
    {
      "type": "text",
      "section": "References",
      "line": 4027,
      "preview": "37. Slicker J, Vermilyea S. Pediatric parenteral nutrition: putting the microscope on macronutrients"
    },
    {
      "type": "text",
      "section": "References",
      "line": 4028,
      "preview": "38. Wang C, Graham DJ. Kane RC, et al. Comparative risk of anaphylactic reactions associated with in"
    },
    {
      "type": "text",
      "section": "References",
      "line": 4029,
      "preview": "39. Powers JM, Shamoun M, McCavit TL, Adix L, Buchanan GR. Intravenous ferric carboxymaltose in chil"
    },
    {
      "type": "text",
      "section": "References",
      "line": 4030,
      "preview": "40. Gura K, Chang E, Casey A, Roach E. Parenteral iron therapy in the pediatric patient: a review. I"
    },
    {
      "type": "text",
      "section": "References",
      "line": 4032,
      "preview": "--- page 209 ---"
    },
    {
      "type": "text",
      "section": "References",
      "line": 4034,
      "preview": "https://doi.org/10.1177/1941406411408600"
    },
    {
      "type": "text",
      "section": "References",
      "line": 4035,
      "preview": "41. Robinson CA, Lee JE. Y-site compatibility of medications with parenteral nutrition. In: Phelps S"
    },
    {
      "type": "text",
      "section": "References",
      "line": 4036,
      "preview": "42. A.S.P.E.N. Clinical Practice Committee Shortage Subcommittee. A.S.P.E.N. parenteral nutrition tr"
    },
    {
      "type": "text",
      "section": "References",
      "line": 4037,
      "preview": "43. da Silva JSV, Seres DS, Sabino K, et al; Parenteral Nutrition Safety and Clinical Practice Commi"
    },
    {
      "type": "text",
      "section": "References",
      "line": 4038,
      "preview": "44. Hill S. Practical management of home parenteral nutrition in infancy. Early Hum Dev. 2019;138:10"
    },
    {
      "type": "text",
      "section": "References",
      "line": 4039,
      "preview": "45. Bendorf K, Friesen CA, Roberts CC. Glucose response to discontinuation of parenteral nutrition i"
    },
    {
      "type": "text",
      "section": "References",
      "line": 4040,
      "preview": "46. Heimburger DC, McLaren DS, Shils ME. Clinical manifestations of nutrient deficiencies and toxici"
    },
    {
      "type": "text",
      "section": "References",
      "line": 4041,
      "preview": "47. Norman JL and Crill CM. Optimizing the transition to home parenteral nutrition in pediatric pati"
    },
    {
      "type": "text",
      "section": "References",
      "line": 4042,
      "preview": "48. Butterworth SA, Lalari V, and Dheensaw K. Evaluation of sodium deficit in infants undergoing int"
    },
    {
      "type": "text",
      "section": "References",
      "line": 4044,
      "preview": "--- page 210 ---"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "APPENDIX 6-1. Sample Parenteral Nutrition Plan",
      "line": 4046
    },
    {
      "type": "text",
      "section": "APPENDIX 6-1. Sample Parenteral Nutrition Plan",
      "line": 4048,
      "preview": "T.B. is a 10-year-old patient with a past surgical history of gastroschisis repair who comes to the "
    },
    {
      "type": "text",
      "section": "APPENDIX 6-1. Sample Parenteral Nutrition Plan",
      "line": 4050,
      "preview": "Admission weight: 30 kg"
    },
    {
      "type": "text",
      "section": "APPENDIX 6-1. Sample Parenteral Nutrition Plan",
      "line": 4051,
      "preview": "Allergies: No known drug allergy"
    },
    {
      "type": "heading",
      "level": 2,
      "section": "Laboratory results on the day of PN initiation:",
      "line": 4053
    },
    {
      "type": "text",
      "section": "Laboratory results on the day of PN initiation:",
      "line": 4055,
      "preview": "Sodium $=138 \\mathrm{mmol} / \\mathrm{L}$, potassium $=3.5 \\mathrm{mmol} / \\mathrm{L}$, chloride $=10"
    },
    {
      "type": "text",
      "section": "Laboratory results on the day of PN initiation:",
      "line": 4056,
      "preview": "Calcium $=9.1 \\mathrm{mg} / \\mathrm{dL}$, Phosphorus $=3.7 \\mathrm{mg} / \\mathrm{dL}$, magnesium $=1"
    },
    {
      "type": "text",
      "section": "Laboratory results on the day of PN initiation:",
      "line": 4057,
      "preview": "Current intravenous fluid: dextrose 5\\% with $0.9 \\%$ sodium chloride plus $20 \\mathrm{mEq} / \\mathr"
    },
    {
      "type": "text",
      "section": "Laboratory results on the day of PN initiation:",
      "line": 4058,
      "preview": "Calorie and protein goal $=1600 \\mathrm{cal} / \\mathrm{d}, 1.5 \\mathrm{gm} / \\mathrm{kg} / \\mathrm{d"
    },
    {
      "type": "text",
      "section": "Laboratory results on the day of PN initiation:",
      "line": 4059,
      "preview": "Nasogastric tube replacement with Lactated Ringer's solution at $0.5-1 \\mathrm{~mL}$ every 4 h"
    },
    {
      "type": "text",
      "section": "Laboratory results on the day of PN initiation:",
      "line": 4061,
      "preview": "--- page 211 ---"
    },
    {
      "type": "text",
      "section": "Laboratory results on the day of PN initiation:",
      "line": 4063,
      "preview": "Plan for PN initiation: Weight $=30 \\mathrm{~kg}$"
    },
    {
      "type": "table",
      "section": "Laboratory results on the day of PN initiation:",
      "line": 4065,
      "preview": "|  | Day 1 | Day 2 | Day 3 |"
    },
    {
      "type": "table",
      "section": "Laboratory results on the day of PN initiation:",
      "line": 4066,
      "preview": "| :-- | :-- | :-- | :-- |"
    },
    {
      "type": "table",
      "section": "Laboratory results on the day of PN initiation:",
      "line": 4067,
      "preview": "| Total PN volume | 1700 mL | 1700 mL | 1700 mL |"
    },
    {
      "type": "table",
      "section": "Laboratory results on the day of PN initiation:",
      "line": 4068,
      "preview": "| Amino acids $(\\mathrm{g} / \\mathrm{kg} / \\mathrm{d})$ | 1.5 | 1.5 | 1.5 |"
    },
    {
      "type": "table",
      "section": "Laboratory results on the day of PN initiation:",
      "line": 4069,
      "preview": "| Calories from amino acids | 180 kcal | 180 kcal | 180 kcal |"
    },
    {
      "type": "table",
      "section": "Laboratory results on the day of PN initiation:",
      "line": 4070,
      "preview": "| Dextrose $(\\mathrm{mg} / \\mathrm{kg} / \\mathrm{min})$ | $4 \\mathrm{mg} / \\mathrm{kg} / \\mathrm{min"
    },
    {
      "type": "table",
      "section": "Laboratory results on the day of PN initiation:",
      "line": 4071,
      "preview": "| Calories from dextrose | 587 kcal | 734 kcal | 984 kcal |"
    },
    {
      "type": "table",
      "section": "Laboratory results on the day of PN initiation:",
      "line": 4072,
      "preview": "| Lipids | $1 \\mathrm{~g} / \\mathrm{kg} / \\mathrm{d}$ | $1.5 \\mathrm{~g} / \\mathrm{kg} / \\mathrm{d}$"
    },
    {
      "type": "table",
      "section": "Laboratory results on the day of PN initiation:",
      "line": 4073,
      "preview": "| Calories from lipids | 300 kcal | 450 kcal | 450 kcal |"
    },
    {
      "type": "table",
      "section": "Laboratory results on the day of PN initiation:",
      "line": 4074,
      "preview": "| Total calories from PN/d | 1067 | 1364 | 1614 |"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "Micronutrient additions to PN:",
      "line": 4076
    },
    {
      "type": "text",
      "section": "Micronutrient additions to PN:",
      "line": 4078,
      "preview": "Sodium: $3 \\mathrm{mEq} / \\mathrm{kg} / \\mathrm{d}$"
    },
    {
      "type": "text",
      "section": "Micronutrient additions to PN:",
      "line": 4079,
      "preview": "Potassium: $3 \\mathrm{mEq} / \\mathrm{kg} / \\mathrm{d}$"
    },
    {
      "type": "text",
      "section": "Micronutrient additions to PN:",
      "line": 4080,
      "preview": "Chloride: $3 \\mathrm{mEq} / \\mathrm{kg} / \\mathrm{d}$"
    },
    {
      "type": "text",
      "section": "Micronutrient additions to PN:",
      "line": 4081,
      "preview": "Excess anion: acetate"
    },
    {
      "type": "text",
      "section": "Micronutrient additions to PN:",
      "line": 4082,
      "preview": "Calcium: $1 \\mathrm{mEq} / \\mathrm{kg} / \\mathrm{d}$"
    },
    {
      "type": "text",
      "section": "Micronutrient additions to PN:",
      "line": 4083,
      "preview": "Phosphorus: $0.8 \\mathrm{mmol} / \\mathrm{kg} / \\mathrm{d}$"
    },
    {
      "type": "text",
      "section": "Micronutrient additions to PN:",
      "line": 4084,
      "preview": "Magnesium: $0.3 \\mathrm{mEq} / \\mathrm{kg} / \\mathrm{d}$"
    },
    {
      "type": "text",
      "section": "Micronutrient additions to PN:",
      "line": 4085,
      "preview": "Standard multivitamin"
    },
    {
      "type": "text",
      "section": "Micronutrient additions to PN:",
      "line": 4086,
      "preview": "Standard trace metal solution"
    },
    {
      "type": "text",
      "section": "Micronutrient additions to PN:",
      "line": 4087,
      "preview": "Monitoring: Daily weights, intake/output, laboratory results as follows."
    },
    {
      "type": "text",
      "section": "Micronutrient additions to PN:",
      "line": 4089,
      "preview": "--- page 212 ---"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "Frequency of Short-Term Metabolic Monitoring ${ }^{a}$",
      "line": 4091
    },
    {
      "type": "table",
      "section": "Frequency of Short-Term Metabolic Monitoring ${ }^{a}$",
      "line": 4093,
      "preview": "| Parameter | Initial |"
    },
    {
      "type": "table",
      "section": "Frequency of Short-Term Metabolic Monitoring ${ }^{a}$",
      "line": 4094,
      "preview": "| :-- | :-- |"
    },
    {
      "type": "table",
      "section": "Frequency of Short-Term Metabolic Monitoring ${ }^{a}$",
      "line": 4095,
      "preview": "| Basic metabolic profile | Daily |"
    },
    {
      "type": "table",
      "section": "Frequency of Short-Term Metabolic Monitoring ${ }^{a}$",
      "line": 4096,
      "preview": "| Magnesium | Daily to weekly |"
    },
    {
      "type": "table",
      "section": "Frequency of Short-Term Metabolic Monitoring ${ }^{a}$",
      "line": 4097,
      "preview": "| Phosphorus | Daily to weekly |"
    },
    {
      "type": "table",
      "section": "Frequency of Short-Term Metabolic Monitoring ${ }^{a}$",
      "line": 4098,
      "preview": "| Complete metabolic profile | Weekly |"
    },
    {
      "type": "table",
      "section": "Frequency of Short-Term Metabolic Monitoring ${ }^{a}$",
      "line": 4099,
      "preview": "| Complete blood cell count with <br> differential/platelets | Weekly |"
    },
    {
      "type": "table",
      "section": "Frequency of Short-Term Metabolic Monitoring ${ }^{a}$",
      "line": 4100,
      "preview": "| Triglyceride level | Baseline and then weekly or as <br> indicated |"
    },
    {
      "type": "table",
      "section": "Frequency of Short-Term Metabolic Monitoring ${ }^{a}$",
      "line": 4101,
      "preview": "| $\\gamma$-Glutamyl transpeptidase | Baseline if indicated |"
    },
    {
      "type": "table",
      "section": "Frequency of Short-Term Metabolic Monitoring ${ }^{a}$",
      "line": 4102,
      "preview": "| Direct or conjugated bilirubin | Baseline if indicated |"
    },
    {
      "type": "table",
      "section": "Frequency of Short-Term Metabolic Monitoring ${ }^{a}$",
      "line": 4103,
      "preview": "| Prothrombin time/international normalized <br> ratio | Baseline |"
    },
    {
      "type": "text",
      "section": "Frequency of Short-Term Metabolic Monitoring ${ }^{a}$",
      "line": 4105,
      "preview": "${ }^{a}$ May need to consider monitoring more frequently as patient is at risk for refeeding syndro"
    },
    {
      "type": "text",
      "section": "Frequency of Short-Term Metabolic Monitoring ${ }^{a}$",
      "line": 4107,
      "preview": "--- page 213 ---"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "Neonatal Nutrition",
      "line": 4109
    },
    {
      "type": "text",
      "section": "Neonatal Nutrition",
      "line": 4111,
      "preview": "Austin Michalski, RDN, CNSC"
    },
    {
      "type": "text",
      "section": "Neonatal Nutrition",
      "line": 4113,
      "preview": "Kathleen Gura, PharmD, BCNSP"
    },
    {
      "type": "heading",
      "level": 2,
      "section": "Overview",
      "line": 4115
    },
    {
      "type": "text",
      "section": "Overview",
      "line": 4117,
      "preview": "The nutrition needs for the growth and development of neonates and infants are unique compared with "
    },
    {
      "type": "text",
      "section": "Overview",
      "line": 4119,
      "preview": "TABLE 7-1. Gestational Age Categories"
    },
    {
      "type": "table",
      "section": "Overview",
      "line": 4121,
      "preview": "| Category | Gestational Age at Birth (wk) |"
    },
    {
      "type": "table",
      "section": "Overview",
      "line": 4122,
      "preview": "| :-- | :-- |"
    },
    {
      "type": "table",
      "section": "Overview",
      "line": 4123,
      "preview": "| Full term | $\\geq 370 / 7$ |"
    },
    {
      "type": "table",
      "section": "Overview",
      "line": 4124,
      "preview": "| Late preterm | $34-366 / 7$ |"
    },
    {
      "type": "table",
      "section": "Overview",
      "line": 4125,
      "preview": "| Moderate preterm | $32-34$ |"
    },
    {
      "type": "table",
      "section": "Overview",
      "line": 4126,
      "preview": "| Very preterm | $28-32$ |"
    },
    {
      "type": "table",
      "section": "Overview",
      "line": 4127,
      "preview": "| Extremely preterm | $<280 / 7$ |"
    },
    {
      "type": "text",
      "section": "Overview",
      "line": 4129,
      "preview": "TABLE 7-2. Birth Weight Classifications"
    },
    {
      "type": "table",
      "section": "Overview",
      "line": 4131,
      "preview": "| Classification | Birth Weight |"
    },
    {
      "type": "table",
      "section": "Overview",
      "line": 4132,
      "preview": "| :-- | :-- |"
    },
    {
      "type": "table",
      "section": "Overview",
      "line": 4133,
      "preview": "| Low birth weight | $<2500 \\mathrm{~g}$ |"
    },
    {
      "type": "table",
      "section": "Overview",
      "line": 4134,
      "preview": "| Very low birth weight | $<1500 \\mathrm{~g}$ |"
    },
    {
      "type": "table",
      "section": "Overview",
      "line": 4135,
      "preview": "| Extremely low birth weight | $<1000 \\mathrm{~g}$ |"
    },
    {
      "type": "text",
      "section": "Overview",
      "line": 4137,
      "preview": "--- page 214 ---"
    },
    {
      "type": "text",
      "section": "Overview",
      "line": 4139,
      "preview": "TABLE 7-3. Birth Size Assessment ${ }^{a}$"
    },
    {
      "type": "table",
      "section": "Overview",
      "line": 4141,
      "preview": "| Size | Description |"
    },
    {
      "type": "table",
      "section": "Overview",
      "line": 4142,
      "preview": "| :-- | :-- |"
    },
    {
      "type": "table",
      "section": "Overview",
      "line": 4143,
      "preview": "| AGA | Birth weight between 10th and 90th percentile plotted on an intrauterine growth chart (Olsen"
    },
    {
      "type": "table",
      "section": "Overview",
      "line": 4144,
      "preview": "| LGA | Birth weight $>90$ th percentile plotted on an intrauterine growth chart (Olsen/Fenton) |"
    },
    {
      "type": "table",
      "section": "Overview",
      "line": 4145,
      "preview": "| SGA | Birth weight $<10$ th percentile plotted on an intrauterine growth chart (Olsen/Fenton) |"
    },
    {
      "type": "text",
      "section": "Overview",
      "line": 4147,
      "preview": "Abbreviations: AGA, appropriate for gestational age; IUGR, intrauterine growth restriction; LGA, lar"
    },
    {
      "type": "text",
      "section": "Overview",
      "line": 4148,
      "preview": "${ }^{a}$ IUGR is not synonymous with SGA. IUGR is an assessment of fetal growth trajectory, whereas"
    },
    {
      "type": "text",
      "section": "Overview",
      "line": 4150,
      "preview": "TABLE 7-4. Indications for Nutrition Support"
    },
    {
      "type": "table",
      "section": "Overview",
      "line": 4152,
      "preview": "| EN | PN |"
    },
    {
      "type": "table",
      "section": "Overview",
      "line": 4153,
      "preview": "| :--: | :--: |"
    },
    {
      "type": "table",
      "section": "Overview",
      "line": 4154,
      "preview": "| - Inability to feed by mouth <br> - Congenital malformation (esophageal atresia/tracheoesophageal "
    },
    {
      "type": "text",
      "section": "Overview",
      "line": 4156,
      "preview": "Abbreviations: EN, enteral nutrition; GA, gestational age; GI, gastrointestinal; NPO, nothing by mou"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "Growth Monitoring and Assessment",
      "line": 4158
    },
    {
      "type": "text",
      "section": "Growth Monitoring and Assessment",
      "line": 4160,
      "preview": "Infant weight, length, and head circumference should be measured regularly and plotted on an appropr"
    },
    {
      "type": "text",
      "section": "Growth Monitoring and Assessment",
      "line": 4162,
      "preview": "--- page 215 ---"
    },
    {
      "type": "text",
      "section": "Growth Monitoring and Assessment",
      "line": 4164,
      "preview": "TABLE 7-5. Neonatal Growth Charts"
    },
    {
      "type": "table",
      "section": "Growth Monitoring and Assessment",
      "line": 4166,
      "preview": "| Preterm Infants (<37 0/7 wk at Birth) |  |"
    },
    {
      "type": "table",
      "section": "Growth Monitoring and Assessment",
      "line": 4167,
      "preview": "| :--: | :--: |"
    },
    {
      "type": "table",
      "section": "Growth Monitoring and Assessment",
      "line": 4168,
      "preview": "| Fenton (2013) ${ }^{a}$ | - Intrauterine growth chart, 22-50 wk of gestational age <br> - Data/cur"
    },
    {
      "type": "table",
      "section": "Growth Monitoring and Assessment",
      "line": 4169,
      "preview": "| Olsen (2010) ${ }^{b}$ | - Intrauterine growth chart, 22-39 wk of gestational age <br> - Transitio"
    },
    {
      "type": "table",
      "section": "Growth Monitoring and Assessment",
      "line": 4170,
      "preview": "| Term Infants (>37 0/7 wk) |  |"
    },
    {
      "type": "table",
      "section": "Growth Monitoring and Assessment",
      "line": 4171,
      "preview": "| WHO 0-24 mo (2006) ${ }^{\\text {C }}$ | - Growth standard for human milk-fed infants <br> - *Did n"
    },
    {
      "type": "text",
      "section": "Growth Monitoring and Assessment",
      "line": 4173,
      "preview": "Abbreviations: GA, gestational age; WHO, World Health Organization."
    },
    {
      "type": "text",
      "section": "Growth Monitoring and Assessment",
      "line": 4174,
      "preview": "${ }^{a}$ Fenton Preterm Growth Charts. University of Calgary. Accessed February 21, 2023. https://l"
    },
    {
      "type": "text",
      "section": "Growth Monitoring and Assessment",
      "line": 4175,
      "preview": "ucalgary.ucalgary.ca/resource/preterm-growth-chart/preterm-growth-chart"
    },
    {
      "type": "text",
      "section": "Growth Monitoring and Assessment",
      "line": 4176,
      "preview": "${ }^{\\text {b }}$ Olsen IE, Groveman SA, Lawson ML, Clark RH, Zemel BS. New intrauterine growth cur"
    },
    {
      "type": "text",
      "section": "Growth Monitoring and Assessment",
      "line": 4177,
      "preview": "${ }^{\\text {c }}$ World Health Organization. Growth Standards. Accessed February 23, 2023. https://"
    },
    {
      "type": "text",
      "section": "Growth Monitoring and Assessment",
      "line": 4179,
      "preview": "Growth monitoring and assessment in the first 1-2 weeks should focus on the degree of weight loss co"
    },
    {
      "type": "text",
      "section": "Growth Monitoring and Assessment",
      "line": 4181,
      "preview": "TABLE 7-6. Growth Monitoring"
    },
    {
      "type": "table",
      "section": "Growth Monitoring and Assessment",
      "line": 4183,
      "preview": "| Anthropometric <br> Measurement | Frequency | Target Growth Rates ${ }^{\\text {a-c }}$ | z Score C"
    },
    {
      "type": "table",
      "section": "Growth Monitoring and Assessment",
      "line": 4184,
      "preview": "| :-- | :-- | :-- | :-- |"
    },
    {
      "type": "table",
      "section": "Growth Monitoring and Assessment",
      "line": 4185,
      "preview": "| Weight | Daily or at least 2-3 <br> times/wk | Preterm/LBW: <br> $15-20 \\mathrm{~g} / \\mathrm{kg} "
    },
    {
      "type": "table",
      "section": "Growth Monitoring and Assessment",
      "line": 4186,
      "preview": "| Length | Weekly | Preterm: $>1 \\mathrm{~cm} / \\mathrm{wk}$ <br> Term: $0.6-0.8 \\mathrm{~cm} / \\mat"
    },
    {
      "type": "table",
      "section": "Growth Monitoring and Assessment",
      "line": 4187,
      "preview": "| Head circumference | Weekly | Preterm: $0.8-1 \\mathrm{~cm} / \\mathrm{wk}$ <br> Term: $0.5 \\mathrm{"
    },
    {
      "type": "text",
      "section": "Growth Monitoring and Assessment",
      "line": 4189,
      "preview": "Abbreviations: CA, corrected age; LBW, low birth weight."
    },
    {
      "type": "text",
      "section": "Growth Monitoring and Assessment",
      "line": 4190,
      "preview": "${ }^{a}$ Goldberg DL, Becker PJ, Brigham K, et al. Identifying malnutrition in preterm and neonatal"
    },
    {
      "type": "text",
      "section": "Growth Monitoring and Assessment",
      "line": 4191,
      "preview": "${ }^{\\text {b }}$ Taylor SN, Buck Co. Monitoring of growth and body composition: New methodologies."
    },
    {
      "type": "text",
      "section": "Growth Monitoring and Assessment",
      "line": 4192,
      "preview": "${ }^{\\text {c }}$ American Academy of Pediatrics Committee on Nutrition. Nutritional needs of the p"
    },
    {
      "type": "text",
      "section": "Growth Monitoring and Assessment",
      "line": 4194,
      "preview": "--- page 216 ---"
    },
    {
      "type": "text",
      "section": "Growth Monitoring and Assessment",
      "line": 4196,
      "preview": "The current goal for neonates and preterm infants is to maintain the growth trajectory within approx"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "Energy and Protein Needs",
      "line": 4198
    },
    {
      "type": "text",
      "section": "Energy and Protein Needs",
      "line": 4200,
      "preview": "Term infants require energy and protein intakes to support optimal health, development, and a normal"
    },
    {
      "type": "heading",
      "level": 2,
      "section": "Energy Needs",
      "line": 4202
    },
    {
      "type": "text",
      "section": "Energy Needs",
      "line": 4204,
      "preview": "Total energy needs are determined by considering the basal energy requirements, energy cost of growt"
    },
    {
      "type": "text",
      "section": "Energy Needs",
      "line": 4206,
      "preview": "- Physical activity"
    },
    {
      "type": "text",
      "section": "Energy Needs",
      "line": 4207,
      "preview": "- Dietary intake"
    },
    {
      "type": "text",
      "section": "Energy Needs",
      "line": 4208,
      "preview": "- Environmental interactions"
    },
    {
      "type": "text",
      "section": "Energy Needs",
      "line": 4209,
      "preview": "- Clinical conditions"
    },
    {
      "type": "text",
      "section": "Energy Needs",
      "line": 4210,
      "preview": "- Medications"
    },
    {
      "type": "text",
      "section": "Energy Needs",
      "line": 4212,
      "preview": "Measurement of energy expenditure by using indirect calorimetry in neonates, although possible, is n"
    },
    {
      "type": "text",
      "section": "Energy Needs",
      "line": 4214,
      "preview": "Parenterally fed infants typically require less energy than enterally fed infants, as the energy cos"
    },
    {
      "type": "text",
      "section": "Energy Needs",
      "line": 4216,
      "preview": "--- page 217 ---"
    },
    {
      "type": "text",
      "section": "Energy Needs",
      "line": 4218,
      "preview": "TABLE 7-7. Term Infant Energy and Protein Needs: Daily Requirements ${ }^{\\text {a-c }}$"
    },
    {
      "type": "table",
      "section": "Energy Needs",
      "line": 4220,
      "preview": "| Birth to 3 <br> mo | Energy <br> (kcal/kg/d) | Protein <br> (g/kg/d) | Notes |"
    },
    {
      "type": "table",
      "section": "Energy Needs",
      "line": 4221,
      "preview": "| :-- | :--: | :--: | :-- |"
    },
    {
      "type": "table",
      "section": "Energy Needs",
      "line": 4222,
      "preview": "| Enteral | $105-120$ | $2-2.5$ | Values serve as starting points; intakes may vary depending on cli"
    },
    {
      "type": "table",
      "section": "Energy Needs",
      "line": 4223,
      "preview": "| Parenteral | $90-110$ | $2.5-3$ |  |"
    },
    {
      "type": "text",
      "section": "Energy Needs",
      "line": 4225,
      "preview": "${ }^{a}$ Data from Goldberg DL, Becker PJ, Brigham K, et al. Identifying malnutrition in preterm an"
    },
    {
      "type": "text",
      "section": "Energy Needs",
      "line": 4226,
      "preview": "${ }^{\\text {b }}$ Data from American Academy of Pediatrics Committee on Nutrition. Nutritional need"
    },
    {
      "type": "text",
      "section": "Energy Needs",
      "line": 4227,
      "preview": "${ }^{\\text {c }}$ Data from Huff KA, Denn SC, Hay WW. Energy requirements and carbohydrates in pret"
    },
    {
      "type": "text",
      "section": "Energy Needs",
      "line": 4229,
      "preview": "TABLE 7-8. Preterm Infant Energy and Protein Needs: Daily Requirements ${ }^{\\text {a-c }}$"
    },
    {
      "type": "table",
      "section": "Energy Needs",
      "line": 4231,
      "preview": "| Birth Weight/Current Weight <br> $(\\mathbf{g})$ | PN Energy <br> $(\\mathbf{k c a l} / \\mathbf{k g}"
    },
    {
      "type": "table",
      "section": "Energy Needs",
      "line": 4232,
      "preview": "| :-- | :--: | :--: | :--: | :--: |"
    },
    {
      "type": "table",
      "section": "Energy Needs",
      "line": 4233,
      "preview": "| $<1000$ | $100-115$ | $3.5-4$ | $110-130$ | $3.5-4.5$ |"
    },
    {
      "type": "table",
      "section": "Energy Needs",
      "line": 4234,
      "preview": "| $1000-1500$ | $90-110$ | $3.2-3.8$ | $110-130$ | $3.5-4.5$ |"
    },
    {
      "type": "table",
      "section": "Energy Needs",
      "line": 4235,
      "preview": "| $1500-2000$ | $90-100$ | $3-3.5$ | $110-130$ | $3-4$ |"
    },
    {
      "type": "table",
      "section": "Energy Needs",
      "line": 4236,
      "preview": "| $2000-2500$ | $90-105$ | $3-3.5$ | $110-130$ | $2.5-3.5$ |"
    },
    {
      "type": "text",
      "section": "Energy Needs",
      "line": 4238,
      "preview": "Abbreviations: EN, enteral nutrition; PN, parenteral nutrition."
    },
    {
      "type": "text",
      "section": "Energy Needs",
      "line": 4239,
      "preview": "${ }^{a}$ Data from Goldberg DL, Becker PJ, Brigham K, et al. Identifying malnutrition in preterm an"
    },
    {
      "type": "text",
      "section": "Energy Needs",
      "line": 4240,
      "preview": "${ }^{\\text {b }}$ Data from American Academy of Pediatrics Committee on Nutrition. Nutritional need"
    },
    {
      "type": "text",
      "section": "Energy Needs",
      "line": 4241,
      "preview": "${ }^{\\text {c }}$ Data from Huff KA, Denn SC, Hay WW. Energy requirements and carbohydrates in pret"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "Protein Needs",
      "line": 4243
    },
    {
      "type": "text",
      "section": "Protein Needs",
      "line": 4245,
      "preview": "Human milk serves as the model for determining protein needs for neonates and informs the recommende"
    },
    {
      "type": "heading",
      "level": 2,
      "section": "Vitamin and Micronutrients",
      "line": 4247
    },
    {
      "type": "heading",
      "level": 2,
      "section": "Micronutrient Requirements",
      "line": 4249
    },
    {
      "type": "text",
      "section": "Micronutrient Requirements",
      "line": 4251,
      "preview": "Clinical conditions will affect absorption of micronutrients. For example, absorption of calcium and"
    },
    {
      "type": "text",
      "section": "Micronutrient Requirements",
      "line": 4253,
      "preview": "--- page 218 ---"
    },
    {
      "type": "text",
      "section": "Micronutrient Requirements",
      "line": 4255,
      "preview": "however, vitamin D may contribute little to calcium absorption. ${ }^{20}$ Similarly, vitamins are s"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "Fluid Needs",
      "line": 4257
    },
    {
      "type": "text",
      "section": "Fluid Needs",
      "line": 4259,
      "preview": "Fluid requirements for the neonate should be based on weight and clinical condition. In the first fe"
    },
    {
      "type": "heading",
      "level": 2,
      "section": "Neonatal Parenteral Nutrition",
      "line": 4261
    },
    {
      "type": "heading",
      "level": 2,
      "section": "Indications",
      "line": 4263
    },
    {
      "type": "text",
      "section": "Indications",
      "line": 4265,
      "preview": "Because of their low nutrient reserves at birth, many preterm and LBW infants require parenteral nut"
    },
    {
      "type": "heading",
      "level": 2,
      "section": "Venous Access",
      "line": 4267
    },
    {
      "type": "text",
      "section": "Venous Access",
      "line": 4269,
      "preview": "The type of vascular access and the location of the catheter will dictate the type of PN formulation"
    },
    {
      "type": "text",
      "section": "Venous Access",
      "line": 4271,
      "preview": "Peripheral vascular access may be used to infuse PN, but the final osmolarity must be less than 900 "
    },
    {
      "type": "text",
      "section": "Venous Access",
      "line": 4273,
      "preview": "--- page 219 ---"
    },
    {
      "type": "table",
      "section": "Venous Access",
      "line": 4275,
      "preview": "| [Dextrose g/L $\\times 5]+[$ amino acid $\\mathrm{g} / \\mathrm{L} \\times 10]+[($ sodium + potassium "
    },
    {
      "type": "table",
      "section": "Venous Access",
      "line": 4276,
      "preview": "| :-- | :-- |"
    },
    {
      "type": "table",
      "section": "Venous Access",
      "line": 4277,
      "preview": "| calcium + magnesium $\\mathrm{mEq} / \\mathrm{L}) \\times 2]=$ approximate $\\mathrm{mOsm} / \\mathrm{L"
    },
    {
      "type": "text",
      "section": "Venous Access",
      "line": 4279,
      "preview": "TABLE 7-9. Osmolarity of Select PN Solutions"
    },
    {
      "type": "table",
      "section": "Venous Access",
      "line": 4281,
      "preview": "| Solution | Osmolarity $(\\mathrm{mOsm} / \\mathrm{L})$ |"
    },
    {
      "type": "table",
      "section": "Venous Access",
      "line": 4282,
      "preview": "| :-- | :--: |"
    },
    {
      "type": "table",
      "section": "Venous Access",
      "line": 4283,
      "preview": "| $5 \\%$ dextrose | 300 |"
    },
    {
      "type": "table",
      "section": "Venous Access",
      "line": 4284,
      "preview": "| $10 \\%$ dextrose | 600 |"
    },
    {
      "type": "table",
      "section": "Venous Access",
      "line": 4285,
      "preview": "| $20 \\%$ dextrose | 1200 |"
    },
    {
      "type": "table",
      "section": "Venous Access",
      "line": 4286,
      "preview": "| $10 \\%$ dextrose $+2 \\%$ amino acids | 900 |"
    },
    {
      "type": "table",
      "section": "Venous Access",
      "line": 4287,
      "preview": "| $20 \\%$ dextrose $+2 \\%$ amino acids | 1500 |"
    },
    {
      "type": "table",
      "section": "Venous Access",
      "line": 4288,
      "preview": "| $25 \\%$ dextrose $+3 \\%$ amino acids | 1800 |"
    },
    {
      "type": "table",
      "section": "Venous Access",
      "line": 4289,
      "preview": "| $30 \\%$ dextrose $+3 \\%$ amino acids | 2200 |"
    },
    {
      "type": "table",
      "section": "Venous Access",
      "line": 4290,
      "preview": "| $10 \\%$ lipid injectable emulsion | 276 |"
    },
    {
      "type": "table",
      "section": "Venous Access",
      "line": 4291,
      "preview": "| $20 \\%$ lipid injectable emulsion | 258 |"
    },
    {
      "type": "table",
      "section": "Venous Access",
      "line": 4292,
      "preview": "| $30 \\%$ lipid injectable emulsion | 310 |"
    },
    {
      "type": "text",
      "section": "Venous Access",
      "line": 4294,
      "preview": "Abbreviation: PN, parenteral nutrition."
    },
    {
      "type": "heading",
      "level": 1,
      "section": "Fluid Requirements",
      "line": 4296
    },
    {
      "type": "text",
      "section": "Fluid Requirements",
      "line": 4298,
      "preview": "Typically, maintenance fluid is provided with the PN solution. Maintenance fluid requirements can be"
    },
    {
      "type": "text",
      "section": "Fluid Requirements",
      "line": 4300,
      "preview": "TABLE 7-10. Conditions That Influence Neonatal Fluid Requirements"
    },
    {
      "type": "table",
      "section": "Fluid Requirements",
      "line": 4302,
      "preview": "| Factors That Increase Fluid Needs | Factors That Decrease Fluid Needs |"
    },
    {
      "type": "table",
      "section": "Fluid Requirements",
      "line": 4303,
      "preview": "| :-- | :-- |"
    },
    {
      "type": "table",
      "section": "Fluid Requirements",
      "line": 4304,
      "preview": "| Radiant warmers | Heat shields |"
    },
    {
      "type": "table",
      "section": "Fluid Requirements",
      "line": 4305,
      "preview": "| Phototherapy | Double-walled incubators |"
    },
    {
      "type": "table",
      "section": "Fluid Requirements",
      "line": 4306,
      "preview": "| Some incubators | Highly humidified environments |"
    },
    {
      "type": "text",
      "section": "Fluid Requirements",
      "line": 4308,
      "preview": "--- page 220 ---"
    },
    {
      "type": "text",
      "section": "Fluid Requirements",
      "line": 4310,
      "preview": "TABLE 7-11. Gastrointestinal Electrolyte Losses and Suggested Replacement Regimen ${ }^{a}$"
    },
    {
      "type": "table",
      "section": "Fluid Requirements",
      "line": 4312,
      "preview": "| Source of <br> Body Fluid <br> Loss | Sodium <br> $(\\mathbf{m E q} / \\mathbf{L})$ | Potassium <br>"
    },
    {
      "type": "table",
      "section": "Fluid Requirements",
      "line": 4313,
      "preview": "| :-- | :--: | :--: | :--: | :--: | :-- |"
    },
    {
      "type": "table",
      "section": "Fluid Requirements",
      "line": 4314,
      "preview": "| Gastric | $20-80$ | $5-20$ | $100-150$ | - | $1 / 2$ NS with 10 mEq potassium/L ${ }^{\\text {b }}$"
    },
    {
      "type": "table",
      "section": "Fluid Requirements",
      "line": 4315,
      "preview": "| Ileostomy | $45-135$ | $3-15$ | $20-115$ | $50-70$ | $1 / 2-3 / 4$ NS: mL replacement for mL losse"
    },
    {
      "type": "table",
      "section": "Fluid Requirements",
      "line": 4316,
      "preview": "| Colostomy | $50-120$ | $30-40$ | $90-95$ | $20-30$ | $1 / 2-3 / 4$ NS with 20 mEq potassium/L ${ }"
    },
    {
      "type": "text",
      "section": "Fluid Requirements",
      "line": 4318,
      "preview": "Abbreviations: $\\mathrm{CO}_{2}$, carbon dioxide; NaCl , sodium chloride; NS, normal saline."
    },
    {
      "type": "text",
      "section": "Fluid Requirements",
      "line": 4319,
      "preview": "${ }^{a}$ Data from Sonneville K, Duggan C, eds. Manual of Pediatric Nutrition. 5th ed. People's Med"
    },
    {
      "type": "text",
      "section": "Fluid Requirements",
      "line": 4320,
      "preview": "${ }^{\\text {b }}$ Any replacement solution with potassium needs to be infused over several hours de"
    },
    {
      "type": "text",
      "section": "Fluid Requirements",
      "line": 4322,
      "preview": "In the parenterally fed patient, if the patient's fluid requirements are being met but their energy "
    },
    {
      "type": "heading",
      "level": 1,
      "section": "Components of PN",
      "line": 4324
    },
    {
      "type": "text",
      "section": "Components of PN",
      "line": 4326,
      "preview": "In neonatal PN solutions, dextrose, amino acids, electrolytes, and micronutrients are typically prov"
    },
    {
      "type": "heading",
      "level": 2,
      "section": "Macronutrients",
      "line": 4328
    },
    {
      "type": "text",
      "section": "Macronutrients",
      "line": 4330,
      "preview": "To achieve optimal growth, neonatal PN contains protein calories (as crystalline amino acids) and no"
    },
    {
      "type": "text",
      "section": "Macronutrients",
      "line": 4332,
      "preview": "--- page 221 ---"
    },
    {
      "type": "text",
      "section": "Macronutrients",
      "line": 4334,
      "preview": "TABLE 7-12. Energy Density of PN Macronutrients"
    },
    {
      "type": "table",
      "section": "Macronutrients",
      "line": 4336,
      "preview": "| Macronutrient | Energy Density | Examples |"
    },
    {
      "type": "table",
      "section": "Macronutrients",
      "line": 4337,
      "preview": "| :-- | :-- | :-- |"
    },
    {
      "type": "table",
      "section": "Macronutrients",
      "line": 4338,
      "preview": "| Amino acids $^{\\mathrm{a}}$ | $4 \\mathrm{kcal} / \\mathrm{g}$ | $2 \\%=2 \\mathrm{~g} / \\mathrm{dL} \\"
    },
    {
      "type": "table",
      "section": "Macronutrients",
      "line": 4339,
      "preview": "| Dextrose $^{\\mathrm{b}}$ | $3.4 \\mathrm{kcal} / \\mathrm{g}$ | $10 \\%=10 \\mathrm{~g} / \\mathrm{dL} "
    },
    {
      "type": "table",
      "section": "Macronutrients",
      "line": 4340,
      "preview": "| Fats $^{\\mathrm{c}}$ | $9 \\mathrm{kcal} / \\mathrm{g}$ | $10 \\%=10 \\mathrm{~g} / \\mathrm{dL} \\times"
    },
    {
      "type": "text",
      "section": "Macronutrients",
      "line": 4342,
      "preview": "Abbreviation: PN, parenteral nutrition."
    },
    {
      "type": "text",
      "section": "Macronutrients",
      "line": 4343,
      "preview": "${ }^{a}$ A normal nonprotein energy (kilocalories)/nitrogen (grams) ratio is between 150:1 and 250:"
    },
    {
      "type": "text",
      "section": "Macronutrients",
      "line": 4344,
      "preview": "${ }^{\\text {b }}$ To convert from \\% dextrose to $\\mathrm{mg} / \\mathrm{kg} / \\mathrm{min}$, use th"
    },
    {
      "type": "text",
      "section": "Macronutrients",
      "line": 4346,
      "preview": "TABLE 7-13. ASPEN Recommendations for Initiation and Advancement of Parenteral Nutrition Macronutrie"
    },
    {
      "type": "table",
      "section": "Macronutrients",
      "line": 4348,
      "preview": "|  | Initiation |  | Advance By |  | Goals |  |"
    },
    {
      "type": "table",
      "section": "Macronutrients",
      "line": 4349,
      "preview": "| :--: | :--: | :--: | :--: | :--: | :--: | :--: |"
    },
    {
      "type": "table",
      "section": "Macronutrients",
      "line": 4350,
      "preview": "| Macronutrient | Preterm | Term | Preterm | Term | Preterm | Term |"
    },
    {
      "type": "table",
      "section": "Macronutrients",
      "line": 4351,
      "preview": "| Protein $^{\\mathrm{b}}(\\mathrm{g} / \\mathrm{kg} / \\mathrm{d})$ | $\\begin{gathered} 1-3 \\\\ (3-4 \\te"
    },
    {
      "type": "table",
      "section": "Macronutrients",
      "line": 4352,
      "preview": "| Dextrose <br> ( $\\mathrm{mg} / \\mathrm{kg} / \\mathrm{min}$ ) | $6-8$ | $6-8$ | $1-2$ | $1-2$ | $10"
    },
    {
      "type": "table",
      "section": "Macronutrients",
      "line": 4353,
      "preview": "| Soy oil ILE ${ }^{\\text {c }}$ <br> ( $\\mathrm{g} / \\mathrm{kg} / \\mathrm{d})$ | $0.5-1$ | $0.5-1$"
    },
    {
      "type": "text",
      "section": "Macronutrients",
      "line": 4355,
      "preview": "Abbreviations: ASPEN, American Society for Parenteral and Enteral Nutrition; ILE, lipid injectable e"
    },
    {
      "type": "text",
      "section": "Macronutrients",
      "line": 4356,
      "preview": "${ }^{a}$ Adapted with permission from the American Society for Parenteral and Enteral Nutrition fro"
    },
    {
      "type": "text",
      "section": "Macronutrients",
      "line": 4357,
      "preview": "https://www.nutritioncare.org/uploadedFiles/Documents/Guidelines_and_Clinical_Resources/PN\\ Dosing\\ "
    },
    {
      "type": "text",
      "section": "Macronutrients",
      "line": 4358,
      "preview": "${ }^{\\text {b }}$ Protein does not need to be titrated; needs are increased with critical illness."
    },
    {
      "type": "text",
      "section": "Macronutrients",
      "line": 4359,
      "preview": "${ }^{\\text {c }}$ The ILE dose $/ \\mathrm{kg}$ is based on pure soy oil products; consult the manuf"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "Protein",
      "line": 4361
    },
    {
      "type": "text",
      "section": "Protein",
      "line": 4363,
      "preview": "Because of hepatic immaturity and different requirements, special crystalline amino acid formulation"
    },
    {
      "type": "text",
      "section": "Protein",
      "line": 4365,
      "preview": "--- page 222 ---"
    },
    {
      "type": "text",
      "section": "Protein",
      "line": 4367,
      "preview": "TABLE 7-14. Brand-Specific Composition of Common Pediatric Parenteral Amino Acid Solutions Designed "
    },
    {
      "type": "table",
      "section": "Protein",
      "line": 4369,
      "preview": "| Component | Product (Manufacturer) |  |"
    },
    {
      "type": "table",
      "section": "Protein",
      "line": 4370,
      "preview": "| :--: | :--: | :--: |"
    },
    {
      "type": "table",
      "section": "Protein",
      "line": 4371,
      "preview": "|  | Aminosyn PF (ICU Medical) | TrophAmine (B. Braun) Premasol (Baxter) |"
    },
    {
      "type": "table",
      "section": "Protein",
      "line": 4372,
      "preview": "| Nitrogen ( $\\mathrm{mg} / 100 \\mathrm{~mL}$ of $1 \\%$ solution) | 152 | 155 |"
    },
    {
      "type": "table",
      "section": "Protein",
      "line": 4373,
      "preview": "| Essential amino acids ( $\\mathrm{mg} / 100 \\mathrm{~mL}$ of a $1 \\%$ solution) |  |  |"
    },
    {
      "type": "table",
      "section": "Protein",
      "line": 4374,
      "preview": "| Isoleucine | 76 | 82 |"
    },
    {
      "type": "table",
      "section": "Protein",
      "line": 4375,
      "preview": "| Leucine | 120 | 140 |"
    },
    {
      "type": "table",
      "section": "Protein",
      "line": 4376,
      "preview": "| Lysine | 68 | 82 |"
    },
    {
      "type": "table",
      "section": "Protein",
      "line": 4377,
      "preview": "| Methionine | 18 | 34 |"
    },
    {
      "type": "table",
      "section": "Protein",
      "line": 4378,
      "preview": "| Phenylalanine | 43 | 48 |"
    },
    {
      "type": "table",
      "section": "Protein",
      "line": 4379,
      "preview": "| Threonine | 51 | 42 |"
    },
    {
      "type": "table",
      "section": "Protein",
      "line": 4380,
      "preview": "| Tryptophan | 18 | 20 |"
    },
    {
      "type": "table",
      "section": "Protein",
      "line": 4381,
      "preview": "| Valine | 67 | 78 |"
    },
    {
      "type": "table",
      "section": "Protein",
      "line": 4382,
      "preview": "| Nonessential amino acids ( $\\mathrm{mg} / 100 \\mathrm{~mL}$ of a $1 \\%$ solution) |  |  |"
    },
    {
      "type": "table",
      "section": "Protein",
      "line": 4383,
      "preview": "| Alanine | 70 | 54 |"
    },
    {
      "type": "table",
      "section": "Protein",
      "line": 4384,
      "preview": "| Arginine | 123 | 120 |"
    },
    {
      "type": "table",
      "section": "Protein",
      "line": 4385,
      "preview": "| Histidine | 31 | 48 |"
    },
    {
      "type": "table",
      "section": "Protein",
      "line": 4386,
      "preview": "| Proline | 81 | 68 |"
    },
    {
      "type": "table",
      "section": "Protein",
      "line": 4387,
      "preview": "| Serine | 50 | 38 |"
    },
    {
      "type": "table",
      "section": "Protein",
      "line": 4388,
      "preview": "| Taurine | 7 | 2.5 |"
    },
    {
      "type": "table",
      "section": "Protein",
      "line": 4389,
      "preview": "| Tyrosine | 4 | 24 |"
    },
    {
      "type": "table",
      "section": "Protein",
      "line": 4390,
      "preview": "| Glycine | 39 | 36 |"
    },
    {
      "type": "table",
      "section": "Protein",
      "line": 4391,
      "preview": "| Glutamic acid | 82 | 50 |"
    },
    {
      "type": "table",
      "section": "Protein",
      "line": 4392,
      "preview": "| Aspartic acid | 53 | 32 |"
    },
    {
      "type": "table",
      "section": "Protein",
      "line": 4393,
      "preview": "| Cysteine | 0 | $<1.6$ |"
    },
    {
      "type": "table",
      "section": "Protein",
      "line": 4394,
      "preview": "| $N$-ac-l-tyrosine | 0 | 24 |"
    },
    {
      "type": "text",
      "section": "Protein",
      "line": 4396,
      "preview": "Abbreviation: PF, pediatric formula."
    },
    {
      "type": "text",
      "section": "Protein",
      "line": 4397,
      "preview": "${ }^{a}$ Accurate at the time of publication, check with manufacturer for most current information."
    },
    {
      "type": "text",
      "section": "Protein",
      "line": 4399,
      "preview": "Traditional doses of cysteine range from 20 to 40 mg per gram of amino acids. In times of shortage, "
    },
    {
      "type": "text",
      "section": "Protein",
      "line": 4401,
      "preview": "To prevent additional losses, protein is dosed as high as $4 \\mathrm{~g} / \\mathrm{kg} / \\mathrm{d}$"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "Carbohydrates",
      "line": 4403
    },
    {
      "type": "text",
      "section": "Carbohydrates",
      "line": 4405,
      "preview": "--- page 223 ---"
    },
    {
      "type": "text",
      "section": "Carbohydrates",
      "line": 4407,
      "preview": "Anhydrous dextrose is the form of carbohydrate used in PN. To meet the neonate's obligatory needs, i"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "Fat",
      "line": 4409
    },
    {
      "type": "text",
      "section": "Fat",
      "line": 4411,
      "preview": "In the parenterally fed neonate, fat is provided as an ILE. These are isotonic emulsions containing "
    },
    {
      "type": "text",
      "section": "Fat",
      "line": 4413,
      "preview": "There are currently 3 ILE formulations approved by the US Food and Drug Administration (FDA) for ped"
    },
    {
      "type": "text",
      "section": "Fat",
      "line": 4415,
      "preview": "Because of differences in oil composition, different dosing strategies for ILE products must be used"
    },
    {
      "type": "text",
      "section": "Fat",
      "line": 4417,
      "preview": "Serum triglyceride (TG) levels should be monitored for ILE tolerance. The goal is to have serum TG l"
    },
    {
      "type": "heading",
      "level": 2,
      "section": "Micronutrients",
      "line": 4419
    },
    {
      "type": "text",
      "section": "Micronutrients",
      "line": 4421,
      "preview": "Preterm infants are born deficient in many micronutrients. Most maternal transfer of these vitamins,"
    },
    {
      "type": "text",
      "section": "Micronutrients",
      "line": 4423,
      "preview": "--- page 224 ---"
    },
    {
      "type": "text",
      "section": "Micronutrients",
      "line": 4425,
      "preview": "TABLE 7-15. ASPEN Recommendations for Parenteral Nutrition Electrolyte and Mineral Daily Doses ${ }^"
    },
    {
      "type": "table",
      "section": "Micronutrients",
      "line": 4427,
      "preview": "| Electrolyte/Mineral | Preterm Neonates | Infants |"
    },
    {
      "type": "table",
      "section": "Micronutrients",
      "line": 4428,
      "preview": "| :-- | :-- | :-- |"
    },
    {
      "type": "table",
      "section": "Micronutrients",
      "line": 4429,
      "preview": "| Sodium | $2-5 \\mathrm{mEq} / \\mathrm{kg}$ | $2-5 \\mathrm{mEq} / \\mathrm{kg}$ |"
    },
    {
      "type": "table",
      "section": "Micronutrients",
      "line": 4430,
      "preview": "| Potassium | $2-4 \\mathrm{mEq} / \\mathrm{kg}$ | $2-4 \\mathrm{mEq} / \\mathrm{kg}$ |"
    },
    {
      "type": "table",
      "section": "Micronutrients",
      "line": 4431,
      "preview": "| Calcium | $2-4 \\mathrm{mEq} / \\mathrm{kg}$ | $0.5-4 \\mathrm{mEq} / \\mathrm{kg}$ |"
    },
    {
      "type": "table",
      "section": "Micronutrients",
      "line": 4432,
      "preview": "| Phosphorus | $1-2 \\mathrm{mmol} / \\mathrm{kg}$ <br> $(3.1-6.2 \\mathrm{mg} / \\mathrm{kg})$ | $0.5-2"
    },
    {
      "type": "table",
      "section": "Micronutrients",
      "line": 4433,
      "preview": "| Magnesium | $0.3-0.5 \\mathrm{mEq} / \\mathrm{kg}$ | $0.3-0.5 \\mathrm{mEq} / \\mathrm{kg}$ |"
    },
    {
      "type": "table",
      "section": "Micronutrients",
      "line": 4434,
      "preview": "| Acetate | As needed to maintain acid-base balance |  |"
    },
    {
      "type": "table",
      "section": "Micronutrients",
      "line": 4435,
      "preview": "| Chloride | As needed to maintain acid-base balance |  |"
    },
    {
      "type": "text",
      "section": "Micronutrients",
      "line": 4437,
      "preview": "Abbreviation: ASPEN, American Society for Parenteral and Enteral Nutrition."
    },
    {
      "type": "text",
      "section": "Micronutrients",
      "line": 4438,
      "preview": "Note: 1 g calcium gluconate $=$ elemental calcium $93 \\mathrm{mg}=$ calcium $4.65 \\mathrm{mEq}=$ cal"
    },
    {
      "type": "text",
      "section": "Micronutrients",
      "line": 4439,
      "preview": "${ }^{a}$ Data from Appropriate Dosing for Parenteral Nutrition. American Society for Parenteral and"
    },
    {
      "type": "text",
      "section": "Micronutrients",
      "line": 4440,
      "preview": "https://www.nutritioncare.org/uploadedFiles/Documents/Guidelines_and_Clinical_Resources/PN\\ Dosing\\ "
    },
    {
      "type": "heading",
      "level": 1,
      "section": "Sodium",
      "line": 4442
    },
    {
      "type": "text",
      "section": "Sodium",
      "line": 4444,
      "preview": "Because of the normal contraction of extracellular volume in the first days of life, there is a loss"
    },
    {
      "type": "heading",
      "level": 2,
      "section": "Potassium",
      "line": 4446
    },
    {
      "type": "text",
      "section": "Potassium",
      "line": 4448,
      "preview": "Potassium is the major intracellular cation responsible for muscle contractility and cardiac functio"
    },
    {
      "type": "heading",
      "level": 2,
      "section": "Calcium and Phosphorus",
      "line": 4450
    },
    {
      "type": "text",
      "section": "Calcium and Phosphorus",
      "line": 4452,
      "preview": "To avoid hypophosphatemia and optimize bone mineralization, high intakes of both calcium and phospho"
    },
    {
      "type": "text",
      "section": "Calcium and Phosphorus",
      "line": 4454,
      "preview": "--- page 225 ---"
    },
    {
      "type": "text",
      "section": "Calcium and Phosphorus",
      "line": 4456,
      "preview": "hypercalcemia can occur if inadequate phosphorus is provided or high calcium/phosphorus ratios are u"
    },
    {
      "type": "text",
      "section": "Calcium and Phosphorus",
      "line": 4458,
      "preview": "Monitoring of the calcium and phosphorus status takes additional factors into consideration. In pati"
    },
    {
      "type": "text",
      "section": "Calcium and Phosphorus",
      "line": 4460,
      "preview": "One of the challenges in providing adequate calcium and phosphorus in the parenterally fed neonate i"
    },
    {
      "type": "text",
      "section": "Calcium and Phosphorus",
      "line": 4462,
      "preview": "TABLE 7-16. Factors That Influence Calcium Phosphorus Precipitation"
    },
    {
      "type": "table",
      "section": "Calcium and Phosphorus",
      "line": 4464,
      "preview": "| Factor | Minimizes Risk of Precipitation | Increases Risk of Precipitation |"
    },
    {
      "type": "table",
      "section": "Calcium and Phosphorus",
      "line": 4465,
      "preview": "| :-- | :-- | :-- |"
    },
    {
      "type": "table",
      "section": "Calcium and Phosphorus",
      "line": 4466,
      "preview": "| pH | pH 4.5-7; addition of cysteine | $\\mathrm{pH}>7$ |"
    },
    {
      "type": "table",
      "section": "Calcium and Phosphorus",
      "line": 4467,
      "preview": "| Calcium salt | Calcium gluconate | Calcium chloride |"
    },
    {
      "type": "table",
      "section": "Calcium and Phosphorus",
      "line": 4468,
      "preview": "| Temperature | Room temperature (ie, $25^{\\circ} \\mathrm{C}$ ) | $>25^{\\circ} \\mathrm{C}$; avoid ex"
    },
    {
      "type": "table",
      "section": "Calcium and Phosphorus",
      "line": 4469,
      "preview": "| Order of mixing | Add phosphorus salts first and dilute well; add <br> calcium gluconate as the la"
    },
    {
      "type": "table",
      "section": "Calcium and Phosphorus",
      "line": 4470,
      "preview": "| Final concentration of <br> dextrose and amino acids | - Final dextrose concentration between 4\\% "
    },
    {
      "type": "table",
      "section": "Calcium and Phosphorus",
      "line": 4471,
      "preview": "| Total concentration of calcium <br> salt (mEq/L) $\\times$ phosphate salt <br> (mEq/L) | Calcium sa"
    },
    {
      "type": "table",
      "section": "Calcium and Phosphorus",
      "line": 4472,
      "preview": "| Age of PN | $<24 \\mathrm{~h}$ from time of compounding | $>24 \\mathrm{~h}$ |"
    },
    {
      "type": "text",
      "section": "Calcium and Phosphorus",
      "line": 4474,
      "preview": "Abbreviation: PN, parenteral nutrition."
    },
    {
      "type": "text",
      "section": "Calcium and Phosphorus",
      "line": 4475,
      "preview": "Data from Ku N. Compounding compatibility, stability, and safety in parenteral nutrition. Support Li"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "Magnesium",
      "line": 4477
    },
    {
      "type": "text",
      "section": "Magnesium",
      "line": 4479,
      "preview": "Magnesium, like calcium, is influenced by albumin status and the following formula can be used to co"
    },
    {
      "type": "text",
      "section": "Magnesium",
      "line": 4481,
      "preview": "$$"
    },
    {
      "type": "text",
      "section": "Magnesium",
      "line": 4482,
      "preview": "\\begin{aligned}"
    },
    {
      "type": "text",
      "section": "Magnesium",
      "line": 4483,
      "preview": "& {[\\text { Dextrose } \\mathrm{g} / \\mathrm{L} \\times 5]+[\\text { amino acid } \\mathrm{g} / \\mathrm{"
    },
    {
      "type": "text",
      "section": "Magnesium",
      "line": 4484,
      "preview": "& \\text { calcium }+ \\text { magnesium } \\mathrm{mEq} / \\mathrm{L}) \\times 2]=\\text { approximate } "
    },
    {
      "type": "text",
      "section": "Magnesium",
      "line": 4485,
      "preview": "\\end{aligned}"
    },
    {
      "type": "text",
      "section": "Magnesium",
      "line": 4486,
      "preview": "$$"
    },
    {
      "type": "text",
      "section": "Magnesium",
      "line": 4488,
      "preview": "--- page 226 ---"
    },
    {
      "type": "text",
      "section": "Magnesium",
      "line": 4490,
      "preview": "Ionized magnesium levels are available but less frequently used. Typically, magnesium can be provide"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "Anion Balance",
      "line": 4492
    },
    {
      "type": "text",
      "section": "Anion Balance",
      "line": 4494,
      "preview": "Patients developing acidosis while receiving PN may benefit from the addition of base to the solutio"
    },
    {
      "type": "heading",
      "level": 2,
      "section": "Levocarnitine",
      "line": 4496
    },
    {
      "type": "text",
      "section": "Levocarnitine",
      "line": 4498,
      "preview": "The ability of preterm infants to oxidize fatty acids is related to their limited carnitine stores. "
    },
    {
      "type": "text",
      "section": "Levocarnitine",
      "line": 4500,
      "preview": "A/F ratio $=($ plasma total carnitine - free carnitine $) /($ free carnitine $)$"
    },
    {
      "type": "text",
      "section": "Levocarnitine",
      "line": 4502,
      "preview": "A normal plasma A/F ratio is 0.25 ; carnitine deficiency is associated with an $\\mathrm{A} / \\mathrm"
    },
    {
      "type": "heading",
      "level": 2,
      "section": "Trace Elements",
      "line": 4504
    },
    {
      "type": "text",
      "section": "Trace Elements",
      "line": 4506,
      "preview": "Maternal transfer of approximately two-thirds of zinc, copper, and iron to the fetus occurs during t"
    },
    {
      "type": "text",
      "section": "Trace Elements",
      "line": 4508,
      "preview": "--- page 227 ---"
    },
    {
      "type": "text",
      "section": "Trace Elements",
      "line": 4510,
      "preview": "TABLE 7-17. ASPEN Recommendations for Parenteral Nutrition Trace Element Daily Dosing"
    },
    {
      "type": "table",
      "section": "Trace Elements",
      "line": 4512,
      "preview": "| Trace Element | Preterm Neonate <3kg | Term Neonates at 3-10 kg |"
    },
    {
      "type": "table",
      "section": "Trace Elements",
      "line": 4513,
      "preview": "| :-- | :-- | :-- |"
    },
    {
      "type": "table",
      "section": "Trace Elements",
      "line": 4514,
      "preview": "| Zinc | $400 \\mu \\mathrm{~g} / \\mathrm{kg}$ | $250 \\mu \\mathrm{~g} / \\mathrm{kg}$ |"
    },
    {
      "type": "table",
      "section": "Trace Elements",
      "line": 4515,
      "preview": "| Copper | $20 \\mu \\mathrm{~g} / \\mathrm{kg}$ | $20 \\mu \\mathrm{~g} / \\mathrm{kg}$ |"
    },
    {
      "type": "table",
      "section": "Trace Elements",
      "line": 4516,
      "preview": "| Manganese | $1 \\mu \\mathrm{~g} / \\mathrm{kg}$ | $1 \\mu \\mathrm{~g} / \\mathrm{kg}$ |"
    },
    {
      "type": "table",
      "section": "Trace Elements",
      "line": 4517,
      "preview": "| Chromium | $0.05-0.3 \\mu \\mathrm{~g} / \\mathrm{kg}$ | $0.2 \\mu \\mathrm{~g} / \\mathrm{kg}$ |"
    },
    {
      "type": "table",
      "section": "Trace Elements",
      "line": 4518,
      "preview": "| Selenium | $2 \\mu \\mathrm{~g} / \\mathrm{kg}$ | $2 \\mu \\mathrm{~g} / \\mathrm{kg}$ |"
    },
    {
      "type": "text",
      "section": "Trace Elements",
      "line": 4520,
      "preview": "Abbreviation: American Society for Parenteral and Enteral Nutrition."
    },
    {
      "type": "text",
      "section": "Trace Elements",
      "line": 4521,
      "preview": "Data from Appropriate Dosing for Parenteral Nutrition. American Society for Parenteral and Enteral N"
    },
    {
      "type": "text",
      "section": "Trace Elements",
      "line": 4522,
      "preview": "Accessed June 26, 2022."
    },
    {
      "type": "text",
      "section": "Trace Elements",
      "line": 4523,
      "preview": "https://www.nutritioncare.org/uploadedFiles/Documents/Guidelines_and_Clinical_Resources/PN\\ Dosing\\ "
    },
    {
      "type": "text",
      "section": "Trace Elements",
      "line": 4525,
      "preview": "TABLE 7-18. Trace Element Dosing Using Combination Product: Multrys (American Regents $^{a}$"
    },
    {
      "type": "table",
      "section": "Trace Elements",
      "line": 4527,
      "preview": "| Daily Dose of Multrys (mL/d) |  |  |  |  |  |"
    },
    {
      "type": "table",
      "section": "Trace Elements",
      "line": 4528,
      "preview": "| :--: | :--: | :--: | :--: | :--: | :--: |"
    },
    {
      "type": "table",
      "section": "Trace Elements",
      "line": 4529,
      "preview": "|  |  | Amount of Trace Element Provided by the Corresponding Multrys Volume |  |  |  |"
    },
    {
      "type": "table",
      "section": "Trace Elements",
      "line": 4530,
      "preview": "| Body Weight | Volume of Multrys | Zinc | Copper | Manganese | Selenium |"
    },
    {
      "type": "table",
      "section": "Trace Elements",
      "line": 4531,
      "preview": "| 0.4 to $<0.6 \\mathrm{~kg}$ | 0.2 mL (every other day) | $200 \\mu \\mathrm{~g}$ | $12 \\mu \\mathrm{~g"
    },
    {
      "type": "table",
      "section": "Trace Elements",
      "line": 4532,
      "preview": "| 0.6 to $<0.9 \\mathrm{~kg}$ | 0.2 mL daily | $200 \\mu \\mathrm{~g}$ | $12 \\mu \\mathrm{~g}$ | $0.6 \\m"
    },
    {
      "type": "table",
      "section": "Trace Elements",
      "line": 4533,
      "preview": "| 0.9 to $<1.2 \\mathrm{~kg}$ | 0.3 mL daily | $300 \\mu \\mathrm{~g}$ | $18 \\mu \\mathrm{~g}$ | $0.9 \\m"
    },
    {
      "type": "table",
      "section": "Trace Elements",
      "line": 4534,
      "preview": "| 1.2 to $<1.5 \\mathrm{~kg}$ | 0.4 mL daily | $400 \\mu \\mathrm{~g}$ | $24 \\mu \\mathrm{~g}$ | $1.2 \\m"
    },
    {
      "type": "table",
      "section": "Trace Elements",
      "line": 4535,
      "preview": "| 1.5 to $<1.8 \\mathrm{~kg}$ | 0.5 mL daily | $500 \\mu \\mathrm{~g}$ | $30 \\mu \\mathrm{~g}$ | $1.5 \\m"
    },
    {
      "type": "table",
      "section": "Trace Elements",
      "line": 4536,
      "preview": "| 1.8 to $<2.1 \\mathrm{~kg}$ | 0.6 mL daily | $600 \\mu \\mathrm{~g}$ | $36 \\mu \\mathrm{~g}$ | $1.8 \\m"
    },
    {
      "type": "table",
      "section": "Trace Elements",
      "line": 4537,
      "preview": "| 2.1 to $<2.4 \\mathrm{~kg}$ | 0.7 mL daily | $700 \\mu \\mathrm{~g}$ | $42 \\mu \\mathrm{~g}$ | $2.1 \\m"
    },
    {
      "type": "table",
      "section": "Trace Elements",
      "line": 4538,
      "preview": "| 2.4 to $<2.7 \\mathrm{~kg}$ | 0.8 mL daily | $800 \\mu \\mathrm{~g}$ | $48 \\mu \\mathrm{~g}$ | $2.4 \\m"
    },
    {
      "type": "table",
      "section": "Trace Elements",
      "line": 4539,
      "preview": "| 2.7 to $<3 \\mathrm{~kg}$ | 0.9 mL daily | $900 \\mu \\mathrm{~g}$ | $54 \\mu \\mathrm{~g}$ | $2.7 \\mu "
    },
    {
      "type": "table",
      "section": "Trace Elements",
      "line": 4540,
      "preview": "| 3 to $<10 \\mathrm{~kg}$ | 1 mL daily (max dose) | $1000 \\mu \\mathrm{~g}$ | $60 \\mu \\mathrm{~g}$ | "
    },
    {
      "type": "text",
      "section": "Trace Elements",
      "line": 4542,
      "preview": "Note: Additional daily supplementation of zinc, copper, and/or selenium may be needed to meet daily "
    },
    {
      "type": "heading",
      "level": 1,
      "section": "Zinc",
      "line": 4544
    },
    {
      "type": "text",
      "section": "Zinc",
      "line": 4546,
      "preview": "Zinc is an essential trace element necessary for metabolism of energy and growth. Neonates receiving"
    },
    {
      "type": "heading",
      "level": 2,
      "section": "Copper",
      "line": 4548
    },
    {
      "type": "text",
      "section": "Copper",
      "line": 4550,
      "preview": "--- page 228 ---"
    },
    {
      "type": "text",
      "section": "Copper",
      "line": 4552,
      "preview": "Like zinc, copper is also important to infant growth. It is also important for bone health, as coppe"
    },
    {
      "type": "text",
      "section": "Copper",
      "line": 4554,
      "preview": "$$"
    },
    {
      "type": "text",
      "section": "Copper",
      "line": 4555,
      "preview": "\\begin{gathered}"
    },
    {
      "type": "text",
      "section": "Copper",
      "line": 4556,
      "preview": "\\text { Adjusted copper in } \\mu \\mathrm{mol} / \\mathrm{L}=(\\text { total copper in } \\mu \\mathrm{mo"
    },
    {
      "type": "text",
      "section": "Copper",
      "line": 4557,
      "preview": "(0.052 \\times \\text { ceruloplasmin in } \\mathrm{mg} / \\mathrm{L})+(17.5 \\mu \\mathrm{~mol} / \\mathrm"
    },
    {
      "type": "text",
      "section": "Copper",
      "line": 4558,
      "preview": "\\end{gathered}"
    },
    {
      "type": "text",
      "section": "Copper",
      "line": 4559,
      "preview": "$$"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "Selenium",
      "line": 4561
    },
    {
      "type": "text",
      "section": "Selenium",
      "line": 4563,
      "preview": "The addition of selenium may be necessary after 30 days of PN and no or minimal enteral intake. Neon"
    },
    {
      "type": "heading",
      "level": 2,
      "section": "Chromium",
      "line": 4565
    },
    {
      "type": "text",
      "section": "Chromium",
      "line": 4567,
      "preview": "Early hyperglycemia is prevalent in preterm infants receiving PN therapy. Chromium improves glucose "
    },
    {
      "type": "heading",
      "level": 2,
      "section": "Manganese",
      "line": 4569
    },
    {
      "type": "text",
      "section": "Manganese",
      "line": 4571,
      "preview": "Manganese is a component of the antioxidant enzyme superoxide dismutase, which helps fight free radi"
    },
    {
      "type": "heading",
      "level": 2,
      "section": "Vitamins",
      "line": 4573
    },
    {
      "type": "text",
      "section": "Vitamins",
      "line": 4575,
      "preview": "The importance of vitamins in neonates receiving PN has been underscored in the United States by sev"
    },
    {
      "type": "text",
      "section": "Vitamins",
      "line": 4577,
      "preview": "--- page 229 ---"
    },
    {
      "type": "text",
      "section": "Vitamins",
      "line": 4579,
      "preview": "TABLE 7-19. ASPEN Recommended Parenteral Nutrition Daily Multiple Vitamin Product Dosing $^{\\mathbf{"
    },
    {
      "type": "table",
      "section": "Vitamins",
      "line": 4581,
      "preview": "| Manufacturer Recommendation ${ }^{\\text {b }}$ |  | NAG-AMA Recommendations |  |"
    },
    {
      "type": "table",
      "section": "Vitamins",
      "line": 4582,
      "preview": "| :-- | :--: | :--: | :--: |"
    },
    {
      "type": "table",
      "section": "Vitamins",
      "line": 4583,
      "preview": "| Weight (kg) | Dose (mL) | Weight (kg) | Dose (mL) |"
    },
    {
      "type": "table",
      "section": "Vitamins",
      "line": 4584,
      "preview": "| $<1$ | 1.5 | $<2.5$ | 2 |"
    },
    {
      "type": "table",
      "section": "Vitamins",
      "line": 4585,
      "preview": "| $1-3$ | 3.25 | $>2.5$ | 5 |"
    },
    {
      "type": "table",
      "section": "Vitamins",
      "line": 4586,
      "preview": "| $>3$ | 5 |  |  |"
    },
    {
      "type": "text",
      "section": "Vitamins",
      "line": 4588,
      "preview": "Abbreviations: AMA, American Medical Association; NAG, Nutrition Advisory Group."
    },
    {
      "type": "text",
      "section": "Vitamins",
      "line": 4589,
      "preview": "${ }^{a}$ Data from Appropriate Dosing for Parenteral Nutrition. American Society for Parenteral and"
    },
    {
      "type": "text",
      "section": "Vitamins",
      "line": 4590,
      "preview": "${ }^{\\mathrm{b}}$ Infuvite (Baxter)."
    },
    {
      "type": "text",
      "section": "Vitamins",
      "line": 4592,
      "preview": "In comparison with the products intended for patients older than age 11, the pediatric versions of m"
    },
    {
      "type": "text",
      "section": "Vitamins",
      "line": 4594,
      "preview": "In the event of a parenteral multivitamin shortage, it is imperative that practitioners provide adeq"
    },
    {
      "type": "text",
      "section": "Vitamins",
      "line": 4596,
      "preview": "--- page 230 ---"
    },
    {
      "type": "text",
      "section": "Vitamins",
      "line": 4598,
      "preview": "TABLE 7-20. Recommended Levels of Intake for Intravenous Multivitamins for Term and Preterm Infants "
    },
    {
      "type": "table",
      "section": "Vitamins",
      "line": 4600,
      "preview": "| Vitamin | Term Infants (Dose/d) ${ }^{b}$ | Preterm Infants (Dose/kg) ${ }^{\\text {c }}$ |  |"
    },
    {
      "type": "table",
      "section": "Vitamins",
      "line": 4601,
      "preview": "| :--: | :--: | :--: | :--: |"
    },
    {
      "type": "table",
      "section": "Vitamins",
      "line": 4602,
      "preview": "|  |  | Current Suggestion ${ }^{d}$ | Best New Estimate ${ }^{e}$ |"
    },
    {
      "type": "table",
      "section": "Vitamins",
      "line": 4603,
      "preview": "| A (IU) | 2300 | 920 | 1643 |"
    },
    {
      "type": "table",
      "section": "Vitamins",
      "line": 4604,
      "preview": "| $D(\\mu \\mathrm{~g})$ | 10 | 4 | 4 |"
    },
    {
      "type": "table",
      "section": "Vitamins",
      "line": 4605,
      "preview": "| E (mg) | 7 | 2.8 | 2.8 |"
    },
    {
      "type": "table",
      "section": "Vitamins",
      "line": 4606,
      "preview": "| K ( $\\mu \\mathrm{g}$ ) | 200 | 80 | 80 |"
    },
    {
      "type": "table",
      "section": "Vitamins",
      "line": 4607,
      "preview": "| Ascorbic acid (mg) | 80 | 32 | 25 |"
    },
    {
      "type": "table",
      "section": "Vitamins",
      "line": 4608,
      "preview": "| Thiamine (mg) | 1.2 | 0.48 | 0.35 |"
    },
    {
      "type": "table",
      "section": "Vitamins",
      "line": 4609,
      "preview": "| Riboflavin (mg) | 1.4 | 0.56 | 0.15 |"
    },
    {
      "type": "table",
      "section": "Vitamins",
      "line": 4610,
      "preview": "| Niacin (mg) | 17 | 6.8 | 6.8 |"
    },
    {
      "type": "table",
      "section": "Vitamins",
      "line": 4611,
      "preview": "| Pantothenate (mg) | 5 | 2.0 | 2.0 |"
    },
    {
      "type": "table",
      "section": "Vitamins",
      "line": 4612,
      "preview": "| Pyridoxine (mg) | 1.0 | 0.4 | 0.18 |"
    },
    {
      "type": "table",
      "section": "Vitamins",
      "line": 4613,
      "preview": "| Vitamin $B_{12}(\\mu \\mathrm{~g})$ | 1.0 | 0.4 | 0.3 |"
    },
    {
      "type": "table",
      "section": "Vitamins",
      "line": 4614,
      "preview": "| Biotin ( $\\mu \\mathrm{g}$ ) | 20 | 8.0 | 6.0 |"
    },
    {
      "type": "table",
      "section": "Vitamins",
      "line": 4615,
      "preview": "| Folate ( $\\mu \\mathrm{g}$ ) | 140 | 56 | 56 |"
    },
    {
      "type": "text",
      "section": "Vitamins",
      "line": 4617,
      "preview": "${ }^{a}$ Data from Sonneville K, Duggan C, eds. Manual of Pediatric Nutrition. 5th ed. People's Med"
    },
    {
      "type": "text",
      "section": "Vitamins",
      "line": 4618,
      "preview": "${ }^{\\text {b }}$ These are all met by currently available pediatric parenteral multivitamins."
    },
    {
      "type": "text",
      "section": "Vitamins",
      "line": 4619,
      "preview": "${ }^{\\text {c }}$ Maximum dose not to exceed term infant dose."
    },
    {
      "type": "text",
      "section": "Vitamins",
      "line": 4620,
      "preview": "${ }^{d}$ These are met by $40 \\%$ of the single dose $(0.4 \\times 5 \\mathrm{~mL}=2 \\mathrm{~mL})$ o"
    },
    {
      "type": "text",
      "section": "Vitamins",
      "line": 4621,
      "preview": "${ }^{e}$ Based on data suggesting a reduced need for water-soluble vitamins and increased need for "
    },
    {
      "type": "heading",
      "level": 1,
      "section": "Other Additives",
      "line": 4623
    },
    {
      "type": "heading",
      "level": 2,
      "section": "Heparin",
      "line": 4625
    },
    {
      "type": "text",
      "section": "Heparin",
      "line": 4627,
      "preview": "Heparin is often added to neonatal PN, especially those infusing via a central venous catheter (CVC)"
    },
    {
      "type": "heading",
      "level": 2,
      "section": "Insulin",
      "line": 4629
    },
    {
      "type": "text",
      "section": "Insulin",
      "line": 4631,
      "preview": "Because the risk of hypoglycemia outweighs the potential benefits of insulin on growth, the addition"
    },
    {
      "type": "heading",
      "level": 2,
      "section": "Special Situations",
      "line": 4633
    },
    {
      "type": "heading",
      "level": 2,
      "section": "Starter PN",
      "line": 4635
    },
    {
      "type": "text",
      "section": "Starter PN",
      "line": 4637,
      "preview": "Evidence has demonstrated that early PN administration in preterm LBW neonates can improve growth an"
    },
    {
      "type": "text",
      "section": "Starter PN",
      "line": 4639,
      "preview": "--- page 231 ---"
    },
    {
      "type": "text",
      "section": "Starter PN",
      "line": 4641,
      "preview": "after birth and are intended to prevent the catabolic processes that can result in additional muscle"
    },
    {
      "type": "text",
      "section": "Starter PN",
      "line": 4643,
      "preview": "Term neonates should also be provided PN if they are unable to receive enteral feedings for more tha"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "Compounding PN for the Neonate",
      "line": 4645
    },
    {
      "type": "text",
      "section": "Compounding PN for the Neonate",
      "line": 4647,
      "preview": "In addition to the calcium and phosphorus compatibility issues, other compounding factors have been "
    },
    {
      "type": "text",
      "section": "Compounding PN for the Neonate",
      "line": 4649,
      "preview": "Practitioners responsible for overseeing the compounding of PN solutions for neonates must be famili"
    },
    {
      "type": "heading",
      "level": 2,
      "section": "Ambient Light",
      "line": 4651
    },
    {
      "type": "text",
      "section": "Ambient Light",
      "line": 4653,
      "preview": "When PN is exposed to ambient light, hydrogen peroxide and lipid peroxides are generated. ${ }^{67}$"
    },
    {
      "type": "heading",
      "level": 2,
      "section": "Di(2-Ethylhexyl)Phthalate Toxicity",
      "line": 4655
    },
    {
      "type": "text",
      "section": "Di(2-Ethylhexyl)Phthalate Toxicity",
      "line": 4657,
      "preview": "$\\mathrm{Di}(2$-ethylhexyl)phthalate (DEHP) is an industrial additive plasticizer found in polyvinyl"
    },
    {
      "type": "text",
      "section": "Di(2-Ethylhexyl)Phthalate Toxicity",
      "line": 4659,
      "preview": "--- page 232 ---"
    },
    {
      "type": "text",
      "section": "Di(2-Ethylhexyl)Phthalate Toxicity",
      "line": 4661,
      "preview": "metabolites are consistently detected in human bodily fluids such as plasma and urine. ${ }^{74}$ In"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "Aluminum Contamination",
      "line": 4663
    },
    {
      "type": "text",
      "section": "Aluminum Contamination",
      "line": 4665,
      "preview": "Aluminum exposure is a risk in patients receiving prolonged courses of receiving PN. This nonessenti"
    },
    {
      "type": "text",
      "section": "Aluminum Contamination",
      "line": 4667,
      "preview": "Calcium gluconate salts are a major source of aluminum contamination in PN patients. Because calcium"
    },
    {
      "type": "text",
      "section": "Aluminum Contamination",
      "line": 4669,
      "preview": "The implementation of the FDA mandate has been difficult to incorporate into clinical practice becau"
    },
    {
      "type": "heading",
      "level": 2,
      "section": "Monitoring",
      "line": 4671
    },
    {
      "type": "text",
      "section": "Monitoring",
      "line": 4673,
      "preview": "Monitoring the neonate's biochemical and clinical response to the initiation and continuation of PN "
    },
    {
      "type": "text",
      "section": "Monitoring",
      "line": 4675,
      "preview": "--- page 233 ---"
    },
    {
      "type": "text",
      "section": "Monitoring",
      "line": 4677,
      "preview": "TABLE 7-21. Suggested PN Monitoring Guidelines ${ }^{a}$"
    },
    {
      "type": "table",
      "section": "Monitoring",
      "line": 4679,
      "preview": "| Parameter | Daily | Weekly $^{\\text {b }}$ | Periodically ${ }^{\\text {b }}$ |"
    },
    {
      "type": "table",
      "section": "Monitoring",
      "line": 4680,
      "preview": "| :--: | :--: | :--: | :--: |"
    },
    {
      "type": "table",
      "section": "Monitoring",
      "line": 4681,
      "preview": "| Weight | X |  |  |"
    },
    {
      "type": "table",
      "section": "Monitoring",
      "line": 4682,
      "preview": "| Fluid balance | X |  |  |"
    },
    {
      "type": "table",
      "section": "Monitoring",
      "line": 4683,
      "preview": "| Vital signs | X |  |  |"
    },
    {
      "type": "table",
      "section": "Monitoring",
      "line": 4684,
      "preview": "| Urine sugar/ketones | X |  |  |"
    },
    {
      "type": "table",
      "section": "Monitoring",
      "line": 4685,
      "preview": "| Catheter site/function | X |  |  |"
    },
    {
      "type": "table",
      "section": "Monitoring",
      "line": 4686,
      "preview": "| Laboratory test: |  |  |  |"
    },
    {
      "type": "table",
      "section": "Monitoring",
      "line": 4687,
      "preview": "| Sodium |  | X |  |"
    },
    {
      "type": "table",
      "section": "Monitoring",
      "line": 4688,
      "preview": "| Potassium |  | X |  |"
    },
    {
      "type": "table",
      "section": "Monitoring",
      "line": 4689,
      "preview": "| Chloride |  | X |  |"
    },
    {
      "type": "table",
      "section": "Monitoring",
      "line": 4690,
      "preview": "| $\\mathrm{TCO}_{2}$ |  | X |  |"
    },
    {
      "type": "table",
      "section": "Monitoring",
      "line": 4691,
      "preview": "| Glucose |  | X |  |"
    },
    {
      "type": "table",
      "section": "Monitoring",
      "line": 4692,
      "preview": "| Serum urea nitrogen |  | X |  |"
    },
    {
      "type": "table",
      "section": "Monitoring",
      "line": 4693,
      "preview": "| Creatinine |  | X |  |"
    },
    {
      "type": "table",
      "section": "Monitoring",
      "line": 4694,
      "preview": "| Triglycerides |  | X |  |"
    },
    {
      "type": "table",
      "section": "Monitoring",
      "line": 4695,
      "preview": "| Calcium |  | X |  |"
    },
    {
      "type": "table",
      "section": "Monitoring",
      "line": 4696,
      "preview": "| Magnesium |  | X |  |"
    },
    {
      "type": "table",
      "section": "Monitoring",
      "line": 4697,
      "preview": "| Phosphorus |  | X |  |"
    },
    {
      "type": "table",
      "section": "Monitoring",
      "line": 4698,
      "preview": "| Prealbumin |  | X |  |"
    },
    {
      "type": "table",
      "section": "Monitoring",
      "line": 4699,
      "preview": "| Albumin |  | X |  |"
    },
    {
      "type": "table",
      "section": "Monitoring",
      "line": 4700,
      "preview": "| Total protein |  | X |  |"
    },
    {
      "type": "table",
      "section": "Monitoring",
      "line": 4701,
      "preview": "| SGPT |  | X |  |"
    },
    {
      "type": "table",
      "section": "Monitoring",
      "line": 4702,
      "preview": "| Alkaline phosphatase |  | X |  |"
    },
    {
      "type": "table",
      "section": "Monitoring",
      "line": 4703,
      "preview": "| Bilirubin (total and direct) |  | X |  |"
    },
    {
      "type": "table",
      "section": "Monitoring",
      "line": 4704,
      "preview": "| GGTP |  | X |  |"
    },
    {
      "type": "table",
      "section": "Monitoring",
      "line": 4705,
      "preview": "| Selenium |  |  | X |"
    },
    {
      "type": "table",
      "section": "Monitoring",
      "line": 4706,
      "preview": "| Copper |  |  | X |"
    },
    {
      "type": "table",
      "section": "Monitoring",
      "line": 4707,
      "preview": "| Zinc |  |  | X |"
    },
    {
      "type": "table",
      "section": "Monitoring",
      "line": 4708,
      "preview": "| Iron |  |  | X |"
    },
    {
      "type": "table",
      "section": "Monitoring",
      "line": 4709,
      "preview": "| Carnitine |  |  | X |"
    },
    {
      "type": "table",
      "section": "Monitoring",
      "line": 4710,
      "preview": "| C-reactive protein |  |  | X |"
    },
    {
      "type": "table",
      "section": "Monitoring",
      "line": 4711,
      "preview": "| Vitamins A, D, E |  |  | X |"
    },
    {
      "type": "table",
      "section": "Monitoring",
      "line": 4712,
      "preview": "| Aluminum |  |  | X |"
    },
    {
      "type": "text",
      "section": "Monitoring",
      "line": 4714,
      "preview": "Abbreviations: GGTP, y-glutamyl transpeptidase; PN, parenteral nutrition; SGPT, serum glutamate pyru"
    },
    {
      "type": "text",
      "section": "Monitoring",
      "line": 4715,
      "preview": "Note: Frequency will depend on clinical status; metabolically unstable patients should be assessed m"
    },
    {
      "type": "text",
      "section": "Monitoring",
      "line": 4716,
      "preview": "${ }^{a}$ Data from Sonneville K, Duggan C, eds. Manual of Pediatric Nutrition. 5th ed. People's Med"
    },
    {
      "type": "text",
      "section": "Monitoring",
      "line": 4717,
      "preview": "${ }^{\\text {b }}$ More often as necessitated by clinical condition."
    },
    {
      "type": "text",
      "section": "Monitoring",
      "line": 4719,
      "preview": "--- page 234 ---"
    },
    {
      "type": "text",
      "section": "Monitoring",
      "line": 4721,
      "preview": "TABLE 7-22. Metabolic Complications Associated With PN Use ${ }^{a}$"
    },
    {
      "type": "table",
      "section": "Monitoring",
      "line": 4723,
      "preview": "| Complication | Possible Etiology | Clinical Findings | Prevention/Monitoring | Intervention |"
    },
    {
      "type": "table",
      "section": "Monitoring",
      "line": 4724,
      "preview": "| :--: | :--: | :--: | :--: | :--: |"
    },
    {
      "type": "table",
      "section": "Monitoring",
      "line": 4725,
      "preview": "| Complications related to macronutrients |  |  |  |  |"
    },
    {
      "type": "table",
      "section": "Monitoring",
      "line": 4726,
      "preview": "| Hyperglycemia | - Excessive dextrose infusion <br> - Metabolic stress/sepsis <br> - Corticosteroid"
    },
    {
      "type": "table",
      "section": "Monitoring",
      "line": 4727,
      "preview": "| Hypoglycemia | - Sudden discontinuation of PN <br> - Exogenous insulin administration <br> - Sepsi"
    },
    {
      "type": "table",
      "section": "Monitoring",
      "line": 4728,
      "preview": "| Hypercapnia (elevated $\\mathrm{pCO}_{2}$ ) | - Excessive dextrose or total caloric intake <br> - R"
    },
    {
      "type": "table",
      "section": "Monitoring",
      "line": 4729,
      "preview": "| Azotemia | - Dehydration <br> - Renal insufficiency <br> - Excessive amino acid infusion <br> - Le"
    },
    {
      "type": "table",
      "section": "Monitoring",
      "line": 4730,
      "preview": "| Abnormal amino acid profile | - Inborn errors of metabolism <br> - Hepatic disease <br> - Composit"
    },
    {
      "type": "table",
      "section": "Monitoring",
      "line": 4731,
      "preview": "| Hypertriglyceridemia | - Excessive ILE rate of infusion <br> - Decreased clearance (stress/sepsis,"
    },
    {
      "type": "text",
      "section": "Monitoring",
      "line": 4733,
      "preview": "--- page 235 ---"
    },
    {
      "type": "table",
      "section": "Monitoring",
      "line": 4735,
      "preview": "| Complication | Possible Etiology | Clinical Findings | Prevention/Monitoring | Intervention |"
    },
    {
      "type": "table",
      "section": "Monitoring",
      "line": 4736,
      "preview": "| :--: | :--: | :--: | :--: | :--: |"
    },
    {
      "type": "table",
      "section": "Monitoring",
      "line": 4737,
      "preview": "| Fluid overload | - Excessive fluid administration <br> - Renal dysfunction, congestive heart failu"
    },
    {
      "type": "table",
      "section": "Monitoring",
      "line": 4738,
      "preview": "| Dehydration | - Inadequate fluid intake <br> - Excessive diuresis <br> - Increased Gl losses <br> "
    },
    {
      "type": "table",
      "section": "Monitoring",
      "line": 4739,
      "preview": "| Hypokalemia | - Inadequate potassium supplementation during anabolism <br> - Increased Gl losses ("
    },
    {
      "type": "table",
      "section": "Monitoring",
      "line": 4740,
      "preview": "| Hyperkalemia | - Renal insufficiency <br> - Excessive potassium administration <br> - Medications "
    },
    {
      "type": "table",
      "section": "Monitoring",
      "line": 4741,
      "preview": "| Hyponatremia | - Fluid overload <br> - SIADH <br> - Excessive losses (urinary, GI, or through skin"
    },
    {
      "type": "table",
      "section": "Monitoring",
      "line": 4742,
      "preview": "| Hypernatremia | - Dehydration <br> - Excessive sodium administration <br> - Osmotic diuresis secon"
    },
    {
      "type": "text",
      "section": "Monitoring",
      "line": 4744,
      "preview": "--- page 236 ---"
    },
    {
      "type": "table",
      "section": "Monitoring",
      "line": 4746,
      "preview": "| Complication | Possible Etiology | Clinical Findings | Prevention/Monitoring | Intervention |"
    },
    {
      "type": "table",
      "section": "Monitoring",
      "line": 4747,
      "preview": "| :--: | :--: | :--: | :--: | :--: |"
    },
    {
      "type": "table",
      "section": "Monitoring",
      "line": 4748,
      "preview": "| Metabolic acidosis | - Increased intestinal losses of bicarbonate (diarrhea, fistulas) <br> - Rena"
    },
    {
      "type": "table",
      "section": "Monitoring",
      "line": 4749,
      "preview": "| Metabolic alkalosis | - Gastric acid losses (increased NG tube output) <br> - Excess base administ"
    },
    {
      "type": "table",
      "section": "Monitoring",
      "line": 4750,
      "preview": "| Mineral imbalances |  |  |  |  |"
    },
    {
      "type": "table",
      "section": "Monitoring",
      "line": 4751,
      "preview": "| Hypocalcemia | - Hypoalbuminemia <br> - Hypomagnesemia <br> - Hyperphosphatemia <br> - Hypoparathy"
    },
    {
      "type": "table",
      "section": "Monitoring",
      "line": 4752,
      "preview": "| Hypercalcemia | - Renal insufficiency <br> - Excessive vitamin D intake <br> - Bone resorption cau"
    },
    {
      "type": "table",
      "section": "Monitoring",
      "line": 4753,
      "preview": "| Hypomagnesemia | - Increased GI losses (vomiting, diarrhea, fistula) <br> - Increased urinary loss"
    },
    {
      "type": "text",
      "section": "Monitoring",
      "line": 4755,
      "preview": "--- page 237 ---"
    },
    {
      "type": "table",
      "section": "Monitoring",
      "line": 4757,
      "preview": "| Complication | Possible Etiology | Clinical Findings | Prevention/Monitoring | Intervention |"
    },
    {
      "type": "table",
      "section": "Monitoring",
      "line": 4758,
      "preview": "| :--: | :--: | :--: | :--: | :--: |"
    },
    {
      "type": "table",
      "section": "Monitoring",
      "line": 4759,
      "preview": "| Hypermagnesemia | - Renal insufficiency <br> - Excessive magnesium intake | - Nausea/vomiting <br>"
    },
    {
      "type": "table",
      "section": "Monitoring",
      "line": 4760,
      "preview": "| Hypophosphatemia | Inadequate phosphorous supplementation during anabolism/refeeding | - Serum lev"
    },
    {
      "type": "table",
      "section": "Monitoring",
      "line": 4761,
      "preview": "| Hyperphosphatemia | - Renal insufficiency <br> - Excessive phosphorus administration <br> - PTH de"
    },
    {
      "type": "table",
      "section": "Monitoring",
      "line": 4762,
      "preview": "| Other |  |  |  |  |"
    },
    {
      "type": "table",
      "section": "Monitoring",
      "line": 4763,
      "preview": "| Refeeding syndrome | Rapid or excessive dextrose infusion (especially in malnourished patients) | "
    },
    {
      "type": "table",
      "section": "Monitoring",
      "line": 4764,
      "preview": "|  |  |  | - Supplement phosphorus in PN; advance PN cautiously <br> - Monitor serum glucose, electr"
    },
    {
      "type": "text",
      "section": "Monitoring",
      "line": 4766,
      "preview": "--- page 238 ---"
    },
    {
      "type": "table",
      "section": "Monitoring",
      "line": 4768,
      "preview": "| Complication | Possible Etiology | Clinical Findings | Prevention/Monitoring | Intervention |"
    },
    {
      "type": "table",
      "section": "Monitoring",
      "line": 4769,
      "preview": "| :--: | :--: | :--: | :--: | :--: |"
    },
    {
      "type": "table",
      "section": "Monitoring",
      "line": 4770,
      "preview": "| EFAD | Prolonged insufficient ILE intake | - Dry, scaly skin <br> - Hair loss <br> - Thrombocytope"
    },
    {
      "type": "table",
      "section": "Monitoring",
      "line": 4771,
      "preview": "| Hepatic dysfunction | Cholestasis | Elevated LFT results and direct bilirubin | - Avoid excess ene"
    },
    {
      "type": "table",
      "section": "Monitoring",
      "line": 4772,
      "preview": "| Trace nutrient deficiencies |  |  |  |  |"
    },
    {
      "type": "table",
      "section": "Monitoring",
      "line": 4773,
      "preview": "| Iron | - Long-term NPO status without iron supplementation <br> - Increased blood loss | - Decreas"
    },
    {
      "type": "table",
      "section": "Monitoring",
      "line": 4774,
      "preview": "| Zinc | - Increased GI losses <br> - Acrodermatitis enteropathica | - Growth failure <br> - Perinea"
    },
    {
      "type": "table",
      "section": "Monitoring",
      "line": 4775,
      "preview": "| Selenium | - Increased GI losses <br> - Inadequate supplementation <br> - Long-term NPO status wit"
    },
    {
      "type": "table",
      "section": "Monitoring",
      "line": 4776,
      "preview": "| Carnitine | Long-term NPO status without supplementation | - Liver dysfunction <br> - Steatosis <b"
    },
    {
      "type": "text",
      "section": "Monitoring",
      "line": 4778,
      "preview": "--- page 239 ---"
    },
    {
      "type": "table",
      "section": "Monitoring",
      "line": 4780,
      "preview": "| Complication | Possible Etiology | Clinical Findings | Prevention/Monitoring | Intervention |"
    },
    {
      "type": "table",
      "section": "Monitoring",
      "line": 4781,
      "preview": "| :--: | :--: | :--: | :--: | :--: |"
    },
    {
      "type": "table",
      "section": "Monitoring",
      "line": 4782,
      "preview": "| Metabolic bone disease | - Etiology unclear/possibly multifactorial <br> - Possible etiologies inc"
    },
    {
      "type": "text",
      "section": "Monitoring",
      "line": 4784,
      "preview": "Abbreviations: CAVH-D, continuous arteriovenous hemodialysis; CHF, congestive heart failure; CHO, ca"
    },
    {
      "type": "text",
      "section": "Monitoring",
      "line": 4785,
      "preview": "${ }^{a}$ Data from Sonneville K, Duggan C, eds. Manual of Pediatric Nutrition. 5th ed. People's Med"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "Weaning/Discontinuing PN",
      "line": 4787
    },
    {
      "type": "text",
      "section": "Weaning/Discontinuing PN",
      "line": 4789,
      "preview": "When the patient is tolerating more than $50 \\mathrm{~mL} / \\mathrm{kg} / \\mathrm{d}$ of feedings, P"
    },
    {
      "type": "heading",
      "level": 2,
      "section": "Enteral Nutrition",
      "line": 4791
    },
    {
      "type": "heading",
      "level": 2,
      "section": "Human Milk",
      "line": 4793
    },
    {
      "type": "text",
      "section": "Human Milk",
      "line": 4795,
      "preview": "Human milk is the preferred feeding choice for all infants, especially those who are hospitalized an"
    },
    {
      "type": "text",
      "section": "Human Milk",
      "line": 4797,
      "preview": "--- page 240 ---"
    },
    {
      "type": "text",
      "section": "Human Milk",
      "line": 4799,
      "preview": "Human milk is a biological fluid, and contamination is a risk that must be mitigated by establishing"
    },
    {
      "type": "text",
      "section": "Human Milk",
      "line": 4801,
      "preview": "- Human Milk Banking Association of North America (https://www.hmbana.org/ ${ }^{85}$"
    },
    {
      "type": "text",
      "section": "Human Milk",
      "line": 4802,
      "preview": "- Infant and Pediatric Feedings: Guidelines for Preparation of Human Milk and Formula in Healthcare "
    },
    {
      "type": "text",
      "section": "Human Milk",
      "line": 4803,
      "preview": "- LactMed (https://www.ncbi.nlm.nih.gov/books/NBK501922/) ${ }^{87}$"
    },
    {
      "type": "text",
      "section": "Human Milk",
      "line": 4804,
      "preview": "- Hale's Medications \\& Mother's Milk (https://www.halesmeds.com/) ${ }^{88}$"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "Human Milk Fortification",
      "line": 4807
    },
    {
      "type": "text",
      "section": "Human Milk Fortification",
      "line": 4809,
      "preview": "Although human milk is the ideal source of nutrition for neonates and infants, it does not meet the "
    },
    {
      "type": "text",
      "section": "Human Milk Fortification",
      "line": 4811,
      "preview": "For preterm infants, multiple commercially sterile, multinutrient, concentrated liquid human milk fo"
    },
    {
      "type": "text",
      "section": "Human Milk Fortification",
      "line": 4813,
      "preview": "There are 2 categories of HMFs for preterm infants: bovine or cow's milk-based fortifiers and human "
    },
    {
      "type": "text",
      "section": "Human Milk Fortification",
      "line": 4815,
      "preview": "--- page 241 ---"
    },
    {
      "type": "text",
      "section": "Human Milk Fortification",
      "line": 4817,
      "preview": "TABLE 7-23. Multinutrient Human Milk Fortifiers ${ }^{\\text {a-c }}$"
    },
    {
      "type": "table",
      "section": "Human Milk Fortification",
      "line": 4819,
      "preview": "| Manufacturer | Human Milk Fortifier Product(s) | Protein Type | Clinical Considerations |"
    },
    {
      "type": "table",
      "section": "Human Milk Fortification",
      "line": 4820,
      "preview": "| :--: | :--: | :--: | :--: |"
    },
    {
      "type": "table",
      "section": "Human Milk Fortification",
      "line": 4821,
      "preview": "| Mead <br> Johnson | - Enfamil Human Milk Fortifier <br> - Nonacidified concentrated liquid <br> - "
    },
    {
      "type": "table",
      "section": "Human Milk Fortification",
      "line": 4822,
      "preview": "| Similac | Similac Human Milk Fortifier <br> - Concentrated liquid, hydrolyzed protein <br> - Conce"
    },
    {
      "type": "table",
      "section": "Human Milk Fortification",
      "line": 4823,
      "preview": "| Prolacta Bioscience | Prolact $+\\mathrm{H}^{3} \\mathrm{MF}$ <br> - Prolact +4 <br> - Prolact +6 <b"
    },
    {
      "type": "text",
      "section": "Human Milk Fortification",
      "line": 4825,
      "preview": "Abbreviations: BW, birth weight; HMF, human milk fortifier; MCT, medium-chain triglyceride; PN, pare"
    },
    {
      "type": "text",
      "section": "Human Milk Fortification",
      "line": 4826,
      "preview": "Note: Information accurate at the time of publication."
    },
    {
      "type": "text",
      "section": "Human Milk Fortification",
      "line": 4827,
      "preview": "${ }^{a}$ Data from Thanigainathan S, Abiramalatha T. Early fortification of human milk versus late "
    },
    {
      "type": "text",
      "section": "Human Milk Fortification",
      "line": 4828,
      "preview": "https://doi.org/10.1002/14651858.CD013392.pub2"
    },
    {
      "type": "text",
      "section": "Human Milk Fortification",
      "line": 4829,
      "preview": "${ }^{\\text {b }}$ Data from Alyahya W, Simpson J, Garcia AL, Mactier H, Edwards CA. Early versus de"
    },
    {
      "type": "text",
      "section": "Human Milk Fortification",
      "line": 4830,
      "preview": "${ }^{\\text {c }}$ Data from Bergner EM, Taylor SN, Gollins LA, Hair AB. Human milk fortification: a"
    },
    {
      "type": "text",
      "section": "Human Milk Fortification",
      "line": 4832,
      "preview": "Donor milk provided to preterm infants should be fortified with a multinutrient HMF product and may "
    },
    {
      "type": "text",
      "section": "Human Milk Fortification",
      "line": 4834,
      "preview": "The precise feeding volume for early fortification will depend on the type of fortifier used. Cow's "
    },
    {
      "type": "text",
      "section": "Human Milk Fortification",
      "line": 4836,
      "preview": "--- page 242 ---"
    },
    {
      "type": "text",
      "section": "Human Milk Fortification",
      "line": 4838,
      "preview": "before a feeding volume of $60 \\mathrm{~mL} / \\mathrm{kg} / \\mathrm{d}$ and continue until 34 weeks."
    },
    {
      "type": "heading",
      "level": 1,
      "section": "Neonatal Infant Formulas",
      "line": 4840
    },
    {
      "type": "text",
      "section": "Neonatal Infant Formulas",
      "line": 4842,
      "preview": "If human milk, either MOM or DHM, is unavailable for the neonate, a broad range and selection of inf"
    },
    {
      "type": "text",
      "section": "Neonatal Infant Formulas",
      "line": 4844,
      "preview": "TABLE 7-24. Preterm Infant Formulas and Human Milk Fortifiers"
    },
    {
      "type": "table",
      "section": "Neonatal Infant Formulas",
      "line": 4846,
      "preview": "| Formula or Fortifier | Type | $\\begin{gathered} \\text { Protect/ } \\\\ 100 \\text { kcal } \\\\ (g)^{a"
    },
    {
      "type": "table",
      "section": "Neonatal Infant Formulas",
      "line": 4847,
      "preview": "| :--: | :--: | :--: | :--: | :--: | :--: | :--: | :--: | :--: |"
    },
    {
      "type": "table",
      "section": "Neonatal Infant Formulas",
      "line": 4848,
      "preview": "| Enfamil Premature | PF | 3.3 | 165 | 90 | 7.5 | 1.8 | - Available as 20, 24, and 30-kcal/oz RTF <b"
    },
    {
      "type": "table",
      "section": "Neonatal Infant Formulas",
      "line": 4849,
      "preview": "| Enfamil Premature 24-cal/fl oz HP | PF | 3.6 | 165 | 90 | 7.5 | 1.8 | - Only available as 24-kcal/"
    },
    {
      "type": "table",
      "section": "Neonatal Infant Formulas",
      "line": 4850,
      "preview": "| Similac Special Care | PF | 3 | 180 | 100 | 3.75 | 1.8 | - Available as 20, 24, and 30-kcal/oz RTF"
    },
    {
      "type": "table",
      "section": "Neonatal Infant Formulas",
      "line": 4851,
      "preview": "| Similac Special Care 24 HP | PF | 3.3 | 180 | 100 | 3.75 | 1.8 | - Only available as 24-kcal/oz RT"
    },
    {
      "type": "table",
      "section": "Neonatal Infant Formulas",
      "line": 4852,
      "preview": "| Enfamil Liquid Human Milk Fortifier Standard Protein | HMF | 2.7 | 145 | 80 | 5 | 1.9 | - 5.5-8 oz"
    },
    {
      "type": "table",
      "section": "Neonatal Infant Formulas",
      "line": 4853,
      "preview": "| Enfamil Liquid Human Milk Fortifier HP | HMF | 3.2 | 145 | 80 | 5 | 1.9 | - 5.5-8 oz bottle for ho"
    },
    {
      "type": "table",
      "section": "Neonatal Infant Formulas",
      "line": 4854,
      "preview": "| Enfamil Human Milk Fortifier Acidified Liquid | HMF | 3.2 | 145 | 80 | 5 | 1.9 | May require vitam"
    },
    {
      "type": "table",
      "section": "Neonatal Infant Formulas",
      "line": 4855,
      "preview": "| Similac Human Milk Fortifier Hydrolyzed Protein Concentrated Liquid | HMF | 3 | 150 | 85 | 4.05 | "
    },
    {
      "type": "table",
      "section": "Neonatal Infant Formulas",
      "line": 4856,
      "preview": "| Similac Human Milk Fortifier Concentrated Liquid | HMF | 2.4 | 172 | 97 | 3.95 | 0.5 | May require"
    },
    {
      "type": "table",
      "section": "Neonatal Infant Formulas",
      "line": 4857,
      "preview": "| Liquid Protein Fortifier (extensively hydrolyzed protein) | Protein <br> modular | - | - | - | - |"
    },
    {
      "type": "table",
      "section": "Neonatal Infant Formulas",
      "line": 4858,
      "preview": "| Enfamil NeuroPro EnfaCare | PDF | 2.8 | 120 | 66 | 1.875 | 1.8 | - Available RTF at 22 kcal/oz or "
    },
    {
      "type": "table",
      "section": "Neonatal Infant Formulas",
      "line": 4859,
      "preview": "| Similac NeoSure | PDF | 2.8 | 105 | 62 | 1.75 | 1.8 | - Available RTF at 22 kcal/oz or powder <br>"
    },
    {
      "type": "table",
      "section": "Neonatal Infant Formulas",
      "line": 4860,
      "preview": "| Prolact $+4^{\\mathrm{c}}$ | HMB <br> HMF | 2.3 | 146 | 78.5 | $1.9(0 . /)$ | 0.1 | Requires vitami"
    },
    {
      "type": "table",
      "section": "Neonatal Infant Formulas",
      "line": 4861,
      "preview": "| Prolact $+6^{\\mathrm{c}}$ | HMB <br> HMF | 2.6 | 135 | 73 | $0.1(0 . /)$ | 0.1 | Requires vitamin "
    },
    {
      "type": "table",
      "section": "Neonatal Infant Formulas",
      "line": 4862,
      "preview": "| Prolact $+8^{\\mathrm{c}}$ | HMB <br> HMF | 3 | 126 | 68 | $0.1(0 . /)$ | 0.1 | Requires vitamin an"
    },
    {
      "type": "text",
      "section": "Neonatal Infant Formulas",
      "line": 4864,
      "preview": "Abbreviations: Ca, calcium; HMB, human milk-based; HMF, human milk fortifier; HP, high protein; PDF,"
    },
    {
      "type": "text",
      "section": "Neonatal Infant Formulas",
      "line": 4865,
      "preview": "${ }^{a}$ Nutrition data from published values on manufacturer websites."
    },
    {
      "type": "text",
      "section": "Neonatal Infant Formulas",
      "line": 4866,
      "preview": "${ }^{\\text {b }}$ Nutrient values for human milk fortifiers added to term human milk. Term human mi"
    },
    {
      "type": "text",
      "section": "Neonatal Infant Formulas",
      "line": 4867,
      "preview": "${ }^{c}$ Prolact values are calculated per standard recipes as recommended by Prolacta Bioscience."
    },
    {
      "type": "text",
      "section": "Neonatal Infant Formulas",
      "line": 4869,
      "preview": "--- page 243 ---"
    },
    {
      "type": "text",
      "section": "Neonatal Infant Formulas",
      "line": 4871,
      "preview": "TABLE 7-25. Preterm Infant Formula Composition ${ }^{\\mathrm{a}, \\mathrm{b}}$"
    },
    {
      "type": "table",
      "section": "Neonatal Infant Formulas",
      "line": 4873,
      "preview": "| Formula Type | Protein | Fat | Carbohydrate | Vitamin/Mineral |"
    },
    {
      "type": "table",
      "section": "Neonatal Infant Formulas",
      "line": 4874,
      "preview": "| :--: | :--: | :--: | :--: | :--: |"
    },
    {
      "type": "table",
      "section": "Neonatal Infant Formulas",
      "line": 4875,
      "preview": "| Preterm | - Whey protein concentrate <br> - Nonfat milk <br> - Whey/casein ratios of 80:20 (Enfami"
    },
    {
      "type": "table",
      "section": "Neonatal Infant Formulas",
      "line": 4876,
      "preview": "| Preterm discharge formula | - Nonfat milk <br> - Whey protein concentrate <br> - Added taurine | -"
    },
    {
      "type": "text",
      "section": "Neonatal Infant Formulas",
      "line": 4878,
      "preview": "Abbreviations: LCPUFA, long-chain polyunsaturated fatty acid; MCT, medium-chain triglyceride."
    },
    {
      "type": "text",
      "section": "Neonatal Infant Formulas",
      "line": 4879,
      "preview": "${ }^{a}$ Data from Thanigainathan S, Abiramalatha T. Early fortification of human milk versus late "
    },
    {
      "type": "text",
      "section": "Neonatal Infant Formulas",
      "line": 4880,
      "preview": "https://doi.org/10.1002/14651858.CD013392.pub2"
    },
    {
      "type": "text",
      "section": "Neonatal Infant Formulas",
      "line": 4881,
      "preview": "${ }^{\\text {b }}$ Data from Alyahya W, Simpson J, Garcia AL, Mactier H, Edwards CA. Early versus de"
    },
    {
      "type": "text",
      "section": "Neonatal Infant Formulas",
      "line": 4883,
      "preview": "Preterm infant formulas are not routinely available outside of the hospital, and infants are typical"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "Feeding Initiation and Advancement",
      "line": 4885
    },
    {
      "type": "text",
      "section": "Feeding Initiation and Advancement",
      "line": 4887,
      "preview": "Initiating feedings in the neonate requires careful consideration of clinical status, medical and su"
    },
    {
      "type": "text",
      "section": "Feeding Initiation and Advancement",
      "line": 4889,
      "preview": "- GA at birth"
    },
    {
      "type": "text",
      "section": "Feeding Initiation and Advancement",
      "line": 4890,
      "preview": "- GA at time oral feeding is considered"
    },
    {
      "type": "text",
      "section": "Feeding Initiation and Advancement",
      "line": 4892,
      "preview": "--- page 244 ---"
    },
    {
      "type": "text",
      "section": "Feeding Initiation and Advancement",
      "line": 4894,
      "preview": "- Severity of illness"
    },
    {
      "type": "text",
      "section": "Feeding Initiation and Advancement",
      "line": 4895,
      "preview": "- Respiratory and cardiovascular stability (need for oxygen, apnea, or bradycardia events)"
    },
    {
      "type": "text",
      "section": "Feeding Initiation and Advancement",
      "line": 4896,
      "preview": "- Motor stability (tone, posture, quality of movement)"
    },
    {
      "type": "text",
      "section": "Feeding Initiation and Advancement",
      "line": 4897,
      "preview": "- Sucking, swallowing, and breathing coordination"
    },
    {
      "type": "text",
      "section": "Feeding Initiation and Advancement",
      "line": 4898,
      "preview": "- Temperature stability"
    },
    {
      "type": "text",
      "section": "Feeding Initiation and Advancement",
      "line": 4899,
      "preview": "- Alertness"
    },
    {
      "type": "text",
      "section": "Feeding Initiation and Advancement",
      "line": 4900,
      "preview": "- Hunger cues"
    },
    {
      "type": "text",
      "section": "Feeding Initiation and Advancement",
      "line": 4901,
      "preview": "- Tolerance of enteral feedings"
    },
    {
      "type": "text",
      "section": "Feeding Initiation and Advancement",
      "line": 4903,
      "preview": "Full-term infants may be able to initiate feedings orally by breast or bottle if their clinical stat"
    },
    {
      "type": "text",
      "section": "Feeding Initiation and Advancement",
      "line": 4905,
      "preview": "Tube feedings are routinely administered in the hospitalized neonate if the infant is unable to feed"
    },
    {
      "type": "text",
      "section": "Feeding Initiation and Advancement",
      "line": 4907,
      "preview": "Delays initiating even trophic feeds or \"minimal enteral feeding\" (MEF) for preterm infants should b"
    },
    {
      "type": "text",
      "section": "Feeding Initiation and Advancement",
      "line": 4909,
      "preview": "There are potential advantages and disadvantages of these feeding administration methods, and change"
    },
    {
      "type": "text",
      "section": "Feeding Initiation and Advancement",
      "line": 4911,
      "preview": "--- page 245 ---"
    },
    {
      "type": "text",
      "section": "Feeding Initiation and Advancement",
      "line": 4913,
      "preview": "TABLE 7-26. Enteral Feeding Routes in Term and Preterm Infants"
    },
    {
      "type": "table",
      "section": "Feeding Initiation and Advancement",
      "line": 4915,
      "preview": "| Feeding <br> Route | Administration <br> Methods | Clinical Considerations |"
    },
    {
      "type": "table",
      "section": "Feeding Initiation and Advancement",
      "line": 4916,
      "preview": "| :--: | :--: | :--: |"
    },
    {
      "type": "table",
      "section": "Feeding Initiation and Advancement",
      "line": 4917,
      "preview": "| Gastric <br> - Nasogastric tube <br> - Orogastric tube <br> - Gastrostomy tube | - Continuous drip"
    },
    {
      "type": "table",
      "section": "Feeding Initiation and Advancement",
      "line": 4918,
      "preview": "| Postpyloric <br> - Nasojejunal tube <br> - Orojejunal tube | Continuous drip via feeding pump | - "
    },
    {
      "type": "text",
      "section": "Feeding Initiation and Advancement",
      "line": 4920,
      "preview": "${ }^{a}$ Castro M, Asbury M, Shama S, et al. Energy and fat intake for preterm infants fed donor mi"
    },
    {
      "type": "text",
      "section": "Feeding Initiation and Advancement",
      "line": 4921,
      "preview": "${ }^{\\text {b }}$ Paulsson M, Jacobsson L, Ahlsson F. Factors influencing breast milk fat loss duri"
    },
    {
      "type": "text",
      "section": "Feeding Initiation and Advancement",
      "line": 4923,
      "preview": "It is important to consider each infant's individual risk factors when determining feeding initiatio"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "Micronutrient Requirements of the Enterally Fed Infant",
      "line": 4925
    },
    {
      "type": "text",
      "section": "Micronutrient Requirements of the Enterally Fed Infant",
      "line": 4927,
      "preview": "The absorption of micronutrients will be impacted by clinical conditions. For example, calcium and p"
    },
    {
      "type": "text",
      "section": "Micronutrient Requirements of the Enterally Fed Infant",
      "line": 4929,
      "preview": "--- page 246 ---"
    },
    {
      "type": "text",
      "section": "Micronutrient Requirements of the Enterally Fed Infant",
      "line": 4931,
      "preview": "TABLE 7-27. Recommended Daily Enteral Intake of Electrolytes, Minerals, and Trace Elements ${ }^{\\te"
    },
    {
      "type": "table",
      "section": "Micronutrient Requirements of the Enterally Fed Infant",
      "line": 4933,
      "preview": "| Component | Preterm Infants <1500 g Birth Weight | Term Infants |"
    },
    {
      "type": "table",
      "section": "Micronutrient Requirements of the Enterally Fed Infant",
      "line": 4934,
      "preview": "| :--: | :--: | :--: |"
    },
    {
      "type": "table",
      "section": "Micronutrient Requirements of the Enterally Fed Infant",
      "line": 4935,
      "preview": "| Sodium | $3-5 \\mathrm{mEq} / \\mathrm{kg}(69-115 \\mathrm{mg} / \\mathrm{kg})$ | 2-5 mEq/kg/d |"
    },
    {
      "type": "table",
      "section": "Micronutrient Requirements of the Enterally Fed Infant",
      "line": 4936,
      "preview": "| Potassium | $2-3 \\mathrm{mEq} / \\mathrm{kg}(78-117 \\mathrm{mg} / \\mathrm{kg})$ | Initial: 1-2 mEq/"
    },
    {
      "type": "table",
      "section": "Micronutrient Requirements of the Enterally Fed Infant",
      "line": 4937,
      "preview": "| Chloride | $3-5 \\mathrm{mEq} / \\mathrm{kg}(106-177 \\mathrm{mg} / \\mathrm{kg})$ | - |"
    },
    {
      "type": "table",
      "section": "Micronutrient Requirements of the Enterally Fed Infant",
      "line": 4938,
      "preview": "| Calcium | $150-220 \\mathrm{mg} / \\mathrm{kg}$ | $150-220 \\mathrm{mg} / \\mathrm{kg} / \\mathrm{d}$ |"
    },
    {
      "type": "table",
      "section": "Micronutrient Requirements of the Enterally Fed Infant",
      "line": 4939,
      "preview": "| Phosphorus | $75-140 \\mathrm{mg} / \\mathrm{kg}$ | $3.2 \\mathrm{mmol} / \\mathrm{d}(100 \\mathrm{mg} "
    },
    {
      "type": "table",
      "section": "Micronutrient Requirements of the Enterally Fed Infant",
      "line": 4940,
      "preview": "| Magnesium | $8-15 \\mathrm{mg} / \\mathrm{kg}$ | 30 mg daily |"
    },
    {
      "type": "table",
      "section": "Micronutrient Requirements of the Enterally Fed Infant",
      "line": 4941,
      "preview": "| Iron | - $2-3 \\mathrm{mg} / \\mathrm{kg}$ <br> - $2-2.5 \\mathrm{~kg}$ : oral: $1-2 \\mathrm{mg}$ ele"
    },
    {
      "type": "table",
      "section": "Micronutrient Requirements of the Enterally Fed Infant",
      "line": 4942,
      "preview": "| Zinc | $2-3 \\mathrm{mg} / \\mathrm{kg}$ | $2 \\mathrm{mg} / \\mathrm{d}$ |"
    },
    {
      "type": "table",
      "section": "Micronutrient Requirements of the Enterally Fed Infant",
      "line": 4943,
      "preview": "| Copper | $120-230 \\mu \\mathrm{~g} / \\mathrm{kg}$ | $200 \\mu \\mathrm{~g} / \\mathrm{d}(-30 \\mu \\math"
    },
    {
      "type": "table",
      "section": "Micronutrient Requirements of the Enterally Fed Infant",
      "line": 4944,
      "preview": "| Chromium | $0.03-2.25 \\mu \\mathrm{~g} / \\mathrm{kg}$ | - |"
    },
    {
      "type": "table",
      "section": "Micronutrient Requirements of the Enterally Fed Infant",
      "line": 4945,
      "preview": "| lodine | $10-55 \\mu \\mathrm{~g} / \\mathrm{kg}$ | - |"
    },
    {
      "type": "table",
      "section": "Micronutrient Requirements of the Enterally Fed Infant",
      "line": 4946,
      "preview": "| Manganese | $1-15 \\mu \\mathrm{~g} / \\mathrm{kg}$ | - |"
    },
    {
      "type": "table",
      "section": "Micronutrient Requirements of the Enterally Fed Infant",
      "line": 4947,
      "preview": "| Molybdenum | $0.3-5 \\mu \\mathrm{~g} / \\mathrm{kg}$ | - |"
    },
    {
      "type": "table",
      "section": "Micronutrient Requirements of the Enterally Fed Infant",
      "line": 4948,
      "preview": "| Selenium | $7-10 \\mu \\mathrm{~g} / \\mathrm{kg}$ | - |"
    },
    {
      "type": "text",
      "section": "Micronutrient Requirements of the Enterally Fed Infant",
      "line": 4950,
      "preview": "Abbreviations: AAP, American Association of Pediatrics; GA, gestational age."
    },
    {
      "type": "text",
      "section": "Micronutrient Requirements of the Enterally Fed Infant",
      "line": 4951,
      "preview": "${ }^{a}$ Data from Microminerals: Iron, zinc, copper, selenium, manganese, iodine, chromium and mol"
    },
    {
      "type": "text",
      "section": "Micronutrient Requirements of the Enterally Fed Infant",
      "line": 4952,
      "preview": "${ }^{\\text {b }}$ Data from Abrams SA; Committee on Nutrition. Calcium and vitamin D requirements o"
    },
    {
      "type": "text",
      "section": "Micronutrient Requirements of the Enterally Fed Infant",
      "line": 4953,
      "preview": "${ }^{\\text {c }}$ Data from Mirtallo J, Canada T, Johnson D, et al; Task Force for the Revision of "
    },
    {
      "type": "text",
      "section": "Micronutrient Requirements of the Enterally Fed Infant",
      "line": 4954,
      "preview": "https://doi.org/10.1177/0148607104028006s39"
    },
    {
      "type": "text",
      "section": "Micronutrient Requirements of the Enterally Fed Infant",
      "line": 4955,
      "preview": "${ }^{\\text {d }}$ Data from Corkins MR, ed. Bobo E, Christensen ML, Larson-Nath C, Nuse Tome R, Plo"
    },
    {
      "type": "text",
      "section": "Micronutrient Requirements of the Enterally Fed Infant",
      "line": 4956,
      "preview": "${ }^{\\text {e }}$ Data from Institute of Medicine (US) Panel on Micronutrients. Dietary Reference I"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "Vitamin Needs",
      "line": 4958
    },
    {
      "type": "text",
      "section": "Vitamin Needs",
      "line": 4960,
      "preview": "Vitamins are supplied to the fetus via maternal transfer. Water-soluble vitamins are actively transp"
    },
    {
      "type": "text",
      "section": "Vitamin Needs",
      "line": 4962,
      "preview": "--- page 247 ---"
    },
    {
      "type": "text",
      "section": "Vitamin Needs",
      "line": 4964,
      "preview": "during the last trimester of pregnancy. There is negligible transfer of vitamin $\\mathrm{K} .{ }^{11"
    },
    {
      "type": "text",
      "section": "Vitamin Needs",
      "line": 4966,
      "preview": "--- page 248 ---"
    },
    {
      "type": "text",
      "section": "Vitamin Needs",
      "line": 4968,
      "preview": "TABLE 7-28. Recommended Enteral Intake of Vitamins ${ }^{\\mathrm{a}, \\mathrm{b}}$"
    },
    {
      "type": "table",
      "section": "Vitamin Needs",
      "line": 4970,
      "preview": "| Vitamin | Suggested Enteral Dose |  |  |  |"
    },
    {
      "type": "table",
      "section": "Vitamin Needs",
      "line": 4971,
      "preview": "| :--: | :--: | :--: | :--: | :--: |"
    },
    {
      "type": "table",
      "section": "Vitamin Needs",
      "line": 4972,
      "preview": "|  | Preterm Infants <1500 g Birth Weight | $>1500 \\mathrm{~g}$ | Healthy Term Infants, 0-6 mo | 6-1"
    },
    {
      "type": "table",
      "section": "Vitamin Needs",
      "line": 4973,
      "preview": "| Vitamin A | - 1332-3330 <br> IU/kg/d <br> - Corresponds to $400-1100$ <br> $\\mu \\mathrm{g}$ retino"
    },
    {
      "type": "table",
      "section": "Vitamin Needs",
      "line": 4974,
      "preview": "| Vitamin D | - 5-10 $\\mu \\mathrm{g}$ (200-400 IU) <br> - Increase to 10 $\\mu \\mathrm{g}(400 \\mathrm"
    },
    {
      "type": "table",
      "section": "Vitamin Needs",
      "line": 4975,
      "preview": "| Vitamin E | $2.2-11 \\mathrm{mg} \\alpha$ tocopherol $/ \\mathrm{kg}$ | - 25-50 U/kg/d; monitor close"
    },
    {
      "type": "table",
      "section": "Vitamin Needs",
      "line": 4976,
      "preview": "| Vitamin K | $4.4-28 \\mu \\mathrm{~g} / \\mathrm{kg}$ | $8-10 \\mu \\mathrm{~g} / \\mathrm{kg} / \\mathrm"
    },
    {
      "type": "table",
      "section": "Vitamin Needs",
      "line": 4977,
      "preview": "| Folic acid | $35-100 \\mu \\mathrm{~g} / \\mathrm{kg}$ | - $65 \\mu \\mathrm{~g} \\mathrm{DFE} / \\mathrm"
    },
    {
      "type": "table",
      "section": "Vitamin Needs",
      "line": 4978,
      "preview": "| Niacin | $1-5.5 \\mathrm{mg} / \\mathrm{kg}$ | $2 \\mathrm{mg} / \\mathrm{d}$ | $1100-5500 \\mu \\mathrm"
    },
    {
      "type": "table",
      "section": "Vitamin Needs",
      "line": 4979,
      "preview": "| Pyridoxine | $50-300 \\mu \\mathrm{~g} / \\mathrm{kg}$ | $0.1 \\mathrm{mg} / \\mathrm{d}(0.01 \\mathrm{m"
    },
    {
      "type": "table",
      "section": "Vitamin Needs",
      "line": 4980,
      "preview": "| Riboflavin | $200-400 \\mu \\mathrm{~g} / \\mathrm{kg}$ | $0.3 \\mathrm{mg} / \\mathrm{d}(0.04 \\mathrm{"
    },
    {
      "type": "table",
      "section": "Vitamin Needs",
      "line": 4981,
      "preview": "| Thiamine | $104-300 \\mu \\mathrm{~g} / \\mathrm{kg}$ | Preterm neonates: $180-240 \\mu \\mathrm{~g} / "
    },
    {
      "type": "table",
      "section": "Vitamin Needs",
      "line": 4982,
      "preview": "| Vitamin $\\mathrm{B}_{12}$ | $0.1-0.8 \\mu \\mathrm{~g} / \\mathrm{kg}$ | $0.4 \\mu \\mathrm{~g} / \\math"
    },
    {
      "type": "table",
      "section": "Vitamin Needs",
      "line": 4983,
      "preview": "| Vitamin C | $20-55 \\mathrm{mg} / \\mathrm{kg}$ | $40 \\mathrm{mg} / \\mathrm{d}$ | $16.5-41 \\mathrm{m"
    },
    {
      "type": "text",
      "section": "Vitamin Needs",
      "line": 4985,
      "preview": "Abbreviation: DFE, dietary folate equivalent."
    },
    {
      "type": "text",
      "section": "Vitamin Needs",
      "line": 4986,
      "preview": "${ }^{a}$ Data from Domell\u00f6of M. Microminerals: Iron, zinc, copper, selenium, manganese, iodine, chr"
    },
    {
      "type": "text",
      "section": "Vitamin Needs",
      "line": 4987,
      "preview": "${ }^{\\text {b }}$ Data from Vanek VW, Borum P, Buchman A, et al; Novel Nutrient Task Force, Parente"
    },
    {
      "type": "text",
      "section": "Vitamin Needs",
      "line": 4988,
      "preview": "${ }^{c} 0.3 \\mu \\mathrm{~g}$ retinol $=1 \\mathrm{U}$ vitamin A ."
    },
    {
      "type": "heading",
      "level": 1,
      "section": "Monitoring",
      "line": 4990
    },
    {
      "type": "text",
      "section": "Monitoring",
      "line": 4992,
      "preview": "Neonates receiving EN support require careful growth monitoring as previously described. If growth t"
    },
    {
      "type": "text",
      "section": "Monitoring",
      "line": 4994,
      "preview": "--- page 249 ---"
    },
    {
      "type": "text",
      "section": "Monitoring",
      "line": 4996,
      "preview": "calorie or protein modular, and the concentration of infant formula to $22-30 \\mathrm{cal} / \\mathrm"
    },
    {
      "type": "text",
      "section": "Monitoring",
      "line": 4998,
      "preview": "No routine biochemical monitoring is required for the enterally fed neonate, with the only exception"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "Conclusion",
      "line": 5000
    },
    {
      "type": "text",
      "section": "Conclusion",
      "line": 5002,
      "preview": "The nutrition care of the neonate, whether full term or preterm, brings unique challenges during thi"
    },
    {
      "type": "heading",
      "level": 2,
      "section": "References",
      "line": 5004
    },
    {
      "type": "text",
      "section": "References",
      "line": 5006,
      "preview": "1. Cordova EG, Belfort MB. Updates on assessment and monitoring of the postnatal growth of preterm i"
    },
    {
      "type": "text",
      "section": "References",
      "line": 5007,
      "preview": "2. Engle WA; American Academy of Pediatrics Committee on Fetus and Newborn. Age terminology during t"
    },
    {
      "type": "text",
      "section": "References",
      "line": 5008,
      "preview": "3. Preterm birth. World Health Organization. November 14, 2022. https://www.who.int/news-room/fact-s"
    },
    {
      "type": "text",
      "section": "References",
      "line": 5009,
      "preview": "4. Fenton TR, Kim JH. A systematic review and meta-analysis to revise the Fenton growth chart for pr"
    },
    {
      "type": "text",
      "section": "References",
      "line": 5010,
      "preview": "5. Olsen IE, Groveman SA, Lawson ML, Clark RH, Zemel BS. New intrauterine growth curves based on Uni"
    },
    {
      "type": "text",
      "section": "References",
      "line": 5011,
      "preview": "6. Goldberg DL, Becker PJ, Brigham K, et al. Identifying malnutrition in preterm and neonatal popula"
    },
    {
      "type": "text",
      "section": "References",
      "line": 5012,
      "preview": "7. Taylor SN, Buck Co. Monitoring of growth and body composition: New methodologies. In: Koletzko B,"
    },
    {
      "type": "text",
      "section": "References",
      "line": 5013,
      "preview": "8. Fenton TR, Anderson D, Groh-Wargo S, Hoyos A, Ehrenkranz RA, Senterre T. An attempt to standardiz"
    },
    {
      "type": "text",
      "section": "References",
      "line": 5015,
      "preview": "--- page 250 ---"
    },
    {
      "type": "text",
      "section": "References",
      "line": 5017,
      "preview": "9. Fenton TR, Senterre T, Griffin IJ. Time interval for preterm infant weight gain velocity calculat"
    },
    {
      "type": "text",
      "section": "References",
      "line": 5018,
      "preview": "10. Becker P, Carney LN, Corkins MR, et al; Academy of Nutrition and Dietetics; American Society for"
    },
    {
      "type": "text",
      "section": "References",
      "line": 5019,
      "preview": "11. Rochow N, Raja P, Liu K, et al. Physiological adjustment to postnatal growth trajectories in hea"
    },
    {
      "type": "text",
      "section": "References",
      "line": 5020,
      "preview": "12. Keller JA. Counting the Weighs: Growth Velocity Tables for Preterm Infants. Nutr Clin Pract. 202"
    },
    {
      "type": "text",
      "section": "References",
      "line": 5021,
      "preview": "13. American Academy of Pediatrics Committee on Nutrition. Nutritional needs of the preterm infant. "
    },
    {
      "type": "text",
      "section": "References",
      "line": 5022,
      "preview": "14. Huff KA, Denn SC, Hay WW. Energy requirements and carbohydrates in preterm infants. In: Koletzko"
    },
    {
      "type": "text",
      "section": "References",
      "line": 5023,
      "preview": "15. Bauer J, Werner C, Gerss J. Metabolic rate analysis of healthy preterm and full-term infants dur"
    },
    {
      "type": "text",
      "section": "References",
      "line": 5024,
      "preview": "16. Bechard LJ, Ziegler J, Duggan C. Is energy expenditure of infants predictable after surgery?: a "
    },
    {
      "type": "text",
      "section": "References",
      "line": 5025,
      "preview": "17. Dupont C. Protein requirements during the first year of life. Am J Clin Nutr. 2003;77(6):1544S-1"
    },
    {
      "type": "text",
      "section": "References",
      "line": 5026,
      "preview": "18. Van den Akker CH, de Pipaon MS, van Goudoever JB. Proteins and amino acids. In: Koletzko B, Chea"
    },
    {
      "type": "text",
      "section": "References",
      "line": 5027,
      "preview": "19. Embleton ND, van den Akker CHP. Protein intakes to optimize outcomes for preterm infants. Semin "
    },
    {
      "type": "text",
      "section": "References",
      "line": 5028,
      "preview": "20. Bronner F, Salle BL, Putet G, Rigo J, Senterre J. Net calcium absorption in premature infants: r"
    },
    {
      "type": "text",
      "section": "References",
      "line": 5029,
      "preview": "21. Powers HJ. Vitamin requirements for term infants: considerations for infant formulae. Nutr Res R"
    },
    {
      "type": "text",
      "section": "References",
      "line": 5030,
      "preview": "22. Darmaun D, Lapillonne A, Simeoni U, et al; Committee on Nutrition of the French Society of Pedia"
    },
    {
      "type": "text",
      "section": "References",
      "line": 5031,
      "preview": "23. Johnson PJ. Review of micronutrients in parenteral nutrition for the NICU population. Neonatal N"
    },
    {
      "type": "text",
      "section": "References",
      "line": 5032,
      "preview": "24. Baraton L, Ancel PY, Flamant C, Orsonneau JL, Darmaun D, Roz\u00e9 JC. Impact of changes in serum sod"
    },
    {
      "type": "text",
      "section": "References",
      "line": 5033,
      "preview": "25. Bell EF, Acarregui MJ. Restricted versus liberal water intake for preventing morbidity and morta"
    },
    {
      "type": "text",
      "section": "References",
      "line": 5034,
      "preview": "26. Racadio JM, Doellman DA, Johnson ND, Bean JA, Jacobs BR. Pediatric peripherally inserted central"
    },
    {
      "type": "text",
      "section": "References",
      "line": 5035,
      "preview": "27. American Society for Parenteral and Enteral Nutrition (A.S.P.E.N.) Board of Directors. Clinical "
    },
    {
      "type": "text",
      "section": "References",
      "line": 5036,
      "preview": "28. Holliday MA, Segar WE. The maintenance need for water in parenteral fluid therapy. Pediatrics. 1"
    },
    {
      "type": "text",
      "section": "References",
      "line": 5037,
      "preview": "29. Collier S, Gura KM, DeLoid L. Dalton M, Summers L. Parenteral nutrition. In: Sonneville K, Dugga"
    },
    {
      "type": "text",
      "section": "References",
      "line": 5038,
      "preview": "30. Osborn DA, Schindler T, Jones LJ, Sinn JK, Bolisetty S. Higher versus lower amino acid intake in"
    },
    {
      "type": "text",
      "section": "References",
      "line": 5039,
      "preview": "31. Cober MP, Gura KM, Mirtallo JM, et al; ASPEN Parenteral Nutrition Safety Committee. ASPEN lipid "
    },
    {
      "type": "text",
      "section": "References",
      "line": 5040,
      "preview": "32. Zaidan H, Dhanireddy R, Hamosh M, Bengtsson-Olivecrona G, Hamosh P. Lipid clearing in premature "
    },
    {
      "type": "text",
      "section": "References",
      "line": 5041,
      "preview": "33. Btaiche IF, Khalidi N. Parenteral nutrition-associated liver complications in children. Pharmaco"
    },
    {
      "type": "text",
      "section": "References",
      "line": 5042,
      "preview": "34. Vanp\u00e9e M, Herin P, Broberger U, Aperia A. Sodium supplementation optimizes weight gain in preter"
    },
    {
      "type": "text",
      "section": "References",
      "line": 5043,
      "preview": "35. Schrier RW. Diagnostic value of urinary sodium, chloride, urea, and flow. J Am Soc Nephrol. 2011"
    },
    {
      "type": "text",
      "section": "References",
      "line": 5044,
      "preview": "36. Lee Hamm L, Hering-Smith KS, Nakhoul NL. Acid-base and potassium homeostasis. Semin Nephrol. 201"
    },
    {
      "type": "text",
      "section": "References",
      "line": 5046,
      "preview": "--- page 251 ---"
    },
    {
      "type": "text",
      "section": "References",
      "line": 5048,
      "preview": "37. Bolisetty S, Osborn D, Sinn J, Lui K; Australasian Neonatal Parenteral Nutrition Consensus Group"
    },
    {
      "type": "text",
      "section": "References",
      "line": 5049,
      "preview": "38. Nehra D, Carlson SJ, Fallon EM, et al; American Society for Parenteral and Enteral Nutrition. A."
    },
    {
      "type": "text",
      "section": "References",
      "line": 5050,
      "preview": "39. Christmann V, Gradussen CJ, K\u00f6rnmann MN, Roeleveld N, van Goudoever JB, van Heijst AF. Changes i"
    },
    {
      "type": "text",
      "section": "References",
      "line": 5051,
      "preview": "40. Kliegman R. Stanton b, Geme St J, Schor N, eds. Nelson Textbook of Pediatrics. 20th ed. Elsevier"
    },
    {
      "type": "text",
      "section": "References",
      "line": 5052,
      "preview": "41. Worthington P, Gura KM, Kraft MD, Nishikawa R, Guenter P, Sacks GS; ASPEN PN Safety Committee. U"
    },
    {
      "type": "text",
      "section": "References",
      "line": 5053,
      "preview": "42. Kroll MH, Elin RJ. Relationships between magnesium and protein concentrations in serum. Clin Che"
    },
    {
      "type": "text",
      "section": "References",
      "line": 5054,
      "preview": "43. Brown EW, McClellan NH, Minard G, Maish GO III, Dickerson RN. Avoiding patient harm with parente"
    },
    {
      "type": "text",
      "section": "References",
      "line": 5055,
      "preview": "44. Ayers P, Dixon C, Mays A. Acid-base disorders: learning the basics. Nutr Clin Pract. 2015;30(1):"
    },
    {
      "type": "text",
      "section": "References",
      "line": 5056,
      "preview": "45. Rebouche CJ. Carnitine function and requirements during the life cycle. FASEB J. 1992;6(15):3379"
    },
    {
      "type": "text",
      "section": "References",
      "line": 5057,
      "preview": "46. Corkins MR, ed. Bobo E, Christensen ML, Larson-Nath C, Nuse Tome R, Plogsted S, associate eds. A"
    },
    {
      "type": "text",
      "section": "References",
      "line": 5058,
      "preview": "47. Schmidt-Sommerfeld E, Penn D, Wolf H. Carnitine deficiency in premature infants receiving total "
    },
    {
      "type": "text",
      "section": "References",
      "line": 5059,
      "preview": "48. Widdowson EM, Dauncey J, Shaw JCL. Trace elements in foetal and early postnatal development. Pro"
    },
    {
      "type": "text",
      "section": "References",
      "line": 5060,
      "preview": "49. Chen W, Wong WK, Chen TC. A case of zinc deficiency during long-term total parenteral nutrition."
    },
    {
      "type": "text",
      "section": "References",
      "line": 5061,
      "preview": "50. Naber TH, Baadenhuysen H, Jansen JB, van den Hamer CJ, van den Broek W. Serum alkaline phosphata"
    },
    {
      "type": "text",
      "section": "References",
      "line": 5062,
      "preview": "51. Hurwitz M, Garcia MG, Poole RL, Kerner JA. Copper deficiency during parenteral nutrition: a repo"
    },
    {
      "type": "text",
      "section": "References",
      "line": 5063,
      "preview": "52. Twomey PJ, Viljoen A, House IM, Reynolds TM, Wierzbicki AS. Adjusting copper concentrations for "
    },
    {
      "type": "text",
      "section": "References",
      "line": 5064,
      "preview": "53. Masumoto K, Nagata K, Higashi M, et al. Clinical features of selenium deficiency in infants rece"
    },
    {
      "type": "text",
      "section": "References",
      "line": 5065,
      "preview": "54. Capone K, Sriram S, Patton T, et al. Effects of chromium on glucose tolerance in infants receivi"
    },
    {
      "type": "text",
      "section": "References",
      "line": 5066,
      "preview": "55. Sauberan J, Mercier M, Katheria A. Sources of unintentional manganese delivery in neonatal paren"
    },
    {
      "type": "text",
      "section": "References",
      "line": 5067,
      "preview": "56. Takagi Y, Okada A, Sando K, Wasa M, Yoshida H, Hirabuki N. Evaluation of indexes of in vivo mang"
    },
    {
      "type": "text",
      "section": "References",
      "line": 5068,
      "preview": "57. Hardy IJ, Gillanders L, Hardy G. Is manganese an essential supplement for parenteral nutrition? "
    },
    {
      "type": "text",
      "section": "References",
      "line": 5069,
      "preview": "58. Hanson C, Thoene M, Wagner J, Collier D, Lecci K, Anderson-Berry A. Parenteral nutrition additiv"
    },
    {
      "type": "text",
      "section": "References",
      "line": 5070,
      "preview": "59. Hahn JS, Berquist W, Alcorn DM, Chamberlain L, Bass D. Wernicke encephalopathy and beriberi duri"
    },
    {
      "type": "text",
      "section": "References",
      "line": 5071,
      "preview": "60. Dudrick SJ, Maharaj AR, McKelvey AA. Artificial nutritional support in patients with gastrointes"
    },
    {
      "type": "text",
      "section": "References",
      "line": 5072,
      "preview": "61. MacDonald MG, Fletcher AB, Johnson EL, Boeckx RL, Getson PR, Miller MK. The potential toxicity t"
    },
    {
      "type": "text",
      "section": "References",
      "line": 5073,
      "preview": "62. Green H, Hambridge KM, Schanler R, et al. Guidelines for the use of vitamins, trace elements, ca"
    },
    {
      "type": "text",
      "section": "References",
      "line": 5074,
      "preview": "63. Shah PS, Kalyn A, Satodia P, et al. A randomized, controlled trial of heparin versus placebo inf"
    },
    {
      "type": "text",
      "section": "References",
      "line": 5076,
      "preview": "--- page 252 ---"
    },
    {
      "type": "text",
      "section": "References",
      "line": 5078,
      "preview": "64. Arsenault D, Brenn M, Kim S, et al; American Society for Parenteral and Enteral Nutrition Board "
    },
    {
      "type": "text",
      "section": "References",
      "line": 5079,
      "preview": "65. Kresch M, Mehra K, Jack R, Greecher C. Sustaining improved nutritional support for very low birt"
    },
    {
      "type": "text",
      "section": "References",
      "line": 5080,
      "preview": "66. Neonatal Parenteral Nutrition. National Institute for Health and Care Excellence (NICE); 2020. N"
    },
    {
      "type": "text",
      "section": "References",
      "line": 5081,
      "preview": "67. Sherlock R, Chessex P. Shielding parenteral nutrition from light: does the available evidence su"
    },
    {
      "type": "text",
      "section": "References",
      "line": 5082,
      "preview": "68. Laborie S, Lavoie JC, Chessex P. Paradoxical role of ascorbic acid and riboflavin in solutions o"
    },
    {
      "type": "text",
      "section": "References",
      "line": 5083,
      "preview": "69. Lavoie, J.C., Belanger, S., Spalinger, M., et al. Admixture of a multivitamin preparation to par"
    },
    {
      "type": "text",
      "section": "References",
      "line": 5084,
      "preview": "70. Shattuck KE, Bhatia J, Grinnell C, Rassin DK. The effects of light exposure on the in vitro hepa"
    },
    {
      "type": "text",
      "section": "References",
      "line": 5085,
      "preview": "71. Bhatia J, Moslen MT, Kaphalia L, Rassin DK. Glutathione and tissue amino acid responses to light"
    },
    {
      "type": "text",
      "section": "References",
      "line": 5086,
      "preview": "72. Neuzil J, Darlow BA, Inder TE, Sluis KB, Winterbourn CC, Stocker R. Oxidation of parenteral lipi"
    },
    {
      "type": "text",
      "section": "References",
      "line": 5087,
      "preview": "73. Robinson DT, Ayers P, Fleming B, et al. Recommendations for photoprotection of parenteral nutrit"
    },
    {
      "type": "text",
      "section": "References",
      "line": 5088,
      "preview": "74. Calafat AM, Needham LL, Silva MJ, Lambert G. Exposure to di-(2-ethylhexyl) phthalate among prema"
    },
    {
      "type": "text",
      "section": "References",
      "line": 5089,
      "preview": "75. von Rettberg H, Hannman T, Subotic U, et al. Use of di(2-ethylhexyl)phthalate-containing infusio"
    },
    {
      "type": "text",
      "section": "References",
      "line": 5090,
      "preview": "76. Gura KM. Aluminum contamination in parenteral products. Curr Opin Clin Nutr Metab Care. 2014;17("
    },
    {
      "type": "text",
      "section": "References",
      "line": 5091,
      "preview": "77. Aluminum in large and small volume parenterals used in total parenteral nutrition. Fed Regist. 2"
    },
    {
      "type": "text",
      "section": "References",
      "line": 5092,
      "preview": "78. Bishop NJ, Morley R, Day JP, Lucas A. Aluminum neurotoxicity in preterm infants receiving intrav"
    },
    {
      "type": "text",
      "section": "References",
      "line": 5093,
      "preview": "79. Newton DW, Driscoll DF. Calcium and phosphate compatibility: revisited again. Am J Health Syst P"
    },
    {
      "type": "text",
      "section": "References",
      "line": 5094,
      "preview": "80. Gura KM. Aluminum contamination in products used in parenteral nutrition: has anything changed? "
    },
    {
      "type": "text",
      "section": "References",
      "line": 5095,
      "preview": "81. Eidelman AI, Schanler RJ, Johnston M, et al; Section on Breastfeeding. Breastfeeding and the use"
    },
    {
      "type": "text",
      "section": "References",
      "line": 5096,
      "preview": "82. Parker MG, Stellwagen LM, Noble L, Kim JH, Poindexter BB, Puopolo KM; Section on Breastfeeding; "
    },
    {
      "type": "text",
      "section": "References",
      "line": 5097,
      "preview": "83. Daniels S, Corkins M, de Ferranti S, et al; Committee on Nutrition; Section on Breastfeeding; Co"
    },
    {
      "type": "text",
      "section": "References",
      "line": 5098,
      "preview": "84. Valentine CJ, Gates A. Human milk feeding and clinical considerations. In: Corkins MR, ed. Bobo "
    },
    {
      "type": "text",
      "section": "References",
      "line": 5099,
      "preview": "85. Human Milk Banking Association of North America. Accessed June 2022. https://www.hmbana.org/"
    },
    {
      "type": "text",
      "section": "References",
      "line": 5100,
      "preview": "86. Steele C, Collins E, eds. Infant and Pediatric Feedings: Guidelines for Preparation of Human Mil"
    },
    {
      "type": "text",
      "section": "References",
      "line": 5101,
      "preview": "87. Drugs and Lactation Database (LactMed). National Library of Medicine (US); 2006. Accessed June 2"
    },
    {
      "type": "text",
      "section": "References",
      "line": 5102,
      "preview": "88. Hale's Medications \\& Mother's Milk. 2022. Accessed June 21, 2022. https://www.halesmeds.com/"
    },
    {
      "type": "text",
      "section": "References",
      "line": 5103,
      "preview": "89. DiLauro S, Unger S, Stone D, O'Connor DL. Human milk for ill and medically compromised infants: "
    },
    {
      "type": "text",
      "section": "References",
      "line": 5104,
      "preview": "90. Ong ML, Belfort MB. Preterm infant nutrition and growth with a human milk diet. Semin Perinatol."
    },
    {
      "type": "text",
      "section": "References",
      "line": 5105,
      "preview": "91. Moro GE, Arslanoglu S, Bertino E, et al; American Academy of Pediatrics; European Society for Pe"
    },
    {
      "type": "text",
      "section": "References",
      "line": 5106,
      "preview": "92. Agostoni C, Buonocore G, Carnielli VP, et al; ESPGHAN Committee on Nutrition. Enteral nutrient s"
    },
    {
      "type": "text",
      "section": "References",
      "line": 5108,
      "preview": "--- page 253 ---"
    },
    {
      "type": "text",
      "section": "References",
      "line": 5110,
      "preview": "93. Picaud JC, Vincent M, Buffin R. Human milk fortification for preterm infants: A review. In: Kole"
    },
    {
      "type": "text",
      "section": "References",
      "line": 5111,
      "preview": "94. Sapsford A, Smith C. Enteral nutrition. In: Groh-Wargo S, Thompson M, Hovasi Cox J, eds. Pocket "
    },
    {
      "type": "text",
      "section": "References",
      "line": 5112,
      "preview": "95. Basu S, Upadhyay J, Singh P, Kumar M. Early versus late fortification of breast milk in preterm "
    },
    {
      "type": "text",
      "section": "References",
      "line": 5113,
      "preview": "96. Thanigainathan S, Abiramalatha T. Early fortification of human milk versus late fortification to"
    },
    {
      "type": "text",
      "section": "References",
      "line": 5114,
      "preview": "97. Alyahya W, Simpson J, Garcia AL, Mactier H, Edwards CA. Early versus delayed fortification of hu"
    },
    {
      "type": "text",
      "section": "References",
      "line": 5115,
      "preview": "98. Bergner EM, Taylor SN, Gollins LA, Hair AB. Human milk fortification: a practical analysis of cu"
    },
    {
      "type": "text",
      "section": "References",
      "line": 5116,
      "preview": "99. Huston R, Lee M, Rider E, et al. Early fortification of enteral feedings for infants.J Neonatal "
    },
    {
      "type": "text",
      "section": "References",
      "line": 5117,
      "preview": "100. Mead Johnson Nutrition. Updated 2021. Accessed June 2022. https://www.hcp.meadjohnson.com"
    },
    {
      "type": "text",
      "section": "References",
      "line": 5118,
      "preview": "101. Abbott Nutrition. Updated 2023. Accessed June 2022. https://abbottnutrition.com"
    },
    {
      "type": "text",
      "section": "References",
      "line": 5119,
      "preview": "102. Prolacta Bioscience. Accessed June 2022. https://www.prolacta.com"
    },
    {
      "type": "text",
      "section": "References",
      "line": 5120,
      "preview": "103. Jones LR. Oral feeding readiness in the neonatal intensive care unit. Neonatal Netw. 2012;31(3)"
    },
    {
      "type": "text",
      "section": "References",
      "line": 5121,
      "preview": "104. Barbas KH, Kelleher DK. Breastfeeding success among infants with congenital heart disease. Pedi"
    },
    {
      "type": "text",
      "section": "References",
      "line": 5122,
      "preview": "105. Boies EG, Vaucher YE. ABM clinical protocol \\#10: breastfeeding the late preterm (34-36 6/7 wee"
    },
    {
      "type": "text",
      "section": "References",
      "line": 5123,
      "preview": "106. Baby-Friendly USA. BFUSA Neonatal Intensive Care (NICU) Resources: A Guide to Recommended Pract"
    },
    {
      "type": "text",
      "section": "References",
      "line": 5124,
      "preview": "107. Wallenstein MB, Stevenson DK. Need for reassessment of early transpyloric feeding in preterm in"
    },
    {
      "type": "text",
      "section": "References",
      "line": 5125,
      "preview": "108. Bozzetti V, Martin CR. The practice of enteral nutrition in very low and extremely low birth we"
    },
    {
      "type": "text",
      "section": "References",
      "line": 5126,
      "preview": "109. Konnikova Y, Zaman MM, Makda M, D\u2019Onofrio D, Freedman SD, Martin CR. Late enteral feedings are "
    },
    {
      "type": "text",
      "section": "References",
      "line": 5127,
      "preview": "110. Sadrudin Premji S, Chessell L, Stewart F. Continuous nasogastric milk feeding versus intermitte"
    },
    {
      "type": "text",
      "section": "References",
      "line": 5128,
      "preview": "111. Jones A. Congenital anomalies of the alimentary tract. In: Groh-Wargo S, Thompson M, Hovasi Cox"
    },
    {
      "type": "text",
      "section": "References",
      "line": 5129,
      "preview": "112. Oddie SJ, Young L, McGuire W. Slow advancement of enteral feed volumes to prevent necrotising e"
    },
    {
      "type": "text",
      "section": "References",
      "line": 5130,
      "preview": "113. Dorling J, Abbott J, Berrington J, et al; SIFT Investigators Group. Controlled trial of two inc"
    },
    {
      "type": "text",
      "section": "References",
      "line": 5131,
      "preview": "114. Castro M, Asbury M, Shama S, et al. Energy and fat intake for preterm infants fed donor milk is"
    },
    {
      "type": "text",
      "section": "References",
      "line": 5132,
      "preview": "115. Paulsson M, Jacobsson L, Ahlsson F. Factors influencing breast milk fat loss during administrat"
    },
    {
      "type": "text",
      "section": "References",
      "line": 5133,
      "preview": "116. Ziegler EE, Biga RL, Fomon SJ. Nutritional requirements of the premature infant. In: Suskind RM"
    },
    {
      "type": "text",
      "section": "References",
      "line": 5134,
      "preview": "117. Poindexter BB, Cormack BE, Bloomfield FH. Approaches to growth faltering. In: Koletzko B, Cheah"
    },
    {
      "type": "text",
      "section": "References",
      "line": 5135,
      "preview": "118. Domell\u00f6of M. Microminerals: Iron, zinc, copper, selenium, manganese, iodine, chromium, and moly"
    },
    {
      "type": "text",
      "section": "References",
      "line": 5136,
      "preview": "119. Ziegler EE. Meeting the nutritional needs of the low-birth-weight infant. Ann Nutr Metab. 2011;"
    },
    {
      "type": "text",
      "section": "References",
      "line": 5137,
      "preview": "120. Fenton TR, Cormack B, Goldberg D, et al. \"Extrauterine growth restriction\" and \"postnatal growt"
    },
    {
      "type": "text",
      "section": "References",
      "line": 5139,
      "preview": "--- page 254 ---"
    },
    {
      "type": "text",
      "section": "References",
      "line": 5141,
      "preview": "PART"
    },
    {
      "type": "text",
      "section": "References",
      "line": 5142,
      "preview": "III"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "Disease-Specific Nutrition",
      "line": 5144
    },
    {
      "type": "text",
      "section": "Disease-Specific Nutrition",
      "line": 5146,
      "preview": "--- page 255 ---"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "8",
      "line": 5148
    },
    {
      "type": "heading",
      "level": 2,
      "section": "Allergy and Eosinophilic Esophagitis",
      "line": 5150
    },
    {
      "type": "text",
      "section": "Allergy and Eosinophilic Esophagitis",
      "line": 5152,
      "preview": "Anam Bashir, MD<br>Praveen S. Goday, MBBS"
    },
    {
      "type": "heading",
      "level": 2,
      "section": "Introduction",
      "line": 5154
    },
    {
      "type": "text",
      "section": "Introduction",
      "line": 5156,
      "preview": "A food allergy is an adverse reaction arising from a specific immune response that occurs reproducib"
    },
    {
      "type": "text",
      "section": "Introduction",
      "line": 5158,
      "preview": "--- page 256 ---"
    },
    {
      "type": "text",
      "section": "Introduction",
      "line": 5160,
      "preview": "TABLE 8-1. Different Categories of Food Allergies"
    },
    {
      "type": "table",
      "section": "Introduction",
      "line": 5162,
      "preview": "| Category | Manifestations |"
    },
    {
      "type": "table",
      "section": "Introduction",
      "line": 5163,
      "preview": "| :-- | :-- |"
    },
    {
      "type": "table",
      "section": "Introduction",
      "line": 5164,
      "preview": "| IgE-mediated | - Urticaria |"
    },
    {
      "type": "table",
      "section": "Introduction",
      "line": 5165,
      "preview": "|  | - Angioedema |"
    },
    {
      "type": "table",
      "section": "Introduction",
      "line": 5166,
      "preview": "|  | - Anaphylaxis |"
    },
    {
      "type": "table",
      "section": "Introduction",
      "line": 5167,
      "preview": "| Non-IgE-mediated | - FPIES |"
    },
    {
      "type": "table",
      "section": "Introduction",
      "line": 5168,
      "preview": "|  | - Food protein-induced enteropathy |"
    },
    {
      "type": "table",
      "section": "Introduction",
      "line": 5169,
      "preview": "|  | - Food protein-induced proctitis |"
    },
    {
      "type": "table",
      "section": "Introduction",
      "line": 5170,
      "preview": "|  | - Food protein-induced hemosiderosis |"
    },
    {
      "type": "table",
      "section": "Introduction",
      "line": 5171,
      "preview": "| Mixed | - Atopic dermatitis |"
    },
    {
      "type": "table",
      "section": "Introduction",
      "line": 5172,
      "preview": "|  | - EoE |"
    },
    {
      "type": "table",
      "section": "Introduction",
      "line": 5173,
      "preview": "|  | - Eosinophilic gastroenteritis |"
    },
    {
      "type": "text",
      "section": "Introduction",
      "line": 5175,
      "preview": "Abbreviations: EoE, eosinophilic esophagitis; FPIES, food protein-induced enterocolitis syndrome; $\\"
    },
    {
      "type": "text",
      "section": "Introduction",
      "line": 5177,
      "preview": "Children with food allergies may have nutrient deficiencies because of food restriction and are at r"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "Assessment and Nutrient Requirements",
      "line": 5179
    },
    {
      "type": "text",
      "section": "Assessment and Nutrient Requirements",
      "line": 5181,
      "preview": "Because of allergen avoidance, children with food allergies are at risk for nutrient deficiencies. A"
    },
    {
      "type": "text",
      "section": "Assessment and Nutrient Requirements",
      "line": 5183,
      "preview": "- History: feeding history, dietary recall, and use of food substitutes"
    },
    {
      "type": "text",
      "section": "Assessment and Nutrient Requirements",
      "line": 5184,
      "preview": "- Nutrition-focused physical examination"
    },
    {
      "type": "text",
      "section": "Assessment and Nutrient Requirements",
      "line": 5185,
      "preview": "- Anthropometric assessment: weight, height or length, head circumference, body mass index, weight f"
    },
    {
      "type": "heading",
      "level": 2,
      "section": "Implementation of Nutrition Plan and Monitoring",
      "line": 5188
    },
    {
      "type": "text",
      "section": "Implementation of Nutrition Plan and Monitoring",
      "line": 5190,
      "preview": "--- page 257 ---"
    },
    {
      "type": "text",
      "section": "Implementation of Nutrition Plan and Monitoring",
      "line": 5192,
      "preview": "The mainstay of managing food allergies is allergen avoidance, therefore it is important that patien"
    },
    {
      "type": "text",
      "section": "Implementation of Nutrition Plan and Monitoring",
      "line": 5194,
      "preview": "- reading and understanding food labels,"
    },
    {
      "type": "text",
      "section": "Implementation of Nutrition Plan and Monitoring",
      "line": 5195,
      "preview": "- prevention of cross-contamination through shared utensils and other means, and"
    },
    {
      "type": "text",
      "section": "Implementation of Nutrition Plan and Monitoring",
      "line": 5196,
      "preview": "- careful replacement with foods that are nutritionally similar and micronutrient supplementation wh"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "Milk Allergy",
      "line": 5199
    },
    {
      "type": "text",
      "section": "Milk Allergy",
      "line": 5201,
      "preview": "Maternal restriction of cow milk protein is not required for IgE-mediated allergies in breastfed inf"
    },
    {
      "type": "text",
      "section": "Milk Allergy",
      "line": 5203,
      "preview": "Some plant-based milks like enriched soy milk may be a suitable replacement. Pea protein-based milk,"
    },
    {
      "type": "heading",
      "level": 2,
      "section": "Egg Allergy",
      "line": 5205
    },
    {
      "type": "text",
      "section": "Egg Allergy",
      "line": 5207,
      "preview": "Eggs are a source of vitamins $\\mathrm{B}_{2}, \\mathrm{~B}_{3}, \\mathrm{~B}_{12}$, E, folic acid, bi"
    },
    {
      "type": "text",
      "section": "Egg Allergy",
      "line": 5209,
      "preview": "--- page 258 ---"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "Soybean Allergy",
      "line": 5211
    },
    {
      "type": "text",
      "section": "Soybean Allergy",
      "line": 5213,
      "preview": "Soy is rich in thiamin, vitamin $B_{2}$, niacin, iron, zinc, selenium, chromium, and folic acid. ${ "
    },
    {
      "type": "heading",
      "level": 2,
      "section": "Wheat Allergy",
      "line": 5215
    },
    {
      "type": "text",
      "section": "Wheat Allergy",
      "line": 5217,
      "preview": "Wheat is a major source of carbohydrates. Wheat is also rich in micronutrients like thiamin, vitamin"
    },
    {
      "type": "heading",
      "level": 2,
      "section": "Nuts",
      "line": 5219
    },
    {
      "type": "text",
      "section": "Nuts",
      "line": 5221,
      "preview": "Nuts do not form a large portion of daily dietary intake and hence do not need replacement. Tree nut"
    },
    {
      "type": "heading",
      "level": 2,
      "section": "Food Protein-Induced Enterocolitis",
      "line": 5223
    },
    {
      "type": "text",
      "section": "Food Protein-Induced Enterocolitis",
      "line": 5225,
      "preview": "Food protein-induced enterocolitis (FPIES) is a potential emergency, which can present in infants an"
    },
    {
      "type": "text",
      "section": "Food Protein-Induced Enterocolitis",
      "line": 5227,
      "preview": "--- page 259 ---"
    },
    {
      "type": "text",
      "section": "Food Protein-Induced Enterocolitis",
      "line": 5229,
      "preview": "develop 1-4 hours after ingestion and resolve 24 hours after ingestion. The diagnosis is made clinic"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "Implementation of Nutrition Plan and Monitoring",
      "line": 5231
    },
    {
      "type": "text",
      "section": "Implementation of Nutrition Plan and Monitoring",
      "line": 5233,
      "preview": "Particularly with FPIES to multiple foods, the risk of nutrient deficiency increases, and consultati"
    },
    {
      "type": "heading",
      "level": 2,
      "section": "Eosinophilic Esophagitis",
      "line": 5235
    },
    {
      "type": "text",
      "section": "Eosinophilic Esophagitis",
      "line": 5237,
      "preview": "Eosinophilic esophagitis (EoE) is a chronic allergen-mediated esophageal inflammatory disease. Class"
    },
    {
      "type": "heading",
      "level": 2,
      "section": "Implementation of Nutrition Plan and Monitoring",
      "line": 5239
    },
    {
      "type": "text",
      "section": "Implementation of Nutrition Plan and Monitoring",
      "line": 5241,
      "preview": "Elemental (or amino acid-based) formula eliminates all potential food allergens. It is $90 \\%$ effec"
    },
    {
      "type": "text",
      "section": "Implementation of Nutrition Plan and Monitoring",
      "line": 5243,
      "preview": "--- page 260 ---"
    },
    {
      "type": "text",
      "section": "Implementation of Nutrition Plan and Monitoring",
      "line": 5245,
      "preview": "An allergen-directed elimination diet refers to the avoidance of foods that are identified as allerg"
    },
    {
      "type": "text",
      "section": "Implementation of Nutrition Plan and Monitoring",
      "line": 5247,
      "preview": "Empiric elimination diets involve removing the most common food allergens (cow's milk, wheat, soy, e"
    },
    {
      "type": "text",
      "section": "Implementation of Nutrition Plan and Monitoring",
      "line": 5249,
      "preview": "The rates of success vary from approximately $50 \\%$ for elimination of cow's milk alone (the most c"
    },
    {
      "type": "text",
      "section": "Implementation of Nutrition Plan and Monitoring",
      "line": 5251,
      "preview": "With the empiric elimination diets, histologic response is monitored, and foods can be sequentially "
    },
    {
      "type": "text",
      "section": "Implementation of Nutrition Plan and Monitoring",
      "line": 5253,
      "preview": "With the avoidance of foods that constitute a major portion of the diet, understanding how to avoid "
    },
    {
      "type": "heading",
      "level": 1,
      "section": "References",
      "line": 5255
    },
    {
      "type": "text",
      "section": "References",
      "line": 5257,
      "preview": "1. Cassin A, Devonshire A, Ward S, McNeill M. Food Allergy. In: Goday PS, Walia CLS, eds. Pediatric "
    },
    {
      "type": "text",
      "section": "References",
      "line": 5258,
      "preview": "2. Merritt RJ, Fleet SE, Fifi A, et al; NASPGHAN Committee on Nutrition. North American Society for "
    },
    {
      "type": "text",
      "section": "References",
      "line": 5259,
      "preview": "3. Goday PS. Food allergies. In: Corkins MR, ed. Bobo E, Christensen ML, Larson-Nath C, Nuse Tome R,"
    },
    {
      "type": "text",
      "section": "References",
      "line": 5260,
      "preview": "4. Nowak-W\u0119grzyn A, Chehade M, Groetch ME, et al. International consensus guidelines for the diagnos"
    },
    {
      "type": "text",
      "section": "References",
      "line": 5262,
      "preview": "--- page 261 ---"
    },
    {
      "type": "text",
      "section": "References",
      "line": 5264,
      "preview": "American Academy of Allergy, Asthma \\& Immunology. J Allergy Clin Immunol. 2017;139(4):1111-1126.e4."
    },
    {
      "type": "text",
      "section": "References",
      "line": 5265,
      "preview": "5. Turner J, Schwartz S. Gastrointestinal diseases. In: Goday PS, Walia CLS, eds. Pediatric Nutritio"
    },
    {
      "type": "text",
      "section": "References",
      "line": 5267,
      "preview": "--- page 262 ---"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "9",
      "line": 5269
    },
    {
      "type": "heading",
      "level": 2,
      "section": "Cardiac Disease",
      "line": 5271
    },
    {
      "type": "text",
      "section": "Cardiac Disease",
      "line": 5273,
      "preview": "Erin Sullivan, RD, LDN, CSPCC<br>Sharon Y. Irving, PhD, CRNP<br>Vijay Srinivasan, MBBS, MD<br>Chitra"
    },
    {
      "type": "heading",
      "level": 2,
      "section": "Introduction",
      "line": 5275
    },
    {
      "type": "text",
      "section": "Introduction",
      "line": 5277,
      "preview": "Congenital heart disease (CHD) is the most common birth anomaly in children with a prevalence in 9 o"
    },
    {
      "type": "text",
      "section": "Introduction",
      "line": 5279,
      "preview": "--- page 263 ---"
    },
    {
      "type": "text",
      "section": "Introduction",
      "line": 5281,
      "preview": "To identify best nutrition practices to improve growth, the National Pediatric Cardiology Quality Im"
    },
    {
      "type": "text",
      "section": "Introduction",
      "line": 5283,
      "preview": "In this chapter, we focus on nutrition considerations in neonates who require cardiac interventions "
    },
    {
      "type": "heading",
      "level": 1,
      "section": "Risks and Special Considerations",
      "line": 5285
    },
    {
      "type": "text",
      "section": "Risks and Special Considerations",
      "line": 5287,
      "preview": "The etiology of growth failure is multifactorial from a combination of inadequate caloric intake; hi"
    },
    {
      "type": "text",
      "section": "Risks and Special Considerations",
      "line": 5289,
      "preview": "Neonates with CHD experience NEC more commonly compared with healthy neonates who have reported inci"
    },
    {
      "type": "text",
      "section": "Risks and Special Considerations",
      "line": 5291,
      "preview": "--- page 264 ---"
    },
    {
      "type": "text",
      "section": "Risks and Special Considerations",
      "line": 5293,
      "preview": "persists in infants with shunt-dependent circulation, including those with an aortopulmonary shunt o"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "Assessment and Nutrient Requirements",
      "line": 5295
    },
    {
      "type": "heading",
      "level": 2,
      "section": "Anthropometry and Energy Expenditure",
      "line": 5297
    },
    {
      "type": "text",
      "section": "Anthropometry and Energy Expenditure",
      "line": 5299,
      "preview": "For hospitalized neonates with CHD,"
    },
    {
      "type": "text",
      "section": "Anthropometry and Energy Expenditure",
      "line": 5301,
      "preview": "- weight should be measured daily (unless hemodynamically unstable)"
    },
    {
      "type": "text",
      "section": "Anthropometry and Energy Expenditure",
      "line": 5302,
      "preview": "- length should be measured weekly"
    },
    {
      "type": "text",
      "section": "Anthropometry and Energy Expenditure",
      "line": 5303,
      "preview": "- head circumference should be measured monthly"
    },
    {
      "type": "text",
      "section": "Anthropometry and Energy Expenditure",
      "line": 5305,
      "preview": "Fluid shifts and fluid overload may affect anthropometric measurements, especially weight. There is "
    },
    {
      "type": "heading",
      "level": 2,
      "section": "Implementation of Nutrition Plan and Monitoring",
      "line": 5307
    },
    {
      "type": "text",
      "section": "Implementation of Nutrition Plan and Monitoring",
      "line": 5309,
      "preview": "Nutrition therapy for infants and children with CHD is vital to the care continuum and life span-fro"
    },
    {
      "type": "text",
      "section": "Implementation of Nutrition Plan and Monitoring",
      "line": 5311,
      "preview": "--- page 265 ---"
    },
    {
      "type": "text",
      "section": "Implementation of Nutrition Plan and Monitoring",
      "line": 5313,
      "preview": "enhancing outcomes. ${ }^{11}$ Close monitoring and evaluation are required to minimize risk of maln"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "Preoperative Feeding Guidelines",
      "line": 5315
    },
    {
      "type": "text",
      "section": "Preoperative Feeding Guidelines",
      "line": 5317,
      "preview": "Prostaglandin infusions are not a contraindication to enteral feeding. There is sufficient evidence "
    },
    {
      "type": "text",
      "section": "Preoperative Feeding Guidelines",
      "line": 5319,
      "preview": "Human milk is the preferred feeding option given its immunologic benefits and high biologically avai"
    },
    {
      "type": "heading",
      "level": 2,
      "section": "Postoperative Nutrition Support",
      "line": 5321
    },
    {
      "type": "text",
      "section": "Postoperative Nutrition Support",
      "line": 5323,
      "preview": "The best surgical outcomes are accomplished when patients can establish positive nitrogen balance an"
    },
    {
      "type": "text",
      "section": "Postoperative Nutrition Support",
      "line": 5325,
      "preview": "1. Acute phase"
    },
    {
      "type": "text",
      "section": "Postoperative Nutrition Support",
      "line": 5326,
      "preview": "2. Stable phase"
    },
    {
      "type": "text",
      "section": "Postoperative Nutrition Support",
      "line": 5327,
      "preview": "3. Recovery phase"
    },
    {
      "type": "text",
      "section": "Postoperative Nutrition Support",
      "line": 5329,
      "preview": "Metabolic targets and nutrition goals change based on the phase of disease state, but generally grow"
    },
    {
      "type": "text",
      "section": "Postoperative Nutrition Support",
      "line": 5331,
      "preview": "--- page 266 ---"
    },
    {
      "type": "text",
      "section": "Postoperative Nutrition Support",
      "line": 5333,
      "preview": "postoperative stress response resolves, and positive nitrogen balance is attained."
    },
    {
      "type": "text",
      "section": "Postoperative Nutrition Support",
      "line": 5335,
      "preview": "Studies of REE in critically ill infants after cardiac surgery have observed that outcomes are impro"
    },
    {
      "type": "text",
      "section": "Postoperative Nutrition Support",
      "line": 5337,
      "preview": "--- page 267 ---"
    },
    {
      "type": "text",
      "section": "Postoperative Nutrition Support",
      "line": 5339,
      "preview": "TABLE 9-1. Nutrition Guidelines for Neonates Undergoing Surgery for $\\mathrm{CHD}^{\\mathrm{a}}$"
    },
    {
      "type": "table",
      "section": "Postoperative Nutrition Support",
      "line": 5341,
      "preview": "|  | Postoperative Guidelines | Acute Care Guidelines |"
    },
    {
      "type": "table",
      "section": "Postoperative Nutrition Support",
      "line": 5342,
      "preview": "| :--: | :--: | :--: |"
    },
    {
      "type": "table",
      "section": "Postoperative Nutrition Support",
      "line": 5343,
      "preview": "| Energy | - Determined by indirect calorimetry ${ }^{b}$ <br> - $55-65 \\mathrm{kcal} / \\mathrm{kg} "
    },
    {
      "type": "table",
      "section": "Postoperative Nutrition Support",
      "line": 5344,
      "preview": "| Protein | - Preterm: $3-4.5 \\mathrm{~g} / \\mathrm{kg} / \\mathrm{d}$ <br> - Term: $3-4 \\mathrm{~g} "
    },
    {
      "type": "table",
      "section": "Postoperative Nutrition Support",
      "line": 5345,
      "preview": "| Carbohydrate | - $40 \\%-60 \\%$ of total cal/d <br> - Initiate GIR of $4-8 \\mathrm{mg} / \\mathrm{kg"
    },
    {
      "type": "table",
      "section": "Postoperative Nutrition Support",
      "line": 5346,
      "preview": "| Lipid | $1.5-3 \\mathrm{~g} / \\mathrm{kg}^{\\mathrm{d}}$ | - |"
    },
    {
      "type": "table",
      "section": "Postoperative Nutrition Support",
      "line": 5347,
      "preview": "| Fluid | Restriction 50\\%-85\\% maintenance/d | - Advance to 100-150 $\\mathrm{mL} / \\mathrm{kg} / \\m"
    },
    {
      "type": "text",
      "section": "Postoperative Nutrition Support",
      "line": 5349,
      "preview": "Abbreviations: CHD, congenital heart disease; GIR, glucose infusion rate."
    },
    {
      "type": "text",
      "section": "Postoperative Nutrition Support",
      "line": 5350,
      "preview": "${ }^{a}$ Adapted with permission from the American Society for Parental and Enteral Nutrition from "
    },
    {
      "type": "text",
      "section": "Postoperative Nutrition Support",
      "line": 5351,
      "preview": "${ }^{\\text {b }}$ If available. Results may be affected by ventilation, sedation, medications."
    },
    {
      "type": "text",
      "section": "Postoperative Nutrition Support",
      "line": 5352,
      "preview": "${ }^{c}$ Estimated needs from enteral nutrition."
    },
    {
      "type": "text",
      "section": "Postoperative Nutrition Support",
      "line": 5353,
      "preview": "${ }^{d}$ Limited with cholestasis or hypertriglyceridemia."
    },
    {
      "type": "text",
      "section": "Postoperative Nutrition Support",
      "line": 5355,
      "preview": "A standardized approach to nutrition therapy using clinical pathways has demonstrated positive outco"
    },
    {
      "type": "text",
      "section": "Postoperative Nutrition Support",
      "line": 5357,
      "preview": "--- page 268 ---"
    },
    {
      "type": "text",
      "section": "Postoperative Nutrition Support",
      "line": 5359,
      "preview": "The following are general guidelines for provision of nutrition in the postoperative period:"
    },
    {
      "type": "text",
      "section": "Postoperative Nutrition Support",
      "line": 5361,
      "preview": "- Use PN in the early postoperative period while advancing enteral feeds."
    },
    {
      "type": "text",
      "section": "Postoperative Nutrition Support",
      "line": 5362,
      "preview": "- Initiate enteral feeds as early as possible once hemodynamic stability is established."
    },
    {
      "type": "text",
      "section": "Postoperative Nutrition Support",
      "line": 5363,
      "preview": "- Consider use of a standardized protocol or algorithm for nutrition delivery that includes guidance"
    },
    {
      "type": "text",
      "section": "Postoperative Nutrition Support",
      "line": 5365,
      "preview": "--- page 269 ---"
    },
    {
      "type": "image",
      "section": "Postoperative Nutrition Support",
      "line": 5367,
      "content": "![img-10.jpeg](images/b5f666a73590ed61.png)"
    },
    {
      "type": "text",
      "section": "Postoperative Nutrition Support",
      "line": 5369,
      "preview": "FIGURE 9-1. Pathway for nutrition of neonates undergoing surgery for congenital heart disease. Abbre"
    },
    {
      "type": "text",
      "section": "Postoperative Nutrition Support",
      "line": 5371,
      "preview": "Types of feeds include the following:"
    },
    {
      "type": "text",
      "section": "Postoperative Nutrition Support",
      "line": 5373,
      "preview": "- Human milk is preferred but often needs to be fortified, and higher concentration standard formula"
    },
    {
      "type": "text",
      "section": "Postoperative Nutrition Support",
      "line": 5374,
      "preview": "- In infants with a history of NEC or significant feeding intolerance, the use of semielemental or e"
    },
    {
      "type": "text",
      "section": "Postoperative Nutrition Support",
      "line": 5376,
      "preview": "--- page 270 ---"
    },
    {
      "type": "text",
      "section": "Postoperative Nutrition Support",
      "line": 5378,
      "preview": "- Emerging literature suggests that peptide nutrient-energy dense formulas can be safely provided to"
    },
    {
      "type": "text",
      "section": "Postoperative Nutrition Support",
      "line": 5380,
      "preview": "Postpyloric rather than gastric tube feedings are frequently used in infants with marginal respirato"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "Special Situations",
      "line": 5382
    },
    {
      "type": "heading",
      "level": 2,
      "section": "Chylothorax",
      "line": 5384
    },
    {
      "type": "text",
      "section": "Chylothorax",
      "line": 5386,
      "preview": "Chylothorax, or an accumulation of milky-appearing chyle within the pleural space, is a well-known a"
    },
    {
      "type": "text",
      "section": "Chylothorax",
      "line": 5388,
      "preview": "Recognizing the large and often unnecessary practice variation in management of chylous effusions an"
    },
    {
      "type": "text",
      "section": "Chylothorax",
      "line": 5390,
      "preview": "--- page 271 ---"
    },
    {
      "type": "image",
      "section": "Chylothorax",
      "line": 5392,
      "content": "![img-11.jpeg](images/56eb62278a50f3ad.png)"
    },
    {
      "type": "text",
      "section": "Chylothorax",
      "line": 5394,
      "preview": "FIGURE 9-2. Clinical management algorithm for postoperative chylothorax. (a) Flowchart for the diagn"
    },
    {
      "type": "text",
      "section": "Chylothorax",
      "line": 5396,
      "preview": "--- page 272 ---"
    },
    {
      "type": "text",
      "section": "Chylothorax",
      "line": 5398,
      "preview": "therapies, and fat-modified diet duration for chylothorax after pediatric cardiac surgery. Adapted w"
    },
    {
      "type": "text",
      "section": "Chylothorax",
      "line": 5399,
      "preview": "(b)"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "BOX 1: Diagnostic Studies to Consider",
      "line": 5401
    },
    {
      "type": "text",
      "section": "BOX 1: Diagnostic Studies to Consider",
      "line": 5403,
      "preview": "Concern for chylothorax may include: milky CTO, CTO $>20 \\mathrm{~mL} / \\mathrm{kg} /$ day beginning"
    },
    {
      "type": "text",
      "section": "BOX 1: Diagnostic Studies to Consider",
      "line": 5404,
      "preview": "Pleural fluid studies confirmatory for chylothorax (at least 1 of the following must be positive):"
    },
    {
      "type": "text",
      "section": "BOX 1: Diagnostic Studies to Consider",
      "line": 5406,
      "preview": "- Triglycerides ( $>110 \\mathrm{mg} / \\mathrm{dL}$ )"
    },
    {
      "type": "text",
      "section": "BOX 1: Diagnostic Studies to Consider",
      "line": 5407,
      "preview": "- Lymphocyte predominance ( $>00 \\%$ )"
    },
    {
      "type": "text",
      "section": "BOX 1: Diagnostic Studies to Consider",
      "line": 5408,
      "preview": "- Positive chylomicrons"
    },
    {
      "type": "text",
      "section": "BOX 1: Diagnostic Studies to Consider",
      "line": 5409,
      "preview": "- Pleural>serum triglycerides"
    },
    {
      "type": "text",
      "section": "BOX 1: Diagnostic Studies to Consider",
      "line": 5411,
      "preview": "BOX 2: Etiology Work-up (Risk factors: previous chylothorax, elevated venous pressure, decreased fun"
    },
    {
      "type": "text",
      "section": "BOX 1: Diagnostic Studies to Consider",
      "line": 5412,
      "preview": "-Venous doppler head/neck ultrasound: If VTE present, provide anticoagulation per institutional stan"
    },
    {
      "type": "text",
      "section": "BOX 1: Diagnostic Studies to Consider",
      "line": 5413,
      "preview": "-Echo to include evaluation of SVC for thrombus and consider venogram with negative echo but suspici"
    },
    {
      "type": "text",
      "section": "BOX 1: Diagnostic Studies to Consider",
      "line": 5414,
      "preview": "-Prior to referral to lymphatic center, complete echocardiogram and diagnostic cardiac catheterizati"
    },
    {
      "type": "heading",
      "level": 2,
      "section": "Box 3: Diet Modifications Following Chylous Effusion Diagnosis",
      "line": 5416
    },
    {
      "type": "text",
      "section": "Box 3: Diet Modifications Following Chylous Effusion Diagnosis",
      "line": 5418,
      "preview": "Defatted human milk, fortify as below with MCT based formula for $<1$ year of age. Supplement with A"
    },
    {
      "type": "heading",
      "level": 2,
      "section": "MCT based enteral formulas:",
      "line": 5420
    },
    {
      "type": "text",
      "section": "MCT based enteral formulas:",
      "line": 5422,
      "preview": "$<1$ year of age: Monogen*, Enfaport, Lipstart*, or Vivonex Pediatric* (for milk protein intolerance"
    },
    {
      "type": "text",
      "section": "MCT based enteral formulas:",
      "line": 5423,
      "preview": "Medium Chain Triglyceride (MCT) Based Calorie Modulars: MCT oil ( 8 Cal/ml), Nutricia Liquigen ( $4."
    },
    {
      "type": "text",
      "section": "MCT based enteral formulas:",
      "line": 5425,
      "preview": "Oral Fat Modified Diet:"
    },
    {
      "type": "text",
      "section": "MCT based enteral formulas:",
      "line": 5426,
      "preview": "Start $\\leq 10 \\mathrm{~g}$ fat/day from long-chain triglycerides to provide $2-4 \\%$ total calories"
    },
    {
      "type": "heading",
      "level": 2,
      "section": "Essential Fatty Acid (EFA) Deficiency Monitoring:",
      "line": 5428
    },
    {
      "type": "text",
      "section": "Essential Fatty Acid (EFA) Deficiency Monitoring:",
      "line": 5430,
      "preview": "EFA deficiency may develop in 1-3 weeks on no/low exogenous EFA delivery. Watch for physical symptom"
    },
    {
      "type": "text",
      "section": "Essential Fatty Acid (EFA) Deficiency Monitoring:",
      "line": 5431,
      "preview": "For prolonged restriction or manifestation of symptoms: obtain EFA profiles, monitoring triene:tetra"
    },
    {
      "type": "text",
      "section": "Essential Fatty Acid (EFA) Deficiency Monitoring:",
      "line": 5433,
      "preview": "Parenteral Nutrition: Optimize calories and protein. Protein may need to be increased by $1.5-2 \\tim"
    },
    {
      "type": "text",
      "section": "Essential Fatty Acid (EFA) Deficiency Monitoring:",
      "line": 5434,
      "preview": "Dose lipids (IL) per needs/tolerance but with minimum of $0.5 \\mathrm{~g} / \\mathrm{kg} /$ day $20 \\"
    },
    {
      "type": "text",
      "section": "Essential Fatty Acid (EFA) Deficiency Monitoring:",
      "line": 5436,
      "preview": "Parental Nutrition Screening Labs: daily until stability: electrolytes (BMP) including Mg, PO4; 1-2x"
    },
    {
      "type": "text",
      "section": "Essential Fatty Acid (EFA) Deficiency Monitoring:",
      "line": 5437,
      "preview": "*Nutritionally complete but off label use in patients less than 1 yo"
    },
    {
      "type": "text",
      "section": "Essential Fatty Acid (EFA) Deficiency Monitoring:",
      "line": 5438,
      "preview": "**Not nutritionally complete, requires trace mineral supplementation"
    },
    {
      "type": "heading",
      "level": 2,
      "section": "BOX 4: Additional Therapies",
      "line": 5440
    },
    {
      "type": "text",
      "section": "BOX 4: Additional Therapies",
      "line": 5442,
      "preview": "Additional considerations for refractory chylothorax: defined as 7 cumulative days of NPO with chest"
    },
    {
      "type": "heading",
      "level": 2,
      "section": "BOX 5: Fat-modified Diet Duration",
      "line": 5444
    },
    {
      "type": "text",
      "section": "BOX 5: Fat-modified Diet Duration",
      "line": 5446,
      "preview": "Concurrent PC4 Chylothorax Work Group project aims to decrease current fat-modified diet duration at"
    },
    {
      "type": "text",
      "section": "BOX 5: Fat-modified Diet Duration",
      "line": 5448,
      "preview": "If no current institutional standard, we recommend no more than 4 week duration of fat-modified diet"
    },
    {
      "type": "heading",
      "level": 2,
      "section": "FIGURE 9-2. (Continued)",
      "line": 5450
    },
    {
      "type": "text",
      "section": "FIGURE 9-2. (Continued)",
      "line": 5452,
      "preview": "--- page 273 ---"
    },
    {
      "type": "text",
      "section": "FIGURE 9-2. (Continued)",
      "line": 5454,
      "preview": "Chylothorax management involves strategies to decrease thoracic flow, allowing the lymphatic channel"
    },
    {
      "type": "text",
      "section": "FIGURE 9-2. (Continued)",
      "line": 5456,
      "preview": "TABLE 9-2. High MCT and/or Low LCT Formulas"
    },
    {
      "type": "table",
      "section": "FIGURE 9-2. (Continued)",
      "line": 5458,
      "preview": "| Formula $^{\\mathbf{a}}$ | MCT/LCT <br> Ratio | Calories From <br> LCT Fat (\\%) | LCT Fat Grams <br"
    },
    {
      "type": "table",
      "section": "FIGURE 9-2. (Continued)",
      "line": 5459,
      "preview": "| :-- | :-- | :--: | :--: | :-- |"
    },
    {
      "type": "table",
      "section": "FIGURE 9-2. (Continued)",
      "line": 5460,
      "preview": "| Enfaport | $83: 17$ | 7.8 | 0.9 | Contains milk <br> proteins |"
    },
    {
      "type": "table",
      "section": "FIGURE 9-2. (Continued)",
      "line": 5461,
      "preview": "| LIPIstart | $80: 20$ | 7.6 | 0.82 |  |"
    },
    {
      "type": "table",
      "section": "FIGURE 9-2. (Continued)",
      "line": 5462,
      "preview": "| Monogen | $83: 17$ | 4.5 | 0.5 |  |"
    },
    {
      "type": "table",
      "section": "FIGURE 9-2. (Continued)",
      "line": 5463,
      "preview": "| Portagen | $87: 13$ | 5.5 | 0.6 |  |"
    },
    {
      "type": "table",
      "section": "FIGURE 9-2. (Continued)",
      "line": 5464,
      "preview": "| Tolerex | $0: 100$ | 2 | 0.2 | Elemental, 100\\% <br> free amino acids |"
    },
    {
      "type": "table",
      "section": "FIGURE 9-2. (Continued)",
      "line": 5465,
      "preview": "| Vivonex <br> Pediatric | $70: 30$ | 7.5 | 0.87 |  |"
    },
    {
      "type": "table",
      "section": "FIGURE 9-2. (Continued)",
      "line": 5466,
      "preview": "| Vivonex <br> T.E.N. | $0: 100$ | 3 | 0.3 |  |"
    },
    {
      "type": "text",
      "section": "FIGURE 9-2. (Continued)",
      "line": 5468,
      "preview": "Abbreviations: LCT, long-chain triglyceride; MCT, medium-chain triglyceride."
    },
    {
      "type": "text",
      "section": "FIGURE 9-2. (Continued)",
      "line": 5469,
      "preview": "${ }^{a}$ Compiled from published manufacturer product information. Always confirm nutrient contents"
    },
    {
      "type": "text",
      "section": "FIGURE 9-2. (Continued)",
      "line": 5471,
      "preview": "Inadequate dietary intake of linoleic acid (LA) and $\\alpha$-LA (ALA) associated with prolonged diet"
    },
    {
      "type": "text",
      "section": "FIGURE 9-2. (Continued)",
      "line": 5473,
      "preview": "--- page 274 ---"
    },
    {
      "type": "text",
      "section": "FIGURE 9-2. (Continued)",
      "line": 5475,
      "preview": "An abnormal triene/tetraene ratio ( $>0.2$ ), is indicative of essential fattyacid deficiency. ${ }^"
    },
    {
      "type": "text",
      "section": "FIGURE 9-2. (Continued)",
      "line": 5477,
      "preview": "Prolonged dietary restriction is not recommended and may be harmful, resulting in nutrition deficien"
    },
    {
      "type": "text",
      "section": "FIGURE 9-2. (Continued)",
      "line": 5479,
      "preview": "Resumption of regular diet, human milk, or standard formula in a stepped approach 4-6 weeks after re"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "Protein-Losing Enteropathy",
      "line": 5481
    },
    {
      "type": "text",
      "section": "Protein-Losing Enteropathy",
      "line": 5483,
      "preview": "Protein-losing enteropathy (PLE) occurs when excess albumin and other protein-rich materials leak in"
    },
    {
      "type": "heading",
      "level": 2,
      "section": "References",
      "line": 5485
    },
    {
      "type": "text",
      "section": "References",
      "line": 5487,
      "preview": "1. Mozaffarian D, Benjamin EJ, Go AS, et al; American Heart Association Statistics Committee and Str"
    },
    {
      "type": "text",
      "section": "References",
      "line": 5488,
      "preview": "2. Chen MY, Riehle-Colarusso T, Yeung LF, Smith C, Farr SL, Ed S. Children with heart conditions and"
    },
    {
      "type": "text",
      "section": "References",
      "line": 5489,
      "preview": "3. Medoff-Cooper B, Ravishankar C. Nutrition and growth in congenital heart disease: a challenge in "
    },
    {
      "type": "text",
      "section": "References",
      "line": 5491,
      "preview": "--- page 275 ---"
    },
    {
      "type": "text",
      "section": "References",
      "line": 5493,
      "preview": "https://doi.org/10.1097/HCO.0b013e32835dd005"
    },
    {
      "type": "text",
      "section": "References",
      "line": 5494,
      "preview": "4. Williams RV, Zak V, Ravishankar C, et al; Pediatric Heart Network Investigators. Factors affectin"
    },
    {
      "type": "text",
      "section": "References",
      "line": 5495,
      "preview": "5. Burch PT, Ravishankar C, Newburger JW, et al; Pediatric Heart Network Investigators. Assessment o"
    },
    {
      "type": "text",
      "section": "References",
      "line": 5496,
      "preview": "6. Slicker J, Hehir DA, Horsley M, et al; Feeding Work Group of the National Pediatric Cardiology Qu"
    },
    {
      "type": "text",
      "section": "References",
      "line": 5497,
      "preview": "7. Lisanti AJ, Savoca M, Gaynor JW, et al. Standardized feeding approach mitigates weight loss in in"
    },
    {
      "type": "text",
      "section": "References",
      "line": 5498,
      "preview": "8. Kelleher, ST, McMahon CJ, James A. Necrotizing enterocolitis in children with congenital heart di"
    },
    {
      "type": "text",
      "section": "References",
      "line": 5499,
      "preview": "9. Sagiv E, Tjoeng YL, Davis M, et al. Assessing the association between pre-operative feeding and t"
    },
    {
      "type": "text",
      "section": "References",
      "line": 5500,
      "preview": "10. Mehta NM, Skillman HE, Irving SY, et al. Guidelines for the provision and assessment of nutritio"
    },
    {
      "type": "text",
      "section": "References",
      "line": 5501,
      "preview": "11. Larsen BMK, Beggs MR, Leong AY, Kang SH, Persad R, Garcia Guerra G. Can energy intake alter clin"
    },
    {
      "type": "text",
      "section": "References",
      "line": 5502,
      "preview": "12. Owens JL, and Musa N. Nutrition support after neonatal cardiac surgery. Nutr Clin Pract. 2009;24"
    },
    {
      "type": "text",
      "section": "References",
      "line": 5503,
      "preview": "13. Kelleher DK, Laussen P, Teixeira-Pinto A, Duggan C. Growth and correlates of nutritional status "
    },
    {
      "type": "text",
      "section": "References",
      "line": 5504,
      "preview": "14. Larsen BMK, Goonewardene LA, Field CJ et al. Low energy intakes are associated with adverse outc"
    },
    {
      "type": "text",
      "section": "References",
      "line": 5505,
      "preview": "15. Srinivasan V, Hasbani NR, Mehta NM, et al; Heart and Lung Failure-Pediatric Insulin Titration (H"
    },
    {
      "type": "text",
      "section": "References",
      "line": 5506,
      "preview": "16. Marino LV, Eveleens RD, Morton K, Verbruggen SCAT, Joosten KFM. Peptide nutrientenergy dense ent"
    },
    {
      "type": "text",
      "section": "References",
      "line": 5508,
      "preview": "--- page 276 ---"
    },
    {
      "type": "text",
      "section": "References",
      "line": 5510,
      "preview": "17. Raatz A, Sch\u00f6ber M, Zant R, et al. Risk factors for chylothorax and persistent serous effusions "
    },
    {
      "type": "text",
      "section": "References",
      "line": 5511,
      "preview": "18. Lion RP, Winder MM, Amirnovin R, et al; PC4 Chylothorax Work Group. Development of consensus rec"
    },
    {
      "type": "text",
      "section": "References",
      "line": 5512,
      "preview": "19. Panthongviriyakul C, Bines JE. Post-operative chylothorax in children: an evidence-based managem"
    },
    {
      "type": "text",
      "section": "References",
      "line": 5513,
      "preview": "20. Marino LV, Bell KL, Woodgate J, Doolan A; British Dietetic Paediatric Cardiology Interest Group."
    },
    {
      "type": "text",
      "section": "References",
      "line": 5514,
      "preview": "21. Carlson SE. Polyunsaturated fatty acids and infant nutrition. In: Galli C, Simopoulos AP, eds. D"
    },
    {
      "type": "text",
      "section": "References",
      "line": 5516,
      "preview": "--- page 277 ---"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "10",
      "line": 5518
    },
    {
      "type": "heading",
      "level": 2,
      "section": "Celiac Disease",
      "line": 5520
    },
    {
      "type": "text",
      "section": "Celiac Disease",
      "line": 5522,
      "preview": "Anam Bashir, MD<br>Praveen S. Goday, MBBS"
    },
    {
      "type": "heading",
      "level": 2,
      "section": "Introduction",
      "line": 5524
    },
    {
      "type": "text",
      "section": "Introduction",
      "line": 5526,
      "preview": "Celiac disease is an autoimmune enteropathy triggered by the intake of gluten, a protein complex fou"
    },
    {
      "type": "heading",
      "level": 2,
      "section": "Assessment and Nutrient Requirements",
      "line": 5528
    },
    {
      "type": "text",
      "section": "Assessment and Nutrient Requirements",
      "line": 5530,
      "preview": "A careful history review, examination, and evaluation are critical for all patients with celiac dise"
    },
    {
      "type": "text",
      "section": "Assessment and Nutrient Requirements",
      "line": 5532,
      "preview": "--- page 278 ---"
    },
    {
      "type": "text",
      "section": "Assessment and Nutrient Requirements",
      "line": 5534,
      "preview": "- History: Extensive review of dietary history to identify any inadvertent exposure to gluten"
    },
    {
      "type": "text",
      "section": "Assessment and Nutrient Requirements",
      "line": 5535,
      "preview": "- Nutrition-focused physical examination"
    },
    {
      "type": "text",
      "section": "Assessment and Nutrient Requirements",
      "line": 5536,
      "preview": "- Anthropometric assessment: Weight, height/length, head circumference, body mass index, weight for "
    },
    {
      "type": "text",
      "section": "Assessment and Nutrient Requirements",
      "line": 5537,
      "preview": "- Laboratory assessment: screening for micronutrient deficiency at diagnosis and periodically, if ne"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "Implementation of Nutrition Plan and Monitoring",
      "line": 5540
    },
    {
      "type": "text",
      "section": "Implementation of Nutrition Plan and Monitoring",
      "line": 5542,
      "preview": "The fundamental treatment of patients with celiac disease is a lifelong gluten-free diet, which invo"
    },
    {
      "type": "text",
      "section": "Implementation of Nutrition Plan and Monitoring",
      "line": 5544,
      "preview": "--- page 279 ---"
    },
    {
      "type": "text",
      "section": "Implementation of Nutrition Plan and Monitoring",
      "line": 5546,
      "preview": "TABLE 10-1. List of Common Gluten-Containing and GlutenFree Foods"
    },
    {
      "type": "table",
      "section": "Implementation of Nutrition Plan and Monitoring",
      "line": 5548,
      "preview": "| Gluten-Containing <br> Foods | Gluten-Free Foods | Foods That May <br> Contain Gluten |"
    },
    {
      "type": "table",
      "section": "Implementation of Nutrition Plan and Monitoring",
      "line": 5549,
      "preview": "| :-- | :-- | :-- |"
    },
    {
      "type": "text",
      "section": "Implementation of Nutrition Plan and Monitoring",
      "line": 5551,
      "preview": "Detailed food-label reading and education with a registered dietitian to ensure patients are not ina"
    },
    {
      "type": "text",
      "section": "Implementation of Nutrition Plan and Monitoring",
      "line": 5553,
      "preview": "--- page 280 ---"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "EXHIBIT 10-1. Common Sources of Contamination",
      "line": 5555
    },
    {
      "type": "text",
      "section": "EXHIBIT 10-1. Common Sources of Contamination",
      "line": 5557,
      "preview": "- Lipstick/lip gloss/lip balms"
    },
    {
      "type": "text",
      "section": "EXHIBIT 10-1. Common Sources of Contamination",
      "line": 5558,
      "preview": "- Oral care and dental products"
    },
    {
      "type": "text",
      "section": "EXHIBIT 10-1. Common Sources of Contamination",
      "line": 5559,
      "preview": "- Herbal supplements"
    },
    {
      "type": "text",
      "section": "EXHIBIT 10-1. Common Sources of Contamination",
      "line": 5560,
      "preview": "- Prescription medications"
    },
    {
      "type": "text",
      "section": "EXHIBIT 10-1. Common Sources of Contamination",
      "line": 5561,
      "preview": "- Over-the-counter medications"
    },
    {
      "type": "text",
      "section": "EXHIBIT 10-1. Common Sources of Contamination",
      "line": 5562,
      "preview": "- Play-Doh"
    },
    {
      "type": "text",
      "section": "EXHIBIT 10-1. Common Sources of Contamination",
      "line": 5563,
      "preview": "- Probiotics"
    },
    {
      "type": "heading",
      "level": 2,
      "section": "Prevention of Micronutrient and Vitamin Deficiency",
      "line": 5566
    },
    {
      "type": "text",
      "section": "Prevention of Micronutrient and Vitamin Deficiency",
      "line": 5568,
      "preview": "Celiac disease can affect bone health. Age-appropriate calcium and vitamin D intake and regular exer"
    },
    {
      "type": "text",
      "section": "Prevention of Micronutrient and Vitamin Deficiency",
      "line": 5570,
      "preview": "With prolonged delay in diagnosis of celiac disease or symptomatic patients with rickets or bone pai"
    },
    {
      "type": "text",
      "section": "Prevention of Micronutrient and Vitamin Deficiency",
      "line": 5572,
      "preview": "Gluten-free diets are known to be low in vitamins $\\mathrm{D}, \\mathrm{E}$, and $\\mathrm{B}_{12}$, f"
    },
    {
      "type": "heading",
      "level": 2,
      "section": "References",
      "line": 5574
    },
    {
      "type": "text",
      "section": "References",
      "line": 5576,
      "preview": "1. Hischenhuber C, Crevel R, Jarry B, et al. Review article: safe amounts of gluten for patients wit"
    },
    {
      "type": "text",
      "section": "References",
      "line": 5577,
      "preview": "2. Snyder J, Butzner JD, DeFelice AR, et al. Evidence-informed expert recommendations for the manage"
    },
    {
      "type": "text",
      "section": "References",
      "line": 5578,
      "preview": "3. Di Nardo G, Villa MP, Conti L, et al. Nutritional deficiencies in children with celiac disease re"
    },
    {
      "type": "text",
      "section": "References",
      "line": 5580,
      "preview": "--- page 281 ---"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "Critical Illness",
      "line": 5582
    },
    {
      "type": "text",
      "section": "Critical Illness",
      "line": 5584,
      "preview": "Sharon Y. Irving, PhD, CRNP<br>Stephanie Seiple, RD, LDN, CNSC<br>Vijay Srinivasan, MBBS, MD"
    },
    {
      "type": "heading",
      "level": 2,
      "section": "Introduction",
      "line": 5586
    },
    {
      "type": "text",
      "section": "Introduction",
      "line": 5588,
      "preview": "Critical illness or trauma in children is a complex state characterized by abnormal vital organ func"
    },
    {
      "type": "text",
      "section": "Introduction",
      "line": 5590,
      "preview": "The physiologic route for delivery of nutrition is via the GI tract and is preferred even during cri"
    },
    {
      "type": "text",
      "section": "Introduction",
      "line": 5592,
      "preview": "--- page 282 ---"
    },
    {
      "type": "text",
      "section": "Introduction",
      "line": 5594,
      "preview": "course of critical illness. Studies of critically ill children who received enteral nutrition (EN) e"
    },
    {
      "type": "text",
      "section": "Introduction",
      "line": 5596,
      "preview": "The decision of when to initiate nutrition involves recognition of the pre-illness nutrition status "
    },
    {
      "type": "heading",
      "level": 1,
      "section": "Assessment of Nutrition Status",
      "line": 5598
    },
    {
      "type": "heading",
      "level": 2,
      "section": "General Principles",
      "line": 5600
    },
    {
      "type": "text",
      "section": "General Principles",
      "line": 5602,
      "preview": "A comprehensive nutrition status assessment is the first step and key component to optimizing nutrit"
    },
    {
      "type": "heading",
      "level": 2,
      "section": "Anthropometry",
      "line": 5604
    },
    {
      "type": "text",
      "section": "Anthropometry",
      "line": 5606,
      "preview": "--- page 283 ---"
    },
    {
      "type": "text",
      "section": "Anthropometry",
      "line": 5608,
      "preview": "Traditional anthropometric measurements, consisting of weight, length, and head circumference, shoul"
    },
    {
      "type": "text",
      "section": "Anthropometry",
      "line": 5610,
      "preview": "No published standards exist to define optimal frequency for obtaining anthropometric measurements i"
    },
    {
      "type": "text",
      "section": "Anthropometry",
      "line": 5612,
      "preview": "- Weight may be measured daily but may also be obtained less frequently (weekly to several times per"
    },
    {
      "type": "text",
      "section": "Anthropometry",
      "line": 5613,
      "preview": "- Stature/length/height should be assessed at least monthly or more frequently based on clinical con"
    },
    {
      "type": "text",
      "section": "Anthropometry",
      "line": 5614,
      "preview": "- Length is measured in children less than 2 years of age."
    },
    {
      "type": "text",
      "section": "Anthropometry",
      "line": 5615,
      "preview": "- Height is measured in children equal to or greater than 2 years (if clinically appropriate). Note:"
    },
    {
      "type": "text",
      "section": "Anthropometry",
      "line": 5616,
      "preview": "- Critically ill children with contractures or other skeletal deformities (eg, scoliosis) require al"
    },
    {
      "type": "text",
      "section": "Anthropometry",
      "line": 5617,
      "preview": "- Head circumference (also referred to as frontal-occipital circumference) should be obtained every "
    },
    {
      "type": "text",
      "section": "Anthropometry",
      "line": 5618,
      "preview": "- MUAC can be used to characterize growth and nutrition status and to monitor body composition, usin"
    },
    {
      "type": "text",
      "section": "Anthropometry",
      "line": 5619,
      "preview": "- MUAC can be used in special circumstances, including, but not limited to, body edema (particularly"
    },
    {
      "type": "text",
      "section": "Anthropometry",
      "line": 5620,
      "preview": "- MUAC should be obtained by RDs or other trained personnel experienced with these measurements."
    },
    {
      "type": "text",
      "section": "Anthropometry",
      "line": 5622,
      "preview": "--- page 284 ---"
    },
    {
      "type": "text",
      "section": "Anthropometry",
      "line": 5624,
      "preview": "The critical illness state poses several challenges to obtaining accurate anthropometric measurement"
    },
    {
      "type": "text",
      "section": "Anthropometry",
      "line": 5626,
      "preview": "- severity of illness,"
    },
    {
      "type": "text",
      "section": "Anthropometry",
      "line": 5627,
      "preview": "- competing priorities,"
    },
    {
      "type": "text",
      "section": "Anthropometry",
      "line": 5628,
      "preview": "- time of day,"
    },
    {
      "type": "text",
      "section": "Anthropometry",
      "line": 5629,
      "preview": "- patient clinical state and device challenges (weight),"
    },
    {
      "type": "text",
      "section": "Anthropometry",
      "line": 5630,
      "preview": "- safety concerns,"
    },
    {
      "type": "text",
      "section": "Anthropometry",
      "line": 5631,
      "preview": "- patient contractures and limb anomalies (stature), and"
    },
    {
      "type": "text",
      "section": "Anthropometry",
      "line": 5632,
      "preview": "- medical devices (weight, length, and head circumference)."
    },
    {
      "type": "text",
      "section": "Anthropometry",
      "line": 5634,
      "preview": "Serial assessment and monitoring of clinical severity and risk for nutrition deterioration should be"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "Malnutrition",
      "line": 5636
    },
    {
      "type": "text",
      "section": "Malnutrition",
      "line": 5638,
      "preview": "Malnutrition is a severe imbalance (either deficiencies or excesses) between nutrient requirements a"
    },
    {
      "type": "text",
      "section": "Malnutrition",
      "line": 5640,
      "preview": "- Acute: Typically severe and sudden in onset, less than 3 months"
    },
    {
      "type": "text",
      "section": "Malnutrition",
      "line": 5641,
      "preview": "- Chronic: Develops and increases in severity over an extended timeframe ( 3 months or longer)"
    },
    {
      "type": "text",
      "section": "Malnutrition",
      "line": 5643,
      "preview": "--- page 285 ---"
    },
    {
      "type": "text",
      "section": "Malnutrition",
      "line": 5645,
      "preview": "TABLE 11-1. Operational Definitions of Malnutrition"
    },
    {
      "type": "table",
      "section": "Malnutrition",
      "line": 5647,
      "preview": "| Definition | BMI Range | z Score | MUAC z <br> Score $^{a}$ |"
    },
    {
      "type": "table",
      "section": "Malnutrition",
      "line": 5648,
      "preview": "| :-- | :-- | :--: | :--: |"
    },
    {
      "type": "table",
      "section": "Malnutrition",
      "line": 5649,
      "preview": "| Severe <br> underweight | - | $<-3$ | $<-3$ |"
    },
    {
      "type": "table",
      "section": "Malnutrition",
      "line": 5650,
      "preview": "| Underweight | $<5$ th percentile | $-3$ to $<$ <br> -1 | -1 to -3 |"
    },
    {
      "type": "table",
      "section": "Malnutrition",
      "line": 5651,
      "preview": "| Healthy weight | 5th to <85th percentile | -1 to < <br> +1 | +1 to -1 |"
    },
    {
      "type": "table",
      "section": "Malnutrition",
      "line": 5652,
      "preview": "| Overweight | 85th to <95th percentile | +1 to < <br> +2 | +1 to +5 |"
    },
    {
      "type": "table",
      "section": "Malnutrition",
      "line": 5653,
      "preview": "| Obesity | $>95$ th to 98th percentile | +2 to < <br> +3 | - |"
    },
    {
      "type": "table",
      "section": "Malnutrition",
      "line": 5654,
      "preview": "| Severe obesity ${ }^{b}$ | $>98$ th percentile (120\\% of the 95th <br> percentile) | $>+3$ | - |"
    },
    {
      "type": "text",
      "section": "Malnutrition",
      "line": 5656,
      "preview": "Abbreviations: BMI, body mass index; MUAC, mid-upper arm circumference."
    },
    {
      "type": "text",
      "section": "Malnutrition",
      "line": 5657,
      "preview": "${ }^{a}$ Stephens K, Orlick M, Beattie S, et al. Examining mid-upper arm circumference malnutrition"
    },
    {
      "type": "text",
      "section": "Malnutrition",
      "line": 5658,
      "preview": "https://doi.org/10.1002/ncp. 10324"
    },
    {
      "type": "text",
      "section": "Malnutrition",
      "line": 5659,
      "preview": "${ }^{\\text {b }}$ Centers for Disease Control and Prevention from CDC extended BMI-for-age growth c"
    },
    {
      "type": "text",
      "section": "Malnutrition",
      "line": 5660,
      "preview": "https://www.cdc.gov/growthcharts/extended-bmi.htm"
    },
    {
      "type": "text",
      "section": "Malnutrition",
      "line": 5662,
      "preview": "Malnutrition is associated with immune system dysfunction leading to increased risks of infection, p"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "Biomarkers/Laboratory Assessment",
      "line": 5664
    },
    {
      "type": "text",
      "section": "Biomarkers/Laboratory Assessment",
      "line": 5666,
      "preview": "There are no biomarkers specific to clinical GI function available for measurement during critical i"
    },
    {
      "type": "text",
      "section": "Biomarkers/Laboratory Assessment",
      "line": 5668,
      "preview": "--- page 286 ---"
    },
    {
      "type": "text",
      "section": "Biomarkers/Laboratory Assessment",
      "line": 5670,
      "preview": "and prealbumin, should not be used or interpreted as nutrition markers as they do not specifically a"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "Implementation of Nutrition Plan and Monitoring",
      "line": 5672
    },
    {
      "type": "heading",
      "level": 2,
      "section": "Nutrition Prescription",
      "line": 5674
    },
    {
      "type": "text",
      "section": "Nutrition Prescription",
      "line": 5676,
      "preview": "Prescription for nutrition therapy should be adequate and individualized to meet energy, protein, an"
    },
    {
      "type": "text",
      "section": "Nutrition Prescription",
      "line": 5678,
      "preview": "The RD must work with the clinical team to determine appropriate nutrient intake over the course of "
    },
    {
      "type": "text",
      "section": "Nutrition Prescription",
      "line": 5680,
      "preview": "Indirect calorimetry (IC) is a noninvasive, per-breath measurement of respiratory gas exchange (oxyg"
    },
    {
      "type": "text",
      "section": "Nutrition Prescription",
      "line": 5682,
      "preview": "--- page 287 ---"
    },
    {
      "type": "text",
      "section": "Nutrition Prescription",
      "line": 5684,
      "preview": "- $\\mathrm{FiO}_{2}$ greater than 0.60"
    },
    {
      "type": "text",
      "section": "Nutrition Prescription",
      "line": 5685,
      "preview": "- Presence of air leak (eg, pneumothorax, uncuffed endotracheal tube or tracheotomy, inability to ca"
    },
    {
      "type": "text",
      "section": "Nutrition Prescription",
      "line": 5686,
      "preview": "- Levels of positive end-expiratory pressure; greater than 10 cm of water"
    },
    {
      "type": "text",
      "section": "Nutrition Prescription",
      "line": 5687,
      "preview": "- Changing dynamics of clinical status"
    },
    {
      "type": "text",
      "section": "Nutrition Prescription",
      "line": 5689,
      "preview": "Considerations for IC use are as follows:"
    },
    {
      "type": "text",
      "section": "Nutrition Prescription",
      "line": 5691,
      "preview": "- Cost of equipment"
    },
    {
      "type": "text",
      "section": "Nutrition Prescription",
      "line": 5692,
      "preview": "- Need for trained operators"
    },
    {
      "type": "text",
      "section": "Nutrition Prescription",
      "line": 5693,
      "preview": "- Accurate interpretation of serial measurements"
    },
    {
      "type": "text",
      "section": "Nutrition Prescription",
      "line": 5694,
      "preview": "- Alignment of output with clinical status of the patient"
    },
    {
      "type": "text",
      "section": "Nutrition Prescription",
      "line": 5695,
      "preview": "- Knowledge regarding application of these measurements for appropriate decisionmaking to modify nut"
    },
    {
      "type": "text",
      "section": "Nutrition Prescription",
      "line": 5697,
      "preview": "Current nutrition intake guidelines recommend use of the Schofield equations ${ }^{20}$ or $\\mathrm{"
    },
    {
      "type": "text",
      "section": "Nutrition Prescription",
      "line": 5699,
      "preview": "Current ASPEN/Society of Critical Care Medicine (SCCM) guidelines recommend a minimum of $1.5 \\mathr"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "Nutrition Delivery",
      "line": 5701
    },
    {
      "type": "text",
      "section": "Nutrition Delivery",
      "line": 5703,
      "preview": "EN is the preferred delivery method, because it is physiologically most appropriate based on clinica"
    },
    {
      "type": "text",
      "section": "Nutrition Delivery",
      "line": 5705,
      "preview": "--- page 288 ---"
    },
    {
      "type": "text",
      "section": "Nutrition Delivery",
      "line": 5707,
      "preview": "enterally delivered feeds but may be affected by other factors including risk of gastric reflux and "
    },
    {
      "type": "text",
      "section": "Nutrition Delivery",
      "line": 5709,
      "preview": "Findings from a recent study of mechanically ventilated critically ill children suggest that intermi"
    },
    {
      "type": "text",
      "section": "Nutrition Delivery",
      "line": 5711,
      "preview": "Postpyloric/transpyloric feedings may be more appropriate when there is evidence of delayed gastric "
    },
    {
      "type": "text",
      "section": "Nutrition Delivery",
      "line": 5713,
      "preview": "Postpyloric/transpyloric feeds must be administered continuously because the duodenum and jejunum ar"
    },
    {
      "type": "text",
      "section": "Nutrition Delivery",
      "line": 5715,
      "preview": "Monitoring tolerance of EN is vital for a successful approach to using EN in critical illness. No sp"
    },
    {
      "type": "text",
      "section": "Nutrition Delivery",
      "line": 5717,
      "preview": "--- page 289 ---"
    },
    {
      "type": "text",
      "section": "Nutrition Delivery",
      "line": 5719,
      "preview": "intolerance. Symptoms of EN intolerance requiring investigation and resolution are listed in Table 1"
    },
    {
      "type": "text",
      "section": "Nutrition Delivery",
      "line": 5721,
      "preview": "- Emesis"
    },
    {
      "type": "text",
      "section": "Nutrition Delivery",
      "line": 5722,
      "preview": "- Abdominal distension and pain"
    },
    {
      "type": "text",
      "section": "Nutrition Delivery",
      "line": 5723,
      "preview": "- High gastric residual volumes"
    },
    {
      "type": "text",
      "section": "Nutrition Delivery",
      "line": 5724,
      "preview": "- Diarrhea/constipation"
    },
    {
      "type": "text",
      "section": "Nutrition Delivery",
      "line": 5726,
      "preview": "--- page 290 ---"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "TABLE 11-2. Approach to Feeding Intolerance",
      "line": 5728
    },
    {
      "type": "table",
      "section": "TABLE 11-2. Approach to Feeding Intolerance",
      "line": 5730,
      "preview": "| Symptom | Definition/Signs | Considerations/Interventions |"
    },
    {
      "type": "table",
      "section": "TABLE 11-2. Approach to Feeding Intolerance",
      "line": 5731,
      "preview": "| :--: | :--: | :--: |"
    },
    {
      "type": "table",
      "section": "TABLE 11-2. Approach to Feeding Intolerance",
      "line": 5732,
      "preview": "| Emesis | - Forceful ejection of stomach contents <br> - May initially be seen as \"spitting up\" or "
    },
    {
      "type": "table",
      "section": "TABLE 11-2. Approach to Feeding Intolerance",
      "line": 5733,
      "preview": "| Abdominal distension | Elevated abdominal girth from known baseline by itself does not constitute "
    },
    {
      "type": "text",
      "section": "TABLE 11-2. Approach to Feeding Intolerance",
      "line": 5735,
      "preview": "--- page 291 ---"
    },
    {
      "type": "table",
      "section": "TABLE 11-2. Approach to Feeding Intolerance",
      "line": 5737,
      "preview": "| Symptom | Definition/Signs | Considerations/Interventions |"
    },
    {
      "type": "table",
      "section": "TABLE 11-2. Approach to Feeding Intolerance",
      "line": 5738,
      "preview": "| :--: | :--: | :--: |"
    },
    {
      "type": "table",
      "section": "TABLE 11-2. Approach to Feeding Intolerance",
      "line": 5739,
      "preview": "| Abdominal pain | - Inconsolable irritability that coincides with feeds <br> - Irritability with ab"
    },
    {
      "type": "table",
      "section": "TABLE 11-2. Approach to Feeding Intolerance",
      "line": 5740,
      "preview": "| Diarrhea | - Loose watery stools $>5$ times in 24 h OR $\\geq 30 \\mathrm{~mL} / \\mathrm{kg} / \\math"
    },
    {
      "type": "text",
      "section": "TABLE 11-2. Approach to Feeding Intolerance",
      "line": 5742,
      "preview": "--- page 292 ---"
    },
    {
      "type": "table",
      "section": "TABLE 11-2. Approach to Feeding Intolerance",
      "line": 5744,
      "preview": "| Symptom | Definition/Signs | Considerations/Interventions |"
    },
    {
      "type": "table",
      "section": "TABLE 11-2. Approach to Feeding Intolerance",
      "line": 5745,
      "preview": "| :-- | :-- | :-- |"
    },
    {
      "type": "table",
      "section": "TABLE 11-2. Approach to Feeding Intolerance",
      "line": 5746,
      "preview": "| Constipation | - Delay or difficulty in passing stool <br> present for $>48 \\mathrm{~h}$, sufficie"
    },
    {
      "type": "text",
      "section": "TABLE 11-2. Approach to Feeding Intolerance",
      "line": 5748,
      "preview": "Data from Irving SY, Srinivasan V, Mascarenhas M, et al. PICU/PCU clinical pathway for initiation an"
    },
    {
      "type": "text",
      "section": "TABLE 11-2. Approach to Feeding Intolerance",
      "line": 5750,
      "preview": "Use of a systematized feeding algorithm/guideline/pathway can help facilitate an organized approach "
    },
    {
      "type": "text",
      "section": "TABLE 11-2. Approach to Feeding Intolerance",
      "line": 5752,
      "preview": "- Example of feeding guideline focused on provision of $\\mathrm{EN}^{27}$ :"
    },
    {
      "type": "text",
      "section": "TABLE 11-2. Approach to Feeding Intolerance",
      "line": 5753,
      "preview": "https://www.chop.edu/clinical-pathway/nutrition-picu-pcu-initiation-and-advancement-clinical-pathway"
    },
    {
      "type": "text",
      "section": "TABLE 11-2. Approach to Feeding Intolerance",
      "line": 5755,
      "preview": "Parenteral nutrition (PN) is not recommended as the major source of nutrient intake in the initial 2"
    },
    {
      "type": "text",
      "section": "TABLE 11-2. Approach to Feeding Intolerance",
      "line": 5757,
      "preview": "- EN is contraindicated (eg, abdominal operation, trauma)."
    },
    {
      "type": "text",
      "section": "TABLE 11-2. Approach to Feeding Intolerance",
      "line": 5758,
      "preview": "- Anticipated delay for initiation of EN beyond 3-5 days."
    },
    {
      "type": "text",
      "section": "TABLE 11-2. Approach to Feeding Intolerance",
      "line": 5759,
      "preview": "- Supplementation of EN with PN is necessary to meet all metabolic needs."
    },
    {
      "type": "text",
      "section": "TABLE 11-2. Approach to Feeding Intolerance",
      "line": 5760,
      "preview": "- Timing and route of PN initiation depends on the patient's clinical status:"
    },
    {
      "type": "text",
      "section": "TABLE 11-2. Approach to Feeding Intolerance",
      "line": 5761,
      "preview": "- Consider at day 3 if moderate to severe malnutrition is present."
    },
    {
      "type": "text",
      "section": "TABLE 11-2. Approach to Feeding Intolerance",
      "line": 5762,
      "preview": "- Consider at day $4-5$ for patients in whom enteral feeds are unable to advance to meet minimum nut"
    },
    {
      "type": "text",
      "section": "TABLE 11-2. Approach to Feeding Intolerance",
      "line": 5764,
      "preview": "--- page 293 ---"
    },
    {
      "type": "text",
      "section": "TABLE 11-2. Approach to Feeding Intolerance",
      "line": 5766,
      "preview": "- Recommend PN via a central venous catheter to optimize nutrition composition in solution. ${ }^{27"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "Special Considerations",
      "line": 5769
    },
    {
      "type": "heading",
      "level": 2,
      "section": "Postsurgical Nutrition",
      "line": 5771
    },
    {
      "type": "text",
      "section": "Postsurgical Nutrition",
      "line": 5773,
      "preview": "Poor nutrition status is associated with suboptimal postsurgical outcomes. ${ }^{25,31}$ Surgical in"
    },
    {
      "type": "text",
      "section": "Postsurgical Nutrition",
      "line": 5775,
      "preview": "- Preoperative oral or enteral feeds for as long as possible"
    },
    {
      "type": "text",
      "section": "Postsurgical Nutrition",
      "line": 5776,
      "preview": "- Intraoperative modified use of opiates and increased use of regional anesthesia to promote the ear"
    },
    {
      "type": "text",
      "section": "Postsurgical Nutrition",
      "line": 5777,
      "preview": "- Postoperative early reintroduction of oral or enteral feeds to mitigate catabolism following surge"
    },
    {
      "type": "text",
      "section": "Postsurgical Nutrition",
      "line": 5778,
      "preview": "- Use of a bowel regimen as appropriate"
    },
    {
      "type": "heading",
      "level": 2,
      "section": "Burns",
      "line": 5781
    },
    {
      "type": "text",
      "section": "Burns",
      "line": 5783,
      "preview": "Thermal injuries are characterized by hypermetabolic and hypercatabolic states associated with drama"
    },
    {
      "type": "text",
      "section": "Burns",
      "line": 5785,
      "preview": "--- page 294 ---"
    },
    {
      "type": "text",
      "section": "Burns",
      "line": 5787,
      "preview": "should be used if EN is not tolerated or is inadequate to meet energy and protein needs."
    },
    {
      "type": "text",
      "section": "Burns",
      "line": 5789,
      "preview": "Hyperglycemia is common and may require administration of insulin infusions to maintain an optimal s"
    },
    {
      "type": "text",
      "section": "Burns",
      "line": 5791,
      "preview": "- Vitamin A: 5000-10,000 U daily"
    },
    {
      "type": "text",
      "section": "Burns",
      "line": 5792,
      "preview": "- Vitamin C: $250-500 \\mathrm{mg}$ twice daily"
    },
    {
      "type": "text",
      "section": "Burns",
      "line": 5793,
      "preview": "- Zinc: $100-220 \\mathrm{mg}$ daily"
    },
    {
      "type": "text",
      "section": "Burns",
      "line": 5794,
      "preview": "- Multivitamin supplementation"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "TABLE 11-3. Nutrition Considerations for Children With Burn Injuries",
      "line": 5797
    },
    {
      "type": "table",
      "section": "TABLE 11-3. Nutrition Considerations for Children With Burn Injuries",
      "line": 5799,
      "preview": "|  | Age <br> Group | Maintenance <br> Energy Needs <br> (kcal/kg/d) | Burn-Related Additional Energ"
    },
    {
      "type": "table",
      "section": "TABLE 11-3. Nutrition Considerations for Children With Burn Injuries",
      "line": 5800,
      "preview": "| :-- | :--: | :--: | :--: |"
    },
    {
      "type": "table",
      "section": "TABLE 11-3. Nutrition Considerations for Children With Burn Injuries",
      "line": 5801,
      "preview": "| Infants | $0-1 y$ | $98-108$ | $+15 \\times$ TBSA |"
    },
    {
      "type": "table",
      "section": "TABLE 11-3. Nutrition Considerations for Children With Burn Injuries",
      "line": 5802,
      "preview": "| Children | $1-3 y$ | 102 | $+25 \\times$ TBSA |"
    },
    {
      "type": "table",
      "section": "TABLE 11-3. Nutrition Considerations for Children With Burn Injuries",
      "line": 5803,
      "preview": "|  | $4-6 y$ | 90 | $+40 \\times$ TBSA |"
    },
    {
      "type": "table",
      "section": "TABLE 11-3. Nutrition Considerations for Children With Burn Injuries",
      "line": 5804,
      "preview": "|  | $7-10 y$ | 70 | $+40 \\times$ TBSA |"
    },
    {
      "type": "table",
      "section": "TABLE 11-3. Nutrition Considerations for Children With Burn Injuries",
      "line": 5805,
      "preview": "| Adolescents | $11-14$ | $47-55$ | $+40 \\times$ TBSA |"
    },
    {
      "type": "table",
      "section": "TABLE 11-3. Nutrition Considerations for Children With Burn Injuries",
      "line": 5806,
      "preview": "|  | $y$ | $40-45$ | $+40 \\times$ TBSA |"
    },
    {
      "type": "table",
      "section": "TABLE 11-3. Nutrition Considerations for Children With Burn Injuries",
      "line": 5807,
      "preview": "|  | $15-18$ |  |  |"
    },
    {
      "type": "text",
      "section": "TABLE 11-3. Nutrition Considerations for Children With Burn Injuries",
      "line": 5809,
      "preview": "Abbreviation: TBSA, total burn surface area."
    },
    {
      "type": "text",
      "section": "TABLE 11-3. Nutrition Considerations for Children With Burn Injuries",
      "line": 5810,
      "preview": "Data from Chan MM, Chan GM. Nutritional therapy for burns in children and adults. Nutrition. 2009 Ma"
    },
    {
      "type": "text",
      "section": "TABLE 11-3. Nutrition Considerations for Children With Burn Injuries",
      "line": 5812,
      "preview": "In situations with resistant hypercatabolism, pharmacologic adjuncts such as recombinant growth horm"
    },
    {
      "type": "heading",
      "level": 2,
      "section": "Extracorporeal Life Support",
      "line": 5814
    },
    {
      "type": "text",
      "section": "Extracorporeal Life Support",
      "line": 5816,
      "preview": "--- page 295 ---"
    },
    {
      "type": "text",
      "section": "Extracorporeal Life Support",
      "line": 5818,
      "preview": "Children supported with extracorporeal life support and extracorporeal membrane oxygenation (ECMO) e"
    },
    {
      "type": "text",
      "section": "Extracorporeal Life Support",
      "line": 5820,
      "preview": "Measurement of TEE is challenging because IC cannot be easily used with ECMO. Predictive energy equa"
    },
    {
      "type": "text",
      "section": "Extracorporeal Life Support",
      "line": 5822,
      "preview": "The impact of ECMO on micronutrients is unclear. Circuit losses of essential amino acids (EAAs), suc"
    },
    {
      "type": "text",
      "section": "Extracorporeal Life Support",
      "line": 5824,
      "preview": "- challenges with device insertion for delivery of EN,"
    },
    {
      "type": "text",
      "section": "Extracorporeal Life Support",
      "line": 5825,
      "preview": "- contraindications such as ongoing resuscitation,"
    },
    {
      "type": "text",
      "section": "Extracorporeal Life Support",
      "line": 5826,
      "preview": "- severe hemorrhage with suspected or proven GI ischemia, and"
    },
    {
      "type": "text",
      "section": "Extracorporeal Life Support",
      "line": 5827,
      "preview": "- feeding intolerance."
    },
    {
      "type": "text",
      "section": "Extracorporeal Life Support",
      "line": 5829,
      "preview": "The use of a center- or facility-specific feeding/nutrition guideline in consultation with the RD is"
    },
    {
      "type": "text",
      "section": "Extracorporeal Life Support",
      "line": 5831,
      "preview": "--- page 296 ---"
    },
    {
      "type": "text",
      "section": "Extracorporeal Life Support",
      "line": 5833,
      "preview": "guidelines and provide recommendations to closely follow these patients, including the use of altern"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "Nutrition Therapy for Pressure Injury and Wound Management",
      "line": 5835
    },
    {
      "type": "text",
      "section": "Nutrition Therapy for Pressure Injury and Wound Management",
      "line": 5837,
      "preview": "Macro- and micronutrient intake is necessary to maintain skin integrity to protect against foreign m"
    },
    {
      "type": "text",
      "section": "Nutrition Therapy for Pressure Injury and Wound Management",
      "line": 5839,
      "preview": "PIs are staged according to severity, with a scale of 1-4, with 4 being the most severe and having t"
    },
    {
      "type": "text",
      "section": "Nutrition Therapy for Pressure Injury and Wound Management",
      "line": 5841,
      "preview": "- Often over a bony prominence"
    },
    {
      "type": "text",
      "section": "Nutrition Therapy for Pressure Injury and Wound Management",
      "line": 5842,
      "preview": "- May be related to medical or other necessary devices"
    },
    {
      "type": "text",
      "section": "Nutrition Therapy for Pressure Injury and Wound Management",
      "line": 5844,
      "preview": "Malnourished children-both underweight and overweight or with obesity-are at increased risk of PI, p"
    },
    {
      "type": "text",
      "section": "Nutrition Therapy for Pressure Injury and Wound Management",
      "line": 5846,
      "preview": "Comorbidities affecting protein metabolism and use such as acute kidney injury and other organ dysfu"
    },
    {
      "type": "text",
      "section": "Nutrition Therapy for Pressure Injury and Wound Management",
      "line": 5848,
      "preview": "--- page 297 ---"
    },
    {
      "type": "text",
      "section": "Nutrition Therapy for Pressure Injury and Wound Management",
      "line": 5850,
      "preview": "Micronutrients for management of PI and wounds ${ }^{36}$ (Table 11-4) include the following:"
    },
    {
      "type": "text",
      "section": "Nutrition Therapy for Pressure Injury and Wound Management",
      "line": 5852,
      "preview": "- Zinc-a mineral: Vital role in wound healing, cell division, immune function, and synthesis of DNA "
    },
    {
      "type": "text",
      "section": "Nutrition Therapy for Pressure Injury and Wound Management",
      "line": 5853,
      "preview": "- Vitamin C-an antioxidant: Key role in fatty acid transport, collagen synthesis, neurotransmitter s"
    },
    {
      "type": "text",
      "section": "Nutrition Therapy for Pressure Injury and Wound Management",
      "line": 5854,
      "preview": "- Vitamin A-an antioxidant: Role in collagen synthesis, gene transcription, and cell and tissue diff"
    },
    {
      "type": "text",
      "section": "Nutrition Therapy for Pressure Injury and Wound Management",
      "line": 5855,
      "preview": "- Iron-a mineral: Essential for skin health; necessary for collagen synthesis, red blood cell produc"
    },
    {
      "type": "text",
      "section": "Nutrition Therapy for Pressure Injury and Wound Management",
      "line": 5856,
      "preview": "- Arginine-EAA: Role in collagen synthesis and immune modulation that may contribute to wound healin"
    },
    {
      "type": "text",
      "section": "Nutrition Therapy for Pressure Injury and Wound Management",
      "line": 5858,
      "preview": "--- page 298 ---"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "TABLE 11-4. Vitamin and Mineral Supplementation and Laboratory Monitoring Recommendations for Pediatric Patients With Pressure Injuries",
      "line": 5860
    },
    {
      "type": "table",
      "section": "TABLE 11-4. Vitamin and Mineral Supplementation and Laboratory Monitoring Recommendations for Pediatric Patients With Pressure Injuries",
      "line": 5862,
      "preview": "| Nutrient | Initial <br> Dose | Route | Wound <br> Assessment | Laboratory <br> Monitoring | Labora"
    },
    {
      "type": "table",
      "section": "TABLE 11-4. Vitamin and Mineral Supplementation and Laboratory Monitoring Recommendations for Pediatric Patients With Pressure Injuries",
      "line": 5863,
      "preview": "| :--: | :--: | :--: | :--: | :--: | :--: | :--: | :--: | :--: |"
    },
    {
      "type": "table",
      "section": "TABLE 11-4. Vitamin and Mineral Supplementation and Laboratory Monitoring Recommendations for Pediatric Patients With Pressure Injuries",
      "line": 5864,
      "preview": "| Vitamin C | $\\begin{aligned} & 62.5- \\\\ & 100 \\mathrm{mg} \\\\ & \\text { daily } \\end{aligned}$ | En"
    },
    {
      "type": "table",
      "section": "TABLE 11-4. Vitamin and Mineral Supplementation and Laboratory Monitoring Recommendations for Pediatric Patients With Pressure Injuries",
      "line": 5865,
      "preview": "|  |  |  | Stable or not healing | Check at time of initiation, then every 4 wk | Sufficient or elev"
    },
    {
      "type": "table",
      "section": "TABLE 11-4. Vitamin and Mineral Supplementation and Laboratory Monitoring Recommendations for Pediatric Patients With Pressure Injuries",
      "line": 5866,
      "preview": "|  |  |  |  |  | Deficient | Increase dose by $50 \\%$ |  |  |"
    },
    {
      "type": "table",
      "section": "TABLE 11-4. Vitamin and Mineral Supplementation and Laboratory Monitoring Recommendations for Pediatric Patients With Pressure Injuries",
      "line": 5867,
      "preview": "| Zinc | $1 \\mathrm{mg} / \\mathrm{kg}$ | Enteral or IV | Improved | NA | NA | Discontinue supplement"
    },
    {
      "type": "table",
      "section": "TABLE 11-4. Vitamin and Mineral Supplementation and Laboratory Monitoring Recommendations for Pediatric Patients With Pressure Injuries",
      "line": 5868,
      "preview": "|  |  |  | Stable or not healing | Check at time of initiation, then every 4 wk | Sufficient or elev"
    },
    {
      "type": "table",
      "section": "TABLE 11-4. Vitamin and Mineral Supplementation and Laboratory Monitoring Recommendations for Pediatric Patients With Pressure Injuries",
      "line": 5869,
      "preview": "|  |  |  |  |  | Deficient | Continue supplement and consider increasing the dose if able |  |  |"
    },
    {
      "type": "table",
      "section": "TABLE 11-4. Vitamin and Mineral Supplementation and Laboratory Monitoring Recommendations for Pediatric Patients With Pressure Injuries",
      "line": 5870,
      "preview": "| Vitamin <br> A | NA | NA | Not healing | Check level | Deficient | Increase total vitamin A dose b"
    },
    {
      "type": "table",
      "section": "TABLE 11-4. Vitamin and Mineral Supplementation and Laboratory Monitoring Recommendations for Pediatric Patients With Pressure Injuries",
      "line": 5871,
      "preview": "| Arginine | NA | NA | Not healing | NA | NA | Consider using arginine-based enteral formula or oral"
    },
    {
      "type": "table",
      "section": "TABLE 11-4. Vitamin and Mineral Supplementation and Laboratory Monitoring Recommendations for Pediatric Patients With Pressure Injuries",
      "line": 5872,
      "preview": "| Iron | NA | NA | Not healing | Check iron panel and ferritin | Deficient | Start enteral iron supp"
    },
    {
      "type": "text",
      "section": "TABLE 11-4. Vitamin and Mineral Supplementation and Laboratory Monitoring Recommendations for Pediatric Patients With Pressure Injuries",
      "line": 5874,
      "preview": "Abbreviations: IV, intravenous; NA, not applicable."
    },
    {
      "type": "heading",
      "level": 2,
      "section": "References",
      "line": 5876
    },
    {
      "type": "text",
      "section": "References",
      "line": 5878,
      "preview": "1. Nates JL, Nunnally M, Kleinpell R, et al. ICU admission, discharge, and triage guidelines: a fram"
    },
    {
      "type": "text",
      "section": "References",
      "line": 5880,
      "preview": "--- page 299 ---"
    },
    {
      "type": "text",
      "section": "References",
      "line": 5882,
      "preview": "further research. Crit Care Med. 2016;44(8):1553-1602. https://doi.org/10.1097/CCM. 0000000000001856"
    },
    {
      "type": "text",
      "section": "References",
      "line": 5883,
      "preview": "2. Lambell KJ, Tatucu-Babet OA, Chapple LA, Gantner D, Ridley EJ. Nutrition therapy in critical illn"
    },
    {
      "type": "text",
      "section": "References",
      "line": 5884,
      "preview": "3. Irving S, McKeever L, Srinivasan V, et al. Nutrition support in critically ill adults and childre"
    },
    {
      "type": "text",
      "section": "References",
      "line": 5885,
      "preview": "4. Mehta NM, Skillman HE, Irving SY, et al. Guidelines for the provision and assessment of nutrition"
    },
    {
      "type": "text",
      "section": "References",
      "line": 5886,
      "preview": "5. Bechard LJ, Duggan C, Touger-Decker R, et al. Nutritional status based on body mass index is asso"
    },
    {
      "type": "text",
      "section": "References",
      "line": 5887,
      "preview": "6. Ayalon I, Woo JG, Basu RK, Kaddourah A, Goldstein SL, Kaplan JM; AWARE Investigators. Weight as a"
    },
    {
      "type": "text",
      "section": "References",
      "line": 5888,
      "preview": "7. Irving SY, Daly B, Verger J, et al. The association of nutrition status expressed as body mass in"
    },
    {
      "type": "text",
      "section": "References",
      "line": 5889,
      "preview": "8. Srinivasan V, Hasbani NR, Mehta NM, et al. Early enteral nutrition is associated with improved cl"
    },
    {
      "type": "text",
      "section": "References",
      "line": 5890,
      "preview": "9. Mikhailov TA, Kuhn EM, Manzi J, et al. Early enteral nutrition is associated with lower mortality"
    },
    {
      "type": "text",
      "section": "References",
      "line": 5891,
      "preview": "10. Haney A, Burritt E, Babbitt CJ. The impact of early enteral nutrition on pediatric acute respira"
    },
    {
      "type": "text",
      "section": "References",
      "line": 5892,
      "preview": "11. Mehta NM, Bechard LJ, Cahill N, et al. Nutritional practices and their relationship to clinical "
    },
    {
      "type": "text",
      "section": "References",
      "line": 5893,
      "preview": "12. Wakeham M, Christensen M, Manzi J, et al. Registered dietitians making a difference: early medic"
    },
    {
      "type": "text",
      "section": "References",
      "line": 5894,
      "preview": "13. Teixeira AF, Viana KD. Nutritional screening in hospitalized pediatric patients: a systematic re"
    },
    {
      "type": "text",
      "section": "References",
      "line": 5895,
      "preview": "14. Becker P, Carney LN, Corkins MR, et al. Consensus statement of the Academy of Nutrition and Diet"
    },
    {
      "type": "text",
      "section": "References",
      "line": 5897,
      "preview": "--- page 300 ---"
    },
    {
      "type": "text",
      "section": "References",
      "line": 5899,
      "preview": "recommended for the identification and documentation of pediatric malnutrition (undernutrition). Nut"
    },
    {
      "type": "text",
      "section": "References",
      "line": 5900,
      "preview": "15. Mehta NM, Corkins MR, Lyman B, et al. Defining pediatric malnutrition: a paradigm shift toward e"
    },
    {
      "type": "text",
      "section": "References",
      "line": 5901,
      "preview": "16. Moreno YMF, Ventura JC, Oliveira LDdA, Silveira TT, Hauschild DB. Undernutrition in critically i"
    },
    {
      "type": "text",
      "section": "References",
      "line": 5902,
      "preview": "17. Stephens K, Orlick M, Beattie S, et al. Examining mid-upper arm circumference malnutrition $z$-s"
    },
    {
      "type": "text",
      "section": "References",
      "line": 5903,
      "preview": "18. Evans DC, Corkins MR, Malone A, et al; ASPEN Malnutrition Committee. The use of visceral protein"
    },
    {
      "type": "text",
      "section": "References",
      "line": 5904,
      "preview": "19. Silva-Gburek J, Zhu PH, Mansour M, Walding D, Coss-Bu JA. A methodological and clinical approach"
    },
    {
      "type": "text",
      "section": "References",
      "line": 5905,
      "preview": "20. Schofield WN. Predicting basal metabolic rate, new standards and review of previous work. Hum Nu"
    },
    {
      "type": "text",
      "section": "References",
      "line": 5906,
      "preview": "21. World Health Organization. Energy and Protein Requirements. Report of a Joint FAO/WHO/UNU Expert"
    },
    {
      "type": "text",
      "section": "References",
      "line": 5907,
      "preview": "22. Tume LN, Valla FV, Joosten K, et al. Nutritional support for children during critical illness: E"
    },
    {
      "type": "text",
      "section": "References",
      "line": 5908,
      "preview": "23. Mehta NM, Compher C; A.S.P.E.N. Board of Directors. A.S.P.E.N. Clinical Guidelines: nutrition su"
    },
    {
      "type": "text",
      "section": "References",
      "line": 5909,
      "preview": "24. Brown AM, Irving SY, Pringle C, et al; NutriNet and Pediatric Acute Lung Injury and Sepsis Inves"
    },
    {
      "type": "text",
      "section": "References",
      "line": 5910,
      "preview": "25. Irving SY, Albert BA, Mehta NM, Srinivasan V. Strategies to optimize enteral feeding and nutriti"
    },
    {
      "type": "text",
      "section": "References",
      "line": 5911,
      "preview": "26. Panchal AK, Manzi J, Connolly S, et al. Safety of enteral feedings in critically ill children re"
    },
    {
      "type": "text",
      "section": "References",
      "line": 5912,
      "preview": "27. Irving SY, Srinivasan V, Mascarenhas M, et al. PICU/PCU clinical pathway for initiation and adva"
    },
    {
      "type": "text",
      "section": "References",
      "line": 5913,
      "preview": "28. Martinez EE, Bechard LJ, Mehta NM. Nutrition algorithms and bedside nutrient delivery practices "
    },
    {
      "type": "text",
      "section": "References",
      "line": 5915,
      "preview": "--- page 301 ---"
    },
    {
      "type": "text",
      "section": "References",
      "line": 5917,
      "preview": "29. Brown A-M, Forbes ML, Vitale VS, Tirodker UH, Zeller R. Effects of a gastric feeding protocol on"
    },
    {
      "type": "text",
      "section": "References",
      "line": 5918,
      "preview": "30. Hamilton S, McAleer DM, Ariagno K, et al. A stepwise enteral nutrition algorithm for critically "
    },
    {
      "type": "text",
      "section": "References",
      "line": 5919,
      "preview": "31. Martins DS, Piper HG. Nutrition considerations in pediatric surgical patients. Nutr Clin Pract. "
    },
    {
      "type": "text",
      "section": "References",
      "line": 5920,
      "preview": "32. Chan MM, Chan GM. Nutritional therapy for burns in children and adults. Nutrition. 2009;25(3):26"
    },
    {
      "type": "text",
      "section": "References",
      "line": 5921,
      "preview": "33. Gonzalez R, Shanti CM. Overview of current pediatric burn care. Semin Pediatr Surg. 2015;24(1):4"
    },
    {
      "type": "text",
      "section": "References",
      "line": 5922,
      "preview": "34. Li J, Zhang G, Herridge J, et al. Energy expenditure and caloric and protein intake in infants f"
    },
    {
      "type": "text",
      "section": "References",
      "line": 5923,
      "preview": "35. Toh TSW, Ong C, Mok YH, Mallory P, Cheifetz IM, Lee JH. Nutrition in pediatric extracorporeal me"
    },
    {
      "type": "text",
      "section": "References",
      "line": 5924,
      "preview": "36. Berry KG, Seiple SM, Stellar JJ, et al. A scoping review to inform a multi-disciplinary approach"
    },
    {
      "type": "text",
      "section": "References",
      "line": 5925,
      "preview": "37. Visscher M, King A, Nie AM, et al. A quality-improvement collaborative project to reduce pressur"
    },
    {
      "type": "text",
      "section": "References",
      "line": 5926,
      "preview": "38. Becker PJ, Nieman Carney L, Corkins MR, et al. Consensus statement of the Academy of Nutrition a"
    },
    {
      "type": "text",
      "section": "References",
      "line": 5928,
      "preview": "--- page 302 ---"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "12",
      "line": 5930
    },
    {
      "type": "heading",
      "level": 2,
      "section": "Cystic Fibrosis",
      "line": 5932
    },
    {
      "type": "text",
      "section": "Cystic Fibrosis",
      "line": 5934,
      "preview": "Anam Bashir, MD<br>Praveen S. Goday, MBBS"
    },
    {
      "type": "heading",
      "level": 2,
      "section": "Introduction",
      "line": 5936
    },
    {
      "type": "text",
      "section": "Introduction",
      "line": 5938,
      "preview": "Cystic fibrosis (CF) is a multisystem genetic disease caused by mutations in the CF transmembrane co"
    },
    {
      "type": "text",
      "section": "Introduction",
      "line": 5940,
      "preview": "Patients with a CF diagnosis are at risk of malnutrition secondary to increased metabolic demand, pa"
    },
    {
      "type": "heading",
      "level": 2,
      "section": "Assessment and Nutrient Requirements",
      "line": 5942
    },
    {
      "type": "text",
      "section": "Assessment and Nutrient Requirements",
      "line": 5944,
      "preview": "--- page 303 ---"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "Frequency of Assessments",
      "line": 5946
    },
    {
      "type": "text",
      "section": "Frequency of Assessments",
      "line": 5948,
      "preview": "Infants should be assessed monthly until they are 1 year of age and then every 3 months. Children ca"
    },
    {
      "type": "heading",
      "level": 2,
      "section": "History, Physical Examination, and Assessment",
      "line": 5950
    },
    {
      "type": "text",
      "section": "History, Physical Examination, and Assessment",
      "line": 5952,
      "preview": "A careful history review, examination, and evaluation are critical for all patients with cystic fibr"
    },
    {
      "type": "text",
      "section": "History, Physical Examination, and Assessment",
      "line": 5954,
      "preview": "- History: 24-hour dietary recall, assessment of appetite, feeding problems (picky eating, family me"
    },
    {
      "type": "text",
      "section": "History, Physical Examination, and Assessment",
      "line": 5955,
      "preview": "- Nutrition-focused physical exam"
    },
    {
      "type": "text",
      "section": "History, Physical Examination, and Assessment",
      "line": 5956,
      "preview": "- Anthropometric assessment: Weight for age, head circumference (up to 2 years of age) length/height"
    },
    {
      "type": "text",
      "section": "History, Physical Examination, and Assessment",
      "line": 5957,
      "preview": "- Laboratory and imaging: Annual assessment of fecal elastase ${ }^{1}$; bone mineral density examin"
    },
    {
      "type": "heading",
      "level": 2,
      "section": "Goals",
      "line": 5960
    },
    {
      "type": "text",
      "section": "Goals",
      "line": 5962,
      "preview": "The Cystic Fibrosis Foundation recommends weight for length higher than the 75 th percentile for age"
    },
    {
      "type": "heading",
      "level": 2,
      "section": "Implementation of Nutrition Plan and Monitoring",
      "line": 5964
    },
    {
      "type": "heading",
      "level": 2,
      "section": "Nutrition",
      "line": 5966
    },
    {
      "type": "text",
      "section": "Nutrition",
      "line": 5968,
      "preview": "Traditionally, a well-balanced, high-energy, high-protein, high-fat diet has been encouraged in pati"
    },
    {
      "type": "text",
      "section": "Nutrition",
      "line": 5970,
      "preview": "--- page 304 ---"
    },
    {
      "type": "text",
      "section": "Nutrition",
      "line": 5972,
      "preview": "expenditure. Thus, patient will need an individualized plan to meet their nutrition needs. ${ }^{3}$"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "Increasing Energy Provision",
      "line": 5974
    },
    {
      "type": "text",
      "section": "Increasing Energy Provision",
      "line": 5976,
      "preview": "Increasing fat additives, frequency of meals and snacks, and increasing calories in general through "
    },
    {
      "type": "heading",
      "level": 2,
      "section": "Essential Fatty Acids",
      "line": 5978
    },
    {
      "type": "text",
      "section": "Essential Fatty Acids",
      "line": 5980,
      "preview": "Foods high in linolenic acid and monounsaturated and polyunsaturated fats should be encouraged. Chil"
    },
    {
      "type": "heading",
      "level": 2,
      "section": "Sodium Supplementation",
      "line": 5982
    },
    {
      "type": "text",
      "section": "Sodium Supplementation",
      "line": 5984,
      "preview": "--- page 305 ---"
    },
    {
      "type": "text",
      "section": "Sodium Supplementation",
      "line": 5986,
      "preview": "Salt supplementation is recommended because of high sodium losses. Infants should be supplemented wi"
    },
    {
      "type": "text",
      "section": "Sodium Supplementation",
      "line": 5988,
      "preview": "In warm environments or during exercise, salted sports drinks or adding $1 / 8$ teaspoon to 12 oz of"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "Vitamin Supplementation",
      "line": 5990
    },
    {
      "type": "text",
      "section": "Vitamin Supplementation",
      "line": 5992,
      "preview": "Patients with CF are at risk of fat-soluble vitamin deficiency because of fat malabsorption. Vitamin"
    },
    {
      "type": "text",
      "section": "Vitamin Supplementation",
      "line": 5994,
      "preview": "--- page 306 ---"
    },
    {
      "type": "text",
      "section": "Vitamin Supplementation",
      "line": 5996,
      "preview": "TABLE 12-1. Vitamin Supplementation in Children With Cystic Fibrosis"
    },
    {
      "type": "table",
      "section": "Vitamin Supplementation",
      "line": 5998,
      "preview": "| Vitamin | Intake | Monitoring |"
    },
    {
      "type": "table",
      "section": "Vitamin Supplementation",
      "line": 5999,
      "preview": "| :--: | :--: | :--: |"
    },
    {
      "type": "table",
      "section": "Vitamin Supplementation",
      "line": 6000,
      "preview": "| Vitamin A | - 0-12 mo: <br> 1500 IU <br> - 1-3 y: <br> 5000 IU <br> - 4- <br> 8 y: 5000- <br> 10,0"
    },
    {
      "type": "table",
      "section": "Vitamin Supplementation",
      "line": 6001,
      "preview": "| Vitamin D | - <1 y: 10- <br> $12.5 \\mu \\mathrm{~g}$ <br> - 1-10 y: <br> $20-25 \\mu \\mathrm{~g}$ <b"
    },
    {
      "type": "table",
      "section": "Vitamin Supplementation",
      "line": 6002,
      "preview": "| Vitamin E | - 0-12 mo: <br> 40-50 IU <br> - 1-3 y: 80- <br> 150 IU <br> - 4-8 y: <br> 100-120 <br>"
    },
    {
      "type": "text",
      "section": "Vitamin Supplementation",
      "line": 6004,
      "preview": "--- page 307 ---"
    },
    {
      "type": "table",
      "section": "Vitamin Supplementation",
      "line": 6006,
      "preview": "| Vitamin | Intake | Monitoring |"
    },
    {
      "type": "table",
      "section": "Vitamin Supplementation",
      "line": 6007,
      "preview": "| :-- | :-- | :-- |"
    },
    {
      "type": "table",
      "section": "Vitamin Supplementation",
      "line": 6008,
      "preview": "| Vitamin K | - 0-12 mo: | Annual screening of prothrombin time/INR or PIVKA II if |"
    },
    {
      "type": "table",
      "section": "Vitamin Supplementation",
      "line": 6009,
      "preview": "|  | $0.3-0.5$ | available |"
    },
    {
      "type": "table",
      "section": "Vitamin Supplementation",
      "line": 6010,
      "preview": "|  | mg |  |"
    },
    {
      "type": "table",
      "section": "Vitamin Supplementation",
      "line": 6011,
      "preview": "|  | - 1-3 y: |  |"
    },
    {
      "type": "table",
      "section": "Vitamin Supplementation",
      "line": 6012,
      "preview": "|  | $0.3-0.5$ |  |"
    },
    {
      "type": "table",
      "section": "Vitamin Supplementation",
      "line": 6013,
      "preview": "|  | mg |  |"
    },
    {
      "type": "table",
      "section": "Vitamin Supplementation",
      "line": 6014,
      "preview": "|  | - 4-8 y: |  |"
    },
    {
      "type": "table",
      "section": "Vitamin Supplementation",
      "line": 6015,
      "preview": "|  | $0.3-0.5$ |  |"
    },
    {
      "type": "table",
      "section": "Vitamin Supplementation",
      "line": 6016,
      "preview": "|  | mg |  |"
    },
    {
      "type": "table",
      "section": "Vitamin Supplementation",
      "line": 6017,
      "preview": "|  | - 8 y and |  |"
    },
    {
      "type": "table",
      "section": "Vitamin Supplementation",
      "line": 6018,
      "preview": "|  | older: |  |"
    },
    {
      "type": "table",
      "section": "Vitamin Supplementation",
      "line": 6019,
      "preview": "|  | $0.3-0.5$ |  |"
    },
    {
      "type": "table",
      "section": "Vitamin Supplementation",
      "line": 6020,
      "preview": "|  | mg |  |"
    },
    {
      "type": "text",
      "section": "Vitamin Supplementation",
      "line": 6022,
      "preview": "Abbreviations: INR, international normalized ratio; PIVKA II, proteins induced by vitamin K absence "
    },
    {
      "type": "text",
      "section": "Vitamin Supplementation",
      "line": 6023,
      "preview": "Data from Sankararaman S, Hendrix SJ, Schindler T. Update on the management of vitamins and minerals"
    },
    {
      "type": "text",
      "section": "Vitamin Supplementation",
      "line": 6024,
      "preview": "https://doi.org/10.1002/ncp. 10899"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "Zinc Supplementation",
      "line": 6026
    },
    {
      "type": "text",
      "section": "Zinc Supplementation",
      "line": 6028,
      "preview": "Fat malabsorption can also cause zinc deficiency. The Cystic Fibrosis Foundation recommends zinc sup"
    },
    {
      "type": "heading",
      "level": 2,
      "section": "Pancreatic Enzyme Supplementation",
      "line": 6030
    },
    {
      "type": "text",
      "section": "Pancreatic Enzyme Supplementation",
      "line": 6032,
      "preview": "In cases of severe CF mutations identified by newborn screening, pancreatic enzyme supplements can b"
    },
    {
      "type": "text",
      "section": "Pancreatic Enzyme Supplementation",
      "line": 6034,
      "preview": "Currently, FDA-approved preparations are enteric coated to prevent damage from gastric acid degradat"
    },
    {
      "type": "text",
      "section": "Pancreatic Enzyme Supplementation",
      "line": 6036,
      "preview": "For infants and young children who cannot swallow capsules, capsules can be opened and placed direct"
    },
    {
      "type": "text",
      "section": "Pancreatic Enzyme Supplementation",
      "line": 6038,
      "preview": "--- page 308 ---"
    },
    {
      "type": "text",
      "section": "Pancreatic Enzyme Supplementation",
      "line": 6040,
      "preview": "a small amount of acidic food like apple sauce or prepared baby foods like pears. The food should be"
    },
    {
      "type": "text",
      "section": "Pancreatic Enzyme Supplementation",
      "line": 6042,
      "preview": "Enzyme-containing cartridges like Relizorb or Alcresta contain only pancreatic lipase and are used w"
    },
    {
      "type": "heading",
      "level": 2,
      "section": "**TABLE 12-2. Dosing of Pancreatic Enzymes**",
      "line": 6044
    },
    {
      "type": "table",
      "section": "**TABLE 12-2. Dosing of Pancreatic Enzymes**",
      "line": 6046,
      "preview": "|  Dosing Type | Dose^{a}  |"
    },
    {
      "type": "table",
      "section": "**TABLE 12-2. Dosing of Pancreatic Enzymes**",
      "line": 6047,
      "preview": "| --- | --- |"
    },
    {
      "type": "table",
      "section": "**TABLE 12-2. Dosing of Pancreatic Enzymes**",
      "line": 6048,
      "preview": "|  Weight-based | \u2022 500\u20132500 U of lipase per kilogram of body weight per meal and 250\u20131250 U of lipa"
    },
    {
      "type": "table",
      "section": "**TABLE 12-2. Dosing of Pancreatic Enzymes**",
      "line": 6049,
      "preview": "|   | \u2022 Infants: 2000\u20134000 U of lipase is used per 120 mL of human milk or formula  |"
    },
    {
      "type": "table",
      "section": "**TABLE 12-2. Dosing of Pancreatic Enzymes**",
      "line": 6050,
      "preview": "|  Fat-based | 500\u20134000 U of lipase per gram of fat  |"
    },
    {
      "type": "text",
      "section": "**TABLE 12-2. Dosing of Pancreatic Enzymes**",
      "line": 6052,
      "preview": "^{a} Total daily dose should not exceed more than 2500 U of lipase per kilogram because of the risk "
    },
    {
      "type": "heading",
      "level": 2,
      "section": "**References**",
      "line": 6054
    },
    {
      "type": "text",
      "section": "**References**",
      "line": 6056,
      "preview": "1. Downs EM, Mai JK, Schwarzenberg SJ. Cystic fibrosis and pancreatic disease. In: Goday PS, Walia C"
    },
    {
      "type": "text",
      "section": "**References**",
      "line": 6057,
      "preview": "2. Sullivan JS, Mascarenhas MR. Nutrition: prevention and management of nutritional failure in cysti"
    },
    {
      "type": "text",
      "section": "**References**",
      "line": 6058,
      "preview": "3. Bass R, Brownell JN, Stallings VA. The impact of highly effective CFTR modulators on growth and n"
    },
    {
      "type": "text",
      "section": "**References**",
      "line": 6060,
      "preview": "--- page 309 ---"
    },
    {
      "type": "text",
      "section": "**References**",
      "line": 6062,
      "preview": "4. Borowitz D, Baker RD, Stallings V. Consensus report on nutrition for pediatric patients with cyst"
    },
    {
      "type": "text",
      "section": "**References**",
      "line": 6064,
      "preview": "--- page 310 ---"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "Neurological Impairment and Developmental Disabilities",
      "line": 6066
    },
    {
      "type": "text",
      "section": "Neurological Impairment and Developmental Disabilities",
      "line": 6068,
      "preview": "Gina Rempel, MD, FRCPC, FASPEN"
    },
    {
      "type": "heading",
      "level": 2,
      "section": "Introduction",
      "line": 6070
    },
    {
      "type": "text",
      "section": "Introduction",
      "line": 6072,
      "preview": "Good nutrition is the cornerstone of health and well-being for all children, whether they are typica"
    },
    {
      "type": "text",
      "section": "Introduction",
      "line": 6074,
      "preview": "--- page 311 ---"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "TABLE 13-1. Factors Impacting Nutrition Status and Their Outcomes in Children With NI",
      "line": 6076
    },
    {
      "type": "table",
      "section": "TABLE 13-1. Factors Impacting Nutrition Status and Their Outcomes in Children With NI",
      "line": 6078,
      "preview": "| Good Nutrition Results in | Malnutrition Results in | Factors Negatively Impacting Nutrition Statu"
    },
    {
      "type": "table",
      "section": "TABLE 13-1. Factors Impacting Nutrition Status and Their Outcomes in Children With NI",
      "line": 6079,
      "preview": "| :--: | :--: | :--: |"
    },
    {
      "type": "table",
      "section": "TABLE 13-1. Factors Impacting Nutrition Status and Their Outcomes in Children With NI",
      "line": 6080,
      "preview": "| - Better growth and weight gain <br> - Improved general health ${ }^{a}$ <br> - More participation"
    },
    {
      "type": "text",
      "section": "TABLE 13-1. Factors Impacting Nutrition Status and Their Outcomes in Children With NI",
      "line": 6082,
      "preview": "Abbreviation: NI, neurological impairment."
    },
    {
      "type": "text",
      "section": "TABLE 13-1. Factors Impacting Nutrition Status and Their Outcomes in Children With NI",
      "line": 6083,
      "preview": "${ }^{a}$ Samson-Fang L, Fung E, Stallings VA, et al. Relationship of nutritional status to health a"
    },
    {
      "type": "text",
      "section": "TABLE 13-1. Factors Impacting Nutrition Status and Their Outcomes in Children With NI",
      "line": 6084,
      "preview": "${ }^{\\text {b }}$ Brooks J, Day S, Shavelle R, Strauss D. Low weight, morbidity and mortality in ch"
    },
    {
      "type": "text",
      "section": "TABLE 13-1. Factors Impacting Nutrition Status and Their Outcomes in Children With NI",
      "line": 6085,
      "preview": "${ }^{c}$ Jesus AO, Stevenson RD. Optimizing nutrition and bone health in children with cerebral pal"
    },
    {
      "type": "text",
      "section": "TABLE 13-1. Factors Impacting Nutrition Status and Their Outcomes in Children With NI",
      "line": 6086,
      "preview": "https://doi.org/10.1016/j.pmr.2019.08.001"
    },
    {
      "type": "text",
      "section": "TABLE 13-1. Factors Impacting Nutrition Status and Their Outcomes in Children With NI",
      "line": 6087,
      "preview": "${ }^{d}$ Cheong JL, Hunt RW, Anderson PJ, et al. Head growth in preterm infants: correlation with m"
    },
    {
      "type": "text",
      "section": "TABLE 13-1. Factors Impacting Nutrition Status and Their Outcomes in Children With NI",
      "line": 6088,
      "preview": "${ }^{e}$ Dabydeen L, Thomas JE, Aston TJ, Hartley H, Sinha SK, Eyre JA. High-energy and -protein di"
    },
    {
      "type": "text",
      "section": "TABLE 13-1. Factors Impacting Nutrition Status and Their Outcomes in Children With NI",
      "line": 6089,
      "preview": "https://doi.org/10.1542/peds.2007-1267"
    },
    {
      "type": "text",
      "section": "TABLE 13-1. Factors Impacting Nutrition Status and Their Outcomes in Children With NI",
      "line": 6090,
      "preview": "${ }^{\\mathrm{f}}$ Pinto C, Borrego R, Eir\u00f3-Gomes M, et al. Embracing the nutritional assessment in "
    },
    {
      "type": "text",
      "section": "TABLE 13-1. Factors Impacting Nutrition Status and Their Outcomes in Children With NI",
      "line": 6092,
      "preview": "--- page 312 ---"
    },
    {
      "type": "text",
      "section": "TABLE 13-1. Factors Impacting Nutrition Status and Their Outcomes in Children With NI",
      "line": 6094,
      "preview": "${ }^{g}$ Fung EB, Samson-Fang L, Stallings VA, et al. Feeding dysfunction is associated with poor g"
    },
    {
      "type": "text",
      "section": "TABLE 13-1. Factors Impacting Nutrition Status and Their Outcomes in Children With NI",
      "line": 6095,
      "preview": "${ }^{\\text {h }}$ Mehta NM, Corkins MR, Lyman B, et al; American Society for Parenteral and Enteral"
    },
    {
      "type": "text",
      "section": "TABLE 13-1. Factors Impacting Nutrition Status and Their Outcomes in Children With NI",
      "line": 6096,
      "preview": "${ }^{i}$ Mehta NM, Skillman HE, Irving SY, et al. Guidelines for the provision and assessment of nu"
    },
    {
      "type": "text",
      "section": "TABLE 13-1. Factors Impacting Nutrition Status and Their Outcomes in Children With NI",
      "line": 6097,
      "preview": "https://doi.org/10.1177/0148607117711387"
    },
    {
      "type": "text",
      "section": "TABLE 13-1. Factors Impacting Nutrition Status and Their Outcomes in Children With NI",
      "line": 6098,
      "preview": "${ }^{j}$ Sullivan PB, Lambert B, Rose M, Ford-Adams M, Johnson A, Griffiths P. Prevalence and sever"
    },
    {
      "type": "text",
      "section": "TABLE 13-1. Factors Impacting Nutrition Status and Their Outcomes in Children With NI",
      "line": 6099,
      "preview": "${ }^{\\text {k}}$ Liptak GS, O'Donnell M, Conaway M, et al. Health status of children with moderate "
    },
    {
      "type": "text",
      "section": "TABLE 13-1. Factors Impacting Nutrition Status and Their Outcomes in Children With NI",
      "line": 6100,
      "preview": "https://doi.org/10.1017/S001216220100069x"
    },
    {
      "type": "text",
      "section": "TABLE 13-1. Factors Impacting Nutrition Status and Their Outcomes in Children With NI",
      "line": 6101,
      "preview": "${ }^{1}$ Karagiozoglou-Lampoudi T, Daskalou E, Vargiami E, Zafeiriou D. Identification of feeding r"
    },
    {
      "type": "text",
      "section": "TABLE 13-1. Factors Impacting Nutrition Status and Their Outcomes in Children With NI",
      "line": 6102,
      "preview": "${ }^{\\text {m}}$ Stevenson RD, Conaway M, Chumlea WC, et al; North American Growth in Cerebral Pals"
    },
    {
      "type": "text",
      "section": "TABLE 13-1. Factors Impacting Nutrition Status and Their Outcomes in Children With NI",
      "line": 6104,
      "preview": "The challenges in achieving good nutrition status require creative solutions, which will vary in dif"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "Assessment and Nutrient Requirements",
      "line": 6106
    },
    {
      "type": "text",
      "section": "Assessment and Nutrient Requirements",
      "line": 6108,
      "preview": "Given that nutrition status has such an impact on health and well-being in children with NI, it is i"
    },
    {
      "type": "text",
      "section": "Assessment and Nutrient Requirements",
      "line": 6110,
      "preview": "--- page 313 ---"
    },
    {
      "type": "text",
      "section": "Assessment and Nutrient Requirements",
      "line": 6112,
      "preview": "required at the beginning of a nutrition assessment. Some considerations are outlined in Table 13-2."
    },
    {
      "type": "text",
      "section": "Assessment and Nutrient Requirements",
      "line": 6114,
      "preview": "--- page 314 ---"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "TABLE 13-2. Cooccurring Conditions and Their Impact on Nutrition in Children With NI",
      "line": 6116
    },
    {
      "type": "table",
      "section": "TABLE 13-2. Cooccurring Conditions and Their Impact on Nutrition in Children With NI",
      "line": 6118,
      "preview": "| Conditions | Impact on Nutrition/Health | Considerations for Diet Plan |"
    },
    {
      "type": "table",
      "section": "TABLE 13-2. Cooccurring Conditions and Their Impact on Nutrition in Children With NI",
      "line": 6119,
      "preview": "| :--: | :--: | :--: |"
    },
    {
      "type": "table",
      "section": "TABLE 13-2. Cooccurring Conditions and Their Impact on Nutrition in Children With NI",
      "line": 6120,
      "preview": "| Motor function | - Affects chewing <br> - Swallowing <br> - Energy expenditure <br> - Body composi"
    },
    {
      "type": "table",
      "section": "TABLE 13-2. Cooccurring Conditions and Their Impact on Nutrition in Children With NI",
      "line": 6121,
      "preview": "| Seizures | - May impact oral feeding skills <br> - May increase aspiration risk | Anticonvulsants "
    },
    {
      "type": "table",
      "section": "TABLE 13-2. Cooccurring Conditions and Their Impact on Nutrition in Children With NI",
      "line": 6122,
      "preview": "| Dental health ${ }^{b}$ | - Food intake <br> - Food processing <br> - General and respiratory heal"
    },
    {
      "type": "table",
      "section": "TABLE 13-2. Cooccurring Conditions and Their Impact on Nutrition in Children With NI",
      "line": 6123,
      "preview": "| Sialorrhea ${ }^{c}$ | Fluid loss may be high. | Adjust fluid intake as needed. |"
    },
    {
      "type": "table",
      "section": "TABLE 13-2. Cooccurring Conditions and Their Impact on Nutrition in Children With NI",
      "line": 6124,
      "preview": "| Respiratory status (chronic lung disease, obstructive sleep apnea) ${ }^{d}$ | High respiratory ra"
    },
    {
      "type": "table",
      "section": "TABLE 13-2. Cooccurring Conditions and Their Impact on Nutrition in Children With NI",
      "line": 6125,
      "preview": "| Gastroesophageal reflux ${ }^{e}$ | - Pain <br> - Nutrient loss <br> - Decreased interest in food "
    },
    {
      "type": "table",
      "section": "TABLE 13-2. Cooccurring Conditions and Their Impact on Nutrition in Children With NI",
      "line": 6126,
      "preview": "| Constipation ${ }^{e}$ | - Pain <br> - Nutrient loss <br> - Decreased interest in food | Consider "
    },
    {
      "type": "table",
      "section": "TABLE 13-2. Cooccurring Conditions and Their Impact on Nutrition in Children With NI",
      "line": 6127,
      "preview": "| Bone health ${ }^{f}$ | - Immobility <br> - Anticonvulsant use <br> - Decreased sun exposure | Ens"
    },
    {
      "type": "text",
      "section": "TABLE 13-2. Cooccurring Conditions and Their Impact on Nutrition in Children With NI",
      "line": 6129,
      "preview": "--- page 315 ---"
    },
    {
      "type": "table",
      "section": "TABLE 13-2. Cooccurring Conditions and Their Impact on Nutrition in Children With NI",
      "line": 6131,
      "preview": "| Conditions | Impact on <br> Nutrition/Health | Considerations for Diet Plan |"
    },
    {
      "type": "table",
      "section": "TABLE 13-2. Cooccurring Conditions and Their Impact on Nutrition in Children With NI",
      "line": 6132,
      "preview": "| :-- | :-- | :-- |"
    },
    {
      "type": "table",
      "section": "TABLE 13-2. Cooccurring Conditions and Their Impact on Nutrition in Children With NI",
      "line": 6133,
      "preview": "| Medications | - May affect <br> appetite <br> - Nausea <br> - Constipation <br> - Affect bone <br>"
    },
    {
      "type": "text",
      "section": "TABLE 13-2. Cooccurring Conditions and Their Impact on Nutrition in Children With NI",
      "line": 6135,
      "preview": "Abbreviation: NI, neurological impairment."
    },
    {
      "type": "text",
      "section": "TABLE 13-2. Cooccurring Conditions and Their Impact on Nutrition in Children With NI",
      "line": 6136,
      "preview": "${ }^{a}$ Vernon-Roberts A, Wells J, Grant H, et al. Gastrostomy feeding in cerebral palsy: enough a"
    },
    {
      "type": "text",
      "section": "TABLE 13-2. Cooccurring Conditions and Their Impact on Nutrition in Children With NI",
      "line": 6137,
      "preview": "https://doi.org/10.1111/j.1469-8749.2010.03789.x"
    },
    {
      "type": "text",
      "section": "TABLE 13-2. Cooccurring Conditions and Their Impact on Nutrition in Children With NI",
      "line": 6138,
      "preview": "${ }^{\\text {b }}$ Costa A, Martin A, Arreola V, et al. Assessment of swallowing disorders, nutritio"
    },
    {
      "type": "text",
      "section": "TABLE 13-2. Cooccurring Conditions and Their Impact on Nutrition in Children With NI",
      "line": 6139,
      "preview": "https://doi.org/10.3390/nu13072413"
    },
    {
      "type": "text",
      "section": "TABLE 13-2. Cooccurring Conditions and Their Impact on Nutrition in Children With NI",
      "line": 6140,
      "preview": "${ }^{c}$ Sialorrhea in cerebral palsy. American Academy of Cerebral Palsyand Developmental Medicine"
    },
    {
      "type": "text",
      "section": "TABLE 13-2. Cooccurring Conditions and Their Impact on Nutrition in Children With NI",
      "line": 6141,
      "preview": "http://www.aacpdm.org/publications/care-pathways/sialorrhea-in-cerebral-palsy"
    },
    {
      "type": "text",
      "section": "TABLE 13-2. Cooccurring Conditions and Their Impact on Nutrition in Children With NI",
      "line": 6142,
      "preview": "${ }^{d}$ Marpole R, Blackmore AM, Gibson N, Cooper MS, Langdon K, Wilson AC."
    },
    {
      "type": "text",
      "section": "TABLE 13-2. Cooccurring Conditions and Their Impact on Nutrition in Children With NI",
      "line": 6143,
      "preview": "Evaluation and management of respiratory illness in children with cerebral palsy. Front Pediatr. 202"
    },
    {
      "type": "text",
      "section": "TABLE 13-2. Cooccurring Conditions and Their Impact on Nutrition in Children With NI",
      "line": 6144,
      "preview": "${ }^{\\text {e }}$ Romano C, van Wynckel M, Hulst J, et al. European Society for Paediatric Gastroen"
    },
    {
      "type": "text",
      "section": "TABLE 13-2. Cooccurring Conditions and Their Impact on Nutrition in Children With NI",
      "line": 6145,
      "preview": "https://doi.org/10.1097/MPG. 0000000000001646"
    },
    {
      "type": "text",
      "section": "TABLE 13-2. Cooccurring Conditions and Their Impact on Nutrition in Children With NI",
      "line": 6146,
      "preview": "${ }^{f}$ Osteoporosis in cerebral palsy. American Academy of Cerebral Palsy and Developmental Medic"
    },
    {
      "type": "text",
      "section": "TABLE 13-2. Cooccurring Conditions and Their Impact on Nutrition in Children With NI",
      "line": 6147,
      "preview": "https://www.aacpdm.org/publications/care-pathways/osteoporosis-in-cerebral-palsy"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "Nutrition-Focused History for Children With NI",
      "line": 6149
    },
    {
      "type": "text",
      "section": "Nutrition-Focused History for Children With NI",
      "line": 6151,
      "preview": "Children with NI frequently need adaptations to their meal plans for a safe and comfortable feeding "
    },
    {
      "type": "text",
      "section": "Nutrition-Focused History for Children With NI",
      "line": 6153,
      "preview": "--- page 316 ---"
    },
    {
      "type": "text",
      "section": "Nutrition-Focused History for Children With NI",
      "line": 6155,
      "preview": "TABLE 13-3. Feeding History Framework for Children With $\\mathrm{Nl}^{\\mathrm{a}-\\mathrm{c}}$"
    },
    {
      "type": "table",
      "section": "Nutrition-Focused History for Children With NI",
      "line": 6157,
      "preview": "| Questions | Secondary Questions | Special Considerations |"
    },
    {
      "type": "table",
      "section": "Nutrition-Focused History for Children With NI",
      "line": 6158,
      "preview": "| :--: | :--: | :--: |"
    },
    {
      "type": "table",
      "section": "Nutrition-Focused History for Children With NI",
      "line": 6159,
      "preview": "| Who feeds the child? | Is there assistance to foster safe feeding at school or daycare? | Lack of "
    },
    {
      "type": "table",
      "section": "Nutrition-Focused History for Children With NI",
      "line": 6160,
      "preview": "|  | Are feeders in all settings familiar with the following? <br> - Safe, comfortable positioning <"
    },
    {
      "type": "table",
      "section": "Nutrition-Focused History for Children With NI",
      "line": 6161,
      "preview": "| What does the child eat? | What and how much does the child eat? | Type, quality, and quantity of "
    },
    {
      "type": "table",
      "section": "Nutrition-Focused History for Children With NI",
      "line": 6162,
      "preview": "|  | Is the liquid thickened? | See section on dysphagia in chapter 3, \"Clinical Considerations.\" |"
    },
    {
      "type": "table",
      "section": "Nutrition-Focused History for Children With NI",
      "line": 6163,
      "preview": "|  | Is the food modified? | - Adjust food texture and consistency to match the child's needs. <br> "
    },
    {
      "type": "table",
      "section": "Nutrition-Focused History for Children With NI",
      "line": 6164,
      "preview": "|  | Is there a limited dietary repertoire? | - Consider monitoring micronutrient values. <br> - For"
    },
    {
      "type": "table",
      "section": "Nutrition-Focused History for Children With NI",
      "line": 6165,
      "preview": "| When does the child eat? | With the family? | Family mealtime is important whether the child is or"
    },
    {
      "type": "table",
      "section": "Nutrition-Focused History for Children With NI",
      "line": 6166,
      "preview": "|  | Is the child fed before going to bed? | Timing of meals may need adjustment to decrease reflux "
    },
    {
      "type": "table",
      "section": "Nutrition-Focused History for Children With NI",
      "line": 6167,
      "preview": "| Where does the child eat? | How is the child positioned? | - Feeding team therapists can help to o"
    },
    {
      "type": "text",
      "section": "Nutrition-Focused History for Children With NI",
      "line": 6169,
      "preview": "--- page 317 ---"
    },
    {
      "type": "table",
      "section": "Nutrition-Focused History for Children With NI",
      "line": 6171,
      "preview": "| Questions | Secondary <br> Questions | Special Considerations |"
    },
    {
      "type": "table",
      "section": "Nutrition-Focused History for Children With NI",
      "line": 6172,
      "preview": "| :--: | :--: | :--: |"
    },
    {
      "type": "table",
      "section": "Nutrition-Focused History for Children With NI",
      "line": 6173,
      "preview": "|  | Is adapted seating required? | - Observation for all feeding/eating may be an essential safety "
    },
    {
      "type": "table",
      "section": "Nutrition-Focused History for Children With NI",
      "line": 6174,
      "preview": "|  | Are distractions limited for meals? | The child may require mealtime routines, environmental cu"
    },
    {
      "type": "table",
      "section": "Nutrition-Focused History for Children With NI",
      "line": 6175,
      "preview": "| How does the child eat? | How long does it take? | - Adequate time to eat is important, but prolon"
    },
    {
      "type": "table",
      "section": "Nutrition-Focused History for Children With NI",
      "line": 6176,
      "preview": "|  | Is the aspiration risk increased? | Watch for clinical signs of aspiration including watery eye"
    },
    {
      "type": "table",
      "section": "Nutrition-Focused History for Children With NI",
      "line": 6177,
      "preview": "|  | Does the child pocket the food in their mouth? | - A speech therapist or occupational therapist"
    },
    {
      "type": "table",
      "section": "Nutrition-Focused History for Children With NI",
      "line": 6178,
      "preview": "|  | Are special utensils required for others to feed the child or to promote self-feeding? | Feedin"
    },
    {
      "type": "text",
      "section": "Nutrition-Focused History for Children With NI",
      "line": 6180,
      "preview": "Abbreviation: NI, neurological impairment."
    },
    {
      "type": "text",
      "section": "Nutrition-Focused History for Children With NI",
      "line": 6181,
      "preview": "${ }^{a}$ Data from Rempel G. The importance of good nutrition in children with cerebral palsy. Phys"
    },
    {
      "type": "text",
      "section": "Nutrition-Focused History for Children With NI",
      "line": 6182,
      "preview": "https://doi.org/10.1016/j.pmr.2014.09.001"
    },
    {
      "type": "text",
      "section": "Nutrition-Focused History for Children With NI",
      "line": 6183,
      "preview": "${ }^{\\text {b }}$ Data from Kuperminc MN, Gottrand F, Samson-Fang L, et al. Nutritional management "
    },
    {
      "type": "text",
      "section": "Nutrition-Focused History for Children With NI",
      "line": 6184,
      "preview": "${ }^{c}$ Data from Gellert-Jones ME. Assessment and treatment of feeding in children and youth with"
    },
    {
      "type": "text",
      "section": "Nutrition-Focused History for Children With NI",
      "line": 6185,
      "preview": "${ }^{d}$ Huysentruyt K, Geeraert F, Allemon H, et al. Nutritional red flags in children with cerebr"
    },
    {
      "type": "text",
      "section": "Nutrition-Focused History for Children With NI",
      "line": 6187,
      "preview": "--- page 318 ---"
    },
    {
      "type": "text",
      "section": "Nutrition-Focused History for Children With NI",
      "line": 6189,
      "preview": "https://doi.org/10.1016/j.clnu.2019.02.040"
    },
    {
      "type": "text",
      "section": "Nutrition-Focused History for Children With NI",
      "line": 6190,
      "preview": "${ }^{\\text {e }}$ Romano C, van Wynckel M, Hulst J, et al. European Society for Paediatric Gastroen"
    },
    {
      "type": "text",
      "section": "Nutrition-Focused History for Children With NI",
      "line": 6191,
      "preview": "https://doi.org/10.1097/MPG. 0000000000001646"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "Tools, Anthropometric Measurements, and Nutrition Targets in Children With NI",
      "line": 6193
    },
    {
      "type": "text",
      "section": "Tools, Anthropometric Measurements, and Nutrition Targets in Children With NI",
      "line": 6195,
      "preview": "Once the history has been taken and there is a good understanding of a child's intake and needs, the"
    },
    {
      "type": "text",
      "section": "Tools, Anthropometric Measurements, and Nutrition Targets in Children With NI",
      "line": 6197,
      "preview": "--- page 319 ---"
    },
    {
      "type": "text",
      "section": "Tools, Anthropometric Measurements, and Nutrition Targets in Children With NI",
      "line": 6199,
      "preview": "TABLE 13-4. Measurements, and Nutrition Targets for Children With NI"
    },
    {
      "type": "table",
      "section": "Tools, Anthropometric Measurements, and Nutrition Targets in Children With NI",
      "line": 6201,
      "preview": "| Tools and Measurements | Descriptions |  | Considerations | Nutrition <br> Targets |"
    },
    {
      "type": "table",
      "section": "Tools, Anthropometric Measurements, and Nutrition Targets in Children With NI",
      "line": 6202,
      "preview": "| :--: | :--: | :--: | :--: | :--: |"
    },
    {
      "type": "table",
      "section": "Tools, Anthropometric Measurements, and Nutrition Targets in Children With NI",
      "line": 6203,
      "preview": "| Subjective Global Nutrition Assessment | Validated tool that provides a framework for targeted his"
    },
    {
      "type": "table",
      "section": "Tools, Anthropometric Measurements, and Nutrition Targets in Children With NI",
      "line": 6204,
      "preview": "| Anthropometry | Each measure may identify a different child at risk of a nutrition deficiency ${ }"
    },
    {
      "type": "table",
      "section": "Tools, Anthropometric Measurements, and Nutrition Targets in Children With NI",
      "line": 6205,
      "preview": "|  | Weight | Direct weights whenever possible | Using $z$ scores provides a special advantage for u"
    },
    {
      "type": "table",
      "section": "Tools, Anthropometric Measurements, and Nutrition Targets in Children With NI",
      "line": 6206,
      "preview": "|  | Height | Segmental measures for height ${ }^{f}$ | Required because of inability to stand or sk"
    },
    {
      "type": "table",
      "section": "Tools, Anthropometric Measurements, and Nutrition Targets in Children With NI",
      "line": 6207,
      "preview": "|  | BMI | Unreliable if child cannot stand or has skeletal deformities | Height measurement error m"
    },
    {
      "type": "table",
      "section": "Tools, Anthropometric Measurements, and Nutrition Targets in Children With NI",
      "line": 6208,
      "preview": "|  | MUAC | Lean body mass is generally low | This may be due to underlying condition and inactivity"
    },
    {
      "type": "table",
      "section": "Tools, Anthropometric Measurements, and Nutrition Targets in Children With NI",
      "line": 6209,
      "preview": "|  | TSF | Good screening tool for depleted fat stores ${ }^{h}$ | Fat is stored centrally in childr"
    },
    {
      "type": "text",
      "section": "Tools, Anthropometric Measurements, and Nutrition Targets in Children With NI",
      "line": 6211,
      "preview": "--- page 320 ---"
    },
    {
      "type": "table",
      "section": "Tools, Anthropometric Measurements, and Nutrition Targets in Children With NI",
      "line": 6213,
      "preview": "| Tools and Measurements | Descriptions |  | Considerations | Nutrition <br> Targets |"
    },
    {
      "type": "table",
      "section": "Tools, Anthropometric Measurements, and Nutrition Targets in Children With NI",
      "line": 6214,
      "preview": "| :--: | :--: | :--: | :--: | :--: |"
    },
    {
      "type": "table",
      "section": "Tools, Anthropometric Measurements, and Nutrition Targets in Children With NI",
      "line": 6215,
      "preview": "| Body composition | - DXA is the standard for measuring body composition. ${ }^{i}$ <br> - BIA is u"
    },
    {
      "type": "table",
      "section": "Tools, Anthropometric Measurements, and Nutrition Targets in Children With NI",
      "line": 6216,
      "preview": "| Growth charts (see chapter 1, \"Nutrition Screening and History\") | Many condition-specific charts "
    },
    {
      "type": "table",
      "section": "Tools, Anthropometric Measurements, and Nutrition Targets in Children With NI",
      "line": 6217,
      "preview": "| Weight gain velocity | - Should be adequate to allow a child to follow their own curve even if the"
    },
    {
      "type": "text",
      "section": "Tools, Anthropometric Measurements, and Nutrition Targets in Children With NI",
      "line": 6219,
      "preview": "Abbreviations: BIA, bioelectrical impedance analysis; BMI, body mass index; CP, cerebral palsy; DXA,"
    },
    {
      "type": "text",
      "section": "Tools, Anthropometric Measurements, and Nutrition Targets in Children With NI",
      "line": 6220,
      "preview": "${ }^{a}$ Secker DJ, Jeejeebhoy KN. Subjective Global Nutritional Assessment for children. Am J Clin"
    },
    {
      "type": "text",
      "section": "Tools, Anthropometric Measurements, and Nutrition Targets in Children With NI",
      "line": 6221,
      "preview": "${ }^{\\text {b }}$ Carter L, Hulst JM, Afzal N, Jeejeebhoy K, Brunet-Wood K. Update to the pediatric"
    },
    {
      "type": "text",
      "section": "Tools, Anthropometric Measurements, and Nutrition Targets in Children With NI",
      "line": 6223,
      "preview": "--- page 321 ---"
    },
    {
      "type": "text",
      "section": "Tools, Anthropometric Measurements, and Nutrition Targets in Children With NI",
      "line": 6225,
      "preview": "${ }^{c}$ Bell K, Benfer K, Ware R, et al. The Pediatric Subjective Global Nutrition Assessment clas"
    },
    {
      "type": "text",
      "section": "Tools, Anthropometric Measurements, and Nutrition Targets in Children With NI",
      "line": 6226,
      "preview": "https://doi.org/10.1016/j.jand.2020.04.012"
    },
    {
      "type": "text",
      "section": "Tools, Anthropometric Measurements, and Nutrition Targets in Children With NI",
      "line": 6227,
      "preview": "${ }^{d}$ Huysentruyt K, Geeraert F, Allemon H, et al. Nutritional red flags in children with cerebr"
    },
    {
      "type": "text",
      "section": "Tools, Anthropometric Measurements, and Nutrition Targets in Children With NI",
      "line": 6228,
      "preview": "https://doi.org/10.1016/j.clnu.2019.02.040"
    },
    {
      "type": "text",
      "section": "Tools, Anthropometric Measurements, and Nutrition Targets in Children With NI",
      "line": 6229,
      "preview": "${ }^{\\text {e }}$ The $z$ scores for age are from references for typically growing children (see ch"
    },
    {
      "type": "text",
      "section": "Tools, Anthropometric Measurements, and Nutrition Targets in Children With NI",
      "line": 6230,
      "preview": "${ }^{f}$ Stevenson RD. Use of segmental measures to estimate stature in children with cerebral pals"
    },
    {
      "type": "text",
      "section": "Tools, Anthropometric Measurements, and Nutrition Targets in Children With NI",
      "line": 6231,
      "preview": "https://doi.org/10.1001/archpedi.1995.02170190068012"
    },
    {
      "type": "text",
      "section": "Tools, Anthropometric Measurements, and Nutrition Targets in Children With NI",
      "line": 6232,
      "preview": "g Oftedal S, Davies PS, Boyd RN, et al. Body composition, diet and physical activity: a longitudinal"
    },
    {
      "type": "text",
      "section": "Tools, Anthropometric Measurements, and Nutrition Targets in Children With NI",
      "line": 6233,
      "preview": "${ }^{\\text {h }}$ Samson-Fang LJ, Stevenson RD. Identification of malnutrition in children with cer"
    },
    {
      "type": "text",
      "section": "Tools, Anthropometric Measurements, and Nutrition Targets in Children With NI",
      "line": 6234,
      "preview": "${ }^{i}$ Romano C, van Wynckel M, Hulst J, et al. European Society for Paediatric Gastroenterology,"
    },
    {
      "type": "text",
      "section": "Tools, Anthropometric Measurements, and Nutrition Targets in Children With NI",
      "line": 6235,
      "preview": "https://doi.org/10.1097/MPG. 0000000000001646"
    },
    {
      "type": "text",
      "section": "Tools, Anthropometric Measurements, and Nutrition Targets in Children With NI",
      "line": 6236,
      "preview": "${ }^{j}$ Bell KL, Boyd RN, Walker JL, Stevenson RD, Davies PS. The use of bioelectrical impedance a"
    },
    {
      "type": "text",
      "section": "Tools, Anthropometric Measurements, and Nutrition Targets in Children With NI",
      "line": 6237,
      "preview": "${ }^{\\text {k }}$ Oeffinger DJ, Gurka MJ, Kuperminc M, Hassani S, Buhr N, Tylkowski C. Accuracy of "
    },
    {
      "type": "text",
      "section": "Tools, Anthropometric Measurements, and Nutrition Targets in Children With NI",
      "line": 6238,
      "preview": "${ }^{1}$ Brooks J, Day S, Shavelle R, Strauss D. Low weight, morbidity and mortality in children wi"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "Identifying Undernutrition in Children With NI",
      "line": 6240
    },
    {
      "type": "text",
      "section": "Identifying Undernutrition in Children With NI",
      "line": 6242,
      "preview": "The goal of all the detailed history, the clinical evaluations, and anthropometric measures is to id"
    },
    {
      "type": "text",
      "section": "Identifying Undernutrition in Children With NI",
      "line": 6244,
      "preview": "--- page 322 ---"
    },
    {
      "type": "text",
      "section": "Identifying Undernutrition in Children With NI",
      "line": 6246,
      "preview": "nutrition indicators, and clinical signs are important. They are outlined in Table 13-5."
    },
    {
      "type": "heading",
      "level": 1,
      "section": "TABLE 13-5. Red Flags for Undernutrition in Children With $\\mathrm{NI}^{\\mathrm{a}-\\mathrm{c}}$",
      "line": 6248
    },
    {
      "type": "table",
      "section": "TABLE 13-5. Red Flags for Undernutrition in Children With $\\mathrm{NI}^{\\mathrm{a}-\\mathrm{c}}$",
      "line": 6250,
      "preview": "| Historical Considerations | Nutrition Indicators | Clinical Signs |"
    },
    {
      "type": "table",
      "section": "TABLE 13-5. Red Flags for Undernutrition in Children With $\\mathrm{NI}^{\\mathrm{a}-\\mathrm{c}}$",
      "line": 6251,
      "preview": "| :--: | :--: | :--: |"
    },
    {
      "type": "table",
      "section": "TABLE 13-5. Red Flags for Undernutrition in Children With $\\mathrm{NI}^{\\mathrm{a}-\\mathrm{c}}$",
      "line": 6252,
      "preview": "| - Children with severe functional limitations and feeding difficulties <br> - Stressful and prolon"
    },
    {
      "type": "text",
      "section": "TABLE 13-5. Red Flags for Undernutrition in Children With $\\mathrm{NI}^{\\mathrm{a}-\\mathrm{c}}$",
      "line": 6254,
      "preview": "Abbreviations: NI, neurological impairment; TSF, triceps skinfold."
    },
    {
      "type": "text",
      "section": "TABLE 13-5. Red Flags for Undernutrition in Children With $\\mathrm{NI}^{\\mathrm{a}-\\mathrm{c}}$",
      "line": 6255,
      "preview": "${ }^{a}$ Data from Romano C, van Wynckel M, Hulst J, et al. European Society for Paediatric Gastroe"
    },
    {
      "type": "text",
      "section": "TABLE 13-5. Red Flags for Undernutrition in Children With $\\mathrm{NI}^{\\mathrm{a}-\\mathrm{c}}$",
      "line": 6256,
      "preview": "https://doi.org/10.1097/MPG. 0000000000001646"
    },
    {
      "type": "text",
      "section": "TABLE 13-5. Red Flags for Undernutrition in Children With $\\mathrm{NI}^{\\mathrm{a}-\\mathrm{c}}$",
      "line": 6257,
      "preview": "${ }^{\\text {b }}$ Data from Kuperminc MN, Gottrand F, Samson-Fang L, et al. Nutritional management "
    },
    {
      "type": "text",
      "section": "TABLE 13-5. Red Flags for Undernutrition in Children With $\\mathrm{NI}^{\\mathrm{a}-\\mathrm{c}}$",
      "line": 6258,
      "preview": "${ }^{c}$ Data from Huysentruyt K, Geeraert F, Allemon H, et al. Nutritional red flags in children w"
    },
    {
      "type": "text",
      "section": "TABLE 13-5. Red Flags for Undernutrition in Children With $\\mathrm{NI}^{\\mathrm{a}-\\mathrm{c}}$",
      "line": 6259,
      "preview": "https://doi.org/10.1016/j.clnu.2019.02.040"
    },
    {
      "type": "heading",
      "level": 2,
      "section": "Implementation of Nutrition Plan and Monitoring",
      "line": 6261
    },
    {
      "type": "heading",
      "level": 2,
      "section": "Designing Diet Plans for Children With NI",
      "line": 6263
    },
    {
      "type": "text",
      "section": "Designing Diet Plans for Children With NI",
      "line": 6265,
      "preview": "Many of the considerations required in developing appropriate diet plans for children with NI are im"
    },
    {
      "type": "text",
      "section": "Designing Diet Plans for Children With NI",
      "line": 6267,
      "preview": "--- page 323 ---"
    },
    {
      "type": "text",
      "section": "Designing Diet Plans for Children With NI",
      "line": 6269,
      "preview": "nutrition assessment, the nutrition targets for children with NI, and the red flags for malnutrition"
    },
    {
      "type": "text",
      "section": "Designing Diet Plans for Children With NI",
      "line": 6271,
      "preview": "Oral nutrition rehabilitation involves increasing a child's caloric and nutrient intake and improvin"
    },
    {
      "type": "text",
      "section": "Designing Diet Plans for Children With NI",
      "line": 6273,
      "preview": "--- page 324 ---"
    },
    {
      "type": "text",
      "section": "Designing Diet Plans for Children With NI",
      "line": 6275,
      "preview": "TABLE 13-6. Designing Diet Plans for Children With NI"
    },
    {
      "type": "table",
      "section": "Designing Diet Plans for Children With NI",
      "line": 6277,
      "preview": "| Nutrients | Consideration | Formulas and Calculations |"
    },
    {
      "type": "table",
      "section": "Designing Diet Plans for Children With NI",
      "line": 6278,
      "preview": "| :--: | :--: | :--: |"
    },
    {
      "type": "table",
      "section": "Designing Diet Plans for Children With NI",
      "line": 6279,
      "preview": "| Energy requirements <br> - Affected by tone, movement, metabolism ${ }^{a}$ <br> - Decreased in no"
    },
    {
      "type": "table",
      "section": "Designing Diet Plans for Children With NI",
      "line": 6280,
      "preview": "|  |  | $<1 \\mathrm{y}$ |"
    },
    {
      "type": "table",
      "section": "Designing Diet Plans for Children With NI",
      "line": 6281,
      "preview": "|  |  | 1 to 3 y |"
    },
    {
      "type": "table",
      "section": "Designing Diet Plans for Children With NI",
      "line": 6282,
      "preview": "|  |  | 4 to 5 y |"
    },
    {
      "type": "table",
      "section": "Designing Diet Plans for Children With NI",
      "line": 6283,
      "preview": "|  |  | 6 to 8 y |"
    },
    {
      "type": "table",
      "section": "Designing Diet Plans for Children With NI",
      "line": 6284,
      "preview": "|  |  | $>9 \\mathrm{y}$ |"
    },
    {
      "type": "table",
      "section": "Designing Diet Plans for Children With NI",
      "line": 6285,
      "preview": "|  |  | Some authors use 75\\% of the dietary reference standard for calorie requirements when initia"
    },
    {
      "type": "table",
      "section": "Designing Diet Plans for Children With NI",
      "line": 6286,
      "preview": "| Fluid | Meet DRIs for age | Children with NI are at risk of dehydration because of the following: "
    },
    {
      "type": "table",
      "section": "Designing Diet Plans for Children With NI",
      "line": 6287,
      "preview": "| Protein | Meet DRIs for age | For severely malnourished children, consider increasing to $2-2.4 \\m"
    },
    {
      "type": "table",
      "section": "Designing Diet Plans for Children With NI",
      "line": 6288,
      "preview": "| Micronutrients | Meet DRIs for age | - Hypocaloric diets, including diluted formula, and highly se"
    },
    {
      "type": "text",
      "section": "Designing Diet Plans for Children With NI",
      "line": 6290,
      "preview": "--- page 325 ---"
    },
    {
      "type": "table",
      "section": "Designing Diet Plans for Children With NI",
      "line": 6292,
      "preview": "| Nutrients | Consideration | Formulas and Calculations |"
    },
    {
      "type": "table",
      "section": "Designing Diet Plans for Children With NI",
      "line": 6293,
      "preview": "| :--: | :--: | :--: |"
    },
    {
      "type": "table",
      "section": "Designing Diet Plans for Children With NI",
      "line": 6294,
      "preview": "| Laboratory evaluation | - | - Full blood count, iron stores <br> - Urea, creatinine, electrolytes,"
    },
    {
      "type": "table",
      "section": "Designing Diet Plans for Children With NI",
      "line": 6295,
      "preview": "| Hypocaloric diets | If weight gain is $>7$ $\\mathrm{g} / \\mathrm{d}$ and/or TSF $>25$ th percentil"
    },
    {
      "type": "text",
      "section": "Designing Diet Plans for Children With NI",
      "line": 6297,
      "preview": "Abbreviations: DRI, dietary reference intake; NI, neurological impairment; TSF, triceps skinfold."
    },
    {
      "type": "text",
      "section": "Designing Diet Plans for Children With NI",
      "line": 6298,
      "preview": "Note: For further information, see chapter 4, \"Infant to Adolescent.\""
    },
    {
      "type": "text",
      "section": "Designing Diet Plans for Children With NI",
      "line": 6299,
      "preview": "${ }^{a}$ Romano C, van Wynckel M, Hulst J, et al. European Society for Paediatric Gastroenterology,"
    },
    {
      "type": "text",
      "section": "Designing Diet Plans for Children With NI",
      "line": 6300,
      "preview": "https://doi.org/10.1097/MPG. 0000000000001646"
    },
    {
      "type": "text",
      "section": "Designing Diet Plans for Children With NI",
      "line": 6301,
      "preview": "${ }^{\\text {b }}$ Walker JL, Bell KL, Boyd RN, Davies PSW. Energy requirements in preschool-age chi"
    },
    {
      "type": "text",
      "section": "Designing Diet Plans for Children With NI",
      "line": 6302,
      "preview": "https://doi.org/10.3945/ajcn. 112.043430"
    },
    {
      "type": "text",
      "section": "Designing Diet Plans for Children With NI",
      "line": 6303,
      "preview": "${ }^{c}$ Arrowsmith FE, Allen JR, Gaskin KJ, et al. Nutritional rehabilitation increases the restin"
    },
    {
      "type": "text",
      "section": "Designing Diet Plans for Children With NI",
      "line": 6304,
      "preview": "${ }^{d}$ Faizan U, Rouster AS. Nutrition and hydration requirements in children and adults. In: Sta"
    },
    {
      "type": "text",
      "section": "Designing Diet Plans for Children With NI",
      "line": 6305,
      "preview": "https://www.ncbi.nlm.nih.gov/books/NBK562207/"
    },
    {
      "type": "text",
      "section": "Designing Diet Plans for Children With NI",
      "line": 6306,
      "preview": "${ }^{\\text {e Vernon-Roberts A, Wells J, Grant H, et al. Gastrostomy feeding in cerebral palsy: }}$"
    },
    {
      "type": "text",
      "section": "Designing Diet Plans for Children With NI",
      "line": 6307,
      "preview": "https://doi.org/10.1111/j.1469-8749.2010.03789.x"
    },
    {
      "type": "text",
      "section": "Designing Diet Plans for Children With NI",
      "line": 6308,
      "preview": "${ }^{\\text {f }}$ American Society for Parenteral and Enteral Nutrition. EN pediatric formulas."
    },
    {
      "type": "text",
      "section": "Designing Diet Plans for Children With NI",
      "line": 6309,
      "preview": "https://www.nutritioncare.org/Guidelines_and_Clinical_Resources/EN_Formula_Guide"
    },
    {
      "type": "text",
      "section": "Designing Diet Plans for Children With NI",
      "line": 6311,
      "preview": "--- page 326 ---"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "References",
      "line": 6313
    },
    {
      "type": "text",
      "section": "References",
      "line": 6315,
      "preview": "1. Kuperminc M, Stevenson RD. Growth and nutrition disorders in children with cerebral palsy. Dev Di"
    },
    {
      "type": "text",
      "section": "References",
      "line": 6316,
      "preview": "2. Rempel G. The importance of good nutrition in children with cerebral palsy. Phys Med Rehabil Clin"
    },
    {
      "type": "text",
      "section": "References",
      "line": 6317,
      "preview": "3. Strauss D, Brooks J, Rosenbloom L, Shavelle R. Life expectancy in cerebral palsy: an update. Dev "
    },
    {
      "type": "text",
      "section": "References",
      "line": 6318,
      "preview": "4. Strauss D, Shavelle R, Reynolds R, Rosenbloom L, Day S. Survival in cerebral palsy in the last 20"
    },
    {
      "type": "text",
      "section": "References",
      "line": 6319,
      "preview": "5. Romano C, van Wynckel M, Hulst J, et al. European Society for Paediatric Gastroenterology, Hepato"
    },
    {
      "type": "text",
      "section": "References",
      "line": 6320,
      "preview": "6. Gellert-Jones. M. Coming to the table. HMS School for Cerebral Palsy. Accessed September 5, 2022."
    },
    {
      "type": "text",
      "section": "References",
      "line": 6321,
      "preview": "7. Mahant S, Friedman JN, Connolly B, Goia C, Macarthur C. Tube feeding and quality of life in child"
    },
    {
      "type": "text",
      "section": "References",
      "line": 6323,
      "preview": "--- page 327 ---"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "14",
      "line": 6325
    },
    {
      "type": "heading",
      "level": 2,
      "section": "Diabetes Mellitus",
      "line": 6327
    },
    {
      "type": "text",
      "section": "Diabetes Mellitus",
      "line": 6329,
      "preview": "Christina Wright Yee, MPH, RD, CSP"
    },
    {
      "type": "text",
      "section": "Diabetes Mellitus",
      "line": 6330,
      "preview": "Emely Reyes, RDN, CDCES"
    },
    {
      "type": "heading",
      "level": 2,
      "section": "Introduction",
      "line": 6332
    },
    {
      "type": "text",
      "section": "Introduction",
      "line": 6334,
      "preview": "In both type 1 diabetes mellitus (T1DM) and type 2 diabetes mellitus (T2DM), a variety of genetic, e"
    },
    {
      "type": "heading",
      "level": 2,
      "section": "Types of Diabetes",
      "line": 6336
    },
    {
      "type": "text",
      "section": "Types of Diabetes",
      "line": 6338,
      "preview": "T1DM is an autoimmune disease that results in a complete loss of betacell function, which results in"
    },
    {
      "type": "text",
      "section": "Types of Diabetes",
      "line": 6340,
      "preview": "--- page 328 ---"
    },
    {
      "type": "text",
      "section": "Types of Diabetes",
      "line": 6342,
      "preview": "weeks or months, whereas in patients with T2DM, it may develop over months or years."
    },
    {
      "type": "heading",
      "level": 1,
      "section": "Hemoglobin A1c and Goal Blood Glucose Ranges Based on Age",
      "line": 6344
    },
    {
      "type": "text",
      "section": "Hemoglobin A1c and Goal Blood Glucose Ranges Based on Age",
      "line": 6346,
      "preview": "The hemoglobin A1c test is an indirect measure of a 90-day average glycemic control of an individual"
    },
    {
      "type": "text",
      "section": "Hemoglobin A1c and Goal Blood Glucose Ranges Based on Age",
      "line": 6348,
      "preview": "TABLE 14-1. HbA1c and Estimated Average Glucose ${ }^{\\text {a-c }}$"
    },
    {
      "type": "table",
      "section": "Hemoglobin A1c and Goal Blood Glucose Ranges Based on Age",
      "line": 6350,
      "preview": "| HbA1c (\\%) | $\\mathbf{m g} / \\mathbf{d L}$ | $\\mathbf{m m o l} / \\mathbf{L}$ |"
    },
    {
      "type": "table",
      "section": "Hemoglobin A1c and Goal Blood Glucose Ranges Based on Age",
      "line": 6351,
      "preview": "| :-- | :-- | :-- |"
    },
    {
      "type": "table",
      "section": "Hemoglobin A1c and Goal Blood Glucose Ranges Based on Age",
      "line": 6352,
      "preview": "| 5 | $97(76-120)$ | $5.4(4.2-6.7)$ |"
    },
    {
      "type": "table",
      "section": "Hemoglobin A1c and Goal Blood Glucose Ranges Based on Age",
      "line": 6353,
      "preview": "| 6 | $126(100-152)$ | $7.0(5.5-8.5)$ |"
    },
    {
      "type": "table",
      "section": "Hemoglobin A1c and Goal Blood Glucose Ranges Based on Age",
      "line": 6354,
      "preview": "| 7 | $154(123-185)$ | $8.6(6.8-10.3)$ |"
    },
    {
      "type": "table",
      "section": "Hemoglobin A1c and Goal Blood Glucose Ranges Based on Age",
      "line": 6355,
      "preview": "| 8 | $183(147-217)$ | $10.2(8.1-12.1)$ |"
    },
    {
      "type": "table",
      "section": "Hemoglobin A1c and Goal Blood Glucose Ranges Based on Age",
      "line": 6356,
      "preview": "| 9 | $212(170-249)$ | $11.8(9.4-13.9)$ |"
    },
    {
      "type": "table",
      "section": "Hemoglobin A1c and Goal Blood Glucose Ranges Based on Age",
      "line": 6357,
      "preview": "| 10 | $240(193-282)$ | $13.4(10.7-15.7)$ |"
    },
    {
      "type": "table",
      "section": "Hemoglobin A1c and Goal Blood Glucose Ranges Based on Age",
      "line": 6358,
      "preview": "| 11 | $269(217-314)$ | $14.9(12.0-17.5)$ |"
    },
    {
      "type": "table",
      "section": "Hemoglobin A1c and Goal Blood Glucose Ranges Based on Age",
      "line": 6359,
      "preview": "| 12 | $298(240-347)$ | $16.5(13.3-19.3)$ |"
    },
    {
      "type": "text",
      "section": "Hemoglobin A1c and Goal Blood Glucose Ranges Based on Age",
      "line": 6361,
      "preview": "Abbreviation: HbA1c, hemoglobin A1c."
    },
    {
      "type": "text",
      "section": "Hemoglobin A1c and Goal Blood Glucose Ranges Based on Age",
      "line": 6362,
      "preview": "${ }^{a}$ Data from American Diabetes Association. 2. Classification and diagnosis of diabetes: stan"
    },
    {
      "type": "text",
      "section": "Hemoglobin A1c and Goal Blood Glucose Ranges Based on Age",
      "line": 6363,
      "preview": "${ }^{\\text {b }}$ Data from American Diabetes Association. EAG/A1C conversion calculator. Accessed "
    },
    {
      "type": "text",
      "section": "Hemoglobin A1c and Goal Blood Glucose Ranges Based on Age",
      "line": 6364,
      "preview": "${ }^{c}$ Data from Draznin B, Aroda VR, Bakris G, et al.; American Diabetes Association Professiona"
    },
    {
      "type": "text",
      "section": "Hemoglobin A1c and Goal Blood Glucose Ranges Based on Age",
      "line": 6365,
      "preview": "https://doi.org/10.2337/dc22-S014"
    },
    {
      "type": "text",
      "section": "Hemoglobin A1c and Goal Blood Glucose Ranges Based on Age",
      "line": 6367,
      "preview": "--- page 329 ---"
    },
    {
      "type": "text",
      "section": "Hemoglobin A1c and Goal Blood Glucose Ranges Based on Age",
      "line": 6369,
      "preview": "TABLE 14-2. Plasma Blood Glucose and HbA1c Target for Pediatric Age Groups With T1DM ${ }^{a}$"
    },
    {
      "type": "table",
      "section": "Hemoglobin A1c and Goal Blood Glucose Ranges Based on Age",
      "line": 6371,
      "preview": "| Plasma Blood Glucose Goal Range |  |  |"
    },
    {
      "type": "table",
      "section": "Hemoglobin A1c and Goal Blood Glucose Ranges Based on Age",
      "line": 6372,
      "preview": "| :-- | :-- | :--: |"
    },
    {
      "type": "table",
      "section": "Hemoglobin A1c and Goal Blood Glucose Ranges Based on Age",
      "line": 6373,
      "preview": "| Before Meals | Bedtime/0vernight | HbA1c |"
    },
    {
      "type": "table",
      "section": "Hemoglobin A1c and Goal Blood Glucose Ranges Based on Age",
      "line": 6374,
      "preview": "| $90-130 \\mathrm{mg} / \\mathrm{dL}$ | $90-150 \\mathrm{mg} / \\mathrm{dL}$ | $<7 \\%$ |"
    },
    {
      "type": "text",
      "section": "Hemoglobin A1c and Goal Blood Glucose Ranges Based on Age",
      "line": 6376,
      "preview": "Abbreviations: HbA1c, hemoglobin A1c; T1DM, type 1 diabetes mellitus."
    },
    {
      "type": "text",
      "section": "Hemoglobin A1c and Goal Blood Glucose Ranges Based on Age",
      "line": 6377,
      "preview": "${ }^{a}$ Data from American Diabetes Association. EAG/A1C conversion calculator. Accessed June 25, "
    },
    {
      "type": "text",
      "section": "Hemoglobin A1c and Goal Blood Glucose Ranges Based on Age",
      "line": 6378,
      "preview": "${ }^{\\mathrm{b}} \\mathrm{HbA1c}$ targets should be set in accordance with guidelines and considerat"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "Assessment and Nutrient Requirements",
      "line": 6380
    },
    {
      "type": "text",
      "section": "Assessment and Nutrient Requirements",
      "line": 6382,
      "preview": "In children with T1DM and T2DM, calorie needs are typically calculated on initial diagnosis. Few stu"
    },
    {
      "type": "text",
      "section": "Assessment and Nutrient Requirements",
      "line": 6384,
      "preview": "For children who are overweight and obese, attaining a body mass index (BMI) below the 85th percenti"
    },
    {
      "type": "text",
      "section": "Assessment and Nutrient Requirements",
      "line": 6386,
      "preview": "Carbohydrate intake should be equivalent to the acceptable macronutrient distribution range of $45 \\"
    },
    {
      "type": "text",
      "section": "Assessment and Nutrient Requirements",
      "line": 6388,
      "preview": "--- page 330 ---"
    },
    {
      "type": "text",
      "section": "Assessment and Nutrient Requirements",
      "line": 6390,
      "preview": "dietary fiber per 1000 kcal . ${ }^{8,9}$ Emphasis should be placed on increasing intake of complex "
    },
    {
      "type": "text",
      "section": "Assessment and Nutrient Requirements",
      "line": 6392,
      "preview": "Protein, fat, and fluid needs do not differ from the average pediatric population, and the DRI is re"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "Implementation of Nutrition Plan and Monitoring",
      "line": 6394
    },
    {
      "type": "heading",
      "level": 2,
      "section": "Assess for Food Insecurity and Social Determinants of Health",
      "line": 6396
    },
    {
      "type": "text",
      "section": "Assess for Food Insecurity and Social Determinants of Health",
      "line": 6398,
      "preview": "These will impact nutrition education and/or delivery of information, including how to overcome thes"
    },
    {
      "type": "text",
      "section": "Assess for Food Insecurity and Social Determinants of Health",
      "line": 6400,
      "preview": "- Use the Hunger Vital Signs tool, which is validated in the pediatric population. ${ }^{12}$"
    },
    {
      "type": "text",
      "section": "Assess for Food Insecurity and Social Determinants of Health",
      "line": 6401,
      "preview": "- Refer to social worker or case manager for assistance and/or resources."
    },
    {
      "type": "heading",
      "level": 2,
      "section": "Nutrition Support",
      "line": 6404
    },
    {
      "type": "text",
      "section": "Nutrition Support",
      "line": 6406,
      "preview": "Use the age-appropriate formula as indicated by the patient's other medical conditions because a \"di"
    },
    {
      "type": "heading",
      "level": 2,
      "section": "Education",
      "line": 6408
    },
    {
      "type": "text",
      "section": "Education",
      "line": 6410,
      "preview": "Education should be provided on the following topics."
    },
    {
      "type": "heading",
      "level": 2,
      "section": "Nutrition",
      "line": 6412
    },
    {
      "type": "text",
      "section": "Nutrition",
      "line": 6414,
      "preview": "--- page 331 ---"
    },
    {
      "type": "text",
      "section": "Nutrition",
      "line": 6416,
      "preview": "A patient's medication regimen, literacy, and numeracy levels, as well as respect for cultural prefe"
    },
    {
      "type": "text",
      "section": "Nutrition",
      "line": 6418,
      "preview": "--- page 332 ---"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "TABLE 14-3. Education Approaches for Mealtime Management for Children With Diabetes",
      "line": 6420
    },
    {
      "type": "table",
      "section": "TABLE 14-3. Education Approaches for Mealtime Management for Children With Diabetes",
      "line": 6422,
      "preview": "| Approach and Description | Benefits | Limitations |"
    },
    {
      "type": "table",
      "section": "TABLE 14-3. Education Approaches for Mealtime Management for Children With Diabetes",
      "line": 6423,
      "preview": "| :--: | :--: | :--: |"
    },
    {
      "type": "table",
      "section": "TABLE 14-3. Education Approaches for Mealtime Management for Children With Diabetes",
      "line": 6424,
      "preview": "| Carbohydrate counting: A method of determining carbohydrate containing foods and estimating the to"
    },
    {
      "type": "table",
      "section": "TABLE 14-3. Education Approaches for Mealtime Management for Children With Diabetes",
      "line": 6425,
      "preview": "| Diabetic exchanges: A method in which portions of foods with 15 g carbohydrates are interchangeabl"
    },
    {
      "type": "text",
      "section": "TABLE 14-3. Education Approaches for Mealtime Management for Children With Diabetes",
      "line": 6427,
      "preview": "--- page 333 ---"
    },
    {
      "type": "table",
      "section": "TABLE 14-3. Education Approaches for Mealtime Management for Children With Diabetes",
      "line": 6429,
      "preview": "| Approach and Description | Benefits | Limitations |"
    },
    {
      "type": "table",
      "section": "TABLE 14-3. Education Approaches for Mealtime Management for Children With Diabetes",
      "line": 6430,
      "preview": "| :--: | :--: | :--: |"
    },
    {
      "type": "table",
      "section": "TABLE 14-3. Education Approaches for Mealtime Management for Children With Diabetes",
      "line": 6431,
      "preview": "| MyPlate plan: The MyPlate method can help families create balanced meals by making one-half of the"
    },
    {
      "type": "table",
      "section": "TABLE 14-3. Education Approaches for Mealtime Management for Children With Diabetes",
      "line": 6432,
      "preview": "| Traffic light plan: Foods are assigned a color on a stoplight based on nutritional and caloric den"
    },
    {
      "type": "text",
      "section": "TABLE 14-3. Education Approaches for Mealtime Management for Children With Diabetes",
      "line": 6434,
      "preview": "Abbreviations: CDCES, Certified Diabetes Care and Education Specialist; ICR, insulin/carbohydrate ra"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "Portion control involves the following:",
      "line": 6436
    },
    {
      "type": "text",
      "section": "Portion control involves the following:",
      "line": 6438,
      "preview": "- Using measuring cups and/or food scales during meal prep and when serving food."
    },
    {
      "type": "text",
      "section": "Portion control involves the following:",
      "line": 6439,
      "preview": "- Reading nutrition facts labels for serving size, servings per container, and total grams of carboh"
    },
    {
      "type": "text",
      "section": "Portion control involves the following:",
      "line": 6441,
      "preview": "Refer to Table 14-4 for helpful tools for carbohydrate counting."
    },
    {
      "type": "text",
      "section": "Portion control involves the following:",
      "line": 6443,
      "preview": "--- page 334 ---"
    },
    {
      "type": "text",
      "section": "Portion control involves the following:",
      "line": 6445,
      "preview": "TABLE 14-4. Helpful Tools for Carbohydrate Counting"
    },
    {
      "type": "table",
      "section": "Portion control involves the following:",
      "line": 6447,
      "preview": "| Name of Tool (Type) | Pros | Cons | Cost |"
    },
    {
      "type": "table",
      "section": "Portion control involves the following:",
      "line": 6448,
      "preview": "| :--: | :--: | :--: | :--: |"
    },
    {
      "type": "table",
      "section": "Portion control involves the following:",
      "line": 6449,
      "preview": "| CalorieKing (app/website) https://www.calorieking.com Available in English/Spanish | - Accuracy of"
    },
    {
      "type": "table",
      "section": "Portion control involves the following:",
      "line": 6450,
      "preview": "| MyFitnessPal (app) Available in multiple languages | - Large database of foods, including cultural"
    },
    {
      "type": "text",
      "section": "Portion control involves the following:",
      "line": 6452,
      "preview": "--- page 335 ---"
    },
    {
      "type": "table",
      "section": "Portion control involves the following:",
      "line": 6454,
      "preview": "| Name of Tool (Type) | Pros | Cons | Cost |"
    },
    {
      "type": "table",
      "section": "Portion control involves the following:",
      "line": 6455,
      "preview": "| :--: | :--: | :--: | :--: |"
    },
    {
      "type": "table",
      "section": "Portion control involves the following:",
      "line": 6456,
      "preview": "| Figwee (app) <br> Available in English | - Provides visual estimator based on how foods appear on "
    },
    {
      "type": "table",
      "section": "Portion control involves the following:",
      "line": 6457,
      "preview": "| MyPlate (app/website) https://www.myplate.gov Available in English/Spanish | Users can navigate th"
    },
    {
      "type": "table",
      "section": "Portion control involves the following:",
      "line": 6458,
      "preview": "| American Diabetes <br> Association: Diabetes Food Hub (website) diabetesfoodhub.org Available in E"
    },
    {
      "type": "text",
      "section": "Portion control involves the following:",
      "line": 6460,
      "preview": "Abbreviation: USDA, US Department of Agriculture."
    },
    {
      "type": "text",
      "section": "Portion control involves the following:",
      "line": 6462,
      "preview": "It is important to consider the difference between simple verses complex carbohydrates that contain "
    },
    {
      "type": "text",
      "section": "Portion control involves the following:",
      "line": 6464,
      "preview": "--- page 336 ---"
    },
    {
      "type": "text",
      "section": "Portion control involves the following:",
      "line": 6466,
      "preview": "carbohydrates; they may cause a laxative effect if consumed in large amounts ( $>20 \\mathrm{~g}$ ), "
    },
    {
      "type": "text",
      "section": "Portion control involves the following:",
      "line": 6468,
      "preview": "For insulin dosing of foods that contain high fiber ( $>5 \\mathrm{~g}$ ) or sugar alcohols ( $>5 \\ma"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "Medications",
      "line": 6470
    },
    {
      "type": "text",
      "section": "Medications",
      "line": 6472,
      "preview": "For those on mealtime insulin, it is important to educate on dosing rapid or fast-acting insulin $10"
    },
    {
      "type": "text",
      "section": "Medications",
      "line": 6474,
      "preview": "--- page 337 ---"
    },
    {
      "type": "text",
      "section": "Medications",
      "line": 6476,
      "preview": "TABLE 14-5. Subcutaneous Insulin Injectables ${ }^{a-c}$"
    },
    {
      "type": "table",
      "section": "Medications",
      "line": 6478,
      "preview": "| Action | Analogue | Insulin Name | Onset | Peak | Effective <br> Duration |"
    },
    {
      "type": "table",
      "section": "Medications",
      "line": 6479,
      "preview": "| :-- | :-- | :-- | :-- | :-- | :-- |"
    },
    {
      "type": "table",
      "section": "Medications",
      "line": 6480,
      "preview": "| Bolus | Very rapid <br> acting | Aspart (Fiasp) | 2.5 min | $\\sim 60 \\mathrm{~min}$ | $3-5 \\mathrm"
    },
    {
      "type": "table",
      "section": "Medications",
      "line": 6481,
      "preview": "|  | Rapid acting | Novolog, Humalog, <br> Apidra | $5-15$ <br> min | $30-90$ <br> min | $<5 \\mathrm"
    },
    {
      "type": "table",
      "section": "Medications",
      "line": 6482,
      "preview": "|  | Short acting | Regular | $30-60$ <br> min | $2-3 \\mathrm{~h}$ | $5-8 \\mathrm{~h}$ |"
    },
    {
      "type": "table",
      "section": "Medications",
      "line": 6483,
      "preview": "|  | Intermediate | NPH | $2-4 \\mathrm{~h}$ | $4-10 \\mathrm{~h}$ | $10-16 \\mathrm{~h}$ |"
    },
    {
      "type": "table",
      "section": "Medications",
      "line": 6484,
      "preview": "|  | Long acting | Lantus/ <br> Basalglar | $2-4 \\mathrm{~h}$ | No peak | $20-24 \\mathrm{~h}$ |"
    },
    {
      "type": "table",
      "section": "Medications",
      "line": 6485,
      "preview": "|  |  | Tresiba | $\\sim 1 \\mathrm{~h}$ | - | $<42 \\mathrm{~h}$ |"
    },
    {
      "type": "text",
      "section": "Medications",
      "line": 6487,
      "preview": "Abbreviation: NPH, Neutral Protamine Hagedorn."
    },
    {
      "type": "text",
      "section": "Medications",
      "line": 6488,
      "preview": "${ }^{a}$ Data from Cornell S, Halstenson C, Miller DK. The Art and Science of Diabetes Care and Edu"
    },
    {
      "type": "text",
      "section": "Medications",
      "line": 6489,
      "preview": "${ }^{\\text {b }}$ Data from medication guides. US Food and Drug Administration. Accessed May 28, 20"
    },
    {
      "type": "text",
      "section": "Medications",
      "line": 6490,
      "preview": "${ }^{c}$ Data from Office of the Commissioner. FDA approves new treatment for pediatric patients wi"
    },
    {
      "type": "text",
      "section": "Medications",
      "line": 6492,
      "preview": "For those on T2DM medications, encourage taking medication with meals to reduce potential gastrointe"
    },
    {
      "type": "text",
      "section": "Medications",
      "line": 6494,
      "preview": "--- page 338 ---"
    },
    {
      "type": "text",
      "section": "Medications",
      "line": 6496,
      "preview": "TABLE 14-6. Approved Medications for Children Over Age 10 Years With T2DM"
    },
    {
      "type": "table",
      "section": "Medications",
      "line": 6498,
      "preview": "| Type of Medication | Medication Name | Frequency | Dose | Considerations |"
    },
    {
      "type": "table",
      "section": "Medications",
      "line": 6499,
      "preview": "| :--: | :--: | :--: | :--: | :--: |"
    },
    {
      "type": "table",
      "section": "Medications",
      "line": 6500,
      "preview": "| Oral medication (Biguanide) | Tablet: <br> Metformin, <br> Glucophage, <br> Fortamet, <br> Metform"
    },
    {
      "type": "text",
      "section": "Medications",
      "line": 6502,
      "preview": "--- page 339 ---"
    },
    {
      "type": "table",
      "section": "Medications",
      "line": 6504,
      "preview": "| Type of <br> Medication | Medication <br> Name | Frequency | Dose | Considerations |"
    },
    {
      "type": "table",
      "section": "Medications",
      "line": 6505,
      "preview": "| :--: | :--: | :--: | :--: | :--: |"
    },
    {
      "type": "table",
      "section": "Medications",
      "line": 6506,
      "preview": "| Subcutaneous injection (GLP-1 RA) | Liraglutide, <br> Victoza | Once a week | - 0.6 mg to improve "
    },
    {
      "type": "table",
      "section": "Medications",
      "line": 6507,
      "preview": "|  | Exenatide, Byetta, Exenatide XR, Bydureon, Bydureon BCise | Once a week | 2 mg once a week, wit"
    },
    {
      "type": "text",
      "section": "Medications",
      "line": 6509,
      "preview": "Abbreviations: BID, twice a day; GFR, glomerular filtration rate; GI, gastrointestinal; GLP-1 RA, gl"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "Exercise",
      "line": 6511
    },
    {
      "type": "text",
      "section": "Exercise",
      "line": 6513,
      "preview": "For children and adolescents, encourage 30-60 minutes of moderate-to-vigorous-intensity exercise dai"
    },
    {
      "type": "text",
      "section": "Exercise",
      "line": 6515,
      "preview": "For adults ( $>18 \\mathrm{y}$ ), encourage 150 minutes or more of moderate-to-vigorous-intensity exe"
    },
    {
      "type": "text",
      "section": "Exercise",
      "line": 6517,
      "preview": "--- page 340 ---"
    },
    {
      "type": "text",
      "section": "Exercise",
      "line": 6519,
      "preview": "acceptable. Moderate-to-intense exercise should be delayed if glucose levels are $\\geq 350 \\mathrm{m"
    },
    {
      "type": "text",
      "section": "Exercise",
      "line": 6521,
      "preview": "A plan should be customized to promote euglycemia during exercise. For those on insulin, consumption"
    },
    {
      "type": "text",
      "section": "Exercise",
      "line": 6523,
      "preview": "Weight Management. For children and adolescents 18 y , weight loss of $7 \\%-10 \\%$ body weight is su"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "Nutrition Monitoring and Recommendations",
      "line": 6525
    },
    {
      "type": "text",
      "section": "Nutrition Monitoring and Recommendations",
      "line": 6527,
      "preview": "Refer to Table 14-7 for a comprehensive list of routine labs and examinations to help prevent or mon"
    },
    {
      "type": "text",
      "section": "Nutrition Monitoring and Recommendations",
      "line": 6529,
      "preview": "--- page 341 ---"
    },
    {
      "type": "text",
      "section": "Nutrition Monitoring and Recommendations",
      "line": 6531,
      "preview": "TABLE 14-7. Monitoring of Laboratory Studies in Pediatric T1DM and T2DM ${ }^{a, b}$"
    },
    {
      "type": "table",
      "section": "Nutrition Monitoring and Recommendations",
      "line": 6533,
      "preview": "| Lab | Frequency of Screening | T1DM | T2DM |"
    },
    {
      "type": "table",
      "section": "Nutrition Monitoring and Recommendations",
      "line": 6534,
      "preview": "| :--: | :--: | :--: | :--: |"
    },
    {
      "type": "table",
      "section": "Nutrition Monitoring and Recommendations",
      "line": 6535,
      "preview": "| Hemoglobin <br> A1c | Every 3 mo | All | All |"
    },
    {
      "type": "table",
      "section": "Nutrition Monitoring and Recommendations",
      "line": 6536,
      "preview": "| T4 and TSH <br> (thyroid <br> function) | At diagnosis and every 1-2 <br> y or if symptoms occur |"
    },
    {
      "type": "table",
      "section": "Nutrition Monitoring and Recommendations",
      "line": 6537,
      "preview": "| tTG IgA <br> (celiac <br> antibodies) | At diagnosis, after 2 y , then <br> every 5 y , or if symp"
    },
    {
      "type": "table",
      "section": "Nutrition Monitoring and Recommendations",
      "line": 6538,
      "preview": "| Blood <br> pressure | At each visit | Increased risk for <br> hypertension with <br> poor glycemic"
    },
    {
      "type": "table",
      "section": "Nutrition Monitoring and Recommendations",
      "line": 6539,
      "preview": "| Lipid panel | T1DM: After glycemic <br> control is attained at <br> diagnosis and if $>2$ y of age"
    },
    {
      "type": "table",
      "section": "Nutrition Monitoring and Recommendations",
      "line": 6540,
      "preview": "| Urine <br> microalbumin | T1DM: 5 y after diagnosis, <br> at puberty, or $>10 \\mathrm{y}$, <br> wh"
    },
    {
      "type": "table",
      "section": "Nutrition Monitoring and Recommendations",
      "line": 6541,
      "preview": "| Retinopathy <br> screening | T1DM: 3-5 y after <br> diagnosis, at puberty, or $>11$ <br> y, whiche"
    },
    {
      "type": "text",
      "section": "Nutrition Monitoring and Recommendations",
      "line": 6543,
      "preview": "--- page 342 ---"
    },
    {
      "type": "table",
      "section": "Nutrition Monitoring and Recommendations",
      "line": 6545,
      "preview": "| Lab | Frequency of Screening | T1DM | T2DM |"
    },
    {
      "type": "table",
      "section": "Nutrition Monitoring and Recommendations",
      "line": 6546,
      "preview": "| :-- | :-- | :-- | :-- |"
    },
    {
      "type": "table",
      "section": "Nutrition Monitoring and Recommendations",
      "line": 6547,
      "preview": "| Neuropathy <br> screening | T1DM: 5 y after diagnosis, <br> at puberty, or $>10 \\mathrm{y}$, <br> "
    },
    {
      "type": "table",
      "section": "Nutrition Monitoring and Recommendations",
      "line": 6548,
      "preview": "| Pancreatic <br> antibodies | Overweight/obese children <br> at diagnosis to rule out <br> T1DM | N"
    },
    {
      "type": "table",
      "section": "Nutrition Monitoring and Recommendations",
      "line": 6549,
      "preview": "| AST and ALT <br> (liver <br> function) | At diagnosis and repeat <br> yearly | At higher risk than"
    },
    {
      "type": "table",
      "section": "Nutrition Monitoring and Recommendations",
      "line": 6550,
      "preview": "| Sleep apnea | When symptoms present | NA | T2DM at higher <br> risk |"
    },
    {
      "type": "table",
      "section": "Nutrition Monitoring and Recommendations",
      "line": 6551,
      "preview": "| Polycystic <br> ovary <br> syndrome | Female adolescents, when <br> symptoms present | NA | T2DM a"
    },
    {
      "type": "text",
      "section": "Nutrition Monitoring and Recommendations",
      "line": 6553,
      "preview": "Abbreviations: ALT, alanine aminotransferase; AST, aspartate aminotransferase; CVD, cardiovascular d"
    },
    {
      "type": "text",
      "section": "Nutrition Monitoring and Recommendations",
      "line": 6554,
      "preview": "${ }^{a}$ Data from Yehl K. AADE practice paper in brief: pediatric diabetes: the role of the diabet"
    },
    {
      "type": "text",
      "section": "Nutrition Monitoring and Recommendations",
      "line": 6555,
      "preview": "${ }^{\\text {b }}$ Data from Draznin B, Aroda VR, Bakris G, et al.; American Diabetes Association Pr"
    },
    {
      "type": "text",
      "section": "Nutrition Monitoring and Recommendations",
      "line": 6557,
      "preview": "Screen youth with T1DM for disordered eating starting at 10 to 12 years of age using the Diabetes Ea"
    },
    {
      "type": "text",
      "section": "Nutrition Monitoring and Recommendations",
      "line": 6559,
      "preview": "--- page 343 ---"
    },
    {
      "type": "text",
      "section": "Nutrition Monitoring and Recommendations",
      "line": 6561,
      "preview": "are at a higher risk than their peers for developing an eating disorder. ${ }^{20,21}$ It is importa"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "References",
      "line": 6563
    },
    {
      "type": "text",
      "section": "References",
      "line": 6565,
      "preview": "1. Serbis A, Giapros V, Kotanidou EP, Galli-Tsinopoulou A, Siomou E. Diagnosis, treatment and preven"
    },
    {
      "type": "text",
      "section": "References",
      "line": 6566,
      "preview": "2. American Diabetes Association. 2. Classification and diagnosis of diabetes: Standards of Medical "
    },
    {
      "type": "text",
      "section": "References",
      "line": 6567,
      "preview": "3. American Diabetes Association. EAG/A1C conversion calculator. Accessed June 25, 2022. https://pro"
    },
    {
      "type": "text",
      "section": "References",
      "line": 6568,
      "preview": "4. ElSayed NA, Aleppo G, Aroda VR, et al. 14. Children and adolescents: Standards of Care in Diabete"
    },
    {
      "type": "text",
      "section": "References",
      "line": 6569,
      "preview": "5. Beaver B, Ling H, Carvalho-Salemi J, et al. Texas Children's Hospital Pediatric Nutrition Referen"
    },
    {
      "type": "text",
      "section": "References",
      "line": 6570,
      "preview": "6. Wheeler ML, Dunbar SA, Jaacks LM, et al. Macronutrients, food groups, and eating patterns in the "
    },
    {
      "type": "text",
      "section": "References",
      "line": 6571,
      "preview": "7. Corbin KD, Driscoll KA, Pratley RE, Smith SR, Maahs DM; Advancing Care for Type 1 Diabetes and Ob"
    },
    {
      "type": "text",
      "section": "References",
      "line": 6572,
      "preview": "8. U.S. Department of Agriculture and U.S. Department of Health and Human Services. Dietary guidelin"
    },
    {
      "type": "text",
      "section": "References",
      "line": 6573,
      "preview": "12/Dietary_Guidelines_for_Americans_2020-2025.pdf"
    },
    {
      "type": "text",
      "section": "References",
      "line": 6574,
      "preview": "9. Daly A. Use of insulin and weight gain: optimizing diabetes nutrition therapy. J Am Diet Assoc. 2"
    },
    {
      "type": "text",
      "section": "References",
      "line": 6575,
      "preview": "10. Gray A, Threlkeld RJ. Nutritional recommendations for individuals with diabetes. In: Feingold KR"
    },
    {
      "type": "text",
      "section": "References",
      "line": 6576,
      "preview": "11. Seckold R, Howley P, King BR, Bell K, Smith A, Smart CE. Dietary intake and eating patterns of y"
    },
    {
      "type": "text",
      "section": "References",
      "line": 6578,
      "preview": "--- page 344 ---"
    },
    {
      "type": "text",
      "section": "References",
      "line": 6580,
      "preview": "12. Hager ER, Quigg AM, Black MM, et al. Development and validity of a 2-item screen to identify fam"
    },
    {
      "type": "text",
      "section": "References",
      "line": 6581,
      "preview": "13. Franz MJ, Bantle JP, Beebe CA, et al.; American Diabetes Association. Nutrition principles and r"
    },
    {
      "type": "text",
      "section": "References",
      "line": 6582,
      "preview": "14. Korytkowski MT, Muniyappa R, Antinori-Lent K, et al. Management of hyperglycemia in hospitalized"
    },
    {
      "type": "text",
      "section": "References",
      "line": 6583,
      "preview": "15. Evert AB, Boucher JL, Cypress M, et al. Nutrition therapy recommendations for the management of "
    },
    {
      "type": "text",
      "section": "References",
      "line": 6584,
      "preview": "16. Msomi NZ, Erukainure OL, Islam MS. Suitability of sugar alcohols as antidiabetic supplements: a "
    },
    {
      "type": "text",
      "section": "References",
      "line": 6585,
      "preview": "17. ElSayed NA, Aleppo G, Aroda VR, et al.; American Diabetes Association. 5. Facilitating positive "
    },
    {
      "type": "text",
      "section": "References",
      "line": 6586,
      "preview": "18. Cornell S, Halstenson C, Miller DK. The Art and Science of Diabetes Care and Education. Associat"
    },
    {
      "type": "text",
      "section": "References",
      "line": 6587,
      "preview": "19. Markowitz JT, Butler DA, Volkening LK, Antisdel JE, Anderson BJ, Laffel LMB. Brief screening too"
    },
    {
      "type": "text",
      "section": "References",
      "line": 6588,
      "preview": "20. Clery P, Stahl D, Ismail K, Treasure J, Kan C. Systematic review and meta-analysis of the effica"
    },
    {
      "type": "text",
      "section": "References",
      "line": 6589,
      "preview": "21. Arslanian S, Bacha F, Grey M, Marcus MD, White NH, Zeitler P. Evaluation and management of youth"
    },
    {
      "type": "text",
      "section": "References",
      "line": 6591,
      "preview": "--- page 345 ---"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "Disordered Eating",
      "line": 6593
    },
    {
      "type": "text",
      "section": "Disordered Eating",
      "line": 6595,
      "preview": "Mary Pat Turon-Findley, Med, RD, CMHIMP, LD"
    },
    {
      "type": "heading",
      "level": 2,
      "section": "Introduction",
      "line": 6597
    },
    {
      "type": "text",
      "section": "Introduction",
      "line": 6599,
      "preview": "Disordered eating and eating disorders are often underdiagnosed disease states that affect many yout"
    },
    {
      "type": "text",
      "section": "Introduction",
      "line": 6601,
      "preview": "This chapter reviews the classification, diagnosis, assessment, general etiology, therapy and treatm"
    },
    {
      "type": "heading",
      "level": 2,
      "section": "Classification and Diagnosis of Disordered Eating",
      "line": 6603
    },
    {
      "type": "text",
      "section": "Classification and Diagnosis of Disordered Eating",
      "line": 6605,
      "preview": "The American Psychiatric Association recommends using a multiaxial system in the assessment and diag"
    },
    {
      "type": "text",
      "section": "Classification and Diagnosis of Disordered Eating",
      "line": 6607,
      "preview": "--- page 346 ---"
    },
    {
      "type": "text",
      "section": "Classification and Diagnosis of Disordered Eating",
      "line": 6609,
      "preview": "TABLE 15-1. Eating Disorder and Feeding Disorder Summary (DSM-5)"
    },
    {
      "type": "table",
      "section": "Classification and Diagnosis of Disordered Eating",
      "line": 6611,
      "preview": "| Anorexia nervosa | - Restriction of energy intake or requirements leading to significantly low bod"
    },
    {
      "type": "table",
      "section": "Classification and Diagnosis of Disordered Eating",
      "line": 6612,
      "preview": "| :--: | :--: |"
    },
    {
      "type": "table",
      "section": "Classification and Diagnosis of Disordered Eating",
      "line": 6613,
      "preview": "| Bulimia nervosa | - Recurrent episodes of binge eating over a discrete period of time and a sense "
    },
    {
      "type": "table",
      "section": "Classification and Diagnosis of Disordered Eating",
      "line": 6614,
      "preview": "| Avoidant/restrictive food intake disorder | - An eating or feeding disturbance with significant we"
    },
    {
      "type": "table",
      "section": "Classification and Diagnosis of Disordered Eating",
      "line": 6615,
      "preview": "| Rumination disorder | - Repeated regurgitation or chewing and spitting foods over a period of at l"
    },
    {
      "type": "table",
      "section": "Classification and Diagnosis of Disordered Eating",
      "line": 6616,
      "preview": "| Binge eating disorder | - Recurrent episodes of binge eating over a discrete period of time of amo"
    },
    {
      "type": "text",
      "section": "Classification and Diagnosis of Disordered Eating",
      "line": 6618,
      "preview": "--- page 347 ---"
    },
    {
      "type": "table",
      "section": "Classification and Diagnosis of Disordered Eating",
      "line": 6620,
      "preview": "|  | during that period, and a sense of lack of control <br> - Eating is more rapid than normal, fee"
    },
    {
      "type": "table",
      "section": "Classification and Diagnosis of Disordered Eating",
      "line": 6621,
      "preview": "| :-- | :-- |"
    },
    {
      "type": "table",
      "section": "Classification and Diagnosis of Disordered Eating",
      "line": 6622,
      "preview": "| Other specified <br> feeding or eating <br> disorder | Applies to presentations associated with di"
    },
    {
      "type": "table",
      "section": "Classification and Diagnosis of Disordered Eating",
      "line": 6623,
      "preview": "| Unspecified <br> feeding or eating <br> disorders | May present as an eating disorder owing to a v"
    },
    {
      "type": "text",
      "section": "Classification and Diagnosis of Disordered Eating",
      "line": 6625,
      "preview": "Abbreviations: BMI, body mass index; DSM-5, Diagnostic and Statistical Manual of Mental Disorders, F"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "Assessment and Nutrient Requirements",
      "line": 6627
    },
    {
      "type": "text",
      "section": "Assessment and Nutrient Requirements",
      "line": 6629,
      "preview": "Establishing trust and rapport is vital to proper assessment and successful treatment with a nonjudg"
    },
    {
      "type": "text",
      "section": "Assessment and Nutrient Requirements",
      "line": 6631,
      "preview": "During the assessment process, the clinical practitioner should assess for signs and symptoms of mal"
    },
    {
      "type": "text",
      "section": "Assessment and Nutrient Requirements",
      "line": 6633,
      "preview": "--- page 348 ---"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "TABLE 15-2. History and Examination Considerations in Disordered Eating ${ }^{\\text {a-e }}$",
      "line": 6635
    },
    {
      "type": "table",
      "section": "TABLE 15-2. History and Examination Considerations in Disordered Eating ${ }^{\\text {a-e }}$",
      "line": 6637,
      "preview": "| History | Examination |  |"
    },
    {
      "type": "table",
      "section": "TABLE 15-2. History and Examination Considerations in Disordered Eating ${ }^{\\text {a-e }}$",
      "line": 6638,
      "preview": "| :-- | :-- | :-- |"
    },
    {
      "type": "table",
      "section": "TABLE 15-2. History and Examination Considerations in Disordered Eating ${ }^{\\text {a-e }}$",
      "line": 6639,
      "preview": "| Growth stunting | Muscle wasting | Scars on knuckles |"
    },
    {
      "type": "table",
      "section": "TABLE 15-2. History and Examination Considerations in Disordered Eating ${ }^{\\text {a-e }}$",
      "line": 6640,
      "preview": "| Cognition changes | Lanugo type hair | Cyanosis of <br> extremities |"
    },
    {
      "type": "table",
      "section": "TABLE 15-2. History and Examination Considerations in Disordered Eating ${ }^{\\text {a-e }}$",
      "line": 6641,
      "preview": "| Impaired healing | Hair loss | Dehydration |"
    },
    {
      "type": "table",
      "section": "TABLE 15-2. History and Examination Considerations in Disordered Eating ${ }^{\\text {a-e }}$",
      "line": 6642,
      "preview": "| Unexplained weight loss or gain | Dental erosions | Bradycardia |"
    },
    {
      "type": "table",
      "section": "TABLE 15-2. History and Examination Considerations in Disordered Eating ${ }^{\\text {a-e }}$",
      "line": 6643,
      "preview": "| Early satiety | Cuts on corners of <br> mouth | Edema |"
    },
    {
      "type": "table",
      "section": "TABLE 15-2. History and Examination Considerations in Disordered Eating ${ }^{\\text {a-e }}$",
      "line": 6644,
      "preview": "| Isolation | Salivary gland <br> swelling | Balance issues |"
    },
    {
      "type": "table",
      "section": "TABLE 15-2. History and Examination Considerations in Disordered Eating ${ }^{\\text {a-e }}$",
      "line": 6645,
      "preview": "| Relationship changes | Dry skin | Marks from self- <br> injury |"
    },
    {
      "type": "table",
      "section": "TABLE 15-2. History and Examination Considerations in Disordered Eating ${ }^{\\text {a-e }}$",
      "line": 6646,
      "preview": "| Changes in menstruation | Constipation or <br> diarrhea | Cognitive <br> impairment |"
    },
    {
      "type": "table",
      "section": "TABLE 15-2. History and Examination Considerations in Disordered Eating ${ }^{\\text {a-e }}$",
      "line": 6647,
      "preview": "| Binging or purging | - | - |"
    },
    {
      "type": "table",
      "section": "TABLE 15-2. History and Examination Considerations in Disordered Eating ${ }^{\\text {a-e }}$",
      "line": 6648,
      "preview": "| Laxative, diet pill, caffeine, or diuretic <br> use | - | - |"
    },
    {
      "type": "text",
      "section": "TABLE 15-2. History and Examination Considerations in Disordered Eating ${ }^{\\text {a-e }}$",
      "line": 6650,
      "preview": "${ }^{a}$ Data from Findley MP. Eating disorders. In: Corkins MR, ed. The A.S.P.E.N. Pediatric Nutri"
    },
    {
      "type": "text",
      "section": "TABLE 15-2. History and Examination Considerations in Disordered Eating ${ }^{\\text {a-e }}$",
      "line": 6651,
      "preview": "${ }^{\\text {b }}$ Data from American Psychiatric Association. Feeding and Eating Disorders. In: Dia"
    },
    {
      "type": "text",
      "section": "TABLE 15-2. History and Examination Considerations in Disordered Eating ${ }^{\\text {a-e }}$",
      "line": 6652,
      "preview": "${ }^{c}$ Data from National Eating Disorders Association. 2022."
    },
    {
      "type": "text",
      "section": "TABLE 15-2. History and Examination Considerations in Disordered Eating ${ }^{\\text {a-e }}$",
      "line": 6653,
      "preview": "https://www.nationaleatingdisorders.org"
    },
    {
      "type": "text",
      "section": "TABLE 15-2. History and Examination Considerations in Disordered Eating ${ }^{\\text {a-e }}$",
      "line": 6654,
      "preview": "${ }^{d}$ Data from Setnick J. The Eating Disorders Clinical Pocket Guide. 2nd ed. Snack Time Press;"
    },
    {
      "type": "text",
      "section": "TABLE 15-2. History and Examination Considerations in Disordered Eating ${ }^{\\text {a-e }}$",
      "line": 6655,
      "preview": "${ }^{e}$ Data from Setnick J. Academy of Nutrition and Dietetics Pocket Guide to Eating Disorders. "
    },
    {
      "type": "heading",
      "level": 2,
      "section": "Macronutrient Requirements",
      "line": 6657
    },
    {
      "type": "text",
      "section": "Macronutrient Requirements",
      "line": 6659,
      "preview": "For patients with anorexia nervosa, estimated energy requirements are $30-40 \\mathrm{kcal} / \\mathrm"
    },
    {
      "type": "text",
      "section": "Macronutrient Requirements",
      "line": 6661,
      "preview": "--- page 349 ---"
    },
    {
      "type": "text",
      "section": "Macronutrient Requirements",
      "line": 6663,
      "preview": "binge eating disorder, energy requirements for weight maintenance are around $1.2-1.3 \\mathrm{kcal} "
    },
    {
      "type": "heading",
      "level": 1,
      "section": "Implementation Plan and Monitoring",
      "line": 6665
    },
    {
      "type": "text",
      "section": "Implementation Plan and Monitoring",
      "line": 6667,
      "preview": "Disordered eating is a complex process, and it is important that any protocol is adjusted based on p"
    },
    {
      "type": "text",
      "section": "Implementation Plan and Monitoring",
      "line": 6669,
      "preview": "The laboratory assessment at presentation includes the following:"
    },
    {
      "type": "text",
      "section": "Implementation Plan and Monitoring",
      "line": 6671,
      "preview": "- Complete blood cell count"
    },
    {
      "type": "text",
      "section": "Implementation Plan and Monitoring",
      "line": 6672,
      "preview": "- Electrolytes, including magnesium, phosphorus, and calcium"
    },
    {
      "type": "text",
      "section": "Implementation Plan and Monitoring",
      "line": 6673,
      "preview": "- Glucose"
    },
    {
      "type": "text",
      "section": "Implementation Plan and Monitoring",
      "line": 6674,
      "preview": "- Zinc"
    },
    {
      "type": "text",
      "section": "Implementation Plan and Monitoring",
      "line": 6675,
      "preview": "- Ferritin, iron-binding capacity, and iron saturation"
    },
    {
      "type": "text",
      "section": "Implementation Plan and Monitoring",
      "line": 6676,
      "preview": "- 25-hydroxy vitamin D"
    },
    {
      "type": "text",
      "section": "Implementation Plan and Monitoring",
      "line": 6677,
      "preview": "- Thiamin"
    },
    {
      "type": "heading",
      "level": 2,
      "section": "Nutrition Support Plan",
      "line": 6680
    },
    {
      "type": "text",
      "section": "Nutrition Support Plan",
      "line": 6682,
      "preview": "When developing the nutrition support plan, the IBW should be used (estimated 50th percentile for ag"
    },
    {
      "type": "text",
      "section": "Nutrition Support Plan",
      "line": 6684,
      "preview": "Recommendations for initiation and advancement of nutrition support in patients with disordered eati"
    },
    {
      "type": "text",
      "section": "Nutrition Support Plan",
      "line": 6686,
      "preview": "--- page 350 ---"
    },
    {
      "type": "text",
      "section": "Nutrition Support Plan",
      "line": 6688,
      "preview": "Clinical professionals should assess patients and advance energy intake goals based on refeeding ris"
    },
    {
      "type": "text",
      "section": "Nutrition Support Plan",
      "line": 6690,
      "preview": "--- page 351 ---"
    },
    {
      "type": "text",
      "section": "Nutrition Support Plan",
      "line": 6692,
      "preview": "TABLE 15-3. Initiation and Advancement of Nutrition Support in Patients With Disordered Eating"
    },
    {
      "type": "table",
      "section": "Nutrition Support Plan",
      "line": 6694,
      "preview": "| Energy or <br> Nutrient | Days 1-3 | Days 4-7 | Days 8-14 |"
    },
    {
      "type": "table",
      "section": "Nutrition Support Plan",
      "line": 6695,
      "preview": "| :-- | :-- | :-- | :-- |"
    },
    {
      "type": "table",
      "section": "Nutrition Support Plan",
      "line": 6696,
      "preview": "| Energy | $50 \\%$ of goal, or 20-40 <br> kcal/kg/d of current body <br> weight | Advance by 200- <b"
    },
    {
      "type": "table",
      "section": "Nutrition Support Plan",
      "line": 6697,
      "preview": "| Carbohydrate | $2-3 \\mathrm{~g} / \\mathrm{kg} / \\mathrm{d}$ | Advance to meet <br> daily calorie <"
    },
    {
      "type": "table",
      "section": "Nutrition Support Plan",
      "line": 6698,
      "preview": "| Protein | $1-1.5 \\mathrm{~g} / \\mathrm{kg} / \\mathrm{d}$ | $1-1.5 \\mathrm{~g} / \\mathrm{kg} / \\mat"
    },
    {
      "type": "table",
      "section": "Nutrition Support Plan",
      "line": 6699,
      "preview": "| Fat | $1 \\mathrm{~g} / \\mathrm{kg} / \\mathrm{d}$ | $1 \\mathrm{~g} / \\mathrm{kg} / \\mathrm{d}$ | $1"
    },
    {
      "type": "table",
      "section": "Nutrition Support Plan",
      "line": 6700,
      "preview": "| Fluid | $800-1000 \\mathrm{~mL} / \\mathrm{d}$ | Advance with <br> calories if <br> electrolytes are"
    },
    {
      "type": "table",
      "section": "Nutrition Support Plan",
      "line": 6701,
      "preview": "| Phosphorus | Correct low serum levels <br> aggressively with 9-18 <br> mmol over 2-12 h as <br> in"
    },
    {
      "type": "table",
      "section": "Nutrition Support Plan",
      "line": 6702,
      "preview": "| Potassium | Correct low serum levels <br> as necessary | $2-4 \\mathrm{mmol} / \\mathrm{kg} / \\mathr"
    },
    {
      "type": "table",
      "section": "Nutrition Support Plan",
      "line": 6703,
      "preview": "| Magnesium | Correct moderately low <br> serum levels with 0.5 <br> mmol/kg over 24 h ; <br> correc"
    },
    {
      "type": "table",
      "section": "Nutrition Support Plan",
      "line": 6704,
      "preview": "| Thiamin | $200-300 \\mathrm{mg} / \\mathrm{d}$ | $200-300 \\mathrm{mg} / \\mathrm{d}$ | $200-300 \\math"
    },
    {
      "type": "table",
      "section": "Nutrition Support Plan",
      "line": 6705,
      "preview": "| Other <br> vitamins/ <br> minerals | Multivitamin/mineral <br> supplement daily | Multivitamin/min"
    },
    {
      "type": "text",
      "section": "Nutrition Support Plan",
      "line": 6707,
      "preview": "--- page 352 ---"
    },
    {
      "type": "text",
      "section": "Nutrition Support Plan",
      "line": 6709,
      "preview": "Adapted with permission from the American Society for Parenteral and Enteral Nutrition from Turon-Fi"
    },
    {
      "type": "text",
      "section": "Nutrition Support Plan",
      "line": 6711,
      "preview": "Protein provision should be $0.8-1.5 \\mathrm{~g} / \\mathrm{kg}$ or $15 \\%-20 \\%$ of total calories f"
    },
    {
      "type": "text",
      "section": "Nutrition Support Plan",
      "line": 6713,
      "preview": "Fluids are critical for hydration, and orthostatic pulse and blood pressure need to be monitored fro"
    },
    {
      "type": "text",
      "section": "Nutrition Support Plan",
      "line": 6715,
      "preview": "The clinical professional should take daily opportunities to reassess health and medical status usin"
    },
    {
      "type": "text",
      "section": "Nutrition Support Plan",
      "line": 6717,
      "preview": "Micronutrient deficiencies often occur in patients with disordered eating, especially in the setting"
    },
    {
      "type": "text",
      "section": "Nutrition Support Plan",
      "line": 6719,
      "preview": "Mealtime should be calm, and clinical professionals should offer patient support and discussion as n"
    },
    {
      "type": "text",
      "section": "Nutrition Support Plan",
      "line": 6721,
      "preview": "--- page 353 ---"
    },
    {
      "type": "text",
      "section": "Nutrition Support Plan",
      "line": 6723,
      "preview": "needs in addition to stabilization of health. An example nutrition support order set for patients wi"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "EXHIBIT 15-1. Nutrition Support Order Set for Patient With Disordered Eating",
      "line": 6725
    },
    {
      "type": "text",
      "section": "EXHIBIT 15-1. Nutrition Support Order Set for Patient With Disordered Eating",
      "line": 6727,
      "preview": "- Order 4-6 feedings daily to provide recommended caloric energy, protein, fat, fluids, and nutrient"
    },
    {
      "type": "text",
      "section": "EXHIBIT 15-1. Nutrition Support Order Set for Patient With Disordered Eating",
      "line": 6728,
      "preview": "- Record calorie count and intake and output."
    },
    {
      "type": "text",
      "section": "EXHIBIT 15-1. Nutrition Support Order Set for Patient With Disordered Eating",
      "line": 6729,
      "preview": "- Blind weight in morning after void in gown, suggest same scale and same time of day with same type"
    },
    {
      "type": "text",
      "section": "EXHIBIT 15-1. Nutrition Support Order Set for Patient With Disordered Eating",
      "line": 6730,
      "preview": "- Restrict physical activity."
    },
    {
      "type": "text",
      "section": "EXHIBIT 15-1. Nutrition Support Order Set for Patient With Disordered Eating",
      "line": 6731,
      "preview": "- Monitor laboratory values."
    },
    {
      "type": "text",
      "section": "EXHIBIT 15-1. Nutrition Support Order Set for Patient With Disordered Eating",
      "line": 6732,
      "preview": "- Monitor orthostatic measures."
    },
    {
      "type": "text",
      "section": "EXHIBIT 15-1. Nutrition Support Order Set for Patient With Disordered Eating",
      "line": 6733,
      "preview": "- Create behavioral plan on allotted time for eating."
    },
    {
      "type": "text",
      "section": "EXHIBIT 15-1. Nutrition Support Order Set for Patient With Disordered Eating",
      "line": 6734,
      "preview": "- Recommend a multivitamin with mineral supplement."
    },
    {
      "type": "text",
      "section": "EXHIBIT 15-1. Nutrition Support Order Set for Patient With Disordered Eating",
      "line": 6735,
      "preview": "- Create a calories and advancement plan."
    },
    {
      "type": "text",
      "section": "EXHIBIT 15-1. Nutrition Support Order Set for Patient With Disordered Eating",
      "line": 6736,
      "preview": "- Create weight goals for stay, per day, and per week."
    },
    {
      "type": "text",
      "section": "EXHIBIT 15-1. Nutrition Support Order Set for Patient With Disordered Eating",
      "line": 6737,
      "preview": "- Monitor for bowel sounds/movements."
    },
    {
      "type": "text",
      "section": "EXHIBIT 15-1. Nutrition Support Order Set for Patient With Disordered Eating",
      "line": 6738,
      "preview": "- Supplement plan for refusal of intake. ${ }^{\\text {a,b }}$"
    },
    {
      "type": "text",
      "section": "EXHIBIT 15-1. Nutrition Support Order Set for Patient With Disordered Eating",
      "line": 6739,
      "preview": "a Turon-Findley MP. Eating disorders. In: Corkins MR, ed. Bobo E, Christensen ML, Larson-Nath C, Nus"
    },
    {
      "type": "text",
      "section": "EXHIBIT 15-1. Nutrition Support Order Set for Patient With Disordered Eating",
      "line": 6740,
      "preview": "${ }^{\\text {b }}$ Setnick J. Academy of Nutrition and Dietetics Pocket Guide to Eating Disorders. 2"
    },
    {
      "type": "text",
      "section": "EXHIBIT 15-1. Nutrition Support Order Set for Patient With Disordered Eating",
      "line": 6742,
      "preview": "The interdisciplinary team should be unified and maintain communication throughout the process of tr"
    },
    {
      "type": "heading",
      "level": 2,
      "section": "Enteral Nutrition Support and Route of Feeding",
      "line": 6744
    },
    {
      "type": "text",
      "section": "Enteral Nutrition Support and Route of Feeding",
      "line": 6746,
      "preview": "--- page 354 ---"
    },
    {
      "type": "text",
      "section": "Enteral Nutrition Support and Route of Feeding",
      "line": 6748,
      "preview": "Disordered eating and eating disorders are complex and in treatment, when patient is refusing oral i"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "Refeeding Syndrome",
      "line": 6750
    },
    {
      "type": "text",
      "section": "Refeeding Syndrome",
      "line": 6752,
      "preview": "Re-initiation of carbohydrate-containing feeding of severely malnourished patients may result in ref"
    },
    {
      "type": "heading",
      "level": 2,
      "section": "Summary",
      "line": 6754
    },
    {
      "type": "text",
      "section": "Summary",
      "line": 6756,
      "preview": "Daily monitoring includes multiple factors during the treatment and implementation of the nutrition "
    },
    {
      "type": "text",
      "section": "Summary",
      "line": 6758,
      "preview": "--- page 355 ---"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "References",
      "line": 6760
    },
    {
      "type": "text",
      "section": "References",
      "line": 6762,
      "preview": "1. Turon-Findley MP. Eating disorders. In: Corkins MR, ed. Bobo E, Christensen ML, Larson-Nath C, Nu"
    },
    {
      "type": "text",
      "section": "References",
      "line": 6763,
      "preview": "2. American Psychiatric Association. Feeding and eating disorders. In: Diagnostic and Statistical Ma"
    },
    {
      "type": "text",
      "section": "References",
      "line": 6764,
      "preview": "3. Eating recovery center webinar and materials. Eating Recovery Center. 2022. Accessed February 23,"
    },
    {
      "type": "text",
      "section": "References",
      "line": 6765,
      "preview": "4. National Eating Disorders Association. 2022. Accessed February 23, 2023. https://www.nationaleati"
    },
    {
      "type": "text",
      "section": "References",
      "line": 6766,
      "preview": "5. Setnick J. The Eating Disorders Clinical Pocket Guide. 2nd ed. Snack Time Press; 2013."
    },
    {
      "type": "text",
      "section": "References",
      "line": 6767,
      "preview": "6. Setnick J. Academy of Nutrition and Dietetics Pocket Guide to Eating Disorders. 2nd ed. Academy o"
    },
    {
      "type": "text",
      "section": "References",
      "line": 6768,
      "preview": "7. Konek SH, Becker PJ. Eating and feeding disorders. Samour \\& King's Pediatric Nutrition in Clinic"
    },
    {
      "type": "text",
      "section": "References",
      "line": 6769,
      "preview": "8. Crosbie C, Sterling W. How to Nourish Your Child Through an Eating Disorder. The Experiment; 2016"
    },
    {
      "type": "text",
      "section": "References",
      "line": 6770,
      "preview": "9. da Silva JSV, Seres DS, Sabino K, et al; Parenteral Nutrition Safety and Clinical Practice Commit"
    },
    {
      "type": "text",
      "section": "References",
      "line": 6771,
      "preview": "10. Hamilton C, ed. Nutrition-Focused Physical Exam for Adults: An Illustrated Guide. 2nd ed. Americ"
    },
    {
      "type": "text",
      "section": "References",
      "line": 6772,
      "preview": "11. Malone A, Carney LN, Carrera AL, Mays A, eds. ASPEN Enteral Nutrition Handbook. 2nd ed. American"
    },
    {
      "type": "text",
      "section": "References",
      "line": 6774,
      "preview": "--- page 356 ---"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "16",
      "line": 6776
    },
    {
      "type": "heading",
      "level": 2,
      "section": "Dyslipidemia",
      "line": 6778
    },
    {
      "type": "text",
      "section": "Dyslipidemia",
      "line": 6780,
      "preview": "Kari Murdy, RD, LD"
    },
    {
      "type": "heading",
      "level": 2,
      "section": "Introduction",
      "line": 6782
    },
    {
      "type": "text",
      "section": "Introduction",
      "line": 6784,
      "preview": "Dyslipidemia is defined as a disorder of lipoprotein metabolism that leads to 1 or more of the follo"
    },
    {
      "type": "text",
      "section": "Introduction",
      "line": 6786,
      "preview": "--- page 357 ---"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "TABLE 16-1. Types of Dyslipidemia",
      "line": 6788
    },
    {
      "type": "table",
      "section": "TABLE 16-1. Types of Dyslipidemia",
      "line": 6790,
      "preview": "| Primary or Genetic <br> Forms | Secondary Causes |"
    },
    {
      "type": "table",
      "section": "TABLE 16-1. Types of Dyslipidemia",
      "line": 6791,
      "preview": "| :--: | :--: |"
    },
    {
      "type": "table",
      "section": "TABLE 16-1. Types of Dyslipidemia",
      "line": 6792,
      "preview": "| - Familial hypercholesterolemia (most common; 1:250 people) <br> - Exogenous hypertriglyceridemia "
    },
    {
      "type": "text",
      "section": "TABLE 16-1. Types of Dyslipidemia",
      "line": 6794,
      "preview": "The prevalence of dyslipidemia in US children (ages 6-19 years) is about $20 \\% .{ }^{3}$ Dyslipidem"
    },
    {
      "type": "heading",
      "level": 2,
      "section": "Assessment and Nutrient Requirements",
      "line": 6796
    },
    {
      "type": "text",
      "section": "Assessment and Nutrient Requirements",
      "line": 6798,
      "preview": "--- page 358 ---"
    },
    {
      "type": "text",
      "section": "Assessment and Nutrient Requirements",
      "line": 6800,
      "preview": "Universal lipid screening is recommended between 9 and 11 years of age. ${ }^{5}$ If a nonfasting sa"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "TABLE 16-2. Lipoprotein Reference Ranges for Children and Adolescents",
      "line": 6802
    },
    {
      "type": "table",
      "section": "TABLE 16-2. Lipoprotein Reference Ranges for Children and Adolescents",
      "line": 6804,
      "preview": "| Category | Low <br> (mg/dL) | Acceptable (mg/dL) | Borderline (mg/dL) | High <br> (mg/dL) |"
    },
    {
      "type": "table",
      "section": "TABLE 16-2. Lipoprotein Reference Ranges for Children and Adolescents",
      "line": 6805,
      "preview": "| :-- | :--: | :--: | :--: | :--: |"
    },
    {
      "type": "table",
      "section": "TABLE 16-2. Lipoprotein Reference Ranges for Children and Adolescents",
      "line": 6806,
      "preview": "| TC | - | $<170$ | $170-199$ | $\\geq 200$ |"
    },
    {
      "type": "table",
      "section": "TABLE 16-2. Lipoprotein Reference Ranges for Children and Adolescents",
      "line": 6807,
      "preview": "| LDL-C | - | $<110$ | $110-129$ | $\\geq 130$ |"
    },
    {
      "type": "table",
      "section": "TABLE 16-2. Lipoprotein Reference Ranges for Children and Adolescents",
      "line": 6808,
      "preview": "| Non-HDL-C | - | $<120$ | $120-144$ | $\\geq 145$ |"
    },
    {
      "type": "table",
      "section": "TABLE 16-2. Lipoprotein Reference Ranges for Children and Adolescents",
      "line": 6809,
      "preview": "| TGs | - | $<75$ | $75-99$ | $\\geq 100$ |"
    },
    {
      "type": "table",
      "section": "TABLE 16-2. Lipoprotein Reference Ranges for Children and Adolescents",
      "line": 6810,
      "preview": "|  | - | $<90$ | $90-129$ | $\\geq 130$ |"
    },
    {
      "type": "table",
      "section": "TABLE 16-2. Lipoprotein Reference Ranges for Children and Adolescents",
      "line": 6811,
      "preview": "| HDL-C | $<40$ | $>45$ | $40-45$ | - |"
    },
    {
      "type": "text",
      "section": "TABLE 16-2. Lipoprotein Reference Ranges for Children and Adolescents",
      "line": 6813,
      "preview": "Abbreviations: HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein cholester"
    },
    {
      "type": "text",
      "section": "TABLE 16-2. Lipoprotein Reference Ranges for Children and Adolescents",
      "line": 6814,
      "preview": "Adapted with permission from the National Heart Lung and Blood Institute from Expert Panel on Integr"
    },
    {
      "type": "text",
      "section": "TABLE 16-2. Lipoprotein Reference Ranges for Children and Adolescents",
      "line": 6815,
      "preview": "https://doi.org/10.1542/peds.2009-2107C"
    },
    {
      "type": "text",
      "section": "TABLE 16-2. Lipoprotein Reference Ranges for Children and Adolescents",
      "line": 6817,
      "preview": "Once two reliable fasting lipid profiles are obtained, review the breakdown of the lipid profiles, a"
    },
    {
      "type": "text",
      "section": "TABLE 16-2. Lipoprotein Reference Ranges for Children and Adolescents",
      "line": 6819,
      "preview": "--- page 359 ---"
    },
    {
      "type": "text",
      "section": "TABLE 16-2. Lipoprotein Reference Ranges for Children and Adolescents",
      "line": 6821,
      "preview": "TABLE 16-3. Management of Specific Lipoprotein Abnormal Findings"
    },
    {
      "type": "table",
      "section": "TABLE 16-2. Lipoprotein Reference Ranges for Children and Adolescents",
      "line": 6823,
      "preview": "| Risk <br> Factor | Dietary <br> Recommendation | Specific <br> Nutrient/Pharmacotherapy <br> Recom"
    },
    {
      "type": "table",
      "section": "TABLE 16-2. Lipoprotein Reference Ranges for Children and Adolescents",
      "line": 6824,
      "preview": "| :--: | :--: | :--: | :--: |"
    },
    {
      "type": "table",
      "section": "TABLE 16-2. Lipoprotein Reference Ranges for Children and Adolescents",
      "line": 6825,
      "preview": "| High <br> LDL-C | Diet focused on polyunsaturated and monounsaturated fats, low in saturated fats "
    },
    {
      "type": "text",
      "section": "TABLE 16-2. Lipoprotein Reference Ranges for Children and Adolescents",
      "line": 6827,
      "preview": "--- page 360 ---"
    },
    {
      "type": "table",
      "section": "TABLE 16-2. Lipoprotein Reference Ranges for Children and Adolescents",
      "line": 6829,
      "preview": "| Risk <br> Factor | Dietary <br> Recommendation | Specific <br> Nutrient/Pharmacotherapy <br> Recom"
    },
    {
      "type": "table",
      "section": "TABLE 16-2. Lipoprotein Reference Ranges for Children and Adolescents",
      "line": 6830,
      "preview": "| :--: | :--: | :--: | :--: |"
    },
    {
      "type": "table",
      "section": "TABLE 16-2. Lipoprotein Reference Ranges for Children and Adolescents",
      "line": 6831,
      "preview": "| High <br> TGs $^{9}$ | Diet low in simple carbohydrates (replacing with complex carbohydrates), lo"
    },
    {
      "type": "table",
      "section": "TABLE 16-2. Lipoprotein Reference Ranges for Children and Adolescents",
      "line": 6832,
      "preview": "| Low <br> HDL-C | Follow a healthy dietary pattern with emphasis on increasing aerobic activity (go"
    },
    {
      "type": "text",
      "section": "TABLE 16-2. Lipoprotein Reference Ranges for Children and Adolescents",
      "line": 6834,
      "preview": "Abbreviations: BMI, body mass index; DHA, docosahexaenoic acid; EPA, eicosapentaenoic acid; HDL-C, h"
    },
    {
      "type": "text",
      "section": "TABLE 16-2. Lipoprotein Reference Ranges for Children and Adolescents",
      "line": 6835,
      "preview": "${ }^{a}$ de Ferranti SD, Steinberger J, Ameduri R, et al. Cardiovascular risk reduction in high-ris"
    },
    {
      "type": "text",
      "section": "TABLE 16-2. Lipoprotein Reference Ranges for Children and Adolescents",
      "line": 6836,
      "preview": "https://doi.org/10.1161/CIR.0000000000000618"
    },
    {
      "type": "text",
      "section": "TABLE 16-2. Lipoprotein Reference Ranges for Children and Adolescents",
      "line": 6837,
      "preview": "${ }^{\\text {b }}$ Reijman MD, Kusters DM, Wiegman A. Advances in familial hypercholesterolaemia in "
    },
    {
      "type": "text",
      "section": "TABLE 16-2. Lipoprotein Reference Ranges for Children and Adolescents",
      "line": 6838,
      "preview": "https://doi.org/10.1016/S2352-4642(21)00095-X"
    },
    {
      "type": "text",
      "section": "TABLE 16-2. Lipoprotein Reference Ranges for Children and Adolescents",
      "line": 6839,
      "preview": "${ }^{c}$ Barkas F, Nomikos T, Liberopoulos E, Panagiotakos D. Diet and cardiovascular disease risk "
    },
    {
      "type": "text",
      "section": "TABLE 16-2. Lipoprotein Reference Ranges for Children and Adolescents",
      "line": 6840,
      "preview": "${ }^{d}$ Clinician's lifestyle modification toolbox. National Lipid Association. 2022. https://www."
    },
    {
      "type": "text",
      "section": "TABLE 16-2. Lipoprotein Reference Ranges for Children and Adolescents",
      "line": 6841,
      "preview": "${ }^{e}$ Expert Panel on Integrated Guidelines for Cardiovascular Health, Risk Reduction in Childre"
    },
    {
      "type": "text",
      "section": "TABLE 16-2. Lipoprotein Reference Ranges for Children and Adolescents",
      "line": 6842,
      "preview": "https://doi.org/10.1542/peds.2009-2107C"
    },
    {
      "type": "text",
      "section": "TABLE 16-2. Lipoprotein Reference Ranges for Children and Adolescents",
      "line": 6844,
      "preview": "--- page 361 ---"
    },
    {
      "type": "text",
      "section": "TABLE 16-2. Lipoprotein Reference Ranges for Children and Adolescents",
      "line": 6846,
      "preview": "${ }^{f}$ Jacobson TA, Maki KC, Orringer CE, et al; NLA Expert Panel. National Lipid Association rec"
    },
    {
      "type": "text",
      "section": "TABLE 16-2. Lipoprotein Reference Ranges for Children and Adolescents",
      "line": 6847,
      "preview": "${ }^{\\text {h }}$ Carson JAS, Lichtenstein AH, Anderson CAM, et al; American Heart Association Nutr"
    },
    {
      "type": "text",
      "section": "TABLE 16-2. Lipoprotein Reference Ranges for Children and Adolescents",
      "line": 6848,
      "preview": "${ }^{i}$ Jain AP, Aggarwal KK, Zhang PY. Omega-3 fatty acids and cardiovascular disease. Eur Rev Me"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "Implementation of Nutrition Plan and Monitoring",
      "line": 6850
    },
    {
      "type": "heading",
      "level": 2,
      "section": "Step 1: History and Education",
      "line": 6852
    },
    {
      "type": "text",
      "section": "Step 1: History and Education",
      "line": 6854,
      "preview": "Obtain a detailed patient dietary history and family history of lipid abnormalities, premature CVD, "
    },
    {
      "type": "heading",
      "level": 2,
      "section": "Diet",
      "line": 6856
    },
    {
      "type": "text",
      "section": "Diet",
      "line": 6858,
      "preview": "Education regarding a healthy dietary pattern is important, especially for the pediatric population."
    },
    {
      "type": "text",
      "section": "Diet",
      "line": 6860,
      "preview": "--- page 362 ---"
    },
    {
      "type": "text",
      "section": "Diet",
      "line": 6862,
      "preview": "sources, low-fat or fat-free dairy products, and healthy fat sources as well as limiting processed f"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "Weight",
      "line": 6864
    },
    {
      "type": "text",
      "section": "Weight",
      "line": 6866,
      "preview": "If a patient's weight is over or equal to the 85 th percentile, discuss achieving and maintaining a "
    },
    {
      "type": "heading",
      "level": 2,
      "section": "Physical Activity",
      "line": 6868
    },
    {
      "type": "text",
      "section": "Physical Activity",
      "line": 6870,
      "preview": "Encourage the patient to increase physical activity level with a goal of 1 hour daily of moderate-to"
    },
    {
      "type": "heading",
      "level": 2,
      "section": "Step 2: Plan",
      "line": 6872
    },
    {
      "type": "text",
      "section": "Step 2: Plan",
      "line": 6874,
      "preview": "Review fasting lipid profile laboratory results to determine the abnormal lipoproteins, and provide "
    },
    {
      "type": "text",
      "section": "Step 2: Plan",
      "line": 6876,
      "preview": "--- page 363 ---"
    },
    {
      "type": "text",
      "section": "Step 2: Plan",
      "line": 6878,
      "preview": "TABLE 16-4. Specific Nutrient Recommendations"
    },
    {
      "type": "table",
      "section": "Step 2: Plan",
      "line": 6880,
      "preview": "| Nutrient | Recommendation | Examples |"
    },
    {
      "type": "table",
      "section": "Step 2: Plan",
      "line": 6881,
      "preview": "| :--: | :--: | :--: |"
    },
    {
      "type": "table",
      "section": "Step 2: Plan",
      "line": 6882,
      "preview": "| Total fat | - $25 \\%-35 \\%$ of daily calories ${ }^{a}$ <br> - Replace saturated and trans fats wi"
    },
    {
      "type": "table",
      "section": "Step 2: Plan",
      "line": 6883,
      "preview": "| Healthy fats (monounsaturated, polyunsaturated) | - $20 \\%$ of daily calories ${ }^{b}$ <br> - Rep"
    },
    {
      "type": "table",
      "section": "Step 2: Plan",
      "line": 6884,
      "preview": "| Unhealthy fats (saturated, trans) | - Limit saturated fats to $<7 \\%$ of daily energy/calorie inta"
    },
    {
      "type": "table",
      "section": "Step 2: Plan",
      "line": 6885,
      "preview": "| Cholesterol | - Limit to $<200 \\mathrm{mg} / \\mathrm{d}^{\\mathrm{b}}$ <br> - Higher cholesterol fo"
    },
    {
      "type": "table",
      "section": "Step 2: Plan",
      "line": 6886,
      "preview": "| Omega-3 fatty acids | The AHA recommends consumption of two 4-oz servings of fish/wk for those wit"
    },
    {
      "type": "table",
      "section": "Step 2: Plan",
      "line": 6887,
      "preview": "| Protein | - About 15\\% of daily calories ${ }^{d}$ <br> - Focus on lean protein sources | Lean sou"
    },
    {
      "type": "text",
      "section": "Step 2: Plan",
      "line": 6889,
      "preview": "--- page 364 ---"
    },
    {
      "type": "table",
      "section": "Step 2: Plan",
      "line": 6891,
      "preview": "| Nutrient | Recommendation | Examples |"
    },
    {
      "type": "table",
      "section": "Step 2: Plan",
      "line": 6892,
      "preview": "| :--: | :--: | :--: |"
    },
    {
      "type": "table",
      "section": "Step 2: Plan",
      "line": 6893,
      "preview": "| Carbohydrates | - About 55\\% of daily calories ${ }^{d}$ <br> - Focus on more complex carbohydrate"
    },
    {
      "type": "table",
      "section": "Step 2: Plan",
      "line": 6894,
      "preview": "| Soluble fiber ${ }^{c}$ | Goal of 5-10 g daily found in plant foods that are not absorbed in intes"
    },
    {
      "type": "text",
      "section": "Step 2: Plan",
      "line": 6896,
      "preview": "Abbreviations: AHA, American Heart Association; CVD, cardiovascular disease; LDLC, low-density lipop"
    },
    {
      "type": "text",
      "section": "Step 2: Plan",
      "line": 6897,
      "preview": "${ }^{a}$ Jacobson TA, Maki KC, Orringer CE, et al; NLA Expert Panel. National Lipid Association rec"
    },
    {
      "type": "text",
      "section": "Step 2: Plan",
      "line": 6898,
      "preview": "${ }^{\\text {b }}$ Expert Panel on Integrated Guidelines for Cardiovascular Health, Risk Reduction i"
    },
    {
      "type": "text",
      "section": "Step 2: Plan",
      "line": 6899,
      "preview": "https://doi.org/10.1542/peds.2009-2107C"
    },
    {
      "type": "text",
      "section": "Step 2: Plan",
      "line": 6900,
      "preview": "${ }^{c}$ Clinician's Lifestyle Modification Toolbox. National Lipid Association. 2022."
    },
    {
      "type": "text",
      "section": "Step 2: Plan",
      "line": 6901,
      "preview": "https://www.lipid.org/CLMT"
    },
    {
      "type": "text",
      "section": "Step 2: Plan",
      "line": 6902,
      "preview": "${ }^{d}$ Corkins MR, Daniels SR, de Ferranti SD, et al. Nutrition in children and adolescents. Med "
    },
    {
      "type": "text",
      "section": "Step 2: Plan",
      "line": 6903,
      "preview": "https://doi.org/10.1016/j.mcna.2016.06.005"
    },
    {
      "type": "text",
      "section": "Step 2: Plan",
      "line": 6904,
      "preview": "${ }^{\\text {e }}$ Carson JAS, Lichtenstein AH, Anderson CAM, et al; American Heart Association Nutr"
    },
    {
      "type": "text",
      "section": "Step 2: Plan",
      "line": 6906,
      "preview": "--- page 365 ---"
    },
    {
      "type": "text",
      "section": "Step 2: Plan",
      "line": 6908,
      "preview": "on Arteriosclerosis, Thrombosis and Vascular Biology; Council on Cardiovascular and Stroke Nursing; "
    },
    {
      "type": "text",
      "section": "Step 2: Plan",
      "line": 6909,
      "preview": "${ }^{\\dagger}$ Jain AP, Aggarwal KK, Zhang PY. Omega-3 fatty acids and cardiovascular disease. Eur "
    },
    {
      "type": "heading",
      "level": 1,
      "section": "Step 3: Monitoring",
      "line": 6911
    },
    {
      "type": "text",
      "section": "Step 3: Monitoring",
      "line": 6913,
      "preview": "A fasting lipid profile should be rechecked $3-12$ months after initiating lifestyle modifications t"
    },
    {
      "type": "heading",
      "level": 2,
      "section": "References",
      "line": 6915
    },
    {
      "type": "text",
      "section": "References",
      "line": 6917,
      "preview": "1. de Ferranti SD, Newburger JW. Dyslipidemia in children and adolescents: definition, screening, an"
    },
    {
      "type": "text",
      "section": "References",
      "line": 6918,
      "preview": "2. McCrindle BW. Hyperlipidemia in children. Thromb Res. 2006;118(1):49-58. https://doi.org/10.1016/"
    },
    {
      "type": "text",
      "section": "References",
      "line": 6919,
      "preview": "3. Nguyen D, Kit B, Carroll M. Abnormal cholesterol among children and adolescents in the United Sta"
    },
    {
      "type": "text",
      "section": "References",
      "line": 6920,
      "preview": "4. Fodor G. Primary prevention of CVD: treating dyslipidaemia. BMJ Clin Evid. 2010;0215."
    },
    {
      "type": "text",
      "section": "References",
      "line": 6921,
      "preview": "5. Expert Panel on Integrated Guidelines for Cardiovascular Health, Risk Reduction in Children and A"
    },
    {
      "type": "text",
      "section": "References",
      "line": 6922,
      "preview": "6. de Ferranti SD, Steinberger J, Ameduri R, et al. Cardiovascular risk reduction in high-risk pedia"
    },
    {
      "type": "text",
      "section": "References",
      "line": 6923,
      "preview": "7. Dietary Guidelines for Americans, 2020-2025. 2020. US Department of Agriculture. https://www.diet"
    },
    {
      "type": "text",
      "section": "References",
      "line": 6924,
      "preview": "8. Grundy SM, Stone NJ, Bailey AL, et al. 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PC"
    },
    {
      "type": "text",
      "section": "References",
      "line": 6926,
      "preview": "--- page 366 ---"
    },
    {
      "type": "text",
      "section": "References",
      "line": 6928,
      "preview": "Cardiology/American Heart Association task force on clinical practice guidelines. J Am Coll Cardiol."
    },
    {
      "type": "text",
      "section": "References",
      "line": 6929,
      "preview": "9. Rosenson RS, Cannon PC. Patient education: high cholesterol and lipid treatment options (beyond t"
    },
    {
      "type": "text",
      "section": "References",
      "line": 6931,
      "preview": "--- page 367 ---"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "Inborn Errors of Metabolism",
      "line": 6933
    },
    {
      "type": "text",
      "section": "Inborn Errors of Metabolism",
      "line": 6935,
      "preview": "Mary Sowa, MS, RD<br>Laura Jaimes, MS, RD, CNSC<br>Sandy Van Calcar, PhD, RD"
    },
    {
      "type": "heading",
      "level": 2,
      "section": "Introduction",
      "line": 6937
    },
    {
      "type": "text",
      "section": "Introduction",
      "line": 6939,
      "preview": "There are over 750 identified inborn errors of metabolism (IEM) to date, with some presenting at bir"
    },
    {
      "type": "text",
      "section": "Introduction",
      "line": 6941,
      "preview": "Newborn screening (NBS) has transformed the outcomes for infants with IEM by allowing for early diag"
    },
    {
      "type": "text",
      "section": "Introduction",
      "line": 6943,
      "preview": "There is a high risk of acute metabolic crises with many IEM and symptoms may be present before NBS "
    },
    {
      "type": "text",
      "section": "Introduction",
      "line": 6945,
      "preview": "In this chapter, we outline the general principles of treatment for the 5 main categories of IEM: am"
    },
    {
      "type": "text",
      "section": "Introduction",
      "line": 6947,
      "preview": "--- page 368 ---"
    },
    {
      "type": "text",
      "section": "Introduction",
      "line": 6949,
      "preview": "and disorders of carbohydrate metabolism. The tables provide a list of the most common IEM in each o"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "Nutrition Therapy Basics",
      "line": 6951
    },
    {
      "type": "heading",
      "level": 2,
      "section": "Aminoacidopathies",
      "line": 6953
    },
    {
      "type": "text",
      "section": "Aminoacidopathies",
      "line": 6955,
      "preview": "Aminoacidopathies are a group of inherited genetic disorders involved in the metabolism of a specifi"
    },
    {
      "type": "text",
      "section": "Aminoacidopathies",
      "line": 6957,
      "preview": "--- page 369 ---"
    },
    {
      "type": "text",
      "section": "Aminoacidopathies",
      "line": 6959,
      "preview": "TABLE 17-1. Amino Acid Disorders"
    },
    {
      "type": "table",
      "section": "Aminoacidopathies",
      "line": 6961,
      "preview": "| Disorder | Enzyme Affected | NBS $^{\\text {a }}$ | Biochemical Findings | Clinical Features | Nutr"
    },
    {
      "type": "table",
      "section": "Aminoacidopathies",
      "line": 6962,
      "preview": "| :--: | :--: | :--: | :--: | :--: | :--: |"
    },
    {
      "type": "table",
      "section": "Aminoacidopathies",
      "line": 6963,
      "preview": "| PKU: severe (classical), moderate (atypical), mild (hyperphenylalaninemia) | Phenylalanine hydroxy"
    },
    {
      "type": "table",
      "section": "Aminoacidopathies",
      "line": 6964,
      "preview": "| Maternal PKU | Phenylalanine hydroxylase |  | Same as above | Untreated PKU in the mother causes i"
    },
    {
      "type": "table",
      "section": "Aminoacidopathies",
      "line": 6965,
      "preview": "| Tyrosinemia type I | Fumarylacetoacetate hydrolase | $X X$ | Increased blood tyrosine and phenylal"
    },
    {
      "type": "table",
      "section": "Aminoacidopathies",
      "line": 6966,
      "preview": "| Tyrosinemia type II | Tyrosine aminotransferase | X | Increased blood tyrosine and phenylalanine |"
    },
    {
      "type": "table",
      "section": "Aminoacidopathies",
      "line": 6967,
      "preview": "| Homocystinuria (pyridoxine nonresponsive) | Cystathionine $\\beta$ synthase | $X X$ | Homocysteine "
    },
    {
      "type": "table",
      "section": "Aminoacidopathies",
      "line": 6968,
      "preview": "| Homocystinuria (pyridoxine responsive) | Cystathionine $\\beta$ synthase | $X X$ | Same as above | "
    },
    {
      "type": "text",
      "section": "Aminoacidopathies",
      "line": 6970,
      "preview": "--- page 370 ---"
    },
    {
      "type": "table",
      "section": "Aminoacidopathies",
      "line": 6972,
      "preview": "| Disorder | Enzyme Affected | $\\mathrm{NBS}^{\\mathrm{a}}$ | Biochemical <br> Findings | Clinical <b"
    },
    {
      "type": "table",
      "section": "Aminoacidopathies",
      "line": 6973,
      "preview": "| :--: | :--: | :--: | :--: | :--: | :--: |"
    },
    {
      "type": "table",
      "section": "Aminoacidopathies",
      "line": 6974,
      "preview": "| Maple syrup urine disease | Branched-chain keto acid dehydrogenase complex | XX | Elevated blood, "
    },
    {
      "type": "text",
      "section": "Aminoacidopathies",
      "line": 6976,
      "preview": "Abbreviations: CSF, cerebrospinal fluid; IEM, inborn errors of metabolism; NBS, newborn screening; N"
    },
    {
      "type": "text",
      "section": "Aminoacidopathies",
      "line": 6977,
      "preview": "Adapted with permission from Springer International from Bernstein LE, Rohr F, Helm JR, eds. Nutriti"
    },
    {
      "type": "text",
      "section": "Aminoacidopathies",
      "line": 6978,
      "preview": "${ }^{a}$ The disorder is included in NBS: $X X=$ listed as core disorder for screening; $X=$ listed"
    },
    {
      "type": "text",
      "section": "Aminoacidopathies",
      "line": 6979,
      "preview": "${ }^{\\text {b }}$ This IEM can include a medical food (formula) as part of treatment."
    },
    {
      "type": "heading",
      "level": 1,
      "section": "Example: MSUD",
      "line": 6981
    },
    {
      "type": "text",
      "section": "Example: MSUD",
      "line": 6983,
      "preview": "MSUD results from a deficiency of the branched-chain ketoacid dehydrogenase complex required for cat"
    },
    {
      "type": "heading",
      "level": 2,
      "section": "Medical Nutrition Therapy Basics for MSUD",
      "line": 6985
    },
    {
      "type": "text",
      "section": "Medical Nutrition Therapy Basics for MSUD",
      "line": 6987,
      "preview": "The goal of nutrition management for MSUD is to maintain near-normal leucine concentrations, prevent"
    },
    {
      "type": "text",
      "section": "Medical Nutrition Therapy Basics for MSUD",
      "line": 6989,
      "preview": "The nutrition treatment of MSUD includes the following ${ }^{9-11}$ :"
    },
    {
      "type": "text",
      "section": "Medical Nutrition Therapy Basics for MSUD",
      "line": 6991,
      "preview": "1. Provide appropriate calories and fluid for age."
    },
    {
      "type": "text",
      "section": "Medical Nutrition Therapy Basics for MSUD",
      "line": 6992,
      "preview": "2. Restrict intact protein sources to limit intake of leucine to meet age-appropriate requirements, "
    },
    {
      "type": "text",
      "section": "Medical Nutrition Therapy Basics for MSUD",
      "line": 6993,
      "preview": "3. Provide a BCAA-free medical food (protein substitute without leucine, valine, and isoleucine [ie,"
    },
    {
      "type": "text",
      "section": "Medical Nutrition Therapy Basics for MSUD",
      "line": 6994,
      "preview": "4. Prevent isoleucine and/or valine deficiency by supplementing these amino acids, as needed."
    },
    {
      "type": "text",
      "section": "Medical Nutrition Therapy Basics for MSUD",
      "line": 6995,
      "preview": "5. Adjust nutrition plan based on leucine, valine, and isoleucine concentrations in plasma amino aci"
    },
    {
      "type": "text",
      "section": "Medical Nutrition Therapy Basics for MSUD",
      "line": 6997,
      "preview": "--- page 371 ---"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "Routine Monitoring for MSUD",
      "line": 6999
    },
    {
      "type": "text",
      "section": "Routine Monitoring for MSUD",
      "line": 7001,
      "preview": "Routine monitoring includes plasma amino acids (or BCAAs on dried blood spots) ${ }^{12}$ :"
    },
    {
      "type": "text",
      "section": "Routine Monitoring for MSUD",
      "line": 7003,
      "preview": "- Treatment goals ${ }^{9,13}$ :"
    },
    {
      "type": "text",
      "section": "Routine Monitoring for MSUD",
      "line": 7004,
      "preview": "- Leucine: $100-300 \\mathrm{umol} / \\mathrm{L}(100-200 \\mathrm{umol} / \\mathrm{L}$ in infants)"
    },
    {
      "type": "text",
      "section": "Routine Monitoring for MSUD",
      "line": 7005,
      "preview": "- Isoleucine: $100-300 \\mathrm{umol} / \\mathrm{L}$"
    },
    {
      "type": "text",
      "section": "Routine Monitoring for MSUD",
      "line": 7006,
      "preview": "- Valine: $200-400 \\mathrm{umol} / \\mathrm{L}$"
    },
    {
      "type": "heading",
      "level": 2,
      "section": "Acute Care for MSUD",
      "line": 7009
    },
    {
      "type": "text",
      "section": "Acute Care for MSUD",
      "line": 7011,
      "preview": "During illness or other catabolic events, individuals are likely to require aggressive nutrition sup"
    },
    {
      "type": "text",
      "section": "Acute Care for MSUD",
      "line": 7013,
      "preview": "1. Provide optimal nonprotein caloric support."
    },
    {
      "type": "text",
      "section": "Acute Care for MSUD",
      "line": 7014,
      "preview": "a. Energy"
    },
    {
      "type": "text",
      "section": "Acute Care for MSUD",
      "line": 7016,
      "preview": "- Individuals may require 1.5 to more than 2 times the estimated energy expenditure for age from ent"
    },
    {
      "type": "text",
      "section": "Acute Care for MSUD",
      "line": 7017,
      "preview": "b. Dextrose"
    },
    {
      "type": "text",
      "section": "Acute Care for MSUD",
      "line": 7018,
      "preview": "- Start with $10 \\%$ dextrose (D10) intravenous (IV) fluids at an age-appropriate glucose infusion r"
    },
    {
      "type": "text",
      "section": "Acute Care for MSUD",
      "line": 7019,
      "preview": "- Insulin may be needed in the presence of hyperglycemia to allow for adequate caloric support. ${ }"
    },
    {
      "type": "text",
      "section": "Acute Care for MSUD",
      "line": 7020,
      "preview": "c. Intralipids"
    },
    {
      "type": "text",
      "section": "Acute Care for MSUD",
      "line": 7021,
      "preview": "- Initiate age-appropriate dosing with goal of $30 \\%-50 \\%$ of nonprotein sources from lipid."
    },
    {
      "type": "text",
      "section": "Acute Care for MSUD",
      "line": 7022,
      "preview": "d. Fluid"
    },
    {
      "type": "text",
      "section": "Acute Care for MSUD",
      "line": 7023,
      "preview": "- Avoid excess fluid administration and hypotonic solutions, given the high risk for cerebral edema."
    },
    {
      "type": "text",
      "section": "Acute Care for MSUD",
      "line": 7025,
      "preview": "2. Initiate a source of BCAA-free amino acids as soon as possible."
    },
    {
      "type": "text",
      "section": "Acute Care for MSUD",
      "line": 7026,
      "preview": "a. Hold leucine intake with elimination of intact protein sources until the leucine concentration is"
    },
    {
      "type": "text",
      "section": "Acute Care for MSUD",
      "line": 7027,
      "preview": "b. Initiate BCAA-free medical food by continuous nasogastric (NG) feeding to provide amino acids to "
    },
    {
      "type": "text",
      "section": "Acute Care for MSUD",
      "line": 7029,
      "preview": "- Goal: $2.0-3.5 \\mathrm{~g} / \\mathrm{kg}$ for infants; it is greater than the DRI for all ages. ${"
    },
    {
      "type": "text",
      "section": "Acute Care for MSUD",
      "line": 7030,
      "preview": "c. Initiate addition of valine and isoleucine solutions $(100 \\mathrm{mg} / \\mathrm{mL})$ to the med"
    },
    {
      "type": "text",
      "section": "Acute Care for MSUD",
      "line": 7031,
      "preview": "d. Consider parenteral BCAA-free specialty amino acid solutions if the patient is unable to tolerate"
    },
    {
      "type": "text",
      "section": "Acute Care for MSUD",
      "line": 7033,
      "preview": "3. When the leucine concentration has decreased ( $<300 \\mu \\mathrm{~mol} / \\mathrm{L}$ ), reintrodu"
    },
    {
      "type": "text",
      "section": "Acute Care for MSUD",
      "line": 7034,
      "preview": "a. Initiate enteral feeds (NG and/or oral) to provide leucine at approximately $25 \\%$ of usual leuc"
    },
    {
      "type": "text",
      "section": "Acute Care for MSUD",
      "line": 7036,
      "preview": "- Continue isoleucine and valine supplements to ensure concentrations of both remain above $400 \\mu "
    },
    {
      "type": "text",
      "section": "Acute Care for MSUD",
      "line": 7037,
      "preview": "b. Increase leucine intake based on tolerance and plasma leucine concentrations."
    },
    {
      "type": "text",
      "section": "Acute Care for MSUD",
      "line": 7038,
      "preview": "c. If enteral feeding is not possible, initiate a standard amino acid parenteral solution to provide"
    },
    {
      "type": "text",
      "section": "Acute Care for MSUD",
      "line": 7040,
      "preview": "4. Reduce parenteral fluids as enteral feeding increases to maintain adequate caloric intake."
    },
    {
      "type": "heading",
      "level": 2,
      "section": "Disorders of the Urea Cycle",
      "line": 7042
    },
    {
      "type": "text",
      "section": "Disorders of the Urea Cycle",
      "line": 7044,
      "preview": "Inborn errors of the urea cycle, called urea cycle disorders (UCDs), are a group of 8 disorders affe"
    },
    {
      "type": "text",
      "section": "Disorders of the Urea Cycle",
      "line": 7046,
      "preview": "--- page 372 ---"
    },
    {
      "type": "text",
      "section": "Disorders of the Urea Cycle",
      "line": 7048,
      "preview": "be detected by NBS; thus, it is essential to include ammonia in the initial laboratory evaluations o"
    },
    {
      "type": "text",
      "section": "Disorders of the Urea Cycle",
      "line": 7050,
      "preview": "TABLE 17-2. Urea Cycle Disorders"
    },
    {
      "type": "table",
      "section": "Disorders of the Urea Cycle",
      "line": 7052,
      "preview": "| Disorder | Enzyme Affected | NBS $^{\\mathrm{a}}$ | Biochemical Findings | Clinical Features | Nutr"
    },
    {
      "type": "table",
      "section": "Disorders of the Urea Cycle",
      "line": 7053,
      "preview": "| :--: | :--: | :--: | :--: | :--: | :--: |"
    },
    {
      "type": "table",
      "section": "Disorders of the Urea Cycle",
      "line": 7054,
      "preview": "| NAGS deficiency | Nacetylglutamate synthase |  | Hyperammonemia | Lethargy, vomiting, apnea, coma,"
    },
    {
      "type": "table",
      "section": "Disorders of the Urea Cycle",
      "line": 7055,
      "preview": "| OTC deficiency | Ornithine transcarbamylase |  | Hyperammonemia, respiratory alkalosis | Lethargy,"
    },
    {
      "type": "table",
      "section": "Disorders of the Urea Cycle",
      "line": 7056,
      "preview": "| CPS deficiency | Carbamoyl phosphate synthetase |  | Hyperammonemia, respiratory alkalosis | Letha"
    },
    {
      "type": "table",
      "section": "Disorders of the Urea Cycle",
      "line": 7057,
      "preview": "| Citrullinemia | Argininosuccinic synthetase | $X X$ | Hyperammonemia, respiratory alkalosis | Leth"
    },
    {
      "type": "table",
      "section": "Disorders of the Urea Cycle",
      "line": 7058,
      "preview": "| Argininosuccinic aciduria | Argininosuccinic lyase | $X X$ | Hyperammonemia, respiratory alkalosis"
    },
    {
      "type": "table",
      "section": "Disorders of the Urea Cycle",
      "line": 7059,
      "preview": "| Argininemia | Arginase | X | $\\pm$ Hyperammonemia | Spastic diplegia, death if untreated; intellec"
    },
    {
      "type": "text",
      "section": "Disorders of the Urea Cycle",
      "line": 7061,
      "preview": "Abbreviations: EAA, essential amino acid; IEM, inborn errors of metabolism; NBS, newborn screening. "
    },
    {
      "type": "text",
      "section": "Disorders of the Urea Cycle",
      "line": 7062,
      "preview": "${ }^{a}$ The disorder is included in NBS: $X X=$ listed as core disorder for screening; $X=$ listed"
    },
    {
      "type": "text",
      "section": "Disorders of the Urea Cycle",
      "line": 7063,
      "preview": "${ }^{\\mathrm{b}}$ This IEM can include a medical food (formula) as part of treatment."
    },
    {
      "type": "text",
      "section": "Disorders of the Urea Cycle",
      "line": 7065,
      "preview": "Except in milder forms of these disorders, diet treatment is typically paired with medications, incl"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "Example: Ornithine Transcarbamylase Deficiency",
      "line": 7067
    },
    {
      "type": "text",
      "section": "Example: Ornithine Transcarbamylase Deficiency",
      "line": 7069,
      "preview": "The most common UCD is ornithine transcarbamylase (OTC) deficiency. OTC deficiency can present in ne"
    },
    {
      "type": "heading",
      "level": 2,
      "section": "Medical Nutrition Therapy Basics for OTC Deficiency",
      "line": 7071
    },
    {
      "type": "text",
      "section": "Medical Nutrition Therapy Basics for OTC Deficiency",
      "line": 7073,
      "preview": "The goal for nutrition management of OTC deficiency is to maintain normal ammonia and plasma amino a"
    },
    {
      "type": "text",
      "section": "Medical Nutrition Therapy Basics for OTC Deficiency",
      "line": 7075,
      "preview": "--- page 373 ---"
    },
    {
      "type": "text",
      "section": "Medical Nutrition Therapy Basics for OTC Deficiency",
      "line": 7077,
      "preview": "limited. This is different from many other IEM wherein total protein is not limited but is provided "
    },
    {
      "type": "text",
      "section": "Medical Nutrition Therapy Basics for OTC Deficiency",
      "line": 7079,
      "preview": "The nutrition treatment for OTC deficiency includes the following ${ }^{20,21}$ :"
    },
    {
      "type": "text",
      "section": "Medical Nutrition Therapy Basics for OTC Deficiency",
      "line": 7081,
      "preview": "1. Ensure adequate energy intake to prevent catabolism."
    },
    {
      "type": "text",
      "section": "Medical Nutrition Therapy Basics for OTC Deficiency",
      "line": 7082,
      "preview": "2. Total protein restriction is typically at DRI for age or below."
    },
    {
      "type": "text",
      "section": "Medical Nutrition Therapy Basics for OTC Deficiency",
      "line": 7083,
      "preview": "3. Protein composition includes essential amino acids (EAAs) and intact protein sources."
    },
    {
      "type": "text",
      "section": "Medical Nutrition Therapy Basics for OTC Deficiency",
      "line": 7084,
      "preview": "a. Provide $30 \\%-50 \\%$ of total protein from a medical food providing only EAAs (ie, Cyclinex 1, A"
    },
    {
      "type": "text",
      "section": "Medical Nutrition Therapy Basics for OTC Deficiency",
      "line": 7085,
      "preview": "b. The remainder of total protein will come from intact sources."
    },
    {
      "type": "text",
      "section": "Medical Nutrition Therapy Basics for OTC Deficiency",
      "line": 7086,
      "preview": "4. Amino acid supplementation: In all UCDs except arginase deficiency, arginine becomes a conditiona"
    },
    {
      "type": "text",
      "section": "Medical Nutrition Therapy Basics for OTC Deficiency",
      "line": 7087,
      "preview": "a. In OTC deficiency, supplement with l-citrulline ( $100-200 \\mathrm{mg} / \\mathrm{kg}$ ) to preven"
    },
    {
      "type": "text",
      "section": "Medical Nutrition Therapy Basics for OTC Deficiency",
      "line": 7088,
      "preview": "b. See Table 17-2 for amino acid (L-arginine or L-citrulline) to supplement in other UCDs."
    },
    {
      "type": "text",
      "section": "Medical Nutrition Therapy Basics for OTC Deficiency",
      "line": 7089,
      "preview": "5. Frequent monitoring of amino acid profiles is the primary marker for diet adjustments."
    },
    {
      "type": "heading",
      "level": 1,
      "section": "Routine Monitoring for OTC",
      "line": 7091
    },
    {
      "type": "heading",
      "level": 2,
      "section": "Routine monitoring for OTC includes the following:",
      "line": 7093
    },
    {
      "type": "text",
      "section": "Routine monitoring for OTC includes the following:",
      "line": 7095,
      "preview": "1. Ammonia: Often only checked during acute situations, given the difficulty of laboratory draw and "
    },
    {
      "type": "text",
      "section": "Routine monitoring for OTC includes the following:",
      "line": 7096,
      "preview": "2. Amino acid profiles"
    },
    {
      "type": "text",
      "section": "Routine monitoring for OTC includes the following:",
      "line": 7097,
      "preview": "a. Glutamine: Primary marker to adjust protein prescription; can be elevated even without hyperammon"
    },
    {
      "type": "text",
      "section": "Routine monitoring for OTC includes the following:",
      "line": 7098,
      "preview": "b. Arginine and citrulline are used to assess success of supplementation."
    },
    {
      "type": "text",
      "section": "Routine monitoring for OTC includes the following:",
      "line": 7099,
      "preview": "c. BCAAs (leucine, valine, isoleucine) are used to assess the overall sufficiency of protein intake;"
    },
    {
      "type": "heading",
      "level": 2,
      "section": "Acute Care for OTC",
      "line": 7101
    },
    {
      "type": "text",
      "section": "Acute Care for OTC",
      "line": 7103,
      "preview": "Acute care for OTC includes the following ${ }^{20,25,26}$ :"
    },
    {
      "type": "text",
      "section": "Acute Care for OTC",
      "line": 7105,
      "preview": "1. Provide optimal nonprotein caloric support."
    },
    {
      "type": "text",
      "section": "Acute Care for OTC",
      "line": 7106,
      "preview": "a. Calories"
    },
    {
      "type": "text",
      "section": "Acute Care for OTC",
      "line": 7108,
      "preview": "- Individuals may require $120 \\%$ of DRI for age."
    },
    {
      "type": "text",
      "section": "Acute Care for OTC",
      "line": 7109,
      "preview": "b. Dextrose"
    },
    {
      "type": "text",
      "section": "Acute Care for OTC",
      "line": 7110,
      "preview": "- Start with $10 \\%-20 \\%$ dextrose solution at an age-appropriate GIR."
    },
    {
      "type": "text",
      "section": "Acute Care for OTC",
      "line": 7111,
      "preview": "- Insulin may be needed in the presence of hyperglycemia to allow for adequate caloric support."
    },
    {
      "type": "text",
      "section": "Acute Care for OTC",
      "line": 7112,
      "preview": "c. Intralipid"
    },
    {
      "type": "text",
      "section": "Acute Care for OTC",
      "line": 7113,
      "preview": "- Age-appropriate dosing: $2-3 \\mathrm{~g} / \\mathrm{kg} / \\mathrm{d}$ (infants/toddlers); up to $3-"
    },
    {
      "type": "text",
      "section": "Acute Care for OTC",
      "line": 7114,
      "preview": "d. Protein"
    },
    {
      "type": "text",
      "section": "Acute Care for OTC",
      "line": 7115,
      "preview": "- Goal is to initiate a source of amino acids within 24 hours of admission or when a patient is dial"
    },
    {
      "type": "text",
      "section": "Acute Care for OTC",
      "line": 7117,
      "preview": "2. Start a parenteral EAA solution (or enteral, if tolerated) at $0.25-0.5 \\mathrm{~g} / \\mathrm{kg}"
    },
    {
      "type": "text",
      "section": "Acute Care for OTC",
      "line": 7118,
      "preview": "a. Advance EAA delivery based on clinical status and ammonia and amino acid concentrations."
    },
    {
      "type": "text",
      "section": "Acute Care for OTC",
      "line": 7119,
      "preview": "b. Initiate enteral EAA source as soon as possible, even if only small volumes are tolerated."
    },
    {
      "type": "text",
      "section": "Acute Care for OTC",
      "line": 7120,
      "preview": "c. Transition, as tolerated, to enteral feeds providing approximately $30 \\%-50 \\%$ of estimated tot"
    },
    {
      "type": "text",
      "section": "Acute Care for OTC",
      "line": 7121,
      "preview": "d. For neonates, intact protein sources can include breast milk."
    },
    {
      "type": "heading",
      "level": 2,
      "section": "Organic Acidemias",
      "line": 7123
    },
    {
      "type": "text",
      "section": "Organic Acidemias",
      "line": 7125,
      "preview": "Organic acidemias (OAs) are a group of inherited genetic disorders involved in the degradation of BC"
    },
    {
      "type": "text",
      "section": "Organic Acidemias",
      "line": 7127,
      "preview": "--- page 374 ---"
    },
    {
      "type": "text",
      "section": "Organic Acidemias",
      "line": 7129,
      "preview": "in the treatment for OAs to avoid depletion of free carnitine stores. ${ }^{27}$ OAs can present in "
    },
    {
      "type": "text",
      "section": "Organic Acidemias",
      "line": 7131,
      "preview": "TABLE 17-3. Organic Acidemias"
    },
    {
      "type": "table",
      "section": "Organic Acidemias",
      "line": 7133,
      "preview": "| Disorder | Enzyme Affected | NBS $^{\\text {a }}$ | Biochemical Findings | Clinical Features | Nutr"
    },
    {
      "type": "table",
      "section": "Organic Acidemias",
      "line": 7134,
      "preview": "| :--: | :--: | :--: | :--: | :--: | :--: |"
    },
    {
      "type": "table",
      "section": "Organic Acidemias",
      "line": 7135,
      "preview": "| Glutaric acidemia type I | Glutaryl-CoA dehydrogenase | XX | Elevated blood, urine, and CSF glutar"
    },
    {
      "type": "table",
      "section": "Organic Acidemias",
      "line": 7136,
      "preview": "| Glutaric acidemia type II | Multiple acyl-CoA dehydrogenase | X | Elevated blood, urine, and CSF g"
    },
    {
      "type": "table",
      "section": "Organic Acidemias",
      "line": 7137,
      "preview": "| Isovaleric acidemia | Isovaleryl-CoA dehydrogenase | XX | Elevated blood, urine, and CSF isovaleri"
    },
    {
      "type": "table",
      "section": "Organic Acidemias",
      "line": 7138,
      "preview": "| Methylmalonic acidemia | Methylmalonyl-CoA mutase | XX | Metabolic acidosis, ketonuria, hypoglycem"
    },
    {
      "type": "table",
      "section": "Organic Acidemias",
      "line": 7139,
      "preview": "| Methylmalonic acidemia | Cobalamin processing defect (hydroxocobalamin or adenosylcobalamin) | X |"
    },
    {
      "type": "table",
      "section": "Organic Acidemias",
      "line": 7140,
      "preview": "| Propionic acidemia | Propionyl-CoA carboxylase | XX | Metabolic acidosis, ketonuria, hyperglycinem"
    },
    {
      "type": "text",
      "section": "Organic Acidemias",
      "line": 7142,
      "preview": "Abbreviations: CoA, coenzyme A; CSF, cerebrospinal fluid; DRI, dietary reference intake; IEM, inborn"
    },
    {
      "type": "text",
      "section": "Organic Acidemias",
      "line": 7143,
      "preview": "Adapted with permission from Springer International from Bernstein LE, Rohr F, Helm JR, eds. Nutriti"
    },
    {
      "type": "text",
      "section": "Organic Acidemias",
      "line": 7144,
      "preview": "${ }^{a}$ The disorder is included in NBS: $X X=$ listed as core disorder for screening; $X=$ listed"
    },
    {
      "type": "text",
      "section": "Organic Acidemias",
      "line": 7145,
      "preview": "${ }^{\\text {b }}$ This IEM can include a medical food (formula) as part of treatment."
    },
    {
      "type": "heading",
      "level": 1,
      "section": "Example: Propionic Acidemia",
      "line": 7147
    },
    {
      "type": "text",
      "section": "Example: Propionic Acidemia",
      "line": 7149,
      "preview": "Oxidation of the propiogenic amino acids valine, methionine, isoleucine, and threonine results in th"
    },
    {
      "type": "text",
      "section": "Example: Propionic Acidemia",
      "line": 7151,
      "preview": "--- page 375 ---"
    },
    {
      "type": "text",
      "section": "Example: Propionic Acidemia",
      "line": 7153,
      "preview": "individuals with propionic acidemia (PROP), this enzyme deficiency results in the accumulation of pr"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "Medical Nutrition Therapy Basics for PROP",
      "line": 7155
    },
    {
      "type": "text",
      "section": "Medical Nutrition Therapy Basics for PROP",
      "line": 7157,
      "preview": "The goals for nutrition management of PROP include restricting the propiogenic amino acids to reduce"
    },
    {
      "type": "text",
      "section": "Medical Nutrition Therapy Basics for PROP",
      "line": 7159,
      "preview": "The nutrition treatment for PROP includes the following ${ }^{27,31}$ :"
    },
    {
      "type": "text",
      "section": "Medical Nutrition Therapy Basics for PROP",
      "line": 7161,
      "preview": "1. Provide age-appropriate calories and fluid depending on activity level."
    },
    {
      "type": "text",
      "section": "Medical Nutrition Therapy Basics for PROP",
      "line": 7162,
      "preview": "2. Restrict intact protein to reduce intake of the propiogenic amino acids, without resulting in def"
    },
    {
      "type": "text",
      "section": "Medical Nutrition Therapy Basics for PROP",
      "line": 7163,
      "preview": "a. Intact protein goal intake is $60 \\%-100 \\%$ of DRI recommendations for age."
    },
    {
      "type": "text",
      "section": "Medical Nutrition Therapy Basics for PROP",
      "line": 7164,
      "preview": "3. Provide a medical food (protein substitute without isoleucine, valine, methionine, and threonine "
    },
    {
      "type": "text",
      "section": "Medical Nutrition Therapy Basics for PROP",
      "line": 7165,
      "preview": "4. L-carnitine supplementation: Provide L-carnitine to maintain free carnitine levels in the normal "
    },
    {
      "type": "heading",
      "level": 2,
      "section": "Routine Monitoring for PROP",
      "line": 7167
    },
    {
      "type": "text",
      "section": "Routine Monitoring for PROP",
      "line": 7169,
      "preview": "Routine monitoring for PROP includes the following ${ }^{27,31}$ :"
    },
    {
      "type": "text",
      "section": "Routine Monitoring for PROP",
      "line": 7171,
      "preview": "1. Plasma amino acids:"
    },
    {
      "type": "text",
      "section": "Routine Monitoring for PROP",
      "line": 7172,
      "preview": "a. Maintain low normal concentrations of valine, methionine, isoleucine, and threonine; each laborat"
    },
    {
      "type": "text",
      "section": "Routine Monitoring for PROP",
      "line": 7173,
      "preview": "b. Low BCAAs (leucine, valine, isoleucine) can suggest overrestriction of protein."
    },
    {
      "type": "text",
      "section": "Routine Monitoring for PROP",
      "line": 7174,
      "preview": "c. Glycine will be elevated in all individuals with PROP."
    },
    {
      "type": "text",
      "section": "Routine Monitoring for PROP",
      "line": 7175,
      "preview": "2. Plasma carnitine profile (total, free, esterified fractions)"
    },
    {
      "type": "text",
      "section": "Routine Monitoring for PROP",
      "line": 7176,
      "preview": "a. Supplemental carnitine dose is adjusted to prevent deficient free carnitine."
    },
    {
      "type": "text",
      "section": "Routine Monitoring for PROP",
      "line": 7177,
      "preview": "3. Complete blood cell count and chemistry panela. Evaluate for neutropenia, metabolic acidosis, and"
    },
    {
      "type": "text",
      "section": "Routine Monitoring for PROP",
      "line": 7178,
      "preview": "4. Ammonia"
    },
    {
      "type": "text",
      "section": "Routine Monitoring for PROP",
      "line": 7179,
      "preview": "a. Some individuals with PROP are prone to hyperammonemia. Goal is to maintain normal concentrations"
    },
    {
      "type": "heading",
      "level": 2,
      "section": "Acute Care for PROP",
      "line": 7181
    },
    {
      "type": "text",
      "section": "Acute Care for PROP",
      "line": 7183,
      "preview": "Management of an acutely ill individual with PROP or another OA focuses on promoting anabolism, deto"
    },
    {
      "type": "text",
      "section": "Acute Care for PROP",
      "line": 7185,
      "preview": "If the individual remains acutely ill, escalation in nutrition support may be needed. Nutrition supp"
    },
    {
      "type": "text",
      "section": "Acute Care for PROP",
      "line": 7187,
      "preview": "Protein recommendations are as follows: ${ }^{27}$"
    },
    {
      "type": "text",
      "section": "Acute Care for PROP",
      "line": 7189,
      "preview": "1. Restrict protein intake no longer that $24-48$ hours, depending on clinical status."
    },
    {
      "type": "text",
      "section": "Acute Care for PROP",
      "line": 7191,
      "preview": "--- page 376 ---"
    },
    {
      "type": "text",
      "section": "Acute Care for PROP",
      "line": 7193,
      "preview": "2. Initiate or restart an enteral source of intact protein when ammonia, plasma amino acids, and oth"
    },
    {
      "type": "text",
      "section": "Acute Care for PROP",
      "line": 7194,
      "preview": "a. Initial goal is $0.50 \\mathrm{~g} / \\mathrm{kg} / \\mathrm{d}$; increase by $0.25 \\mathrm{~g} / \\m"
    },
    {
      "type": "text",
      "section": "Acute Care for PROP",
      "line": 7195,
      "preview": "3. If parenteral support is needed long term and protein goals cannot be met, consider a combination"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "Disorders of Fatty Acid Oxidation",
      "line": 7197
    },
    {
      "type": "text",
      "section": "Disorders of Fatty Acid Oxidation",
      "line": 7199,
      "preview": "Fatty acid oxidation disorders (FAODs) are a group of inherited genetic disorders involved in the ca"
    },
    {
      "type": "heading",
      "level": 2,
      "section": "TABLE 17-4. Fatty Acid Oxidation Disorders",
      "line": 7201
    },
    {
      "type": "table",
      "section": "TABLE 17-4. Fatty Acid Oxidation Disorders",
      "line": 7203,
      "preview": "| Disorder | Enzyme Affected | NBS ${ }^{a}$ | Biochemical Findings | Clinical Features | Nutrition "
    },
    {
      "type": "table",
      "section": "TABLE 17-4. Fatty Acid Oxidation Disorders",
      "line": 7204,
      "preview": "| :--: | :--: | :--: | :--: | :--: | :--: |"
    },
    {
      "type": "table",
      "section": "TABLE 17-4. Fatty Acid Oxidation Disorders",
      "line": 7205,
      "preview": "| VLCAD deficiency: severe, moderate, mild | Very long-chain acyl-CoA dehydrogenase | XX | Hypoketot"
    },
    {
      "type": "table",
      "section": "TABLE 17-4. Fatty Acid Oxidation Disorders",
      "line": 7206,
      "preview": "| LCHAD deficiency | Long-chain hydroxyacyl-CoA dehydrogenase |  |  |  |  |"
    },
    {
      "type": "table",
      "section": "TABLE 17-4. Fatty Acid Oxidation Disorders",
      "line": 7207,
      "preview": "| TFP deficiency | Trifunctional protein |  |  |  |  |"
    },
    {
      "type": "table",
      "section": "TABLE 17-4. Fatty Acid Oxidation Disorders",
      "line": 7208,
      "preview": "| CPT II deficiency | Carnitine palmitoyltransferase II | X |  |  |  |"
    },
    {
      "type": "table",
      "section": "TABLE 17-4. Fatty Acid Oxidation Disorders",
      "line": 7209,
      "preview": "| CACT deficiency | Carnitineacylcarnitine translocase | X |  |  |  |"
    },
    {
      "type": "table",
      "section": "TABLE 17-4. Fatty Acid Oxidation Disorders",
      "line": 7210,
      "preview": "| MCAD deficiency | Medium-chain acylCoA dehydrogenase | XX | Hypoketotic hypoglycemia, mild hyperam"
    },
    {
      "type": "table",
      "section": "TABLE 17-4. Fatty Acid Oxidation Disorders",
      "line": 7211,
      "preview": "| SCAD deficiency | Short-chain acylCoA dehydrogenase | X | Hypoketotic hypoglycemia | Metabolic dec"
    },
    {
      "type": "text",
      "section": "TABLE 17-4. Fatty Acid Oxidation Disorders",
      "line": 7213,
      "preview": "Abbreviations: CoA, coenzyme A; IEM, inborn errors of metabolism; MCT, medium-chain triglyceride; NB"
    },
    {
      "type": "text",
      "section": "TABLE 17-4. Fatty Acid Oxidation Disorders",
      "line": 7214,
      "preview": "Adapted with permission from Springer International from Bernstein LE, Rohr F, Helm JR, eds. Nutriti"
    },
    {
      "type": "text",
      "section": "TABLE 17-4. Fatty Acid Oxidation Disorders",
      "line": 7215,
      "preview": "${ }^{a}$ The disorder is included in NBS: $X X=$ listed as core disorder for screening; $X=$ listed"
    },
    {
      "type": "text",
      "section": "TABLE 17-4. Fatty Acid Oxidation Disorders",
      "line": 7216,
      "preview": "${ }^{\\text {b }}$ This IEM can include a medical food (formula) as part of treatment."
    },
    {
      "type": "heading",
      "level": 2,
      "section": "Example: Very-Long-Chain Acyl-CoA Dehydrogenase Deficiency",
      "line": 7218
    },
    {
      "type": "text",
      "section": "Example: Very-Long-Chain Acyl-CoA Dehydrogenase Deficiency",
      "line": 7220,
      "preview": "The very-long-chain acyl-CoA dehydrogenase enzyme allows for oxidation of fatty acids of 10 20 carbo"
    },
    {
      "type": "text",
      "section": "Example: Very-Long-Chain Acyl-CoA Dehydrogenase Deficiency",
      "line": 7222,
      "preview": "--- page 377 ---"
    },
    {
      "type": "text",
      "section": "Example: Very-Long-Chain Acyl-CoA Dehydrogenase Deficiency",
      "line": 7224,
      "preview": "rhabdomyolysis in adolescence. Nutrition management for other disorders of long-chain fatty acid met"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "Medical Nutrition Therapy Basics for VLCAD",
      "line": 7226
    },
    {
      "type": "text",
      "section": "Medical Nutrition Therapy Basics for VLCAD",
      "line": 7228,
      "preview": "The goals for nutrition management of VLCAD include providing fasting precautions and providing adeq"
    },
    {
      "type": "text",
      "section": "Medical Nutrition Therapy Basics for VLCAD",
      "line": 7230,
      "preview": "The nutrition treatment for VLCAD includes the following ${ }^{36,37}$ :"
    },
    {
      "type": "text",
      "section": "Medical Nutrition Therapy Basics for VLCAD",
      "line": 7232,
      "preview": "1. Avoid extended fasting: Maximum 3-4 hours for those under 4 months of age; $8-10$ hours above 1 y"
    },
    {
      "type": "text",
      "section": "Medical Nutrition Therapy Basics for VLCAD",
      "line": 7233,
      "preview": "2. Provide appropriate energy and fluid needs for age."
    },
    {
      "type": "text",
      "section": "Medical Nutrition Therapy Basics for VLCAD",
      "line": 7234,
      "preview": "3. Meet age-appropriate recommendations for total fat intake from dietary fat and MCT sources."
    },
    {
      "type": "text",
      "section": "Medical Nutrition Therapy Basics for VLCAD",
      "line": 7235,
      "preview": "4. Restrict intake of LCF from dietary sources, depending on age and disease severity."
    },
    {
      "type": "text",
      "section": "Medical Nutrition Therapy Basics for VLCAD",
      "line": 7236,
      "preview": "a. All sources of dietary fat can be counted as LCF and include triglycerides with unsaturated or sa"
    },
    {
      "type": "text",
      "section": "Medical Nutrition Therapy Basics for VLCAD",
      "line": 7237,
      "preview": "b. Those with severe forms of VLCAD need to limit dietary fat to $10 \\%-15 \\%$ of total calories."
    },
    {
      "type": "text",
      "section": "Medical Nutrition Therapy Basics for VLCAD",
      "line": 7238,
      "preview": "5. Provide a source of MCTs."
    },
    {
      "type": "text",
      "section": "Medical Nutrition Therapy Basics for VLCAD",
      "line": 7239,
      "preview": "a. Choose a low-fat, MCT-supplemented medical food (ie, Enfaport, Mead Johnson). MCT oil or powder c"
    },
    {
      "type": "text",
      "section": "Medical Nutrition Therapy Basics for VLCAD",
      "line": 7240,
      "preview": "b. MCT doses range from $10 \\%$ to $45 \\%$ of total kilocalories, or $2-3 \\mathrm{~g} / \\mathrm{kg}$"
    },
    {
      "type": "text",
      "section": "Medical Nutrition Therapy Basics for VLCAD",
      "line": 7241,
      "preview": "c. Replacement of standard sources of MCTs with triheptanoin (Doljolvi, Ultragenyx Pharmaceuticals),"
    },
    {
      "type": "text",
      "section": "Medical Nutrition Therapy Basics for VLCAD",
      "line": 7242,
      "preview": "6. Supplement with sources of essential fatty acids (EFAs) to maintain normal plasma concentrations,"
    },
    {
      "type": "text",
      "section": "Medical Nutrition Therapy Basics for VLCAD",
      "line": 7243,
      "preview": "7. Higher protein intake may preserve lean body mass and reduce hepatic fat deposition. ${ }^{41}$"
    },
    {
      "type": "text",
      "section": "Medical Nutrition Therapy Basics for VLCAD",
      "line": 7244,
      "preview": "8. Adjunct therapy"
    },
    {
      "type": "text",
      "section": "Medical Nutrition Therapy Basics for VLCAD",
      "line": 7245,
      "preview": "a. L-carnitine: Supplementation may not be needed unless free carnitine is $<10 \\mathrm{umol} / \\mat"
    },
    {
      "type": "heading",
      "level": 2,
      "section": "Routine Monitoring for VLCAD",
      "line": 7247
    },
    {
      "type": "text",
      "section": "Routine Monitoring for VLCAD",
      "line": 7249,
      "preview": "Routine monitoring for VLCAD includes the following ${ }^{36,37}$ :"
    },
    {
      "type": "text",
      "section": "Routine Monitoring for VLCAD",
      "line": 7251,
      "preview": "1. Creatine kinase"
    },
    {
      "type": "text",
      "section": "Routine Monitoring for VLCAD",
      "line": 7252,
      "preview": "a. Elevations suggest muscle injury and possible rhabdomyolysis. Normal or mild elevations can be se"
    },
    {
      "type": "text",
      "section": "Routine Monitoring for VLCAD",
      "line": 7253,
      "preview": "2. Plasma carnitine profile (total, free, esterified)"
    },
    {
      "type": "text",
      "section": "Routine Monitoring for VLCAD",
      "line": 7254,
      "preview": "a. Maintain plasma-free carnitine at above $10 \\mathrm{umol} / \\mathrm{L}$."
    },
    {
      "type": "text",
      "section": "Routine Monitoring for VLCAD",
      "line": 7255,
      "preview": "3. Chemistry panel"
    },
    {
      "type": "text",
      "section": "Routine Monitoring for VLCAD",
      "line": 7256,
      "preview": "a. Evaluate for hypoglycemia and liver impairment."
    },
    {
      "type": "text",
      "section": "Routine Monitoring for VLCAD",
      "line": 7257,
      "preview": "b. In a well state, normoglycemia is expected. Individuals with VLCAD can have mild elevations in li"
    },
    {
      "type": "text",
      "section": "Routine Monitoring for VLCAD",
      "line": 7258,
      "preview": "4. EFA profile"
    },
    {
      "type": "text",
      "section": "Routine Monitoring for VLCAD",
      "line": 7259,
      "preview": "a. Normal concentrations of linolenic acid, $\\alpha$-linolenic acid, arachidonic acid, docosahexaeno"
    },
    {
      "type": "text",
      "section": "Routine Monitoring for VLCAD",
      "line": 7260,
      "preview": "5. Troponin and brain natriuretic peptide should be used to evaluate cardiac status. Elevations can "
    },
    {
      "type": "heading",
      "level": 2,
      "section": "Acute Care for VLCAD",
      "line": 7262
    },
    {
      "type": "text",
      "section": "Acute Care for VLCAD",
      "line": 7264,
      "preview": "The management of an acutely ill individual with a LC-FAOD focuses on promoting anabolism, maintaini"
    },
    {
      "type": "text",
      "section": "Acute Care for VLCAD",
      "line": 7266,
      "preview": "--- page 378 ---"
    },
    {
      "type": "text",
      "section": "Acute Care for VLCAD",
      "line": 7268,
      "preview": "Providing dextrose (D10 IV fluids) at an age-appropriate GIR for 24-48 hours may be sufficient to al"
    },
    {
      "type": "text",
      "section": "Acute Care for VLCAD",
      "line": 7270,
      "preview": "Recommendations for IV lipids include the following ${ }^{36,37}$ :"
    },
    {
      "type": "text",
      "section": "Acute Care for VLCAD",
      "line": 7272,
      "preview": "1. Initially hold IV lipid sources because of the inability to use long-chain fatty acids."
    },
    {
      "type": "text",
      "section": "Acute Care for VLCAD",
      "line": 7273,
      "preview": "2. Provide an IV lipid source for EFAs if there is a prolonged nothing-by-mouth status."
    },
    {
      "type": "text",
      "section": "Acute Care for VLCAD",
      "line": 7274,
      "preview": "a. Infants: Add by day 7 ."
    },
    {
      "type": "text",
      "section": "Acute Care for VLCAD",
      "line": 7275,
      "preview": "b. Adults: Add by day 10 ."
    },
    {
      "type": "text",
      "section": "Acute Care for VLCAD",
      "line": 7276,
      "preview": "c. SMOFlipid (Fresenius Kabi) may be beneficial because of its MCT content."
    },
    {
      "type": "text",
      "section": "Acute Care for VLCAD",
      "line": 7277,
      "preview": "3. Initiate or resume enteral feedings following usual age-appropriate guidelines."
    },
    {
      "type": "heading",
      "level": 1,
      "section": "Inborn Errors of Carbohydrate Metabolism",
      "line": 7279
    },
    {
      "type": "text",
      "section": "Inborn Errors of Carbohydrate Metabolism",
      "line": 7281,
      "preview": "Disorders of enzyme deficiencies in the metabolism of glucose, fructose, and galactose include hered"
    },
    {
      "type": "heading",
      "level": 2,
      "section": "TABLE 17-5. Disorders of Carbohydrate Metabolism",
      "line": 7283
    },
    {
      "type": "table",
      "section": "TABLE 17-5. Disorders of Carbohydrate Metabolism",
      "line": 7285,
      "preview": "| Disorder | Enzyme Affected | NBS $^{\\text {a }}$ | Biochemical Findings | Clinical Features | Nutr"
    },
    {
      "type": "table",
      "section": "TABLE 17-5. Disorders of Carbohydrate Metabolism",
      "line": 7286,
      "preview": "| :--: | :--: | :--: | :--: | :--: | :--: |"
    },
    {
      "type": "table",
      "section": "TABLE 17-5. Disorders of Carbohydrate Metabolism",
      "line": 7287,
      "preview": "| GSD, type I | Glucose-6- <br> phosphatase |  | Hypoglycemia, lactic acidosis, hepatomegaly, elevat"
    },
    {
      "type": "table",
      "section": "TABLE 17-5. Disorders of Carbohydrate Metabolism",
      "line": 7288,
      "preview": "| GSD, type III | Debranching enzyme amylo-1,6-glucosidase |  | Hypoglycemia, hepatomegaly, ketosis,"
    },
    {
      "type": "table",
      "section": "TABLE 17-5. Disorders of Carbohydrate Metabolism",
      "line": 7289,
      "preview": "| Galactosemia | Galactose-1phosphate uridyltransferase | XX | Galactose in blood and urine; elevate"
    },
    {
      "type": "table",
      "section": "TABLE 17-5. Disorders of Carbohydrate Metabolism",
      "line": 7290,
      "preview": "| Pyruvate dehydrogenase complex deficiency | Pyruvate dehydrogenase |  | Elevated blood pyruvate an"
    },
    {
      "type": "table",
      "section": "TABLE 17-5. Disorders of Carbohydrate Metabolism",
      "line": 7291,
      "preview": "| Hereditary fructose intolerance | Aldolase B |  | Decreased blood glucose, phosphate, increased fr"
    },
    {
      "type": "text",
      "section": "TABLE 17-5. Disorders of Carbohydrate Metabolism",
      "line": 7293,
      "preview": "Abbreviations: E. coli, Escherichia coli; GSD, glucose storage disorder; IEM, inborn errors of metab"
    },
    {
      "type": "text",
      "section": "TABLE 17-5. Disorders of Carbohydrate Metabolism",
      "line": 7294,
      "preview": "Adapted with permission from Springer International from Bernstein LE, Rohr F, Helm JR, eds. Nutriti"
    },
    {
      "type": "text",
      "section": "TABLE 17-5. Disorders of Carbohydrate Metabolism",
      "line": 7295,
      "preview": "${ }^{a}$ The disorder is included in NBS; $X X=$ listed as core disorder for screening; $X=$ listed"
    },
    {
      "type": "text",
      "section": "TABLE 17-5. Disorders of Carbohydrate Metabolism",
      "line": 7296,
      "preview": "${ }^{\\text {b }}$ This IEM can include a medical food (formula) as part of treatment."
    },
    {
      "type": "heading",
      "level": 2,
      "section": "Example: GSD, Type I (Von Gierke Disease)",
      "line": 7298
    },
    {
      "type": "text",
      "section": "Example: GSD, Type I (Von Gierke Disease)",
      "line": 7300,
      "preview": "--- page 379 ---"
    },
    {
      "type": "text",
      "section": "Example: GSD, Type I (Von Gierke Disease)",
      "line": 7302,
      "preview": "GSD I is the most common of the GSDs with a prevalence of 1 in 100,000 live births. ${ }^{48}$ In GS"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "Medical Nutrition Therapy Basics for GSD la and Ib",
      "line": 7304
    },
    {
      "type": "text",
      "section": "Medical Nutrition Therapy Basics for GSD la and Ib",
      "line": 7306,
      "preview": "The goals for nutrition management of GSD Ia and Ib is to maintain normoglycemia ( $>70 \\mathrm{mg} "
    },
    {
      "type": "text",
      "section": "Medical Nutrition Therapy Basics for GSD la and Ib",
      "line": 7308,
      "preview": "1. Avoid excessive fasting."
    },
    {
      "type": "text",
      "section": "Medical Nutrition Therapy Basics for GSD la and Ib",
      "line": 7309,
      "preview": "a. Fasting should be $2-3$ hours maximum in infants and $4-6$ hours maximum in adults."
    },
    {
      "type": "text",
      "section": "Medical Nutrition Therapy Basics for GSD la and Ib",
      "line": 7310,
      "preview": "b. Evaluate blood glucose frequently to guide fasting tolerance."
    },
    {
      "type": "text",
      "section": "Medical Nutrition Therapy Basics for GSD la and Ib",
      "line": 7311,
      "preview": "c. Gastrostomy feeding with a nighttime drip is often required to avoid hypoglycemia in younger pati"
    },
    {
      "type": "text",
      "section": "Medical Nutrition Therapy Basics for GSD la and Ib",
      "line": 7313,
      "preview": "- Use a sucrose-free, soy-based formula for infants or a high-carbohydrate elemental formula for old"
    },
    {
      "type": "text",
      "section": "Medical Nutrition Therapy Basics for GSD la and Ib",
      "line": 7315,
      "preview": "2. Carbohydrates ( $60 \\%-70 \\%$ of total energy)"
    },
    {
      "type": "text",
      "section": "Medical Nutrition Therapy Basics for GSD la and Ib",
      "line": 7316,
      "preview": "a. Emphasize complex sources; avoid simple sugar sources."
    },
    {
      "type": "text",
      "section": "Medical Nutrition Therapy Basics for GSD la and Ib",
      "line": 7317,
      "preview": "b. Limit fructose to 2.5 g per meal, and limit dairy to 1 serving per day."
    },
    {
      "type": "text",
      "section": "Medical Nutrition Therapy Basics for GSD la and Ib",
      "line": 7318,
      "preview": "c. UCCS can be used to provide a slow-release source of glucose."
    },
    {
      "type": "text",
      "section": "Medical Nutrition Therapy Basics for GSD la and Ib",
      "line": 7320,
      "preview": "- Initiate in infants over 9-12 months of age because insufficient pancreatic amylase enzyme activit"
    },
    {
      "type": "text",
      "section": "Medical Nutrition Therapy Basics for GSD la and Ib",
      "line": 7321,
      "preview": "- Initiate UCCS with 1 g per dose, increasing by 1 g per dose each week until the optimal dose is ac"
    },
    {
      "type": "text",
      "section": "Medical Nutrition Therapy Basics for GSD la and Ib",
      "line": 7322,
      "preview": "- Mix in formula or cold water, and do not heat or add to acidic foods; 1 g of UCCS mixes in $2-3 \\m"
    },
    {
      "type": "text",
      "section": "Medical Nutrition Therapy Basics for GSD la and Ib",
      "line": 7323,
      "preview": "- UCCS needs vary with age, weight, and fasting tolerance. ${ }^{50,51}$ Use the Bier equation to de"
    },
    {
      "type": "text",
      "section": "Medical Nutrition Therapy Basics for GSD la and Ib",
      "line": 7325,
      "preview": "$$"
    },
    {
      "type": "text",
      "section": "Medical Nutrition Therapy Basics for GSD la and Ib",
      "line": 7326,
      "preview": "\\begin{gathered}"
    },
    {
      "type": "text",
      "section": "Medical Nutrition Therapy Basics for GSD la and Ib",
      "line": 7327,
      "preview": "Y=0.0014 X^{3}-0.214 X^{2}+10.411 X-9.084 \\\\"
    },
    {
      "type": "text",
      "section": "Medical Nutrition Therapy Basics for GSD la and Ib",
      "line": 7328,
      "preview": "Y=\\mathrm{mg} / \\text { glucose } / \\mathrm{min} \\text { and } X=\\text { weight in } \\mathrm{kg}"
    },
    {
      "type": "text",
      "section": "Medical Nutrition Therapy Basics for GSD la and Ib",
      "line": 7329,
      "preview": "\\end{gathered}"
    },
    {
      "type": "text",
      "section": "Medical Nutrition Therapy Basics for GSD la and Ib",
      "line": 7330,
      "preview": "$$"
    },
    {
      "type": "text",
      "section": "Medical Nutrition Therapy Basics for GSD la and Ib",
      "line": 7332,
      "preview": "- 1 g UCCS provides 0.9 g glucose. UCCS is typically divided into $4-8$ doses per day and adjusted b"
    },
    {
      "type": "text",
      "section": "Medical Nutrition Therapy Basics for GSD la and Ib",
      "line": 7333,
      "preview": "d. Glycosade (Vitaflo USA) ( 55 g of UCCS $=60 \\mathrm{~g}$ Glycosade) is a high-amylopectin cornsta"
    },
    {
      "type": "text",
      "section": "Medical Nutrition Therapy Basics for GSD la and Ib",
      "line": 7335,
      "preview": "3. Lean protein ( $10 \\%-15 \\%$ of total energy)"
    },
    {
      "type": "text",
      "section": "Medical Nutrition Therapy Basics for GSD la and Ib",
      "line": 7336,
      "preview": "4. Low fat ( $<30 \\%$ of total energy)"
    },
    {
      "type": "text",
      "section": "Medical Nutrition Therapy Basics for GSD la and Ib",
      "line": 7337,
      "preview": "5. Micronutrient supplementation: Complete vitamin and mineral, calcium, and vitamin D supplementati"
    },
    {
      "type": "heading",
      "level": 2,
      "section": "Routine Monitoring for GSD la and Ib",
      "line": 7339
    },
    {
      "type": "text",
      "section": "Routine Monitoring for GSD la and Ib",
      "line": 7341,
      "preview": "Routine monitoring for GSD Ia and Ib includes the following ${ }^{49,50}$ :"
    },
    {
      "type": "text",
      "section": "Routine Monitoring for GSD la and Ib",
      "line": 7343,
      "preview": "1. Blood glucose: avoid hypoglycemia (Goal $>70 \\mathrm{mg} / \\mathrm{dL}$ )"
    },
    {
      "type": "text",
      "section": "Routine Monitoring for GSD la and Ib",
      "line": 7345,
      "preview": "--- page 380 ---"
    },
    {
      "type": "text",
      "section": "Routine Monitoring for GSD la and Ib",
      "line": 7347,
      "preview": "a. Frequent monitoring of blood glucose is required."
    },
    {
      "type": "text",
      "section": "Routine Monitoring for GSD la and Ib",
      "line": 7348,
      "preview": "b. Consider a continuous glucose monitor to assess blood glucose trends. ${ }^{54}$"
    },
    {
      "type": "text",
      "section": "Routine Monitoring for GSD la and Ib",
      "line": 7349,
      "preview": "2. Other laboratory tests include lactic acid, lipid panel, uric acid, liver transaminases, and rena"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "Acute Care for GSD la and Ib",
      "line": 7351
    },
    {
      "type": "text",
      "section": "Acute Care for GSD la and Ib",
      "line": 7353,
      "preview": "Management of an acutely ill individual with GSD type I focuses on preventing hypoglycemia and minim"
    },
    {
      "type": "text",
      "section": "Acute Care for GSD la and Ib",
      "line": 7355,
      "preview": "For individuals that are unable to resume UCCS regimen and oral diet after several days, additional "
    },
    {
      "type": "text",
      "section": "Acute Care for GSD la and Ib",
      "line": 7357,
      "preview": "1. Begin with $25 \\%-50 \\%$ of usual cornstarch doses and advance toward the goal."
    },
    {
      "type": "text",
      "section": "Acute Care for GSD la and Ib",
      "line": 7358,
      "preview": "2. Taper IV support as UCCS is increased and tolerated and maintain blood glucose above $70 \\mathrm{"
    },
    {
      "type": "heading",
      "level": 2,
      "section": "IEM Resources",
      "line": 7360
    },
    {
      "type": "heading",
      "level": 2,
      "section": "Newborn Screening",
      "line": 7362
    },
    {
      "type": "text",
      "section": "Newborn Screening",
      "line": 7364,
      "preview": "- Health Resources \\& Services Administration Newborn Screening Report (https://newbornscreening.hrs"
    },
    {
      "type": "text",
      "section": "Newborn Screening",
      "line": 7365,
      "preview": "- American College of Medical Genetics and Genomics ACT Sheets and Algorithms (https://www.acmg.net/"
    },
    {
      "type": "heading",
      "level": 2,
      "section": "Genetic Metabolic Dietitians International/Southeast Regional Genetics Network Nutrition Guidelines and Toolkit",
      "line": 7368
    },
    {
      "type": "text",
      "section": "Genetic Metabolic Dietitians International/Southeast Regional Genetics Network Nutrition Guidelines and Toolkit",
      "line": 7370,
      "preview": "- https://managementguidelines.net/guidelines.php"
    },
    {
      "type": "text",
      "section": "Genetic Metabolic Dietitians International/Southeast Regional Genetics Network Nutrition Guidelines and Toolkit",
      "line": 7371,
      "preview": "- Available for PKU, MSUD, PROP, and VLCAD deficiency"
    },
    {
      "type": "heading",
      "level": 2,
      "section": "Book on IEM Nutrition Management",
      "line": 7374
    },
    {
      "type": "text",
      "section": "Book on IEM Nutrition Management",
      "line": 7376,
      "preview": "Bernstein LE, Rohr F, Van Calcar S, eds. Nutrition Management of Inherited Metabolic Diseases: Lesso"
    },
    {
      "type": "heading",
      "level": 2,
      "section": "Nutrition Analysis Software for Metabolic Disorders",
      "line": 7378
    },
    {
      "type": "text",
      "section": "Nutrition Analysis Software for Metabolic Disorders",
      "line": 7380,
      "preview": "MetabolicPro (https://metabolicpro.org)"
    },
    {
      "type": "heading",
      "level": 2,
      "section": "Medical Food/Nutrition Support Suppliers",
      "line": 7382
    },
    {
      "type": "text",
      "section": "Medical Food/Nutrition Support Suppliers",
      "line": 7384,
      "preview": "- Parenteral solutions:"
    },
    {
      "type": "text",
      "section": "Medical Food/Nutrition Support Suppliers",
      "line": 7385,
      "preview": "- Integrity Compounding Pharmacy (https://www.mixwithintegrity.com/)"
    },
    {
      "type": "text",
      "section": "Medical Food/Nutrition Support Suppliers",
      "line": 7386,
      "preview": "- Single amino acids:"
    },
    {
      "type": "text",
      "section": "Medical Food/Nutrition Support Suppliers",
      "line": 7387,
      "preview": "- Ajinomoto (https://www.ajinomoto.com)"
    },
    {
      "type": "text",
      "section": "Medical Food/Nutrition Support Suppliers",
      "line": 7388,
      "preview": "- JoMar Labs (https://www.jomarlabs.com)"
    },
    {
      "type": "text",
      "section": "Medical Food/Nutrition Support Suppliers",
      "line": 7389,
      "preview": "- Vitaflo USA (https://www.vitaflousa.com)"
    },
    {
      "type": "text",
      "section": "Medical Food/Nutrition Support Suppliers",
      "line": 7390,
      "preview": "- Medical foods (USA suppliers):"
    },
    {
      "type": "text",
      "section": "Medical Food/Nutrition Support Suppliers",
      "line": 7391,
      "preview": "- Abbott Nutrition (https://abbottnutrition.com/therapeutic)"
    },
    {
      "type": "text",
      "section": "Medical Food/Nutrition Support Suppliers",
      "line": 7392,
      "preview": "- Ajinomoto Cambrooke Foods (https://www.cambrooke.com)"
    },
    {
      "type": "text",
      "section": "Medical Food/Nutrition Support Suppliers",
      "line": 7393,
      "preview": "- Mead Johnson (https://www.hcp.meadjohnson.com/)"
    },
    {
      "type": "text",
      "section": "Medical Food/Nutrition Support Suppliers",
      "line": 7395,
      "preview": "--- page 381 ---"
    },
    {
      "type": "text",
      "section": "Medical Food/Nutrition Support Suppliers",
      "line": 7397,
      "preview": "- Nutricia North America (https://nutricia-na.com)"
    },
    {
      "type": "text",
      "section": "Medical Food/Nutrition Support Suppliers",
      "line": 7398,
      "preview": "- Vitaflo USA (https://www.vitaflousa.com)"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "References",
      "line": 7401
    },
    {
      "type": "text",
      "section": "References",
      "line": 7403,
      "preview": "1. Fabie NAV, Pappas KB, Feldman GL. The current state of newborn screening in the United States. Pe"
    },
    {
      "type": "text",
      "section": "References",
      "line": 7404,
      "preview": "2. Saudubray JM, Garcia-Cazorla \u00c0. Inborn errors of metabolism overview: pathophysiology, manifestat"
    },
    {
      "type": "text",
      "section": "References",
      "line": 7405,
      "preview": "3. Balakrishnan U. Inborn errors of metabolism-approach to diagnosis and management in neonates. Ind"
    },
    {
      "type": "text",
      "section": "References",
      "line": 7406,
      "preview": "4. Chace DH, Kalas TA, Naylor EW. The application of tandem mass spectrometry to neonatal screening "
    },
    {
      "type": "text",
      "section": "References",
      "line": 7407,
      "preview": "5. Watson MS, Mann MY, Lloyd-Puryear MA, Rinaldo P, Howell RR; American College of Medical Genetics "
    },
    {
      "type": "text",
      "section": "References",
      "line": 7408,
      "preview": "6. Ogata BN, Trahms C. Medical nutrition therapy for genetic metabolic disorders. In: Raymond JL, Mo"
    },
    {
      "type": "text",
      "section": "References",
      "line": 7409,
      "preview": "7. Strauss KA, Puffenberger EG, Carson VJ. Maple syrup urine disease. In: Adam MP, Ardinger HH, Pago"
    },
    {
      "type": "text",
      "section": "References",
      "line": 7410,
      "preview": "8. Chapman KA, Gramer G, Viall S, Summar ML. Incidence of maple syrup urine disease, propionic acide"
    },
    {
      "type": "text",
      "section": "References",
      "line": 7411,
      "preview": "9. Frazier DM, Allgeier C, Homer C, et al. Nutrition management guideline for maple syrup urine dise"
    },
    {
      "type": "text",
      "section": "References",
      "line": 7412,
      "preview": "10. Strauss KA, Carson VJ, Soltys K, et al. Branched-chain $\\alpha$-ketoacid dehydrogenase deficienc"
    },
    {
      "type": "text",
      "section": "References",
      "line": 7413,
      "preview": "11. Van Calcar S. Nutrition management of maple syrup urine disease. In: Bernstein LE, Rohr F, Van C"
    },
    {
      "type": "text",
      "section": "References",
      "line": 7414,
      "preview": "12. Kaur J, Nagy L, Wan B, et al. The utility of dried blood spot monitoring of branched-chain amino"
    },
    {
      "type": "text",
      "section": "References",
      "line": 7415,
      "preview": "13. Morton DH, Strauss KA, Robinson DL, Puffenberger EG, Kelley RI. Diagnosis and treatment of maple"
    },
    {
      "type": "text",
      "section": "References",
      "line": 7416,
      "preview": "14. Rodan LH, Aldubayan SH, Berry GT, Levy HL. Acute illness protocol for maple syrup urine disease."
    },
    {
      "type": "text",
      "section": "References",
      "line": 7417,
      "preview": "15. Ah Mew N, Simpson KL, Gropman AL, Lanpher BC, Chapman KA, Summar ML. Urea cycle disorders overvi"
    },
    {
      "type": "text",
      "section": "References",
      "line": 7418,
      "preview": "16. R\u00fcegger CM, Lindner M, Ballhausen D, et al. Cross-sectional observational study of 208 patients "
    },
    {
      "type": "text",
      "section": "References",
      "line": 7419,
      "preview": "17. Summar ML, Dobbelaere D, Brusilow S, Lee B. Diagnosis, symptoms, frequency and mortality of 260 "
    },
    {
      "type": "text",
      "section": "References",
      "line": 7420,
      "preview": "18. Ng VL, Alonso EM, Bucuvalas JC, et al; Studies of Pediatric Liver Transplantation (SPLIT) Resear"
    },
    {
      "type": "text",
      "section": "References",
      "line": 7421,
      "preview": "19. Lamb S, Aye CY, Murphy E, Mackillop L. Multidisciplinary management of ornithine transcarbamylas"
    },
    {
      "type": "text",
      "section": "References",
      "line": 7422,
      "preview": "20. MacLeod EL. Nutrition management of urea cycle disorders. In: Bernstein LE, Rohr F, Van Calcar S"
    },
    {
      "type": "text",
      "section": "References",
      "line": 7423,
      "preview": "21. Singh RH. Nutritional management of patients with urea cycle disorders. J Inherit Metab Dis. 200"
    },
    {
      "type": "text",
      "section": "References",
      "line": 7424,
      "preview": "22. Molema F, Gleich F, Burgard P, et al. Evaluation of dietary treatment and amino acid supplementa"
    },
    {
      "type": "text",
      "section": "References",
      "line": 7426,
      "preview": "--- page 382 ---"
    },
    {
      "type": "text",
      "section": "References",
      "line": 7428,
      "preview": "2019;42(6):1162-1175. https://doi.org/10.1002/jimd. 12066"
    },
    {
      "type": "text",
      "section": "References",
      "line": 7429,
      "preview": "23. Maranda B, Cousineau J, Allard P, Lambert M. False positives in plasma ammonia measurement and t"
    },
    {
      "type": "text",
      "section": "References",
      "line": 7430,
      "preview": "24. Batshaw ML, Tuchman M, Summar M, Seminara J; Members of the Urea Cycle Disorders Consortium. A l"
    },
    {
      "type": "text",
      "section": "References",
      "line": 7431,
      "preview": "25. MacLeod EL, Hall KD, McGuire PJ. Computational modeling to predict nitrogen balance during acute"
    },
    {
      "type": "text",
      "section": "References",
      "line": 7432,
      "preview": "26. H\u00e4berle J, Burlina A, Chakrapani A, et al. Suggested guidelines for the diagnosis and management"
    },
    {
      "type": "text",
      "section": "References",
      "line": 7433,
      "preview": "27. Jurecki E, Ueda K, Frazier D, et al. Nutrition management guideline for propionic acidemia: an e"
    },
    {
      "type": "text",
      "section": "References",
      "line": 7434,
      "preview": "28. McCrory NM, Edick MJ, Ahmad A, et al; Inborn Errors of Metabolism Collaborative. Comparison of m"
    },
    {
      "type": "text",
      "section": "References",
      "line": 7435,
      "preview": "29. Fraser JL, Venditti CP. Methylmalonic and propionic acidemias: Clinical management update. Curr "
    },
    {
      "type": "text",
      "section": "References",
      "line": 7436,
      "preview": "30. Shchelochkov OA, Carrillo N, Venditti C. Propionic acidemia. In: Adam MP, Mirzaa GM, Pagon RA, e"
    },
    {
      "type": "text",
      "section": "References",
      "line": 7437,
      "preview": "31. Sowa M. Nutrition management of propionic acidemia and methylmalonic acidemia. In: Bernstein LE,"
    },
    {
      "type": "text",
      "section": "References",
      "line": 7438,
      "preview": "32. Arrizza C, De Gottardi A, Foglia E, Baumgartner M, Gautschi M, Nuoffer JM. Reversal of cardiomyo"
    },
    {
      "type": "text",
      "section": "References",
      "line": 7439,
      "preview": "33. Baumgartner MR, H\u00f6rster F, Dionisi-Vici C, et al. Proposed guidelines for the diagnosis and mana"
    },
    {
      "type": "text",
      "section": "References",
      "line": 7440,
      "preview": "34. Knottnerus SJG, Bleeker JC, W\u00fcst RCI, et al. Disorders of mitochondrial long-chain fatty acid ox"
    },
    {
      "type": "text",
      "section": "References",
      "line": 7441,
      "preview": "35. Merritt JL, Chang IJ. Medium-chain acyl-coenzyme A dehydrogenase deficiency. In: Adam MP, Mirzaa"
    },
    {
      "type": "text",
      "section": "References",
      "line": 7442,
      "preview": "36. Rohr F. Nutrition management of fatty acid oxidation disorders. In: Bernstein LE, Rohr F, Van Ca"
    },
    {
      "type": "text",
      "section": "References",
      "line": 7443,
      "preview": "37. Van Calcar SC, Sowa M, Rohr F, et al. Nutrition management guideline for very-long chain acyl-Co"
    },
    {
      "type": "text",
      "section": "References",
      "line": 7444,
      "preview": "38. Walter JH. Tolerance to fast: rational and practical evaluation in children with hypoketonaemia."
    },
    {
      "type": "text",
      "section": "References",
      "line": 7445,
      "preview": "39. Gillingham MB, Heitner SB, Martin J, et al. Triheptanoin versus trioctanoin for long-chain fatty"
    },
    {
      "type": "text",
      "section": "References",
      "line": 7446,
      "preview": "40. Vockley J, Burton B, Berry G, et al. Effects of triheptanoin (UX007) in patients with long-chain"
    },
    {
      "type": "text",
      "section": "References",
      "line": 7447,
      "preview": "41. Gillingham MB, Elizondo G, Behrend A, et al. Higher dietary protein intake preserves lean body m"
    },
    {
      "type": "text",
      "section": "References",
      "line": 7448,
      "preview": "42. Ali M, Rellos P, Cox TM. Hereditary fructose intolerance. J Med Genet. 1998;35(5):353-365. https"
    },
    {
      "type": "text",
      "section": "References",
      "line": 7449,
      "preview": "43. Welling L, Bernstein LE, Berry GT, et al. International clinical guideline for the management of"
    },
    {
      "type": "text",
      "section": "References",
      "line": 7450,
      "preview": "44. Mayatepek E, Hoffmann B, Meissner T. Inborn errors of carbohydrate metabolism. Best Pract Res Cl"
    },
    {
      "type": "text",
      "section": "References",
      "line": 7451,
      "preview": "45. Sentner CP, Hoogeveen IJ, Weinstein DA, et al. Glycogen storage disease type III: diagnosis, gen"
    },
    {
      "type": "text",
      "section": "References",
      "line": 7452,
      "preview": "46. Smit GP, Rake JP, Akman HO, DiMauro S. The glycogen storage diseases and related disorders. Inbo"
    },
    {
      "type": "text",
      "section": "References",
      "line": 7454,
      "preview": "--- page 383 ---"
    },
    {
      "type": "text",
      "section": "References",
      "line": 7456,
      "preview": "47. Weinstein DA, Steuerwald U, De Souza CFM, Derks TGJ. Inborn errors of metabolism with hypoglycem"
    },
    {
      "type": "text",
      "section": "References",
      "line": 7457,
      "preview": "48. Herbert M, Goldstein JL, Rehder C, Austin S, Kishnani PS, Bali DS. Phosphorylase kinase deficien"
    },
    {
      "type": "text",
      "section": "References",
      "line": 7458,
      "preview": "49. Korlimarla A, Gibson R, Kishnani PS. Glycogen storage diseases. In: Bernstein LE, Rohr F, Van Ca"
    },
    {
      "type": "text",
      "section": "References",
      "line": 7459,
      "preview": "50. Sowa M. Nutrition management of glycogen storage disease. In: Bernstein LE, Rohr F, Van Calcar S"
    },
    {
      "type": "text",
      "section": "References",
      "line": 7460,
      "preview": "51. Ross KM, Ferrecchia IA, Dahlberg KR, Dambska M, Ryan PT, Weinstein DA. Dietary management of the"
    },
    {
      "type": "text",
      "section": "References",
      "line": 7461,
      "preview": "52. Ross KM, Brown LM, Corrado MM, et al. Safety and efficacy of chronic extended release cornstarch"
    },
    {
      "type": "text",
      "section": "References",
      "line": 7462,
      "preview": "53. Vitaflo USA. A Practical Guide for Overnight Use of Glycosade in Hepatic Glycogen Storage Diseas"
    },
    {
      "type": "text",
      "section": "References",
      "line": 7463,
      "preview": "54. Herbert M, Pendyal S, Rairikar M, Halaby C, Benjamin RW, Kishnani PS. Role of continuous glucose"
    },
    {
      "type": "text",
      "section": "References",
      "line": 7465,
      "preview": "--- page 384 ---"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "18",
      "line": 7467
    },
    {
      "type": "heading",
      "level": 2,
      "section": "Inflammatory Bowel Disease",
      "line": 7469
    },
    {
      "type": "text",
      "section": "Inflammatory Bowel Disease",
      "line": 7471,
      "preview": "Anam Bashir, MD<br>Praveen S. Goday, MBBS"
    },
    {
      "type": "heading",
      "level": 2,
      "section": "Introduction",
      "line": 7473
    },
    {
      "type": "text",
      "section": "Introduction",
      "line": 7475,
      "preview": "Inflammatory bowel disease (IBD) is characterized by inflammation of the gastrointestinal (GI) tract"
    },
    {
      "type": "heading",
      "level": 2,
      "section": "Assessment and Nutrient Requirements",
      "line": 7477
    },
    {
      "type": "text",
      "section": "Assessment and Nutrient Requirements",
      "line": 7479,
      "preview": "--- page 385 ---"
    },
    {
      "type": "text",
      "section": "Assessment and Nutrient Requirements",
      "line": 7481,
      "preview": "Children with IBD are at increased risk for nutrient losses during times of active disease from diar"
    },
    {
      "type": "text",
      "section": "Assessment and Nutrient Requirements",
      "line": 7483,
      "preview": "- History: Nausea, vomiting, appetite, and dietary recall of 3-5 days"
    },
    {
      "type": "text",
      "section": "Assessment and Nutrient Requirements",
      "line": 7484,
      "preview": "- Nutrition-focused physical examination"
    },
    {
      "type": "text",
      "section": "Assessment and Nutrient Requirements",
      "line": 7485,
      "preview": "- Anthropometric data: Weight, height, body mass index, height velocity"
    },
    {
      "type": "text",
      "section": "Assessment and Nutrient Requirements",
      "line": 7486,
      "preview": "- Laboratory assessment: Iron studies (ferritin, total iron binding capacity, transferrin saturation"
    },
    {
      "type": "text",
      "section": "Assessment and Nutrient Requirements",
      "line": 7488,
      "preview": "--- page 386 ---"
    },
    {
      "type": "text",
      "section": "Assessment and Nutrient Requirements",
      "line": 7490,
      "preview": "TABLE 18-1. Monitoring of Vitamin and Micronutrient Deficiency in Children With IBD ${ }^{a}$"
    },
    {
      "type": "table",
      "section": "Assessment and Nutrient Requirements",
      "line": 7492,
      "preview": "| Vitamin and Micronutrient | Laboratory <br> Monitoring | Management | Monitoring <br> Frequency on"
    },
    {
      "type": "table",
      "section": "Assessment and Nutrient Requirements",
      "line": 7493,
      "preview": "| :--: | :--: | :--: | :--: |"
    },
    {
      "type": "table",
      "section": "Assessment and Nutrient Requirements",
      "line": 7494,
      "preview": "| Iron | - CBC annually <br> - Ferritin, serum iron, total iron binding capacity, percent saturation"
    },
    {
      "type": "table",
      "section": "Assessment and Nutrient Requirements",
      "line": 7495,
      "preview": "| Vitamin D | 25hydroxyvitamin D level annually | - Supplement if level $<30 \\mathrm{mg} / \\mathrm{m"
    },
    {
      "type": "table",
      "section": "Assessment and Nutrient Requirements",
      "line": 7496,
      "preview": "| Vitamin $B_{12}$ | - Should be considered in patients with ileal/ileocolonic resections <br> - Eve"
    },
    {
      "type": "text",
      "section": "Assessment and Nutrient Requirements",
      "line": 7498,
      "preview": "--- page 387 ---"
    },
    {
      "type": "table",
      "section": "Assessment and Nutrient Requirements",
      "line": 7500,
      "preview": "| Vitamin and <br> Micronutrient | Laboratory <br> Monitoring | Management | Monitoring <br> Frequen"
    },
    {
      "type": "table",
      "section": "Assessment and Nutrient Requirements",
      "line": 7501,
      "preview": "| :-- | :-- | :-- | :-- |"
    },
    {
      "type": "table",
      "section": "Assessment and Nutrient Requirements",
      "line": 7502,
      "preview": "| Zinc | Every 12 mo in <br> patients with <br> Crohn's disease | $0.5-1 \\mathrm{mg}$ elemental <br>"
    },
    {
      "type": "table",
      "section": "Assessment and Nutrient Requirements",
      "line": 7503,
      "preview": "| Folate | Consider in <br> patients who are <br> on drugs that can <br> exacerbate folate <br> defi"
    },
    {
      "type": "text",
      "section": "Assessment and Nutrient Requirements",
      "line": 7505,
      "preview": "Abbreviations: CBC, complete blood cell count; Hb, hemoglobin; IBD, inflammatory bowel disease; IV, "
    },
    {
      "type": "text",
      "section": "Assessment and Nutrient Requirements",
      "line": 7506,
      "preview": "${ }^{a}$ Data from Corkins MR, ed. Bobo E, Christensen ML, Larson-Nath C, Nuse Tome R, Plogsted S, "
    },
    {
      "type": "heading",
      "level": 1,
      "section": "Implementation of Nutrition Plan and Monitoring",
      "line": 7508
    },
    {
      "type": "text",
      "section": "Implementation of Nutrition Plan and Monitoring",
      "line": 7510,
      "preview": "The nutrition management of IBD involves nutrition therapies and optimizing nutrition to prevent mal"
    },
    {
      "type": "heading",
      "level": 2,
      "section": "Nutrition Therapies for Crohn's Disease",
      "line": 7512
    },
    {
      "type": "text",
      "section": "Nutrition Therapies for Crohn's Disease",
      "line": 7514,
      "preview": "The mainstays of nutrition therapy for patients with CD include exclusive enteral nutrition, which c"
    },
    {
      "type": "text",
      "section": "Nutrition Therapies for Crohn's Disease",
      "line": 7516,
      "preview": "--- page 388 ---"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "TABLE 18-2. Different Dietary Therapies Used in Crohn's Disease",
      "line": 7518
    },
    {
      "type": "table",
      "section": "TABLE 18-2. Different Dietary Therapies Used in Crohn's Disease",
      "line": 7520,
      "preview": "| Type of Diet | Inclusion | Restriction/Avoidance | Nutrition Consideration | Other Information |"
    },
    {
      "type": "table",
      "section": "TABLE 18-2. Different Dietary Therapies Used in Crohn's Disease",
      "line": 7521,
      "preview": "| :--: | :--: | :--: | :--: | :--: |"
    },
    {
      "type": "table",
      "section": "TABLE 18-2. Different Dietary Therapies Used in Crohn's Disease",
      "line": 7522,
      "preview": "| EEN | - 100\\% formula-based diet (polymeric formula/semielemental formula/elemental formula) orall"
    },
    {
      "type": "table",
      "section": "TABLE 18-2. Different Dietary Therapies Used in Crohn's Disease",
      "line": 7523,
      "preview": "| PEN | - Formula for 10\\%-90\\% of caloric intake <br> - Restricted diet such as CDED diet/unrestric"
    },
    {
      "type": "table",
      "section": "TABLE 18-2. Different Dietary Therapies Used in Crohn's Disease",
      "line": 7524,
      "preview": "| CDED (can be combined with PEN) | - Multistage diet including induction phase followed by maintena"
    },
    {
      "type": "table",
      "section": "TABLE 18-2. Different Dietary Therapies Used in Crohn's Disease",
      "line": 7525,
      "preview": "| CD- <br> TREAT | - Matching foods to Modulen formula available in Europe to recreate a similar com"
    },
    {
      "type": "text",
      "section": "TABLE 18-2. Different Dietary Therapies Used in Crohn's Disease",
      "line": 7527,
      "preview": "--- page 389 ---"
    },
    {
      "type": "table",
      "section": "TABLE 18-2. Different Dietary Therapies Used in Crohn's Disease",
      "line": 7529,
      "preview": "| Type of <br> Diet | Inclusion | Restriction/Avoidance | Nutrition <br> Consideration | Other <br> "
    },
    {
      "type": "table",
      "section": "TABLE 18-2. Different Dietary Therapies Used in Crohn's Disease",
      "line": 7530,
      "preview": "| :--: | :--: | :--: | :--: | :--: |"
    },
    {
      "type": "table",
      "section": "TABLE 18-2. Different Dietary Therapies Used in Crohn's Disease",
      "line": 7531,
      "preview": "| SCD | - Unprocessed meats <br> - Eggs <br> - Fish <br> - Nuts <br> - Vegetables <br> - Low-sugar f"
    },
    {
      "type": "text",
      "section": "TABLE 18-2. Different Dietary Therapies Used in Crohn's Disease",
      "line": 7533,
      "preview": "Abbreviations: CDED, Crohn's Disease Exclusion Diet; CD-TREAT, Crohn's Disease Treatment with Eating"
    },
    {
      "type": "text",
      "section": "TABLE 18-2. Different Dietary Therapies Used in Crohn's Disease",
      "line": 7535,
      "preview": "More research is needed to incorporate other dietary therapies in daily practice. Several other excl"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "Prevention of Malnutrition",
      "line": 7537
    },
    {
      "type": "text",
      "section": "Prevention of Malnutrition",
      "line": 7539,
      "preview": "Children with poor energy stores and active inflammation require 5\\%$35 \\%$ more energy than healthy"
    },
    {
      "type": "heading",
      "level": 2,
      "section": "Prevention of Vitamin and Micronutrient Deficiency",
      "line": 7541
    },
    {
      "type": "text",
      "section": "Prevention of Vitamin and Micronutrient Deficiency",
      "line": 7543,
      "preview": "Vitamin D, iron, and zinc deficiencies most commonly occur in children with IBD (Table 18-1). To pre"
    },
    {
      "type": "text",
      "section": "Prevention of Vitamin and Micronutrient Deficiency",
      "line": 7545,
      "preview": "--- page 390 ---"
    },
    {
      "type": "text",
      "section": "Prevention of Vitamin and Micronutrient Deficiency",
      "line": 7547,
      "preview": "- Patients younger than age 8 can usually be supplemented with standard complete multivitamins."
    },
    {
      "type": "text",
      "section": "Prevention of Vitamin and Micronutrient Deficiency",
      "line": 7548,
      "preview": "- For children older than age 9, prenatal vitamins are usually sufficient. ${ }^{4}$"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "References",
      "line": 7551
    },
    {
      "type": "text",
      "section": "References",
      "line": 7553,
      "preview": "1. Verburgt CM, Ghiboub M, Benninga MA, de Jonge WJ, Van Limbergen JE. Nutrition therapy strategies "
    },
    {
      "type": "text",
      "section": "References",
      "line": 7554,
      "preview": "2. Cucinotta U, Romano C, Dipasquale V. Diet and nutrition in pediatric inflammatory bowel diseases."
    },
    {
      "type": "text",
      "section": "References",
      "line": 7555,
      "preview": "3. Levine A, Wine E, Assa A, et al. Crohn's disease exclusion diet plus partial enteral nutrition in"
    },
    {
      "type": "text",
      "section": "References",
      "line": 7556,
      "preview": "4. Corkins MR, ed. Bobo E, Christensen ML, Larson-Nath C, Nuse Tome R, Plogsted S, associate eds. AS"
    },
    {
      "type": "text",
      "section": "References",
      "line": 7557,
      "preview": "5. Fritz J, Walia C, Elkadri A, et al. A systematic review of micronutrient deficiencies in pediatri"
    },
    {
      "type": "text",
      "section": "References",
      "line": 7559,
      "preview": "--- page 391 ---"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "19",
      "line": 7561
    },
    {
      "type": "heading",
      "level": 2,
      "section": "Renal Disease",
      "line": 7563
    },
    {
      "type": "text",
      "section": "Renal Disease",
      "line": 7565,
      "preview": "Paige Balgie, RDN, LD"
    },
    {
      "type": "heading",
      "level": 2,
      "section": "Introduction",
      "line": 7567
    },
    {
      "type": "text",
      "section": "Introduction",
      "line": 7569,
      "preview": "The primary causes of pediatric renal disease differ greatly from adult disease. Chronic kidney dise"
    },
    {
      "type": "text",
      "section": "Introduction",
      "line": 7571,
      "preview": "--- page 392 ---"
    },
    {
      "type": "text",
      "section": "Introduction",
      "line": 7573,
      "preview": "TABLE 19-1. Stages of CKD: Greater Than 2 Years of Age"
    },
    {
      "type": "table",
      "section": "Introduction",
      "line": 7575,
      "preview": "| Stage | Description | eGFR $\\left(\\mathrm{mL} / \\mathrm{min} / 1.73 \\mathrm{~m}^{2}\\right)$ |"
    },
    {
      "type": "table",
      "section": "Introduction",
      "line": 7576,
      "preview": "| :-- | :-- | :--: |"
    },
    {
      "type": "table",
      "section": "Introduction",
      "line": 7577,
      "preview": "| 1 | Normal or high | $\\geq 90$ |"
    },
    {
      "type": "table",
      "section": "Introduction",
      "line": 7578,
      "preview": "| 2 | Mildly decreased | $60-89$ |"
    },
    {
      "type": "table",
      "section": "Introduction",
      "line": 7579,
      "preview": "| 3a | Mildly to moderately decreased | $45-59$ |"
    },
    {
      "type": "table",
      "section": "Introduction",
      "line": 7580,
      "preview": "| 3b | Moderately to severely decreased | $30-44$ |"
    },
    {
      "type": "table",
      "section": "Introduction",
      "line": 7581,
      "preview": "| 4 | Severe decrease | $15-29$ |"
    },
    {
      "type": "table",
      "section": "Introduction",
      "line": 7582,
      "preview": "| 5 | Kidney failure | $<15$ (or dialysis) |"
    },
    {
      "type": "text",
      "section": "Introduction",
      "line": 7584,
      "preview": "Abbreviations: CKD, chronic kidney disease; eGFR, estimated glomerular filtration rate."
    },
    {
      "type": "text",
      "section": "Introduction",
      "line": 7585,
      "preview": "Reproduced with permission from the National Kidney Foundation from K/DOQI clinical practice guideli"
    },
    {
      "type": "text",
      "section": "Introduction",
      "line": 7587,
      "preview": "Acute kidney injury (AKI) is an abrupt decrease in kidney function with rise in serum creatinine or "
    },
    {
      "type": "text",
      "section": "Introduction",
      "line": 7589,
      "preview": "Nephrotic syndrome is a combination of symptoms including proteinuria, hypoalbuminemia, hyperlipidem"
    },
    {
      "type": "text",
      "section": "Introduction",
      "line": 7591,
      "preview": "Nephrolithiasis, or calculi within the urinary tract, also known as kidney stones, can have signific"
    },
    {
      "type": "text",
      "section": "Introduction",
      "line": 7593,
      "preview": "--- page 393 ---"
    },
    {
      "type": "text",
      "section": "Introduction",
      "line": 7595,
      "preview": "risk factors for kidney stones include obesity, hypertension, living in a warm climate, and secondar"
    },
    {
      "type": "text",
      "section": "Introduction",
      "line": 7597,
      "preview": "TABLE 19-2. Nutrition for Kidney Stone Management"
    },
    {
      "type": "table",
      "section": "Introduction",
      "line": 7599,
      "preview": "|  | Increase <br> Fluid | Increase Fruit and Vegetable Intake | Limit <br> Acid- <br> Based <br> Fo"
    },
    {
      "type": "table",
      "section": "Introduction",
      "line": 7600,
      "preview": "| :--: | :--: | :--: | :--: | :--: | :--: | :--: | :--: |"
    },
    {
      "type": "table",
      "section": "Introduction",
      "line": 7601,
      "preview": "| Calcium-based stones | $X$ | $X$ | $X$ | $X$ |  | $X$ | $X$ |"
    },
    {
      "type": "table",
      "section": "Introduction",
      "line": 7602,
      "preview": "| Oxalosis or hyperoxaluria with calciumbased stones | $X$ | $X$ | $X$ | $X$ | $X$ | $X$ | $X$ |"
    },
    {
      "type": "table",
      "section": "Introduction",
      "line": 7603,
      "preview": "| Uric acid stones | $X$ | $X$ | $X$ | DRI, especially limit purines |  |  |  |"
    },
    {
      "type": "table",
      "section": "Introduction",
      "line": 7604,
      "preview": "| Cystine stones | $X$ | $X$ | $X$ | $X$ |  | $X$ |  |"
    },
    {
      "type": "table",
      "section": "Introduction",
      "line": 7605,
      "preview": "| Struvite stones | $X$ |  |  |  |  |  |  |"
    },
    {
      "type": "table",
      "section": "Introduction",
      "line": 7606,
      "preview": "| Other kidney stones | $X$ | ? | ? | $X$ |  | ? |  |"
    },
    {
      "type": "text",
      "section": "Introduction",
      "line": 7608,
      "preview": "Abbreviations: DRI, dietary reference intake."
    },
    {
      "type": "text",
      "section": "Introduction",
      "line": 7609,
      "preview": "Reproduced with permission from the American Society for Parenteral and Enteral Nutrition from Nelms"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "Renal Replacement Therapy",
      "line": 7611
    },
    {
      "type": "heading",
      "level": 2,
      "section": "Continuous Renal Replacement Therapy",
      "line": 7613
    },
    {
      "type": "text",
      "section": "Continuous Renal Replacement Therapy",
      "line": 7615,
      "preview": "Continuous renal replacement therapy is continuous or nearly continuous fluid and/or solute removal,"
    },
    {
      "type": "text",
      "section": "Continuous Renal Replacement Therapy",
      "line": 7617,
      "preview": "--- page 394 ---"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "Hemodialysis",
      "line": 7619
    },
    {
      "type": "text",
      "section": "Hemodialysis",
      "line": 7621,
      "preview": "Hemodialysis (HD) or intermittent HD is fluid and/or solute removal from blood via a central venous "
    },
    {
      "type": "heading",
      "level": 2,
      "section": "Peritoneal Dialysis",
      "line": 7623
    },
    {
      "type": "text",
      "section": "Peritoneal Dialysis",
      "line": 7625,
      "preview": "Peritoneal dialysis is fluid and solute removal via a surgically placed catheter into peritoneal cav"
    },
    {
      "type": "heading",
      "level": 2,
      "section": "Transplant",
      "line": 7627
    },
    {
      "type": "text",
      "section": "Transplant",
      "line": 7629,
      "preview": "Solid organ transplant of a living or deceased donor kidney can be preemptive or for children with E"
    },
    {
      "type": "heading",
      "level": 2,
      "section": "Assessment and Nutrient Requirements",
      "line": 7631
    },
    {
      "type": "heading",
      "level": 2,
      "section": "Assessment and Growth",
      "line": 7633
    },
    {
      "type": "text",
      "section": "Assessment and Growth",
      "line": 7635,
      "preview": "Poor weight gain and linear growth continue to be the most challenging and recognizable adverse even"
    },
    {
      "type": "text",
      "section": "Assessment and Growth",
      "line": 7637,
      "preview": "--- page 395 ---"
    },
    {
      "type": "text",
      "section": "Assessment and Growth",
      "line": 7639,
      "preview": "osteodystrophy, acidosis, uremia, growth hormone abnormalities, prematurity, steroid use, and inflam"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "Euvolemic Weight",
      "line": 7641
    },
    {
      "type": "text",
      "section": "Euvolemic Weight",
      "line": 7643,
      "preview": "Determine the weight at which the child is neither fluid overloaded nor dehydrated, which can be bas"
    },
    {
      "type": "heading",
      "level": 2,
      "section": "Body Mass Index and Body Composition",
      "line": 7645
    },
    {
      "type": "text",
      "section": "Body Mass Index and Body Composition",
      "line": 7647,
      "preview": "Children can have decreased lean mass with higher adiposity. Because of short stature, the body mass"
    },
    {
      "type": "heading",
      "level": 2,
      "section": "Estimating Needs",
      "line": 7649
    },
    {
      "type": "text",
      "section": "Estimating Needs",
      "line": 7651,
      "preview": "Despite poor weight gain and linear growth, estimating energy needs in pediatric kidney disease shou"
    },
    {
      "type": "text",
      "section": "Estimating Needs",
      "line": 7653,
      "preview": "--- page 396 ---"
    },
    {
      "type": "text",
      "section": "Estimating Needs",
      "line": 7655,
      "preview": "TABLE 19-3. Energy and Protein Needs"
    },
    {
      "type": "table",
      "section": "Estimating Needs",
      "line": 7657,
      "preview": "|  | Nephrotic Syndrome | CRRT | CKD <br> Stage <br> 3 | CKD <br> Stages <br> 4-5 | HD | PD |"
    },
    {
      "type": "table",
      "section": "Estimating Needs",
      "line": 7658,
      "preview": "| :--: | :--: | :--: | :--: | :--: | :--: | :--: |"
    },
    {
      "type": "table",
      "section": "Estimating Needs",
      "line": 7659,
      "preview": "| Energy | - Age-appropriate energy needs <br> - CNS: May require $130 \\mathrm{kcal} / \\mathrm{kg} /"
    },
    {
      "type": "table",
      "section": "Estimating Needs",
      "line": 7660,
      "preview": "| Protein | - DRI for age without need for additional protein to replenish urinary losses ${ }^{b}$ "
    },
    {
      "type": "text",
      "section": "Estimating Needs",
      "line": 7662,
      "preview": "Abbreviations: CKD, chronic kidney disease; CNS, congenital nephrotic syndrome; CRRT, continuous ren"
    },
    {
      "type": "text",
      "section": "Estimating Needs",
      "line": 7663,
      "preview": "${ }^{a}$ Hampson KJ, Gay ML, Band ME. Pediatric nephrotic syndrome: pharmacologic and nutrition man"
    },
    {
      "type": "text",
      "section": "Estimating Needs",
      "line": 7664,
      "preview": "https://doi.org/10.1002/ncp. 10622"
    },
    {
      "type": "text",
      "section": "Estimating Needs",
      "line": 7665,
      "preview": "${ }^{\\text {b }}$ Nelms C, Juarez-Calderon M, Warady BA. Renal disease. In: Corkins MR, ed. Bobo E,"
    },
    {
      "type": "text",
      "section": "Estimating Needs",
      "line": 7666,
      "preview": "${ }^{c}$ Shaw V, Polderman N, Renken-Terhaerdt J, et al. Energy and protein requirements for childr"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "Electrolytes and Micronutrients",
      "line": 7668
    },
    {
      "type": "text",
      "section": "Electrolytes and Micronutrients",
      "line": 7670,
      "preview": "Electrolyte and micronutrient intake in pediatric kidney disease continue to be the most challenging"
    },
    {
      "type": "text",
      "section": "Electrolytes and Micronutrients",
      "line": 7672,
      "preview": "--- page 397 ---"
    },
    {
      "type": "text",
      "section": "Electrolytes and Micronutrients",
      "line": 7674,
      "preview": "Micronutrient considerations are listed in Table 19-4, including restrictions, monitoring, and ratio"
    },
    {
      "type": "text",
      "section": "Electrolytes and Micronutrients",
      "line": 7676,
      "preview": "--- page 398 ---"
    },
    {
      "type": "text",
      "section": "Electrolytes and Micronutrients",
      "line": 7678,
      "preview": "TABLE 19-4. Micronutrients"
    },
    {
      "type": "table",
      "section": "Electrolytes and Micronutrients",
      "line": 7680,
      "preview": "| Micronutrient | Description | Recommendations |"
    },
    {
      "type": "table",
      "section": "Electrolytes and Micronutrients",
      "line": 7681,
      "preview": "| :--: | :--: | :--: |"
    },
    {
      "type": "table",
      "section": "Electrolytes and Micronutrients",
      "line": 7682,
      "preview": "| Sodium | Needs can vary pending fluid status, sodium losses in urine or dialysate, hypertension, a"
    },
    {
      "type": "table",
      "section": "Electrolytes and Micronutrients",
      "line": 7683,
      "preview": "| Potassium | 90\\% of potassium excretion is via the kidney, and fatal cardiac arrythmias can occur "
    },
    {
      "type": "text",
      "section": "Electrolytes and Micronutrients",
      "line": 7685,
      "preview": "--- page 399 ---"
    },
    {
      "type": "table",
      "section": "Electrolytes and Micronutrients",
      "line": 7687,
      "preview": "| Micronutrient | Description | Recommendations |"
    },
    {
      "type": "table",
      "section": "Electrolytes and Micronutrients",
      "line": 7688,
      "preview": "| :-- | :-- | :-- |"
    },
    {
      "type": "table",
      "section": "Electrolytes and Micronutrients",
      "line": 7689,
      "preview": "| Phosphorus | Serum levels are sensitive indicators <br> of progression of CKD, including <br> cont"
    },
    {
      "type": "text",
      "section": "Electrolytes and Micronutrients",
      "line": 7691,
      "preview": "--- page 400 ---"
    },
    {
      "type": "table",
      "section": "Electrolytes and Micronutrients",
      "line": 7693,
      "preview": "| Micronutrient | Description | Recommendations |"
    },
    {
      "type": "table",
      "section": "Electrolytes and Micronutrients",
      "line": 7694,
      "preview": "| :--: | :--: | :--: |"
    },
    {
      "type": "table",
      "section": "Electrolytes and Micronutrients",
      "line": 7695,
      "preview": "| Calcium | - Potential for both hypercalcemia and hypocalcemia <br> - Hypercalcemia due to the foll"
    },
    {
      "type": "table",
      "section": "Electrolytes and Micronutrients",
      "line": 7696,
      "preview": "| Vitamin D | - Both inactive (25-hydroxyvitamin D) and active (1,25dihydroxyvitamin D) are importan"
    },
    {
      "type": "text",
      "section": "Electrolytes and Micronutrients",
      "line": 7698,
      "preview": "--- page 401 ---"
    },
    {
      "type": "table",
      "section": "Electrolytes and Micronutrients",
      "line": 7700,
      "preview": "| Micronutrient | Description | Recommendations |"
    },
    {
      "type": "table",
      "section": "Electrolytes and Micronutrients",
      "line": 7701,
      "preview": "| :--: | :--: | :--: |"
    },
    {
      "type": "table",
      "section": "Electrolytes and Micronutrients",
      "line": 7702,
      "preview": "| Vitamin A | - CKD stages 4-5D: Risk of hypercalcemia and worsening of CKD-MBD due to elevated vita"
    },
    {
      "type": "table",
      "section": "Electrolytes and Micronutrients",
      "line": 7703,
      "preview": "| Water-soluble vitamins | - CKD stages 4-5: Often due to poor oral intake, dietary restrictions, an"
    },
    {
      "type": "table",
      "section": "Electrolytes and Micronutrients",
      "line": 7704,
      "preview": "| Iron | Anemia is common Etiologies include the following: <br> - Erythropoietin deficiency and/or "
    },
    {
      "type": "text",
      "section": "Electrolytes and Micronutrients",
      "line": 7706,
      "preview": "--- page 402 ---"
    },
    {
      "type": "table",
      "section": "Electrolytes and Micronutrients",
      "line": 7708,
      "preview": "| Micronutrient | Description | Recommendations |"
    },
    {
      "type": "table",
      "section": "Electrolytes and Micronutrients",
      "line": 7709,
      "preview": "| :-- | :-- | :-- |"
    },
    {
      "type": "table",
      "section": "Electrolytes and Micronutrients",
      "line": 7710,
      "preview": "| Zinc and <br> copper | Inadequate intake is common <br> because of dietary restrictions, <br> dial"
    },
    {
      "type": "text",
      "section": "Electrolytes and Micronutrients",
      "line": 7712,
      "preview": "Abbreviations: CKD, chronic kidney disease; CKD-MBD, CKD-induced mineral bone disease; DRI, dietary "
    },
    {
      "type": "text",
      "section": "Electrolytes and Micronutrients",
      "line": 7713,
      "preview": "${ }^{a}$ Nelms CL, Juarez-Calderon M, Warady BA. Renal disease. In: Corkins MR, ed. Bobo E, Christe"
    },
    {
      "type": "text",
      "section": "Electrolytes and Micronutrients",
      "line": 7714,
      "preview": "${ }^{\\text {b }}$ Shaw V, Polderman N, Renken-Terhaerdt J, et al. Energy and protein requirements f"
    },
    {
      "type": "text",
      "section": "Electrolytes and Micronutrients",
      "line": 7715,
      "preview": "${ }^{c}$ McAlister L, Pugh P, Greenbaum L, et al. The dietary management of calcium and phosphate i"
    },
    {
      "type": "text",
      "section": "Electrolytes and Micronutrients",
      "line": 7716,
      "preview": "${ }^{d}$ Shroff R, Wan M, Nagler EV, et al; European Society for Paediatric Nephrology Chronic Kidn"
    },
    {
      "type": "text",
      "section": "Electrolytes and Micronutrients",
      "line": 7717,
      "preview": "${ }^{e}$ Manickavasagar B, McArdle AJ, Yadav P, et al. Hypervitaminosis A is prevalent in children "
    },
    {
      "type": "text",
      "section": "Electrolytes and Micronutrients",
      "line": 7718,
      "preview": "${ }^{\\text {f }}$ Harris M, Varnell C, Taylor V, Nehus ST, Zhang B, Erkan E. Hypervitaminosis A in "
    },
    {
      "type": "text",
      "section": "Electrolytes and Micronutrients",
      "line": 7719,
      "preview": "${ }^{g}$ Atkinson MA, Warady BA. Anemia in chronic kidney disease. Pediatr Nephrol. 2018;33(2):227-"
    },
    {
      "type": "text",
      "section": "Electrolytes and Micronutrients",
      "line": 7721,
      "preview": "--- page 403 ---"
    },
    {
      "type": "text",
      "section": "Electrolytes and Micronutrients",
      "line": 7723,
      "preview": "TABLE 19-5. Commonly Used Phosphate Binder Medications and Their Calcium Content"
    },
    {
      "type": "table",
      "section": "Electrolytes and Micronutrients",
      "line": 7725,
      "preview": "| Phosphate <br> Binder <br> Medication | Percentage <br> Calcium <br> Content | Percentage <br> Cal"
    },
    {
      "type": "table",
      "section": "Electrolytes and Micronutrients",
      "line": 7726,
      "preview": "| :--: | :--: | :--: | :--: | :--: |"
    },
    {
      "type": "table",
      "section": "Electrolytes and Micronutrients",
      "line": 7727,
      "preview": "| Calcium carbonate | $40 \\%$ | $20 \\%-30 \\%$ | $\\sim 1 \\mathrm{mg} / 8$ <br> mg | High calcium load"
    },
    {
      "type": "table",
      "section": "Electrolytes and Micronutrients",
      "line": 7728,
      "preview": "| Calcium acetate | $25 \\%$ | $22 \\%$ | $\\sim 1 \\mathrm{mg} / 3$ <br> mg | Less calcium load than ca"
    },
    {
      "type": "table",
      "section": "Electrolytes and Micronutrients",
      "line": 7729,
      "preview": "| Sevelamer hydrochloride or sevelamer carbonate | $0 \\%$ | $0 \\%$ | Not <br> applicable | Calcium f"
    },
    {
      "type": "text",
      "section": "Electrolytes and Micronutrients",
      "line": 7731,
      "preview": "Reproduced with permission under a Creative Commons Attribution 4.0 International License (http://cr"
    },
    {
      "type": "text",
      "section": "Electrolytes and Micronutrients",
      "line": 7733,
      "preview": "--- page 404 ---"
    },
    {
      "type": "text",
      "section": "Electrolytes and Micronutrients",
      "line": 7735,
      "preview": "One method of lowering potassium in liquids including human milk, formulas (oral and enteral), and b"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "EXHIBIT 19-1. Pretreatment of Liquids to Reduce Potassium Content",
      "line": 7737
    },
    {
      "type": "text",
      "section": "EXHIBIT 19-1. Pretreatment of Liquids to Reduce Potassium Content",
      "line": 7739,
      "preview": "- Add sodium polystyrene sulfonate (SPS) to volume of formula or expressed human milk, allow it to p"
    },
    {
      "type": "text",
      "section": "EXHIBIT 19-1. Pretreatment of Liquids to Reduce Potassium Content",
      "line": 7740,
      "preview": "- Suggested starting dose of SPS is $0.4-1.5 \\mathrm{~g} / 100 \\mathrm{~mL}$ or $0.25-1 \\mathrm{~g} "
    },
    {
      "type": "text",
      "section": "EXHIBIT 19-1. Pretreatment of Liquids to Reduce Potassium Content",
      "line": 7741,
      "preview": "- Acting as an exchange resin, SPS could increase sodium, aluminum, iron, sulfur, pH while decreasin"
    },
    {
      "type": "text",
      "section": "EXHIBIT 19-1. Pretreatment of Liquids to Reduce Potassium Content",
      "line": 7743,
      "preview": "Reproduced with permission under a Creative Commons Attribution 4.0 International License (http://cr"
    },
    {
      "type": "heading",
      "level": 2,
      "section": "EXHIBIT 19-2. Nondietary Causes of Hyper- or Hypokalemia",
      "line": 7745
    },
    {
      "type": "heading",
      "level": 2,
      "section": "Nondietary causes of chronic hyperkalemia",
      "line": 7747
    },
    {
      "type": "text",
      "section": "Nondietary causes of chronic hyperkalemia",
      "line": 7749,
      "preview": "- Constipation"
    },
    {
      "type": "text",
      "section": "Nondietary causes of chronic hyperkalemia",
      "line": 7750,
      "preview": "- Impaired renal function: low glomerular filtration rate, chronic metabolic acidosis, tubular condi"
    },
    {
      "type": "text",
      "section": "Nondietary causes of chronic hyperkalemia",
      "line": 7751,
      "preview": "- Impaired cellular entry of potassium (beta-blockers)"
    },
    {
      "type": "text",
      "section": "Nondietary causes of chronic hyperkalemia",
      "line": 7753,
      "preview": "--- page 405 ---"
    },
    {
      "type": "text",
      "section": "Nondietary causes of chronic hyperkalemia",
      "line": 7755,
      "preview": "- Exogenous potassium administration (oral potassium supplements, potassiumcontaining medications)"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "Nondietary causes of chronic hypokalemia",
      "line": 7758
    },
    {
      "type": "text",
      "section": "Nondietary causes of chronic hypokalemia",
      "line": 7760,
      "preview": "- Gastrointestinal potassium losses (vomiting, drainage from gastrostomy tubes, diarrhea, laxative o"
    },
    {
      "type": "text",
      "section": "Nondietary causes of chronic hypokalemia",
      "line": 7761,
      "preview": "- Dialysate potassium losses"
    },
    {
      "type": "text",
      "section": "Nondietary causes of chronic hypokalemia",
      "line": 7762,
      "preview": "- Medications: potassium-binding resins, diuretics"
    },
    {
      "type": "text",
      "section": "Nondietary causes of chronic hypokalemia",
      "line": 7763,
      "preview": "- Renal tubular diseases (such as cystinosis and Bartter syndrome)"
    },
    {
      "type": "text",
      "section": "Nondietary causes of chronic hypokalemia",
      "line": 7765,
      "preview": "Adapted with permission under a Creative Commons Attribution 4.0 International License (http://creat"
    },
    {
      "type": "heading",
      "level": 2,
      "section": "EXHIBIT 19-3. Nutrition Considerations of Renal Replacement Therapy",
      "line": 7767
    },
    {
      "type": "text",
      "section": "EXHIBIT 19-3. Nutrition Considerations of Renal Replacement Therapy",
      "line": 7769,
      "preview": "1. Continuous renal replacement therapy:"
    },
    {
      "type": "text",
      "section": "EXHIBIT 19-3. Nutrition Considerations of Renal Replacement Therapy",
      "line": 7770,
      "preview": "a. Higher protein provisions are recommended, and limitations in electrolytes are likely not needed "
    },
    {
      "type": "text",
      "section": "EXHIBIT 19-3. Nutrition Considerations of Renal Replacement Therapy",
      "line": 7771,
      "preview": "b. Consider nonrenal formulas for enteral formula choice to provide lower osmolality and nutrition f"
    },
    {
      "type": "text",
      "section": "EXHIBIT 19-3. Nutrition Considerations of Renal Replacement Therapy",
      "line": 7772,
      "preview": "c. May need additional supplementation of folate, thiamine, selenium, carnitine. ${ }^{a}$"
    },
    {
      "type": "text",
      "section": "EXHIBIT 19-3. Nutrition Considerations of Renal Replacement Therapy",
      "line": 7773,
      "preview": "2. Hemodialysis:"
    },
    {
      "type": "text",
      "section": "EXHIBIT 19-3. Nutrition Considerations of Renal Replacement Therapy",
      "line": 7774,
      "preview": "a. Limited intake of potassium, phosphorus, sodium, and fluid via oral intake, enteral, and parenter"
    },
    {
      "type": "text",
      "section": "EXHIBIT 19-3. Nutrition Considerations of Renal Replacement Therapy",
      "line": 7775,
      "preview": "3. Peritoneal dialysis:"
    },
    {
      "type": "text",
      "section": "EXHIBIT 19-3. Nutrition Considerations of Renal Replacement Therapy",
      "line": 7776,
      "preview": "a. Daily dialysis may allow liberalized diet without potassium, sodium, or fluid restriction. Phosph"
    },
    {
      "type": "text",
      "section": "EXHIBIT 19-3. Nutrition Considerations of Renal Replacement Therapy",
      "line": 7777,
      "preview": "b. May need to consider absorption of dextrose from the dialysate if the child is gaining weight rap"
    },
    {
      "type": "text",
      "section": "EXHIBIT 19-3. Nutrition Considerations of Renal Replacement Therapy",
      "line": 7778,
      "preview": "4. Transplant:"
    },
    {
      "type": "text",
      "section": "EXHIBIT 19-3. Nutrition Considerations of Renal Replacement Therapy",
      "line": 7779,
      "preview": "a. Successful kidney transplant should result in liberalization of electrolyte restrictions with inc"
    },
    {
      "type": "text",
      "section": "EXHIBIT 19-3. Nutrition Considerations of Renal Replacement Therapy",
      "line": 7780,
      "preview": "b. Hypophosphatemia is common posttransplant related to increased urinary phosphate excretion, decre"
    },
    {
      "type": "text",
      "section": "EXHIBIT 19-3. Nutrition Considerations of Renal Replacement Therapy",
      "line": 7781,
      "preview": "c. Calcineurin inhibitor use (tacrolimus, cyclosporine) could result in hypomagnesemia and/or hyperk"
    },
    {
      "type": "text",
      "section": "EXHIBIT 19-3. Nutrition Considerations of Renal Replacement Therapy",
      "line": 7783,
      "preview": "--- page 406 ---"
    },
    {
      "type": "text",
      "section": "EXHIBIT 19-3. Nutrition Considerations of Renal Replacement Therapy",
      "line": 7785,
      "preview": "Despite a functioning kidney, a low-potassium diet may be needed to maintain normal serum potassium "
    },
    {
      "type": "text",
      "section": "EXHIBIT 19-3. Nutrition Considerations of Renal Replacement Therapy",
      "line": 7786,
      "preview": "d. Prevention of hyperlipidemia and cardiovascular disease is key to dietary goals posttransplant, i"
    },
    {
      "type": "text",
      "section": "EXHIBIT 19-3. Nutrition Considerations of Renal Replacement Therapy",
      "line": 7787,
      "preview": "e. Follow food safety guidelines as established by the US Food and Drug Administration (https://www."
    },
    {
      "type": "text",
      "section": "EXHIBIT 19-3. Nutrition Considerations of Renal Replacement Therapy",
      "line": 7788,
      "preview": "${ }^{a}$ Nelms CL, Juarez-Calderon M, Warady BA. Renal disease. In: Corkins MR, ed. Bobo E, Christe"
    },
    {
      "type": "text",
      "section": "EXHIBIT 19-3. Nutrition Considerations of Renal Replacement Therapy",
      "line": 7789,
      "preview": "${ }^{\\text {b }}$ National Kidney Foundation. KDOQI Clinical Practice Guideline for Nutrition in Ch"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "Implementation of Nutrition Plan and Monitoring",
      "line": 7791
    },
    {
      "type": "text",
      "section": "Implementation of Nutrition Plan and Monitoring",
      "line": 7793,
      "preview": "For an infant with CKD, breast feeding and/or breast milk is considered the preferred diet for under"
    },
    {
      "type": "text",
      "section": "Implementation of Nutrition Plan and Monitoring",
      "line": 7795,
      "preview": "--- page 407 ---"
    },
    {
      "type": "text",
      "section": "Implementation of Nutrition Plan and Monitoring",
      "line": 7797,
      "preview": "being used in children greater than 1 year of age. The clinician must be mindful of macro- and micro"
    },
    {
      "type": "text",
      "section": "Implementation of Nutrition Plan and Monitoring",
      "line": 7799,
      "preview": "--- page 408 ---"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "TABLE 19-6. Renal Formulas",
      "line": 7801
    },
    {
      "type": "table",
      "section": "TABLE 19-6. Renal Formulas",
      "line": 7803,
      "preview": "| Name <br> (Manufacturer) | Features |"
    },
    {
      "type": "table",
      "section": "TABLE 19-6. Renal Formulas",
      "line": 7804,
      "preview": "| :--: | :--: |"
    },
    {
      "type": "table",
      "section": "TABLE 19-6. Renal Formulas",
      "line": 7805,
      "preview": "| Similac PM 60/40 <br> (Abbott Nutrition) ${ }^{a}$ | - Infant, powder with standard mixing (2 oz w"
    },
    {
      "type": "table",
      "section": "TABLE 19-6. Renal Formulas",
      "line": 7806,
      "preview": "| Calcilo XD <br> (Abbott Nutrition) ${ }^{a}$ | - Infant, powder with standard mixing (2 oz water +"
    },
    {
      "type": "table",
      "section": "TABLE 19-6. Renal Formulas",
      "line": 7807,
      "preview": "| Renastart <br> (Vitaflo, Nestl\u00e9 <br> Health Science) ${ }^{b}$ | - Pediatric, powder (mixed $1 \\ma"
    },
    {
      "type": "table",
      "section": "TABLE 19-6. Renal Formulas",
      "line": 7808,
      "preview": "| Renastep <br> (Vitaflo, Nestl\u00e9 <br> Health Science) ${ }^{b}$ | - Pediatric, liquid (ready to feed"
    },
    {
      "type": "table",
      "section": "TABLE 19-6. Renal Formulas",
      "line": 7809,
      "preview": "| Nepro <br> (Abbott Nutrition) ${ }^{a}$ | - Adult, liquid (ready to feed), flavors: vanilla, berry"
    },
    {
      "type": "table",
      "section": "TABLE 19-6. Renal Formulas",
      "line": 7810,
      "preview": "| Suplena <br> (Abbott Nutrition) ${ }^{a}$ | - Adult, liquid (ready to feed), flavors: vanilla <br>"
    },
    {
      "type": "table",
      "section": "TABLE 19-6. Renal Formulas",
      "line": 7811,
      "preview": "| NovoSource Renal <br> (Nestl\u00e9 Health <br> Science) ${ }^{c}$ | - Adult, liquid (ready to feed), fl"
    },
    {
      "type": "table",
      "section": "TABLE 19-6. Renal Formulas",
      "line": 7812,
      "preview": "| Kate Farms Renal <br> Support 1.8 <br> (Kate Farms) ${ }^{d}$ | - Adult, liquid (ready to feed), f"
    },
    {
      "type": "text",
      "section": "TABLE 19-6. Renal Formulas",
      "line": 7814,
      "preview": "[^0]"
    },
    {
      "type": "text",
      "section": "TABLE 19-6. Renal Formulas",
      "line": 7815,
      "preview": "[^0]:    ${ }^{a}$ Abbott Nutrition. Accessed July 9, 2022. https://www.abbottnutrition.com"
    },
    {
      "type": "text",
      "section": "TABLE 19-6. Renal Formulas",
      "line": 7816,
      "preview": "${ }^{\\text {b }}$ Vitaflo. Accessed July 9, 2022. https://www.vitaflousa.com"
    },
    {
      "type": "text",
      "section": "TABLE 19-6. Renal Formulas",
      "line": 7818,
      "preview": "--- page 409 ---"
    },
    {
      "type": "text",
      "section": "TABLE 19-6. Renal Formulas",
      "line": 7820,
      "preview": "${ }^{\\text {c }}$ Nestl\u00e9 medical hub. Accessed July 9, 2022. https://www.nestlemedicalhub.com"
    },
    {
      "type": "text",
      "section": "TABLE 19-6. Renal Formulas",
      "line": 7821,
      "preview": "${ }^{\\text {d }}$ Kate Farms. Accessed July 9, 2022. https://www.katefarms.com"
    },
    {
      "type": "text",
      "section": "TABLE 19-6. Renal Formulas",
      "line": 7823,
      "preview": "TABLE 19-7. Modulars and Additives"
    },
    {
      "type": "table",
      "section": "TABLE 19-6. Renal Formulas",
      "line": 7825,
      "preview": "| Name <br> (Manufacturer) | Features |  |  |  |"
    },
    {
      "type": "table",
      "section": "TABLE 19-6. Renal Formulas",
      "line": 7826,
      "preview": "| :--: | :--: | :--: | :--: | :--: |"
    },
    {
      "type": "table",
      "section": "TABLE 19-6. Renal Formulas",
      "line": 7827,
      "preview": "| Beneprotein <br> (Nestl\u00e9 Health Science) ${ }^{a}$ | - Unflavored powder, whey protein, and soy le"
    },
    {
      "type": "table",
      "section": "TABLE 19-6. Renal Formulas",
      "line": 7828,
      "preview": "| Duocal <br> (Nutricia) ${ }^{b}$ | - Unflavored powder, carbohydrates, and fat <br> - No protein o"
    },
    {
      "type": "table",
      "section": "TABLE 19-6. Renal Formulas",
      "line": 7829,
      "preview": "| Table salt, iodized (sodium chloride) ${ }^{\\text {c,d }}$ | Table salt (tsp) | Sodium (mg) | Sodi"
    },
    {
      "type": "table",
      "section": "TABLE 19-6. Renal Formulas",
      "line": 7830,
      "preview": "|  | $1 / 8$ | 295 | 12.8 | 0.77 |"
    },
    {
      "type": "table",
      "section": "TABLE 19-6. Renal Formulas",
      "line": 7831,
      "preview": "|  | $1 / 4$ | 590 | 25.7 | 1.53 |"
    },
    {
      "type": "table",
      "section": "TABLE 19-6. Renal Formulas",
      "line": 7832,
      "preview": "|  | $1 / 2$ | 1180 | 51.3 | 3.05 |"
    },
    {
      "type": "table",
      "section": "TABLE 19-6. Renal Formulas",
      "line": 7833,
      "preview": "|  | 1 | 2360 | 102.6 | 6.1 |"
    },
    {
      "type": "text",
      "section": "TABLE 19-6. Renal Formulas",
      "line": 7835,
      "preview": "Abbreviation: tsp, teaspoon."
    },
    {
      "type": "text",
      "section": "TABLE 19-6. Renal Formulas",
      "line": 7836,
      "preview": "Note: Information current at the time of publication."
    },
    {
      "type": "text",
      "section": "TABLE 19-6. Renal Formulas",
      "line": 7837,
      "preview": "${ }^{a}$ Nestl\u00e9 medical hub. Accessed July 9, 2022. https://www.nestlemedicalhub.com"
    },
    {
      "type": "text",
      "section": "TABLE 19-6. Renal Formulas",
      "line": 7838,
      "preview": "${ }^{\\text {b }}$ Neocate. Nutricia. Accessed July 9, 2022. https://www.neocate.com/"
    },
    {
      "type": "text",
      "section": "TABLE 19-6. Renal Formulas",
      "line": 7839,
      "preview": "${ }^{\\text {c }}$ Salt, table, iodized. US Department of Agriculture FoodData Central. Accessed Jul"
    },
    {
      "type": "text",
      "section": "TABLE 19-6. Renal Formulas",
      "line": 7840,
      "preview": "${ }^{\\text {d }}$ Morton Lite Salt. Morton Salt. Accessed July 9, 2022."
    },
    {
      "type": "text",
      "section": "TABLE 19-6. Renal Formulas",
      "line": 7841,
      "preview": "https://www.mortonsalt.com/home-product/morton-lite-salt-mixture-2/"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "References",
      "line": 7843
    },
    {
      "type": "text",
      "section": "References",
      "line": 7845,
      "preview": "1. Becherucci F, Roperto RM, Materassi M, Romagnani P. Chronic kidney disease in children. Clin Kidn"
    },
    {
      "type": "text",
      "section": "References",
      "line": 7846,
      "preview": "2. Nelms CL, Juarez-Calderon M, Warady BA. Renal disease. In: Corkins MR, ed. Bobo E, Christensen ML"
    },
    {
      "type": "text",
      "section": "References",
      "line": 7847,
      "preview": "3. Hampson KJ, Gay ML, Band ME. Pediatric nephrotic syndrome: pharmacologic and nutrition management"
    },
    {
      "type": "text",
      "section": "References",
      "line": 7849,
      "preview": "--- page 410 ---"
    },
    {
      "type": "text",
      "section": "References",
      "line": 7851,
      "preview": "4. Nelms CL, Shaw V, Greenbaum LA, et al. Assessment of nutritional status in children with kidney d"
    },
    {
      "type": "text",
      "section": "References",
      "line": 7852,
      "preview": "5. Shaw V, Anderson C, Desloovere A, et al. Nutritional management of the infant with chronic kidney"
    },
    {
      "type": "text",
      "section": "References",
      "line": 7853,
      "preview": "6. Rees L, Shaw V, Qizalbash L, et al. Delivery of a nutritional prescription by enteral tube feedin"
    },
    {
      "type": "text",
      "section": "References",
      "line": 7855,
      "preview": "--- page 411 ---"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "20",
      "line": 7857
    },
    {
      "type": "heading",
      "level": 2,
      "section": "Liver Disease",
      "line": 7859
    },
    {
      "type": "text",
      "section": "Liver Disease",
      "line": 7861,
      "preview": "Anam Bashir, MD"
    },
    {
      "type": "text",
      "section": "Liver Disease",
      "line": 7862,
      "preview": "Praveen S. Goday, MBBS"
    },
    {
      "type": "heading",
      "level": 2,
      "section": "Introduction",
      "line": 7864
    },
    {
      "type": "text",
      "section": "Introduction",
      "line": 7866,
      "preview": "The liver plays a role in the metabolism of all macronutrients. It stores glycogen, synthesizes majo"
    },
    {
      "type": "heading",
      "level": 2,
      "section": "Assessment and Nutrient Requirements",
      "line": 7868
    },
    {
      "type": "text",
      "section": "Assessment and Nutrient Requirements",
      "line": 7870,
      "preview": "Regular assessment of nutrition status and nutrition requirements is critical for children with live"
    },
    {
      "type": "text",
      "section": "Assessment and Nutrient Requirements",
      "line": 7872,
      "preview": "--- page 412 ---"
    },
    {
      "type": "text",
      "section": "Assessment and Nutrient Requirements",
      "line": 7874,
      "preview": "- History: Dietary recall"
    },
    {
      "type": "text",
      "section": "Assessment and Nutrient Requirements",
      "line": 7875,
      "preview": "- Nutrition-focused physical examination"
    },
    {
      "type": "text",
      "section": "Assessment and Nutrient Requirements",
      "line": 7876,
      "preview": "- Anthropometrics: Weight (affected by fluid overload and organomegaly in liver disease), length or "
    },
    {
      "type": "text",
      "section": "Assessment and Nutrient Requirements",
      "line": 7877,
      "preview": "- Laboratory test: Screening for fat-soluble vitamin (vitamins A, D, E, and K) deficiencies and for "
    },
    {
      "type": "text",
      "section": "Assessment and Nutrient Requirements",
      "line": 7879,
      "preview": "Liver disease affects macronutrient needs for multiple reasons, as outlined in Figure 20-1."
    },
    {
      "type": "table",
      "section": "Assessment and Nutrient Requirements",
      "line": 7881,
      "preview": "| Carbohydrates | Protein | Fat |"
    },
    {
      "type": "table",
      "section": "Assessment and Nutrient Requirements",
      "line": 7882,
      "preview": "| :--: | :--: | :--: |"
    },
    {
      "type": "table",
      "section": "Assessment and Nutrient Requirements",
      "line": 7883,
      "preview": "| Risk of hypoglycemia due to decreased gluconeogenesis and reduced glycogen stores | - Increased us"
    },
    {
      "type": "text",
      "section": "Assessment and Nutrient Requirements",
      "line": 7885,
      "preview": "FIGURE 20-1. Effects of liver disease on macronutrients. Abbreviations: LCT, longchain triglycerides"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "Implementation of Nutrition Plan and Monitoring",
      "line": 7887
    },
    {
      "type": "text",
      "section": "Implementation of Nutrition Plan and Monitoring",
      "line": 7889,
      "preview": "Children with liver disease require individualized nutrition plans and close monitoring. Energy inta"
    },
    {
      "type": "text",
      "section": "Implementation of Nutrition Plan and Monitoring",
      "line": 7891,
      "preview": "--- page 413 ---"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "TABLE 20-1. Vitamin Supplementation in Patients With Liver Disease",
      "line": 7893
    },
    {
      "type": "table",
      "section": "TABLE 20-1. Vitamin Supplementation in Patients With Liver Disease",
      "line": 7895,
      "preview": "| Micronutrients and Vitamins | Manifestations | Laboratory <br> Monitoring | Deficiency | Supplemen"
    },
    {
      "type": "table",
      "section": "TABLE 20-1. Vitamin Supplementation in Patients With Liver Disease",
      "line": 7896,
      "preview": "| :--: | :--: | :--: | :--: | :--: | :--: |"
    },
    {
      "type": "table",
      "section": "TABLE 20-1. Vitamin Supplementation in Patients With Liver Disease",
      "line": 7897,
      "preview": "| Vitamin A ${ }^{a}$ | Night blindness, xeropthalmia, dry skin | - Retinol <br> - Retinol- <br> bin"
    },
    {
      "type": "table",
      "section": "TABLE 20-1. Vitamin Supplementation in Patients With Liver Disease",
      "line": 7898,
      "preview": "| Vitamin $D^{a}$ | Muscle hypotonia, rickets | 25-hydroxy vitamin D | $<20 \\mathrm{ng} / \\mathrm{mL"
    },
    {
      "type": "table",
      "section": "TABLE 20-1. Vitamin Supplementation in Patients With Liver Disease",
      "line": 7899,
      "preview": "| Vitamin $E^{a}$ | Hyporeflexia, ataxia, peripheral neuropathy, myopathy, hemolytic anemia | Serum "
    },
    {
      "type": "table",
      "section": "TABLE 20-1. Vitamin Supplementation in Patients With Liver Disease",
      "line": 7900,
      "preview": "| Vitamin $K^{a}$ | Hemorrhagic disease | INR | INR > 1.2 | Oral phytonadione 2.5-5.0 mg daily or IM"
    },
    {
      "type": "table",
      "section": "TABLE 20-1. Vitamin Supplementation in Patients With Liver Disease",
      "line": 7901,
      "preview": "| Zinc | Dermatitis, depressed immune function, alopecia | Serum zinc <br> Alkaline <br> phosphatase"
    },
    {
      "type": "table",
      "section": "TABLE 20-1. Vitamin Supplementation in Patients With Liver Disease",
      "line": 7902,
      "preview": "| Iron | Anemia, fatigue, pallor, koilonychia | Hemoglobin Ferritin Total iron-binding capacity | - "
    },
    {
      "type": "table",
      "section": "TABLE 20-1. Vitamin Supplementation in Patients With Liver Disease",
      "line": 7903,
      "preview": "| Calcium | Poor dentition, bone disease | - | - | Vitamin D administration, palatable agents such a"
    },
    {
      "type": "table",
      "section": "TABLE 20-1. Vitamin Supplementation in Patients With Liver Disease",
      "line": 7904,
      "preview": "| Phosphorous | - | Serum phosphorous level | - | $25-50 \\mathrm{mg} / \\mathrm{kg} / \\mathrm{d}$ if "
    },
    {
      "type": "text",
      "section": "TABLE 20-1. Vitamin Supplementation in Patients With Liver Disease",
      "line": 7906,
      "preview": "Abbreviations: IM, intramuscular; INR, internationalized normalized ratio; IU, international unit; R"
    },
    {
      "type": "text",
      "section": "TABLE 20-1. Vitamin Supplementation in Patients With Liver Disease",
      "line": 7907,
      "preview": "${ }^{a}$ Combination aqueous fat-soluble vitamin formulations can be used to maintain vitamin in no"
    },
    {
      "type": "text",
      "section": "TABLE 20-1. Vitamin Supplementation in Patients With Liver Disease",
      "line": 7909,
      "preview": "--- page 414 ---"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "Type and Mode of Feeds",
      "line": 7911
    },
    {
      "type": "heading",
      "level": 2,
      "section": "Enteral Nutrition",
      "line": 7913
    },
    {
      "type": "text",
      "section": "Enteral Nutrition",
      "line": 7915,
      "preview": "Oral feeds are preferred when possible. Human milk is generally preferred, supplemented with medium-"
    },
    {
      "type": "text",
      "section": "Enteral Nutrition",
      "line": 7917,
      "preview": "If nutrition needs are not met orally, supplementation via a nasogastric (NG) tube is required. Star"
    },
    {
      "type": "heading",
      "level": 2,
      "section": "Parenteral Nutrition",
      "line": 7919
    },
    {
      "type": "text",
      "section": "Parenteral Nutrition",
      "line": 7921,
      "preview": "Children who cannot tolerate or fail to grow on EN may need parenteral nutrition (PN). The energy go"
    },
    {
      "type": "text",
      "section": "Parenteral Nutrition",
      "line": 7923,
      "preview": "In end-stage liver disease, PN may be needed to run over 24 hours because of the risk of hypoglycemi"
    },
    {
      "type": "heading",
      "level": 2,
      "section": "Acute Liver Disease",
      "line": 7925
    },
    {
      "type": "text",
      "section": "Acute Liver Disease",
      "line": 7927,
      "preview": "Acute liver disease is a rapidly progressive disease that requires a multidisciplinary team includin"
    },
    {
      "type": "text",
      "section": "Acute Liver Disease",
      "line": 7929,
      "preview": "--- page 415 ---"
    },
    {
      "type": "text",
      "section": "Acute Liver Disease",
      "line": 7931,
      "preview": "Management of acute liver failure requires fluid resuscitation and electrolyte replacements as outli"
    },
    {
      "type": "text",
      "section": "Acute Liver Disease",
      "line": 7933,
      "preview": "TABLE 20-2. Management of Complications of Acute Liver Disease"
    },
    {
      "type": "table",
      "section": "Acute Liver Disease",
      "line": 7935,
      "preview": "| Complication | Monitoring | Management |"
    },
    {
      "type": "table",
      "section": "Acute Liver Disease",
      "line": 7936,
      "preview": "| :-- | :-- | :-- |"
    },
    {
      "type": "table",
      "section": "Acute Liver Disease",
      "line": 7937,
      "preview": "| Hypo/hyperglycemia | Glucose <br> checks | - Maintain blood glucose between 90 and <br> $120 \\math"
    },
    {
      "type": "table",
      "section": "Acute Liver Disease",
      "line": 7938,
      "preview": "| Hypo/hypernatremia | Electrolyte <br> monitoring | - Maintain sodium: 145-155 mmol/L <br> - Sodium"
    },
    {
      "type": "table",
      "section": "Acute Liver Disease",
      "line": 7939,
      "preview": "| Hypophosphatemia | Electrolyte <br> monitoring | Maintain serum level $>3 \\mathrm{mg} / \\mathrm{dL"
    },
    {
      "type": "table",
      "section": "Acute Liver Disease",
      "line": 7940,
      "preview": "| Overhydration or <br> underhydration | - | - Total intravenous fluids restricted to 90\\% of <br> m"
    },
    {
      "type": "table",
      "section": "Acute Liver Disease",
      "line": 7941,
      "preview": "| Increased energy <br> demands | - | - Enteral feeds preferred <br> - Nasogastric or nasojejunal fe"
    },
    {
      "type": "text",
      "section": "Acute Liver Disease",
      "line": 7943,
      "preview": "Data from Squires JE, Alonso EM, Ibrahim SH, et al. North American Society for Pediatric Gastroenter"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "Posttransplant Considerations of Nutrition",
      "line": 7945
    },
    {
      "type": "heading",
      "level": 2,
      "section": "Early Postoperative Period",
      "line": 7947
    },
    {
      "type": "text",
      "section": "Early Postoperative Period",
      "line": 7949,
      "preview": "Early enteral feeds within 24-36 hours are preferred once postoperative ileus has resolved. NG tube "
    },
    {
      "type": "text",
      "section": "Early Postoperative Period",
      "line": 7951,
      "preview": "Once oral feeds are started, enteral feeds can be used at night to maintain daytime appetite. The or"
    },
    {
      "type": "text",
      "section": "Early Postoperative Period",
      "line": 7953,
      "preview": "--- page 416 ---"
    },
    {
      "type": "text",
      "section": "Early Postoperative Period",
      "line": 7955,
      "preview": "energy to compensate for the weight loss before transplant and promote early healing. In the case of"
    },
    {
      "type": "text",
      "section": "Early Postoperative Period",
      "line": 7957,
      "preview": "PN should be used if surgical complications delay the initiation of enteral feeds. Electrolyte abnor"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "Long-Term Posttransplant Nutrition",
      "line": 7959
    },
    {
      "type": "text",
      "section": "Long-Term Posttransplant Nutrition",
      "line": 7961,
      "preview": "A standard age-appropriate diet is appropriate for most children. The goal of energy intake is $100 "
    },
    {
      "type": "text",
      "section": "Long-Term Posttransplant Nutrition",
      "line": 7963,
      "preview": "The diet and anthropometrics of patients with a liver transplant should be monitored at each visit t"
    },
    {
      "type": "text",
      "section": "Long-Term Posttransplant Nutrition",
      "line": 7965,
      "preview": "Patients are at risk of bone disease because of fat-soluble vitamin maldigestion pretransplant, deco"
    },
    {
      "type": "text",
      "section": "Long-Term Posttransplant Nutrition",
      "line": 7967,
      "preview": "- Vitamin D should be monitored at least every 3-6 months for the first 2 years after transplant."
    },
    {
      "type": "text",
      "section": "Long-Term Posttransplant Nutrition",
      "line": 7968,
      "preview": "- Following dual energy x-ray absorptiometry (DEXA) scans annually can be considered."
    },
    {
      "type": "text",
      "section": "Long-Term Posttransplant Nutrition",
      "line": 7969,
      "preview": "- Calcium, magnesium, and phosphorous should be monitored regularly."
    },
    {
      "type": "text",
      "section": "Long-Term Posttransplant Nutrition",
      "line": 7970,
      "preview": "- Calcium supplementation should be considered in those with decreased bone density and vitamin D de"
    },
    {
      "type": "heading",
      "level": 2,
      "section": "References",
      "line": 7973
    },
    {
      "type": "text",
      "section": "References",
      "line": 7975,
      "preview": "1. Cameron R, Kogan-Liberman D. Nutritional considerations in pediatric liver disease. Pediatr Rev. "
    },
    {
      "type": "text",
      "section": "References",
      "line": 7976,
      "preview": "2. Boster JM, Klaczkiewicz KA, Sundaram SS. Liver diseases. In: Goday PS, Walia CLS, eds. Pediatric "
    },
    {
      "type": "text",
      "section": "References",
      "line": 7978,
      "preview": "--- page 417 ---"
    },
    {
      "type": "text",
      "section": "References",
      "line": 7980,
      "preview": "3. Mouzaki M, Bronsky J, Gupte G, et al. Nutrition support of children with chronic liver diseases: "
    },
    {
      "type": "text",
      "section": "References",
      "line": 7981,
      "preview": "4. Yang CH, Perumpail BJ, Yoo ER, Ahmed A, Kerner JA Jr. Nutritional needs and support for children "
    },
    {
      "type": "text",
      "section": "References",
      "line": 7983,
      "preview": "--- page 418 ---"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "Oncology and Hematopoietic Stem Cell Transplant",
      "line": 7985
    },
    {
      "type": "text",
      "section": "Oncology and Hematopoietic Stem Cell Transplant",
      "line": 7987,
      "preview": "Temitope Pedro, MPH, RD, CSP<br>Jocelyn Fry, RD, CSP"
    },
    {
      "type": "heading",
      "level": 2,
      "section": "Introduction",
      "line": 7989
    },
    {
      "type": "text",
      "section": "Introduction",
      "line": 7991,
      "preview": "Childhood cancer is the leading cause of death from a disease in children in the United States, affe"
    },
    {
      "type": "text",
      "section": "Introduction",
      "line": 7993,
      "preview": "Types of childhood cancers include the following:"
    },
    {
      "type": "text",
      "section": "Introduction",
      "line": 7995,
      "preview": "- Leukemia: Cancer of the blood; it is the most common type of childhood cancer. Types include"
    },
    {
      "type": "text",
      "section": "Introduction",
      "line": 7996,
      "preview": "- Acute lymphoblastic leukemia and"
    },
    {
      "type": "text",
      "section": "Introduction",
      "line": 7997,
      "preview": "- Acute myeloid leukemia. ${ }^{2}$"
    },
    {
      "type": "text",
      "section": "Introduction",
      "line": 7998,
      "preview": "- Lymphoma: Cancer of the immune system; types include"
    },
    {
      "type": "text",
      "section": "Introduction",
      "line": 7999,
      "preview": "- Hodgkin and"
    },
    {
      "type": "text",
      "section": "Introduction",
      "line": 8000,
      "preview": "- Non-Hodgkin lymphoma. ${ }^{2}$"
    },
    {
      "type": "text",
      "section": "Introduction",
      "line": 8001,
      "preview": "- Solid tumors: Cancer of the bones, organs, or tissues. The most common solid tumors in children in"
    },
    {
      "type": "text",
      "section": "Introduction",
      "line": 8002,
      "preview": "- Brain and spinal cord tumors"
    },
    {
      "type": "text",
      "section": "Introduction",
      "line": 8003,
      "preview": "- Ewing sarcoma"
    },
    {
      "type": "text",
      "section": "Introduction",
      "line": 8004,
      "preview": "- Germ cell tumors"
    },
    {
      "type": "text",
      "section": "Introduction",
      "line": 8005,
      "preview": "- Hepatoblastoma"
    },
    {
      "type": "text",
      "section": "Introduction",
      "line": 8006,
      "preview": "- Kidney/Wilms tumors"
    },
    {
      "type": "text",
      "section": "Introduction",
      "line": 8007,
      "preview": "- Neuroblastoma"
    },
    {
      "type": "text",
      "section": "Introduction",
      "line": 8008,
      "preview": "- Osteosarcoma"
    },
    {
      "type": "text",
      "section": "Introduction",
      "line": 8009,
      "preview": "- Retinoblastoma"
    },
    {
      "type": "text",
      "section": "Introduction",
      "line": 8011,
      "preview": "--- page 419 ---"
    },
    {
      "type": "text",
      "section": "Introduction",
      "line": 8013,
      "preview": "- Rhabdomyosarcoma ${ }^{2}$"
    },
    {
      "type": "text",
      "section": "Introduction",
      "line": 8015,
      "preview": "Treatment options include surgery, radiation, chemotherapy, immunotherapy, and hematopoietic stem ce"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "Assessment and Nutrient Requirements",
      "line": 8017
    },
    {
      "type": "text",
      "section": "Assessment and Nutrient Requirements",
      "line": 8019,
      "preview": "Standard criteria that put patients at high nutrition risk apply to patients with cancer. Patients w"
    },
    {
      "type": "text",
      "section": "Assessment and Nutrient Requirements",
      "line": 8021,
      "preview": "A standard nutrition assessment should be conducted at diagnosis, throughout treatment, and into sur"
    },
    {
      "type": "heading",
      "level": 2,
      "section": "Malnutrition in Oncology and HSCT Patients",
      "line": 8023
    },
    {
      "type": "text",
      "section": "Malnutrition in Oncology and HSCT Patients",
      "line": 8025,
      "preview": "--- page 420 ---"
    },
    {
      "type": "text",
      "section": "Malnutrition in Oncology and HSCT Patients",
      "line": 8027,
      "preview": "Between $6 \\%$ and $50 \\%$ of children will present with acute malnutrition at diagnosis, whereas $8"
    },
    {
      "type": "text",
      "section": "Malnutrition in Oncology and HSCT Patients",
      "line": 8029,
      "preview": "--- page 421 ---"
    },
    {
      "type": "text",
      "section": "Malnutrition in Oncology and HSCT Patients",
      "line": 8031,
      "preview": "TABLE 21-1. Contributors to Malnutrition in Pediatric Cancer ${ }^{\\mathrm{a}, \\mathrm{b}}$"
    },
    {
      "type": "table",
      "section": "Malnutrition in Oncology and HSCT Patients",
      "line": 8033,
      "preview": "| Categories | Contributors |"
    },
    {
      "type": "table",
      "section": "Malnutrition in Oncology and HSCT Patients",
      "line": 8034,
      "preview": "| :--: | :--: |"
    },
    {
      "type": "table",
      "section": "Malnutrition in Oncology and HSCT Patients",
      "line": 8035,
      "preview": "| Oncologic process- <br> and tumor-related <br> factors | - Mechanical obstruction <br> - Energy co"
    },
    {
      "type": "table",
      "section": "Malnutrition in Oncology and HSCT Patients",
      "line": 8036,
      "preview": "| Nutrition factors | - Growth requirements <br> - Changes in energy needs (BMR, energy expenditure)"
    },
    {
      "type": "table",
      "section": "Malnutrition in Oncology and HSCT Patients",
      "line": 8037,
      "preview": "| Treatment-related <br> factors | - Altered GI function including mucositis, enteritis, ileus, chan"
    },
    {
      "type": "table",
      "section": "Malnutrition in Oncology and HSCT Patients",
      "line": 8038,
      "preview": "| Psychologic factors | - Sadness related to diagnosis and circumstances <br> - Anxiety and anticipa"
    },
    {
      "type": "text",
      "section": "Malnutrition in Oncology and HSCT Patients",
      "line": 8040,
      "preview": "Abbreviations: BMR, basal metabolic rate; GI, gastrointestinal."
    },
    {
      "type": "text",
      "section": "Malnutrition in Oncology and HSCT Patients",
      "line": 8041,
      "preview": "${ }^{a}$ Data from Larson S, Bechard LJ. Oncology and stem cell transplantation. In:"
    },
    {
      "type": "text",
      "section": "Malnutrition in Oncology and HSCT Patients",
      "line": 8042,
      "preview": "Sonneville K, Duggan C, Hendricks KM, eds. Manual of Pediatric Nutrition. 5th ed. People's Medical P"
    },
    {
      "type": "text",
      "section": "Malnutrition in Oncology and HSCT Patients",
      "line": 8043,
      "preview": "${ }^{\\text {b }}$ Data from Kleinman RE, ed. Pediatric Nutrition. 8th ed. American Academy of Pedia"
    },
    {
      "type": "text",
      "section": "Malnutrition in Oncology and HSCT Patients",
      "line": 8045,
      "preview": "The goal of nutrition therapy is to maintain body stores and minimize muscle wasting to promote norm"
    },
    {
      "type": "text",
      "section": "Malnutrition in Oncology and HSCT Patients",
      "line": 8047,
      "preview": "Patients can be at risk for refeeding at time of diagnosis and various periods throughout treatment."
    },
    {
      "type": "text",
      "section": "Malnutrition in Oncology and HSCT Patients",
      "line": 8049,
      "preview": "--- page 422 ---"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "Energy, Protein, and Fluid Needs",
      "line": 8051
    },
    {
      "type": "text",
      "section": "Energy, Protein, and Fluid Needs",
      "line": 8053,
      "preview": "The energy needs of pediatric oncology and HSCT patients will vary depending on their current nutrit"
    },
    {
      "type": "heading",
      "level": 2,
      "section": "TABLE 21-2. Calorie and Protein Requirements of Pediatric Oncology Patients ${ }^{\\mathbf{a}-\\mathbf{c}}$",
      "line": 8055
    },
    {
      "type": "table",
      "section": "TABLE 21-2. Calorie and Protein Requirements of Pediatric Oncology Patients ${ }^{\\mathbf{a}-\\mathbf{c}}$",
      "line": 8057,
      "preview": "| Age | Calories | Protein (g/kg/d) |"
    },
    {
      "type": "table",
      "section": "TABLE 21-2. Calorie and Protein Requirements of Pediatric Oncology Patients ${ }^{\\mathbf{a}-\\mathbf{c}}$",
      "line": 8058,
      "preview": "| :--: | :--: | :--: |"
    },
    {
      "type": "table",
      "section": "TABLE 21-2. Calorie and Protein Requirements of Pediatric Oncology Patients ${ }^{\\mathbf{a}-\\mathbf{c}}$",
      "line": 8059,
      "preview": "| $\\begin{aligned} & 0-12 \\\\ & \\text { mo } \\end{aligned}$ | RDA for age using actual weight or IBW "
    },
    {
      "type": "table",
      "section": "TABLE 21-2. Calorie and Protein Requirements of Pediatric Oncology Patients ${ }^{\\mathbf{a}-\\mathbf{c}}$",
      "line": 8060,
      "preview": "| $1-18 y$ | Normal weight: BMR $\\times 1.6$ <br> Obese: BMR $\\times 1.3$ <br> $>5 \\%$ weight loss a"
    },
    {
      "type": "table",
      "section": "TABLE 21-2. Calorie and Protein Requirements of Pediatric Oncology Patients ${ }^{\\mathbf{a}-\\mathbf{c}}$",
      "line": 8061,
      "preview": "| $>18 y$ | $25-30 \\mathrm{kcal} / \\mathrm{kg}$ | $1-1.5$ |"
    },
    {
      "type": "text",
      "section": "TABLE 21-2. Calorie and Protein Requirements of Pediatric Oncology Patients ${ }^{\\mathbf{a}-\\mathbf{c}}$",
      "line": 8063,
      "preview": "BMR, basal metabolic rate; DRI, dietary reference intake; IBW, ideal body weight."
    },
    {
      "type": "text",
      "section": "TABLE 21-2. Calorie and Protein Requirements of Pediatric Oncology Patients ${ }^{\\mathbf{a}-\\mathbf{c}}$",
      "line": 8064,
      "preview": "${ }^{a}$ Data from Hunt K, Macris PC. Oncology and hematology. In: Konek S, Becker P, eds. Pediatri"
    },
    {
      "type": "text",
      "section": "TABLE 21-2. Calorie and Protein Requirements of Pediatric Oncology Patients ${ }^{\\mathbf{a}-\\mathbf{c}}$",
      "line": 8065,
      "preview": "${ }^{\\text {b }}$ Data from Bechard LJ, Adiv OE, Jaksic T, Duggan C. Nutritional supportive care. I"
    },
    {
      "type": "text",
      "section": "TABLE 21-2. Calorie and Protein Requirements of Pediatric Oncology Patients ${ }^{\\mathbf{a}-\\mathbf{c}}$",
      "line": 8066,
      "preview": "${ }^{c}$ Data from Muscaritoli M, Arends J, Bachmann P, et al. ESPEN practical guideline: clinical "
    },
    {
      "type": "text",
      "section": "TABLE 21-2. Calorie and Protein Requirements of Pediatric Oncology Patients ${ }^{\\mathbf{a}-\\mathbf{c}}$",
      "line": 8067,
      "preview": "https://doi.org/10.1016/j.clnu.2021.02.005"
    },
    {
      "type": "text",
      "section": "TABLE 21-2. Calorie and Protein Requirements of Pediatric Oncology Patients ${ }^{\\mathbf{a}-\\mathbf{c}}$",
      "line": 8069,
      "preview": "--- page 423 ---"
    },
    {
      "type": "text",
      "section": "TABLE 21-2. Calorie and Protein Requirements of Pediatric Oncology Patients ${ }^{\\mathbf{a}-\\mathbf{c}}$",
      "line": 8071,
      "preview": "TABLE 21-3. Calorie and Protein Requirements of Pediatric Patients Undergoing HSCT ${ }^{a}$"
    },
    {
      "type": "table",
      "section": "TABLE 21-2. Calorie and Protein Requirements of Pediatric Oncology Patients ${ }^{\\mathbf{a}-\\mathbf{c}}$",
      "line": 8073,
      "preview": "| Age | Calories $^{\\text {b }}$ | Protein $(\\mathrm{g} / \\mathrm{kg} / \\mathrm{d})$ |"
    },
    {
      "type": "table",
      "section": "TABLE 21-2. Calorie and Protein Requirements of Pediatric Oncology Patients ${ }^{\\mathbf{a}-\\mathbf{c}}$",
      "line": 8074,
      "preview": "| :-- | :-- | :--: |"
    },
    {
      "type": "table",
      "section": "TABLE 21-2. Calorie and Protein Requirements of Pediatric Oncology Patients ${ }^{\\mathbf{a}-\\mathbf{c}}$",
      "line": 8075,
      "preview": "| $0-12 \\mathrm{mo}$ | $\\mathrm{BMR} \\times 1.6-1.8$ | 3 |"
    },
    {
      "type": "table",
      "section": "TABLE 21-2. Calorie and Protein Requirements of Pediatric Oncology Patients ${ }^{\\mathbf{a}-\\mathbf{c}}$",
      "line": 8076,
      "preview": "| $1-6 \\mathrm{y}$ | $\\mathrm{BMR} \\times 1.6-1.8$ | $2.5-3$ |"
    },
    {
      "type": "table",
      "section": "TABLE 21-2. Calorie and Protein Requirements of Pediatric Oncology Patients ${ }^{\\mathbf{a}-\\mathbf{c}}$",
      "line": 8077,
      "preview": "| $7-10 \\mathrm{y}$ | $\\mathrm{BMR} \\times 1.6-1.8$ | 2.4 |"
    },
    {
      "type": "table",
      "section": "TABLE 21-2. Calorie and Protein Requirements of Pediatric Oncology Patients ${ }^{\\mathbf{a}-\\mathbf{c}}$",
      "line": 8078,
      "preview": "| $11-14 \\mathrm{y}$ | $\\mathrm{BMR} \\times 1.6-1.8$ | 2 |"
    },
    {
      "type": "table",
      "section": "TABLE 21-2. Calorie and Protein Requirements of Pediatric Oncology Patients ${ }^{\\mathbf{a}-\\mathbf{c}}$",
      "line": 8079,
      "preview": "| $15-18 \\mathrm{y}$ | $\\mathrm{BMR} \\times 1.6-1.8$ | 1.8 |"
    },
    {
      "type": "table",
      "section": "TABLE 21-2. Calorie and Protein Requirements of Pediatric Oncology Patients ${ }^{\\mathbf{a}-\\mathbf{c}}$",
      "line": 8080,
      "preview": "| $>19 \\mathrm{y}$ | $\\mathrm{BEE} \\times 1.5$ | 1.5 |"
    },
    {
      "type": "text",
      "section": "TABLE 21-2. Calorie and Protein Requirements of Pediatric Oncology Patients ${ }^{\\mathbf{a}-\\mathbf{c}}$",
      "line": 8082,
      "preview": "BEE, basal energy expenditure; BMR, basal metabolic rate; ht, height; wt, weight."
    },
    {
      "type": "text",
      "section": "TABLE 21-2. Calorie and Protein Requirements of Pediatric Oncology Patients ${ }^{\\mathbf{a}-\\mathbf{c}}$",
      "line": 8083,
      "preview": "${ }^{a}$ Reproduced with permission from the American Society for Parenteral and Enteral Nutrition "
    },
    {
      "type": "text",
      "section": "TABLE 21-2. Calorie and Protein Requirements of Pediatric Oncology Patients ${ }^{\\mathbf{a}-\\mathbf{c}}$",
      "line": 8084,
      "preview": "${ }^{\\text {b }}$ For BEE, use the Harris-Benedict equations:"
    },
    {
      "type": "text",
      "section": "TABLE 21-2. Calorie and Protein Requirements of Pediatric Oncology Patients ${ }^{\\mathbf{a}-\\mathbf{c}}$",
      "line": 8085,
      "preview": "Male, $66+(13.7 \\times$ wt in kg$)+(5 \\times$ ht $)-(6.8 \\times$ age $)$"
    },
    {
      "type": "text",
      "section": "TABLE 21-2. Calorie and Protein Requirements of Pediatric Oncology Patients ${ }^{\\mathbf{a}-\\mathbf{c}}$",
      "line": 8086,
      "preview": "Female, $665+(9.6 \\times$ wt in kg$)+(1.7 \\times$ ht $)-(4.7 \\times$ age $)$"
    },
    {
      "type": "text",
      "section": "TABLE 21-2. Calorie and Protein Requirements of Pediatric Oncology Patients ${ }^{\\mathbf{a}-\\mathbf{c}}$",
      "line": 8088,
      "preview": "Use adjusted body weight in overweight patients and patients with obesity, who are over $125 \\%$ of "
    },
    {
      "type": "heading",
      "level": 1,
      "section": "Oral Nutrition",
      "line": 8090
    },
    {
      "type": "text",
      "section": "Oral Nutrition",
      "line": 8092,
      "preview": "Optimization of oral nutrition may be offered as an initial strategy, including an emphasis on small"
    },
    {
      "type": "text",
      "section": "Oral Nutrition",
      "line": 8094,
      "preview": "--- page 424 ---"
    },
    {
      "type": "text",
      "section": "Oral Nutrition",
      "line": 8096,
      "preview": "oral/food aversions because of nausea, vomiting, and taste changes during treatment. Referral to fee"
    },
    {
      "type": "text",
      "section": "Oral Nutrition",
      "line": 8098,
      "preview": "Patients who are immunocompromised (absolute neutrophil count $<500$ cells $/ \\mu \\mathrm{L}$ ) shou"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "EXHIBIT 21-1. Food Safety Practices for Immunocompromised Patients ${ }^{\\text {a,b }}$",
      "line": 8100
    },
    {
      "type": "text",
      "section": "EXHIBIT 21-1. Food Safety Practices for Immunocompromised Patients ${ }^{\\text {a,b }}$",
      "line": 8102,
      "preview": "- Wash hands and surfaces often with warm soapy water."
    },
    {
      "type": "text",
      "section": "EXHIBIT 21-1. Food Safety Practices for Immunocompromised Patients ${ }^{\\text {a,b }}$",
      "line": 8103,
      "preview": "- Do not share foods with others."
    },
    {
      "type": "text",
      "section": "EXHIBIT 21-1. Food Safety Practices for Immunocompromised Patients ${ }^{\\text {a,b }}$",
      "line": 8104,
      "preview": "- Cook meat, poultry, seafood, and eggs to safe internal temperature."
    },
    {
      "type": "text",
      "section": "EXHIBIT 21-1. Food Safety Practices for Immunocompromised Patients ${ }^{\\text {a,b }}$",
      "line": 8105,
      "preview": "- Reheat deli meats until steaming."
    },
    {
      "type": "text",
      "section": "EXHIBIT 21-1. Food Safety Practices for Immunocompromised Patients ${ }^{\\text {a,b }}$",
      "line": 8106,
      "preview": "- Avoid raw eggs and raw sprouts."
    },
    {
      "type": "text",
      "section": "EXHIBIT 21-1. Food Safety Practices for Immunocompromised Patients ${ }^{\\text {a,b }}$",
      "line": 8107,
      "preview": "- Store cold foods at $<40^{\\circ} \\mathrm{F}$ and hot foods at $>140^{\\circ} \\mathrm{F}$ to prevent"
    },
    {
      "type": "text",
      "section": "EXHIBIT 21-1. Food Safety Practices for Immunocompromised Patients ${ }^{\\text {a,b }}$",
      "line": 8108,
      "preview": "- Buy only pasteurized milk, cheese, and dairy products."
    },
    {
      "type": "text",
      "section": "EXHIBIT 21-1. Food Safety Practices for Immunocompromised Patients ${ }^{\\text {a,b }}$",
      "line": 8109,
      "preview": "- Wash raw fruits and vegetables well before eating."
    },
    {
      "type": "text",
      "section": "EXHIBIT 21-1. Food Safety Practices for Immunocompromised Patients ${ }^{\\text {a,b }}$",
      "line": 8110,
      "preview": "- Use separate cutting boards for raw foods and ready-to-eat foods."
    },
    {
      "type": "text",
      "section": "EXHIBIT 21-1. Food Safety Practices for Immunocompromised Patients ${ }^{\\text {a,b }}$",
      "line": 8111,
      "preview": "- Eat foods within their expiration/best-by dates."
    },
    {
      "type": "text",
      "section": "EXHIBIT 21-1. Food Safety Practices for Immunocompromised Patients ${ }^{\\text {a,b }}$",
      "line": 8112,
      "preview": "- Refrigerate perishable foods within 2 hours of purchase/preparation."
    },
    {
      "type": "text",
      "section": "EXHIBIT 21-1. Food Safety Practices for Immunocompromised Patients ${ }^{\\text {a,b }}$",
      "line": 8113,
      "preview": "- Eat refrigerated leftovers within 3 days of preparation."
    },
    {
      "type": "text",
      "section": "EXHIBIT 21-1. Food Safety Practices for Immunocompromised Patients ${ }^{\\text {a,b }}$",
      "line": 8114,
      "preview": "- Avoid food from buffets, potlucks, sidewalk vendors, food trucks, salad bars, and open bins from g"
    },
    {
      "type": "text",
      "section": "EXHIBIT 21-1. Food Safety Practices for Immunocompromised Patients ${ }^{\\text {a,b }}$",
      "line": 8115,
      "preview": "a Data from Food Safety for Older Adults and People With Cancer, Diabetes, HIV/AIDS, Organ Transplan"
    },
    {
      "type": "text",
      "section": "EXHIBIT 21-1. Food Safety Practices for Immunocompromised Patients ${ }^{\\text {a,b }}$",
      "line": 8116,
      "preview": "https://www.fda.gov/media/83744/download"
    },
    {
      "type": "text",
      "section": "EXHIBIT 21-1. Food Safety Practices for Immunocompromised Patients ${ }^{\\text {a,b }}$",
      "line": 8117,
      "preview": "${ }^{\\text {b }}$ Data from Larson S, Bechard LJ. Oncology and stem cell transplantation. In: Sonne"
    },
    {
      "type": "heading",
      "level": 2,
      "section": "Enteral Nutrition",
      "line": 8120
    },
    {
      "type": "text",
      "section": "Enteral Nutrition",
      "line": 8122,
      "preview": "Enteral nutrition (EN) via feeding tube should be considered when oral intake/supplementation is uns"
    },
    {
      "type": "text",
      "section": "Enteral Nutrition",
      "line": 8124,
      "preview": "--- page 425 ---"
    },
    {
      "type": "text",
      "section": "Enteral Nutrition",
      "line": 8126,
      "preview": "hesitation and reluctance in providing EN within the pediatric oncology and HSCT community. EN can o"
    },
    {
      "type": "text",
      "section": "Enteral Nutrition",
      "line": 8128,
      "preview": "Continuous feeds are generally better tolerated than intermittent bolus feedings and are the preferr"
    },
    {
      "type": "text",
      "section": "Enteral Nutrition",
      "line": 8130,
      "preview": "Formula considerations include the following:"
    },
    {
      "type": "text",
      "section": "Enteral Nutrition",
      "line": 8132,
      "preview": "- For most oncology and HSCT patients, a low-osmolarity standard formula with or without fiber may b"
    },
    {
      "type": "text",
      "section": "Enteral Nutrition",
      "line": 8133,
      "preview": "- Extensively hydrolyzed or elemental formulas can be appropriate for patients with significant GI t"
    },
    {
      "type": "text",
      "section": "Enteral Nutrition",
      "line": 8134,
      "preview": "- With postpyloric feeding, consider formulas with fiber or low osmolarity because they may minimize"
    },
    {
      "type": "text",
      "section": "Enteral Nutrition",
      "line": 8136,
      "preview": "Table 21-4 discusses other strategies for symptom management."
    },
    {
      "type": "text",
      "section": "Enteral Nutrition",
      "line": 8138,
      "preview": "--- page 426 ---"
    },
    {
      "type": "text",
      "section": "Enteral Nutrition",
      "line": 8140,
      "preview": "TABLE 21-4. Nutrition Strategies for Symptom Management"
    },
    {
      "type": "table",
      "section": "Enteral Nutrition",
      "line": 8142,
      "preview": "| Symptom | Dietary Intervention Strategies |"
    },
    {
      "type": "table",
      "section": "Enteral Nutrition",
      "line": 8143,
      "preview": "| :-- | :-- |"
    },
    {
      "type": "table",
      "section": "Enteral Nutrition",
      "line": 8144,
      "preview": "| Nausea/vomiting | Small, frequent meals; high-carbohydrate content; nonacidic <br> beverages; cold"
    },
    {
      "type": "table",
      "section": "Enteral Nutrition",
      "line": 8145,
      "preview": "| Anorexia | Small, frequent meals; nutrient-dense foods and supplements; <br> carbohydrate and prot"
    },
    {
      "type": "table",
      "section": "Enteral Nutrition",
      "line": 8146,
      "preview": "| Diarrhea | Low-fat, cold, or room-temperature foods; avoid caffeine; <br> encourage adequate fluid"
    },
    {
      "type": "table",
      "section": "Enteral Nutrition",
      "line": 8147,
      "preview": "| Dysgeusia | Herbs, spices, and marinades; cold non-odorous foods; fruit- <br> flavored beverages; "
    },
    {
      "type": "table",
      "section": "Enteral Nutrition",
      "line": 8148,
      "preview": "| Mucositis | Soft diet; smooth, bland, moist foods; frozen slushes, ices, and <br> ice cream; high-"
    },
    {
      "type": "table",
      "section": "Enteral Nutrition",
      "line": 8149,
      "preview": "| Xerostomia | Moist foods; encourage liquids with meals; add sauces, gravy, <br> butter, or broth; "
    },
    {
      "type": "text",
      "section": "Enteral Nutrition",
      "line": 8151,
      "preview": "Reproduced with permission from the American Society for Parenteral and Enteral Nutrition from Willi"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "Parenteral Nutrition",
      "line": 8153
    },
    {
      "type": "text",
      "section": "Parenteral Nutrition",
      "line": 8155,
      "preview": "Parenteral nutrition (PN) should be considered when all attempts for sufficient oral and enteral fee"
    },
    {
      "type": "text",
      "section": "Parenteral Nutrition",
      "line": 8157,
      "preview": "--- page 427 ---"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "Vitamins and Minerals",
      "line": 8159
    },
    {
      "type": "text",
      "section": "Vitamins and Minerals",
      "line": 8161,
      "preview": "Oncology and HSCT patients are at risk of osteopenia and osteoporosis because of prolonged hospitali"
    },
    {
      "type": "text",
      "section": "Vitamins and Minerals",
      "line": 8163,
      "preview": "The routine use of micronutrient supplements can be controversial, but in the depleted patient, supp"
    },
    {
      "type": "heading",
      "level": 2,
      "section": "Laboratory Values",
      "line": 8165
    },
    {
      "type": "text",
      "section": "Laboratory Values",
      "line": 8167,
      "preview": "Clinical judgement should be used when assessing laboratory values because cancer therapy drugs, inf"
    },
    {
      "type": "heading",
      "level": 2,
      "section": "Additional Treatment-Related Adverse Effects",
      "line": 8169
    },
    {
      "type": "text",
      "section": "Additional Treatment-Related Adverse Effects",
      "line": 8171,
      "preview": "The following are additional treatment-related adverse effects:"
    },
    {
      "type": "text",
      "section": "Additional Treatment-Related Adverse Effects",
      "line": 8173,
      "preview": "- Pancreatitis: Nutrition recommendations for pancreatitis should be followed (see discussion on nut"
    },
    {
      "type": "text",
      "section": "Additional Treatment-Related Adverse Effects",
      "line": 8174,
      "preview": "- Tumor lysis syndrome: In cases of elevated potassium and phosphorus levels, some patients may need"
    },
    {
      "type": "text",
      "section": "Additional Treatment-Related Adverse Effects",
      "line": 8175,
      "preview": "- Neutropenic enterocolitis (typhlitis): Bowel rest may be indicated, and PN may be required. ${ }^{"
    },
    {
      "type": "text",
      "section": "Additional Treatment-Related Adverse Effects",
      "line": 8176,
      "preview": "- Steroids: Acute adverse effects of steroid use include hyperglycemia and increased appetite. A no-"
    },
    {
      "type": "text",
      "section": "Additional Treatment-Related Adverse Effects",
      "line": 8177,
      "preview": "- GVHD: This is a condition in which donor-derived T cells attack host cells after HSCT. In cases of"
    },
    {
      "type": "text",
      "section": "Additional Treatment-Related Adverse Effects",
      "line": 8179,
      "preview": "--- page 428 ---"
    },
    {
      "type": "text",
      "section": "Additional Treatment-Related Adverse Effects",
      "line": 8181,
      "preview": "- Hepatic sinusoidal obstructive syndrome, also called hepatic veno-occlusive disease: This syndrome"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "Monitoring and Late Effects",
      "line": 8184
    },
    {
      "type": "text",
      "section": "Monitoring and Late Effects",
      "line": 8186,
      "preview": "Survivors of childhood cancer are at risk for multiple long-term morbidities, including obesity, met"
    },
    {
      "type": "heading",
      "level": 2,
      "section": "References",
      "line": 8188
    },
    {
      "type": "text",
      "section": "References",
      "line": 8190,
      "preview": "1. Ward E, DeSantis C, Robbins A, Kohler B, Jemal A. Childhood and adolescent cancer statistics, 201"
    },
    {
      "type": "text",
      "section": "References",
      "line": 8191,
      "preview": "2. Types of children's cancer. Children's Oncology Group. Accessed June 25, 2022. https://childrenso"
    },
    {
      "type": "text",
      "section": "References",
      "line": 8192,
      "preview": "3. Treatment options. Children's Oncology Group. Accessed June 25, 2022. https://childrensoncologygr"
    },
    {
      "type": "text",
      "section": "References",
      "line": 8193,
      "preview": "4. Williams H, Squilllante B, Wilhelm D, Smith K, Pineda E, Rheingold S. Pediatric oncology and hema"
    },
    {
      "type": "text",
      "section": "References",
      "line": 8194,
      "preview": "5. Blood-forming stem cell transplants. National Cancer Institute. Updated August 12, 2013. Accessed"
    },
    {
      "type": "text",
      "section": "References",
      "line": 8195,
      "preview": "6. Kleinman RE, ed. Pediatric Nutrition. 8th ed. American Academy of Pediatrics; 2019."
    },
    {
      "type": "text",
      "section": "References",
      "line": 8196,
      "preview": "7. Hunt K, Macris PC. Oncology and hematology. In: Konek S, Becker P, eds. Pediatric Nutrition in Cl"
    },
    {
      "type": "text",
      "section": "References",
      "line": 8197,
      "preview": "8. Coates TD, Rickard KA, Grosfeld JL, Weetman RM. Nutritional support of children with neoplastic d"
    },
    {
      "type": "text",
      "section": "References",
      "line": 8199,
      "preview": "--- page 429 ---"
    },
    {
      "type": "text",
      "section": "References",
      "line": 8201,
      "preview": "9. Han-Markey T. Nutritional considerations in pediatric oncology. Semin Oncol Nurs. 2000;16(2):146-"
    },
    {
      "type": "text",
      "section": "References",
      "line": 8202,
      "preview": "10. Brinksma A, Huizinga G, Sulkers E, Kamps W, Roodbol P, Tissing W. Malnutrition in childhood canc"
    },
    {
      "type": "text",
      "section": "References",
      "line": 8203,
      "preview": "11. Ladas EJ, Sacks N, Meacham L, et al. A multidisciplinary review of nutrition considerations in t"
    },
    {
      "type": "text",
      "section": "References",
      "line": 8204,
      "preview": "12. Texas Children's Hospital. Texas Children's Hospital Pediatric Nutrition Reference Guide. 12th e"
    },
    {
      "type": "text",
      "section": "References",
      "line": 8205,
      "preview": "13. Oncology (2017) comparative standards. In: Pediatric Nutrition Dietetic Practice Group. Pediatri"
    },
    {
      "type": "text",
      "section": "References",
      "line": 8206,
      "preview": "14. Food Safety for Older Adults and People With Cancer, Diabetes, HIV/AIDS, Organ Transplants, and "
    },
    {
      "type": "text",
      "section": "References",
      "line": 8207,
      "preview": "15. Moody KM, Baker RA, Santizo RO, et al. A randomized trial of the effectiveness of the neutropeni"
    },
    {
      "type": "text",
      "section": "References",
      "line": 8208,
      "preview": "16. Taggart C, Neumann N, Alonso PB, et al. Comparing a neutropenic diet to a food safetybased diet "
    },
    {
      "type": "text",
      "section": "References",
      "line": 8209,
      "preview": "17. Evans JC, Hirani SP, Needle JJ. Nutritional and post-transplantation outcomes of enteral versus "
    },
    {
      "type": "text",
      "section": "References",
      "line": 8210,
      "preview": "18. Fisher MJ, Rheingold SR. Oncologic emergencies. In: Pizzo PA, Poplack DG, eds. Principles and Pr"
    },
    {
      "type": "text",
      "section": "References",
      "line": 8211,
      "preview": "19. Lipkin AC, Lenssen P, Dickson BJ. Nutrition issues in hematopoietic stem cell transplantation: s"
    },
    {
      "type": "text",
      "section": "References",
      "line": 8212,
      "preview": "20. Charuhas PM. Hematopoietic Stem Cell Transplantation Nutrition Care Criteria. 2nd ed. Seattle Ca"
    },
    {
      "type": "text",
      "section": "References",
      "line": 8213,
      "preview": "21. Ringo K, Chen L. Nutrition challenges in a patient with sinusoidal obstructive syndrome followin"
    },
    {
      "type": "text",
      "section": "References",
      "line": 8215,
      "preview": "--- page 430 ---"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "22",
      "line": 8217
    },
    {
      "type": "heading",
      "level": 2,
      "section": "Pancreatitis",
      "line": 8219
    },
    {
      "type": "text",
      "section": "Pancreatitis",
      "line": 8221,
      "preview": "Anam Bashir, MD<br>Praveen S. Goday, MBBS"
    },
    {
      "type": "heading",
      "level": 2,
      "section": "Introduction",
      "line": 8223
    },
    {
      "type": "text",
      "section": "Introduction",
      "line": 8225,
      "preview": "In this chapter, we will review the nutrition management of 3 categories of pancreatitis: acute, acu"
    },
    {
      "type": "text",
      "section": "Introduction",
      "line": 8227,
      "preview": "--- page 431 ---"
    },
    {
      "type": "text",
      "section": "Introduction",
      "line": 8229,
      "preview": "TABLE 22-1. Pancreatitis Diagnostic Criteria"
    },
    {
      "type": "table",
      "section": "Introduction",
      "line": 8231,
      "preview": "| Type | Diagnostic Criteria |"
    },
    {
      "type": "table",
      "section": "Introduction",
      "line": 8232,
      "preview": "| :-- | :-- |"
    },
    {
      "type": "table",
      "section": "Introduction",
      "line": 8233,
      "preview": "| Acute | Child meeting 2 of the following 3 criteria: <br> 1. Acute abdominal pain (typically in th"
    },
    {
      "type": "table",
      "section": "Introduction",
      "line": 8234,
      "preview": "| Acute <br> recurrent | Defined as having 2 episodes of acute pancreatitis with either complete <br"
    },
    {
      "type": "table",
      "section": "Introduction",
      "line": 8235,
      "preview": "| Chronic | Defined as having either abdominal pain consistent with a pancreatic <br> origin and ima"
    },
    {
      "type": "text",
      "section": "Introduction",
      "line": 8237,
      "preview": "Abbreviations: CT, computed tomography; MRI, magnetic resonance imaging."
    },
    {
      "type": "heading",
      "level": 1,
      "section": "Assessment and Nutrient Requirements",
      "line": 8239
    },
    {
      "type": "text",
      "section": "Assessment and Nutrient Requirements",
      "line": 8241,
      "preview": "Nutrition screening is required at admission for every child with acute pancreatitis. An initial scr"
    },
    {
      "type": "text",
      "section": "Assessment and Nutrient Requirements",
      "line": 8243,
      "preview": "- History: Dietary recall, assessment of malabsorption (stool frequency and consistency), and adhere"
    },
    {
      "type": "text",
      "section": "Assessment and Nutrient Requirements",
      "line": 8244,
      "preview": "- Physical exam: Anthropometric data (weight for age, weight for length, body mass index, mid-upper "
    },
    {
      "type": "text",
      "section": "Assessment and Nutrient Requirements",
      "line": 8245,
      "preview": "- Laboratory assessment: Screening for pancreatic insufficiency with fecal elastase should be perfor"
    },
    {
      "type": "heading",
      "level": 2,
      "section": "Implementation of Nutrition Plan and Monitoring",
      "line": 8248
    },
    {
      "type": "text",
      "section": "Implementation of Nutrition Plan and Monitoring",
      "line": 8250,
      "preview": "--- page 432 ---"
    },
    {
      "type": "text",
      "section": "Implementation of Nutrition Plan and Monitoring",
      "line": 8252,
      "preview": "The type of pancreatitis a child has influences their nutrition plan and monitoring."
    },
    {
      "type": "heading",
      "level": 1,
      "section": "Acute Pancreatitis",
      "line": 8254
    },
    {
      "type": "text",
      "section": "Acute Pancreatitis",
      "line": 8256,
      "preview": "For acute pancreatitis, early introduction of oral or enteral nutrition (EN) is recommended. ${ }^{1"
    },
    {
      "type": "heading",
      "level": 2,
      "section": "Acute Recurrent Pancreatitis",
      "line": 8258
    },
    {
      "type": "text",
      "section": "Acute Recurrent Pancreatitis",
      "line": 8260,
      "preview": "In between episodes of acute pancreatitis, children should be given a regular-fat diet, except for p"
    },
    {
      "type": "text",
      "section": "Acute Recurrent Pancreatitis",
      "line": 8262,
      "preview": "Pancreatic enzyme supplementation should not be routinely used in children with acute recurrent panc"
    },
    {
      "type": "heading",
      "level": 2,
      "section": "Chronic Pancreatitis",
      "line": 8264
    },
    {
      "type": "text",
      "section": "Chronic Pancreatitis",
      "line": 8266,
      "preview": "Children with chronic pancreatitis should be given a regular diet. In case of diabetes, children wit"
    },
    {
      "type": "text",
      "section": "Chronic Pancreatitis",
      "line": 8268,
      "preview": "--- page 433 ---"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "References",
      "line": 8270
    },
    {
      "type": "text",
      "section": "References",
      "line": 8272,
      "preview": "1. Abu-El-Haija M, Uc A, Werlin SL, et al. Nutritional considerations in pediatric pancreatitis: a p"
    },
    {
      "type": "text",
      "section": "References",
      "line": 8273,
      "preview": "2. O'Brien SJ, Omer E. Chronic pancreatitis and nutrition therapy. Nutr Clin Pract. 2019;34(suppl 1)"
    },
    {
      "type": "text",
      "section": "References",
      "line": 8275,
      "preview": "--- page 434 ---"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "Seizures and the Ketogenic Diet",
      "line": 8277
    },
    {
      "type": "text",
      "section": "Seizures and the Ketogenic Diet",
      "line": 8279,
      "preview": "Jessica Ernst, MS, RDN, CSP, LD<br>Meredith Johnson, MS, RDN, CSP, LD"
    },
    {
      "type": "heading",
      "level": 2,
      "section": "Introduction",
      "line": 8281
    },
    {
      "type": "text",
      "section": "Introduction",
      "line": 8283,
      "preview": "Ketogenic diet therapies (KDTs) are therapeutic interventions for the treatment of refractory epilep"
    },
    {
      "type": "text",
      "section": "Introduction",
      "line": 8285,
      "preview": "The use of KDT involves multiple health care team members who work collaboratively to ensure a succe"
    },
    {
      "type": "heading",
      "level": 2,
      "section": "Types of Ketogenic Diets",
      "line": 8287
    },
    {
      "type": "text",
      "section": "Types of Ketogenic Diets",
      "line": 8289,
      "preview": "--- page 435 ---"
    },
    {
      "type": "text",
      "section": "Types of Ketogenic Diets",
      "line": 8291,
      "preview": "Ketogenic diets fall on a spectrum, with classic diets being the most restrictive and low glycemic i"
    },
    {
      "type": "text",
      "section": "Types of Ketogenic Diets",
      "line": 8293,
      "preview": "--- page 436 ---"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "TABLE 23-1. Types of Ketogenic Diets",
      "line": 8295
    },
    {
      "type": "table",
      "section": "TABLE 23-1. Types of Ketogenic Diets",
      "line": 8297,
      "preview": "| Type of <br> Diet | Description | Sample Meal |"
    },
    {
      "type": "table",
      "section": "TABLE 23-1. Types of Ketogenic Diets",
      "line": 8298,
      "preview": "| :--: | :--: | :--: |"
    },
    {
      "type": "table",
      "section": "TABLE 23-1. Types of Ketogenic Diets",
      "line": 8299,
      "preview": "| Classic ketogenic diet | High ketogenic ratios (4:1, 3:1) <br> - More commonly used in infants, yo"
    },
    {
      "type": "table",
      "section": "TABLE 23-1. Types of Ketogenic Diets",
      "line": 8300,
      "preview": "| Modified ketogenic diet | Lower ketogenic ratios (2:1, 1:1) <br> - More commonly used in adolescen"
    },
    {
      "type": "text",
      "section": "TABLE 23-1. Types of Ketogenic Diets",
      "line": 8302,
      "preview": "--- page 437 ---"
    },
    {
      "type": "table",
      "section": "TABLE 23-1. Types of Ketogenic Diets",
      "line": 8304,
      "preview": "| Type of <br> Diet | Description | Sample Meal |"
    },
    {
      "type": "table",
      "section": "TABLE 23-1. Types of Ketogenic Diets",
      "line": 8305,
      "preview": "| :--: | :--: | :--: |"
    },
    {
      "type": "table",
      "section": "TABLE 23-1. Types of Ketogenic Diets",
      "line": 8306,
      "preview": "| MAD | Relies on carbohydrate counting (either net or total carbohydrates) <br> - Net carbohydrates"
    },
    {
      "type": "table",
      "section": "TABLE 23-1. Types of Ketogenic Diets",
      "line": 8307,
      "preview": "| MCT oil diet $^{\\text {C }}$ | - Uses MCT oil supplementation as primary fat source to make up 50\\"
    },
    {
      "type": "text",
      "section": "TABLE 23-1. Types of Ketogenic Diets",
      "line": 8309,
      "preview": "--- page 438 ---"
    },
    {
      "type": "table",
      "section": "TABLE 23-1. Types of Ketogenic Diets",
      "line": 8311,
      "preview": "| Type of <br> Diet | Description | Sample Meal |"
    },
    {
      "type": "table",
      "section": "TABLE 23-1. Types of Ketogenic Diets",
      "line": 8312,
      "preview": "| :-- | :-- | :-- |"
    },
    {
      "type": "table",
      "section": "TABLE 23-1. Types of Ketogenic Diets",
      "line": 8313,
      "preview": "| LGIT | - Uses carbohydrate exchange lists and <br> allows carbohydrates that are low <br> glycemic"
    },
    {
      "type": "text",
      "section": "TABLE 23-1. Types of Ketogenic Diets",
      "line": 8315,
      "preview": "Abbreviations: cal, calories; LGIT, low glycemic index treatment; MAD, modified Atkins diet; MCT, me"
    },
    {
      "type": "text",
      "section": "TABLE 23-1. Types of Ketogenic Diets",
      "line": 8316,
      "preview": "${ }^{a}$ Kossoff EH, Cervenka MC, Henry BJ, Haney CA, Turner Z. A decade of the modified Atkins die"
    },
    {
      "type": "text",
      "section": "TABLE 23-1. Types of Ketogenic Diets",
      "line": 8317,
      "preview": "${ }^{\\text {b }}$ Zupec-Kania B, Vanatta L, Johnson ML. Ketogenic Diet Therapies for Neurological D"
    },
    {
      "type": "text",
      "section": "TABLE 23-1. Types of Ketogenic Diets",
      "line": 8318,
      "preview": "${ }^{c}$ Liu Y-MC, Wang H-S. Medium-chain triglyceride ketogenic diet, an effective treatment for d"
    },
    {
      "type": "text",
      "section": "TABLE 23-1. Types of Ketogenic Diets",
      "line": 8319,
      "preview": "${ }^{d}$ Pfeifer HH, Thiele EA. Low-glycemic-index treatment: a liberalized ketogenic diet for trea"
    },
    {
      "type": "text",
      "section": "TABLE 23-1. Types of Ketogenic Diets",
      "line": 8320,
      "preview": "https://doi.org/10.1212/01.wnl.0000187071.24292.9e"
    },
    {
      "type": "text",
      "section": "TABLE 23-1. Types of Ketogenic Diets",
      "line": 8322,
      "preview": "When selecting a ketogenic diet option for a patient, consider the following:"
    },
    {
      "type": "text",
      "section": "TABLE 23-1. Types of Ketogenic Diets",
      "line": 8324,
      "preview": "- Diagnosis (see Tables 23-2 and 23-3)"
    },
    {
      "type": "text",
      "section": "TABLE 23-1. Types of Ketogenic Diets",
      "line": 8325,
      "preview": "- Age (certain KDTs can provide greater benefit for specific age ranges)"
    },
    {
      "type": "text",
      "section": "TABLE 23-1. Types of Ketogenic Diets",
      "line": 8326,
      "preview": "- Feeding method (enteral, parenteral, by mouth, or a combination of feeding methods)"
    },
    {
      "type": "text",
      "section": "TABLE 23-1. Types of Ketogenic Diets",
      "line": 8327,
      "preview": "- Family desire for structure vs flexibility"
    },
    {
      "type": "text",
      "section": "TABLE 23-1. Types of Ketogenic Diets",
      "line": 8329,
      "preview": "--- page 439 ---"
    },
    {
      "type": "text",
      "section": "TABLE 23-1. Types of Ketogenic Diets",
      "line": 8331,
      "preview": "TABLE 23-2. Epilepsy Syndromes and Conditions ${ }^{a}$"
    },
    {
      "type": "table",
      "section": "TABLE 23-1. Types of Ketogenic Diets",
      "line": 8333,
      "preview": "| Syndromes/Conditions for Which KDT Has Been Consistently Beneficial ${ }^{b}$ | Syndromes/Conditio"
    },
    {
      "type": "table",
      "section": "TABLE 23-1. Types of Ketogenic Diets",
      "line": 8334,
      "preview": "| :--: | :--: |"
    },
    {
      "type": "table",
      "section": "TABLE 23-1. Types of Ketogenic Diets",
      "line": 8335,
      "preview": "| Angelman syndrome | Adenylosuccinate lyase deficiency |"
    },
    {
      "type": "table",
      "section": "TABLE 23-1. Types of Ketogenic Diets",
      "line": 8336,
      "preview": "| Complex 1 mitochondrial disorders | CDKL5 encephalopathy |"
    },
    {
      "type": "table",
      "section": "TABLE 23-1. Types of Ketogenic Diets",
      "line": 8337,
      "preview": "| Dravet syndrome | Childhood absence epilepsy |"
    },
    {
      "type": "table",
      "section": "TABLE 23-1. Types of Ketogenic Diets",
      "line": 8338,
      "preview": "| Epilepsy with myoclonic-atonic seizures (Doose syndrome) | Cortical malformations |"
    },
    {
      "type": "table",
      "section": "TABLE 23-1. Types of Ketogenic Diets",
      "line": 8339,
      "preview": "|  | Epilepsy of infancy with migrating focal seizures |"
    },
    {
      "type": "table",
      "section": "TABLE 23-1. Types of Ketogenic Diets",
      "line": 8340,
      "preview": "| FIRES |  |"
    },
    {
      "type": "table",
      "section": "TABLE 23-1. Types of Ketogenic Diets",
      "line": 8341,
      "preview": "| Formula-fed (solely) children or infants | Epileptic encephalopathy with continuous spike-and-wave"
    },
    {
      "type": "table",
      "section": "TABLE 23-1. Types of Ketogenic Diets",
      "line": 8342,
      "preview": "| Glut-1 | Glycogenosis type V |"
    },
    {
      "type": "table",
      "section": "TABLE 23-1. Types of Ketogenic Diets",
      "line": 8343,
      "preview": "| Glut1DS | Juvenile myoclonic epilepsy |"
    },
    {
      "type": "table",
      "section": "TABLE 23-1. Types of Ketogenic Diets",
      "line": 8344,
      "preview": "| Infantile spasms | Lafora body disease |"
    },
    {
      "type": "table",
      "section": "TABLE 23-1. Types of Ketogenic Diets",
      "line": 8345,
      "preview": "| Ohtahara syndrome | Landau-Kleffner syndrome |"
    },
    {
      "type": "table",
      "section": "TABLE 23-1. Types of Ketogenic Diets",
      "line": 8346,
      "preview": "| PDHD | Lennox-Gastaut syndrome |"
    },
    {
      "type": "table",
      "section": "TABLE 23-1. Types of Ketogenic Diets",
      "line": 8347,
      "preview": "| Super-refractory status epilepticus | Phosphofructokinase deficiency |"
    },
    {
      "type": "table",
      "section": "TABLE 23-1. Types of Ketogenic Diets",
      "line": 8348,
      "preview": "| Tuberous sclerosis complex | Rett syndrome |"
    },
    {
      "type": "table",
      "section": "TABLE 23-1. Types of Ketogenic Diets",
      "line": 8349,
      "preview": "|  | SSPE |"
    },
    {
      "type": "text",
      "section": "TABLE 23-1. Types of Ketogenic Diets",
      "line": 8351,
      "preview": "Abbreviations: CDKL5, cyclin-dependent kinase-like 5; FIRES, febrile infection-related epilepsy synd"
    },
    {
      "type": "text",
      "section": "TABLE 23-1. Types of Ketogenic Diets",
      "line": 8352,
      "preview": "${ }^{a}$ Adapted with permission from the International League Against Epilepsy from Kossoff EH, Zu"
    },
    {
      "type": "text",
      "section": "TABLE 23-1. Types of Ketogenic Diets",
      "line": 8353,
      "preview": "${ }^{\\mathrm{b}}>70 \\%$ than the average $50 \\%$ KDT response (defined as $>50 \\%$ seizure reductio"
    },
    {
      "type": "text",
      "section": "TABLE 23-1. Types of Ketogenic Diets",
      "line": 8354,
      "preview": "${ }^{c}$ Not better than the average dietary therapy response or in limited single-center case repo"
    },
    {
      "type": "text",
      "section": "TABLE 23-1. Types of Ketogenic Diets",
      "line": 8356,
      "preview": "--- page 440 ---"
    },
    {
      "type": "text",
      "section": "TABLE 23-1. Types of Ketogenic Diets",
      "line": 8358,
      "preview": "TABLE 23-3. Contraindications to the Use of KDT $^{\\text {a }}$"
    },
    {
      "type": "table",
      "section": "TABLE 23-1. Types of Ketogenic Diets",
      "line": 8360,
      "preview": "| Absolute Contraindications | Relative Contraindications |"
    },
    {
      "type": "table",
      "section": "TABLE 23-1. Types of Ketogenic Diets",
      "line": 8361,
      "preview": "| :-- | :-- |"
    },
    {
      "type": "table",
      "section": "TABLE 23-1. Types of Ketogenic Diets",
      "line": 8362,
      "preview": "| Carnitine deficiency (primary) | Inability to maintain adequate nutrition |"
    },
    {
      "type": "table",
      "section": "TABLE 23-1. Types of Ketogenic Diets",
      "line": 8363,
      "preview": "| CPT I or II deficiency | Surgical focus identified by neuroimaging and <br> video-EEG monitoring |"
    },
    {
      "type": "table",
      "section": "TABLE 23-1. Types of Ketogenic Diets",
      "line": 8364,
      "preview": "| Carnitine translocase <br> deficiency | Parent or caregiver nonadherence |"
    },
    {
      "type": "table",
      "section": "TABLE 23-1. Types of Ketogenic Diets",
      "line": 8365,
      "preview": "| $\\beta$-Oxidation defects | Propofol concurrent use (risk of propofol infusion <br> syndrome may b"
    },
    {
      "type": "table",
      "section": "TABLE 23-1. Types of Ketogenic Diets",
      "line": 8366,
      "preview": "| MCADLCADSCAD |  |"
    },
    {
      "type": "table",
      "section": "TABLE 23-1. Types of Ketogenic Diets",
      "line": 8367,
      "preview": "| Long-chain 3-hydroxyacyl- <br> CoA deficiency |  |"
    },
    {
      "type": "table",
      "section": "TABLE 23-1. Types of Ketogenic Diets",
      "line": 8368,
      "preview": "| Medium-chain 3-hydroxyacyl- <br> CoA deficiency |  |"
    },
    {
      "type": "table",
      "section": "TABLE 23-1. Types of Ketogenic Diets",
      "line": 8369,
      "preview": "| Pyruvate carboxylase <br> deficiency |  |"
    },
    {
      "type": "table",
      "section": "TABLE 23-1. Types of Ketogenic Diets",
      "line": 8370,
      "preview": "| Porphyria |  |"
    },
    {
      "type": "text",
      "section": "TABLE 23-1. Types of Ketogenic Diets",
      "line": 8372,
      "preview": "Abbreviations: CoA, coenzyme A; CPT, carnitine palmitoyltransferase; EEG, electroencephalographic; K"
    },
    {
      "type": "text",
      "section": "TABLE 23-1. Types of Ketogenic Diets",
      "line": 8373,
      "preview": "${ }^{a}$ Adapted with permission from the International League Against Epilepsy from Kossoff EH, Zu"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "Indications for Diet Therapy Versus Contraindications",
      "line": 8375
    },
    {
      "type": "text",
      "section": "Indications for Diet Therapy Versus Contraindications",
      "line": 8377,
      "preview": "Indications for ketogenic diets have been grouped into 2 categories by the International Ketogenic D"
    },
    {
      "type": "heading",
      "level": 2,
      "section": "Potential Adverse Effects",
      "line": 8379
    },
    {
      "type": "text",
      "section": "Potential Adverse Effects",
      "line": 8381,
      "preview": "--- page 441 ---"
    },
    {
      "type": "text",
      "section": "Potential Adverse Effects",
      "line": 8383,
      "preview": "All medical treatments for epilepsy can have side effects, including KDTs (see Table 23-4)."
    },
    {
      "type": "text",
      "section": "Potential Adverse Effects",
      "line": 8385,
      "preview": "TABLE 23-4. Possible Adverse Effects of KDT"
    },
    {
      "type": "table",
      "section": "Potential Adverse Effects",
      "line": 8387,
      "preview": "| Common | Sporadic | Rare |"
    },
    {
      "type": "table",
      "section": "Potential Adverse Effects",
      "line": 8388,
      "preview": "| :-- | :-- | :-- |"
    },
    {
      "type": "table",
      "section": "Potential Adverse Effects",
      "line": 8389,
      "preview": "| Acidosis | Bruising | Cardiomyopathy |"
    },
    {
      "type": "table",
      "section": "Potential Adverse Effects",
      "line": 8390,
      "preview": "| Constipation | Carnitine deficiency | Essential fatty acid deficiency |"
    },
    {
      "type": "table",
      "section": "Potential Adverse Effects",
      "line": 8391,
      "preview": "| Reflux | Dehydration | Hunger |"
    },
    {
      "type": "table",
      "section": "Potential Adverse Effects",
      "line": 8392,
      "preview": "|  | Diarrhea | Hypercalcemia |"
    },
    {
      "type": "table",
      "section": "Potential Adverse Effects",
      "line": 8393,
      "preview": "|  | Elevated blood lipids | Hypoproteinemia |"
    },
    {
      "type": "table",
      "section": "Potential Adverse Effects",
      "line": 8394,
      "preview": "|  | Excess ketosis | Increased infections |"
    },
    {
      "type": "table",
      "section": "Potential Adverse Effects",
      "line": 8395,
      "preview": "|  | Feeding intolerance | Increased seizures |"
    },
    {
      "type": "table",
      "section": "Potential Adverse Effects",
      "line": 8396,
      "preview": "|  | Food refusal | Irritability |"
    },
    {
      "type": "table",
      "section": "Potential Adverse Effects",
      "line": 8397,
      "preview": "|  | Hypoglycemia | Medication toxicity |"
    },
    {
      "type": "table",
      "section": "Potential Adverse Effects",
      "line": 8398,
      "preview": "|  | Kidney stones | Optic neuropathy |"
    },
    {
      "type": "table",
      "section": "Potential Adverse Effects",
      "line": 8399,
      "preview": "|  | Lethargy | Osteoporosis |"
    },
    {
      "type": "table",
      "section": "Potential Adverse Effects",
      "line": 8400,
      "preview": "|  | Low ketones | Pancreatitis |"
    },
    {
      "type": "table",
      "section": "Potential Adverse Effects",
      "line": 8401,
      "preview": "|  | Nausea/vomiting |  |"
    },
    {
      "type": "table",
      "section": "Potential Adverse Effects",
      "line": 8402,
      "preview": "|  | Slow growth |  |"
    },
    {
      "type": "table",
      "section": "Potential Adverse Effects",
      "line": 8403,
      "preview": "|  | Weight loss |  |"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "Suggested Treatment Recommendations for Most Common Adverse Effects",
      "line": 8405
    },
    {
      "type": "text",
      "section": "Suggested Treatment Recommendations for Most Common Adverse Effects",
      "line": 8407,
      "preview": "The following are potential adverse effects that the health care team will need to address and advis"
    },
    {
      "type": "text",
      "section": "Suggested Treatment Recommendations for Most Common Adverse Effects",
      "line": 8409,
      "preview": "1. Acidosis"
    },
    {
      "type": "text",
      "section": "Suggested Treatment Recommendations for Most Common Adverse Effects",
      "line": 8411,
      "preview": "- Signs and symptoms include dehydration, fatigue, and vomiting."
    },
    {
      "type": "text",
      "section": "Suggested Treatment Recommendations for Most Common Adverse Effects",
      "line": 8412,
      "preview": "- Consider prescribing a bicarbonate and/or citrate buffer at initiation of classic ketogenic ratios"
    },
    {
      "type": "text",
      "section": "Suggested Treatment Recommendations for Most Common Adverse Effects",
      "line": 8413,
      "preview": "o $1-2 \\mathrm{mEq} / \\mathrm{kg}$ divided into $2-3$ doses daily."
    },
    {
      "type": "text",
      "section": "Suggested Treatment Recommendations for Most Common Adverse Effects",
      "line": 8415,
      "preview": "--- page 442 ---"
    },
    {
      "type": "text",
      "section": "Suggested Treatment Recommendations for Most Common Adverse Effects",
      "line": 8417,
      "preview": "- Discuss with the health care team whether topiramate or zonisamide can be reduced or avoided as KD"
    },
    {
      "type": "text",
      "section": "Suggested Treatment Recommendations for Most Common Adverse Effects",
      "line": 8419,
      "preview": "2. Constipation"
    },
    {
      "type": "text",
      "section": "Suggested Treatment Recommendations for Most Common Adverse Effects",
      "line": 8421,
      "preview": "- Ensure adequate hydration."
    },
    {
      "type": "text",
      "section": "Suggested Treatment Recommendations for Most Common Adverse Effects",
      "line": 8422,
      "preview": "- Incorporate medium-chain triglyceride oil, avocados, or high insoluble fiber vegetables into the d"
    },
    {
      "type": "text",
      "section": "Suggested Treatment Recommendations for Most Common Adverse Effects",
      "line": 8423,
      "preview": "- The child may require additional medications, such as milk of magnesia, suppository, enema, or pol"
    },
    {
      "type": "text",
      "section": "Suggested Treatment Recommendations for Most Common Adverse Effects",
      "line": 8425,
      "preview": "3. Gastroesophageal Reflux (GER)"
    },
    {
      "type": "text",
      "section": "Suggested Treatment Recommendations for Most Common Adverse Effects",
      "line": 8427,
      "preview": "- Recommend smaller, more frequent meals."
    },
    {
      "type": "text",
      "section": "Suggested Treatment Recommendations for Most Common Adverse Effects",
      "line": 8428,
      "preview": "- Children with GER will likely require an acid blocker reflux medication."
    },
    {
      "type": "heading",
      "level": 1,
      "section": "Assessment and Nutrient Requirements",
      "line": 8431
    },
    {
      "type": "heading",
      "level": 2,
      "section": "Pediatric Growth Assessment",
      "line": 8433
    },
    {
      "type": "text",
      "section": "Pediatric Growth Assessment",
      "line": 8435,
      "preview": "Use the following guidelines for pediatric growth assessment:"
    },
    {
      "type": "text",
      "section": "Pediatric Growth Assessment",
      "line": 8437,
      "preview": "- World Health Organization growth charts: $0-24$ months of age"
    },
    {
      "type": "text",
      "section": "Pediatric Growth Assessment",
      "line": 8438,
      "preview": "- Centers for Disease Control and Prevention growth charts: 2-20 years of age"
    },
    {
      "type": "text",
      "section": "Pediatric Growth Assessment",
      "line": 8439,
      "preview": "- Use of body mass index (BMI) may not be useful for this population because many children have neur"
    },
    {
      "type": "heading",
      "level": 2,
      "section": "Estimating Nutrient Needs",
      "line": 8442
    },
    {
      "type": "text",
      "section": "Estimating Nutrient Needs",
      "line": 8444,
      "preview": "Table 23-5 provides guidance on estimating nutrient needs, and Table 236 provides macronutrient comp"
    },
    {
      "type": "text",
      "section": "Estimating Nutrient Needs",
      "line": 8446,
      "preview": "--- page 443 ---"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "TABLE 23-5. Estimating Nutrient Needs",
      "line": 8448
    },
    {
      "type": "table",
      "section": "TABLE 23-5. Estimating Nutrient Needs",
      "line": 8450,
      "preview": "| Energy | May use predictive equations, match energy intake to current estimated <br> intake, or es"
    },
    {
      "type": "table",
      "section": "TABLE 23-5. Estimating Nutrient Needs",
      "line": 8451,
      "preview": "| :-- | :-- |"
    },
    {
      "type": "table",
      "section": "TABLE 23-5. Estimating Nutrient Needs",
      "line": 8452,
      "preview": "| Protein | Ensure minimum requirements for age are met. Continue to adjust protein <br> requirement"
    },
    {
      "type": "table",
      "section": "TABLE 23-5. Estimating Nutrient Needs",
      "line": 8453,
      "preview": "| Fluid | Recommend using the Holliday-Segar method (see chapter 4, \"Infant to <br> Adolescent\") to "
    },
    {
      "type": "text",
      "section": "TABLE 23-5. Estimating Nutrient Needs",
      "line": 8455,
      "preview": "${ }^{a}$ Data from Nation J, Humphrey M, MacKay M, Boneh A. Linear growth of children on a ketogeni"
    },
    {
      "type": "text",
      "section": "TABLE 23-5. Estimating Nutrient Needs",
      "line": 8456,
      "preview": "2014;29(11):1496-1501. https://doi.org/10.1177/0883073813508222"
    },
    {
      "type": "heading",
      "level": 2,
      "section": "TABLE 23-6. Macronutrient Composition of Each Diet in Percentage of Total Calories",
      "line": 8458
    },
    {
      "type": "table",
      "section": "TABLE 23-6. Macronutrient Composition of Each Diet in Percentage of Total Calories",
      "line": 8460,
      "preview": "| Macronutrient Ratio | Fat | Protein | Carbohydrate |"
    },
    {
      "type": "table",
      "section": "TABLE 23-6. Macronutrient Composition of Each Diet in Percentage of Total Calories",
      "line": 8461,
      "preview": "| :-- | :--: | :--: | :--: |"
    },
    {
      "type": "table",
      "section": "TABLE 23-6. Macronutrient Composition of Each Diet in Percentage of Total Calories",
      "line": 8462,
      "preview": "| Classic keto (4:1) | $90 \\%$ | $6 \\%$ | $4 \\%$ |"
    },
    {
      "type": "table",
      "section": "TABLE 23-6. Macronutrient Composition of Each Diet in Percentage of Total Calories",
      "line": 8463,
      "preview": "| Modified keto (3:1) | $87 \\%$ | $10 \\%$ | $3 \\%$ |"
    },
    {
      "type": "table",
      "section": "TABLE 23-6. Macronutrient Composition of Each Diet in Percentage of Total Calories",
      "line": 8464,
      "preview": "| Modified keto (2:1) | $82 \\%$ | $12 \\%$ | $6 \\%$ |"
    },
    {
      "type": "table",
      "section": "TABLE 23-6. Macronutrient Composition of Each Diet in Percentage of Total Calories",
      "line": 8465,
      "preview": "| Modified keto (1:1) | $70 \\%$ | $15 \\%$ | $15 \\%$ |"
    },
    {
      "type": "table",
      "section": "TABLE 23-6. Macronutrient Composition of Each Diet in Percentage of Total Calories",
      "line": 8466,
      "preview": "| MCT oil (1.9:1) | $50 \\% / 21 \\%$ | $19 \\%$ | $10 \\%$ |"
    },
    {
      "type": "table",
      "section": "TABLE 23-6. Macronutrient Composition of Each Diet in Percentage of Total Calories",
      "line": 8467,
      "preview": "| LGIT (2:3) | $60 \\%$ | $28 \\%$ | $12 \\%$ |"
    },
    {
      "type": "table",
      "section": "TABLE 23-6. Macronutrient Composition of Each Diet in Percentage of Total Calories",
      "line": 8468,
      "preview": "| MAD (0.8:1) | $65 \\%$ | $29 \\%-32 \\%$ | $3 \\%-6 \\%$ |"
    },
    {
      "type": "text",
      "section": "TABLE 23-6. Macronutrient Composition of Each Diet in Percentage of Total Calories",
      "line": 8470,
      "preview": "Abbreviations: LCT, long-chain triglyceride; LGIT, low glycemic index treatment; MAD, modified Atkin"
    },
    {
      "type": "text",
      "section": "TABLE 23-6. Macronutrient Composition of Each Diet in Percentage of Total Calories",
      "line": 8471,
      "preview": "Reproduced with permission from Beth Zupec-Kania for The Charlie Foundation for Ketogenic Therapies."
    },
    {
      "type": "text",
      "section": "TABLE 23-6. Macronutrient Composition of Each Diet in Percentage of Total Calories",
      "line": 8472,
      "preview": "a $50 \\%$ MCTs/21\\% LCTs."
    },
    {
      "type": "heading",
      "level": 2,
      "section": "Vitamin and Electrolyte Supplementation",
      "line": 8474
    },
    {
      "type": "text",
      "section": "Vitamin and Electrolyte Supplementation",
      "line": 8476,
      "preview": "--- page 444 ---"
    },
    {
      "type": "text",
      "section": "Vitamin and Electrolyte Supplementation",
      "line": 8478,
      "preview": "Vitamin and mineral supplementation is required for all types of medical ketogenic diets because of "
    },
    {
      "type": "text",
      "section": "Vitamin and Electrolyte Supplementation",
      "line": 8480,
      "preview": "- Vitamin $B_{1}$"
    },
    {
      "type": "text",
      "section": "Vitamin and Electrolyte Supplementation",
      "line": 8481,
      "preview": "- Vitamin D"
    },
    {
      "type": "text",
      "section": "Vitamin and Electrolyte Supplementation",
      "line": 8482,
      "preview": "- Magnesium"
    },
    {
      "type": "text",
      "section": "Vitamin and Electrolyte Supplementation",
      "line": 8483,
      "preview": "- Phosphorus"
    },
    {
      "type": "text",
      "section": "Vitamin and Electrolyte Supplementation",
      "line": 8484,
      "preview": "- Copper"
    },
    {
      "type": "text",
      "section": "Vitamin and Electrolyte Supplementation",
      "line": 8485,
      "preview": "- Zinc"
    },
    {
      "type": "text",
      "section": "Vitamin and Electrolyte Supplementation",
      "line": 8486,
      "preview": "- Selenium"
    },
    {
      "type": "text",
      "section": "Vitamin and Electrolyte Supplementation",
      "line": 8487,
      "preview": "- Carnitine ${ }^{3}$"
    },
    {
      "type": "text",
      "section": "Vitamin and Electrolyte Supplementation",
      "line": 8489,
      "preview": "Vitamin and mineral supplementation plans should be specific to the patient and their individual nee"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "Medication and Carbohydrate Content",
      "line": 8491
    },
    {
      "type": "text",
      "section": "Medication and Carbohydrate Content",
      "line": 8493,
      "preview": "Many medications contain carbohydrates that may need to be calculated into a child's ketogenic diet "
    },
    {
      "type": "heading",
      "level": 2,
      "section": "Implementation and Nutrition Plan and Monitoring",
      "line": 8495
    },
    {
      "type": "text",
      "section": "Implementation and Nutrition Plan and Monitoring",
      "line": 8497,
      "preview": "Most ketogenic diets can be initiated at home or in the hospital. However, medical supervision is re"
    },
    {
      "type": "text",
      "section": "Implementation and Nutrition Plan and Monitoring",
      "line": 8499,
      "preview": "--- page 445 ---"
    },
    {
      "type": "text",
      "section": "Implementation and Nutrition Plan and Monitoring",
      "line": 8501,
      "preview": "recommendations) and should then be obtained regularly during initiation."
    },
    {
      "type": "heading",
      "level": 1,
      "section": "TABLE 23-7. Initiation Location",
      "line": 8503
    },
    {
      "type": "table",
      "section": "TABLE 23-7. Initiation Location",
      "line": 8505,
      "preview": "| Location | Classic | Modified Ketogenic | Modified Atkins | MCT Oil | LGIT |"
    },
    {
      "type": "table",
      "section": "TABLE 23-7. Initiation Location",
      "line": 8506,
      "preview": "| :-- | :-- | :-- | :-- | :-- | :-- |"
    },
    {
      "type": "table",
      "section": "TABLE 23-7. Initiation Location",
      "line": 8507,
      "preview": "| Home | Yes | Yes | Yes | Yes | Yes |"
    },
    {
      "type": "table",
      "section": "TABLE 23-7. Initiation Location",
      "line": 8508,
      "preview": "| Hospital | Yes | Yes | No | Yes | No |"
    },
    {
      "type": "text",
      "section": "TABLE 23-7. Initiation Location",
      "line": 8510,
      "preview": "Abbreviations: LGIT, low glycemic index treatment; MCT, medium-chain triglyceride. Data from van der"
    },
    {
      "type": "text",
      "section": "TABLE 23-7. Initiation Location",
      "line": 8511,
      "preview": "https://doi.org/10.1016/j.ejpn.2019.06.001"
    },
    {
      "type": "heading",
      "level": 2,
      "section": "Initiation Methods of Classic Ketogenic Diets",
      "line": 8513
    },
    {
      "type": "text",
      "section": "Initiation Methods of Classic Ketogenic Diets",
      "line": 8515,
      "preview": "Table 23-8 provides initiation methods of classic ketogenic diets."
    },
    {
      "type": "heading",
      "level": 2,
      "section": "TABLE 23-8. Classic KDT Initiation Methods",
      "line": 8517
    },
    {
      "type": "table",
      "section": "TABLE 23-8. Classic KDT Initiation Methods",
      "line": 8519,
      "preview": "| Ratio- <br> Based | Strength-Based | Meal-Based |"
    },
    {
      "type": "table",
      "section": "TABLE 23-8. Classic KDT Initiation Methods",
      "line": 8520,
      "preview": "| :-- | :-- | :-- |"
    },
    {
      "type": "table",
      "section": "TABLE 23-8. Classic KDT Initiation Methods",
      "line": 8521,
      "preview": "| $1: 1 \\rightarrow$ | $1 / 3$ ketogenic | Change 1 meal/d to goal ratio $\\rightarrow$ change 2 meal"
    },
    {
      "type": "table",
      "section": "TABLE 23-8. Classic KDT Initiation Methods",
      "line": 8522,
      "preview": "| $2: 1 \\rightarrow$ | formula + | goal ratio $\\rightarrow$ change 3 meals/d to goal ratio $\\rightar"
    },
    {
      "type": "table",
      "section": "TABLE 23-8. Classic KDT Initiation Methods",
      "line": 8523,
      "preview": "| $3: 1 \\rightarrow$ | $2 / 3$ home formula | meals and snacks at goal ratio |"
    },
    {
      "type": "table",
      "section": "TABLE 23-8. Classic KDT Initiation Methods",
      "line": 8524,
      "preview": "| $4: 1$ | $\\rightarrow 2 / 3$ ketogenic |  |"
    },
    {
      "type": "table",
      "section": "TABLE 23-8. Classic KDT Initiation Methods",
      "line": 8525,
      "preview": "|  | formula + |  |"
    },
    {
      "type": "table",
      "section": "TABLE 23-8. Classic KDT Initiation Methods",
      "line": 8526,
      "preview": "|  | $1 / 3$ home formula |  |"
    },
    {
      "type": "table",
      "section": "TABLE 23-8. Classic KDT Initiation Methods",
      "line": 8527,
      "preview": "|  | $\\rightarrow$ goal ketogenic |  |"
    },
    {
      "type": "table",
      "section": "TABLE 23-8. Classic KDT Initiation Methods",
      "line": 8528,
      "preview": "|  | formula |  |"
    },
    {
      "type": "text",
      "section": "TABLE 23-8. Classic KDT Initiation Methods",
      "line": 8530,
      "preview": "Abbreviation: KDT, ketogenic diet therapy."
    },
    {
      "type": "text",
      "section": "TABLE 23-8. Classic KDT Initiation Methods",
      "line": 8532,
      "preview": "Note the following:"
    },
    {
      "type": "text",
      "section": "TABLE 23-8. Classic KDT Initiation Methods",
      "line": 8534,
      "preview": "- Ketogenic diet formulas are more concentrated ( $\\sim 1.5 \\mathrm{kcal} / \\mathrm{mL}$ ) than stan"
    },
    {
      "type": "text",
      "section": "TABLE 23-8. Classic KDT Initiation Methods",
      "line": 8536,
      "preview": "--- page 446 ---"
    },
    {
      "type": "text",
      "section": "TABLE 23-8. Classic KDT Initiation Methods",
      "line": 8538,
      "preview": "- In the intensive care unit, ketogenic diets are often initiated at the goal ratio, whereas calorie"
    },
    {
      "type": "text",
      "section": "TABLE 23-8. Classic KDT Initiation Methods",
      "line": 8539,
      "preview": "- Outpatient (home) diet initiations are typically a slower induction process, making 1 change every"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "Laboratory Monitoring Protocol",
      "line": 8542
    },
    {
      "type": "text",
      "section": "Laboratory Monitoring Protocol",
      "line": 8544,
      "preview": "Laboratory monitoring is important throughout the course of KDT to monitor for any abnormalities and"
    },
    {
      "type": "heading",
      "level": 2,
      "section": "TABLE 23-9. Laboratory Monitoring",
      "line": 8546
    },
    {
      "type": "table",
      "section": "TABLE 23-9. Laboratory Monitoring",
      "line": 8548,
      "preview": "| Frequency | Laboratory Measurement |"
    },
    {
      "type": "table",
      "section": "TABLE 23-9. Laboratory Monitoring",
      "line": 8549,
      "preview": "| :-- | :-- |"
    },
    {
      "type": "table",
      "section": "TABLE 23-9. Laboratory Monitoring",
      "line": 8550,
      "preview": "| Prior to <br> starting <br> KDT | Urine organic acids, complete metabolic panel, CBC with platelet"
    },
    {
      "type": "table",
      "section": "TABLE 23-9. Laboratory Monitoring",
      "line": 8551,
      "preview": "| Daily <br> during <br> initiation <br> phase | Complete metabolic panel, CBC with platelets, $\\bet"
    },
    {
      "type": "table",
      "section": "TABLE 23-9. Laboratory Monitoring",
      "line": 8552,
      "preview": "| Every 3 mo <br> until stable | Complete metabolic panel, CBC with platelets, liver profile, <br> m"
    },
    {
      "type": "table",
      "section": "TABLE 23-9. Laboratory Monitoring",
      "line": 8553,
      "preview": "| Every 12 <br> mo | DXA, EKG, renal ultrasonography |"
    },
    {
      "type": "text",
      "section": "TABLE 23-9. Laboratory Monitoring",
      "line": 8555,
      "preview": "Abbreviations: CBC, complete blood cell count; DXA, dual-energy x-ray absorptiometry; EKG, electroca"
    },
    {
      "type": "heading",
      "level": 2,
      "section": "Ketone Measurements",
      "line": 8557
    },
    {
      "type": "text",
      "section": "Ketone Measurements",
      "line": 8559,
      "preview": "Ketones are generally checked frequently during the initial period of the KDT (sometimes twice daily"
    },
    {
      "type": "text",
      "section": "Ketone Measurements",
      "line": 8561,
      "preview": "--- page 447 ---"
    },
    {
      "type": "text",
      "section": "Ketone Measurements",
      "line": 8563,
      "preview": "TABLE 23-10. Ketone Measurements"
    },
    {
      "type": "table",
      "section": "Ketone Measurements",
      "line": 8565,
      "preview": "| Measurement Type | Description |"
    },
    {
      "type": "table",
      "section": "Ketone Measurements",
      "line": 8566,
      "preview": "| :--: | :--: |"
    },
    {
      "type": "table",
      "section": "Ketone Measurements",
      "line": 8567,
      "preview": "| Blood ketones ( $\\beta$ hydroxybutyrate) | - The most reliable and accurate form of ketosis <br> -"
    },
    {
      "type": "table",
      "section": "Ketone Measurements",
      "line": 8568,
      "preview": "| Urine ketones (acetoacetate) | - Hydration dependent and not as accurate as blood ketones <br> - L"
    },
    {
      "type": "table",
      "section": "Ketone Measurements",
      "line": 8569,
      "preview": "| Breath ketones (acetone) | - Noninvasive measurement <br> - Many external factors can negatively a"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "Sick Day Management",
      "line": 8571
    },
    {
      "type": "text",
      "section": "Sick Day Management",
      "line": 8573,
      "preview": "When a child on a ketogenic diet is ill and unable to consume the prescribed diet plan, it is very i"
    },
    {
      "type": "text",
      "section": "Sick Day Management",
      "line": 8575,
      "preview": "If the patient can tolerate clear liquids, advance to a half-strength formula or half of a ketogenic"
    },
    {
      "type": "text",
      "section": "Sick Day Management",
      "line": 8577,
      "preview": "--- page 448 ---"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "Special Circumstances",
      "line": 8579
    },
    {
      "type": "heading",
      "level": 2,
      "section": "Infants ${ }^{5}$",
      "line": 8581
    },
    {
      "type": "text",
      "section": "Infants ${ }^{5}$",
      "line": 8583,
      "preview": "Initiation of KDT in all infants should occur in the hospital setting. The goal ratio is at least $3"
    },
    {
      "type": "text",
      "section": "Infants ${ }^{5}$",
      "line": 8585,
      "preview": "- Blood glucose (minimum of twice daily) to watch for hypoglycemia"
    },
    {
      "type": "text",
      "section": "Infants ${ }^{5}$",
      "line": 8586,
      "preview": "- Blood ketones twice daily (blood ketones are more accurate than urine ketones in infants)"
    },
    {
      "type": "text",
      "section": "Infants ${ }^{5}$",
      "line": 8588,
      "preview": "Blood ketone and blood glucose monitoring can be decreased based on trends and provider discretion."
    },
    {
      "type": "heading",
      "level": 2,
      "section": "Intensive Care Unit ${ }^{6}$",
      "line": 8590
    },
    {
      "type": "text",
      "section": "Intensive Care Unit ${ }^{6}$",
      "line": 8592,
      "preview": "Ketogenic diets may be emergently started in the intensive care unit (ICU) setting for patients with"
    },
    {
      "type": "text",
      "section": "Intensive Care Unit ${ }^{6}$",
      "line": 8594,
      "preview": "- New-onset refractory status epilepticus"
    },
    {
      "type": "text",
      "section": "Intensive Care Unit ${ }^{6}$",
      "line": 8595,
      "preview": "- Febrile infection-related epilepsy syndrome"
    },
    {
      "type": "text",
      "section": "Intensive Care Unit ${ }^{6}$",
      "line": 8596,
      "preview": "- Super-refractory status epilepticus"
    },
    {
      "type": "text",
      "section": "Intensive Care Unit ${ }^{6}$",
      "line": 8598,
      "preview": "Generally, classic diets are initiated at goal ratio (4:1) with $50 \\%$ of calories that are titrate"
    },
    {
      "type": "heading",
      "level": 2,
      "section": "Total Parenteral Nutrition ${ }^{7}$",
      "line": 8600
    },
    {
      "type": "text",
      "section": "Total Parenteral Nutrition ${ }^{7}$",
      "line": 8602,
      "preview": "Ketogenic total parenteral nutrition (TPN) is indicated when enteral feedings are not tolerated. The"
    },
    {
      "type": "text",
      "section": "Total Parenteral Nutrition ${ }^{7}$",
      "line": 8604,
      "preview": "--- page 449 ---"
    },
    {
      "type": "text",
      "section": "Total Parenteral Nutrition ${ }^{7}$",
      "line": 8606,
      "preview": "adjusted based on clinical need. Dextrose limits are individualized per institution. Attempt to prov"
    },
    {
      "type": "text",
      "section": "Total Parenteral Nutrition ${ }^{7}$",
      "line": 8608,
      "preview": "- Lipid infusion should start at $0.5-1 \\mathrm{~mL} / \\mathrm{kg} / \\mathrm{h}$ and be advanced by "
    },
    {
      "type": "text",
      "section": "Total Parenteral Nutrition ${ }^{7}$",
      "line": 8609,
      "preview": "- Count the carbohydrate content of glycerol from the lipids when calculating the ketogenic ratio."
    },
    {
      "type": "text",
      "section": "Total Parenteral Nutrition ${ }^{7}$",
      "line": 8610,
      "preview": "- Protein intake should be adequate for need based on the clinical condition."
    },
    {
      "type": "text",
      "section": "Total Parenteral Nutrition ${ }^{7}$",
      "line": 8612,
      "preview": "Monitor laboratory measurements daily, specifically triglycerides (TGs), electrolytes, and bicarbona"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "Discontinuing the Ketogenic Diet",
      "line": 8614
    },
    {
      "type": "text",
      "section": "Discontinuing the Ketogenic Diet",
      "line": 8616,
      "preview": "Significant variation of when and how quickly to discontinue diet therapy is based on the child's in"
    },
    {
      "type": "text",
      "section": "Discontinuing the Ketogenic Diet",
      "line": 8618,
      "preview": "There has been a concern that weaning KDTs too quickly would cause a dramatic increase in seizures, "
    },
    {
      "type": "text",
      "section": "Discontinuing the Ketogenic Diet",
      "line": 8620,
      "preview": "--- page 450 ---"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "TABLE 23-11. Sample KDT Weaning Plan",
      "line": 8622
    },
    {
      "type": "table",
      "section": "TABLE 23-11. Sample KDT Weaning Plan",
      "line": 8624,
      "preview": "| Classic KDT: <br> Sample A | Classic KDT: <br> Sample B | Modified Atkins |"
    },
    {
      "type": "table",
      "section": "TABLE 23-11. Sample KDT Weaning Plan",
      "line": 8625,
      "preview": "| :-- | :-- | :-- |"
    },
    {
      "type": "table",
      "section": "TABLE 23-11. Sample KDT Weaning Plan",
      "line": 8626,
      "preview": "| Starting point-4:1 <br> ratio | Starting point-4:1 <br> ratio | Increase carbohydrate restriction "
    },
    {
      "type": "table",
      "section": "TABLE 23-11. Sample KDT Weaning Plan",
      "line": 8627,
      "preview": "| Step 1-3:1 ratio <br> Step 2-2:1 ratio <br> Step 3-1:1 ratio <br> Step 4-off | Step 1-3.5:1 ratio "
    },
    {
      "type": "text",
      "section": "TABLE 23-11. Sample KDT Weaning Plan",
      "line": 8629,
      "preview": "Abbreviation: KDT, ketogenic diet therapy."
    },
    {
      "type": "heading",
      "level": 2,
      "section": "Helpful Resources",
      "line": 8631
    },
    {
      "type": "text",
      "section": "Helpful Resources",
      "line": 8633,
      "preview": "The following are helpful resources for clinicians who are treating patients with refractory epileps"
    },
    {
      "type": "text",
      "section": "Helpful Resources",
      "line": 8635,
      "preview": "- Keto Diet Calculator (https://www.ketodietcalculator.org)"
    },
    {
      "type": "text",
      "section": "Helpful Resources",
      "line": 8636,
      "preview": "- Charlie Foundation (https://charliefoundation.org)"
    },
    {
      "type": "text",
      "section": "Helpful Resources",
      "line": 8637,
      "preview": "- Matthew's Friends (https://www.matthewsfriends.org)"
    },
    {
      "type": "text",
      "section": "Helpful Resources",
      "line": 8638,
      "preview": "- Atkins for Seizures (https://atkinsforseizures.com)"
    },
    {
      "type": "text",
      "section": "Helpful Resources",
      "line": 8639,
      "preview": "- International Neurological Ketogenic Society (https://neuroketo.org)"
    },
    {
      "type": "text",
      "section": "Helpful Resources",
      "line": 8640,
      "preview": "- Devinsky O, Conway E, Schnabel Glick C. Epilepsy in Children: What Every Parent Needs to Know. Dem"
    },
    {
      "type": "text",
      "section": "Helpful Resources",
      "line": 8641,
      "preview": "- Whitmer E, Riether JL. Fighting Back with Fat: A Guide to Battling Epilepsy Through the Ketogenic "
    },
    {
      "type": "text",
      "section": "Helpful Resources",
      "line": 8642,
      "preview": "- Snyder D. Keto Kid: Helping Your Child Succeed on the Ketogenic Diet. Demos Health; 2006."
    },
    {
      "type": "text",
      "section": "Helpful Resources",
      "line": 8643,
      "preview": "- Martenz DM, Cramp L. The Keto Cookbook. Demos Health; 2011."
    },
    {
      "type": "text",
      "section": "Helpful Resources",
      "line": 8644,
      "preview": "- Kossoff EH, Turner Z, Cervenka MC, Barron BJ. Ketogenic Diet Therapies for Epilepsy and Other Cond"
    },
    {
      "type": "text",
      "section": "Helpful Resources",
      "line": 8645,
      "preview": "- Martenz DM, Zupec-Kania B. The Modified Keto Cookbook: Quick, Convenient GreatTasting Recipes for "
    },
    {
      "type": "text",
      "section": "Helpful Resources",
      "line": 8646,
      "preview": "- Bergqvist C, Vondran P, Chee C, Walker M, Groveman S, Fenton C; Ketogenic Diet Team, Children's Ho"
    },
    {
      "type": "heading",
      "level": 2,
      "section": "References",
      "line": 8649
    },
    {
      "type": "text",
      "section": "References",
      "line": 8651,
      "preview": "--- page 451 ---"
    },
    {
      "type": "text",
      "section": "References",
      "line": 8653,
      "preview": "1. Wheless JW. History of the ketogenic diet. Epilepsia. 2008;49(suppl 8):3-5. https://doi.org/10.11"
    },
    {
      "type": "text",
      "section": "References",
      "line": 8654,
      "preview": "2. Kossoff EH, Zupec-Kania BA, Auvin S, et al; Charlie Foundation; Matthew's Friends; Practice Commi"
    },
    {
      "type": "text",
      "section": "References",
      "line": 8655,
      "preview": "3. Andrewski E, Cheng K, Vanderpool C. Nutritional deficiencies in vegetarian, gluten-free, and keto"
    },
    {
      "type": "text",
      "section": "References",
      "line": 8656,
      "preview": "4. Siegel BI, Johnson M, Dawson TE, et al. Reducing prescribing errors in hospitalized children on t"
    },
    {
      "type": "text",
      "section": "References",
      "line": 8657,
      "preview": "5. van der Louw E, van den Hurk D, Neal E, et al. Ketogenic diet guidelines for infants with refract"
    },
    {
      "type": "text",
      "section": "References",
      "line": 8658,
      "preview": "6. Cobo NH, Sankar R, Murata KK, Sewak SL, Kezele MA, Matsumoto JH. The ketogenic diet as broad-spec"
    },
    {
      "type": "text",
      "section": "References",
      "line": 8659,
      "preview": "7. van der Louw E, Aldaz V, Harvey J, et al; Review Group. Optimal clinical management of children r"
    },
    {
      "type": "text",
      "section": "References",
      "line": 8660,
      "preview": "8. Kossoff EH, Turner Z, Cervenka MC, Barron BJ. Ketogenic Diet Therapies for Epilepsy and Other Con"
    },
    {
      "type": "text",
      "section": "References",
      "line": 8662,
      "preview": "--- page 452 ---"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "24",
      "line": 8664
    },
    {
      "type": "heading",
      "level": 2,
      "section": "Short Bowel Syndrome",
      "line": 8666
    },
    {
      "type": "text",
      "section": "Short Bowel Syndrome",
      "line": 8668,
      "preview": "Anam Bashir, MD<br>Praveen S. Goday, MBBS"
    },
    {
      "type": "heading",
      "level": 2,
      "section": "Introduction",
      "line": 8670
    },
    {
      "type": "text",
      "section": "Introduction",
      "line": 8672,
      "preview": "Pediatric intestinal failure is the reduction of functional intestinal mass below that which can sus"
    },
    {
      "type": "heading",
      "level": 2,
      "section": "Assessment and Nutrient Requirements",
      "line": 8674
    },
    {
      "type": "text",
      "section": "Assessment and Nutrient Requirements",
      "line": 8676,
      "preview": "--- page 453 ---"
    },
    {
      "type": "text",
      "section": "Assessment and Nutrient Requirements",
      "line": 8678,
      "preview": "Nutrition rehabilitation is key to promoting adaptation in children with SBS. Children with SBS are "
    },
    {
      "type": "text",
      "section": "Assessment and Nutrient Requirements",
      "line": 8680,
      "preview": "- History: Evaluation of intake (oral nutrition, EN, parenteral nutrition [PN]) and evaluation of ou"
    },
    {
      "type": "text",
      "section": "Assessment and Nutrient Requirements",
      "line": 8681,
      "preview": "- Physical exam: Anthropometrics (height/length, weight, weight for age, body mass index) and a nutr"
    },
    {
      "type": "text",
      "section": "Assessment and Nutrient Requirements",
      "line": 8682,
      "preview": "- Laboratory assessment: Table 24-1 outlines the laboratory monitoring in patients with SBS."
    },
    {
      "type": "text",
      "section": "Assessment and Nutrient Requirements",
      "line": 8684,
      "preview": "TABLE 24-1. Laboratory Monitoring in Patients With Short Bowel Syndrome"
    },
    {
      "type": "table",
      "section": "Assessment and Nutrient Requirements",
      "line": 8686,
      "preview": "| Laboratory Test | Monitoring on PN | Monitoring <br> on EN |"
    },
    {
      "type": "table",
      "section": "Assessment and Nutrient Requirements",
      "line": 8687,
      "preview": "| :-- | :-- | :-- |"
    },
    {
      "type": "table",
      "section": "Assessment and Nutrient Requirements",
      "line": 8688,
      "preview": "| CBC | On initiating PN, with every <br> change in PN, every 1-3 mo <br> while on PN | Every 6 mo |"
    },
    {
      "type": "table",
      "section": "Assessment and Nutrient Requirements",
      "line": 8689,
      "preview": "| Iron studies | Every 3 mo | Every 6-12 <br> mo |"
    },
    {
      "type": "table",
      "section": "Assessment and Nutrient Requirements",
      "line": 8690,
      "preview": "| TPN profile (electrolytes, serum <br> urea nitrogen, creatinine, glucose, <br> phosphorous, calciu"
    },
    {
      "type": "table",
      "section": "Assessment and Nutrient Requirements",
      "line": 8691,
      "preview": "| Urine electrolytes/urine specific <br> gravity | On initiating PN, with every <br> change in PN, w"
    },
    {
      "type": "table",
      "section": "Assessment and Nutrient Requirements",
      "line": 8692,
      "preview": "| Vitamin D | 3 mo after starting PN, then <br> every 3-6 mo | Every 6 mo |"
    },
    {
      "type": "table",
      "section": "Assessment and Nutrient Requirements",
      "line": 8693,
      "preview": "| Vitamin B12 | Every 6 mo | Anatomy <br> dependent |"
    },
    {
      "type": "table",
      "section": "Assessment and Nutrient Requirements",
      "line": 8694,
      "preview": "| Vitamins A, E, K | 3-6 mo after starting PN, then <br> every 3-6 mo | Anatomy <br> dependent |"
    },
    {
      "type": "text",
      "section": "Assessment and Nutrient Requirements",
      "line": 8696,
      "preview": "Abbreviations: CBC, complete blood cell count; EN, enteral nutrition; PN, parenteral nutrition; TPN,"
    },
    {
      "type": "text",
      "section": "Assessment and Nutrient Requirements",
      "line": 8698,
      "preview": "--- page 454 ---"
    },
    {
      "type": "text",
      "section": "Assessment and Nutrient Requirements",
      "line": 8700,
      "preview": "In addition to these, the prothrombin time/partial thromboplastin time, copper, zinc, selenium, chro"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "Implementation of Nutrition Plan and Monitoring",
      "line": 8702
    },
    {
      "type": "text",
      "section": "Implementation of Nutrition Plan and Monitoring",
      "line": 8704,
      "preview": "Maximizing enteral/oral feeds and lowering dependence on PN should be the goal of management in chil"
    },
    {
      "type": "heading",
      "level": 2,
      "section": "Nutrition Prescription",
      "line": 8706
    },
    {
      "type": "text",
      "section": "Nutrition Prescription",
      "line": 8708,
      "preview": "Daily energy intake of infants with SBS is most often higher than 100$140 \\mathrm{kcal} / \\mathrm{kg"
    },
    {
      "type": "text",
      "section": "Nutrition Prescription",
      "line": 8710,
      "preview": "The total energy needs are ultimately guided by gain in weight and length. PN energy needs are less "
    },
    {
      "type": "heading",
      "level": 2,
      "section": "Enteral Nutrition",
      "line": 8712
    },
    {
      "type": "text",
      "section": "Enteral Nutrition",
      "line": 8714,
      "preview": "EN should be started as soon as clinically appropriate after a resection. At the very least, minimal"
    },
    {
      "type": "text",
      "section": "Enteral Nutrition",
      "line": 8716,
      "preview": "Human milk is recommended in infants because it contains immunoglobulins, prebiotics, and growth fac"
    },
    {
      "type": "text",
      "section": "Enteral Nutrition",
      "line": 8718,
      "preview": "--- page 455 ---"
    },
    {
      "type": "text",
      "section": "Enteral Nutrition",
      "line": 8720,
      "preview": "preferred because children with SBS absorb nutrients better if they are broken down. ${ }^{2}$"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "Mode of Feeds",
      "line": 8722
    },
    {
      "type": "text",
      "section": "Mode of Feeds",
      "line": 8724,
      "preview": "Feeds can be given as continuous, bolus, or a combination of both. Bolus feeds mimic physiologic fee"
    },
    {
      "type": "heading",
      "level": 2,
      "section": "Advancement of Enteral Nutrition",
      "line": 8726
    },
    {
      "type": "text",
      "section": "Advancement of Enteral Nutrition",
      "line": 8728,
      "preview": "The volume of enteral feeds should be increased slowly to allow the intestine to adapt. Monitoring o"
    },
    {
      "type": "text",
      "section": "Advancement of Enteral Nutrition",
      "line": 8730,
      "preview": "Solids can be introduced at 4-6 months of age. ${ }^{2}$ New foods should be introduced after 3-5 da"
    },
    {
      "type": "text",
      "section": "Advancement of Enteral Nutrition",
      "line": 8732,
      "preview": "- Pectin should be $3 \\%$ of feed volume."
    },
    {
      "type": "text",
      "section": "Advancement of Enteral Nutrition",
      "line": 8733,
      "preview": "- Pureed green beans should be provided at 4 oz per 8 -oz formula, bringing the $30-\\mathrm{kcal} / "
    },
    {
      "type": "text",
      "section": "Advancement of Enteral Nutrition",
      "line": 8734,
      "preview": "- Guar gum should be provided at $20 \\mathrm{~g} / \\mathrm{L}$."
    },
    {
      "type": "text",
      "section": "Advancement of Enteral Nutrition",
      "line": 8736,
      "preview": "There are some data indicating that patients older than 1 year of age can benefit from food-based fo"
    },
    {
      "type": "text",
      "section": "Advancement of Enteral Nutrition",
      "line": 8738,
      "preview": "--- page 456 ---"
    },
    {
      "type": "text",
      "section": "Advancement of Enteral Nutrition",
      "line": 8740,
      "preview": "are absorbed better, do not require micelle formation, and bypass the need for lymphatic continuity."
    },
    {
      "type": "text",
      "section": "Advancement of Enteral Nutrition",
      "line": 8742,
      "preview": "Limiting simple sugars like juices and fruits is a general rule because of osmotic diarrhea. Complex"
    },
    {
      "type": "text",
      "section": "Advancement of Enteral Nutrition",
      "line": 8744,
      "preview": "TABLE 24-2. Simple and Complex Carbohydrates"
    },
    {
      "type": "table",
      "section": "Advancement of Enteral Nutrition",
      "line": 8746,
      "preview": "| Type of Carbohydrate | Source |"
    },
    {
      "type": "table",
      "section": "Advancement of Enteral Nutrition",
      "line": 8747,
      "preview": "| :--: | :--: |"
    },
    {
      "type": "table",
      "section": "Advancement of Enteral Nutrition",
      "line": 8748,
      "preview": "| Simple carbohydrates |  |"
    },
    {
      "type": "table",
      "section": "Advancement of Enteral Nutrition",
      "line": 8749,
      "preview": "| Monosaccharides <br> - Glucose <br> - Galactose <br> - Fructose | Honey, fruit, fruit juice, maple"
    },
    {
      "type": "table",
      "section": "Advancement of Enteral Nutrition",
      "line": 8750,
      "preview": "| Disaccharides <br> - Sucrose (glucose + fructose) <br> - Lactose (glucose + galactose) | Table sug"
    },
    {
      "type": "table",
      "section": "Advancement of Enteral Nutrition",
      "line": 8751,
      "preview": "| Complex carbohydrates |  |"
    },
    {
      "type": "table",
      "section": "Advancement of Enteral Nutrition",
      "line": 8752,
      "preview": "| Polysaccharides <br> - Glycogen <br> - Amylose <br> - Amylopectin <br> - Soluble fiber <br> - Inso"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "Parenteral Nutrition",
      "line": 8754
    },
    {
      "type": "text",
      "section": "Parenteral Nutrition",
      "line": 8756,
      "preview": "PN is needed to support the partial or complete energy needs of patients with SBS until they achieve"
    },
    {
      "type": "text",
      "section": "Parenteral Nutrition",
      "line": 8758,
      "preview": "--- page 457 ---"
    },
    {
      "type": "text",
      "section": "Parenteral Nutrition",
      "line": 8760,
      "preview": "- Blended lipid injectable emulsions (ILEs; eg, soy, MCT, olive, fish oil-based ILEs) are preferred "
    },
    {
      "type": "text",
      "section": "Parenteral Nutrition",
      "line": 8761,
      "preview": "- Iron is not compatible with 3-in-1 PN preparations and needs to be given either orally/enterally o"
    },
    {
      "type": "text",
      "section": "Parenteral Nutrition",
      "line": 8762,
      "preview": "- Multivitamin and micronutrient additives are available based on the age and weight of the patient."
    },
    {
      "type": "text",
      "section": "Parenteral Nutrition",
      "line": 8764,
      "preview": "PN can be started over 24 hours, but \"cycling,\" which is the process of building in time off PN duri"
    },
    {
      "type": "text",
      "section": "Parenteral Nutrition",
      "line": 8766,
      "preview": "During the transition period from PN to EN and after successful transition, patients are at risk of "
    },
    {
      "type": "heading",
      "level": 1,
      "section": "References",
      "line": 8768
    },
    {
      "type": "text",
      "section": "References",
      "line": 8770,
      "preview": "1. Modi BP, Galloway DP, Gura K, et al. ASPEN definitions in pediatric intestinal failure. JPEN J Pa"
    },
    {
      "type": "text",
      "section": "References",
      "line": 8771,
      "preview": "2. Channabasappa N, Girouard S, Nguyen V, Piper H. Enteral nutrition in pediatric shortbowel syndrom"
    },
    {
      "type": "text",
      "section": "References",
      "line": 8772,
      "preview": "3. Patil R, King E, Rudolph J. Intestinal failure. In: Goday PS, Walia C, eds. Pediatric Nutrition f"
    },
    {
      "type": "text",
      "section": "References",
      "line": 8773,
      "preview": "4. Youssef NN, Mezoff AG, Carter BA, Cole CR. Medical update and potential advances in the treatment"
    },
    {
      "type": "text",
      "section": "References",
      "line": 8774,
      "preview": "5. Ubesie AC, Kocoshis SA, Mezoff AG, Henderson CJ, Helmrath MA, Cole CR. Multiple micronutrient def"
    },
    {
      "type": "text",
      "section": "References",
      "line": 8776,
      "preview": "--- page 458 ---"
    },
    {
      "type": "text",
      "section": "References",
      "line": 8778,
      "preview": "to enteral nutrition. $J$ Pediatr. 2013;163(6):1692-1696."
    },
    {
      "type": "text",
      "section": "References",
      "line": 8779,
      "preview": "https://doi.org/10.1016/j.jpeds.2013.07.015"
    },
    {
      "type": "text",
      "section": "References",
      "line": 8781,
      "preview": "--- page 459 ---"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "25",
      "line": 8783
    },
    {
      "type": "heading",
      "level": 2,
      "section": "Weight Management and Obesity",
      "line": 8785
    },
    {
      "type": "text",
      "section": "Weight Management and Obesity",
      "line": 8787,
      "preview": "Jessica Graumann, MS, RDN, LD"
    },
    {
      "type": "heading",
      "level": 2,
      "section": "Introduction",
      "line": 8789
    },
    {
      "type": "text",
      "section": "Introduction",
      "line": 8791,
      "preview": "Childhood obesity continues to be an ongoing health problem affecting the United States, with 1 out "
    },
    {
      "type": "heading",
      "level": 2,
      "section": "Assessment and Nutrient Requirements",
      "line": 8793
    },
    {
      "type": "text",
      "section": "Assessment and Nutrient Requirements",
      "line": 8795,
      "preview": "Anthropometrics should be assessed including height, weight, and body mass index (BMI). BMI is a met"
    },
    {
      "type": "text",
      "section": "Assessment and Nutrient Requirements",
      "line": 8797,
      "preview": "--- page 460 ---"
    },
    {
      "type": "text",
      "section": "Assessment and Nutrient Requirements",
      "line": 8799,
      "preview": "$$"
    },
    {
      "type": "text",
      "section": "Assessment and Nutrient Requirements",
      "line": 8800,
      "preview": "\\text { BMI }=(\\text { weight in kilograms/height in centimeters squared }) \\times 10,000"
    },
    {
      "type": "text",
      "section": "Assessment and Nutrient Requirements",
      "line": 8801,
      "preview": "$$"
    },
    {
      "type": "text",
      "section": "Assessment and Nutrient Requirements",
      "line": 8803,
      "preview": "$$"
    },
    {
      "type": "text",
      "section": "Assessment and Nutrient Requirements",
      "line": 8804,
      "preview": "\\text { BMI }=(\\text { weight in pounds/height in inches squared }) \\times 703"
    },
    {
      "type": "text",
      "section": "Assessment and Nutrient Requirements",
      "line": 8805,
      "preview": "$$"
    },
    {
      "type": "text",
      "section": "Assessment and Nutrient Requirements",
      "line": 8807,
      "preview": "Anthropometrics including height, weight, and BMI are plotted on ageand sex-specific growth charts f"
    },
    {
      "type": "text",
      "section": "Assessment and Nutrient Requirements",
      "line": 8809,
      "preview": "- Overweight: BMI between 85th and 94th percentile"
    },
    {
      "type": "text",
      "section": "Assessment and Nutrient Requirements",
      "line": 8810,
      "preview": "- Obesity: BMI greater than or equal to the 95th percentile"
    },
    {
      "type": "text",
      "section": "Assessment and Nutrient Requirements",
      "line": 8811,
      "preview": "- Severe obesity: BMI greater than the 99th percentile"
    },
    {
      "type": "text",
      "section": "Assessment and Nutrient Requirements",
      "line": 8813,
      "preview": "A more specific classification divides obesity into 3 classes ${ }^{10,11}$ :"
    },
    {
      "type": "text",
      "section": "Assessment and Nutrient Requirements",
      "line": 8815,
      "preview": "- Class I obesity: greater than or equal to the 95 th percentile"
    },
    {
      "type": "text",
      "section": "Assessment and Nutrient Requirements",
      "line": 8816,
      "preview": "- Class II obesity: greater than or equal to $120 \\%$ of the 95 th percentile"
    },
    {
      "type": "text",
      "section": "Assessment and Nutrient Requirements",
      "line": 8817,
      "preview": "- Class III obesity: greater than or equal to $140 \\%$ of the 95 th percentile"
    },
    {
      "type": "text",
      "section": "Assessment and Nutrient Requirements",
      "line": 8819,
      "preview": "If a child has obesity, further evaluation is needed and should include a history assessment (Exhibi"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "EXHIBIT 25-1. History Assessment",
      "line": 8821
    },
    {
      "type": "text",
      "section": "EXHIBIT 25-1. History Assessment",
      "line": 8823,
      "preview": "Weight History: Review the child's rate of weight gain and age at onset of obesity."
    },
    {
      "type": "text",
      "section": "EXHIBIT 25-1. History Assessment",
      "line": 8824,
      "preview": "Diet History: This information helps to identify targets for change and should include information a"
    },
    {
      "type": "text",
      "section": "EXHIBIT 25-1. History Assessment",
      "line": 8826,
      "preview": "Activity: Evaluate child's level of activity during structured (sports and physical conditioning) an"
    },
    {
      "type": "text",
      "section": "EXHIBIT 25-1. History Assessment",
      "line": 8828,
      "preview": "--- page 461 ---"
    },
    {
      "type": "text",
      "section": "EXHIBIT 25-1. History Assessment",
      "line": 8830,
      "preview": "Sleep: Assess sleep habits including duration, quality, and schedule, as well as symptoms of sleep d"
    },
    {
      "type": "text",
      "section": "EXHIBIT 25-1. History Assessment",
      "line": 8832,
      "preview": "Family History: Inquire about first- and second-degree relatives' history of obesity and common como"
    },
    {
      "type": "text",
      "section": "EXHIBIT 25-1. History Assessment",
      "line": 8833,
      "preview": "${ }^{a}$ Krebs NF, Himes JH, Jacobson D, Nicklas TA, Guilday P, Styne D. Assessment of child and ad"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "EXHIBIT 25-2. Physical Examination for Childhood Obesity",
      "line": 8835
    },
    {
      "type": "text",
      "section": "EXHIBIT 25-2. Physical Examination for Childhood Obesity",
      "line": 8837,
      "preview": "1. Anthropometrics"
    },
    {
      "type": "text",
      "section": "EXHIBIT 25-2. Physical Examination for Childhood Obesity",
      "line": 8838,
      "preview": "a. Short stature"
    },
    {
      "type": "text",
      "section": "EXHIBIT 25-2. Physical Examination for Childhood Obesity",
      "line": 8839,
      "preview": "b. Unexpected decrease in height velocity"
    },
    {
      "type": "text",
      "section": "EXHIBIT 25-2. Physical Examination for Childhood Obesity",
      "line": 8840,
      "preview": "2. Vital signs"
    },
    {
      "type": "text",
      "section": "EXHIBIT 25-2. Physical Examination for Childhood Obesity",
      "line": 8841,
      "preview": "a. Blood pressure"
    },
    {
      "type": "text",
      "section": "EXHIBIT 25-2. Physical Examination for Childhood Obesity",
      "line": 8842,
      "preview": "b. Pulse"
    },
    {
      "type": "text",
      "section": "EXHIBIT 25-2. Physical Examination for Childhood Obesity",
      "line": 8843,
      "preview": "3. Skin"
    },
    {
      "type": "text",
      "section": "EXHIBIT 25-2. Physical Examination for Childhood Obesity",
      "line": 8844,
      "preview": "a. Acanthosis nigricans"
    },
    {
      "type": "text",
      "section": "EXHIBIT 25-2. Physical Examination for Childhood Obesity",
      "line": 8845,
      "preview": "b. Excessive acne"
    },
    {
      "type": "text",
      "section": "EXHIBIT 25-2. Physical Examination for Childhood Obesity",
      "line": 8846,
      "preview": "4. Head, eyes, ears, nose, and throat"
    },
    {
      "type": "text",
      "section": "EXHIBIT 25-2. Physical Examination for Childhood Obesity",
      "line": 8847,
      "preview": "a. Enlarged tonsils and abnormal breathing"
    },
    {
      "type": "text",
      "section": "EXHIBIT 25-2. Physical Examination for Childhood Obesity",
      "line": 8848,
      "preview": "b. Enlarged or swollen thyroid gland (goiter)"
    },
    {
      "type": "text",
      "section": "EXHIBIT 25-2. Physical Examination for Childhood Obesity",
      "line": 8849,
      "preview": "c. Papilledema or optic disc swelling"
    },
    {
      "type": "text",
      "section": "EXHIBIT 25-2. Physical Examination for Childhood Obesity",
      "line": 8850,
      "preview": "5. Chest and abdomen"
    },
    {
      "type": "text",
      "section": "EXHIBIT 25-2. Physical Examination for Childhood Obesity",
      "line": 8851,
      "preview": "a. Irregular rhythms or sounds"
    },
    {
      "type": "text",
      "section": "EXHIBIT 25-2. Physical Examination for Childhood Obesity",
      "line": 8852,
      "preview": "b. Wheezing (asthma)"
    },
    {
      "type": "text",
      "section": "EXHIBIT 25-2. Physical Examination for Childhood Obesity",
      "line": 8853,
      "preview": "c. Right-upper-quadrant tenderness"
    },
    {
      "type": "text",
      "section": "EXHIBIT 25-2. Physical Examination for Childhood Obesity",
      "line": 8854,
      "preview": "d. Hepatomegaly or enlargement of liver"
    },
    {
      "type": "text",
      "section": "EXHIBIT 25-2. Physical Examination for Childhood Obesity",
      "line": 8855,
      "preview": "6. Secondary sexual development"
    },
    {
      "type": "text",
      "section": "EXHIBIT 25-2. Physical Examination for Childhood Obesity",
      "line": 8856,
      "preview": "a. Premature/abnormal puberty"
    },
    {
      "type": "text",
      "section": "EXHIBIT 25-2. Physical Examination for Childhood Obesity",
      "line": 8857,
      "preview": "7. Musculoskeletal"
    },
    {
      "type": "text",
      "section": "EXHIBIT 25-2. Physical Examination for Childhood Obesity",
      "line": 8858,
      "preview": "a. Limited range of motion or pain within the lower extremities including hips, knees, and ankles"
    },
    {
      "type": "heading",
      "level": 2,
      "section": "Physical Examination",
      "line": 8860
    },
    {
      "type": "text",
      "section": "Physical Examination",
      "line": 8862,
      "preview": "The physical examination should be used to evaluate comorbidities and possible causes of the obesity"
    },
    {
      "type": "text",
      "section": "Physical Examination",
      "line": 8864,
      "preview": "--- page 462 ---"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "Laboratory Data",
      "line": 8866
    },
    {
      "type": "text",
      "section": "Laboratory Data",
      "line": 8868,
      "preview": "Laboratory tests recommended are determined by the classification of obesity, physical examination, "
    },
    {
      "type": "heading",
      "level": 2,
      "section": "TABLE 25-1. Laboratory Assessment for Childhood and Adolescent Obesity",
      "line": 8870
    },
    {
      "type": "table",
      "section": "TABLE 25-1. Laboratory Assessment for Childhood and Adolescent Obesity",
      "line": 8872,
      "preview": "| BMI Percentile for Age <br> and Sex | Risk Factors | Recommended <br> Laboratory Test |"
    },
    {
      "type": "table",
      "section": "TABLE 25-1. Laboratory Assessment for Childhood and Adolescent Obesity",
      "line": 8873,
      "preview": "| :-- | :-- | :-- |"
    },
    {
      "type": "table",
      "section": "TABLE 25-1. Laboratory Assessment for Childhood and Adolescent Obesity",
      "line": 8874,
      "preview": "| 85th-94th | None | Fasting lipid panel |"
    },
    {
      "type": "table",
      "section": "TABLE 25-1. Laboratory Assessment for Childhood and Adolescent Obesity",
      "line": 8875,
      "preview": "| 85th-94th | 10 y old or older with other <br> risk factors | - Fasting lipid panel <br> - AST <br>"
    },
    {
      "type": "table",
      "section": "TABLE 25-1. Laboratory Assessment for Childhood and Adolescent Obesity",
      "line": 8876,
      "preview": "| $\\geq 95$ th | All patients 10 y of age or <br> older | - Fasting lipid panel <br> - AST <br> - AL"
    },
    {
      "type": "text",
      "section": "TABLE 25-1. Laboratory Assessment for Childhood and Adolescent Obesity",
      "line": 8878,
      "preview": "Abbreviations: ALT, alanine aminotransferase; AST, aspartate aminotransferase; BMI, body mass index."
    },
    {
      "type": "text",
      "section": "TABLE 25-1. Laboratory Assessment for Childhood and Adolescent Obesity",
      "line": 8879,
      "preview": "Reproduced with permission from the Academy of Nutrition and Dietetics from Mullen MC, Shield J. Aca"
    },
    {
      "type": "heading",
      "level": 2,
      "section": "Implementation of Nutrition Plan and Monitoring",
      "line": 8881
    },
    {
      "type": "text",
      "section": "Implementation of Nutrition Plan and Monitoring",
      "line": 8883,
      "preview": "Although there are numerous diets available for the general public, scientific evidence shows weight"
    },
    {
      "type": "text",
      "section": "Implementation of Nutrition Plan and Monitoring",
      "line": 8885,
      "preview": "--- page 463 ---"
    },
    {
      "type": "text",
      "section": "Implementation of Nutrition Plan and Monitoring",
      "line": 8887,
      "preview": "- Plan what to eat in advance."
    },
    {
      "type": "text",
      "section": "Implementation of Nutrition Plan and Monitoring",
      "line": 8888,
      "preview": "- Eat 3 daily meals that are balanced."
    },
    {
      "type": "text",
      "section": "Implementation of Nutrition Plan and Monitoring",
      "line": 8889,
      "preview": "- Do not skip meals."
    },
    {
      "type": "text",
      "section": "Implementation of Nutrition Plan and Monitoring",
      "line": 8890,
      "preview": "- Make physical activity a daily part of the routine, aiming for more than $1 \\mathrm{~h} / \\mathrm{"
    },
    {
      "type": "text",
      "section": "Implementation of Nutrition Plan and Monitoring",
      "line": 8891,
      "preview": "- Decrease sedentary behavior, such as watching television and playing video games, to fewer than $2"
    },
    {
      "type": "text",
      "section": "Implementation of Nutrition Plan and Monitoring",
      "line": 8892,
      "preview": "- Make physical activity fun and age-appropriate for each individual child."
    },
    {
      "type": "text",
      "section": "Implementation of Nutrition Plan and Monitoring",
      "line": 8894,
      "preview": "A staged approach to weight management in children and adolescents is provided in Table 25-2. Specif"
    },
    {
      "type": "text",
      "section": "Implementation of Nutrition Plan and Monitoring",
      "line": 8896,
      "preview": "TABLE 25-2. Staged Approach to Weight Management in Children and Adolescents"
    },
    {
      "type": "table",
      "section": "Implementation of Nutrition Plan and Monitoring",
      "line": 8898,
      "preview": "| Stage | Description |"
    },
    {
      "type": "table",
      "section": "Implementation of Nutrition Plan and Monitoring",
      "line": 8899,
      "preview": "| :-- | :-- |"
    },
    {
      "type": "table",
      "section": "Implementation of Nutrition Plan and Monitoring",
      "line": 8900,
      "preview": "| 1: Plus-implemented in primary care <br> setting | Healthy lifestyle changes including 5 or <br> m"
    },
    {
      "type": "table",
      "section": "Implementation of Nutrition Plan and Monitoring",
      "line": 8901,
      "preview": "| 2: Structured Weight Management- <br> implemented in primary care setting <br> with referral to di"
    },
    {
      "type": "table",
      "section": "Implementation of Nutrition Plan and Monitoring",
      "line": 8902,
      "preview": "| 3: Comprehensive Multidisciplinary <br> Intervention-implemented within <br> primary care setting "
    },
    {
      "type": "table",
      "section": "Implementation of Nutrition Plan and Monitoring",
      "line": 8903,
      "preview": "| 4: Tertiary Care Intervention- <br> implemented in a pediatric weight <br> management center with "
    },
    {
      "type": "text",
      "section": "Implementation of Nutrition Plan and Monitoring",
      "line": 8905,
      "preview": "Adapted with permission from the American Academy of Pediatrics from Spear BS, Barlow SE, Ervin C, e"
    },
    {
      "type": "text",
      "section": "Implementation of Nutrition Plan and Monitoring",
      "line": 8906,
      "preview": "https://doi.org/10.1542/peds.2007-2329F"
    },
    {
      "type": "text",
      "section": "Implementation of Nutrition Plan and Monitoring",
      "line": 8908,
      "preview": "--- page 464 ---"
    },
    {
      "type": "text",
      "section": "Implementation of Nutrition Plan and Monitoring",
      "line": 8910,
      "preview": "TABLE 25-3. Weight Recommendations According to Age and BMI Percentile"
    },
    {
      "type": "table",
      "section": "Implementation of Nutrition Plan and Monitoring",
      "line": 8912,
      "preview": "| Age: 2-5 y |  |"
    },
    {
      "type": "table",
      "section": "Implementation of Nutrition Plan and Monitoring",
      "line": 8913,
      "preview": "| :--: | :--: |"
    },
    {
      "type": "table",
      "section": "Implementation of Nutrition Plan and Monitoring",
      "line": 8914,
      "preview": "| $\\begin{aligned} & \\text { BMI } \\\\ & 85 \\mathrm{th}- \\\\ & 94 \\mathrm{th} \\\\ & \\text { percentile "
    },
    {
      "type": "table",
      "section": "Implementation of Nutrition Plan and Monitoring",
      "line": 8915,
      "preview": "| $\\mathrm{BMI} \\geq$ <br> 95th <br> percentile | Weight maintenance until BMI is $<85$ th percentil"
    },
    {
      "type": "table",
      "section": "Implementation of Nutrition Plan and Monitoring",
      "line": 8916,
      "preview": "| Age: 6-11 y |  |"
    },
    {
      "type": "table",
      "section": "Implementation of Nutrition Plan and Monitoring",
      "line": 8917,
      "preview": "| $\\begin{aligned} & \\text { BMI } \\\\ & 85 \\mathrm{th}- \\\\ & 94 \\mathrm{th} \\\\ & \\text { percentile "
    },
    {
      "type": "table",
      "section": "Implementation of Nutrition Plan and Monitoring",
      "line": 8918,
      "preview": "| $\\begin{aligned} & \\text { BMI } \\\\ & 95 \\mathrm{th}- \\\\ & 98 \\mathrm{th} \\\\ & \\text { percentile "
    },
    {
      "type": "table",
      "section": "Implementation of Nutrition Plan and Monitoring",
      "line": 8919,
      "preview": "| $\\mathrm{BMI} \\geq$ <br> 99th <br> percentile | Weight loss not to exceed average of $2 \\mathrm{lb"
    },
    {
      "type": "table",
      "section": "Implementation of Nutrition Plan and Monitoring",
      "line": 8920,
      "preview": "| Age: 12-18 y |  |"
    },
    {
      "type": "table",
      "section": "Implementation of Nutrition Plan and Monitoring",
      "line": 8921,
      "preview": "| $\\begin{aligned} & \\text { BMI } \\\\ & 85 \\mathrm{th}- \\\\ & 94 \\mathrm{th} \\\\ & \\text { percentile "
    },
    {
      "type": "table",
      "section": "Implementation of Nutrition Plan and Monitoring",
      "line": 8922,
      "preview": "| $\\begin{aligned} & \\text { BMI } \\\\ & 95 \\mathrm{th}- \\\\ & 98 \\mathrm{th} \\\\ & \\text { percentile "
    },
    {
      "type": "table",
      "section": "Implementation of Nutrition Plan and Monitoring",
      "line": 8923,
      "preview": "| $\\mathrm{BMI} \\geq$ <br> 99th <br> percentile | Weight loss not to exceed average of $2 \\mathrm{lb"
    },
    {
      "type": "text",
      "section": "Implementation of Nutrition Plan and Monitoring",
      "line": 8925,
      "preview": "Abbreviation: BMI, body mass index."
    },
    {
      "type": "text",
      "section": "Implementation of Nutrition Plan and Monitoring",
      "line": 8926,
      "preview": "Reproduced with permission from the American Academy of Pediatrics from Spear BS, Barlow SE, Ervin C"
    },
    {
      "type": "text",
      "section": "Implementation of Nutrition Plan and Monitoring",
      "line": 8928,
      "preview": "--- page 465 ---"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "Diets Designed for Use in Children and Adolescents",
      "line": 8930
    },
    {
      "type": "heading",
      "level": 2,
      "section": "Balanced-Macronutrient, Low-Kilocalorie Diet",
      "line": 8932
    },
    {
      "type": "text",
      "section": "Balanced-Macronutrient, Low-Kilocalorie Diet",
      "line": 8934,
      "preview": "Within a multicomponent weight management program, reduced calorie intake (no less than 1200 kcal ) "
    },
    {
      "type": "text",
      "section": "Balanced-Macronutrient, Low-Kilocalorie Diet",
      "line": 8936,
      "preview": "Weight Maintenance TEE for Boys Ages 3-18 Years Who Are Overweight. To calculate the weight maintena"
    },
    {
      "type": "text",
      "section": "Balanced-Macronutrient, Low-Kilocalorie Diet",
      "line": 8937,
      "preview": "(Recommended dietary allowance [RDA] for age and weight in $\\mathrm{kcal} / \\mathrm{kg}$ $\\times$ id"
    },
    {
      "type": "text",
      "section": "Balanced-Macronutrient, Low-Kilocalorie Diet",
      "line": 8939,
      "preview": "PA is the physical activity coefficient:"
    },
    {
      "type": "text",
      "section": "Balanced-Macronutrient, Low-Kilocalorie Diet",
      "line": 8941,
      "preview": "$$"
    },
    {
      "type": "text",
      "section": "Balanced-Macronutrient, Low-Kilocalorie Diet",
      "line": 8942,
      "preview": "\\begin{gathered}"
    },
    {
      "type": "text",
      "section": "Balanced-Macronutrient, Low-Kilocalorie Diet",
      "line": 8943,
      "preview": "\\text { PA }=1.00 \\text { if the physical activity level (PAL) is } \\geq 1.0 \\\\"
    },
    {
      "type": "text",
      "section": "Balanced-Macronutrient, Low-Kilocalorie Diet",
      "line": 8944,
      "preview": "\\text { and }<1.4 \\text { (sedentary) } \\\\"
    },
    {
      "type": "text",
      "section": "Balanced-Macronutrient, Low-Kilocalorie Diet",
      "line": 8945,
      "preview": "\\text { PA }=1.12 \\text { if PAL is } \\geq 1.4 \\text { and }<1.6 \\text { (low active) } \\\\"
    },
    {
      "type": "text",
      "section": "Balanced-Macronutrient, Low-Kilocalorie Diet",
      "line": 8946,
      "preview": "\\text { PA }=1.24 \\text { if PAL is } \\geq 1.6 \\text { and }<1.9 \\text { (active) } \\\\"
    },
    {
      "type": "text",
      "section": "Balanced-Macronutrient, Low-Kilocalorie Diet",
      "line": 8947,
      "preview": "\\text { PA }=1.45 \\text { if PAL is } \\geq 1.9 \\text { and }<2.5 \\text { (very active) }"
    },
    {
      "type": "text",
      "section": "Balanced-Macronutrient, Low-Kilocalorie Diet",
      "line": 8948,
      "preview": "\\end{gathered}"
    },
    {
      "type": "text",
      "section": "Balanced-Macronutrient, Low-Kilocalorie Diet",
      "line": 8949,
      "preview": "$$"
    },
    {
      "type": "text",
      "section": "Balanced-Macronutrient, Low-Kilocalorie Diet",
      "line": 8951,
      "preview": "--- page 466 ---"
    },
    {
      "type": "text",
      "section": "Balanced-Macronutrient, Low-Kilocalorie Diet",
      "line": 8953,
      "preview": "Weight Maintenance TEE for Girls Ages 3-18 Years Who Are Overweight. To calculate the weight mainten"
    },
    {
      "type": "text",
      "section": "Balanced-Macronutrient, Low-Kilocalorie Diet",
      "line": 8955,
      "preview": "$$"
    },
    {
      "type": "text",
      "section": "Balanced-Macronutrient, Low-Kilocalorie Diet",
      "line": 8956,
      "preview": "\\begin{gathered}"
    },
    {
      "type": "text",
      "section": "Balanced-Macronutrient, Low-Kilocalorie Diet",
      "line": 8957,
      "preview": "\\text { TEE }=[389-(41.2 \\times \\text { age in years })] \\\\"
    },
    {
      "type": "text",
      "section": "Balanced-Macronutrient, Low-Kilocalorie Diet",
      "line": 8958,
      "preview": "+(P A \\times[(15.0 \\times \\text { weight in kilograms })+(701.6 \\times \\text { height in meters })])"
    },
    {
      "type": "text",
      "section": "Balanced-Macronutrient, Low-Kilocalorie Diet",
      "line": 8959,
      "preview": "P A=1.00 \\text { if PAL is } \\geq 1.0 \\text { and }<1.4 \\text { (sedentary) } \\\\"
    },
    {
      "type": "text",
      "section": "Balanced-Macronutrient, Low-Kilocalorie Diet",
      "line": 8960,
      "preview": "\\text { PA }=1.18 \\text { if PAL is } \\geq 1.4 \\text { and }<1.6 \\text { (low active) } \\\\"
    },
    {
      "type": "text",
      "section": "Balanced-Macronutrient, Low-Kilocalorie Diet",
      "line": 8961,
      "preview": "\\text { PA }=1.35 \\text { if PAL is } \\geq 1.6 \\text { and }<1.9 \\text { (active) } \\\\"
    },
    {
      "type": "text",
      "section": "Balanced-Macronutrient, Low-Kilocalorie Diet",
      "line": 8962,
      "preview": "\\text { PA }=1.60 \\text { if PAL is } \\geq 1.9 \\text { and }<2.5 \\text { (very active) }"
    },
    {
      "type": "text",
      "section": "Balanced-Macronutrient, Low-Kilocalorie Diet",
      "line": 8963,
      "preview": "\\end{gathered}"
    },
    {
      "type": "text",
      "section": "Balanced-Macronutrient, Low-Kilocalorie Diet",
      "line": 8964,
      "preview": "$$"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "MyPlate",
      "line": 8966
    },
    {
      "type": "text",
      "section": "MyPlate",
      "line": 8968,
      "preview": "MyPlate (https://www.myplate.gov/) was created to replace the Food Guide Pyramid and provide a guide"
    },
    {
      "type": "text",
      "section": "MyPlate",
      "line": 8970,
      "preview": "- Making half your plate fruits and vegetables"
    },
    {
      "type": "text",
      "section": "MyPlate",
      "line": 8971,
      "preview": "- Making at least half your grains whole grains"
    },
    {
      "type": "text",
      "section": "MyPlate",
      "line": 8972,
      "preview": "- Cutting back on sugary drinks and drinking more water"
    },
    {
      "type": "text",
      "section": "MyPlate",
      "line": 8974,
      "preview": "--- page 467 ---"
    },
    {
      "type": "text",
      "section": "MyPlate",
      "line": 8976,
      "preview": "TABLE 25-4. Estimated Daily Amounts of Food Groups Based on Calorie Range"
    },
    {
      "type": "table",
      "section": "MyPlate",
      "line": 8978,
      "preview": "| Food Group | $\\mathbf{1 0 0 0}$ cal | $\\mathbf{1 2 0 0}$ cal | $\\mathbf{1 4 0 0}$ cal | $\\mathbf{1"
    },
    {
      "type": "table",
      "section": "MyPlate",
      "line": 8979,
      "preview": "| :-- | :-- | :-- | :-- | :-- | :-- | :-- |"
    },
    {
      "type": "table",
      "section": "MyPlate",
      "line": 8980,
      "preview": "| Fruits | 1 cup | 1 cup | 1.5 cups | 1.5 cups | 1.5 cups | 2 cups |"
    },
    {
      "type": "table",
      "section": "MyPlate",
      "line": 8981,
      "preview": "| Vegetables | 1 cup | 1.5 cups | 1.5 cups | 2 cups | 2.5 cups | 2.5 cups |"
    },
    {
      "type": "table",
      "section": "MyPlate",
      "line": 8982,
      "preview": "| Grains | 3 oz | 4 oz | 5 oz | 5 oz | 6 oz | 6 oz |"
    },
    {
      "type": "table",
      "section": "MyPlate",
      "line": 8983,
      "preview": "| Protein | 2 oz | 3 oz | 4 oz | 5 oz | 5 oz | 5.5 oz |"
    },
    {
      "type": "table",
      "section": "MyPlate",
      "line": 8984,
      "preview": "| Dairy | 2 cups | 2.5 cups | 2.5 cups | 3 cups | 3 cups | 3 cups |"
    },
    {
      "type": "text",
      "section": "MyPlate",
      "line": 8986,
      "preview": "Adapted from the US Department of Agriculture and US Department of Health and Human Services. Dietar"
    },
    {
      "type": "text",
      "section": "MyPlate",
      "line": 8987,
      "preview": "https://www.dietaryguidelines.gov/sites/default/files/2021-"
    },
    {
      "type": "text",
      "section": "MyPlate",
      "line": 8988,
      "preview": "03/Dietary_Guidelines_for_Americans-2020-2025.pdf"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "Traffic Light Diet",
      "line": 8990
    },
    {
      "type": "text",
      "section": "Traffic Light Diet",
      "line": 8992,
      "preview": "The Traffic Light Diet was designed to promote weight loss while being easy to follow for families. "
    },
    {
      "type": "text",
      "section": "Traffic Light Diet",
      "line": 8994,
      "preview": "--- page 468 ---"
    },
    {
      "type": "text",
      "section": "Traffic Light Diet",
      "line": 8996,
      "preview": "TABLE 25-5. Traffic Light Diet Guidelines ${ }^{\\text {a,b }}$"
    },
    {
      "type": "table",
      "section": "Traffic Light Diet",
      "line": 8998,
      "preview": "| Go (green) | - Foods you can eat as much as you like <br> - Foods <20 kcal/serving (vegetables) |"
    },
    {
      "type": "table",
      "section": "Traffic Light Diet",
      "line": 8999,
      "preview": "| :-- | :-- |"
    },
    {
      "type": "table",
      "section": "Traffic Light Diet",
      "line": 9000,
      "preview": "| Caution <br> (yellow) | - Foods to eat in moderate amounts <br> - Staple foods (protein, grain, fr"
    },
    {
      "type": "table",
      "section": "Traffic Light Diet",
      "line": 9001,
      "preview": "| Stop (red) | - Foods to be eaten rarely or occasionally <br> - Foods high in calories, sugar, or f"
    },
    {
      "type": "text",
      "section": "Traffic Light Diet",
      "line": 9003,
      "preview": "${ }^{a}$ Data from Freestone D. Childhood overweight and obesity: Efficacy and safety of popular di"
    },
    {
      "type": "text",
      "section": "Traffic Light Diet",
      "line": 9004,
      "preview": "${ }^{\\text {b }}$ Data from Epstein LH, Valoski A, Wing RR, McCurley J. Ten-year follow-up of behav"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "Weight Loss Medications for Treatment of Pediatric Obesity",
      "line": 9006
    },
    {
      "type": "text",
      "section": "Weight Loss Medications for Treatment of Pediatric Obesity",
      "line": 9008,
      "preview": "Weight loss through lifestyle changes alone is ideal; however, it has been shown to be less effectiv"
    },
    {
      "type": "heading",
      "level": 2,
      "section": "Weight Loss Surgery",
      "line": 9010
    },
    {
      "type": "text",
      "section": "Weight Loss Surgery",
      "line": 9012,
      "preview": "Because of lifestyle modifications having a modest effect on weight loss ${ }^{19}$, weight loss sur"
    },
    {
      "type": "text",
      "section": "Weight Loss Surgery",
      "line": 9014,
      "preview": "--- page 469 ---"
    },
    {
      "type": "text",
      "section": "Weight Loss Surgery",
      "line": 9016,
      "preview": "loss surgery, no data has shown these measurements are affected negatively by weight loss surgery, a"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "EXHIBIT 25-3. Indications and Contradictions for Adolescent Weight Loss Surgery",
      "line": 9018
    },
    {
      "type": "text",
      "section": "EXHIBIT 25-3. Indications and Contradictions for Adolescent Weight Loss Surgery",
      "line": 9020,
      "preview": "Indications for adolescent weight loss surgery:"
    },
    {
      "type": "text",
      "section": "EXHIBIT 25-3. Indications and Contradictions for Adolescent Weight Loss Surgery",
      "line": 9022,
      "preview": "- BMI $\\geq 35 \\mathrm{~kg} / \\mathrm{m} 2$ or $120 \\%$ of the 95 th percentile with a comorbidity ("
    },
    {
      "type": "text",
      "section": "EXHIBIT 25-3. Indications and Contradictions for Adolescent Weight Loss Surgery",
      "line": 9023,
      "preview": "- BMI $\\geq 40 \\mathrm{~kg} / \\mathrm{m} 2$ or $140 \\%$ of the 95 th percentile"
    },
    {
      "type": "text",
      "section": "EXHIBIT 25-3. Indications and Contradictions for Adolescent Weight Loss Surgery",
      "line": 9025,
      "preview": "Contraindications for adolescent weight loss surgery:"
    },
    {
      "type": "text",
      "section": "EXHIBIT 25-3. Indications and Contradictions for Adolescent Weight Loss Surgery",
      "line": 9027,
      "preview": "- Medically correctable cause of obesity"
    },
    {
      "type": "text",
      "section": "EXHIBIT 25-3. Indications and Contradictions for Adolescent Weight Loss Surgery",
      "line": 9028,
      "preview": "- Ongoing substance use (within previous year)"
    },
    {
      "type": "text",
      "section": "EXHIBIT 25-3. Indications and Contradictions for Adolescent Weight Loss Surgery",
      "line": 9029,
      "preview": "- A condition (medical, psychiatric, psychosocial, or cognitive) that prevents adherence with postop"
    },
    {
      "type": "text",
      "section": "EXHIBIT 25-3. Indications and Contradictions for Adolescent Weight Loss Surgery",
      "line": 9030,
      "preview": "- Current or planned pregnancy within 12-18 mo of surgery"
    },
    {
      "type": "text",
      "section": "EXHIBIT 25-3. Indications and Contradictions for Adolescent Weight Loss Surgery",
      "line": 9032,
      "preview": "Abbreviations: BMI, body mass index; HTN, hypertension; NAFLD, nonalcoholic fatty liver disease; OSA"
    },
    {
      "type": "text",
      "section": "EXHIBIT 25-3. Indications and Contradictions for Adolescent Weight Loss Surgery",
      "line": 9033,
      "preview": "Adapted with permission from the American Society for Metabolic and Bariatric Surgery from Pratt JSA"
    },
    {
      "type": "text",
      "section": "EXHIBIT 25-3. Indications and Contradictions for Adolescent Weight Loss Surgery",
      "line": 9035,
      "preview": "Under the Metabolic and Bariatric Surgery Accreditation and Quality Improvement Program, a multidisc"
    },
    {
      "type": "text",
      "section": "EXHIBIT 25-3. Indications and Contradictions for Adolescent Weight Loss Surgery",
      "line": 9037,
      "preview": "- Surgeon (experienced in weight loss surgery)"
    },
    {
      "type": "text",
      "section": "EXHIBIT 25-3. Indications and Contradictions for Adolescent Weight Loss Surgery",
      "line": 9038,
      "preview": "- Pediatric specialist (specialty in endocrinology, gastroenterology, nutrition, and/or adolescent m"
    },
    {
      "type": "text",
      "section": "EXHIBIT 25-3. Indications and Contradictions for Adolescent Weight Loss Surgery",
      "line": 9039,
      "preview": "- Registered dietitian"
    },
    {
      "type": "text",
      "section": "EXHIBIT 25-3. Indications and Contradictions for Adolescent Weight Loss Surgery",
      "line": 9040,
      "preview": "- Mental health specialist"
    },
    {
      "type": "text",
      "section": "EXHIBIT 25-3. Indications and Contradictions for Adolescent Weight Loss Surgery",
      "line": 9041,
      "preview": "- Coordinator (registered nurse, social worker, or team member responsible for coordinating care for"
    },
    {
      "type": "text",
      "section": "EXHIBIT 25-3. Indications and Contradictions for Adolescent Weight Loss Surgery",
      "line": 9042,
      "preview": "- Exercise physiology/physical therapist"
    },
    {
      "type": "text",
      "section": "EXHIBIT 25-3. Indications and Contradictions for Adolescent Weight Loss Surgery",
      "line": 9044,
      "preview": "--- page 470 ---"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "Diet Progression",
      "line": 9046
    },
    {
      "type": "text",
      "section": "Diet Progression",
      "line": 9048,
      "preview": "The diet advancement guidelines for weight loss surgery, including Roux-en-Y gastric bypass (RYGB) a"
    },
    {
      "type": "text",
      "section": "Diet Progression",
      "line": 9050,
      "preview": "--- page 471 ---"
    },
    {
      "type": "text",
      "section": "Diet Progression",
      "line": 9052,
      "preview": "TABLE 25-6. Postoperative Diet by Stages ${ }^{a}$"
    },
    {
      "type": "table",
      "section": "Diet Progression",
      "line": 9054,
      "preview": "| Stage | Diet <br> Advancement | Goals per Day |"
    },
    {
      "type": "table",
      "section": "Diet Progression",
      "line": 9055,
      "preview": "| :--: | :--: | :--: |"
    },
    {
      "type": "table",
      "section": "Diet Progression",
      "line": 9056,
      "preview": "| 1: Clear liquid (sugar free) | RYGB: $1 \\mathrm{oz} / \\mathrm{h}$ for the first 2448 h , then for "
    },
    {
      "type": "table",
      "section": "Diet Progression",
      "line": 9057,
      "preview": "| 2: High-protein full liquids | RYGB: wk 2-4 SG: wk 1-5 | Calories: 500-600 kcal <br> Protein: 60 g"
    },
    {
      "type": "table",
      "section": "Diet Progression",
      "line": 9058,
      "preview": "| 3: Smoothconsistency, high-protein foods | RYGB: wk 4-6 SG: wk 5-8 | Calories: 500-700 kcal/d <br>"
    },
    {
      "type": "text",
      "section": "Diet Progression",
      "line": 9060,
      "preview": "--- page 472 ---"
    },
    {
      "type": "table",
      "section": "Diet Progression",
      "line": 9062,
      "preview": "| Stage | Diet <br> Advancement | Goals per Day |"
    },
    {
      "type": "table",
      "section": "Diet Progression",
      "line": 9063,
      "preview": "| :--: | :--: | :--: |"
    },
    {
      "type": "table",
      "section": "Diet Progression",
      "line": 9064,
      "preview": "| 4: Soft foods | RYGB: wk 7-9 <br> SG: wk 9-12 | Calories: 700-800 kcal <br> Protein: 60 g <br> Flu"
    },
    {
      "type": "table",
      "section": "Diet Progression",
      "line": 9065,
      "preview": "| 5: Healthy <br> foods for <br> life | RYGB: begin <br> at wk 9 for life <br> SG: begin at <br> wk "
    },
    {
      "type": "text",
      "section": "Diet Progression",
      "line": 9067,
      "preview": "Abbreviations: RYGB, Roux-en-Y gastric bypass; SG, sleeve gastrectomy."
    },
    {
      "type": "text",
      "section": "Diet Progression",
      "line": 9068,
      "preview": "Adapted with permission from the European Society for Pediatric Gastroenterology, Hepatology, and Nu"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "Micronutrient Needs for Adolescents",
      "line": 9070
    },
    {
      "type": "text",
      "section": "Micronutrient Needs for Adolescents",
      "line": 9072,
      "preview": "There is a potential for deficiencies after weight loss surgery; therefore, adolescents will need to"
    },
    {
      "type": "text",
      "section": "Micronutrient Needs for Adolescents",
      "line": 9074,
      "preview": "--- page 473 ---"
    },
    {
      "type": "text",
      "section": "Micronutrient Needs for Adolescents",
      "line": 9076,
      "preview": "- Multivitamin-multimineral supplement"
    },
    {
      "type": "text",
      "section": "Micronutrient Needs for Adolescents",
      "line": 9077,
      "preview": "- Thiamin: 1.2 mg for male patients and 1.1 mg for female patients"
    },
    {
      "type": "text",
      "section": "Micronutrient Needs for Adolescents",
      "line": 9078,
      "preview": "- Folic acid: $400 \\mu \\mathrm{~g}$ for male and female patients"
    },
    {
      "type": "text",
      "section": "Micronutrient Needs for Adolescents",
      "line": 9079,
      "preview": "- Iron: 8 mg for male patients, 18 mg for female patients"
    },
    {
      "type": "text",
      "section": "Micronutrient Needs for Adolescents",
      "line": 9080,
      "preview": "- Copper: $900 \\mu \\mathrm{~g}$ for male and female patients"
    },
    {
      "type": "text",
      "section": "Micronutrient Needs for Adolescents",
      "line": 9081,
      "preview": "- Vitamin $\\mathrm{B}_{12}$"
    },
    {
      "type": "text",
      "section": "Micronutrient Needs for Adolescents",
      "line": 9082,
      "preview": "- Dosage: $350-500 \\mu \\mathrm{~g} / \\mathrm{d}$ as an oral, sublingual, or nasal supplement or $100"
    },
    {
      "type": "text",
      "section": "Micronutrient Needs for Adolescents",
      "line": 9083,
      "preview": "- Calcium"
    },
    {
      "type": "text",
      "section": "Micronutrient Needs for Adolescents",
      "line": 9084,
      "preview": "- Dose: 1200 mg"
    },
    {
      "type": "text",
      "section": "Micronutrient Needs for Adolescents",
      "line": 9085,
      "preview": "- Calcium citrate or carbonate and should include Vitamin D"
    },
    {
      "type": "text",
      "section": "Micronutrient Needs for Adolescents",
      "line": 9086,
      "preview": "- Vitamin $\\mathrm{D}_{3}$"
    },
    {
      "type": "text",
      "section": "Micronutrient Needs for Adolescents",
      "line": 9087,
      "preview": "- Dosage: $3000 \\mathrm{IU} / \\mathrm{d}$"
    },
    {
      "type": "text",
      "section": "Micronutrient Needs for Adolescents",
      "line": 9088,
      "preview": "- Elemental iron"
    },
    {
      "type": "text",
      "section": "Micronutrient Needs for Adolescents",
      "line": 9089,
      "preview": "- Dosage: iron in multivitamin possibly sufficient for some patients (males); 45$60 \\mathrm{mg} / \\m"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "Monitoring",
      "line": 9092
    },
    {
      "type": "text",
      "section": "Monitoring",
      "line": 9094,
      "preview": "Follow-up with the child or adolescent is essential to monitor and evaluate change. Data that can be"
    },
    {
      "type": "heading",
      "level": 2,
      "section": "References",
      "line": 9096
    },
    {
      "type": "text",
      "section": "References",
      "line": 9098,
      "preview": "1. Hales CM, Carroll MD, Fryar CD, Ogden CL. Prevalence of Obesity Among Adults and Youth: United St"
    },
    {
      "type": "text",
      "section": "References",
      "line": 9099,
      "preview": "2. Barlow SE; Expert Committee. Expert committee recommendations regarding the prevention, assessmen"
    },
    {
      "type": "text",
      "section": "References",
      "line": 9101,
      "preview": "--- page 474 ---"
    },
    {
      "type": "text",
      "section": "References",
      "line": 9103,
      "preview": "3. Daniels SR. The consequences of childhood overweight and obesity. Future Child. 2006;16(1):47-67."
    },
    {
      "type": "text",
      "section": "References",
      "line": 9104,
      "preview": "4. Freedman DS, Khan LK, Dietz WH, Srinivasan SR, Berenson GS. Relationship of childhood obesity to "
    },
    {
      "type": "text",
      "section": "References",
      "line": 9105,
      "preview": "5. Must A, Strauss RS. Risks and consequences of childhood and adolescent obesity. Int $J$ Obesity. "
    },
    {
      "type": "text",
      "section": "References",
      "line": 9106,
      "preview": "6. Puhl RM. Weight stigmatization toward youth: a significant problem in need of societal solutions."
    },
    {
      "type": "text",
      "section": "References",
      "line": 9107,
      "preview": "7. Styne DM, Arslanian SA, Connor EL, et al. Pediatric obesity - assessment, treatment, and preventi"
    },
    {
      "type": "text",
      "section": "References",
      "line": 9108,
      "preview": "8. Mei Z, Grummer-Strawn LM, Pietrobelli A, Goulding A, Goran MI, Dietz WH. Validity of body mass in"
    },
    {
      "type": "text",
      "section": "References",
      "line": 9109,
      "preview": "9. Kuczmarski RJ, Ogden CL, Grummer-Strawn LM, et al. CDC growth charts: United States. Adv Data. 20"
    },
    {
      "type": "text",
      "section": "References",
      "line": 9110,
      "preview": "10. Skinner AC, Ravanbakht SN, Skelton JA, Perrin EM, Armstrong SC. Prevalence of obesity and severe"
    },
    {
      "type": "text",
      "section": "References",
      "line": 9111,
      "preview": "11. Skinner AC, Perrin EM, Moss LA, Skelton JA. Cardiometabolic risks and severity of obesity in chi"
    },
    {
      "type": "text",
      "section": "References",
      "line": 9112,
      "preview": "12. Krebs NF, Himes JH, Jacobson D, Nicklas TA, Guilday P, Styne D. Assessment of child and adolesce"
    },
    {
      "type": "text",
      "section": "References",
      "line": 9113,
      "preview": "13. Mullen MC, Shield J. Academy of Nutrition and Dietetics Pocket Guide to Pediatric Weight Managem"
    },
    {
      "type": "text",
      "section": "References",
      "line": 9114,
      "preview": "14. Spear BA, Barlow SE, Ervin C, et al. Recommendations for treatment of child and adolescent overw"
    },
    {
      "type": "text",
      "section": "References",
      "line": 9115,
      "preview": "15. Freestone D. Childhood overweight and obesity: Efficacy and safety of popular diets and weight c"
    },
    {
      "type": "text",
      "section": "References",
      "line": 9116,
      "preview": "16. Institute of Medicine. Dietary Reference Intake for Energy, Carbohydrates, Fat, Fatty Acids, Cho"
    },
    {
      "type": "text",
      "section": "References",
      "line": 9117,
      "preview": "17. US Department of Agriculture; US Department of Health and Human Services. Dietary Guidelines for"
    },
    {
      "type": "text",
      "section": "References",
      "line": 9119,
      "preview": "--- page 475 ---"
    },
    {
      "type": "text",
      "section": "References",
      "line": 9121,
      "preview": "18. Epstein LH, Valoski A, Wing RR, McCurley J. Ten-year follow-up of behavioral, familybased treatm"
    },
    {
      "type": "text",
      "section": "References",
      "line": 9122,
      "preview": "19. Johnston CA, Tyler C, Palcic JL, Stansberry SA, Gallagher MR, Foreyt JP. Smaller weight changes "
    },
    {
      "type": "text",
      "section": "References",
      "line": 9123,
      "preview": "20. Pratt JSA, Browne A, Browne NT, et al. ASMBS pediatric metabolic and bariatric surgery guideline"
    },
    {
      "type": "text",
      "section": "References",
      "line": 9124,
      "preview": "21. Alqahtani A, Elahmedi M, Al Qahtani AR. Laparoscopic sleeve gastrectomy in children younger than"
    },
    {
      "type": "text",
      "section": "References",
      "line": 9125,
      "preview": "22. Fullmer MA, Abrams SH, Hrovat K, et al; National Association of Children's Hospitals and Related"
    },
    {
      "type": "text",
      "section": "References",
      "line": 9126,
      "preview": "23. Cummings S, Ison KA. Academy of Nutrition and Dietetics Pocket Guide to Bariatric Surgery. 2nd e"
    },
    {
      "type": "text",
      "section": "References",
      "line": 9128,
      "preview": "--- page 476 ---"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "Additional Resources: ASPEN Endorsed Pediatric Guidelines, Consensus Recommendations, and Other Documents",
      "line": 9130
    },
    {
      "type": "heading",
      "level": 2,
      "section": "Guidelines",
      "line": 9132
    },
    {
      "type": "text",
      "section": "Guidelines",
      "line": 9134,
      "preview": "Clinical Guidelines are systematically developed statements to assist practitioner and patient decis"
    },
    {
      "type": "heading",
      "level": 2,
      "section": "Intensive care",
      "line": 9136
    },
    {
      "type": "text",
      "section": "Intensive care",
      "line": 9138,
      "preview": "2017 Guidelines for the Provision and Assessment of Nutrition Support Therapy in the Pediatric Criti"
    },
    {
      "type": "heading",
      "level": 2,
      "section": "Neonatal",
      "line": 9140
    },
    {
      "type": "text",
      "section": "Neonatal",
      "line": 9142,
      "preview": "2013 ASPEN Clinical Guidelines: Nutrition Support of Neonatal Patients at Risk for Metabolic Bone Di"
    },
    {
      "type": "text",
      "section": "Neonatal",
      "line": 9143,
      "preview": "2012 ASPEN Clinical Guidelines: Nutrition Support of Neonatal Patients at Risk for Necrotizing Enter"
    },
    {
      "type": "text",
      "section": "Neonatal",
      "line": 9144,
      "preview": "2012 ASPEN Clinical Guidelines: Hyperglycemia and Hypoglycemia in the Neonate Receiving Parenteral N"
    },
    {
      "type": "text",
      "section": "Neonatal",
      "line": 9146,
      "preview": "--- page 477 ---"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "Parenteral Nutrition",
      "line": 9148
    },
    {
      "type": "text",
      "section": "Parenteral Nutrition",
      "line": 9150,
      "preview": "2014 ASPEN Clinical Guidelines: Parenteral Nutrition Ordering, Order Review, Compounding, Labeling, "
    },
    {
      "type": "heading",
      "level": 2,
      "section": "Intestinal Failure",
      "line": 9152
    },
    {
      "type": "text",
      "section": "Intestinal Failure",
      "line": 9154,
      "preview": "2014 ASPEN Clinical Guidelines: Support of Pediatric Patients with Intestinal Failure at Risk of Par"
    },
    {
      "type": "heading",
      "level": 2,
      "section": "General Nutrition Support",
      "line": 9156
    },
    {
      "type": "text",
      "section": "General Nutrition Support",
      "line": 9158,
      "preview": "2012 Clinical Guidelines for the Use of Parenteral and Enteral Nutrition in Adult and Pediatric Pati"
    },
    {
      "type": "text",
      "section": "General Nutrition Support",
      "line": 9159,
      "preview": "2010 Nutrition Support of Hospitalized Pediatric Patients with Obesity JPEN J Paren Ent Nutr. 2010;3"
    },
    {
      "type": "text",
      "section": "General Nutrition Support",
      "line": 9160,
      "preview": "2009 Clinical Guidelines for the Use of Parenteral and Enteral Nutrition in Adult and Pediatric Pati"
    },
    {
      "type": "heading",
      "level": 2,
      "section": "Consensus Recommendations",
      "line": 9162
    },
    {
      "type": "text",
      "section": "Consensus Recommendations",
      "line": 9164,
      "preview": "Consensus Recommendations answer questions for which the level of evidence in the literature did not"
    },
    {
      "type": "text",
      "section": "Consensus Recommendations",
      "line": 9165,
      "preview": "https://www.nutritioncare.org/Guidelines_and_Clinical_Resources/Clinic al_Practice_Library/Consensus"
    },
    {
      "type": "text",
      "section": "Consensus Recommendations",
      "line": 9167,
      "preview": "--- page 478 ---"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "Parenteral Nutrition",
      "line": 9169
    },
    {
      "type": "text",
      "section": "Parenteral Nutrition",
      "line": 9171,
      "preview": "ASPEN lipid injectable emulsion safety recommendations part 2: Neonate and pediatric considerations "
    },
    {
      "type": "text",
      "section": "Parenteral Nutrition",
      "line": 9172,
      "preview": "Standardized Competencies for Parenteral Nutrition Order Review and Parenteral Nutrition Preparation"
    },
    {
      "type": "text",
      "section": "Parenteral Nutrition",
      "line": 9173,
      "preview": "Standardized Competencies for Parenteral Nutrition Prescribing: The American Society for Parenteral "
    },
    {
      "type": "text",
      "section": "Parenteral Nutrition",
      "line": 9174,
      "preview": "Standardized Competencies for Parenteral Nutrition Prescribing: The American Society for Parenteral "
    },
    {
      "type": "text",
      "section": "Parenteral Nutrition",
      "line": 9175,
      "preview": "PN Safety Consensus Recommendations. JPEN. 2014;38(3):296-333. https://doi.org/10.1177/0148607113511"
    },
    {
      "type": "heading",
      "level": 2,
      "section": "Malnutrition",
      "line": 9177
    },
    {
      "type": "text",
      "section": "Malnutrition",
      "line": 9179,
      "preview": "Consensus Statement of the Academy of Nutrition and Dietetics/American Society for Parenteral and En"
    },
    {
      "type": "heading",
      "level": 2,
      "section": "General Nutrition Support",
      "line": 9181
    },
    {
      "type": "text",
      "section": "General Nutrition Support",
      "line": 9183,
      "preview": "Nutritional care is a human right: Translating principles to clinical practice. Nutr Clin Pract. 202"
    },
    {
      "type": "text",
      "section": "General Nutrition Support",
      "line": 9185,
      "preview": "ASPEN Consensus Recommendations for Refeeding Syndrome Nutr Clin Pract. 2020;35(2):178-195. https://"
    },
    {
      "type": "text",
      "section": "General Nutrition Support",
      "line": 9186,
      "preview": "Consensus Recommendations for Optimizing Electronic Health Records for Nutrition Care. Nutr Clin Pra"
    },
    {
      "type": "text",
      "section": "General Nutrition Support",
      "line": 9187,
      "preview": "ASPEN Safe Practices for Enteral Nutrition Therapy. JPEN J Paren Ent Nutr. 2017;41(1):15103. https:/"
    },
    {
      "type": "heading",
      "level": 2,
      "section": "Position Papers",
      "line": 9189
    },
    {
      "type": "text",
      "section": "Position Papers",
      "line": 9191,
      "preview": "Position papers present the official opinion of ASPEN on a particular topic. These papers include a "
    },
    {
      "type": "text",
      "section": "Position Papers",
      "line": 9193,
      "preview": "--- page 479 ---"
    },
    {
      "type": "text",
      "section": "Position Papers",
      "line": 9195,
      "preview": "https://www.nutritioncare.org/Guidelines_and_Clinical_Resources/Clinic al_Practice_Library/Position_"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "Neonatal",
      "line": 9197
    },
    {
      "type": "text",
      "section": "Neonatal",
      "line": 9199,
      "preview": "Recommendations for Photoprotection of Parenteral Nutrition for Neonates and Premature Infants: An A"
    },
    {
      "type": "heading",
      "level": 2,
      "section": "Parenteral Nutrition",
      "line": 9201
    },
    {
      "type": "text",
      "section": "Parenteral Nutrition",
      "line": 9203,
      "preview": "Update on the Use of Filters for Parenteral Nutrition: An ASPEN Position Paper. Nutr Clin Pract. 202"
    },
    {
      "type": "text",
      "section": "Parenteral Nutrition",
      "line": 9204,
      "preview": "ASPEN Position Paper: Recommendations for Changes in Commercially Available Parenteral Multivitamin "
    },
    {
      "type": "text",
      "section": "Parenteral Nutrition",
      "line": 9205,
      "preview": "ASPEN Clinical Role for Alternative Intravenous Fat Emulsions Adopted by the Academy of Nutrition an"
    },
    {
      "type": "text",
      "section": "Parenteral Nutrition",
      "line": 9206,
      "preview": "A.S.P.E.N. Position Paper: Parenteral Nutrition Glutamine Supplementation Adopted by the Academy of "
    },
    {
      "type": "heading",
      "level": 2,
      "section": "General Nutrition Support",
      "line": 9208
    },
    {
      "type": "text",
      "section": "General Nutrition Support",
      "line": 9210,
      "preview": "Ethical Aspects of Artificially Administered Nutrition and Hydration: An ASPEN Position Paper. Nutr "
    },
    {
      "type": "text",
      "section": "General Nutrition Support",
      "line": 9211,
      "preview": "The Use of Visceral Proteins as Nutrition Markers: An ASPEN Position Paper. Nutr Clin Pract. 2020, p"
    },
    {
      "type": "text",
      "section": "General Nutrition Support",
      "line": 9212,
      "preview": "The State of Nutrition Support Teams and Update on Current Models for Providing Nutrition Support Th"
    },
    {
      "type": "text",
      "section": "General Nutrition Support",
      "line": 9213,
      "preview": "Advocacy and Public Policy Special Report: Disease-Related Malnutrition and Enteral Nutrition Therap"
    },
    {
      "type": "heading",
      "level": 2,
      "section": "Practice Standards",
      "line": 9215
    },
    {
      "type": "text",
      "section": "Practice Standards",
      "line": 9217,
      "preview": "--- page 480 ---"
    },
    {
      "type": "text",
      "section": "Practice Standards",
      "line": 9219,
      "preview": "https://www.nutritioncare.org/Guidelines_and_Clinical_Resources/Clinical_Practice_Library/S tandards"
    },
    {
      "type": "text",
      "section": "Practice Standards",
      "line": 9220,
      "preview": "2021 Academy of Nutrition and Dietetics and American Society for Parenteral and Enteral Nutrition: R"
    },
    {
      "type": "text",
      "section": "Practice Standards",
      "line": 9221,
      "preview": "2016 Standards of Nutrition Care Practice and Professional Performance for Nutrition Support and Gen"
    },
    {
      "type": "text",
      "section": "Practice Standards",
      "line": 9222,
      "preview": "2015 American Society for Parenteral and Enteral Nutrition (ASPEN) Standards of Practice for Nutriti"
    },
    {
      "type": "text",
      "section": "Practice Standards",
      "line": 9223,
      "preview": "2013 Standards for Nutrition Support: Pediatric Hospitalized Patients. https://doi.org/10.1177/08845"
    },
    {
      "type": "text",
      "section": "Practice Standards",
      "line": 9224,
      "preview": "2012 Standards of Practice for Nutrition Support Physicians. https://doi.org/10.1177/088453361243828"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "Special Reports",
      "line": 9226
    },
    {
      "type": "text",
      "section": "Special Reports",
      "line": 9228,
      "preview": "Documents that present ASPEN generated clinical, research, or public policy information or findings "
    },
    {
      "type": "heading",
      "level": 2,
      "section": "Intestinal Failure",
      "line": 9230
    },
    {
      "type": "text",
      "section": "Intestinal Failure",
      "line": 9232,
      "preview": "2021 ASPEN Definitions in Pediatric Intestinal Failure. https://doi.org/10.1002/jpen. 2232"
    },
    {
      "type": "heading",
      "level": 2,
      "section": "General Nutrition Support",
      "line": 9234
    },
    {
      "type": "text",
      "section": "General Nutrition Support",
      "line": 9236,
      "preview": "2018 Definition of Terms, Style and Conventions Used in ASPEN Board of DirectorsApproved"
    },
    {
      "type": "text",
      "section": "General Nutrition Support",
      "line": 9238,
      "preview": "Documents. https://www.nutritioncare.org/uploadedFiles/Documents/Guidelines_and_Clinical_Resour ces/"
    },
    {
      "type": "text",
      "section": "General Nutrition Support",
      "line": 9239,
      "preview": "Resources for the Provision of Nutrition Support to Children in Educational Environments. Nutr Clin "
    },
    {
      "type": "heading",
      "level": 2,
      "section": "ASPEN Endorsed Documents",
      "line": 9241
    },
    {
      "type": "text",
      "section": "ASPEN Endorsed Documents",
      "line": 9243,
      "preview": "--- page 481 ---"
    },
    {
      "type": "text",
      "section": "ASPEN Endorsed Documents",
      "line": 9245,
      "preview": "ASPEN endorses these key resources from other organizations that are in line with our mission and sc"
    },
    {
      "type": "text",
      "section": "ASPEN Endorsed Documents",
      "line": 9247,
      "preview": "Evidence-Based Strategies and Recommendations for Preservation of Central Venous Access in Children."
    }
  ],
  "images": [
    {
      "sha_name": "37eeb497adc74299.png",
      "original_ref": "img-0.jpeg",
      "page": 37,
      "relative_path": "images/37eeb497adc74299.png",
      "absolute_path": "/Users/cv/Desktop/MistralOCR RAG/data/parsed/ASPEN Pediatric Neonatal Nutrition Handbook 3rd Edition/images/37eeb497adc74299.png",
      "bbox": {
        "x": 0.0,
        "y": 0.0,
        "w": 0.0,
        "h": 0.0
      },
      "caption": "",
      "hash": "37eeb497adc74299"
    },
    {
      "sha_name": "97a7a5524c7b4785.png",
      "original_ref": "img-1.jpeg",
      "page": 38,
      "relative_path": "images/97a7a5524c7b4785.png",
      "absolute_path": "/Users/cv/Desktop/MistralOCR RAG/data/parsed/ASPEN Pediatric Neonatal Nutrition Handbook 3rd Edition/images/97a7a5524c7b4785.png",
      "bbox": {
        "x": 0.0,
        "y": 0.0,
        "w": 0.0,
        "h": 0.0
      },
      "caption": "",
      "hash": "97a7a5524c7b4785"
    },
    {
      "sha_name": "31cb07498dae0b63.png",
      "original_ref": "img-2.jpeg",
      "page": 39,
      "relative_path": "images/31cb07498dae0b63.png",
      "absolute_path": "/Users/cv/Desktop/MistralOCR RAG/data/parsed/ASPEN Pediatric Neonatal Nutrition Handbook 3rd Edition/images/31cb07498dae0b63.png",
      "bbox": {
        "x": 0.0,
        "y": 0.0,
        "w": 0.0,
        "h": 0.0
      },
      "caption": "",
      "hash": "31cb07498dae0b63"
    },
    {
      "sha_name": "598a13bc1afd8de9.png",
      "original_ref": "img-3.jpeg",
      "page": 40,
      "relative_path": "images/598a13bc1afd8de9.png",
      "absolute_path": "/Users/cv/Desktop/MistralOCR RAG/data/parsed/ASPEN Pediatric Neonatal Nutrition Handbook 3rd Edition/images/598a13bc1afd8de9.png",
      "bbox": {
        "x": 0.0,
        "y": 0.0,
        "w": 0.0,
        "h": 0.0
      },
      "caption": "",
      "hash": "598a13bc1afd8de9"
    },
    {
      "sha_name": "1efd974d1d479d0a.png",
      "original_ref": "img-4.jpeg",
      "page": 56,
      "relative_path": "images/1efd974d1d479d0a.png",
      "absolute_path": "/Users/cv/Desktop/MistralOCR RAG/data/parsed/ASPEN Pediatric Neonatal Nutrition Handbook 3rd Edition/images/1efd974d1d479d0a.png",
      "bbox": {
        "x": 0.0,
        "y": 0.0,
        "w": 0.0,
        "h": 0.0
      },
      "caption": "",
      "hash": "1efd974d1d479d0a"
    },
    {
      "sha_name": "af0f796d36132aa6.png",
      "original_ref": "img-5.jpeg",
      "page": 89,
      "relative_path": "images/af0f796d36132aa6.png",
      "absolute_path": "/Users/cv/Desktop/MistralOCR RAG/data/parsed/ASPEN Pediatric Neonatal Nutrition Handbook 3rd Edition/images/af0f796d36132aa6.png",
      "bbox": {
        "x": 0.0,
        "y": 0.0,
        "w": 0.0,
        "h": 0.0
      },
      "caption": "",
      "hash": "af0f796d36132aa6"
    },
    {
      "sha_name": "1293d58c6dff208b.png",
      "original_ref": "img-6.jpeg",
      "page": 91,
      "relative_path": "images/1293d58c6dff208b.png",
      "absolute_path": "/Users/cv/Desktop/MistralOCR RAG/data/parsed/ASPEN Pediatric Neonatal Nutrition Handbook 3rd Edition/images/1293d58c6dff208b.png",
      "bbox": {
        "x": 0.0,
        "y": 0.0,
        "w": 0.0,
        "h": 0.0
      },
      "caption": "",
      "hash": "1293d58c6dff208b"
    },
    {
      "sha_name": "9f2f7438aacc3b5b.png",
      "original_ref": "img-7.jpeg",
      "page": 115,
      "relative_path": "images/9f2f7438aacc3b5b.png",
      "absolute_path": "/Users/cv/Desktop/MistralOCR RAG/data/parsed/ASPEN Pediatric Neonatal Nutrition Handbook 3rd Edition/images/9f2f7438aacc3b5b.png",
      "bbox": {
        "x": 0.0,
        "y": 0.0,
        "w": 0.0,
        "h": 0.0
      },
      "caption": "",
      "hash": "9f2f7438aacc3b5b"
    },
    {
      "sha_name": "5459020903f860ef.png",
      "original_ref": "img-8.jpeg",
      "page": 118,
      "relative_path": "images/5459020903f860ef.png",
      "absolute_path": "/Users/cv/Desktop/MistralOCR RAG/data/parsed/ASPEN Pediatric Neonatal Nutrition Handbook 3rd Edition/images/5459020903f860ef.png",
      "bbox": {
        "x": 0.0,
        "y": 0.0,
        "w": 0.0,
        "h": 0.0
      },
      "caption": "",
      "hash": "5459020903f860ef"
    },
    {
      "sha_name": "71b18c5337391a90.png",
      "original_ref": "img-9.jpeg",
      "page": 170,
      "relative_path": "images/71b18c5337391a90.png",
      "absolute_path": "/Users/cv/Desktop/MistralOCR RAG/data/parsed/ASPEN Pediatric Neonatal Nutrition Handbook 3rd Edition/images/71b18c5337391a90.png",
      "bbox": {
        "x": 0.0,
        "y": 0.0,
        "w": 0.0,
        "h": 0.0
      },
      "caption": "",
      "hash": "71b18c5337391a90"
    },
    {
      "sha_name": "b5f666a73590ed61.png",
      "original_ref": "img-10.jpeg",
      "page": 269,
      "relative_path": "images/b5f666a73590ed61.png",
      "absolute_path": "/Users/cv/Desktop/MistralOCR RAG/data/parsed/ASPEN Pediatric Neonatal Nutrition Handbook 3rd Edition/images/b5f666a73590ed61.png",
      "bbox": {
        "x": 0.0,
        "y": 0.0,
        "w": 0.0,
        "h": 0.0
      },
      "caption": "",
      "hash": "b5f666a73590ed61"
    },
    {
      "sha_name": "56eb62278a50f3ad.png",
      "original_ref": "img-11.jpeg",
      "page": 271,
      "relative_path": "images/56eb62278a50f3ad.png",
      "absolute_path": "/Users/cv/Desktop/MistralOCR RAG/data/parsed/ASPEN Pediatric Neonatal Nutrition Handbook 3rd Edition/images/56eb62278a50f3ad.png",
      "bbox": {
        "x": 0.0,
        "y": 0.0,
        "w": 0.0,
        "h": 0.0
      },
      "caption": "",
      "hash": "56eb62278a50f3ad"
    }
  ],
  "extraction": {
    "ocr_model": "mistral-ocr-latest",
    "request_id": "local-1754696388",
    "ts": "2025-08-08T23:39:48.672892+00:00"
  }
}